Citrus Sinensis ID: 042887
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 628 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.742 | 0.461 | 0.407 | 6e-91 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.710 | 0.432 | 0.402 | 9e-87 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.724 | 0.443 | 0.405 | 2e-82 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.694 | 0.444 | 0.346 | 5e-61 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.711 | 0.381 | 0.337 | 2e-58 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.684 | 0.376 | 0.336 | 6e-55 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.640 | 0.354 | 0.344 | 4e-54 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.675 | 0.338 | 0.329 | 9e-52 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.632 | 0.357 | 0.328 | 6e-51 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.652 | 0.372 | 0.318 | 8e-51 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 200/491 (40%), Positives = 295/491 (60%), Gaps = 25/491 (5%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L L +++ N + GK P + N + LE + +S N L G IP + QL + L +
Sbjct: 160 SLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVA 219
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
NNFS P +++N+SSL+++ + N F G L ++G +PN+ ++G N FTGS+P +
Sbjct: 220 NNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTL 279
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
SN S L+ L + +N+ +G + F + NL LFL N+LG++S+ DL+FLT LTNC+Q+
Sbjct: 280 SNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQL 338
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
E L + N+ GG SIANLSAK+ + +G ISG+IP +I NL+N+ ++ N L+
Sbjct: 339 ETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLS 398
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
G +P ++G+L NL+ L+L N L G IP +GN+T+L L L N +G VP+SLGNC +
Sbjct: 399 GPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSH 458
Query: 460 L------------------MTLSRL--LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
L M + +L LD+SGN L GS+P ++G L+NL L +N S
Sbjct: 459 LLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLS 518
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
++P TL C T+E L L+GN F G +P LK L +KE+DLS N+LSG IP+Y +
Sbjct: 519 GKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSK 577
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRI--- 616
L YLNLS+N+ EG+VP KG+F N T + ++GN LCGG+ L C P + +
Sbjct: 578 LEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSS 637
Query: 617 TLLKVVIPVAV 627
L KVVI V+V
Sbjct: 638 RLKKVVIGVSV 648
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 9e-87, Method: Compositional matrix adjust.
Identities = 188/467 (40%), Positives = 278/467 (59%), Gaps = 21/467 (4%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L KL ++D+ N L G FP + N ++L+ +D + N + G IPD + +L + + I+
Sbjct: 167 SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIAL 226
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N+FS P +++NISSLE +SL N F G+L + G+ +PN+ L +G N FTG++P +
Sbjct: 227 NSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTL 286
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
+N S+L+ D+ N+ SG + + F +L NL L + N+LG S+S L+F+ + NC+Q+
Sbjct: 287 ANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQL 346
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
E L + N+ GG SIANLS +T + +G N ISGTIP +I NLV++ +E N L+
Sbjct: 347 EYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLS 406
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
G +P + G+L NLQ + L N++ G IP GN+T L +L L N+ G +P SLG C+
Sbjct: 407 GELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRY 466
Query: 460 LMTL----SRL----------------LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
L+ L +RL +DLS N L G P EVG L L S N S
Sbjct: 467 LLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLS 526
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
++P + C ++E+L +QGNSF G++P + L S+K +D S NNLSG+IP+YL +L
Sbjct: 527 GKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPS 585
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
L LNLS N FEG VP GVF N T + + GN +CGG+ E+ L C
Sbjct: 586 LRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPC 632
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 194/478 (40%), Positives = 289/478 (60%), Gaps = 23/478 (4%)
Query: 170 GDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLS 229
G N L GKFP + N ++L+ +D N + G IP + +L+ + + I+ N F+ P
Sbjct: 185 GRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPP 244
Query: 230 IWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLD 289
I+N+SSL +S+ N F G+L + G +PN+ L +G N+FTG++P + SN S+L+ LD
Sbjct: 245 IYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLD 304
Query: 290 VYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF 349
+ NH +G++ + F RL NL L L+ N+LG S+ DLDFL LTNCSQ++ L + NK
Sbjct: 305 IPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKL 364
Query: 350 GGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGEL 409
GG IANLS ++T + +G N ISG+IP I NLV++ + N LTG +P ++GEL
Sbjct: 365 GGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGEL 424
Query: 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLS----- 464
L+ + L N L G IP +LGN++ L L+L N+ +G++PSSLG+C L+ L+
Sbjct: 425 SELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNK 484
Query: 465 ---------------RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSAC 509
+L++S NLL G + ++G L+ L D+S N S +IP TL+ C
Sbjct: 485 LNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANC 544
Query: 510 TTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
+LE+L LQGNSF G +P ++ L ++ LDLS+NNLSG IP+Y+ N L LNLS N+
Sbjct: 545 LSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNN 603
Query: 570 FEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRITLLKVVIPVAV 627
F+G VP +GVF N + + + GN LCGG+ L L C PR R + ++ +I + V
Sbjct: 604 FDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPR--RHSSVRKIITICV 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 172/497 (34%), Positives = 251/497 (50%), Gaps = 61/497 (12%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANF-SALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
NL L ++D+ N +GK P I + L+ + +S N+L G IP L L L YL +
Sbjct: 88 NLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLG 147
Query: 219 ENNFSCKLPLSIW---NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL 275
N + +P+ ++ + SSL+ I L +N G +PLN ++ + FL + N TG++
Sbjct: 148 SNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTV 207
Query: 276 PHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTES--TSDLDFLTL 332
P S SN++NL+ +D+ N SG++ +++ L L+LS N+ + + T+ F
Sbjct: 208 PSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFAS 267
Query: 333 LTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI---------- 382
L N S ++ L L N GG S+ +LS + I + N+I G+IP EI
Sbjct: 268 LANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLN 327
Query: 383 -----------KNLVNINAFGVEY---NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPD 428
+ L ++ Y N LTG IP +G++ L L + RN+L G+IPD
Sbjct: 328 LSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPD 387
Query: 429 TLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRN 487
+ GNL+ L RL L N+L G VP SLG C NL +LDLS N L G+IP+EV NLRN
Sbjct: 388 SFGNLSQLRRLLLYGNHLSGTVPQSLGKCINL----EILDLSHNNLTGTIPVEVVSNLRN 443
Query: 488 LAEF-------------------------DLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522
L + DLS N S +IP L +C LE+L+L N F
Sbjct: 444 LKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGF 503
Query: 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
S +LP SL L +KELD+S N L+G IP + L +LN S+N G V KG F
Sbjct: 504 SSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSK 563
Query: 583 RTGIHLIGNERLCGGLE 599
T +G+ LCG ++
Sbjct: 564 LTIESFLGDSLLCGSIK 580
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 165/489 (33%), Positives = 249/489 (50%), Gaps = 42/489 (8%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L LE++ + N G+FP I N L + + N + G +P L L +L LS +N
Sbjct: 335 LESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDN 394
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
+ +P SI N + L+++ L N+ G +P GF N+ F+S+G+N+FTG +P
Sbjct: 395 LLTGPIPSSISNCTGLKLLDLSHNQMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIF 452
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
N SNL+ L V N+ +G +K +L L L +S N+L ++ N +
Sbjct: 453 NCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIG------NLKDLN 506
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
+LYL++N F G R ++NL+ + + M N + G IP E+ ++ ++ + N+ +G
Sbjct: 507 ILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSG 565
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
IP +L++L L+L N G+IP +L +L+LLN + N L G +P L +L
Sbjct: 566 QIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGEL--LASL 623
Query: 461 MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT---TLEY--- 514
+ L+ S NLL G+IP E+G L + E DLS N FS IP +L AC TL++
Sbjct: 624 KNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQN 683
Query: 515 -------------------LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE 555
L+L NSFSG +P S + + LDLS NNL+G+IP+ L
Sbjct: 684 NLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLA 743
Query: 556 NLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEEL-----HLPSCHFG- 609
NL L +L L+ N+ +G VP GVF N L+GN LCG + L S HF
Sbjct: 744 NLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSK 803
Query: 610 RPRITRITL 618
R R+ I L
Sbjct: 804 RTRVILIIL 812
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 155/460 (33%), Positives = 232/460 (50%), Gaps = 30/460 (6%)
Query: 164 LEMIDVGDNQLI-GKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNF 222
LE+I +G N+ I G+ P I + S L + ++ + G +P SL +L+ L LSI
Sbjct: 203 LEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMI 262
Query: 223 SCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNA 282
S ++P + N S L + L+ N GS+P IG + + L + QN+ G +P N
Sbjct: 263 SGEIPSDLGNCSELVDLFLYENSLSGSIPREIG-QLTKLEQLFLWQNSLVGGIPEEIGNC 321
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
SNL+++D+ N SG + RLS L +S N T ++NCS + L
Sbjct: 322 SNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGS------IPTTISNCSSLVQL 375
Query: 343 YLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTI 402
L+ N+ G+ + L+ K+T+ NQ+ G+IP + + ++ A + N LTGTI
Sbjct: 376 QLDKNQISGLIPSELGTLT-KLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTI 434
Query: 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMT 462
P + L+NL L L+ NSL G IP +GN + L RL LGFN + G +PS +G+ + +
Sbjct: 435 PSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINF 494
Query: 463 LS--------------------RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEI 502
L +++DLS N L GS+P V +L L D+S N FS +I
Sbjct: 495 LDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKI 554
Query: 503 PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAY 562
P +L +L L L N FSGS+P SL ++ LDL N LSG+IP L ++ L
Sbjct: 555 PASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEI 614
Query: 563 -LNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEEL 601
LNLS N G++P K N+ I + + L G L L
Sbjct: 615 ALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPL 654
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 143/415 (34%), Positives = 218/415 (52%), Gaps = 13/415 (3%)
Query: 164 LEMIDVGDN-QLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNF 222
LE I G N +L GK P+ I N L+ + ++A + G +P SL QL L LS+
Sbjct: 204 LESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTML 263
Query: 223 SCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNA 282
S ++P + N S L + L+ N G+LP +G + N+ + + QNN G +P
Sbjct: 264 SGEIPKELGNCSELINLFLYDNDLSGTLPKELG-KLQNLEKMLLWQNNLHGPIPEEIGFM 322
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
+L +D+ N+FSG + F LSNL L LS NN+ S +L+NC+++
Sbjct: 323 KSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPS------ILSNCTKLVQF 376
Query: 343 YLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTI 402
++ N+ G+ I L +G N++ G IP E+ N+ A + N LTG++
Sbjct: 377 QIDANQISGLIPPEIGLLKELNIFLGW-QNKLEGNIPDELAGCQNLQALDLSQNYLTGSL 435
Query: 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMT 462
P + +L+NL L L+ N++ G IP +GN T L RL L N + G +P +G QNL
Sbjct: 436 PAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNL-- 493
Query: 463 LSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522
LDLS N L G +PLE+ N R L +LS N +P++LS+ T L+ L + N
Sbjct: 494 --SFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDL 551
Query: 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577
+G +P SL L S+ L LS+N+ +G+IP L + L L+LS N+ G +P +
Sbjct: 552 TGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEE 606
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 205 bits (521), Expect = 9e-52, Method: Compositional matrix adjust.
Identities = 153/465 (32%), Positives = 234/465 (50%), Gaps = 41/465 (8%)
Query: 152 NLGLIQRLNLLK-LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLR 210
N L LN LK L+ +++GDN G+ P + + +++ +++ N L G IP L +L
Sbjct: 229 NGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELA 288
Query: 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNN 270
+L L +S NN + + W ++ LE + L NR GSLP I N ++ L + +
Sbjct: 289 NLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQ 348
Query: 271 FTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL-GTESTS---- 325
+G +P SN +L++LD+ N +GQ+ +L L+ L+L+ N+L GT S+S
Sbjct: 349 LSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNL 408
Query: 326 -DLDFLTLLTN------------CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372
+L TL N ++E++YL N+F G I N + ++ I N
Sbjct: 409 TNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCT-RLQEIDWYGN 467
Query: 373 QISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGN 432
++SG IPS I L ++ + N+L G IP ++G + + L N L G+IP + G
Sbjct: 468 RLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGF 527
Query: 433 LTLLNRLFLGFNN-LQGNVPSSLGNCQNLM-----------TLSRL--------LDLSGN 472
LT L LF+ +NN LQGN+P SL N +NL ++S L D++ N
Sbjct: 528 LTAL-ELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTEN 586
Query: 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKT 532
G IPLE+G NL L +N F+ IP T + L L + NS SG +P+ L
Sbjct: 587 GFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGL 646
Query: 533 LKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577
K + +DL+ N LSG IP +L L L L LS N F G +P +
Sbjct: 647 CKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTE 691
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 151/459 (32%), Positives = 217/459 (47%), Gaps = 62/459 (13%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L KL+ + + N G+ P + ++ + + N L G IP L L L YL + N
Sbjct: 307 LTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTN 366
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
N S ++PLSIW I SL+ + L+ N G LP+++ + + L++ +N+FTG +P
Sbjct: 367 NLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMT-ELKQLVSLALYENHFTGVIPQDLG 425
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
S+L+VLD+ +N F+G + + L RL L N L SDL CS +E
Sbjct: 426 ANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLG------GCSTLE 479
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
L L +N + G +P ++ N+ F + N TG
Sbjct: 480 RLILE-------------------------ENNLRGGLPDFVEK-QNLLFFDLSGNNFTG 513
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
IP ++G LKN+ + L N L G+IP LG+L L L L N L+G +PS L NC L
Sbjct: 514 PIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKL 573
Query: 461 MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL-------------- 506
L D S NLL GSIP +G+L L + L EN FS IP +L
Sbjct: 574 SEL----DASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGN 629
Query: 507 ---------SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557
A L L+L N +G LP+ L LK ++ELD+S NNLSG + + L +
Sbjct: 630 LLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTI 688
Query: 558 LFLAYLNLSYNHFEGEVPRK-GVFGNRTGIHLIGNERLC 595
L ++N+S+N F G VP F N + GN LC
Sbjct: 689 QSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLC 727
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 8e-51, Method: Compositional matrix adjust.
Identities = 153/481 (31%), Positives = 233/481 (48%), Gaps = 71/481 (14%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L +L +I G N G P I+ +L+ + ++ N+L G +P L +L++L L + +N
Sbjct: 186 LRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQN 245
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGF-----------------------N 257
S ++P S+ NIS LE+++LH N F GS+P IG N
Sbjct: 246 RLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGN 305
Query: 258 IPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317
+ + + +N TG +P F + NL++L +++N G + + L+ L +L LS N
Sbjct: 306 LIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSIN 365
Query: 318 NLGTESTSDLDFLTLLTNCS----QME--------------------------------- 340
L +L FL L + Q+E
Sbjct: 366 RLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCR 425
Query: 341 -----MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395
+L L +NK G R + + +T + +GDNQ++G++P E+ NL N+ A +
Sbjct: 426 FQTLILLSLGSNKLSGNIPRDLKTCKS-LTKLMLGDNQLTGSLPIELFNLQNLTALELHQ 484
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG 455
N L+G I +G+LKNL+ L L N+ G IP +GNLT + + N L G++P LG
Sbjct: 485 NWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELG 544
Query: 456 NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYL 515
+C +T+ R LDLSGN G I E+G L L LS+N + EIP + T L L
Sbjct: 545 SC---VTIQR-LDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMEL 600
Query: 516 HLQGNSFSGSLPLSLKTLKSIK-ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEV 574
L GN S ++P+ L L S++ L++S NNLSG IP L NL L L L+ N GE+
Sbjct: 601 QLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEI 660
Query: 575 P 575
P
Sbjct: 661 P 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 628 | ||||||
| 357484501 | 1006 | Kinase-like protein [Medicago truncatula | 0.743 | 0.464 | 0.457 | 1e-109 | |
| 356529793 | 922 | PREDICTED: probable LRR receptor-like se | 0.746 | 0.508 | 0.434 | 1e-107 | |
| 449441592 | 1023 | PREDICTED: probable LRR receptor-like se | 0.740 | 0.454 | 0.452 | 1e-104 | |
| 449499190 | 1023 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.740 | 0.454 | 0.452 | 1e-104 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.737 | 0.455 | 0.451 | 1e-104 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.700 | 0.423 | 0.448 | 1e-102 | |
| 357497603 | 1027 | CCP [Medicago truncatula] gi|355494105|g | 0.743 | 0.454 | 0.441 | 1e-102 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.700 | 0.231 | 0.445 | 1e-101 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.716 | 0.437 | 0.449 | 1e-101 | |
| 357461167 | 1022 | Kinase-like protein [Medicago truncatula | 0.738 | 0.454 | 0.424 | 1e-100 |
| >gi|357484501|ref|XP_003612538.1| Kinase-like protein [Medicago truncatula] gi|355513873|gb|AES95496.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1032), Expect = e-109, Method: Compositional matrix adjust.
Identities = 224/490 (45%), Positives = 304/490 (62%), Gaps = 23/490 (4%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L KL++I+V N L G FP FI N S+L I ++ N L G IP +C L+++ L + EN
Sbjct: 155 LKKLQLINVWGNNLTGGFPSFIGNLSSLIGIAVTYNNLKGEIPQEICNLKNIRRLHVGEN 214
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
N S P ++NISSL +SL N+F GSLP N+ +PN+N +G+N F GS+P S
Sbjct: 215 NLSGMFPSCLYNISSLTQLSLTENKFIGSLPSNLFNTLPNLNMFQIGKNQFFGSMPISIV 274
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
NAS+LQ+LD+ +N+ GQV +L +L L L N G ST DL+FL LTNCS++E
Sbjct: 275 NASSLQLLDLAQNYLVGQVP-SLEKLQDLYWLNLEDNYFGNNSTIDLEFLKYLTNCSKLE 333
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
++ + NKFGG SI +LS ++T + +G N ISG IP EI NLV + +++N G
Sbjct: 334 VVSICNNKFGGSLPNSIGSLSTQLTELCLGGNLISGKIPVEIGNLVELILLAIDFNHFEG 393
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
IP + G+ + +Q LAL N L G IP +GNL+ L +L L N QGN+P S+ NCQ L
Sbjct: 394 IIPTSFGKFQKMQYLALSGNKLSGYIPPFIGNLSQLFKLDLYRNMFQGNIPPSIENCQKL 453
Query: 461 ---------------------MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
+LS LL+LS N L GS+P EVG L+N+ D+SENH S
Sbjct: 454 QYLDLSHNKLSGTIPSEIFHIFSLSNLLNLSHNFLSGSLPREVGLLKNIDWLDVSENHLS 513
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
+IP T+ CT LEYLHLQGNSF+G++P SL +L+ ++ LDLSRN LSG IP ++N+
Sbjct: 514 GDIPTTIGDCTALEYLHLQGNSFNGTIPSSLASLEGLQHLDLSRNRLSGSIPDVMQNISV 573
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHF-GRPRITRITL 618
L YLN+S+N EGEVP+ GVFGN T + LIGN +LCGG+ LHLP C GR
Sbjct: 574 LEYLNVSFNMLEGEVPKNGVFGNVTKVELIGNNKLCGGILLLHLPPCPIKGRKDTKHHKF 633
Query: 619 LKVVIPVAVI 628
+ V + V+V+
Sbjct: 634 MLVAVIVSVV 643
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529793|ref|XP_003533472.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1012), Expect = e-107, Method: Compositional matrix adjust.
Identities = 216/497 (43%), Positives = 308/497 (61%), Gaps = 28/497 (5%)
Query: 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYL 215
I+ ++L KL+ + + N+L G+ P FI N S+L + + N L G IP +C+L+SL +L
Sbjct: 142 IEIVSLQKLQYLSISQNKLTGRIPSFIGNLSSLIVLGVGYNNLEGEIPQEICRLKSLKWL 201
Query: 216 SISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL 275
S N + P ++N+SSL +++ N+ G+LP N+ +PN+ +G N +G +
Sbjct: 202 STGINKLTGTFPSCLYNMSSLTVLAATENQLNGTLPPNMFHTLPNLRVFEIGGNKISGPI 261
Query: 276 PHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTN 335
P S +N S L +L++ HF GQV +L NL L LS NNLG ST+DL+FL LTN
Sbjct: 262 PPSITNTSILSILEI-GGHFRGQVP-SLGKLQNLQILNLSPNNLGNNSTNDLEFLNSLTN 319
Query: 336 CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395
CS++++L + N FGG S+ NLS +++ + +G NQISG IP+E+ NL+N+ G+E
Sbjct: 320 CSKLQVLSIAHNNFGGQLPNSLGNLSTQLSELALGGNQISGKIPTELGNLINLVLLGLEQ 379
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG 455
+ G IP A G+ + LQ L L N L G +P LGNL+ L L LG N L+GN+PSS+G
Sbjct: 380 SHFQGIIPSAFGKFQKLQLLELSANKLSGDLPAFLGNLSQLFHLGLGENKLEGNIPSSIG 439
Query: 456 NCQ---------------------NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLS 494
NCQ NL +L+++LDLS N L GSIP EV NL+N+ D+S
Sbjct: 440 NCQMLQYLYLRQNNLRGTIPLEIFNLSSLTQVLDLSQNSLSGSIPKEVNNLKNINLLDVS 499
Query: 495 ENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYL 554
ENH S EIP T+ CT LEYL+LQGNS G +P SL +LKS++ LDLSRN LSG IP L
Sbjct: 500 ENHLSGEIPGTIRECTMLEYLYLQGNSLQGIIPSSLASLKSLQRLDLSRNRLSGSIPNVL 559
Query: 555 ENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRIT 614
+N+ FL YLN+S+N +GEVP +GVF N +G+ + GN +LCGG+ +LHLP C ++
Sbjct: 560 QNMSFLEYLNVSFNMLDGEVPTEGVFQNASGLVVTGNSKLCGGISKLHLPPCPVKGKKLA 619
Query: 615 -----RITLLKVVIPVA 626
+ L+ V++ V
Sbjct: 620 KHHNHKFRLIAVIVSVV 636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441592|ref|XP_004138566.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 387 bits (993), Expect = e-104, Method: Compositional matrix adjust.
Identities = 221/488 (45%), Positives = 291/488 (59%), Gaps = 23/488 (4%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L KLE+ N+L G+ P+ N S+L + N G IP S QLR+L L I N
Sbjct: 175 LTKLEVFQCSSNELFGEIPETFGNLSSLRGFWGTLNNFHGNIPSSFGQLRNLTALVIGAN 234
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
S +P SI+NISS+ I SL N+ EG LP N+GF PN+ L + N F+G +P + S
Sbjct: 235 KLSGTIPSSIYNISSMRIFSLPVNQLEGGLPTNLGFIFPNLQILKIHTNQFSGPIPFTLS 294
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
NAS L+ + N FSG+V +L + +NNLG + DL+FL L NC+ +
Sbjct: 295 NASKLEEFVISNNMFSGKVP-SLASTRHLEVFGIDRNNLGYGNVDDLNFLFPLVNCTNLS 353
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
+ ++ N FGG I+N S K+ +IG G NQI GTIP+EI NL + A G+E NQLTG
Sbjct: 354 SVVISDNNFGGALPEYISNFSTKLRIIGFGRNQIHGTIPTEIGNLFQLEALGLETNQLTG 413
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
+IP + G+L L L L N L GTIP +LGNL+ L R L NNL G +P SLG Q+L
Sbjct: 414 SIPSSFGKLYKLNDLFLNMNKLSGTIPKSLGNLSALGRCNLRLNNLTGAIPPSLGESQSL 473
Query: 461 M---------------------TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
+ +LS LDLS N L GSIPLEVG L NL +S+N +
Sbjct: 474 LMLALSQNQLSGAIPKELLSISSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLT 533
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
IP TLSACT+LE L+L GN G +P SL +L+ I+ELDLSRNNLSG+IP YL+
Sbjct: 534 GVIPSTLSACTSLEDLYLDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEV 593
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRITL- 618
L+YLNLS+N+ EGEVP +GVF N T ++GN++LC G+ EL+LP C PR ++T
Sbjct: 594 LSYLNLSFNNLEGEVPTQGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTK 653
Query: 619 LKVVIPVA 626
LK++I V
Sbjct: 654 LKIIISVV 661
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449499190|ref|XP_004160745.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 386 bits (992), Expect = e-104, Method: Compositional matrix adjust.
Identities = 221/488 (45%), Positives = 291/488 (59%), Gaps = 23/488 (4%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L KLE+ N+L G+ P+ N S+L + N G IP S QLR+L L I N
Sbjct: 175 LTKLEVFQCSSNELFGEIPETFGNLSSLRGFWGTLNNFHGNIPSSFGQLRNLTALVIGAN 234
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
S +P SI+NISS+ I SL N+ EG LP N+GF PN+ L + N F+G +P + S
Sbjct: 235 KLSGTIPSSIYNISSMRIFSLPVNQLEGGLPTNLGFIFPNLQILKIHTNQFSGPIPFTLS 294
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
NAS L+ + N FSG+V +L + +NNLG + DL+FL L NC+ +
Sbjct: 295 NASKLEEFVISNNMFSGKVP-SLASTRHLEVFGIDRNNLGYGNVDDLNFLFPLVNCTNLS 353
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
+ ++ N FGG I+N S K+ +IG G NQI GTIP+EI NL + A G+E NQLTG
Sbjct: 354 SVVISDNNFGGALPEYISNFSTKLRIIGFGRNQIHGTIPTEIGNLFQLEALGLETNQLTG 413
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
+IP + G+L L L L N L GTIP +LGNL+ L R L NNL G +P SLG Q+L
Sbjct: 414 SIPSSFGKLYKLNDLFLNMNKLSGTIPKSLGNLSALGRCNLRLNNLTGAIPPSLGESQSL 473
Query: 461 M---------------------TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
+ +LS LDLS N L GSIPLEVG L NL +S+N +
Sbjct: 474 LMLALSQNQLSGAIPKELLSISSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLT 533
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
IP TLSACT+LE L+L GN G +P SL +L+ I+ELDLSRNNLSG+IP YL+
Sbjct: 534 GVIPSTLSACTSLEDLYLDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEV 593
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRITL- 618
L+YLNLS+N+ EGEVP +GVF N T ++GN++LC G+ EL+LP C PR ++T
Sbjct: 594 LSYLNLSFNNLEGEVPTQGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTK 653
Query: 619 LKVVIPVA 626
LK++I V
Sbjct: 654 LKIIISVV 661
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 385 bits (988), Expect = e-104, Method: Compositional matrix adjust.
Identities = 220/487 (45%), Positives = 315/487 (64%), Gaps = 24/487 (4%)
Query: 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
++L KLE + + N L G P FI N ++L +I +AN GRIPD+L QL++L L +
Sbjct: 173 VSLSKLEKLVIHKNNLSGAIPPFIGNLTSLNSISAAANNFQGRIPDTLGQLKNLESLGLG 232
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N S +PL I+N+S+L I+SL N+ +G LP +IG ++PN+ ++ + N F+GS+P S
Sbjct: 233 TNFLSGTIPLPIYNLSTLSILSLSENQLQGYLPSDIGVSLPNLQYIQIRANQFSGSIPLS 292
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
SN+SNLQVL+ N FSG++ ++F L +L+ + LS N +G+ +L FL L NC+
Sbjct: 293 ISNSSNLQVLEAGDNSFSGKLSVNFGGLKHLAVVSLSFNKMGSGEPGELSFLDSLINCTS 352
Query: 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398
+ + + N F G+ S+ NLS +T +G+G NQ+ G I S I NL+N+N G+E+NQL
Sbjct: 353 LYAIDIVGNHFEGMLPNSLGNLSTGLTFLGLGQNQLFGGIHSGIGNLINLNTLGLEFNQL 412
Query: 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQ 458
+G IP IG+L+ LQ +L N L G IP ++GNLTLL L N LQG +PSS+GNCQ
Sbjct: 413 SGPIPLDIGKLRMLQRFSLSYNRLSGHIPSSIGNLTLLLEFDLQGNQLQGTIPSSIGNCQ 472
Query: 459 N--LMTLSRLLDLSG--------------------NLLGGSIPLEVGNLRNLAEFDLSEN 496
L+ LSR +LSG N GS+P E+G+L++LA+ ++S N
Sbjct: 473 KLLLLHLSR-NNLSGNAPKELFAISSLSVSLDLSQNYFNGSLPSEIGSLKSLAKLNVSYN 531
Query: 497 HFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556
FS EIP TL++CT+LEYL++Q N F GS+P S TL+ I++LDLS NNLSGQIPK+L+
Sbjct: 532 EFSGEIPSTLASCTSLEYLYMQHNFFQGSIPSSFSTLRGIQKLDLSHNNLSGQIPKFLDT 591
Query: 557 LLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRI 616
L LNLS+N FEGEVP KG FGN T I + GN++LCGG+ EL LP C+F + + +I
Sbjct: 592 FALLT-LNLSFNDFEGEVPTKGAFGNATAISVDGNKKLCGGISELKLPKCNFKKSKKWKI 650
Query: 617 TLLKVVI 623
L +++
Sbjct: 651 PLWLILL 657
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 378 bits (970), Expect = e-102, Method: Compositional matrix adjust.
Identities = 207/462 (44%), Positives = 294/462 (63%), Gaps = 22/462 (4%)
Query: 172 NQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIW 231
N L G PD + N ++++++ + N L G IP +L QL++L ++ + N FS +P S++
Sbjct: 187 NNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVY 246
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
N+SSLE+ SL N+ GSLP ++ F +PN+ L++G N+FTGSLP S SNASNL D+
Sbjct: 247 NMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDIT 306
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351
++F+G+V IDF + NL LFL+ N LG DL FL L C +++L L+ ++FGG
Sbjct: 307 MSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGG 366
Query: 352 VFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKN 411
V SIANLS ++ + + +NQ+SGTIP I NLVN+ + N TG+IP IG L+
Sbjct: 367 VLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQM 426
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGN--------------- 456
L + L RN L G IP +LGN+T L L L N+L G +PSS GN
Sbjct: 427 LGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLN 486
Query: 457 ------CQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
+L++L+ L+L+ N L G +P EV L+NL D+SEN S EIP L +C
Sbjct: 487 GTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCL 546
Query: 511 TLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHF 570
TLE+LH++GN F GS+P S +L+ + +LDLSRNNLSGQIP++L+ L L+ LNLS+N+F
Sbjct: 547 TLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQ-LSLSNLNLSFNNF 605
Query: 571 EGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPR 612
EG++P KGVF N T + GN +LCGG+ ELHLP+C +P+
Sbjct: 606 EGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPK 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357497603|ref|XP_003619090.1| CCP [Medicago truncatula] gi|355494105|gb|AES75308.1| CCP [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 378 bits (970), Expect = e-102, Method: Compositional matrix adjust.
Identities = 217/491 (44%), Positives = 293/491 (59%), Gaps = 24/491 (4%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L KL+ I VG+N L P FI N S L +++ N G+IP +C L+ L L +SEN
Sbjct: 179 LKKLQAISVGNNHLTEGIPSFIGNLSCLTRLNLGENNFSGKIPQEICFLKHLTILGVSEN 238
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
N S K+P ++NISSL +++ N GS P N+ +PN+ + N F+G +P S +
Sbjct: 239 NLSGKIPSCLYNISSLISLTVTQNHLHGSFPPNMFHTLPNIQIFAFAANQFSGPIPTSIA 298
Query: 281 NASNLQVLDVYKN-HFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
NAS LQ+LD+ N + GQV L +LS L L NNLG ST DL+FL LTNCS++
Sbjct: 299 NASALQILDLGNNMNLVGQVP-SLRNLQDLSFLSLEVNNLGNNSTMDLEFLKYLTNCSKL 357
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
+L ++ N FGG SI NLS ++ + MG N ISG IP+E+ LV + +E N
Sbjct: 358 YVLSISYNNFGGHLPNSIGNLSTELPELYMGGNMISGKIPAELGRLVGLILLTMESNCFE 417
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
G IP G+ + +Q L+L N L G IP +GNL+ L L L N QG++P S+GNCQN
Sbjct: 418 GIIPTNFGKFQKMQVLSLRENKLSGGIPPFIGNLSQLYYLELNHNMFQGSIPPSIGNCQN 477
Query: 460 L---------------------MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHF 498
L +LS LL+LS N L GS+P EVG L+N+ D+SENH
Sbjct: 478 LQSLDLSHNKLRGTIPVEVLNLFSLSILLNLSHNSLSGSLPREVGMLKNIEALDVSENHL 537
Query: 499 SNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
S +IP + CT+LEY+HLQ NSF+G++P SL LK ++ LDLSRN LSG IP ++N+
Sbjct: 538 SGDIPREIGECTSLEYIHLQRNSFNGTIPSSLTFLKGLRYLDLSRNQLSGSIPDGMQNIS 597
Query: 559 FLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHF-GRPRITRIT 617
L YLN+S+N EGEVP GVFGN T I LIGN++LCGG+ LHLP C GR +
Sbjct: 598 VLEYLNVSFNMLEGEVPTNGVFGNATQIDLIGNKKLCGGISHLHLPPCPIKGRKHAKQHK 657
Query: 618 LLKVVIPVAVI 628
+ + V+V+
Sbjct: 658 FRLIAVLVSVV 668
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 375 bits (964), Expect = e-101, Method: Compositional matrix adjust.
Identities = 206/462 (44%), Positives = 293/462 (63%), Gaps = 22/462 (4%)
Query: 172 NQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIW 231
N L G PD + N ++++++ + N L G IP +L QL++L ++ + N FS +P S++
Sbjct: 218 NNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVY 277
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
N+SSLE+ SL N+ GSLP ++ F +PN+ L++G N+FTG LP S SNASNL D+
Sbjct: 278 NMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDIT 337
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351
++F+G+V IDF + NL LFL+ N LG DL FL L C +++L L+ ++FGG
Sbjct: 338 MSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGG 397
Query: 352 VFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKN 411
V SIANLS ++ + + +NQ+SGTIP I NLVN+ + N TG+IP IG L+
Sbjct: 398 VLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQM 457
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGN--------------- 456
L + L RN L G IP +LGN+T L L L N+L G +PSS GN
Sbjct: 458 LGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLN 517
Query: 457 ------CQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
+L++L+ L+L+ N L G +P EV L+NL D+SEN S EIP L +C
Sbjct: 518 GTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCL 577
Query: 511 TLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHF 570
TLE+LH++GN F GS+P S +L+ + +LDLSRNNLSGQIP++L+ L L+ LNLS+N+F
Sbjct: 578 TLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQ-LSLSNLNLSFNNF 636
Query: 571 EGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPR 612
EG++P KGVF N T + GN +LCGG+ ELHLP+C +P+
Sbjct: 637 EGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPK 678
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 374 bits (961), Expect = e-101, Method: Compositional matrix adjust.
Identities = 212/472 (44%), Positives = 298/472 (63%), Gaps = 22/472 (4%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L KL+M + N L G+ +N S+LE I + N G IP+S+ QL+SL S+
Sbjct: 170 SLSKLQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGG 229
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
+NFS +P SI+N+SSL I+S+ N+ G+LP ++G ++P + L + N F+GS+P +
Sbjct: 230 SNFSGVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTI 289
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
SNASNL LDV +N+F+G+V RL NLS + + KNNLG DL FL L N + +
Sbjct: 290 SNASNLVALDVSQNNFTGKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNL 348
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
E+L + N GGV ++N S K+ + G N+I G IPSEI NL+ + A G E N+LT
Sbjct: 349 EILAITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELT 408
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
G+IP ++G+LKNL L L N++ G+IP +LGN+T L+ + L NNL+G++PSSLGNCQ
Sbjct: 409 GSIPSSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQ 468
Query: 460 --LMTLSR-------------------LLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHF 498
LM LSR LDLS N GS+P+EVG L NL D+S+N
Sbjct: 469 MLLMDLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKL 528
Query: 499 SNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
S EIP +L +CT LE L+LQGN+F G++P+SL +L+ I +L+LS NNL+GQIP +
Sbjct: 529 SGEIPKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFK 588
Query: 559 FLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGR 610
L L+LSYN FEGEVP +GVF N + + GN+ LCGG+ E++LP C +
Sbjct: 589 SLEKLDLSYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNK 640
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461167|ref|XP_003600865.1| Kinase-like protein [Medicago truncatula] gi|355489913|gb|AES71116.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 372 bits (956), Expect = e-100, Method: Compositional matrix adjust.
Identities = 208/490 (42%), Positives = 306/490 (62%), Gaps = 26/490 (5%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L KL+ +++ +N L + P I N ++L +++ +N L G IP +C L++L +S+ N
Sbjct: 171 LRKLQRVNIWNNNLTAEIPPSIENLTSLINLNLGSNNLEGNIPPEICHLKNLATISVGIN 230
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
FS LPL ++N+SSL ++++ N+F GSLP + +PN+ L +G N F+G +P S S
Sbjct: 231 KFSGNLPLCLYNMSSLTLLAVDLNKFNGSLPQKMFHTLPNLKTLFIGGNQFSGPIPTSIS 290
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
NASNL+ D+ +N F+GQV + +L +L + LS+NNLG+ ST DL+F+ L NCS++
Sbjct: 291 NASNLRSFDITQNRFTGQVP-NLGKLKDLQLIGLSQNNLGSNSTKDLEFIKSLVNCSKLY 349
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
++ ++ N FGG S+ N+S + + +G N I G IP+E+ NL N+ VE N+ G
Sbjct: 350 VVDISYNNFGGPLPNSLGNMS-NLNNLYLGGNHILGKIPAELGNLANLYLLTVENNRFEG 408
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQ-- 458
IP G+ + LQ L L N L G IP +GNL+ L L LG N L+GN+P S+GNCQ
Sbjct: 409 IIPDTFGKFQKLQVLELSGNRLSGNIPAFIGNLSQLFYLGLGDNILEGNIPLSIGNCQKL 468
Query: 459 -------------------NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
+L +L+RLLDLSGNLL GS+ EVG L N+ + + SEN+ S
Sbjct: 469 YHLDLSQNNLRGTIPIEVFSLFSLTRLLDLSGNLLSGSLLQEVGRLENIGKLNFSENNLS 528
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
+IP T+ C +LEYL+LQGNSF G +P SL +LK ++ LDLSRN+LSG IPK L+N+ F
Sbjct: 529 GDIPRTIGECVSLEYLYLQGNSFHGVIPTSLASLKGLQHLDLSRNHLSGSIPKGLQNISF 588
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITR---I 616
L Y N+S+N EGEVP +GVF N + + + GN LCGG+ +LHLP C + ++
Sbjct: 589 LQYFNVSFNMLEGEVPTEGVFQNSSEVAVTGNNNLCGGVSKLHLPPCPLKGEKHSKHRDF 648
Query: 617 TLLKVVIPVA 626
L+ V++ V
Sbjct: 649 KLIAVIVSVV 658
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 628 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.703 | 0.431 | 0.316 | 1.3e-53 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.617 | 0.376 | 0.316 | 2.6e-52 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.656 | 0.506 | 0.294 | 8.7e-50 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.640 | 0.398 | 0.314 | 4.1e-49 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.652 | 0.4 | 0.307 | 5.6e-49 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.734 | 0.456 | 0.287 | 2.8e-47 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.668 | 0.369 | 0.264 | 7.5e-46 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.732 | 0.454 | 0.270 | 8.5e-45 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.603 | 0.323 | 0.313 | 1.9e-43 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.617 | 0.395 | 0.299 | 2.3e-42 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 1.3e-53, P = 1.3e-53
Identities = 142/449 (31%), Positives = 201/449 (44%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L+ D+ N+L G P + S+L +++ N L G IP+S+ L SL S+ E
Sbjct: 198 NLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRE 257
Query: 220 NNFSCKLPLSIWN-ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N +P + + + LE+I + +NRF G +P ++ N ++ + + N F+G +
Sbjct: 258 NKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVA-NASHLTVIQIYGNLFSGIITSG 316
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCS- 337
F NL L +++N F + + D N S
Sbjct: 317 FGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLST 376
Query: 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397
+ L L NK G + I NL + + + +N G++PS + L N+ N
Sbjct: 377 SLSFLALELNKITGSIPKDIGNLIG-LQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENN 435
Query: 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGNC 457
L+G+IP AIG L L L L N G IP G +PS L N
Sbjct: 436 LSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNI 495
Query: 458 QNLMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHL 517
Q L IP E+G+L+NL EF N S +IP TL C L YL+L
Sbjct: 496 QTL---SIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYL 552
Query: 518 QGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKXXXXXXXXXXXXXXXXHFEGEVPRK 577
Q N SGS+P +L LK ++ LDLS NNLSGQIP F GEVP
Sbjct: 553 QNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTI 612
Query: 578 GVFGNRTGIHLIGNERLCGGLEELHLPSC 606
G F +GI + GN +LCGG+ +LHLP C
Sbjct: 613 GAFAAASGISIQGNAKLCGGIPDLHLPRC 641
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 2.6e-52, P = 2.6e-52
Identities = 124/392 (31%), Positives = 194/392 (49%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L KL ++D+ N L G FP + N ++L+ +D + N + G IPD + +L + + I+
Sbjct: 167 SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIAL 226
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N+FS P +++NISSLE +SL N F G+L + G+ +PN+ L +G N FTG++P +
Sbjct: 227 NSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTL 286
Query: 280 SNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCSQM 339
+N S+L+ D+ N+ SG + + G NC+Q+
Sbjct: 287 ANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQL 346
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
E L + N+ GG SIANLS +T + +G N ISGTIP +I NLV++ +E N L+
Sbjct: 347 EYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLS 406
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGNCQN 459
G +P + G+L NLQ + L N++ G IP G +P SLG C+
Sbjct: 407 GELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRY 466
Query: 460 LMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
L+ IP E+ + +LA DLS N + P + L L
Sbjct: 467 LLDLWMDTNRLNGT----IPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASY 522
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP 551
N SG +P ++ S++ L + N+ G IP
Sbjct: 523 NKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP 554
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 523 (189.2 bits), Expect = 8.7e-50, P = 8.7e-50
Identities = 123/417 (29%), Positives = 195/417 (46%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L ++++ +N L G P + + L + ++ N L G IP S QLR L++LS++
Sbjct: 148 NLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAF 207
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
NN S +P IWNISSL I + SN+ G+LP N N+P++ + + N F G +P S
Sbjct: 208 NNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASI 267
Query: 280 SNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCSQM 339
NASN+ + + N FSG V + NCS +
Sbjct: 268 GNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCSNL 327
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
+ + L KFGGV S++NLS+ + + + DN+ISG++P +I NLVN+ + N LT
Sbjct: 328 QEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANNSLT 387
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGNCQN 459
G++P + +LKNL+ L + N L G++P G +PS+LGN
Sbjct: 388 GSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGN--- 444
Query: 460 LMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEF-DLSENHFSNEIPVTLSACTTLEYLHLQ 518
+T IP+E+ ++ L+E D+S N+ IP + + H
Sbjct: 445 -LTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHAD 503
Query: 519 GNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKXXXXXXXXXXXXXXXXHFEGEVP 575
N SG P ++ + ++ L L N L+G IP + G++P
Sbjct: 504 SNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIP 560
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 4.1e-49, P = 4.1e-49
Identities = 129/410 (31%), Positives = 201/410 (49%)
Query: 145 NDKLEAGNLG--LIQRL-NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGR 201
N +L++ LG + L +L L +++ N + GK P + N + LE + +S N L G
Sbjct: 142 NLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 202 IPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
IP + QL + L + NNFS P +++N+SSL+++ + N F G L ++G +PN+
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGX 321
++G N FTGS+P + SN S L+ L + +N+ +G + G
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGS 320
Query: 322 XXXXXXXXXXXXXNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSE 381
NC+Q+E L + N+ GG SIANLSAK+ + +G ISG+IP +
Sbjct: 321 DSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 382 IKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXX 441
I NL+N+ ++ N L+G +P ++G+L NL+ L+L N L G IP
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 442 XXXXXQGNVPSSLGNCQNLMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNE 501
+G VP+SLGNC +L+ IPLE+ ++ L D+S N
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGT----IPLEIMKIQQLLRLDMSGNSLIGS 496
Query: 502 IPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP 551
+P + A L L L N SG LP +L +++ L L N G IP
Sbjct: 497 LPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP 546
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 5.6e-49, P = 5.6e-49
Identities = 128/416 (30%), Positives = 203/416 (48%)
Query: 136 SSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISA 195
SS + S++ LE G ++ +L KL ++ +G N L GKFP + N ++L+ +D
Sbjct: 153 SSLSTLDLSSNHLEQGVP--LEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIY 210
Query: 196 NMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIG 255
N + G IP + +L+ + + I+ N F+ P I+N+SSL +S+ N F G+L + G
Sbjct: 211 NQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG 270
Query: 256 FNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXX 315
+PN+ L +G N+FTG++P + SN S+L+ LD+ NH +G++ +
Sbjct: 271 SLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLN 330
Query: 316 XXXXGXXXXXXXXXXXXXXNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
G NCSQ++ L + NK GG IANLS ++T + +G N IS
Sbjct: 331 NNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLIS 390
Query: 376 GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXX 435
G+IP I NLV++ + N LTG +P ++GEL L+ + L N L G IP
Sbjct: 391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450
Query: 436 XXXXXXXXXXXQGNVPSSLGNCQNLMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSE 495
+G++PSSLG+C L+ IP E+ L +L ++S
Sbjct: 451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGS----IPHELMELPSLVVLNVSF 506
Query: 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP 551
N + + L L + N SG +P +L S++ L L N+ G IP
Sbjct: 507 NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP 562
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 2.8e-47, P = 2.8e-47
Identities = 136/473 (28%), Positives = 209/473 (44%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L ++++G N L G+ PD IA S + ++ ++ N G P + L SL L +
Sbjct: 184 NLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLG 243
Query: 220 NNFSCKLPLSIWNI-SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N FS L N+ ++ +SLH N G++P + NI + +G+N TGS+ +
Sbjct: 244 NGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLA-NISTLEMFGIGKNRMTGSISPN 302
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCS- 337
F NL L++ N D N S
Sbjct: 303 FGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMST 362
Query: 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397
++ +L L N G I NL +++ + DN ++G +P+ + NLV + + N+
Sbjct: 363 ELTVLNLKGNLIYGSIPHDIGNLIGLQSLL-LADNLLTGPLPTSLGNLVGLGELILFSNR 421
Query: 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGNC 457
+G IP IG L L L L NS G +P G +P +
Sbjct: 422 FSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQI 481
Query: 458 QNLMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHL 517
L+ +P ++G L+NL E L N+ S +P TL C ++E ++L
Sbjct: 482 PTLV----HLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYL 537
Query: 518 QGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKXXXXXXXXXXXXXXXXHFEGEVPRK 577
Q N F G++P +K L +K +DLS NNLSG I + +FEG VP +
Sbjct: 538 QENHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTE 596
Query: 578 GVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRI-TRI-TLLK-VVIPVAV 627
G+F N T + + GN+ LCG ++EL L C P + TR +LLK V I V+V
Sbjct: 597 GIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSV 649
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 7.5e-46, Sum P(2) = 7.5e-46
Identities = 115/435 (26%), Positives = 198/435 (45%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
L+++D+ +N++ G+FP ++ N +L+ +D+S N+ G IP + L+ L L ++ N+ +
Sbjct: 310 LQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEELKLANNSLT 369
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNAS 283
++P+ I SL+++ N +G +P +G+ + + LS+G+N+F+G +P S N
Sbjct: 370 GEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGY-MKALKVLSLGRNSFSGYVPSSMVNLQ 428
Query: 284 NLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCSQMEMLY 343
L+ L++ +N+ +G ++ N S + L
Sbjct: 429 QLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSIS------NLSNLSFLN 482
Query: 344 LNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIP 403
L+ N F G S+ NL K+T + + +SG +P E+ L N+ ++ N +G +P
Sbjct: 483 LSGNGFSGEIPASVGNLF-KLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNNFSGVVP 541
Query: 404 HAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGNCQNLMTX 463
L +L+ + L NS G IP G++P +GNC L
Sbjct: 542 EGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSALEVL 601
Query: 464 XXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523
IP ++ L L DL +N+ S EIP +S ++L L L N S
Sbjct: 602 ELRSNRLMGH----IPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLSLDHNHLS 657
Query: 524 GSLPLSLKTLKSIKELDLSRNNLSGQIPKXXXXXXXXXXXXXXXXH-FEGEVPRK-GVFG 581
G +P S L ++ ++DLS NNL+G+IP + +GE+P G
Sbjct: 658 GVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIPASLGSRI 717
Query: 582 NRTGIHLIGNERLCG 596
N T GN LCG
Sbjct: 718 NNTS-EFSGNTELCG 731
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 8.5e-45, P = 8.5e-45
Identities = 128/474 (27%), Positives = 210/474 (44%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L+ + DN + G+ PD +A S + + +S N G P ++ L +L L +
Sbjct: 184 NLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFG 243
Query: 220 NNFSCKLPLSIWNI-SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
+ FS L N+ ++ ++L N G++P + NI + + +N TG + +
Sbjct: 244 SGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLS-NISTLQKFGINKNMMTGGIYPN 302
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCSQ 338
F +LQ LD+ +N D N S
Sbjct: 303 FGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMST 362
Query: 339 MEMLYLNT--NKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYN 396
E++ LN N F G + I NL + + +G N ++G +P+ + L+ + + N
Sbjct: 363 -ELISLNLIGNHFFGSIPQDIGNLIG-LQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSN 420
Query: 397 QLTGTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGN 456
+++G IP IG L L+ L L NS G +P G +P +
Sbjct: 421 RMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQ 480
Query: 457 CQNLMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLH 516
L+ +P ++G+L+NL + L N FS +P TL C +E L
Sbjct: 481 IPTLVNLSMEGNSLSGS----LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLF 536
Query: 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKXXXXXXXXXXXXXXXXHFEGEVPR 576
LQGNSF G++P +++ L ++ +DLS N+LSG IP+ +F G+VP
Sbjct: 537 LQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPS 595
Query: 577 KGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRI-TRIT--LLKVVIPVAV 627
KG F N T + + GN+ LCGG+++L L C P + T+ + L KV I V++
Sbjct: 596 KGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSI 649
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 1.9e-43, P = 1.9e-43
Identities = 123/392 (31%), Positives = 184/392 (46%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NLL L+ + + +N L G P I N S+L +++ N L G+IP L L L L I +
Sbjct: 238 NLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYK 297
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N + +P S++ ++ L + L N G + IGF + ++ L++ NNFTG P S
Sbjct: 298 NKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGF-LESLEVLTLHSNNFTGEFPQSI 356
Query: 280 SNASNLQVLDVYKNHFSGQVKIDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXXXXNCSQM 339
+N NL VL V N+ SG++ D NC+ +
Sbjct: 357 TNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLL------TGPIPSSISNCTGL 410
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
++L L+ N+ G R ++ +T I +G N +G IP +I N N+ V N LT
Sbjct: 411 KLLDLSHNQMTGEIPRGFGRMN--LTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLT 468
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPSSLGNCQN 459
GT+ IG+L+ L+ L + NSL G IP G +P + N
Sbjct: 469 GTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSN--- 525
Query: 460 LMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
+T IP E+ +++ L+ DLS N FS +IP S +L YL LQG
Sbjct: 526 -LTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQG 584
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP 551
N F+GS+P SLK+L + D+S N L+G IP
Sbjct: 585 NKFNGSIPASLKSLSLLNTFDISDNLLTGTIP 616
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 2.3e-42, P = 2.3e-42
Identities = 120/401 (29%), Positives = 182/401 (45%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANF-SALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
NL L ++D+ N +GK P I + L+ + +S N+L G IP L L L YL +
Sbjct: 88 NLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLG 147
Query: 219 ENNFSCKLPLSIW---NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL 275
N + +P+ ++ + SSL+ I L +N G +PLN ++ + FL + N TG++
Sbjct: 148 SNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTV 207
Query: 276 PHSFSNASNLQVLDVYKNHFSGQVK---IDXXXXXXXXXXXXXXXXXGXXXXXXXXXXXX 332
P S SN++NL+ +D+ N SG++ I
Sbjct: 208 PSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFAS 267
Query: 333 XXNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFG 392
N S ++ L L N GG S+ +LS + I + N+I G+IP EI NL+N+
Sbjct: 268 LANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLN 327
Query: 393 VEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDXXXXXXXXXXXXXXXXXXQGNVPS 452
+ N L+G IP + +L L+ + L N L G IP G++P
Sbjct: 328 LSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPD 387
Query: 453 SLGNCQNLMTXXXXXXXXXXXXXXXIPLEVGNLRNLAEFDLSENHFSNEIPV-TLSACTT 511
S GN L +P +G NL DLS N+ + IPV +S
Sbjct: 388 SFGNLSQLRRLLLYGNHLSGT----VPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRN 443
Query: 512 LE-YLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP 551
L+ YL+L N SG +PL L + + +DLS N LSG+IP
Sbjct: 444 LKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIP 484
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 628 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-59 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-58 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-57 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-50 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-30 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-10 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-09 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-09 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-09 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-04 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-04 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.001 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.001 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.002 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.003 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 0.004 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 5e-59
Identities = 147/440 (33%), Positives = 223/440 (50%), Gaps = 17/440 (3%)
Query: 136 SSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISA 195
SS +++ SN+ G I R ++ LE +D+ +N L G+ P+ I +FS+L+ +D+
Sbjct: 118 SSLRYLNLSNNNFT----GSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173
Query: 196 NMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIG 255
N+L G+IP+SL L SL +L+++ N ++P + + SL+ I L N G +P IG
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233
Query: 256 FNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315
+ ++N L + NN TG +P S N NLQ L +Y+N SG + L L L LS
Sbjct: 234 -GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
N+L E L+ +E+L+L +N F G ++ +L ++ V+ + N+ S
Sbjct: 293 DNSLSGEIPE------LVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFS 345
Query: 376 GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTL 435
G IP + N+ + N LTG IP + NL L L NSL G IP +LG
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
Query: 436 LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSE 495
L R+ L N+ G +PS L LD+S N L G I ++ +L L+
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLP----LVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461
Query: 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE 555
N F +P LE L L N FSG++P L +L + +L LS N LSG+IP L
Sbjct: 462 NKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS 520
Query: 556 NLLFLAYLNLSYNHFEGEVP 575
+ L L+LS+N G++P
Sbjct: 521 SCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 2e-58
Identities = 151/471 (32%), Positives = 226/471 (47%), Gaps = 61/471 (12%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL LE + + NQL+G+ P + +L+ I + N L G IP + L SLN+L +
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV-------NFLS------V 266
NN + +P S+ N+ +L+ + L+ N+ G +P +I F++ + N LS V
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELV 304
Query: 267 GQ-----------NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315
Q NNFTG +P + ++ LQVL ++ N FSG++ + + +NL+ L LS
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
NNL E L + + L L +N G +S+ + + + + DN S
Sbjct: 365 TNNLTGEIPEG------LCSSGNLFKLILFSNSLEGEIPKSLGACRS-LRRVRLQDNSFS 417
Query: 376 GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTL 435
G +PSE L + + N L G I ++ +LQ L+L RN G +PD+ G+ L
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRL 477
Query: 436 LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSE 495
N LDLS N G++P ++G+L L + LSE
Sbjct: 478 EN-----------------------------LDLSRNQFSGAVPRKLGSLSELMQLKLSE 508
Query: 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE 555
N S EIP LS+C L L L N SG +P S + + +LDLS+N LSG+IPK L
Sbjct: 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568
Query: 556 NLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
N+ L +N+S+NH G +P G F + GN LCGG LP C
Sbjct: 569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC 619
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 3e-57
Identities = 137/417 (32%), Positives = 214/417 (51%), Gaps = 15/417 (3%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQL-RSLNYLSIS 218
N ++ ID+ + GK I ++ I++S N L G IPD + SL YL++S
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
NNF+ +P +I +LE + L +N G +P +IG ++ L +G N G +P+S
Sbjct: 127 NNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGS-FSSLKVLDLGGNVLVGKIPNS 183
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
+N ++L+ L + N GQ+ + ++ +L ++L NNL E ++ LT L +
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL---NH 240
Query: 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398
++++Y N G S+ NL + + + N++SG IP I +L + + + N L
Sbjct: 241 LDLVY---NNLTGPIPSSLGNLK-NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQ 458
+G IP + +L+NL+ L L N+ G IP L +L L L L N G +P +LG
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 459 NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQ 518
NL +LDLS N L G IP + + NL + L N EIP +L AC +L + LQ
Sbjct: 357 NLT----VLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412
Query: 519 GNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575
NSFSG LP L + LD+S NNL G+I ++ L L+L+ N F G +P
Sbjct: 413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 4e-50
Identities = 124/362 (34%), Positives = 186/362 (51%), Gaps = 37/362 (10%)
Query: 215 LSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274
+ +S N S K+ +I+ + ++ I+L +N+ G +P +I ++ +L++ NNFTGS
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 275 LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLT 334
+P NL+ LD+ N SG++ D S+L L L N L
Sbjct: 134 IPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN-----------VLV--- 177
Query: 335 NCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394
G S+ NL+ + + + NQ+ G IP E+ + ++ +
Sbjct: 178 ----------------GKIPNSLTNLT-SLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454
YN L+G IP+ IG L +L L LV N+L G IP +LGNL L LFL N L G +P S+
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
+ Q L++ LDLS N L G IP V L+NL L N+F+ +IPV L++ L+
Sbjct: 281 FSLQKLIS----LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEV 574
L L N FSG +P +L ++ LDLS NNL+G+IP+ L + L L L N EGE+
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396
Query: 575 PR 576
P+
Sbjct: 397 PK 398
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-43
Identities = 110/313 (35%), Positives = 164/313 (52%), Gaps = 22/313 (7%)
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG-------TESTSDLDFLTL 332
+N+S + +D+ + SG++ RL + + LS N L ++S L +L L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 333 LTN----------CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI 382
N +E L L+ N G I + S + V+ +G N + G IP+ +
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNVLVGKIPNSL 184
Query: 383 KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442
NL ++ + NQL G IP +G++K+L+ + L N+L G IP +G LT LN L L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244
Query: 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEI 502
+NNL G +PSSLGN +NL + L L N L G IP + +L+ L DLS+N S EI
Sbjct: 245 YNNLTGPIPSSLGNLKNL----QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 503 PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAY 562
P + LE LHL N+F+G +P++L +L ++ L L N SG+IPK L L
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 563 LNLSYNHFEGEVP 575
L+LS N+ GE+P
Sbjct: 361 LDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-34
Identities = 90/273 (32%), Positives = 142/273 (52%), Gaps = 12/273 (4%)
Query: 304 NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK 363
N S + + LS N+ + +S + L + + + L+ N+ G I S+
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYI------QTINLSNNQLSGPIPDDIFTTSSS 119
Query: 364 ITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR 423
+ + + +N +G+IP ++ N+ + N L+G IP+ IG +L+ L L N L
Sbjct: 120 LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483
G IP++L NLT L L L N L G +P LG ++L + + L N L G IP E+G
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSL----KWIYLGYNNLSGEIPYEIG 233
Query: 484 NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSR 543
L +L DL N+ + IP +L L+YL L N SG +P S+ +L+ + LDLS
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 544 NNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576
N+LSG+IP+ + L L L+L N+F G++P
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 91/262 (34%), Positives = 131/262 (50%), Gaps = 19/262 (7%)
Query: 359 NLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGEL-KNLQGLAL 417
N S+++ I + ISG I S I L I + NQL+G IP I +L+ L L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 418 VRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477
N+ G+IP G++ L L L N L G +P+ +G+ +L ++LDL GN+L G
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL----KVLDLGGNVLVGK 179
Query: 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIK 537
IP + NL +L L+ N +IP L +L++++L N+ SG +P + L S+
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
Query: 538 ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHL-IGNERLCG 596
LDL NNL+G IP L NL L YL L N G +P +F + I L + + L G
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSIFSLQKLISLDLSDNSLSG 298
Query: 597 ----------GLEELHLPSCHF 608
LE LHL S +F
Sbjct: 299 EIPELVIQLQNLEILHLFSNNF 320
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 43/110 (39%), Positives = 69/110 (62%), Gaps = 5/110 (4%)
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
I+ G++ L G IP+ I +L++LQ + L NS+RG IP +LG++T L L L +N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGN-LRNLAEFDLSEN 496
G++P SLG +T R+L+L+GN L G +P +G L + A F+ ++N
Sbjct: 480 GSIPESLG----QLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK-SFVTECEALSNVRHRNLIKIITVC 114
+G+G FG VY + +TG VA+K++ + + + E E L + H N++K+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+ L+ EY + GS +D + ++ KL
Sbjct: 61 EDENHLY-----LVMEYCEGGSLKDLLKENEGKLS 90
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 35/86 (40%), Positives = 54/86 (62%), Gaps = 1/86 (1%)
Query: 371 DNQ-ISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDT 429
DNQ + G IP++I L ++ + + N + G IP ++G + +L+ L L NS G+IP++
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 430 LGNLTLLNRLFLGFNNLQGNVPSSLG 455
LG LT L L L N+L G VP++LG
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 31/116 (26%), Positives = 55/116 (47%), Gaps = 13/116 (11%)
Query: 54 NMIGQGSFGFVYKGKL---GETGTTVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNLIK 109
+G+G+FG VYKGKL T VAVK + + K F+ E + + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 110 IITVCSSID--FKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLK 163
++ VC+ + + L+ EYM+ G D++ +S + + +LL
Sbjct: 61 LLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 39/92 (42%), Positives = 55/92 (59%)
Query: 467 LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL 526
L L L G IP ++ LR+L +LS N IP +L + T+LE L L NSF+GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 527 PLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
P SL L S++ L+L+ N+LSG++P L L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 9e-12
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G+FG VYKG L T T VAVK + + + F+ E + + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+ VC+ +G ++ EYM G D++ + +KL
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGEKL 99
|
Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 41/110 (37%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 502 IPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLA 561
IP +S L+ ++L GNS G++P SL ++ S++ LDLS N+ +G IP+ L L L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 562 YLNLSYNHFEGEVPRK--GVFGNRTGIHLIGNERLCG--GLEEL--HLPS 605
LNL+ N G VP G +R + N LCG GL HL
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSV 543
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 414 GLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473
GL L LRG IP+ + L L + L N+++GN+P SLG+ +T +LDLS N
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS----ITSLEVLDLSYNS 477
Query: 474 LGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA 508
GSIP +G L +L +L+ N S +P L
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNLIKIITVC 114
+G+GSFG VY + +TG VA+KV+ K K + + E + L ++H N++++ V
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65
Query: 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
F+ D L+ EY + G D + +
Sbjct: 66 ----FEDEDKLYLVMEYCEGGDLFDLLKK 90
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 6/114 (5%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIK 109
F IG+G FG VYK + TG VA+KV+ L+ K + + E + L +H N++K
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLK 163
S K D ++ E+ GS +D + +N L + + + LLK
Sbjct: 62 YYG---SYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK-ELLK 109
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVRHRN 106
N+ ++IG+G+FG VYKG ETG VA+K ++L ++ A KS + E + L N++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
++K I + D +I EY + GS
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGS 85
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 32/86 (37%), Positives = 52/86 (60%), Gaps = 1/86 (1%)
Query: 171 DNQ-LIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLS 229
DNQ L G P+ I+ L++I++S N + G IP SL + SL L +S N+F+ +P S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 230 IWNISSLEIISLHSNRFEGSLPLNIG 255
+ ++SL I++L+ N G +P +G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 10/87 (11%)
Query: 55 MIGQGSFGFVYKGKL----GETGTTVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNLIK 109
+G+G+FG VYKG L VAVK + + + F+ E + + H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGS 136
++ VC+ + ++ EYM G
Sbjct: 66 LLGVCTE-----EEPLMIVMEYMPGGD 87
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 22/85 (25%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA--AKSFVTECEALSNVRHRNLIKII 111
++G+GSFG VY +TG +AVK + L ++ E LS+++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGS 136
+ ++ + EY+ GS
Sbjct: 66 GSERDEEKNTLN---IFLEYVSGGS 87
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 3e-09
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 10/99 (10%)
Query: 55 MIGQGSFGFVYKGKL----GETGTTVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNLIK 109
+G+G+FG VYKGKL G+ VAVK + + + F+ E + + H N++K
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
++ VC+ + ++ EYM+ G ++ ++ KL
Sbjct: 66 LLGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRPKL 99
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
+G GSFG VYK K TG VAVK++ + ++ E L + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
F+ D L+ EY + G D++ +
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRGG 93
|
Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 26/91 (28%), Positives = 55/91 (60%), Gaps = 1/91 (1%)
Query: 188 LEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFE 247
++ + + L G IP+ + +LR L +++S N+ +P S+ +I+SLE++ L N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 248 GSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
GS+P ++G + ++ L++ N+ +G +P +
Sbjct: 480 GSIPESLG-QLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 2/107 (1%)
Query: 342 LYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGT 401
L L+ G I+ L + I + N I G IP + ++ ++ + YN G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448
IP ++G+L +L+ L L NSL G +P LG LL+R F + G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR-LLHRASFNFTDNAG 527
|
Length = 623 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 36/107 (33%), Positives = 51/107 (47%), Gaps = 23/107 (21%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVK------VMNLKQKGAAKSFVTECEALSNVRHRNLIK 109
IG+G+FG VYKG L + T VAVK +LK+K F+ E E L H N++K
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 110 IITVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
+I VC K IY E + GS ++ + ++L L
Sbjct: 57 LIGVCVQ--------KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL 95
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 75/272 (27%), Positives = 112/272 (41%), Gaps = 21/272 (7%)
Query: 298 QVKIDFNRLSNLSRLF-LSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRS 356
+++ + + L L+ L L +N L L L L+ NK L S
Sbjct: 104 RLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKE----LDLSDNKIE--SLPS 157
Query: 357 IANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLA 416
+ + + N +S +P + NL N+N + N+++ +P I L L+ L
Sbjct: 158 PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD 215
Query: 417 LVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGG 476
L NS+ + +L NL L+ L L NN ++P S+GN NL LDLS N +
Sbjct: 216 LSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNL----ETLDLSNNQI-- 267
Query: 477 SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSI 536
S +G+L NL E DLS N SN +P+ LE L N L LK +
Sbjct: 268 SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLE---LLLNLLLTLKALELKLNSIL 324
Query: 537 KELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
++ N P+ L L L L N
Sbjct: 325 LNNNILSNGE-TSSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 24/70 (34%), Positives = 43/70 (61%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
L L+ I++ N + G P + + ++LE +D+S N G IP+SL QL SL L+++ N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 221 NFSCKLPLSI 230
+ S ++P ++
Sbjct: 501 SLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 31/106 (29%), Positives = 48/106 (45%), Gaps = 8/106 (7%)
Query: 53 SNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNL 107
+G+G FG V + TG VAVK +N + +S F E E L + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
+K VC + + LI EY+ GS D++ + D++ L
Sbjct: 69 VKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQINLKRL 111
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 15/88 (17%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNL 107
+G+G+FG V+ G+ VAVK LK+ A K F E E L+N +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCG 135
+K VC+ +G D +++EYM+ G
Sbjct: 71 VKFYGVCT----EG-DPPIMVFEYMEHG 93
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 7/79 (8%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G+ G V+K K ETG TVA+K + L++ G + E +AL +H ++K++ V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 114 CSSIDFKGVDFKALIYEYM 132
G F L+ EYM
Sbjct: 68 FP----HGSGF-VLVMEYM 81
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 22/79 (27%), Positives = 46/79 (58%), Gaps = 5/79 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G++G VYK + +TG VA+K + ++ + G + + E + L +RH N++++ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 114 CSSIDFKGVDFKALIYEYM 132
+S + +++EYM
Sbjct: 67 VTSKGKGSI---YMVFEYM 82
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 9/99 (9%)
Query: 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE 97
VS D + N IG+G+ G VYK TG VA+K M L+++ + + E
Sbjct: 12 VSEGDPRELYKNLE---KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEIL 67
Query: 98 ALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
+ + +H N++ S + ++ EYM GS
Sbjct: 68 IMKDCKHPNIVDYY---DSYLVGDELW--VVMEYMDGGS 101
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 1/67 (1%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIK 109
F+ +G G FG V++G L + VA+K++ + F E +AL +RH++LI
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 110 IITVCSS 116
+ VCS
Sbjct: 67 LFAVCSV 73
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG+G FG V G G VAVK + AA++F+ E ++ +RH NL++++ V
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV- 69
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWM 141
+ + ++ EYM GS D++
Sbjct: 70 -LQGNPL---YIVTEYMAKGSLVDYL 91
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 22/84 (26%), Positives = 44/84 (52%), Gaps = 2/84 (2%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVK--VMNLKQKGAAKSFVTECEALSNVRHR 105
+ + IGQG+FG V+K + +T VA+K +M +++G + + E + L ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 106 NLIKIITVCSSIDFKGVDFKALIY 129
N++ +I +C + +K Y
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFY 95
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 17/86 (19%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-------HRNLI 108
+G G+FG VY + ETG VA+K M K+K + EC L V+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM--KKKFYSWE---ECMNLREVKSLRKLNEHPNIV 61
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKC 134
K+ V F+ D ++EYM+
Sbjct: 62 KLKEV-----FRENDELYFVFEYMEG 82
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 5/110 (4%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG G++G VYK + TG VA+KV+ L+ + E L RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG--- 67
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLE 165
+ D ++ EY GS +D + L + + R L L
Sbjct: 68 --SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 22/58 (37%), Positives = 37/58 (63%), Gaps = 4/58 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G FG V +G+ TG VAVK N+K A++F+ E ++ + H+NL++++ V
Sbjct: 14 IGEGEFGAVLQGEY--TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 1/92 (1%)
Query: 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY 553
S +T + + + + L G + SG + ++ L I+ ++LS N LSG IP
Sbjct: 53 SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD 112
Query: 554 LENLLF-LAYLNLSYNHFEGEVPRKGVFGNRT 584
+ L YLNLS N+F G +PR + T
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPRGSIPNLET 144
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 19/106 (17%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVC 114
+G G FG V+ G T T VAVK LK + ++F+ E + + +RH L+++ VC
Sbjct: 14 LGAGQFGEVWMGTWNGT-TKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 115 SSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNLGLIQ 157
S + IY EYM GS D++ E L L Q
Sbjct: 71 SEEE--------PIYIVTEYMSKGSLLDFLKSG----EGKKLRLPQ 104
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG+G FG V G G VAVK +K A++F+ E ++ +RH NL++++ V
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWM 141
++ KG + ++ EYM GS D++
Sbjct: 69 -VEEKGGLY--IVTEYMAKGSLVDYL 91
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 27/122 (22%), Positives = 61/122 (50%), Gaps = 13/122 (10%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIK 109
+G+G+FG VYKG+L + T+VA+K + + + F E E +S+++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDW--MHQSNDKLEAGNLGLIQRLNLLKLEMI 167
++ VC+ K +++EY+ G ++ + + + A + + +L + +
Sbjct: 73 LLGVCT----KEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 168 DV 169
+
Sbjct: 128 HI 129
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G++G VYK + TG VA+K + L+ +G K+ + E + L + H N+IK++ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 114 CSSIDFKGVDFKALIYEYMK 133
F+ L++E+M
Sbjct: 67 -----FRHKGDLYLVFEFMD 81
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 27/103 (26%), Positives = 52/103 (50%), Gaps = 15/103 (14%)
Query: 55 MIGQGSFGFVYKG---KLGET-GTTVAVKVMNLKQKGAAKS---FVTECEALSNVRHRNL 107
++G G+FG VYKG GE VA+KV L+++ + K+ + E +++V H ++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHV 71
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150
++++ +C S LI + M G D++ D + +
Sbjct: 72 VRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGS 108
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 50 FSASNMIGQGSFGFVYKGKLG-ETGTTVAVKVMNLKQKGAAKS----FVTECEALSNVRH 104
++G+G FG V +G+L + G+ + V V +K S F++E + + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 105 RNLIKIITVC-SSIDFKGVDFKALIYEYMKCG 135
N++K+I VC + + + +I +MK G
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHG 92
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 8/61 (13%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNL-----KQKGAAKSFVTECEALSNVRHRNLI 108
IG+GSFG VY + G +K ++L K++ A + E + L + H N+I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPNII 62
Query: 109 K 109
K
Sbjct: 63 K 63
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 32/204 (15%)
Query: 55 MIGQGSFGFVYKGKLGETGTT----VAVKVMNLKQKGAAK-SFVTECEALSNVRHRNLIK 109
++G G+FG VYKG G T VA+K++N A F+ E ++++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND------------KLEAGNLGLIQ 157
++ VC S + L+ + M G D++H+ D ++ G + L +
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 158 RLNLLKLEMIDVGDNQLIGKFPDF--IANFS---ALEAIDISANMLGGRIPDSLCQLRSL 212
R +L D+ ++ K P+ I +F LE + N GG++P L +
Sbjct: 128 R----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 213 NYLSISENNFSCKLPLSIWNISSL 236
+Y + + ++IW + +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 16/34 (47%), Positives = 21/34 (61%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL 83
F+ IG+GSFG VYK T VA+KV++L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL 36
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIIT 112
+ +G G +G VY+G + TVAVK LK+ + F+ E + ++H NL++++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
VC+ + F +I E+M G+ D++ + N +
Sbjct: 70 VCT----REPPF-YIITEFMTYGNLLDYLRECNRQE 100
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 15/91 (16%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA-AKSFVTECEALSNVRHRNLIKIITVC 114
+G G FG V++G T T VAVK LK K F+ E + + +RH LI++ VC
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 115 SSIDFKGVDFKALIY---EYMKCGSSEDWMH 142
+ + IY E MK GS +++
Sbjct: 71 TLEE--------PIYIVTELMKYGSLLEYLQ 93
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 20/56 (35%), Positives = 32/56 (57%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G G+FG VYK K ETG A KV+ K + + ++ E E L+ H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 9/91 (9%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVRHRNL 107
F IG+G++G VYK + +TG VA+K + L +++G + + E + L + HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 108 IKIITVCSSIDFKGVDFKA------LIYEYM 132
+ + + + +DFK L++EYM
Sbjct: 69 VNLKEIVTD-KQDALDFKKDKGAFYLVFEYM 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 22/70 (31%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVRHRN 106
NF IG+G++G VYK + TG VA+K + L + +G + + E L + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 107 LIKIITVCSS 116
++K++ V +
Sbjct: 61 IVKLLDVIHT 70
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 25/102 (24%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 56 IGQGSFGFVYKGKLGETG-------TTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLI 108
+GQG+F ++KG E G T V +KV++ + ++SF +S + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150
VC D ++ EY+K GS + ++ ++ + +
Sbjct: 63 LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKNLINI 99
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 40/130 (30%), Positives = 57/130 (43%), Gaps = 18/130 (13%)
Query: 49 NFSASNMIGQGSFGFVYKGKL----GETG-TTVAVKVMNLKQKGAAKS----FVTECEAL 99
N +G+G FG V K G G TTVAVK++ ++ A+ S ++E L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLL 57
Query: 100 SNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRL 159
V H ++IK+ CS G LI EY K GS ++ +S K+ LG
Sbjct: 58 KQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESR-KVGPSYLGSDGNR 111
Query: 160 NLLKLEMIDV 169
N L+ D
Sbjct: 112 NSSYLDNPDE 121
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 15/29 (51%), Positives = 23/29 (79%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNL 83
+IG+G++G VY+GK TG VA+K++NL
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINL 36
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 18/56 (32%), Positives = 33/56 (58%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G G+FG VYK + ETG A K++ ++ + + F+ E + LS +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY 68
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 21/61 (34%), Positives = 34/61 (55%)
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEV 574
L L G +P + L+ ++ ++LS N++ G IP L ++ L L+LSYN F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 575 P 575
P
Sbjct: 483 P 483
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKV--MNLKQKGAAKSFVTECEALSNVRHRN 106
F N IG+G++G VY+ + +G VA+K M+ ++ G S + E L N+RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 107 LIKIITV 113
++++ V
Sbjct: 68 IVELKEV 74
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIK 109
N IG G+FG VY +TG +AVK + ++ K E + L ++H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 25/142 (17%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+GQG FG V+ G T T VA+K + + ++F+ E + + +RH L+++ V S
Sbjct: 14 LGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE------------AGNLGLIQRLNL-- 161
+ ++ EYM GS D++ K A + ++R+N
Sbjct: 72 E------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 162 --LKLEMIDVGDNQLIGKFPDF 181
L+ I VG+N L+ K DF
Sbjct: 126 RDLRAANILVGEN-LVCKVADF 146
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 14/89 (15%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA-KSFVTECEALSNVRHRNLIKIITVC 114
+GQGS G VYK + TG A+K +++ K + E + L + ++K
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63
Query: 115 SSIDFKGVDFK----ALIYEYMKCGSSED 139
G +K +++ EYM GS D
Sbjct: 64 ----CYGAFYKEGEISIVLEYMDGGSLAD 88
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 19/92 (20%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSF---VTECEALSNVRHRNLIKIIT 112
IG GSFG VY + T VA+K M+ K + + + + E L +RH N
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN------ 76
Query: 113 VCSSIDFKGVDFKA----LIYEYMKC-GSSED 139
+I++KG + L+ EY C GS+ D
Sbjct: 77 ---TIEYKGCYLREHTAWLVMEY--CLGSASD 103
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 20/63 (31%), Positives = 37/63 (58%), Gaps = 2/63 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G++G VYK + T T+A+K + L+Q +G + + E L ++H N++++ V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 114 CSS 116
S
Sbjct: 70 VHS 72
|
Length = 294 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNV-RHRNLIKII 111
IG+GSF V K ET A+K+++ L ++ K E E L+ + H +IK+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 24/82 (29%), Positives = 44/82 (53%), Gaps = 10/82 (12%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK-----SFVTECEALSNVRHRNLIKI 110
+G+G++ VYK + ETG VA+K + L ++ AK + + E + L ++H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 111 ITVCSSIDFKGVDFKALIYEYM 132
+ V F L++E+M
Sbjct: 68 LDV-----FGHKSNINLVFEFM 84
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 55 MIGQGSFGFVYKGK---LGE-TGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G+FG V + L + TG VAVK + + F E E L +++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
VC S + + L+ EY+ GS D++ + ++L+ L
Sbjct: 71 KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKL 110
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 4/63 (6%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVM--NLKQKGAAKSFVTECEALSNVRHRNLIKIIT 112
++G+G+FG V+KG L + T VAVK +L Q+ K F++E L H N++K+I
Sbjct: 2 LLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 113 VCS 115
VC+
Sbjct: 60 VCT 62
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 18/92 (19%)
Query: 54 NMIGQGSFGFVYKGKL------GETGTTVAVKVMNLKQKGAA----KSFVTECEALSNVR 103
N +G G+FG VY+G G VAVK + +KGA K F+ E +SN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 104 HRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
H N++K++ VC + + +I E M+ G
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGG 84
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 23/82 (28%), Positives = 43/82 (52%), Gaps = 9/82 (10%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITV 113
+G+G++G VYK + +TG VA+K + L + G + + E L ++H N++K++ V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 114 CSSIDFKGVDFK-ALIYEYMKC 134
+ K L++EY
Sbjct: 67 IHTER------KLYLVFEYCDM 82
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 19/56 (33%), Positives = 35/56 (62%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G G+FG VYK + ETG A KV++ K + + ++ E + L++ H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 5/60 (8%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA-AKSFVTECEA----LSNVRHRNLIK 109
++G GSFG VY+G + G AVK ++L G + V + E LS ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 20/60 (33%), Positives = 37/60 (61%), Gaps = 2/60 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G++G VYKG+ +TG VA+K + L+ ++G + + E L ++H N++ + V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 22/81 (27%), Positives = 37/81 (45%), Gaps = 6/81 (7%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVRHRNLIKIITV 113
IG G++G V TG VA+K ++ AK + E + L ++RH N+I ++ +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 114 CSSIDFKGVDFKAL--IYEYM 132
DF + + E M
Sbjct: 68 --LRPPSPEDFNDVYIVTELM 86
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVM--NLKQKGAAKSFVTECEALSNVRHRNLIKIIT 112
++G+GS+G V K K ETG VA+K + K K + E L +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 113 VC 114
V
Sbjct: 68 VF 69
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 33/121 (27%), Positives = 53/121 (43%), Gaps = 20/121 (16%)
Query: 56 IGQGSFGFVYKGKLGETGTT-----VAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G+FG V+ + T VAVK + A K F E E L+N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMH----------QSNDKLEAGNLGLIQRLN 160
VC D +++EYMK G ++ + G LGL Q L+
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 161 L 161
+
Sbjct: 128 I 128
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 24/66 (36%), Positives = 35/66 (53%), Gaps = 11/66 (16%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVM------NLKQKGAAKSFVTECEALSNVRHRNLIK 109
IG+G+FG V+ G+L T VAVK +LK K F+ E L H N+++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 110 IITVCS 115
+I VC+
Sbjct: 58 LIGVCT 63
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK 84
L T F +IG+G++G VYK + +TG VA+K+M++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII 42
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 33/110 (30%), Positives = 52/110 (47%), Gaps = 21/110 (19%)
Query: 54 NMIGQGSFGFVYKGKLGETG---TTVAVKVMNLKQKGAAKS---FVTECEALSNVRHRNL 107
+IG G FG V +G+L G VA+K LK + K F+TE + H N+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 108 IKIITVCSSIDFKGVDFKA----LIYEYMKCGSSEDWMHQSNDKLEAGNL 153
I++ GV K+ +I EYM+ GS + ++ +++ K G L
Sbjct: 68 IRLE---------GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL 108
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 53/166 (31%), Positives = 72/166 (43%), Gaps = 5/166 (3%)
Query: 431 GNLTLLNRLFLGFNNLQGN-VPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLA 489
G+ LLN L L +L N + S++ L T LDL N + PL NL
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ 549
E DLS+N +P L L+ L L N S LP L L ++ LDLS N +S
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 550 IPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLC 595
+P +E L L L+LS N + N +G+ L N+
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246
|
Length = 394 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 15/97 (15%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G+GS+G VYK ETG VA+KV+ + + + + E L ++K
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62
Query: 116 SIDFKGVDFKA----LIYEYMKCGSSEDWMHQSNDKL 148
+ G FK ++ EY GS D M +N L
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL 96
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 4/63 (6%)
Query: 56 IGQGSFGFVYKGK-LGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKII 111
+G G+FG V KG L ++G V V V LKQ K F+ E ++ + H ++++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 112 TVC 114
VC
Sbjct: 63 GVC 65
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNV 102
+N +G+G+FG V+ + + VAVK + A K F E E L+N+
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 103 RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
+H +++K VC +G D +++EYMK G
Sbjct: 65 QHEHIVKFYGVC----VEG-DPLIMVFEYMKHG 92
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 29/120 (24%), Positives = 56/120 (46%), Gaps = 19/120 (15%)
Query: 56 IGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G+FG V+ + + VAVK + + A + F E E L+ ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWM--HQSNDKLEA-------GNLGLIQRLNL 161
VC+ +++EYM+ G ++ H + K+ A G L L Q L +
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 24/85 (28%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNL 107
NF +G+G++ VYKG+ TG VA+K ++L ++G + + E + ++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 108 IKIITVCSSIDFKGVDFKALIYEYM 132
+++ V + + K + L++EYM
Sbjct: 61 VRLHDVIHTEN-KLM----LVFEYM 80
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 4/65 (6%)
Query: 55 MIGQGSFGFVYKG---KLGETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIKI 110
IG+G FG VY+G VAVK + + F+ E + H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 111 ITVCS 115
I V +
Sbjct: 73 IGVIT 77
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 30/123 (24%), Positives = 57/123 (46%), Gaps = 20/123 (16%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL---GETGTTVAVKVMNL----KQKGAAKSFVTECEALS 100
++ + +IG G FG V++G L G VA+K + KQ+ + F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61
Query: 101 NVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLN 160
H N+I++ V + FK +I EYM+ G+ + ++ + G Q +
Sbjct: 62 QFSHHNIIRLEGVVTK--FKPA---MIITEYMENGALDKYLRDHD-----GEFSSYQLVG 111
Query: 161 LLK 163
+L+
Sbjct: 112 MLR 114
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 25/142 (17%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G FG V+ G T VAVK + + +SF+ E + + +RH L+++ V S
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSND---KLE---------AGNLGLIQRLNLLK 163
++ EYM GS D++ KL A + I+R+N +
Sbjct: 72 EEPI------YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 164 LEM----IDVGDNQLIGKFPDF 181
++ I VGD L+ K DF
Sbjct: 126 RDLRSANILVGDG-LVCKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 15/88 (17%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAA---KSFVTECEALSNVRHRNL 107
IGQG+FG V++ + E T VAVK+ LK++ +A F E ++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCG 135
+K++ VC+ G L++EYM G
Sbjct: 71 VKLLGVCA----VGKPM-CLLFEYMAYG 93
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 21/59 (35%), Positives = 30/59 (50%)
Query: 512 LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHF 570
L+ L L N + + K L ++K LDLS NNL+ P+ L L L+LS N+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 19/68 (27%), Positives = 38/68 (55%), Gaps = 2/68 (2%)
Query: 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVK-VMNLKQK-GAAKSFVTECEALSNVR 103
++ +G+G+FG VYK + +TG VA+K ++ +K G + + E + L ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 104 HRNLIKII 111
H N++ +I
Sbjct: 66 HPNVVPLI 73
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 21/63 (33%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G++G V+K K ET VA+K + L +G S + E L ++H+N++++ V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 114 CSS 116
S
Sbjct: 68 LHS 70
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 24/89 (26%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 231 WNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDV 290
W I L L + G +P +I + ++ +++ N+ G++P S + ++L+VLD+
Sbjct: 418 WFIDGL---GLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL 473
Query: 291 YKNHFSGQVKIDFNRLSNLSRLFLSKNNL 319
N F+G + +L++L L L+ N+L
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 53 SNMIGQGSFGFVYKGKLGETGTTVAVK--VMNLKQKGAAKSFVTECEALSNVR---HRNL 107
IG+G++G VYK + TG VA+K + L ++G S + E L + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKC 134
++++ VC L++E++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ 90
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 19/60 (31%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+G++G VYK + TG VA+K + L+ +G + + E L + H N+++++ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 31 MEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK 90
+E+ +VS D K F IGQG+ G VY TG VA+K MNL+Q+ +
Sbjct: 5 LEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE 61
Query: 91 SFVTECEALSNVRHRNLIKIIT---VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
+ E + +H N++ + V + ++ EY+ GS D + ++
Sbjct: 62 LIINEILVMRENKHPNIVNYLDSYLVGDEL--------WVVMEYLAGGSLTDVVTET--C 111
Query: 148 LEAGNLGLIQRLNLLKLEMI--------DV-GDNQLIG-----KFPDF 181
++ G + + R L LE + D+ DN L+G K DF
Sbjct: 112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 44/217 (20%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA---KSFVTECEALSNV-RHRNLIK 109
++IG+G+FG V + + + G + + LK+ + + F E E L + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQS----NDKL---EAGNLGLIQRLNLL 162
++ C + +G + A+ EY G+ D++ +S D E G + LL
Sbjct: 68 LLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 163 KLEM-----------------------IDVGDNQLIGKFPDFIANFSALEAIDISANMLG 199
+ + VG+N L K DF S E + + M
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LASKIADF--GLSRGEEVYVKKTM-- 177
Query: 200 GRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236
GR+P + SLNY + + + +W I SL
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.003
Identities = 23/64 (35%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 411 NLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLS 470
NL+ L L N L L L L L NNL P + +L R LDLS
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL----RSLDLS 56
Query: 471 GNLL 474
GN L
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 12/147 (8%)
Query: 31 MEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK 90
+E+ +VS D K F IGQG+ G VY TG VA++ MNL+Q+ +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 91 SFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150
+ E + ++ N++ + + D ++ EY+ GS D + ++ ++
Sbjct: 63 LIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC--MDE 115
Query: 151 GNLGLIQRLNLLKLEMIDVGDNQLIGK 177
G + + R L LE + NQ+I +
Sbjct: 116 GQIAAVCRECLQALEFLH--SNQVIHR 140
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 23/89 (25%), Positives = 35/89 (39%), Gaps = 14/89 (15%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKV-----MNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
IG+GSFG V K + G + K M K+K + V+E L ++H N I
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK---QQLVSEVNILRELKHPN---I 61
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSED 139
+ I + +Y M+ D
Sbjct: 62 VRYYDRIIDRS---NQTLYIVMEYCEGGD 87
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 56 IGQGSFGFV----YKGKLGETGTTVAVKVMNLKQKGA-AKSFVTECEALSNVRHRNLIKI 110
+G+G FG V Y + TG VAVK + + G E E L N+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+C+ G+ LI E++ GS ++++ ++ +K+
Sbjct: 72 KGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKI 106
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 628 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.69 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.51 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.48 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.45 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.4 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.39 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.39 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.39 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.38 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.37 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.37 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.36 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.36 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.33 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.33 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.31 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.31 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.3 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.29 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.28 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.28 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.27 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.27 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.27 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.27 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.26 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.25 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.24 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.24 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.23 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.21 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.21 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.2 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.19 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.18 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.18 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.18 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.17 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.17 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.17 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.16 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.15 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.14 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.14 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.14 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.14 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.14 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.14 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.13 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.13 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.13 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.13 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.13 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.12 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.12 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.12 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.12 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.1 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.1 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.1 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.09 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.09 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.08 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.08 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.08 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.08 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.08 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.07 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.07 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.07 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.07 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.06 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.05 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.05 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.05 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.04 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.04 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.04 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.04 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.04 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.04 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.04 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.04 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.03 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.03 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.03 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.02 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.02 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.02 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.02 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.01 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.01 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.01 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.01 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.01 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.0 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 98.99 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 98.99 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 98.99 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 98.99 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 98.99 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 98.99 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 98.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 98.98 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 98.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 98.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 98.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 98.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 98.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 98.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 98.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 98.97 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 98.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 98.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 98.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 98.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 98.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 98.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 98.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 98.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 98.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 98.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 98.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 98.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 98.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 98.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 98.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 98.94 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 98.93 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 98.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 98.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 98.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 98.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 98.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 98.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 98.93 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 98.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 98.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 98.92 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 98.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 98.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 98.92 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 98.92 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 98.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 98.92 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 98.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 98.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 98.92 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 98.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 98.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 98.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 98.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 98.91 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 98.91 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 98.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 98.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 98.9 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 98.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 98.9 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 98.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 98.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 98.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 98.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 98.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 98.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 98.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 98.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 98.89 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 98.89 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 98.89 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 98.89 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 98.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 98.89 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 98.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 98.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 98.89 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 98.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 98.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 98.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 98.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 98.88 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 98.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 98.88 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 98.88 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 98.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 98.88 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 98.87 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 98.87 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 98.87 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 98.87 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 98.87 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 98.87 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 98.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 98.87 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 98.87 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 98.87 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 98.87 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 98.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 98.86 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 98.86 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 98.86 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 98.86 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 98.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 98.86 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 98.86 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 98.86 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 98.86 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 98.86 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 98.85 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 98.85 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 98.85 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 98.85 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 98.85 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 98.84 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 98.84 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 98.84 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 98.84 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 98.84 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 98.84 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 98.84 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 98.84 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 98.84 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 98.84 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 98.84 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 98.84 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 98.83 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 98.83 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 98.83 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 98.83 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 98.82 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.82 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 98.82 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 98.82 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 98.82 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 98.82 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 98.82 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 98.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 98.82 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 98.81 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 98.81 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 98.81 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 98.81 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 98.81 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 98.81 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 98.81 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 98.81 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 98.8 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 98.8 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 98.8 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 98.8 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 98.8 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 98.8 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 98.8 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 98.8 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 98.79 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 98.79 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 98.79 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 98.79 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 98.78 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 98.78 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 98.78 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 98.78 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 98.78 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 98.78 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 98.78 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 98.77 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 98.77 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 98.77 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 98.77 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 98.76 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 98.76 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 98.76 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 98.76 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 98.76 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 98.76 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 98.76 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 98.76 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 98.75 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 98.75 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 98.75 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 98.74 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 98.74 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 98.74 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 98.74 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 98.74 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 98.74 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 98.73 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 98.73 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 98.73 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 98.73 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 98.73 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 98.72 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 98.72 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 98.72 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 98.72 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 98.72 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 98.72 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 98.71 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 98.71 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 98.71 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 98.71 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 98.71 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 98.71 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 98.71 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 98.7 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 98.7 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 98.7 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 98.7 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 98.7 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 98.7 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 98.7 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 98.69 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 98.69 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 98.69 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 98.69 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 98.69 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 98.68 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 98.68 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 98.68 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 98.68 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 98.68 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 98.68 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 98.67 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 98.67 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 98.67 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 98.67 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 98.66 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 98.66 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 98.66 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 98.66 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.66 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 98.66 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 98.65 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 98.65 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 98.65 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 98.65 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 98.64 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 98.63 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 98.63 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 98.62 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 98.6 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 98.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.6 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 98.59 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 98.59 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 98.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 98.58 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 98.57 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 98.57 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 98.57 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 98.56 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 98.56 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 98.55 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 98.55 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 98.55 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 98.54 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 98.54 | |
| PTZ00284 | 467 | protein kinase; Provisional | 98.53 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 98.51 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 98.51 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 98.51 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 98.51 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 98.5 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 98.5 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 98.49 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 98.47 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 98.47 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 98.47 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 98.46 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 98.46 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 98.44 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.44 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 98.44 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.44 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 98.42 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 98.41 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.39 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.38 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.36 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 98.35 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.35 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.35 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 98.34 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.3 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 98.29 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 98.26 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 98.26 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.24 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 98.22 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 98.2 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.19 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.18 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 98.13 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.12 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.09 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.08 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.03 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.03 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 98.02 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.01 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 97.99 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 97.97 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.95 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 97.94 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 97.9 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 97.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 97.86 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.84 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.8 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 97.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 97.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 97.69 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 97.67 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 97.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.62 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 97.6 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 97.6 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 97.59 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 97.47 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.46 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 97.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.42 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 97.26 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 97.25 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 97.21 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.19 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.05 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 97.0 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 96.93 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 96.88 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 96.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.58 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 96.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 96.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.01 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 95.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 95.98 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 95.74 | |
| KOG0473 | 326 | consensus Leucine-rich repeat protein [Function un | 95.46 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 95.39 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.32 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.27 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 95.08 | |
| KOG4308 | 478 | consensus LRR-containing protein [Function unknown | 95.06 | |
| KOG1947 | 482 | consensus Leucine rich repeat proteins, some prote | 94.85 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-54 Score=494.55 Aligned_cols=441 Identities=34% Similarity=0.565 Sum_probs=279.5
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
+++++|++||+++|.+.+..|..++++++|++|+|++|.+.+..|..++.+++|++|+|++|.+++.+|..++++++|++
T Consensus 161 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 240 (968)
T PLN00113 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240 (968)
T ss_pred hcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCE
Confidence 34444555555555544444444445555555555555444444444445555555555555444444444445555555
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
|++++|.+++.+|..+. .+++|+.|++++|++++..|..+.++++|++|++++|.+.+..|..+..+++|++|++++|.
T Consensus 241 L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~ 319 (968)
T PLN00113 241 LDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319 (968)
T ss_pred EECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCc
Confidence 55555544444444333 24455555555554444444444444555555555554444444444444555555555544
Q ss_pred CCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccc
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 398 (628)
+.+. .+..+..+++|+.|++++|.+.+..+..+..+. +|+.|++++|++.+..|..+..+++|+.+++++|.+
T Consensus 320 ~~~~------~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l 392 (968)
T PLN00113 320 FTGK------IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392 (968)
T ss_pred cCCc------CChhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEe
Confidence 4331 122344455556666666655555555555443 555555555555555555555444555555555554
Q ss_pred cccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchh-----------------
Q 042887 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLM----------------- 461 (628)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----------------- 461 (628)
.+..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..|..+..+++|.
T Consensus 393 ~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~ 472 (968)
T PLN00113 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472 (968)
T ss_pred cccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc
Confidence 444444444555555555555555544454454455555555554444444443333332221
Q ss_pred ---cccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCE
Q 042887 462 ---TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKE 538 (628)
Q Consensus 462 ---~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 538 (628)
.+ +.|++++|++.+..|..+.++++|++|++++|++.+.+|..+..+++|++|++++|.+++.+|..+..+++|+.
T Consensus 473 ~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 551 (968)
T PLN00113 473 GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551 (968)
T ss_pred ccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCE
Confidence 11 77899999998888999999999999999999999999999999999999999999999999999999999999
Q ss_pred EECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCcccCCCCCCCCCCC
Q 042887 539 LDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHF 608 (628)
Q Consensus 539 L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~~l~l~~c~~ 608 (628)
|+|++|++++.+|..+.++++|+.|++++|+++|.+|..+.+.++....+.||+.+|++.+....++|..
T Consensus 552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~ 621 (968)
T PLN00113 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR 621 (968)
T ss_pred EECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc
Confidence 9999999999999999999999999999999999999999999888899999999998766556778864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=470.06 Aligned_cols=427 Identities=34% Similarity=0.544 Sum_probs=384.7
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
+.+.+++|++|||++|.+.+..|..++++++|++|++++|.+.+..|..|+++++|++|+|++|.+.+..|..++++++|
T Consensus 135 p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 214 (968)
T PLN00113 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSL 214 (968)
T ss_pred CccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCc
Confidence 44568899999999999999999999999999999999999999999999999999999999999998999999999999
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccC
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 316 (628)
++|++++|.+++.+|..+. .+++|++|++++|++++..|..++++++|++|++++|++++..|..+..+++|++|++++
T Consensus 215 ~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 293 (968)
T PLN00113 215 KWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293 (968)
T ss_pred cEEECcCCccCCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcC
Confidence 9999999999988998876 499999999999999999999999999999999999999998999999999999999999
Q ss_pred CcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccc
Q 042887 317 NNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYN 396 (628)
Q Consensus 317 n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 396 (628)
|.+.+ ..+..+.++++|+.|++++|.+.+..+..+..++ +|+.|++++|.+.+.+|..+..+++|+.|++++|
T Consensus 294 n~l~~------~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n 366 (968)
T PLN00113 294 NSLSG------EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366 (968)
T ss_pred Ceecc------CCChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCC
Confidence 99876 3445677889999999999999999888888887 8999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCcc
Q 042887 397 QLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGG 476 (628)
Q Consensus 397 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~ 476 (628)
++.+..|..++.+++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..+..+++| +.|++++|.+.+
T Consensus 367 ~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L----~~L~Ls~N~l~~ 442 (968)
T PLN00113 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLV----YFLDISNNNLQG 442 (968)
T ss_pred eeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCC----CEEECcCCcccC
Confidence 9999999999999999999999999999999999999999999999999999999999998888 777888888776
Q ss_pred ccchhhhccC-----------------------CCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCC
Q 042887 477 SIPLEVGNLR-----------------------NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTL 533 (628)
Q Consensus 477 ~~~~~~~~l~-----------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 533 (628)
..+..+..++ +|+.|++++|++++..|..+..+++|+.|++++|++.+.+|..+..+
T Consensus 443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 522 (968)
T PLN00113 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522 (968)
T ss_pred ccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCc
Confidence 6665544444 45556666666666777777888889999999999998899999999
Q ss_pred CCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCC-CCCCCCCcccccCCCCCc
Q 042887 534 KSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK-GVFGNRTGIHLIGNERLC 595 (628)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c 595 (628)
++|++|+|++|.+++.+|..|..+++|+.||+++|++++.+|.. ..+.+++.+++++|+..+
T Consensus 523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 99999999999999999999999999999999999999888753 456788899999997654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=354.19 Aligned_cols=374 Identities=22% Similarity=0.244 Sum_probs=259.9
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
.+.||+|+|++....+..|.++++|+++++.+|.++ .+|.-.....+|+.|+|.+|.|+.+..+.+..++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 344555555555555555555555555555555554 3444333344455555555555544444455555555555555
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcC
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTES 323 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 323 (628)
|.|+ ++|...|-.-.++++|+|++|.|+....+.|.++.+|.+|.|+.|+|+..++..|.++++|+.|+|..|+|
T Consensus 159 N~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~i---- 233 (873)
T KOG4194|consen 159 NLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRI---- 233 (873)
T ss_pred chhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccce----
Confidence 5554 44444443344455555555555544445555555555555555555544444455555555555555544
Q ss_pred CCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCC
Q 042887 324 TSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIP 403 (628)
Q Consensus 324 ~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 403 (628)
.....-.|..+. +++.|.+..|.+...-...|-.+.++++|+|+.|++.....
T Consensus 234 --------------------------rive~ltFqgL~-Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~ 286 (873)
T KOG4194|consen 234 --------------------------RIVEGLTFQGLP-SLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE 286 (873)
T ss_pred --------------------------eeehhhhhcCch-hhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc
Confidence 333333334443 56666666666666666778888999999999999988888
Q ss_pred cCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhh
Q 042887 404 HAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483 (628)
Q Consensus 404 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~ 483 (628)
.++.++++|+.|++|+|.|...-++++...++|+.|+|++|+|+...+..|..+..| +.|+|++|++...-...|.
T Consensus 287 g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L----e~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 287 GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL----EELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHh----hhhcccccchHHHHhhHHH
Confidence 889999999999999999998888899999999999999999998888888888888 7889999999977778899
Q ss_pred ccCCCCEeeCcCCcCcccCC---ccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCC
Q 042887 484 NLRNLAEFDLSENHFSNEIP---VTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFL 560 (628)
Q Consensus 484 ~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 560 (628)
.+++|++|||++|.++..+. ..|.++++|+.|++.+|++..+...+|.++++|++|||.+|.|..+-|++|..+ .|
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~L 441 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-EL 441 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hh
Confidence 99999999999999886543 457789999999999999997777889999999999999999998889999998 89
Q ss_pred CeEeccCCcCcccCC
Q 042887 561 AYLNLSYNHFEGEVP 575 (628)
Q Consensus 561 ~~L~ls~N~l~~~~p 575 (628)
++|-++.-.|-.+..
T Consensus 442 k~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 442 KELVMNSSSFLCDCQ 456 (873)
T ss_pred hhhhhcccceEEecc
Confidence 998887665554433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=351.14 Aligned_cols=396 Identities=22% Similarity=0.248 Sum_probs=294.8
Q ss_pred ccEEEccCCccccccchhhhCC--CCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 164 LEMIDVGDNQLIGKFPDFIANF--SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
-..||.+++.+.......+.++ +.-+.||+|+|++..+.+..|.++++|+.+++..|.++ .+|.......+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 3456777766654333333322 23334555555555555555555555555555555555 44544444444555555
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
.+|.|+ .+....++.++.|+.|||+.|.|+.+....|..-.++++|+|++|+|+.
T Consensus 133 ~~N~I~-------------------------sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~ 187 (873)
T KOG4194|consen 133 RHNLIS-------------------------SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITT 187 (873)
T ss_pred eccccc-------------------------cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccc
Confidence 555554 4444444445555555555555555544455555555555555555555
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccccc
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGT 401 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 401 (628)
+..+.| ..+.+|..|.|+.|+++...+..|..++ .|+.|++..|+|.-.-...|.++++|+.|.+..|+|...
T Consensus 188 l~~~~F------~~lnsL~tlkLsrNrittLp~r~Fk~L~-~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL 260 (873)
T KOG4194|consen 188 LETGHF------DSLNSLLTLKLSRNRITTLPQRSFKRLP-KLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKL 260 (873)
T ss_pred cccccc------cccchheeeecccCcccccCHHHhhhcc-hhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccc
Confidence 444332 2233455555566666666666777666 899999999999866567899999999999999999988
Q ss_pred CCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchh
Q 042887 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481 (628)
Q Consensus 402 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~ 481 (628)
-..+|..+.++++|+|+.|++...--.++.+++.|+.|++|+|.|+...++.+..+++| ++|+|++|+|+...+..
T Consensus 261 ~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL----~~LdLs~N~i~~l~~~s 336 (873)
T KOG4194|consen 261 DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL----KELDLSSNRITRLDEGS 336 (873)
T ss_pred cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc----eeEeccccccccCChhH
Confidence 88899999999999999999998888999999999999999999999999999999999 89999999999888999
Q ss_pred hhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCc---cccCCCCCCEEECCCCcccccCchhhhccc
Q 042887 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL---SLKTLKSIKELDLSRNNLSGQIPKYLENLL 558 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (628)
|..+..|++|+|++|.+...-...|.++++|++|||++|.++..+.+ .|.++++|+.|++.+|+|..+...+|.+++
T Consensus 337 f~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~ 416 (873)
T KOG4194|consen 337 FRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLE 416 (873)
T ss_pred HHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCc
Confidence 99999999999999999977778899999999999999999976543 588899999999999999988888999999
Q ss_pred CCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCcc
Q 042887 559 FLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 559 ~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~ 596 (628)
.|++|||.+|.|-..-|..-.-..++.+.+..-.++|.
T Consensus 417 ~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 417 ALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred ccceecCCCCcceeecccccccchhhhhhhcccceEEe
Confidence 99999999999987666432223677777777777884
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=324.03 Aligned_cols=412 Identities=27% Similarity=0.404 Sum_probs=299.6
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
.+.++..+++|++++|++. ..|.+++.+..++.|+.++|++. .+|..+..+.+|+.|+.++|.+. ..|+.++.+..|
T Consensus 63 dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l 139 (565)
T KOG0472|consen 63 DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDL 139 (565)
T ss_pred hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhh
Confidence 3456677788888888877 56667778888888888888877 67777888888888888888877 577777888888
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccC
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 316 (628)
+.|+..+|+++ ..|.+++. +.+|..+++.+|+++...|..+. ++.|++||..+|-++ ..|..++.+.+|..|++..
T Consensus 140 ~dl~~~~N~i~-slp~~~~~-~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 140 EDLDATNNQIS-SLPEDMVN-LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhccccccc-cCchHHHH-HHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 88888888887 67777765 77777778888877754444444 777788887777776 4455677777777777777
Q ss_pred CcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccc
Q 042887 317 NNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYN 396 (628)
Q Consensus 317 n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 396 (628)
|++... ..|..|+.|++++++.|++.........++. ++.+||+.+|++. ..|+.+.-+.+|..||+++|
T Consensus 216 Nki~~l--------Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~-~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN 285 (565)
T KOG0472|consen 216 NKIRFL--------PEFPGCSLLKELHVGENQIEMLPAEHLKHLN-SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNN 285 (565)
T ss_pred cccccC--------CCCCccHHHHHHHhcccHHHhhHHHHhcccc-cceeeeccccccc-cCchHHHHhhhhhhhcccCC
Confidence 777543 2455666677777777766555444444444 6667777777776 55666666677777777777
Q ss_pred cccccCCcCCCCCCCCCeEecccCcccc----------------------------------------------------
Q 042887 397 QLTGTIPHAIGELKNLQGLALVRNSLRG---------------------------------------------------- 424 (628)
Q Consensus 397 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------------------------------------------- 424 (628)
.|+ ..|..++++ +|+.|-+.+|.++.
T Consensus 286 ~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~ 363 (565)
T KOG0472|consen 286 DIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIIT 363 (565)
T ss_pred ccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhh
Confidence 776 345566666 66666666665541
Q ss_pred ------------ccCccccCCC---CCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCC
Q 042887 425 ------------TIPDTLGNLT---LLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLA 489 (628)
Q Consensus 425 ------------~~~~~~~~l~---~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~ 489 (628)
.+|+....-. -....+++.|++. ..|..+..+..+. +.+.+++|.++ .+|..++.+++|.
T Consensus 364 tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelv---T~l~lsnn~is-fv~~~l~~l~kLt 438 (565)
T KOG0472|consen 364 TKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELV---TDLVLSNNKIS-FVPLELSQLQKLT 438 (565)
T ss_pred hhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHH---HHHHhhcCccc-cchHHHHhhhcce
Confidence 1111111111 1334444555554 4444433333332 34667777776 6777889999999
Q ss_pred EeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCc
Q 042887 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569 (628)
Q Consensus 490 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~ 569 (628)
.|+|++|.+. .+|..++.+..|+.|++++|++. ..|.....+..|+.+-.++|++....|+.+.+|..|..||+.+|.
T Consensus 439 ~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNd 516 (565)
T KOG0472|consen 439 FLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNND 516 (565)
T ss_pred eeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCc
Confidence 9999999987 78888999999999999999998 788888888889999889999998888889999999999999999
Q ss_pred CcccCCCCCCCCCCCcccccCCCCC
Q 042887 570 FEGEVPRKGVFGNRTGIHLIGNERL 594 (628)
Q Consensus 570 l~~~~p~~~~~~~l~~~~~~~n~~~ 594 (628)
+...+|..|.+.+++++.+.|||+-
T Consensus 517 lq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 517 LQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhCChhhccccceeEEEecCCccC
Confidence 9999999999999999999999875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=310.64 Aligned_cols=429 Identities=27% Similarity=0.376 Sum_probs=351.7
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
.++.+++++|.+.. ..+.+.++..|.+|++++|++. ..|.+++.+..++.|+.++|+++ .+|..++.+.+|..|+.+
T Consensus 46 ~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 47889999999985 4456889999999999999998 78889999999999999999998 899999999999999999
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCc
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTE 322 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 322 (628)
+|.+. ++|++++. +-.++.++..+|+++ ..|.++..+.+|..+++.+|++....+.... ++.|++||...|.++.+
T Consensus 123 ~n~~~-el~~~i~~-~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGR-LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETL 198 (565)
T ss_pred cccee-ecCchHHH-Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcC
Confidence 99999 89999986 999999999999999 6788899999999999999999977776665 99999999999999875
Q ss_pred CCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccC
Q 042887 323 STSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTI 402 (628)
Q Consensus 323 ~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 402 (628)
++ .++.+.+|+.|++..|++...+ .|++.. .+.+++++.|++.-...+..+++.++.+||+..|+++ ..
T Consensus 199 P~-------~lg~l~~L~~LyL~~Nki~~lP--ef~gcs-~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 199 PP-------ELGGLESLELLYLRRNKIRFLP--EFPGCS-LLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred Ch-------hhcchhhhHHHHhhhcccccCC--CCCccH-HHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cC
Confidence 54 4777889999999999997654 555554 7899999999998444445669999999999999998 78
Q ss_pred CcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccC-------------------------------
Q 042887 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP------------------------------- 451 (628)
Q Consensus 403 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------------------------- 451 (628)
|+.++-+.+|.+||+|+|.++ ..|.+++++ +|+.|.+.+|.+...--
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 999999999999999999999 578889999 99999999998742100
Q ss_pred -------CcccCCcchh-------------------------cccceEEcCCCcCccccchhhhccCCCCE-eeCcCCcC
Q 042887 452 -------SSLGNCQNLM-------------------------TLSRLLDLSGNLLGGSIPLEVGNLRNLAE-FDLSENHF 498 (628)
Q Consensus 452 -------~~~~~l~~L~-------------------------~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l 498 (628)
..+....... ......+++.|++. .+|..+..+..+.+ +++++|.+
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 0010000000 11134666667666 45655555544443 44555555
Q ss_pred cccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC-C
Q 042887 499 SNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR-K 577 (628)
Q Consensus 499 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-~ 577 (628)
. .+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|+|++. ..|+.+..+..|+.+-.++|++....|. .
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL 501 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence 4 78888899999999999999987 78888999999999999999998 7888888888888888888998765555 4
Q ss_pred CCCCCCCcccccCCC--------CCcccCCCCCCCCCCCCCCCcce
Q 042887 578 GVFGNRTGIHLIGNE--------RLCGGLEELHLPSCHFGRPRITR 615 (628)
Q Consensus 578 ~~~~~l~~~~~~~n~--------~~c~~~~~l~l~~c~~~~~~~~~ 615 (628)
..+.+++++++..|. ..|.++.+|.+.+++|+.||-..
T Consensus 502 ~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr~Pr~~i 547 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFRQPRHQI 547 (565)
T ss_pred hhhhhcceeccCCCchhhCChhhccccceeEEEecCCccCCCHHHH
Confidence 668889999998874 33567889999999999887543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=311.26 Aligned_cols=366 Identities=24% Similarity=0.377 Sum_probs=249.0
Q ss_pred cCcccEEEccCCccc-cccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEE
Q 042887 161 LLKLEMIDVGDNQLI-GKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEII 239 (628)
Q Consensus 161 l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 239 (628)
++-++-.|+++|.++ +..|+....++.++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-+.+..++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 445678899999998 678899999999999999998887 78999999999999999999987 577788889999999
Q ss_pred EeecccCcc-cCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 240 SLHSNRFEG-SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 240 ~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
++..|++.. -+|.++|. +..|+.||||+|+++ ..|..+...+++-.|+|++|+|..++...|.+++.|-.||||+|+
T Consensus 84 ~~R~N~LKnsGiP~diF~-l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFR-LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhcc-cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 999998853 57888885 999999999999998 778889999999999999999998888888899999999999999
Q ss_pred CCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccc
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 398 (628)
+...++ ....+..|++|.|++|.+.......++.+. +|++|.+++.+-+
T Consensus 162 Le~LPP-------Q~RRL~~LqtL~Ls~NPL~hfQLrQLPsmt-sL~vLhms~TqRT----------------------- 210 (1255)
T KOG0444|consen 162 LEMLPP-------QIRRLSMLQTLKLSNNPLNHFQLRQLPSMT-SLSVLHMSNTQRT----------------------- 210 (1255)
T ss_pred hhhcCH-------HHHHHhhhhhhhcCCChhhHHHHhcCccch-hhhhhhcccccch-----------------------
Confidence 876543 355667788888888876544444333333 4444444443322
Q ss_pred cccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCcccc
Q 042887 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478 (628)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~ 478 (628)
..-+|..+..+.+|..+|+|+|.+. ..|+.+-++++|+.|+||+|+|+ ......+...++ +.|++|.|+++ .+
T Consensus 211 l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~l----EtLNlSrNQLt-~L 283 (1255)
T KOG0444|consen 211 LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENL----ETLNLSRNQLT-VL 283 (1255)
T ss_pred hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhh----hhhccccchhc-cc
Confidence 1123444555555555555555554 45555555555555555555555 233333334444 44555555555 45
Q ss_pred chhhhccCCCCEeeCcCCcCcc-cCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcc
Q 042887 479 PLEVGNLRNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557 (628)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 557 (628)
|..+..+++|+.|++.+|+++- -+|..++.+..|+.+..++|.+. ..|+.+..+..|+.|.|++|++. ..|+.+.-+
T Consensus 284 P~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL 361 (1255)
T KOG0444|consen 284 PDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLL 361 (1255)
T ss_pred hHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhc
Confidence 5555555555555555555542 24555555555555555555554 55555555555555555555554 455555555
Q ss_pred cCCCeEeccCCcC
Q 042887 558 LFLAYLNLSYNHF 570 (628)
Q Consensus 558 ~~L~~L~ls~N~l 570 (628)
+.|+.||+..|+=
T Consensus 362 ~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 362 PDLKVLDLRENPN 374 (1255)
T ss_pred CCcceeeccCCcC
Confidence 5555555555543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.23 Aligned_cols=403 Identities=28% Similarity=0.397 Sum_probs=291.0
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
+|++||+|+|++. ..|..+..+.+|+.|+++.|.|. ..|.+...+.+|++|.|.+|.+. ..|..+..+.+|++|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3899999999986 68888999999999999999998 67888999999999999999887 789999999999999999
Q ss_pred cccCcccCChhhhhCCCCCcEEecccC-------------------cccccccccccCCCCCCEEEcccccceeeccccc
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQN-------------------NFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDF 303 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N-------------------~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 303 (628)
+|++. .+|..+.. +..++.+..++| .+.+.++.....++. .|+|++|.+. ...+
T Consensus 123 ~N~f~-~~Pl~i~~-lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dl 195 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEV-LTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDL 195 (1081)
T ss_pred hhccC-CCchhHHh-hhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhh
Confidence 99997 78877764 666666666666 222222222222222 3455555443 1123
Q ss_pred ccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhh
Q 042887 304 NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIK 383 (628)
Q Consensus 304 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 383 (628)
..+++|+.|....|++..+.. .-++++.|+.++|.+....... .+.+++.+++++|++++ +|+++.
T Consensus 196 s~~~~l~~l~c~rn~ls~l~~----------~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~~-lp~wi~ 261 (1081)
T KOG0618|consen 196 SNLANLEVLHCERNQLSELEI----------SGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLSN-LPEWIG 261 (1081)
T ss_pred hhccchhhhhhhhcccceEEe----------cCcchheeeeccCcceeecccc---ccccceeeecchhhhhc-chHHHH
Confidence 334444444444444433211 1245566666666655332221 22367777777777774 347777
Q ss_pred ccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcch---
Q 042887 384 NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL--- 460 (628)
Q Consensus 384 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--- 460 (628)
.+.+|+.++..+|.+. ..|..+....+|+.|++.+|.+. -+|+....+++|++|+|..|+|. ..|+.+....+.
T Consensus 262 ~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~ 338 (1081)
T KOG0618|consen 262 ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLN 338 (1081)
T ss_pred hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHH
Confidence 7777777777777775 55666666677777777777776 45555666777777777777776 333322111110
Q ss_pred -------------------hcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCce
Q 042887 461 -------------------MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521 (628)
Q Consensus 461 -------------------~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 521 (628)
...++.|.+.+|.+++..-+.+.++.+|+.|+|++|++.......+.+++.|+.|+||+|+
T Consensus 339 ~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNk 418 (1081)
T KOG0618|consen 339 TLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNK 418 (1081)
T ss_pred HHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccch
Confidence 0112678899999998888889999999999999999986666778899999999999999
Q ss_pred eeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcc-cCCCCCCCCCCCcccccCCCCCc
Q 042887 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG-EVPRKGVFGNRTGIHLIGNERLC 595 (628)
Q Consensus 522 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~~~l~~~~~~~n~~~c 595 (628)
++ .+|..+..++.|++|...+|++. ..| .+..++.|+.+|+|.|+++. .+|.....++++.++++||++.-
T Consensus 419 L~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 419 LT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred hh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 99 88899999999999999999998 566 78899999999999999986 45555445899999999999744
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=295.10 Aligned_cols=367 Identities=23% Similarity=0.360 Sum_probs=269.3
Q ss_pred CCCCCEEecccCcCc-ccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcE
Q 042887 185 FSALEAIDISANMLG-GRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNF 263 (628)
Q Consensus 185 l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 263 (628)
++-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+. .++.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs-~Lp~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELS-DLPRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhc-cchhhHH
Confidence 344455566666665 345555666666666666666555 45666666666666666666555 3333333 2555555
Q ss_pred EecccCcccc-cccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCcee
Q 042887 264 LSVGQNNFTG-SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342 (628)
Q Consensus 264 L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L 342 (628)
+.+.+|++.. -+|..+-.+..|+.|||++|++. ..|..+....++-.|+||+|+|.+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet--------------------- 140 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET--------------------- 140 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcccc---------------------
Confidence 5555555542 23444444555555555555554 234444444445555555555444
Q ss_pred ecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCcc
Q 042887 343 YLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSL 422 (628)
Q Consensus 343 ~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 422 (628)
++-..+.++. .|-.||+++|++. .+|..+..+..|++|.+++|.+.-.--..+..+++|++|++++.+-
T Consensus 141 ---------IPn~lfinLt-DLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR 209 (1255)
T KOG0444|consen 141 ---------IPNSLFINLT-DLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR 209 (1255)
T ss_pred ---------CCchHHHhhH-hHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence 4334444444 5677778888776 6677889999999999999987533233455678899999998654
Q ss_pred c-cccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCccc
Q 042887 423 R-GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNE 501 (628)
Q Consensus 423 ~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 501 (628)
+ .-+|.++..+.+|..+|+|.|.+. ..|+.+..+.+| +.|+||+|+|+ .+....+...+|++|+||.|+++ .
T Consensus 210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~L----rrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 210 TLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNL----RRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred hhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhh----heeccCcCcee-eeeccHHHHhhhhhhccccchhc-c
Confidence 4 357889999999999999999998 899999999999 88999999998 45556666789999999999999 8
Q ss_pred CCccccCCCCCCeEECcCceeee-ecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCC
Q 042887 502 IPVTLSACTTLEYLHLQGNSFSG-SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVF 580 (628)
Q Consensus 502 ~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 580 (628)
.|..+..+++|+.|++.+|+++- -+|..++.+.+|+.+..++|.+. ..|+.+..+..|+.|.|++|++.+.+..+..+
T Consensus 283 LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL 361 (1255)
T KOG0444|consen 283 LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLL 361 (1255)
T ss_pred chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhc
Confidence 99999999999999999999873 57899999999999999999998 89999999999999999999999877788889
Q ss_pred CCCCcccccCCCCCc
Q 042887 581 GNRTGIHLIGNERLC 595 (628)
Q Consensus 581 ~~l~~~~~~~n~~~c 595 (628)
+.+..+++..||.+-
T Consensus 362 ~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 362 PDLKVLDLRENPNLV 376 (1255)
T ss_pred CCcceeeccCCcCcc
Confidence 999999999998654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=288.54 Aligned_cols=413 Identities=25% Similarity=0.356 Sum_probs=328.3
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
.++.|+++.|-+....-+...+..+|+.||+++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 3888999999887544455666667999999999997 88999999999999999999998 789999999999999999
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccc-------------------cceeeccccc
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN-------------------HFSGQVKIDF 303 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-------------------~i~~~~~~~~ 303 (628)
.|.+. .+|..+.. +.+|+.|+++.|++. ..|..+..++.++.+..++| .+.+......
T Consensus 100 ~n~l~-~lP~~~~~-lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i 176 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISE-LKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDI 176 (1081)
T ss_pred cchhh-cCchhHHh-hhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcch
Confidence 99998 89998875 999999999999998 56666666666666666655 3333333333
Q ss_pred ccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhh
Q 042887 304 NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIK 383 (628)
Q Consensus 304 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 383 (628)
..++. .|+|++|.+.. ..+.++.+|+.+....|++...... .++++.|+.++|.+....+. .
T Consensus 177 ~~l~~--~ldLr~N~~~~---------~dls~~~~l~~l~c~rn~ls~l~~~-----g~~l~~L~a~~n~l~~~~~~--p 238 (1081)
T KOG0618|consen 177 YNLTH--QLDLRYNEMEV---------LDLSNLANLEVLHCERNQLSELEIS-----GPSLTALYADHNPLTTLDVH--P 238 (1081)
T ss_pred hhhhe--eeecccchhhh---------hhhhhccchhhhhhhhcccceEEec-----CcchheeeeccCcceeeccc--c
Confidence 33333 47777777652 2355667778888888776543321 13788899999988844322 2
Q ss_pred ccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcc
Q 042887 384 NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTL 463 (628)
Q Consensus 384 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l 463 (628)
.-.+|+++++++|++.+ .|++++.+.+|+.++..+|+++ ..|..+...++|+.|.+..|.+. .+|....++..|
T Consensus 239 ~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL--- 312 (1081)
T KOG0618|consen 239 VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSL--- 312 (1081)
T ss_pred ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccccccee---
Confidence 23578999999999985 5699999999999999999996 78888899999999999999998 777788888888
Q ss_pred cceEEcCCCcCccccchhhh-------------------------ccCCCCEeeCcCCcCcccCCccccCCCCCCeEECc
Q 042887 464 SRLLDLSGNLLGGSIPLEVG-------------------------NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQ 518 (628)
Q Consensus 464 ~~~L~Ls~N~l~~~~~~~~~-------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 518 (628)
+.|+|..|+|....+..+. .++.|+.|++.+|.+++..-..+.+++.|+.|+|+
T Consensus 313 -~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLs 391 (1081)
T KOG0618|consen 313 -RTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLS 391 (1081)
T ss_pred -eeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeec
Confidence 8899999999843222111 13457788999999998777788899999999999
Q ss_pred CceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCc---
Q 042887 519 GNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLC--- 595 (628)
Q Consensus 519 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c--- 595 (628)
+|++.......+.+++.|++|+||+|+++ .+|+.+..+..|++|...+|++.. .|+....+.++.+|++.|.-.-
T Consensus 392 yNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fPe~~~l~qL~~lDlS~N~L~~~~l 469 (1081)
T KOG0618|consen 392 YNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FPELAQLPQLKVLDLSCNNLSEVTL 469 (1081)
T ss_pred ccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-chhhhhcCcceEEecccchhhhhhh
Confidence 99998555556889999999999999999 788999999999999999999984 5588889999999999874221
Q ss_pred ------ccCCCCCCCCCC
Q 042887 596 ------GGLEELHLPSCH 607 (628)
Q Consensus 596 ------~~~~~l~l~~c~ 607 (628)
..+++|+++++.
T Consensus 470 ~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 470 PEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhhCCCcccceeeccCCc
Confidence 456777887765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-30 Score=242.33 Aligned_cols=277 Identities=18% Similarity=0.194 Sum_probs=174.0
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeeccc-ccCcccCCcCccCCCCCCEEEe
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE-NNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~L 241 (628)
+...++|..|+|+.+.|.+|+.+++|++||||+|.|+.+.|++|.++++|..|-+.+ |+|+....+.|.+|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 467788888888888888888888888888888888888888888888877776666 8888766677888888888888
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccce------------eecccccccCCCC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFS------------GQVKIDFNRLSNL 309 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~------------~~~~~~~~~l~~L 309 (628)
.-|++. .++.+.++.+++|..|.+-+|.+..+--.+|..+..++++.+..|.+- ...+..++..+..
T Consensus 148 Nan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 148 NANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred Chhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 888887 788888888888888888888888555557888888888888877632 1122223333333
Q ss_pred CEEEccCCcCCCcCCCCccccccccCCCCCc-eeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCc
Q 042887 310 SRLFLSKNNLGTESTSDLDFLTLLTNCSQME-MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNI 388 (628)
Q Consensus 310 ~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~-~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L 388 (628)
.-..+.++++..+....|.. ....+. .+....+.........|..++ +|+.|++++|+++++-+.+|..+..+
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c-----~~esl~s~~~~~d~~d~~cP~~cf~~L~-~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLC-----SLESLPSRLSSEDFPDSICPAKCFKKLP-NLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred chHHHHHHHhcccchhhhhh-----hHHhHHHhhccccCcCCcChHHHHhhcc-cceEeccCCCccchhhhhhhcchhhh
Confidence 33333333333322221110 000110 111112222222333444444 55556666666655555556555666
Q ss_pred CeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccc
Q 042887 389 NAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446 (628)
Q Consensus 389 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 446 (628)
++|.+..|++..+....|.++..|+.|+|++|+|+...|.+|..+.+|.+|++-.|.+
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 6666666655544445555555666666666666555555555555555555555443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-29 Score=233.77 Aligned_cols=301 Identities=19% Similarity=0.205 Sum_probs=239.0
Q ss_pred EEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec-cc
Q 042887 167 IDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS-NR 245 (628)
Q Consensus 167 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~-n~ 245 (628)
.|=++-.++ .+|..+. ..-.+++|..|.|+.+.|.+|+.+++|+.||||+|+|+.+.|++|.++++|.+|-+.+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 444555555 4554332 3678899999999999999999999999999999999999999999999998888777 99
Q ss_pred CcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCC
Q 042887 246 FEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTS 325 (628)
Q Consensus 246 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 325 (628)
|+ .+|...|.++..|+.|.+..|++..+..+.|..+++|..|.+.+|.+..+....|..+..++.+.+..|.+.....-
T Consensus 128 I~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 128 IT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 99 99999999999999999999999999999999999999999999999988888999999999999999974332110
Q ss_pred C------ccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCc-hhhhccCCcCeeeeccccc
Q 042887 326 D------LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIP-SEIKNLVNINAFGVEYNQL 398 (628)
Q Consensus 326 ~------~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~l~~n~l 398 (628)
. ...+..++...-.....+.+.++..+....+......+..--.+.+...+..| ..|..+++|+.+++++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 0 01112233333444555666666666655554432222111122222222333 4699999999999999999
Q ss_pred cccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCc
Q 042887 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLG 475 (628)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~ 475 (628)
+++-+.+|.++.++++|.|..|++...-...|.++..|+.|+|.+|+|+...|..|..+..| ..|+|-.|.+.
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l----~~l~l~~Np~~ 359 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL----STLNLLSNPFN 359 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee----eeeehccCccc
Confidence 99999999999999999999999998778889999999999999999999999999888888 67788777664
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-24 Score=249.11 Aligned_cols=341 Identities=18% Similarity=0.236 Sum_probs=257.2
Q ss_pred ccchhhhCCCCCCEEecccCc------CcccccccccCCC-CCCEeecccccCcccCCcCccCCCCCCEEEeecccCccc
Q 042887 177 KFPDFIANFSALEAIDISANM------LGGRIPDSLCQLR-SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGS 249 (628)
Q Consensus 177 ~~~~~~~~l~~L~~L~Ls~n~------l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~ 249 (628)
..+++|.++++|+.|.+..+. +...+|..|..++ +|+.|++.++.++ .+|..| ...+|++|++++|.+. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence 456789999999999997654 3334677777775 6999999999987 678777 5789999999999998 7
Q ss_pred CChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc-CCCcCCCCcc
Q 042887 250 LPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN-LGTESTSDLD 328 (628)
Q Consensus 250 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~ 328 (628)
++..+. .+++|+.|+|+++.....+| .++.+++|++|++++|......|..+..+++|+.|++++|. +..++.
T Consensus 626 L~~~~~-~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~---- 699 (1153)
T PLN03210 626 LWDGVH-SLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT---- 699 (1153)
T ss_pred cccccc-cCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC----
Confidence 877765 59999999999876554566 48889999999999987666778889999999999999864 443322
Q ss_pred ccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccc-------cc
Q 042887 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT-------GT 401 (628)
Q Consensus 329 ~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-------~~ 401 (628)
. .++++|+.|++++|...... +....+++.|++++|.+. .+|..+ .+++|+.|++.++... ..
T Consensus 700 ---~-i~l~sL~~L~Lsgc~~L~~~----p~~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l 769 (1153)
T PLN03210 700 ---G-INLKSLYRLNLSGCSRLKSF----PDISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPL 769 (1153)
T ss_pred ---c-CCCCCCCEEeCCCCCCcccc----ccccCCcCeeecCCCccc-cccccc-cccccccccccccchhhcccccccc
Confidence 1 25788999999988643332 233458899999999986 445544 5677888877764321 11
Q ss_pred CCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchh
Q 042887 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481 (628)
Q Consensus 402 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~ 481 (628)
.+..+...++|+.|++++|...+.+|..+.++++|+.|++++|..-+.+|..+ ++++| +.|++++|.....+|..
T Consensus 770 ~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL----~~L~Ls~c~~L~~~p~~ 844 (1153)
T PLN03210 770 TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESL----ESLDLSGCSRLRTFPDI 844 (1153)
T ss_pred chhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Ccccc----CEEECCCCCcccccccc
Confidence 12223345689999999988777788889999999999998875444666655 56666 78899987654444432
Q ss_pred hhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCc
Q 042887 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNN 545 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 545 (628)
.++|++|+|++|.++ .+|..+..+++|+.|++++|+-...+|..+..+++|+.+++++|.
T Consensus 845 ---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 845 ---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 367889999999987 678888889999999998854434677778888899999988885
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-24 Score=244.97 Aligned_cols=341 Identities=19% Similarity=0.246 Sum_probs=258.2
Q ss_pred cccccccCCCCCCEeeccccc------CcccCCcCccCCC-CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccc
Q 042887 201 RIPDSLCQLRSLNYLSISENN------FSCKLPLSIWNIS-SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTG 273 (628)
Q Consensus 201 ~~~~~~~~l~~L~~L~Ls~N~------i~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 273 (628)
..+.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.++.++ .+|..+ ...+|+.|++++|++.
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~- 624 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE- 624 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-
Confidence 346679999999999997664 3335677777764 6999999999998 888876 3789999999999998
Q ss_pred cccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCccccc
Q 042887 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVF 353 (628)
Q Consensus 274 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~ 353 (628)
..+..+..+++|+.|+++++......| .+..+++|++|++++|.... ..+..+.++++|+.|++++|..-...
T Consensus 625 ~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~------~lp~si~~L~~L~~L~L~~c~~L~~L 697 (1153)
T PLN03210 625 KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLV------ELPSSIQYLNKLEDLDMSRCENLEIL 697 (1153)
T ss_pred ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCcc------ccchhhhccCCCCEEeCCCCCCcCcc
Confidence 567778899999999999876444445 47889999999999875432 34456778889999999987543333
Q ss_pred chHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccc-------ccc
Q 042887 354 LRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR-------GTI 426 (628)
Q Consensus 354 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~ 426 (628)
+..+ .+ .+|+.|++++|...+.+|.. .++|+.|++++|.+. .+|..+ .+++|+.|++.++... ...
T Consensus 698 p~~i-~l-~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~ 770 (1153)
T PLN03210 698 PTGI-NL-KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLT 770 (1153)
T ss_pred CCcC-CC-CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccc
Confidence 3333 33 37899999998765555543 467889999999887 455544 5788888888774322 122
Q ss_pred CccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccc
Q 042887 427 PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL 506 (628)
Q Consensus 427 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 506 (628)
+..+...++|+.|++++|.....+|..++++++| +.|++++|...+.+|..+ ++++|+.|++++|.....+|..
T Consensus 771 ~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L----~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~- 844 (1153)
T PLN03210 771 PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL----EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI- 844 (1153)
T ss_pred hhhhhccccchheeCCCCCCccccChhhhCCCCC----CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc-
Confidence 2233345789999999998777889889888888 889999875444666655 6889999999998655445443
Q ss_pred cCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC-cccccCchhhhcccCCCeEeccCCc
Q 042887 507 SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN-NLSGQIPKYLENLLFLAYLNLSYNH 569 (628)
Q Consensus 507 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~ls~N~ 569 (628)
.++|+.|+|++|.++ .+|.++..+++|+.|++++| ++. .+|..+..+++|+.+++++|.
T Consensus 845 --~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 845 --STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred --ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 368999999999998 68888999999999999984 455 567777888899999998885
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=218.12 Aligned_cols=267 Identities=28% Similarity=0.365 Sum_probs=141.1
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEe
Q 042887 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265 (628)
Q Consensus 186 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~ 265 (628)
..-..|+++.|.++ .+|..+. ++|+.|++++|+++ .+|.. .++|++|++++|+++ .+|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL----PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc----ccccceee
Confidence 34556777777776 4555554 36777777777776 34532 356666666666666 45531 34555666
Q ss_pred cccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecc
Q 042887 266 VGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLN 345 (628)
Q Consensus 266 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~ 345 (628)
+++|.++. +|.. .++|+.|++++|+++.+.. ..++|+.|++++|+++.++.
T Consensus 269 Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~--------------------- 319 (788)
T PRK15387 269 IFSNPLTH-LPAL---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA--------------------- 319 (788)
T ss_pred ccCCchhh-hhhc---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC---------------------
Confidence 66665552 2221 1334455555555543221 12344444444444432110
Q ss_pred cCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccc
Q 042887 346 TNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGT 425 (628)
Q Consensus 346 ~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 425 (628)
.+..+ +.|++++|++++ +|.. ..+|+.|++++|++++
T Consensus 320 --------------lp~~L------------------------~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 320 --------------LPSEL------------------------CKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS- 356 (788)
T ss_pred --------------Ccccc------------------------cccccccCcccc-cccc---ccccceEecCCCccCC-
Confidence 01122 333344444432 2211 1245556666665553
Q ss_pred cCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCcc
Q 042887 426 IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVT 505 (628)
Q Consensus 426 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 505 (628)
+|.. ..+|+.|++++|+|+. +|... .+| +.|++++|++++ +|.. .++|+.|++++|+++. +|..
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L----~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l 420 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLTS-LPALP---SGL----KELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML 420 (788)
T ss_pred CCCC---Ccccceehhhcccccc-Ccccc---ccc----ceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc
Confidence 3322 2345555666666552 33322 223 556666666663 3322 2457777777777763 4432
Q ss_pred ccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhc
Q 042887 506 LSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556 (628)
Q Consensus 506 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 556 (628)
..+|+.|++++|+|+ .+|..+..+++|+.|+|++|++++..+..+..
T Consensus 421 ---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 421 ---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred ---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 235667777777776 56777777777777777777777666665543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=217.98 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=174.9
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
.+-..||+++|.++ .+|+.+. ++|+.|++++|+++. +|. .+++|++|++++|+++ .+|.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 45678999999998 5677665 489999999999984 554 3589999999999999 45643 468999999
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
++|.++ .+|.. ..+|+.|++++|+++. +|.. .++|+.|++++|+++++.. . ..+|+.|++++|.++.
T Consensus 270 s~N~L~-~Lp~l----p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 270 FSNPLT-HLPAL----PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTS 336 (788)
T ss_pred cCCchh-hhhhc----hhhcCEEECcCCcccc-cccc---ccccceeECCCCccccCCC-C---cccccccccccCcccc
Confidence 999998 67652 5689999999999994 4542 4789999999999986533 2 2468888999998875
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccccc
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGT 401 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 401 (628)
++.. ..+|+.|++++|+++.. |.. ..+|+.|++++|++..
T Consensus 337 LP~l----------p~~Lq~LdLS~N~Ls~L--------------------------P~l---p~~L~~L~Ls~N~L~~- 376 (788)
T PRK15387 337 LPTL----------PSGLQELSVSDNQLASL--------------------------PTL---PSELYKLWAYNNRLTS- 376 (788)
T ss_pred cccc----------ccccceEecCCCccCCC--------------------------CCC---Ccccceehhhcccccc-
Confidence 4320 02455555555555432 211 1234445555555552
Q ss_pred CCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchh
Q 042887 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481 (628)
Q Consensus 402 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~ 481 (628)
+|.. ..+|+.|++++|.+++ +|.. .++|+.|++++|++++ +|... .+| +.|++++|+|+ .+|..
T Consensus 377 LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L----~~L~Ls~NqLt-~LP~s 440 (788)
T PRK15387 377 LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGL----LSLSVYRNQLT-RLPES 440 (788)
T ss_pred Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhh----hhhhhccCccc-ccChH
Confidence 3322 2356666666666663 3322 2456666666666653 34322 123 45566666665 45666
Q ss_pred hhccCCCCEeeCcCCcCcccCCccc
Q 042887 482 VGNLRNLAEFDLSENHFSNEIPVTL 506 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N~l~~~~~~~~ 506 (628)
+.++++|+.|+|++|++++..+..+
T Consensus 441 l~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 441 LIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred HhhccCCCeEECCCCCCCchHHHHH
Confidence 6666666666666666665544444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=203.45 Aligned_cols=119 Identities=20% Similarity=0.366 Sum_probs=72.5
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
+...|+++++.++. +|..+. ++|+.|+|++|+++ .+|..+. .+|++|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 45677777777773 454443 46777777777777 3444443 46777777777776 4555443 357777777
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccccccee
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG 297 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 297 (628)
+|.++ .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|+++.
T Consensus 250 ~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 250 INRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT 297 (754)
T ss_pred CCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc
Confidence 77776 6665542 45666666666666 3444332 355666666665553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=202.39 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=133.4
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEe
Q 042887 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265 (628)
Q Consensus 186 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~ 265 (628)
.+...|+++++.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|.++ .+|..+ .++|+.|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l---~~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATL---PDTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhh---hccccEEE
Confidence 35667777777777 4455443 46777777777777 4555443 46777777777776 666654 24677777
Q ss_pred cccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecc
Q 042887 266 VGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLN 345 (628)
Q Consensus 266 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~ 345 (628)
|++|+++ .+|..+. ++|+.|++++|+++.+ |..+. ++|+.|++++|+++.++.. + .++|+.|+++
T Consensus 248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~LP~~-------l--p~sL~~L~Ls 312 (754)
T PRK15370 248 LSINRIT-ELPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRTLPAH-------L--PSGITHLNVQ 312 (754)
T ss_pred CcCCccC-cCChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccccCccc-------c--hhhHHHHHhc
Confidence 7777776 4454443 4677777777776643 33332 3566666666666543211 0 0133344444
Q ss_pred cCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccc
Q 042887 346 TNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGT 425 (628)
Q Consensus 346 ~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 425 (628)
+| .++. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+++ .
T Consensus 313 ~N-------------------------~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~ 360 (754)
T PRK15370 313 SN-------------------------SLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-V 360 (754)
T ss_pred CC-------------------------cccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-c
Confidence 44 4432 12211 1345555555555553 333332 45666666666665 3
Q ss_pred cCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhh----hccCCCCEeeCcCCcCc
Q 042887 426 IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV----GNLRNLAEFDLSENHFS 499 (628)
Q Consensus 426 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~ 499 (628)
+|..+. ++|+.|++++|+++ .+|..+. ..| +.|++++|++. .+|..+ +.++.+..|++.+|.++
T Consensus 361 LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL----~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 361 LPETLP--PTITTLDVSRNALT-NLPENLP--AAL----QIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CChhhc--CCcCEEECCCCcCC-CCCHhHH--HHH----HHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 444332 45666666666665 2333322 122 45566666665 233322 22355555666666554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-20 Score=187.18 Aligned_cols=88 Identities=23% Similarity=0.220 Sum_probs=43.6
Q ss_pred EEecccCccc-ccccccccCCCCCCEEEcccccceee----cccccccCCCCCEEEccCCcCCCcCCCCccccccccCCC
Q 042887 263 FLSVGQNNFT-GSLPHSFSNASNLQVLDVYKNHFSGQ----VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCS 337 (628)
Q Consensus 263 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~ 337 (628)
.|+|..+.++ ......+..+.+|+.|+++++.++.. .+..+...+++++++++++.+...+.........+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666665 23334455666677777777766432 222334455566666666655421111011122333344
Q ss_pred CCceeecccCCcc
Q 042887 338 QMEMLYLNTNKFG 350 (628)
Q Consensus 338 ~L~~L~l~~n~~~ 350 (628)
+|+.|++++|.+.
T Consensus 82 ~L~~L~l~~~~~~ 94 (319)
T cd00116 82 GLQELDLSDNALG 94 (319)
T ss_pred ceeEEEccCCCCC
Confidence 5555555555444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-21 Score=161.15 Aligned_cols=179 Identities=27% Similarity=0.410 Sum_probs=118.6
Q ss_pred CCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCC
Q 042887 408 ELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRN 487 (628)
Q Consensus 408 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~ 487 (628)
.+.+++.|.+|+|+++ ..|+.+..+.+|+.|++++|+|+ ..|..++.+++| +.|+++-|++. ..|..|+.++.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~kl----r~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKL----RILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhh----hheecchhhhh-cCccccCCCch
Confidence 3455566666666666 45556666666666666666666 566666666666 66666666665 56667777777
Q ss_pred CCEeeCcCCcCcc-cCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEecc
Q 042887 488 LAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566 (628)
Q Consensus 488 L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls 566 (628)
|+.|||++|++.. ..|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- ..|..+..++.|++|.+.
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 7777777777654 35666666777777777777776 66777777777777777777776 566777777777777777
Q ss_pred CCcCcccCCCCCCCC---CCCcccccCCCCCc
Q 042887 567 YNHFEGEVPRKGVFG---NRTGIHLIGNERLC 595 (628)
Q Consensus 567 ~N~l~~~~p~~~~~~---~l~~~~~~~n~~~c 595 (628)
+|+++-.+|+.+.+. +-+...+..|||.-
T Consensus 182 gnrl~vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 182 GNRLTVLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred cceeeecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 777776666654432 22334455666654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-20 Score=185.84 Aligned_cols=285 Identities=22% Similarity=0.282 Sum_probs=155.7
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCccccc----ccccccCCCCCCEEEccccccee------ecccccccCC
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS----LPHSFSNASNLQVLDVYKNHFSG------QVKIDFNRLS 307 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~------~~~~~~~~l~ 307 (628)
.|+|..+.+++.--..++..+.+|+.|+++++.++.. ++..+...++|++++++++.+.+ ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5778888887444445555688899999999988542 45556677889999999988762 2234566788
Q ss_pred CCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhcc-C
Q 042887 308 NLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNL-V 386 (628)
Q Consensus 308 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l-~ 386 (628)
+|++|++++|.+.......+ ...... ++|+.|++++|++++.....+ ...+..+ +
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~--~~l~~~-~~L~~L~ls~~~~~~~~~~~l---------------------~~~l~~~~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVL--ESLLRS-SSLQELKLNNNGLGDRGLRLL---------------------AKGLKDLPP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHHH--HHHhcc-CcccEEEeeCCccchHHHHHH---------------------HHHHHhCCC
Confidence 99999999998864221111 111111 446667776666553222111 1122233 4
Q ss_pred CcCeeeecccccccc----CCcCCCCCCCCCeEecccCccccc----cCccccCCCCCCeEecCCcccccccCCcccCCc
Q 042887 387 NINAFGVEYNQLTGT----IPHAIGELKNLQGLALVRNSLRGT----IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQ 458 (628)
Q Consensus 387 ~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 458 (628)
+|+.|++++|.+++. .+..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++...
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~------- 210 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA------- 210 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH-------
Confidence 444555555444421 112233344455555555544421 11222223344444444444331110
Q ss_pred chhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCcccc-----CCCCCCeEECcCceeee----ecCcc
Q 042887 459 NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS-----ACTTLEYLHLQGNSFSG----SLPLS 529 (628)
Q Consensus 459 ~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~----~~~~~ 529 (628)
..+...+..+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...
T Consensus 211 -----------------~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~ 273 (319)
T cd00116 211 -----------------SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEV 273 (319)
T ss_pred -----------------HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHH
Confidence 01222344556677777777766642222221 23677777777777752 22334
Q ss_pred ccCCCCCCEEECCCCccccc----Cchhhhcc-cCCCeEeccCCcC
Q 042887 530 LKTLKSIKELDLSRNNLSGQ----IPKYLENL-LFLAYLNLSYNHF 570 (628)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~ls~N~l 570 (628)
+..+++|+++++++|.++.. ....+... +.|+++++.+|++
T Consensus 274 ~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 274 LAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 55567788888888888744 23333334 5677888877764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-20 Score=158.14 Aligned_cols=161 Identities=26% Similarity=0.458 Sum_probs=145.5
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
.++..++.|.||+|+++ .+|..++.+.+|++|++++|+|+ ..|.+++++++|+.|+++-|++. +.|..|+.++-|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 35667888999999998 56667999999999999999998 78999999999999999999998 89999999999999
Q ss_pred EEeecccCcc-cCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 239 ISLHSNRFEG-SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 239 L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
|||++|++.. .+|..+|. +..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- ..|..++.+++|++|++.+|
T Consensus 107 ldltynnl~e~~lpgnff~-m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFY-MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhccccccccccCCcchhH-HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 9999999963 57888876 999999999999999 88999999999999999999987 46778999999999999999
Q ss_pred cCCCcCCC
Q 042887 318 NLGTESTS 325 (628)
Q Consensus 318 ~l~~~~~~ 325 (628)
+++.++++
T Consensus 184 rl~vlppe 191 (264)
T KOG0617|consen 184 RLTVLPPE 191 (264)
T ss_pred eeeecChh
Confidence 99876643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-17 Score=157.67 Aligned_cols=95 Identities=29% Similarity=0.575 Sum_probs=85.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
...+|.+.+.||+|+||+||+|++++++..||||.+.+. .+...+-...|+.+|++++|||||++++++ ++.+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 356899999999999999999999999999999999776 445567788999999999999999999995 4588
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+.|+|||||.||||.+|++..+
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~ 104 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG 104 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC
Confidence 9999999999999999998776
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.4e-14 Score=137.54 Aligned_cols=95 Identities=25% Similarity=0.433 Sum_probs=80.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-------chhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-------GAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
..+.|.+.+.+|+|+||.|-+|..+++|+.||||++++... .......+|+++|+++.|||||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~----- 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF----- 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence 34668889999999999999999999999999999976421 112335799999999999999999999
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
|+..+..||||||++||+|.+++-.+.
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk 271 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANK 271 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhcc
Confidence 556888899999999999999986554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-13 Score=138.97 Aligned_cols=107 Identities=46% Similarity=0.740 Sum_probs=92.5
Q ss_pred CCCcccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccce
Q 042887 34 QFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITV 113 (628)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 113 (628)
..+.+++.++..++++|.....||+|+||.||+|... +|+.||||.+........++|.+|++++.+++|||+|+++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4667899999999999999999999999999999994 458999998765443214569999999999999999999999
Q ss_pred eeeccccccc-eeeeeecccccCCchhhhhcccc
Q 042887 114 CSSIDFKGVD-FKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 114 ~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
|.+ .. ...+|+|||++|+|++++.....
T Consensus 140 C~e-----~~~~~~LVYEym~nGsL~d~L~~~~~ 168 (361)
T KOG1187|consen 140 CLE-----GGEHRLLVYEYMPNGSLEDHLHGKKG 168 (361)
T ss_pred Eec-----CCceEEEEEEccCCCCHHHHhCCCCC
Confidence 975 34 58999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-13 Score=139.22 Aligned_cols=101 Identities=21% Similarity=0.370 Sum_probs=89.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..|...+.||+||||.||.+++..+|+.||+|++.+. .....+...+||++++.++|||||+++++ |++...
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 5699999999999999999999999999999999874 45567889999999999999999999999 677999
Q ss_pred eeeeecccccCCchhhhhccccccccccCC
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDKLEAGNLG 154 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (628)
.|||.|+|+.|+|.++++ .++.+++..+.
T Consensus 93 VYivLELC~~~sL~el~K-rrk~ltEpEar 121 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK-RRKPLTEPEAR 121 (592)
T ss_pred eEEEEEecCCccHHHHHH-hcCCCCcHHHH
Confidence 999999999999999988 55566655443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.5e-14 Score=128.42 Aligned_cols=89 Identities=26% Similarity=0.431 Sum_probs=76.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+++|+....+|+|+||+||+|+++.+|+.||||.+.... ....+-..||+++|++++|||+|.++++ |...+.
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrk 75 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRK 75 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhcce
Confidence 367888899999999999999999999999999996543 3444567999999999999999999999 556899
Q ss_pred eeeeecccccCCchhh
Q 042887 125 KALIYEYMKCGSSEDW 140 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~ 140 (628)
.++|+|||+..-|++.
T Consensus 76 lhLVFE~~dhTvL~eL 91 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHEL 91 (396)
T ss_pred eEEEeeecchHHHHHH
Confidence 9999999987555443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-14 Score=145.24 Aligned_cols=190 Identities=28% Similarity=0.460 Sum_probs=138.9
Q ss_pred EEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcc
Q 042887 366 VIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNN 445 (628)
Q Consensus 366 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 445 (628)
..|++.|++. .+|..+..+..|+.+.+..|.+. .+|..++.+..|+.|||+.|+++ ..|..++.++ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 4455566655 55667777777777777788776 67777888888888888888887 6677777765 7778888888
Q ss_pred cccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeee
Q 042887 446 LQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS 525 (628)
Q Consensus 446 l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 525 (628)
++ ..|..++....| ..||.+.|.+. .+|..++++.+|+.|.+..|++. ..|..+..+ .|..||+|+|+++ .
T Consensus 155 l~-~lp~~ig~~~tl----~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTL----AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred cc-cCCcccccchhH----HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 87 677777766666 56788888887 57777888888888888888887 566666644 4788888888887 7
Q ss_pred cCccccCCCCCCEEECCCCcccccCchhhhccc---CCCeEeccCCc
Q 042887 526 LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL---FLAYLNLSYNH 569 (628)
Q Consensus 526 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~---~L~~L~ls~N~ 569 (628)
+|-.|..|+.|++|-|.+|.++ .+|..+...- =.++|+..-++
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 8888888888888888888887 4555543222 23556666553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.1e-13 Score=122.60 Aligned_cols=95 Identities=29% Similarity=0.538 Sum_probs=82.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+.|...+.+|+|.||+||+|++.++|+.||||.++... .+......||+..|++++|+||++++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 46888899999999999999999999999999998753 3455678999999999999999999999 5568889
Q ss_pred eeeecccccCCchhhhhcccccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
.+|+||++. +|+..+++....+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l 98 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIIL 98 (318)
T ss_pred EEEEEeccc-cHHHHhccccccc
Confidence 999999985 8988887766444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-15 Score=146.76 Aligned_cols=177 Identities=31% Similarity=0.470 Sum_probs=159.0
Q ss_pred ccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcc
Q 042887 384 NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTL 463 (628)
Q Consensus 384 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l 463 (628)
.+..-...|++.|++. .+|..++.+..|+.+.|++|.+. .+|..+.++..|+++|++.|+++ ..|..++.|+ |
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-L--- 145 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-L--- 145 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-c---
Confidence 4455567899999998 78888899999999999999999 78899999999999999999998 7888888876 3
Q ss_pred cceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCC
Q 042887 464 SRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSR 543 (628)
Q Consensus 464 ~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (628)
+.|-+++|+++ .+|..++.++.|..||.+.|.+. ..|..++++.+|+.|.+..|++. .+|..+..|+ |..||+|.
T Consensus 146 -kvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfSc 220 (722)
T KOG0532|consen 146 -KVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSC 220 (722)
T ss_pred -eeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeeccc
Confidence 78999999998 78889999999999999999998 67888999999999999999998 6777777654 99999999
Q ss_pred CcccccCchhhhcccCCCeEeccCCcCccc
Q 042887 544 NNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 544 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
|+++ .+|-.|.+|+.|++|-|.+|+++..
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 9999 7899999999999999999999854
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-13 Score=136.15 Aligned_cols=93 Identities=26% Similarity=0.420 Sum_probs=83.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+..+ ...+...+|++++++++|||||.++++ |++...
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~ 75 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAH 75 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccce
Confidence 3678899999999999999999999999999999987643 455678999999999999999999999 788999
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+++|+|||.| +|++++.++.
T Consensus 76 ~~vVte~a~g-~L~~il~~d~ 95 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDG 95 (808)
T ss_pred EEEEehhhhh-hHHHHHHhcc
Confidence 9999999997 9999997765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.4e-13 Score=133.37 Aligned_cols=95 Identities=23% Similarity=0.420 Sum_probs=85.6
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|+++++||+|+||.||.|+-+.+|+.||+|++++.. ....+.+..|-++|....+|+||+++.+ |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999998763 5667788899999999999999999988 6779
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...|+||||.+|||+..++.+.+
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~ 236 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD 236 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC
Confidence 99999999999999999886554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.3e-13 Score=128.64 Aligned_cols=96 Identities=26% Similarity=0.439 Sum_probs=86.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.++||+|+||+||.++.+.+++.||+|++++. .....+...+|..+|.+++||.||+++.. |++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 46899999999999999999999999999999999875 34456778899999999999999999988 78899
Q ss_pred eeeeeecccccCCchhhhhccccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
..|+|+||+.||+|..++.+.+..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F 122 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRF 122 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCc
Confidence 999999999999999999866643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-13 Score=131.95 Aligned_cols=94 Identities=22% Similarity=0.415 Sum_probs=84.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
...|++.+.+|+|.||+|-+|.....|+.||||.+++. ++++.-.+.||++||..+.||||++++++ |+..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 45789999999999999999999899999999999765 34556678999999999999999999999 78899
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...+||||..+|+|++|+.+.+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~ 148 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERG 148 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhc
Confidence 9999999999999999998765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-13 Score=130.50 Aligned_cols=114 Identities=25% Similarity=0.347 Sum_probs=93.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc-eee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD-FKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~-~~~ 126 (628)
+.+..+.||+|..|+||+++|+.+++.+|+|.+... +....+++.+|++++.+.+||+||++++++.+ .. ..+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEE
Confidence 566778999999999999999999999999999654 34566889999999999999999999999764 44 699
Q ss_pred eeecccccCCchhhhhccccccccccCCccccCCcCcccEEE
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMID 168 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~l~~L~~L~ 168 (628)
++||||.+|+|+...+.. +.+++..++.+..+-++.|.+|+
T Consensus 155 I~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh 195 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLH 195 (364)
T ss_pred eehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh
Confidence 999999999999988765 45666666665555555565555
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.7e-13 Score=128.10 Aligned_cols=100 Identities=25% Similarity=0.427 Sum_probs=80.8
Q ss_pred ccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc--CCCCcccccceee
Q 042887 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV--RHRNLIKIITVCS 115 (628)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~ 115 (628)
.++-.......+..+.+.||+|.||.||+|.| .|+.||||++...+ .+.+.||.++.+.. +|+||+.++++-.
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 34445566677888999999999999999999 78999999997543 36778888887654 8999999998754
Q ss_pred eccccccceeeeeecccccCCchhhhhc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.. -......|+|.+|.+.|+|++|+.+
T Consensus 276 ~~-~gs~TQLwLvTdYHe~GSL~DyL~r 302 (513)
T KOG2052|consen 276 KD-NGSWTQLWLVTDYHEHGSLYDYLNR 302 (513)
T ss_pred cC-CCceEEEEEeeecccCCcHHHHHhh
Confidence 21 1334689999999999999999976
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-13 Score=135.01 Aligned_cols=106 Identities=25% Similarity=0.408 Sum_probs=87.8
Q ss_pred cHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCc---E-EEEEEeecc---ccchhhhHHHHHHHHhhcCCCCccccc
Q 042887 39 SYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGT---T-VAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKII 111 (628)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~-~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~ 111 (628)
+-..|+...++..+.+.||+|+||.||+|.....+. . ||+|..... .+.....|.+|+++|++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344566667777888999999999999999875432 3 899998752 355678899999999999999999999
Q ss_pred ceeeeccccccceeeeeecccccCCchhhhhccccccc
Q 042887 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 112 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
+++.. ....|+|||+|+||+|.+++++..+.++
T Consensus 228 GVa~~-----~~Pl~ivmEl~~gGsL~~~L~k~~~~v~ 260 (474)
T KOG0194|consen 228 GVAVL-----EEPLMLVMELCNGGSLDDYLKKNKKSLP 260 (474)
T ss_pred EEEcC-----CCccEEEEEecCCCcHHHHHHhCCCCCC
Confidence 99765 7789999999999999999988776443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3e-13 Score=142.18 Aligned_cols=98 Identities=24% Similarity=0.484 Sum_probs=83.6
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
..++.+.+..+.||+|+||+||+|+... ....||||.++..... ...+|.||++.|+.++|||||+++++|..
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~- 560 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE- 560 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-
Confidence 3456677778899999999999999642 2356999999876544 67889999999999999999999999986
Q ss_pred cccccceeeeeecccccCCchhhhhcccc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
.+.++||+|||..|||.+|++....
T Consensus 561 ----~~P~~MvFEYm~~GDL~eFLra~sP 585 (774)
T KOG1026|consen 561 ----GDPLCMVFEYMDHGDLHEFLRARSP 585 (774)
T ss_pred ----CCeeEEEEEecccccHHHHHHhhCC
Confidence 7889999999999999999986653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.6e-13 Score=131.51 Aligned_cols=100 Identities=28% Similarity=0.449 Sum_probs=82.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..+.|+..+.||+|.||.||+|++..+|+.||+|.+.... .+......|||.+|+++.||||+++.+..++ ....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCc
Confidence 3467888899999999999999999999999999998754 4455667899999999999999999998765 2357
Q ss_pred eeeeeecccccCCchhhhhccccccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
.+|||+|||+. ||..++...+-+++
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft 216 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFT 216 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccC
Confidence 89999999985 77777655444443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.3e-13 Score=136.90 Aligned_cols=98 Identities=27% Similarity=0.468 Sum_probs=83.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCC---cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETG---TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
...+.++||.|.||.|++|+.+.-| ..||||.++... +.....|..|+.||.+.+||||+++.++.+. .+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence 4467889999999999999987655 469999998763 4567889999999999999999999999554 788
Q ss_pred eeeeecccccCCchhhhhccccccccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDKLEAG 151 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~ 151 (628)
.++|.|||++|+|+.|++.+.+.++..
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftvi 731 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVI 731 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEee
Confidence 899999999999999999888666543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-12 Score=135.65 Aligned_cols=178 Identities=33% Similarity=0.519 Sum_probs=86.3
Q ss_pred cccEEEccCCcceeeCchhhhccC-CcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEec
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLV-NINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFL 441 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 441 (628)
.++.+++.+|.++. ++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++. ..|......+.|+.|++
T Consensus 117 ~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 45555555555552 233333332 5555555555555 23344555555555555555555 23333334555555555
Q ss_pred CCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCce
Q 042887 442 GFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521 (628)
Q Consensus 442 ~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 521 (628)
++|+++ .+|........| +.+++++|.+. ..+..+..+.++..+.+++|++. ..+..+..++++++|++++|.
T Consensus 194 s~N~i~-~l~~~~~~~~~L----~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 194 SGNKIS-DLPPEIELLSAL----EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred cCCccc-cCchhhhhhhhh----hhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence 555555 333332222233 44455555322 23444455555555555555554 224444555555555555555
Q ss_pred eeeecCccccCCCCCCEEECCCCcccccCch
Q 042887 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPK 552 (628)
Q Consensus 522 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 552 (628)
++.. +. +..+.+++.|++++|.+...+|.
T Consensus 267 i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 267 ISSI-SS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccc-cc-ccccCccCEEeccCccccccchh
Confidence 5522 22 45555555555555555544333
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=140.33 Aligned_cols=118 Identities=34% Similarity=0.546 Sum_probs=92.8
Q ss_pred CCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEecc
Q 042887 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566 (628)
Q Consensus 487 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls 566 (628)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|+.+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36778888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCcCcccCCCC--CCCCCCCcccccCCCCCcccCCCCCCCCCC
Q 042887 567 YNHFEGEVPRK--GVFGNRTGIHLIGNERLCGGLEELHLPSCH 607 (628)
Q Consensus 567 ~N~l~~~~p~~--~~~~~l~~~~~~~n~~~c~~~~~l~l~~c~ 607 (628)
+|+++|.+|.. ....++..+++.+|+.+|+. +. ++.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~-p~--l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI-PG--LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC-CC--CCCCc
Confidence 88888888753 22334567888999999974 32 46675
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-13 Score=125.94 Aligned_cols=94 Identities=22% Similarity=0.356 Sum_probs=79.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..+|++.+.||+|+||.||++.+..+|+.+|.|.++-. +.........|+.+|++++|||||++++... .++..-
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence 45688999999999999999999999999999998743 3445677899999999999999999988432 123444
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.++|||||.+|||.++++.
T Consensus 95 lnivmE~c~~GDLsqmIk~ 113 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKH 113 (375)
T ss_pred hHHHHHhhcccCHHHHHHH
Confidence 8999999999999998853
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.7e-13 Score=131.88 Aligned_cols=97 Identities=27% Similarity=0.459 Sum_probs=82.3
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
.+.+...++.+.+.+.||+|.||.||.|.+. ....||+|.++... ...+.|.+|+.+|++++|++||+++++|..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--- 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK--- 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec---
Confidence 4556666677788899999999999999993 23479999997653 345789999999999999999999999874
Q ss_pred cccceeeeeecccccCCchhhhhc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
....|||||||+.|+|.+|+++
T Consensus 273 --~~piyIVtE~m~~GsLl~yLr~ 294 (468)
T KOG0197|consen 273 --QEPIYIVTEYMPKGSLLDYLRT 294 (468)
T ss_pred --CCceEEEEEecccCcHHHHhhh
Confidence 4579999999999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.6e-13 Score=125.99 Aligned_cols=103 Identities=23% Similarity=0.425 Sum_probs=81.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.+.|+...+|++|+||.||+|+++++++.||+|+++... .+-.=...|||.++.+.+|||||.+.++... ...+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence 457888999999999999999999999999999997653 2333356899999999999999999887653 33567
Q ss_pred eeeeecccccCCchhhhhccccccccccC
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDKLEAGNL 153 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 153 (628)
+|||||||+. ||...|..-...+..+.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~ev 179 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEV 179 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHH
Confidence 9999999985 787777655544443333
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-12 Score=117.13 Aligned_cols=94 Identities=26% Similarity=0.371 Sum_probs=83.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.+|+|.||.||.|+.++++-.||+|++.+.. .+...++.||+++-++++||||+++++. |.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eeccc
Confidence 578999999999999999999999999999999997653 4556789999999999999999999999 55689
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+++||.++|++...+....
T Consensus 96 riyLilEya~~gel~k~L~~~~ 117 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGR 117 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcc
Confidence 9999999999999998887544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.1e-12 Score=133.10 Aligned_cols=147 Identities=29% Similarity=0.428 Sum_probs=67.6
Q ss_pred EEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCC-CCCEeecccccCcccCCcCccCCCCCCEEEeecc
Q 042887 166 MIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLR-SLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244 (628)
Q Consensus 166 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n 244 (628)
.++++.|.+.. ....+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 34444444432 2222334455555555555554 3333444442 5555555555554 33444555555555555555
Q ss_pred cCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcC
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL 319 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l 319 (628)
+++ .+|.... .+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+..+.++..+.+.+|++
T Consensus 174 ~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~ 244 (394)
T COG4886 174 DLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244 (394)
T ss_pred hhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCcee
Confidence 554 4444332 2455555555555555 33333333444555555555322 1222344444444444444444
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.1e-12 Score=126.41 Aligned_cols=93 Identities=27% Similarity=0.405 Sum_probs=73.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHH--HhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEA--LSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
....++.+.||+|.||+||+|.. +++.||||++...+. +.|..|-++ +-.++|+||++++++....+-. ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence 44567778999999999999999 779999999976543 556666555 4566899999999986553322 457
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++|+||.+.|+|.+|++.+-
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt 303 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT 303 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc
Confidence 899999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3e-12 Score=128.24 Aligned_cols=91 Identities=35% Similarity=0.594 Sum_probs=76.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcE-EEEEEeeccccc--hhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTT-VAVKVMNLKQKG--AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~-~avK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..+....+.+|+|+||+||+|.+ .|+. ||+|++...... ..++|.+|+.+|.+++|||||+++++|.+ ..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~-----~~ 112 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS-----PP 112 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CC
Confidence 34455667799999999999999 5666 999999765422 25689999999999999999999999875 33
Q ss_pred -eeeeeecccccCCchhhhhcc
Q 042887 124 -FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 -~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...+||||+++|+|.+++...
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~ 134 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK 134 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc
Confidence 689999999999999999774
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-13 Score=127.28 Aligned_cols=115 Identities=20% Similarity=0.308 Sum_probs=93.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+-|.+.+.+|+|+||.||+|.++++|+.+|||.+.... +.+.+..|+.+|++.+.|+||++++.+ ......|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLW 104 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLW 104 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceE
Confidence 345777889999999999999999999999999987643 457789999999999999999999984 4477899
Q ss_pred eeecccccCCchhhhhccccccccccCCccccCCcCcccEEE
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMID 168 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~l~~L~~L~ 168 (628)
+|||||-.|+..+.++.+++.+.+-....+-...++.|++|+
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH 146 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH 146 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH
Confidence 999999999999999888877765444444333444455443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.6e-13 Score=128.70 Aligned_cols=194 Identities=21% Similarity=0.235 Sum_probs=136.9
Q ss_pred ccCCcCcccEEEccCCccccccc-hhhhCCCCCCEEecccCcCccccc--ccccCCCCCCEeecccccCcccCCcC-ccC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFP-DFIANFSALEAIDISANMLGGRIP--DSLCQLRSLNYLSISENNFSCKLPLS-IWN 232 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~p~~-~~~ 232 (628)
.-.++.+|+.+.|.+..+..... .....+++++.||||.|-++...+ .-...|++|+.|+|+.|.+....... -..
T Consensus 116 kQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 116 KQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred HhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 34678889999999888753222 467789999999999998874432 33568999999999999987433222 236
Q ss_pred CCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeec-ccccccCCCCCE
Q 042887 233 ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQV-KIDFNRLSNLSR 311 (628)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~ 311 (628)
+++|+.|.|+.|.++..--..+...+|+|+.|+|.+|............+..|++|||++|++-... -...+.++.|..
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 7889999999999874333333446899999999999644455556677888999999999886433 134567888888
Q ss_pred EEccCCcCCCcCCCCccccccccCCCCCceeecccCCcc
Q 042887 312 LFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFG 350 (628)
Q Consensus 312 L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~ 350 (628)
|+++.+.+.++...+.+.......+++|++|+++.|++.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 999988887765444333333445566666666666553
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.2e-12 Score=113.52 Aligned_cols=129 Identities=22% Similarity=0.296 Sum_probs=44.0
Q ss_pred hhCCCCCCEEecccCcCccccccccc-CCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCC
Q 042887 182 IANFSALEAIDISANMLGGRIPDSLC-QLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPN 260 (628)
Q Consensus 182 ~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~ 260 (628)
+.+..++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+. ++ .+..+++|++|++++|.++ .++..+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 33455677777777777633 2344 46777777777777773 32 4667777777777777777 565544434777
Q ss_pred CcEEecccCccccccc-ccccCCCCCCEEEcccccceeec---ccccccCCCCCEEEcc
Q 042887 261 VNFLSVGQNNFTGSLP-HSFSNASNLQVLDVYKNHFSGQV---KIDFNRLSNLSRLFLS 315 (628)
Q Consensus 261 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~l~~L~~L~L~ 315 (628)
|++|++++|+|..... ..++.+++|+.|++.+|.++... ...+..+|+|+.||-.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 7777777777764322 34666777777777777775331 1134566777777643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-12 Score=133.31 Aligned_cols=101 Identities=26% Similarity=0.409 Sum_probs=82.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecc-cccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~~~ 125 (628)
..|...+.+|+||||-||+|+++++|+.||||..+.. ....+++..+|+++|++++|||||+++++..... ....+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3466678999999999999999999999999999764 3456678999999999999999999999854310 1124567
Q ss_pred eeeecccccCCchhhhhcccccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
.++||||+||||...+.+..+.+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~ 115 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAY 115 (732)
T ss_pred eEEEeecCCCcHHHHhcCccccc
Confidence 88999999999999998766443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.6e-12 Score=116.85 Aligned_cols=94 Identities=23% Similarity=0.321 Sum_probs=83.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|+..+.+|.|+||+|..++.+.+|.+||+|++++.. ..+.+....|..+|+.+.||.++++.+.+ .+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 457889999999999999999999999999999998753 34567788999999999999999999884 5589
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..||||||++||.+..++++.+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~ 139 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG 139 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC
Confidence 9999999999999999998765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.8e-12 Score=126.52 Aligned_cols=99 Identities=25% Similarity=0.410 Sum_probs=83.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc----cc-chhhhHHHHHHHHhhcC-CCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK----QK-GAAKSFVTECEALSNVR-HRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 119 (628)
..+.|.+.+.||+|+||+|+.|.+..+|+.||+|+++.. .. ...+.+.||+.+++.++ ||||++++++.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----- 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----- 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence 457899999999999999999999999999999987653 11 23456778999999999 99999999994
Q ss_pred cccceeeeeecccccCCchhhhhcccccccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 150 (628)
.+....|+|||||.||+|.+++.+ .+.+.+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E 119 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN-KGRLKE 119 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH-cCCCCh
Confidence 457779999999999999999988 444433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-12 Score=110.94 Aligned_cols=99 Identities=23% Similarity=0.457 Sum_probs=83.6
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|.-.+.||+|.||+||+|+..++++.||+|.++..+ ++......||+.++++++|.|||+++++ .+.++..-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 4666678999999999999999999999999998753 4566788999999999999999999999 55688999
Q ss_pred eeecccccCCchhhhhccccccccccC
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEAGNL 153 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~ 153 (628)
+|+|||.. ++..|+..-++.++....
T Consensus 78 lvfe~cdq-dlkkyfdslng~~d~~~~ 103 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNGDLDPEIV 103 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCCcCCHHHH
Confidence 99999974 788888777766654433
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.6e-12 Score=129.28 Aligned_cols=101 Identities=24% Similarity=0.447 Sum_probs=90.1
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
++.|+..+.+..+...+|-|.||.||.|.|++....||||.++... ...+.|..|+.+|+.++|||+|+++++|+.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~--- 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--- 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc---
Confidence 4678777888888899999999999999999999999999987543 356889999999999999999999999986
Q ss_pred cccceeeeeecccccCCchhhhhcccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...+|+|+|||..|.|.+|+++.+.
T Consensus 335 --EpPFYIiTEfM~yGNLLdYLRecnr 359 (1157)
T KOG4278|consen 335 --EPPFYIITEFMCYGNLLDYLRECNR 359 (1157)
T ss_pred --CCCeEEEEecccCccHHHHHHHhch
Confidence 6789999999999999999987653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.3e-13 Score=125.93 Aligned_cols=133 Identities=23% Similarity=0.377 Sum_probs=76.0
Q ss_pred CCCCeEecccCccccc----cCccccCCCCCCeEecCCccccccc----CCcccCCcchhcccceEEcCCCcCccc----
Q 042887 410 KNLQGLALVRNSLRGT----IPDTLGNLTLLNRLFLGFNNLQGNV----PSSLGNCQNLMTLSRLLDLSGNLLGGS---- 477 (628)
Q Consensus 410 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~l~~~L~Ls~N~l~~~---- 477 (628)
+.|+++...+|++... +...|...+.|+.+.++.|.|.... ...+..+++| +.|||.+|-++..
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~L----evLdl~DNtft~egs~~ 232 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHL----EVLDLRDNTFTLEGSVA 232 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcc----eeeecccchhhhHHHHH
Confidence 4566666666655421 2233455566666666666654221 1234455555 6666666666532
Q ss_pred cchhhhccCCCCEeeCcCCcCcccCCccc-----cCCCCCCeEECcCceeee----ecCccccCCCCCCEEECCCCcc
Q 042887 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTL-----SACTTLEYLHLQGNSFSG----SLPLSLKTLKSIKELDLSRNNL 546 (628)
Q Consensus 478 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l 546 (628)
+...++.+++|++|++++|.+...-...+ ...|+|+.|.+.+|.|+. .+..++...+.|+.|+|++|.+
T Consensus 233 LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 233 LAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 23445566777777777777765433332 235677777777777763 2223344567777777777777
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-11 Score=121.06 Aligned_cols=94 Identities=24% Similarity=0.329 Sum_probs=78.9
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---------c-----chhhhHHHHHHHHhhcCCCCccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---------K-----GAAKSFVTECEALSNVRHRNLIK 109 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~nIv~ 109 (628)
....++|++.+.||+|.||+|-+|+...+++.||||++.+.. . ...+...+||.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999999999999999997632 1 12357899999999999999999
Q ss_pred ccceeeeccccccceeeeeecccccCCchhh
Q 042887 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDW 140 (628)
Q Consensus 110 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 140 (628)
++++-.+ .....+|||+|||..|.+.+.
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~ 200 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWC 200 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccC
Confidence 9998554 346789999999999987643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-12 Score=127.59 Aligned_cols=106 Identities=26% Similarity=0.418 Sum_probs=88.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|.+.+.+|.|+||.||+|+...+|+.||||.++... .+..-.-.||+..|+++. |||||++.++..+ ...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCc
Confidence 4578999999999999999999999999999999997653 444455689999999998 9999999999643 233
Q ss_pred eeeeeecccccCCchhhhhccccccccccCCcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLI 156 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 156 (628)
..|+|||||++ .|++.|+++++.+++..+-.+
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irni 115 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNI 115 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHH
Confidence 89999999986 799999998777666555443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.4e-12 Score=116.48 Aligned_cols=87 Identities=21% Similarity=0.384 Sum_probs=80.7
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceeeeeeccc
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
+.+|+|+||.|-.++...+|..||||++.+.......++.||++++...+ |+||++++++ |+++..+|+|||-|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEKM 158 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEecc
Confidence 67999999999999999999999999999887778889999999999996 9999999999 77899999999999
Q ss_pred ccCCchhhhhccc
Q 042887 133 KCGSSEDWMHQSN 145 (628)
Q Consensus 133 ~~g~L~~~l~~~~ 145 (628)
.||.+..+|.++.
T Consensus 159 ~GGplLshI~~~~ 171 (463)
T KOG0607|consen 159 RGGPLLSHIQKRK 171 (463)
T ss_pred cCchHHHHHHHhh
Confidence 9999999987654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-11 Score=124.32 Aligned_cols=94 Identities=23% Similarity=0.384 Sum_probs=83.7
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHhhcC-CCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 121 (628)
....|++.+.+|+|.||.||+|+.+.+|+.+|+|.+.+... ...+.+.+|+.+|+++. |||||+++++ |++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence 45679999999999999999999999999999999976543 23468899999999998 9999999999 566
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....++|||+|.||+|.+.+...
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~ 130 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK 130 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc
Confidence 88999999999999999998765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-11 Score=132.24 Aligned_cols=107 Identities=28% Similarity=0.496 Sum_probs=73.4
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
++.|+|++|.+.+.+|..++.+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..++++++|++|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 66677777777777777777777777777777777767777777777777777777777766777777777777777777
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCc
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNN 270 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~ 270 (628)
|.+++.+|..+.....++..+++.+|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCc
Confidence 777766666655433445555555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-12 Score=123.20 Aligned_cols=68 Identities=19% Similarity=0.364 Sum_probs=36.6
Q ss_pred hhhhCCCCCCEEecccCcCcccc----cccccCCCCCCEeeccccc---CcccCCcC-------ccCCCCCCEEEeeccc
Q 042887 180 DFIANFSALEAIDISANMLGGRI----PDSLCQLRSLNYLSISENN---FSCKLPLS-------IWNISSLEIISLHSNR 245 (628)
Q Consensus 180 ~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~N~---i~~~~p~~-------~~~l~~L~~L~L~~n~ 245 (628)
+....+..++.++||+|.+...- ...+.+.++|+..++|+-- ....+|.+ +...++|++||||.|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 34556677777777777775332 2334556677777766431 11122322 2334456666666665
Q ss_pred Cc
Q 042887 246 FE 247 (628)
Q Consensus 246 l~ 247 (628)
+.
T Consensus 104 ~G 105 (382)
T KOG1909|consen 104 FG 105 (382)
T ss_pred cC
Confidence 54
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-11 Score=124.00 Aligned_cols=100 Identities=23% Similarity=0.349 Sum_probs=86.9
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
......|.+.+.||+|.||+|..|++..++..||||.+++..- .....+.+|+++|+.+.|||||+++.+ .++
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t 126 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IET 126 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eee
Confidence 3446789999999999999999999999999999999987642 233458999999999999999999999 566
Q ss_pred cceeeeeecccccCCchhhhhcccccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
....|+||||+.+|++++|+..++...
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr~~ 153 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGRMK 153 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcccch
Confidence 899999999999999999998776443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-11 Score=109.11 Aligned_cols=126 Identities=27% Similarity=0.252 Sum_probs=39.0
Q ss_pred CCCCCCeEecCCcccccccCCccc-CCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccc-cCC
Q 042887 432 NLTLLNRLFLGFNNLQGNVPSSLG-NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL-SAC 509 (628)
Q Consensus 432 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l 509 (628)
+...+++|+|++|.|+.. +.++ .+.+| +.|++++|.|+.. ..+..+++|++|++++|+|+.. ...+ ..+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L----~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~l 87 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKL----EVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNL 87 (175)
T ss_dssp ---------------------S--TT-TT------EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-
T ss_pred cccccccccccccccccc--cchhhhhcCC----CEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhC
Confidence 334556666666666521 1222 23334 5566666666532 2355566777777777777633 2223 346
Q ss_pred CCCCeEECcCceeeeecC-ccccCCCCCCEEECCCCcccccC---chhhhcccCCCeEecc
Q 042887 510 TTLEYLHLQGNSFSGSLP-LSLKTLKSIKELDLSRNNLSGQI---PKYLENLLFLAYLNLS 566 (628)
Q Consensus 510 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~ls 566 (628)
++|++|++++|+|..... ..+..+++|+.|+|.+|+++... ...+..+|+|+.||-.
T Consensus 88 p~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 88 PNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 677777777777663211 34556777777777777776321 1135667777777643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-11 Score=123.84 Aligned_cols=96 Identities=28% Similarity=0.475 Sum_probs=83.0
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+.++....+.+.||+|.||.|..|+. ..+..||+|+++... ......|.+|+++|.+++|||||+++++|.. +
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----D 607 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----D 607 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----C
Confidence 34556677889999999999999998 346899999998764 3445889999999999999999999999985 7
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+...+++|||++|+|.+|+..+.
T Consensus 608 ePicmI~EYmEnGDLnqFl~ahe 630 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHE 630 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhcc
Confidence 78899999999999999997764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-11 Score=118.13 Aligned_cols=97 Identities=27% Similarity=0.325 Sum_probs=84.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+.|++.+.+|.|.-|.||+++...++..+|+|++.+.. +....+...|.+||+.++||.++.++.. |++.++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 46778899999999999999999999999999998753 4445677889999999999999999998 677999
Q ss_pred eeeeecccccCCchhhhhccccccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
.+++||||+||+|+....+...++.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~f 176 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRF 176 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCcc
Confidence 9999999999999988876665543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.9e-12 Score=115.70 Aligned_cols=136 Identities=27% Similarity=0.236 Sum_probs=99.0
Q ss_pred ccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCC
Q 042887 430 LGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSAC 509 (628)
Q Consensus 430 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 509 (628)
...+..|+.+||++|.|+ .+.++..-++.+ +.|++|+|+|.. ...+..+++|+.||||+|.++ .+..+-..+
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pki----r~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KL 351 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKL----RRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKL 351 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccce----eEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhh
Confidence 344567888888888887 555666666666 788888888873 234777888888888888887 344444567
Q ss_pred CCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccC-chhhhcccCCCeEeccCCcCcccCC
Q 042887 510 TTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQI-PKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 510 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
-+++.|.|++|.|. .-..+..+-+|..||+++|+|.... -..++++|.|+++.|.+|++.+.+.
T Consensus 352 GNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 352 GNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred cCEeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 78888888888875 2345677788888888888887432 2357788888888888888876554
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.5e-11 Score=124.02 Aligned_cols=92 Identities=22% Similarity=0.350 Sum_probs=80.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+++++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47899999999999999999999999999999997542 23445678899999999999999999884 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++...
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~ 95 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK 95 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc
Confidence 99999999999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.6e-12 Score=116.87 Aligned_cols=130 Identities=25% Similarity=0.276 Sum_probs=78.5
Q ss_pred cCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhccc
Q 042887 385 LVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLS 464 (628)
Q Consensus 385 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ 464 (628)
...|+++|+++|.|+ .+.++..-+|.++.|++|+|.++.. +.+..+++|+.|||++|.++ ....+-..+-+.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI---- 354 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI---- 354 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE----
Confidence 344556666666665 3444555566666666666666622 23566666667777766665 233333333344
Q ss_pred ceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccC-CccccCCCCCCeEECcCceeee
Q 042887 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEI-PVTLSACTTLEYLHLQGNSFSG 524 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~ 524 (628)
+.|.|++|.|.. -..+..+-+|..||+++|+|.... ...++++|.|+.+.|.+|.+.+
T Consensus 355 KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 566777776652 224555667777777777776422 3456777888888888888773
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-11 Score=118.88 Aligned_cols=93 Identities=20% Similarity=0.302 Sum_probs=79.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 46889999999999999999999899999999997532 23446688999999999999999999884 45788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+||||+++|+|.+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~ 96 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG 96 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC
Confidence 999999999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.8e-11 Score=123.50 Aligned_cols=92 Identities=20% Similarity=0.302 Sum_probs=79.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47889999999999999999999999999999986532 23446788999999999999999999984 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+++|+|.+++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~ 95 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY 95 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc
Confidence 99999999999999988643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.9e-11 Score=115.84 Aligned_cols=104 Identities=30% Similarity=0.437 Sum_probs=85.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|...+.||+|+||.||++.+.++|+.+|||.+........+.+.+|+.+|.+++|||||++++.... ......+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeE
Confidence 4457888999999999999999998899999999987643336778999999999999999999997432 1114789
Q ss_pred eeecccccCCchhhhhccccccccccC
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEAGNL 153 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~ 153 (628)
+.|||+++|++.+++.+.++.+++..+
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v 119 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLV 119 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHH
Confidence 999999999999999887755554433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-11 Score=123.45 Aligned_cols=109 Identities=25% Similarity=0.415 Sum_probs=91.7
Q ss_pred CCCCcccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccc
Q 042887 33 QQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKI 110 (628)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l 110 (628)
......+..+|....+.+.+..+||+|+||+||+|+|-.+ ||||++.... ....+.|..|+.++++.+|.||+-+
T Consensus 377 ~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 377 NRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred cccCCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheee
Confidence 3445556678888888999999999999999999999544 9999997653 4467889999999999999999999
Q ss_pred cceeeeccccccceeeeeecccccCCchhhhhcccccccc
Q 042887 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150 (628)
Q Consensus 111 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 150 (628)
.++|+. ..+.+|+.+|+|.+|+.+++....+++.
T Consensus 454 MG~~~~------p~~AIiTqwCeGsSLY~hlHv~etkfdm 487 (678)
T KOG0193|consen 454 MGACMN------PPLAIITQWCEGSSLYTHLHVQETKFDM 487 (678)
T ss_pred ehhhcC------CceeeeehhccCchhhhhccchhhhhhH
Confidence 999873 4448999999999999999887766654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.6e-11 Score=123.08 Aligned_cols=91 Identities=18% Similarity=0.238 Sum_probs=79.4
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5888899999999999999999999999999997542 334567889999999999999999999854 47789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
|+||||+++|+|.+++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~ 95 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM 95 (381)
T ss_pred EEEEecCCCCcHHHHHHhc
Confidence 9999999999999988654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-11 Score=123.69 Aligned_cols=96 Identities=21% Similarity=0.363 Sum_probs=85.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.+.|++++.+|+|+.|+|-.|++.+||+.+|||++.+.. ......+.+|+-+|+-+.||||++++++ |++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 467999999999999999999999999999999997652 3345678999999999999999999999 56789
Q ss_pred eeeeeecccccCCchhhhhccccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
..|+|.||+++|.|++++.+++..
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l 109 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPL 109 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCC
Confidence 999999999999999999877643
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.4e-11 Score=122.57 Aligned_cols=92 Identities=18% Similarity=0.253 Sum_probs=79.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++.+ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999999999999999986532 23446688999999999999999999884 45789
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++.+.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~ 95 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL 95 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc
Confidence 99999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.9e-11 Score=119.79 Aligned_cols=93 Identities=18% Similarity=0.303 Sum_probs=80.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 467999999999999999999999999999999997542 234467889999999999999999999854 478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++...
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~ 112 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKA 112 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHc
Confidence 899999999999999988654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-12 Score=123.08 Aligned_cols=232 Identities=18% Similarity=0.142 Sum_probs=153.6
Q ss_pred EEccCCccccccchhh----hCCCCCCEEecccCcCccccc--ccccCCCCCCEeecccccCcccC--CcCccCCCCCCE
Q 042887 167 IDVGDNQLIGKFPDFI----ANFSALEAIDISANMLGGRIP--DSLCQLRSLNYLSISENNFSCKL--PLSIWNISSLEI 238 (628)
Q Consensus 167 L~Ls~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~--p~~~~~l~~L~~ 238 (628)
+.+++-++...--+.+ +++++|++..|.+.... ..+ .....+++++.||||+|-+.... ..-...+++|+.
T Consensus 98 ~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~ 176 (505)
T KOG3207|consen 98 LSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN 176 (505)
T ss_pred hhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence 3444444444433333 47889999999998876 333 36778999999999999877432 233567999999
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccc-cccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL-PHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
|+|+.|.+..-........++.|+.|.|+.|.++... ......+++|+.|+|..|....+......-+..|++|||++|
T Consensus 177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N 256 (505)
T KOG3207|consen 177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN 256 (505)
T ss_pred cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC
Confidence 9999999974333334445899999999999998533 234567899999999999644455556667889999999999
Q ss_pred cCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccc
Q 042887 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397 (628)
Q Consensus 318 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 397 (628)
++-+.+ .......++.|+.|.++.+.+..+...... . -+-....++|++|++..|+
T Consensus 257 ~li~~~-----~~~~~~~l~~L~~Lnls~tgi~si~~~d~~-------s------------~~kt~~f~kL~~L~i~~N~ 312 (505)
T KOG3207|consen 257 NLIDFD-----QGYKVGTLPGLNQLNLSSTGIASIAEPDVE-------S------------LDKTHTFPKLEYLNISENN 312 (505)
T ss_pred cccccc-----cccccccccchhhhhccccCcchhcCCCcc-------c------------hhhhcccccceeeecccCc
Confidence 987643 334567778888888888877543211110 0 0012334555666666665
Q ss_pred cccc-CCcCCCCCCCCCeEecccCccc
Q 042887 398 LTGT-IPHAIGELKNLQGLALVRNSLR 423 (628)
Q Consensus 398 l~~~-~~~~~~~l~~L~~L~L~~n~l~ 423 (628)
|.+. .-..+..+++|+.|.+..|.+.
T Consensus 313 I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 313 IRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccccccchhhccchhhhhhccccccc
Confidence 5321 1122344555666666666655
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.6e-11 Score=119.44 Aligned_cols=92 Identities=24% Similarity=0.406 Sum_probs=79.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++..++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 36899999999999999999999999999999997542 234567889999999999999999998854 4778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+++|+|.+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~ 95 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL 95 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc
Confidence 99999999999999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.14 E-value=9e-11 Score=120.72 Aligned_cols=92 Identities=21% Similarity=0.287 Sum_probs=79.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++.+++||+|+++++.+ ++...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47899999999999999999999999999999997542 23345678899999999999999999884 45778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++.+.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~ 95 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK 95 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc
Confidence 99999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-10 Score=118.73 Aligned_cols=93 Identities=23% Similarity=0.337 Sum_probs=80.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+++.||+|++.+. .....+.+.+|+.++..++|+||+++++++ ++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4789999999999999999999999999999999753 223445688899999999999999999984 45788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+||||+++|+|.+++.+..
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~ 96 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE 96 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc
Confidence 999999999999999986543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.6e-11 Score=119.66 Aligned_cols=98 Identities=22% Similarity=0.322 Sum_probs=85.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+.+-|.+.+.||+|.|++|-.|++.-+|+.||||++.+..- .....+.+|++.|+-++|||||++|++ .++..
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence 34668999999999999999999999999999999987643 334568899999999999999999999 66788
Q ss_pred eeeeeecccccCCchhhhhcccccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
..|+|.|...+|++++||-++...+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl 115 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGL 115 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccc
Confidence 9999999999999999998776544
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.3e-11 Score=123.24 Aligned_cols=100 Identities=20% Similarity=0.398 Sum_probs=82.4
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCC-----CcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGET-----GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~ 114 (628)
.+..+.++|.+.+.||+|+||.||+|.+... +..||+|++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 4556678999999999999999999987433 3469999996543 334467899999999996 99999999996
Q ss_pred eeccccccceeeeeecccccCCchhhhhcccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
. .....|+|||||++|+|.+++.+...
T Consensus 111 ~-----~~~~~~lv~Ey~~~g~L~~~l~~~~~ 137 (400)
T cd05105 111 T-----KSGPIYIITEYCFYGDLVNYLHKNRD 137 (400)
T ss_pred c-----cCCceEEEEEecCCCcHHHHHHHhhh
Confidence 4 36789999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.3e-11 Score=126.03 Aligned_cols=98 Identities=22% Similarity=0.331 Sum_probs=81.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecc-ccc-cc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSID-FKG-VD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~-~~ 123 (628)
..++++.+.|.+|||+.||.|.....|..||+|++-..++...+.+.+|+++|+.|+ |+|||.+++...... ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 456788899999999999999998877999999997777777888999999999997 999999999533211 112 35
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+.+.||||.||.|-++|...
T Consensus 116 EvllLmEyC~gg~Lvd~mn~R 136 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTR 136 (738)
T ss_pred EEEeehhhccCCcHHHHHHHH
Confidence 678899999999999999744
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.7e-11 Score=121.81 Aligned_cols=91 Identities=16% Similarity=0.257 Sum_probs=79.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++.+. +....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5888999999999999999999999999999997542 334567889999999999999999999854 47789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
|+|||||++|+|.+++.+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~ 95 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM 95 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc
Confidence 9999999999999988654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.6e-11 Score=119.95 Aligned_cols=96 Identities=25% Similarity=0.427 Sum_probs=83.9
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
....+|.+++.||+|+|++|++|+.+++++.||||++.+. .+.-.+-+.+|-.+|..| .||.||+++.. |+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence 3457899999999999999999999999999999999764 233455677899999999 79999999988 67
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+....|+|+||+++|+|.++|++-+
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~G 169 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKYG 169 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHhC
Confidence 7999999999999999999998765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.5e-11 Score=130.09 Aligned_cols=94 Identities=27% Similarity=0.499 Sum_probs=80.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCc-----EEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGT-----TVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~-----~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
+...+..+.||+|+||.||+|.+..... .||+|.+++. +.+....|.+|+.+|++++|||||+++++|.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 4566778899999999999999864332 3999998765 45677899999999999999999999999864
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++++|||++|||..|+++.+
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r 790 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESR 790 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcc
Confidence 677899999999999999998775
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-11 Score=122.36 Aligned_cols=99 Identities=22% Similarity=0.383 Sum_probs=81.2
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEE-----CCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
++..+.++|++.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3445567899999999999999999974 3456789999986532 33456789999999999 799999999986
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .....++|||||++|+|.+++....
T Consensus 109 ~-----~~~~~~lv~E~~~~g~L~~~l~~~~ 134 (375)
T cd05104 109 T-----VGGPTLVITEYCCYGDLLNFLRRKR 134 (375)
T ss_pred c-----cCCcceeeehhccCCcHHHHHHhcc
Confidence 4 4678899999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.9e-12 Score=134.14 Aligned_cols=109 Identities=18% Similarity=0.288 Sum_probs=92.9
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeee
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
..+....+++|++.++||+|+||.|..++++.+++.||+|++++. .+....-|..|-++|..-..+.||+++.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 344555678999999999999999999999999999999999874 34455667888889999999999999999
Q ss_pred ccccccceeeeeecccccCCchhhhhccccccccccCC
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLG 154 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (628)
|++....||||||++|||+...|.+.. .+++.|..
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~Ar 178 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWAR 178 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhcC-CChHHHHH
Confidence 777999999999999999999998776 66655443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.6e-11 Score=121.73 Aligned_cols=98 Identities=20% Similarity=0.390 Sum_probs=79.3
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceeee
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCSS 116 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 116 (628)
..+.++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345678999999999999999999852 345689999986532 23456789999999999 89999999998642
Q ss_pred ccccccceeeeeecccccCCchhhhhccc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....+++|||+++|+|.+++....
T Consensus 83 ----~~~~~~lv~ey~~~g~L~~~l~~~~ 107 (338)
T cd05102 83 ----PNGPLMVIVEFCKYGNLSNFLRAKR 107 (338)
T ss_pred ----CCCceEEEEecCCCCcHHHHHHhcc
Confidence 3456899999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.6e-10 Score=117.31 Aligned_cols=93 Identities=18% Similarity=0.277 Sum_probs=81.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+ .+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 468999999999999999999999899999999987642 3345678999999999999999999999654 6789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~ 97 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA 97 (333)
T ss_pred EEEEecCCCCcHHHHHHHc
Confidence 9999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.8e-11 Score=119.08 Aligned_cols=94 Identities=18% Similarity=0.332 Sum_probs=81.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|...+++|+|+||+++.++++.+++.|++|.+.... ....+...+|+.++++++|||||.+.+.+ ...+.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCc
Confidence 468999999999999999999999999999999997653 33445678999999999999999999995 44666
Q ss_pred -eeeeecccccCCchhhhhccc
Q 042887 125 -KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 -~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||+||+||++.+.+.+..
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k 99 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK 99 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh
Confidence 999999999999999997666
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.7e-11 Score=114.20 Aligned_cols=97 Identities=20% Similarity=0.286 Sum_probs=84.6
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-chhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
+....++|++.++||.|.-+.||+|++..+++.||||++....- .....+.+|+..|+.++||||++++..+. .
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v 95 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----V 95 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----e
Confidence 33456789999999999999999999999999999999987542 33678999999999999999999988854 4
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+..|.||.||.+|++.+.++..
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~ 118 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTY 118 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHH
Confidence 88999999999999999988654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.7e-10 Score=117.13 Aligned_cols=93 Identities=18% Similarity=0.257 Sum_probs=81.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+|..||+|.+.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence 468999999999999999999999999999999997642 3345679999999999999999999998643 6789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~ 97 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA 97 (331)
T ss_pred EEEeecCCCCcHHHHHHHc
Confidence 9999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.7e-11 Score=123.25 Aligned_cols=116 Identities=24% Similarity=0.376 Sum_probs=96.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+...|..-..||+|+-|.||.|....+++.||||.+........+-+..|+.+|+..+|+|||.+++.+. ..+..
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----cccee
Confidence 4567888889999999999999999999999999998876666677899999999999999999999854 46889
Q ss_pred eeeecccccCCchhhhhccccccccccCCccccCCcCcccEEE
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMID 168 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~l~~L~~L~ 168 (628)
|.||||++||+|.+.+... .++++....+|+.-+..|+.|+
T Consensus 346 WVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH 386 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH 386 (550)
T ss_pred EEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999888644 3566666666665555555444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-10 Score=114.19 Aligned_cols=94 Identities=19% Similarity=0.416 Sum_probs=78.3
Q ss_pred hCCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++... ......+.+|+.++++++||||+++++.+. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 356889999999999999999875 345689999987642 334467899999999999999999999854 46
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++||||+++|++.+++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~ 101 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE 101 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC
Confidence 78999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-10 Score=119.41 Aligned_cols=93 Identities=16% Similarity=0.312 Sum_probs=80.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 4578999999999999999999999999999999997532 23345678899999999999999999884 457
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...|+|||||++|+|.+++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~ 136 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN 136 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh
Confidence 889999999999999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-10 Score=116.70 Aligned_cols=93 Identities=20% Similarity=0.310 Sum_probs=79.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|+.++..++|++|+++++++ ++...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47899999999999999999999999999999987532 23345578889999999999999999884 45788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+||||+++|+|.+++.+..
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~ 96 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE 96 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc
Confidence 999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.4e-11 Score=115.31 Aligned_cols=93 Identities=27% Similarity=0.363 Sum_probs=81.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..|...+.||+|+||.||+|.+.++++.||+|++.... +...+.+.+|+.++..++++||.++++++.. ....+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-----g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-----GTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-----cccHH
Confidence 45677789999999999999999999999999998764 4556889999999999999999999999654 77899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||.||++.+.++...
T Consensus 88 iiMey~~gGsv~~lL~~~~ 106 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN 106 (467)
T ss_pred HHHHHhcCcchhhhhccCC
Confidence 9999999999999886554
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-10 Score=114.89 Aligned_cols=96 Identities=22% Similarity=0.388 Sum_probs=83.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+.++|++.+.||+|+||.||+|.+..+++.||+|..........+.+.+|++++++++||||+++++.+. .....
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeE
Confidence 3567999999999999999999998889999999997665555678999999999999999999999854 47788
Q ss_pred eeeecccccCCchhhhhcccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~ 146 (628)
|+||||++++++.+++.+...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~ 98 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER 98 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC
Confidence 999999999999999876443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-10 Score=118.79 Aligned_cols=92 Identities=24% Similarity=0.400 Sum_probs=80.2
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
...++|.+.+++|+|+||+|+.|..+.+++.||||++++. .+.+++....|.+++.-. +||.+++++.. |+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cc
Confidence 3457899999999999999999999999999999999875 356778888999888777 59999999998 78
Q ss_pred ccceeeeeecccccCCchhhh
Q 042887 121 GVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l 141 (628)
+..+.|+||||+.|||+..+.
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~ 460 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHI 460 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEE
Confidence 899999999999999954333
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-10 Score=118.68 Aligned_cols=99 Identities=18% Similarity=0.308 Sum_probs=83.3
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeee
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
..+.....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 3344455689999999999999999999999999999999986532 23345678899999999999999999885
Q ss_pred ccccccceeeeeecccccCCchhhhhc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
......|+|||||++|+|.+++..
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~ 136 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSN 136 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHh
Confidence 447889999999999999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-10 Score=117.33 Aligned_cols=92 Identities=21% Similarity=0.307 Sum_probs=79.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|+..+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++..++||+|+++++.+ ++...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46888999999999999999999999999999997532 33456788899999999999999999884 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++.+.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~ 95 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK 95 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc
Confidence 99999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-10 Score=119.42 Aligned_cols=93 Identities=17% Similarity=0.322 Sum_probs=79.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ++.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 3467999999999999999999999999999999997532 23345578899999999999999999884 457
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...|+||||+++|+|.+++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~ 136 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN 136 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh
Confidence 889999999999999998864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.08 E-value=4e-10 Score=110.70 Aligned_cols=93 Identities=23% Similarity=0.334 Sum_probs=80.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+++.||+|+...........+.+|+.++++++||||+++++.+. .....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 467999999999999999999998899999999997654444567889999999999999999999854 367889
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+||||+++++|.+++.+.
T Consensus 83 iv~e~~~~~~L~~~~~~~ 100 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVT 100 (267)
T ss_pred EEEeCCCCCcHHHHHHhc
Confidence 999999999999988643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-10 Score=120.14 Aligned_cols=99 Identities=21% Similarity=0.437 Sum_probs=81.6
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~ 114 (628)
.+..+.++|.+.+.||+|+||.||+|.+. ..++.||+|+++... ....+.+.+|+.+|..+. |||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35566778999999999999999999964 344679999997543 233457889999999997 99999999986
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.. .+..++|||||++|+|.+++....
T Consensus 111 ~~-----~~~~~iv~E~~~~g~L~~~l~~~~ 136 (401)
T cd05107 111 TK-----GGPIYIITEYCRYGDLVDYLHRNK 136 (401)
T ss_pred cc-----CCCcEEEEeccCCCcHHHHHHhcc
Confidence 53 567899999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.3e-10 Score=116.30 Aligned_cols=94 Identities=17% Similarity=0.297 Sum_probs=78.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCC-cEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETG-TTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~-~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++. +
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence 3457999999999999999999976554 689999986532 334567889999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+||||+++|+|.+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~ 125 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRN 125 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc
Confidence 77899999999999999998654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-10 Score=115.33 Aligned_cols=96 Identities=23% Similarity=0.308 Sum_probs=81.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++ .....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 46899999999999999999999999999999997642 23445688899999999999999999884 34678
Q ss_pred eeeeecccccCCchhhhhcccccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
.|+||||+++|+|.+++.+....+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l 99 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQF 99 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCC
Confidence 999999999999999997653333
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.8e-12 Score=114.03 Aligned_cols=91 Identities=19% Similarity=0.370 Sum_probs=79.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.+.|++.++||+|.|+.||++.+..+|+.+|+|++... +....+.+.+|+++.+.++|||||++.+. +...++
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 35788889999999999999999999999999999653 34467889999999999999999999998 455899
Q ss_pred eeeeecccccCCchhhhh
Q 042887 125 KALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~ 142 (628)
.|+|+|+|.|+++..-|-
T Consensus 85 ~ylvFe~m~G~dl~~eIV 102 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIV 102 (355)
T ss_pred eEEEEecccchHHHHHHH
Confidence 999999999999965543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.7e-10 Score=114.17 Aligned_cols=93 Identities=27% Similarity=0.463 Sum_probs=76.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECC----------------CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE----------------TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIK 109 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 109 (628)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678999999999999999998632 33479999987542 334567999999999999999999
Q ss_pred ccceeeeccccccceeeeeecccccCCchhhhhcc
Q 042887 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 110 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+++++.+ ....+++|||+++|+|.+++...
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~ 113 (304)
T cd05096 84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSH 113 (304)
T ss_pred EEEEEec-----CCceEEEEecCCCCcHHHHHHhc
Confidence 9998643 56789999999999999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.2e-10 Score=116.23 Aligned_cols=92 Identities=22% Similarity=0.374 Sum_probs=80.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|++++..++||||+++++++ .....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 46899999999999999999999999999999997542 24456788999999999999999999884 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+++|+|.+++...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~ 95 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK 95 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc
Confidence 99999999999999998755
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-11 Score=127.30 Aligned_cols=85 Identities=24% Similarity=0.269 Sum_probs=37.4
Q ss_pred cCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCC
Q 042887 231 WNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLS 310 (628)
Q Consensus 231 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 310 (628)
..+..++.++++.|.+. .+-..+. .+.+|+.|++.+|+|..+. ..+..+++|++|++++|+|+.+.+ +..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~-~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLS-KLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccc-cccceeeeeccccchhhcc-cchhhhhcchheeccccccccccc--hhhccchh
Confidence 34455555555555554 2111121 2455555555555555221 113444445555555555443322 23333444
Q ss_pred EEEccCCcCC
Q 042887 311 RLFLSKNNLG 320 (628)
Q Consensus 311 ~L~L~~n~l~ 320 (628)
.|++++|.|+
T Consensus 144 ~L~l~~N~i~ 153 (414)
T KOG0531|consen 144 ELNLSGNLIS 153 (414)
T ss_pred hheeccCcch
Confidence 4444444443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.6e-10 Score=111.54 Aligned_cols=93 Identities=22% Similarity=0.477 Sum_probs=78.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.++++++||||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 467999999999999999999999999999999987543 23345678999999999999999999984 446789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+++ ++.+++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~ 97 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCG 97 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcC
Confidence 999999985 8888886543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.7e-10 Score=112.63 Aligned_cols=92 Identities=17% Similarity=0.236 Sum_probs=79.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... .....++.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 36899999999999999999999999999999987542 233456889999999999999999999854 478899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++++|.+++...
T Consensus 76 lv~ey~~~~~L~~~l~~~ 93 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA 93 (308)
T ss_pred EEeeccCCCcHHHHHHhc
Confidence 999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.5e-10 Score=123.79 Aligned_cols=91 Identities=19% Similarity=0.305 Sum_probs=79.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+++.+|++++++++||||+++++++.+ .+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 57999999999999999999999999999999986532 2334679999999999999999999998643 678
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.|++|||++||+|.+++..
T Consensus 77 lyLVMEY~eGGSL~~lL~s 95 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKS 95 (932)
T ss_pred EEEEEEcCCCCCHHHHHHH
Confidence 8999999999999998864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.8e-10 Score=113.33 Aligned_cols=86 Identities=24% Similarity=0.323 Sum_probs=73.8
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.||+|+||.||+|++..+|+.||+|+++... ......+.+|+.++++++||||+++++++ ......|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997542 23445678999999999999999999884 45788999999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|++.+++...
T Consensus 76 ~~~~~~L~~~l~~~ 89 (323)
T cd05571 76 YANGGELFFHLSRE 89 (323)
T ss_pred CCCCCcHHHHHHHc
Confidence 99999999888654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.9e-10 Score=113.25 Aligned_cols=86 Identities=26% Similarity=0.335 Sum_probs=73.4
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.||+|+||.||+|++..+|+.||+|++... .......+.+|+.+++.++||||+++++++ ......|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 4699999999999999999999999999754 223445678899999999999999999884 44778999999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|++.+++...
T Consensus 76 ~~~~~~L~~~l~~~ 89 (323)
T cd05595 76 YANGGELFFHLSRE 89 (323)
T ss_pred CCCCCcHHHHHHHc
Confidence 99999998887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.6e-10 Score=111.36 Aligned_cols=90 Identities=21% Similarity=0.300 Sum_probs=76.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.|+..+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.++++++|++|+++.+++ .+.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3777899999999999999999999999999986532 22334678999999999999999999885 346789
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
++||||+++|++.+++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~ 93 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN 93 (285)
T ss_pred EEEEEecCCCcHHHHHHh
Confidence 999999999999887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.2e-10 Score=110.99 Aligned_cols=91 Identities=21% Similarity=0.299 Sum_probs=76.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+ ......
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4788899999999999999998899999999986532 22335578899999999999999999884 446789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|++.+++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~ 94 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM 94 (285)
T ss_pred EEEEeccCCCcHHHHHHhc
Confidence 9999999999999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-11 Score=127.20 Aligned_cols=247 Identities=24% Similarity=0.276 Sum_probs=155.3
Q ss_pred cCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHh
Q 042887 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIAN 359 (628)
Q Consensus 280 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~ 359 (628)
..+..++.+++..|.+.. ....+..+++|+.|++.+|.|..+... +..++
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~-------l~~~~---------------------- 118 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL-------LSSLV---------------------- 118 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc-------hhhhh----------------------
Confidence 344555556666666653 222345556666666666666542210 22233
Q ss_pred ccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccC-ccccCCCCCCe
Q 042887 360 LSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTLGNLTLLNR 438 (628)
Q Consensus 360 ~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~ 438 (628)
+|++|++++|.|+.. ..+..++.|+.|++++|.|... ..+..++.|+.+++++|.+....+ . ...+.+++.
T Consensus 119 ---~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~ 190 (414)
T KOG0531|consen 119 ---NLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEE 190 (414)
T ss_pred ---cchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHH
Confidence 455555555555533 3456666788899999988743 456668888999999998885444 2 467788888
Q ss_pred EecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccC--CCCEeeCcCCcCcccCCccccCCCCCCeEE
Q 042887 439 LFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLR--NLAEFDLSENHFSNEIPVTLSACTTLEYLH 516 (628)
Q Consensus 439 L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 516 (628)
++++.|.+... ..+..+..+ ..+++..|.++...+ +..+. .|+.+++++|++. ..+..+..+..+..|+
T Consensus 191 l~l~~n~i~~i--~~~~~~~~l----~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~ 261 (414)
T KOG0531|consen 191 LDLGGNSIREI--EGLDLLKKL----VLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLD 261 (414)
T ss_pred HhccCCchhcc--cchHHHHHH----HHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccc
Confidence 88888888632 223333333 445788888874322 22222 3788888888887 3335667778888888
Q ss_pred CcCceeeeecCccccCCCCCCEEECCCCccccc---Cchh-hhcccCCCeEeccCCcCcccCC
Q 042887 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ---IPKY-LENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 517 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~ls~N~l~~~~p 575 (628)
+.+|++... ..+...+.+..+....|.+... .... ....+.++.+++..|++....+
T Consensus 262 ~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 262 LSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 888888632 2345567777888888887622 1121 4556778888888888776544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-10 Score=109.07 Aligned_cols=99 Identities=22% Similarity=0.334 Sum_probs=83.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeec--cccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
....|...+.||+|+||.|+.|.+..+|+.||||.+.. ...-.+++..||+..++.++|+||+.+.++......+...
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566667899999999999999999999999999973 3455678899999999999999999999987654455678
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|+|+|+ .||++.++...
T Consensus 100 DvYiV~elMe-tDL~~iik~~~ 120 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQ 120 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCc
Confidence 8999999995 58888887654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-10 Score=115.90 Aligned_cols=96 Identities=21% Similarity=0.403 Sum_probs=78.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceeeecc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCSSID 118 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 118 (628)
+.++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 4568999999999999999999852 457889999997543 23345788999999999 58999999998643
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....+++||||++|+|.+++....
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~ 107 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKR 107 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcC
Confidence 3457889999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-10 Score=105.08 Aligned_cols=98 Identities=19% Similarity=0.251 Sum_probs=86.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|.+.+.+|+|||+.||.++...+++.||+|++......+.+...+|++..++++||||+++++.+....-+..+..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46799999999999999999999999999999999877766778899999999999999999999987653344567899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++++|...|++.+.+...
T Consensus 100 ll~Pyy~~Gsl~d~i~~~ 117 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERL 117 (302)
T ss_pred EEeehhccccHHHHHHHH
Confidence 999999999999988543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.03 E-value=6e-10 Score=111.62 Aligned_cols=93 Identities=25% Similarity=0.505 Sum_probs=77.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 468999999999999999999999899999999987543 22345678999999999999999999985 447789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+. +++.+++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~ 97 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHP 97 (303)
T ss_pred EEEEECCC-cCHHHHHHhCC
Confidence 99999996 57777776543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.3e-10 Score=113.50 Aligned_cols=93 Identities=20% Similarity=0.300 Sum_probs=79.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||++++..+++.||+|++.+.. ......+.+|+.++..++|++|+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47899999999999999999999999999999986532 23344578899999999999999999885 44788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+||||+++|+|.+++.+..
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~ 96 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE 96 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc
Confidence 999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=4e-10 Score=115.46 Aligned_cols=89 Identities=28% Similarity=0.333 Sum_probs=76.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|+..+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+++++.++|+||+++++++ ...+..
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence 456888899999999999999999899999999986543 23456789999999999999999999984 457889
Q ss_pred eeeecccccCCchhh
Q 042887 126 ALIYEYMKCGSSEDW 140 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~ 140 (628)
|+||||+++|++.+.
T Consensus 148 ~lv~e~~~~~~L~~~ 162 (353)
T PLN00034 148 QVLLEFMDGGSLEGT 162 (353)
T ss_pred EEEEecCCCCccccc
Confidence 999999999998653
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.1e-10 Score=110.48 Aligned_cols=95 Identities=29% Similarity=0.485 Sum_probs=79.6
Q ss_pred CCCCcCceeecCCceeEEEEEE----CCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.+|++.+.||+|+||.||+|.+ ..+++.||+|.+........+.+.+|+++++.++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4788899999999999999984 35688999999876655556788999999999999999999987643 2345
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++|+||+++|+|.+++.+..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~ 102 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR 102 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC
Confidence 6899999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.9e-11 Score=121.35 Aligned_cols=120 Identities=26% Similarity=0.311 Sum_probs=93.7
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
-|+-.+.||.|+||-||.|++..+.+.||||.+.-..+ .....+..|+..|.+++|||+|.+.+++.. ....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence 45666789999999999999999999999999975433 233568999999999999999999999654 7889
Q ss_pred eeeecccccCCchhhhhccccccccccCCccccCCcCcccEEEccCCccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLI 175 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 175 (628)
|+|||||-| +-.+.+.-..+.+.+.....++.+.+..|.+|+ |.|.|.
T Consensus 102 WLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH-S~~~IH 149 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNRIH 149 (948)
T ss_pred HHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH-HhhHHh
Confidence 999999975 666677666666665555556666666777666 555554
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-10 Score=117.51 Aligned_cols=99 Identities=21% Similarity=0.395 Sum_probs=81.1
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCC-----cEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETG-----TTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
.|....++|++.+.||+|+||.||+|++...| +.||+|+++... ....+.+.+|+.+++.+ +|+|||++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34556678999999999999999999864433 579999997543 33456788999999999 799999999986
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .....++|||||++|+|.+++....
T Consensus 112 ~-----~~~~~~lv~ey~~~g~L~~~l~~~~ 137 (374)
T cd05106 112 T-----HGGPVLVITEYCCYGDLLNFLRKKA 137 (374)
T ss_pred c-----CCCCeEEeHhhccCCcHHHHHHhhh
Confidence 4 4678899999999999999997544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.7e-10 Score=111.72 Aligned_cols=84 Identities=18% Similarity=0.267 Sum_probs=72.6
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||+|+||.||+|++..+++.||+|++... .......+.+|+.++++++||||+++++.+. .....|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 69999999999999999999999999753 2334567889999999999999999998853 478899999999
Q ss_pred ccCCchhhhhcc
Q 042887 133 KCGSSEDWMHQS 144 (628)
Q Consensus 133 ~~g~L~~~l~~~ 144 (628)
++|+|.+++...
T Consensus 76 ~~g~L~~~l~~~ 87 (312)
T cd05585 76 NGGELFHHLQRE 87 (312)
T ss_pred CCCcHHHHHHhc
Confidence 999999988654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.9e-10 Score=110.75 Aligned_cols=93 Identities=25% Similarity=0.357 Sum_probs=80.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+++.||+|.++.........+.+|+.+++.++||||+++++.+. .....|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEE
Confidence 457888899999999999999999899999999987655445567889999999999999999999854 367889
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++++|.+++...
T Consensus 83 lv~e~~~~~~L~~~~~~~ 100 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT 100 (267)
T ss_pred EEEeccCCCcHHHHHHhc
Confidence 999999999999988643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.9e-10 Score=107.74 Aligned_cols=98 Identities=22% Similarity=0.485 Sum_probs=81.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCC-cccccceeeecc-cccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRN-LIKIITVCSSID-FKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~-~~~~ 122 (628)
+..|+..+.+|+|+||+||+|+.+.+|+.||+|.+.... ++......||+.++++++|+| ||.+++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777788999999999999999999999999998764 345667899999999999999 999999976521 2233
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++|+||+.. ++..++....
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~ 111 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLP 111 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhcc
Confidence 589999999974 8999987655
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.4e-10 Score=110.42 Aligned_cols=104 Identities=22% Similarity=0.375 Sum_probs=85.8
Q ss_pred ccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeee
Q 042887 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSS 116 (628)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 116 (628)
+.++....+.++|++.+.||+|+||.||+|.+..+++.+|+|....... ....+.+|+.+++++ +||||+++++.+..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4455566678899999999999999999999999999999998764322 335678899999999 69999999998754
Q ss_pred ccccccceeeeeecccccCCchhhhh
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
.........++||||+++|+|.+++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~ 112 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVK 112 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHH
Confidence 33445678999999999999998875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.01 E-value=9e-10 Score=111.54 Aligned_cols=86 Identities=23% Similarity=0.336 Sum_probs=73.6
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.||+|+||.||+|++..+|+.||+|++... .......+.+|+.+++.++||||+++++.+ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4699999999999999999999999999754 233456788999999999999999998884 45788999999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|++.+++...
T Consensus 76 y~~~g~L~~~l~~~ 89 (328)
T cd05593 76 YVNGGELFFHLSRE 89 (328)
T ss_pred CCCCCCHHHHHHhc
Confidence 99999998887543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.5e-11 Score=119.62 Aligned_cols=102 Identities=28% Similarity=0.488 Sum_probs=82.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECC--CCc--EEEEEEeec-cccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGE--TGT--TVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~--~~avK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++.....+.||+|-||.||+|.+.. .|+ -||||.-+. +.....+.|.+|+.+|++++|||||+++++|.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~----- 461 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV----- 461 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-----
Confidence 34445566789999999999999742 233 388888765 34556788999999999999999999999987
Q ss_pred ccceeeeeecccccCCchhhhhccccccccccC
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 153 (628)
....|+|||.++.|+|..|+......++.+.+
T Consensus 462 -e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL 493 (974)
T KOG4257|consen 462 -EQPMWIVMELAPLGELREYLQQNKDSLPLRTL 493 (974)
T ss_pred -ccceeEEEecccchhHHHHHHhccccchHHHH
Confidence 46789999999999999999887776654433
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.3e-12 Score=125.64 Aligned_cols=118 Identities=20% Similarity=0.303 Sum_probs=98.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+.+.|.++..+|.|+||+||+|..++++-..|.|++...+....+.|.-||+||...+||+||+++++++ .....
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkL 104 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKL 104 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCce
Confidence 4556778888999999999999999998889999998877778899999999999999999999999854 36788
Q ss_pred eeeecccccCCchhhhhccccccccccCCccccCCcCcccEEE
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMID 168 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~l~~L~~L~ 168 (628)
||+.|||.||.+...|..-+..+++.....+|..-+..|.+|+
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH 147 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH 147 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh
Confidence 9999999999999888777777776666555655555555443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.4e-10 Score=109.64 Aligned_cols=89 Identities=21% Similarity=0.367 Sum_probs=75.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 36899999999999999999999999999999987542 23456788999999999999999999985 447789
Q ss_pred eeeecccccCCchhhh
Q 042887 126 ALIYEYMKCGSSEDWM 141 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l 141 (628)
|+||||++++.+..+.
T Consensus 76 ~lv~e~~~~~~l~~~~ 91 (287)
T cd07848 76 YLVFEYVEKNMLELLE 91 (287)
T ss_pred EEEEecCCCCHHHHHH
Confidence 9999999987765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.9e-10 Score=84.03 Aligned_cols=60 Identities=40% Similarity=0.546 Sum_probs=33.9
Q ss_pred CCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcC
Q 042887 511 TLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHF 570 (628)
Q Consensus 511 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l 570 (628)
+|++|++++|+++...+..|.++++|++|++++|+++...++.|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555555555555555555555555555555555555555543
|
... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.7e-10 Score=123.06 Aligned_cols=99 Identities=19% Similarity=0.335 Sum_probs=83.5
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
+.....++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++|||||++++++..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d--- 83 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN--- 83 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---
Confidence 3344567899999999999999999999999999999998753 23345678999999999999999999998643
Q ss_pred cccceeeeeecccccCCchhhhhc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.....+|+||||+++|+|.+++..
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k 107 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQK 107 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHH
Confidence 335678999999999999998865
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-10 Score=108.08 Aligned_cols=96 Identities=24% Similarity=0.342 Sum_probs=83.5
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..+++|...+++|+|.||+|..++.+.+|+.||+|++++. .+..+..-..|-++|+..+||.+..+... |++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt 239 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQT 239 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hcc
Confidence 3568899999999999999999999999999999999764 34445566788999999999999988777 788
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++.++||||+.||+|..++.+..
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer 263 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRER 263 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhh
Confidence 999999999999999998886543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.1e-09 Score=109.23 Aligned_cols=92 Identities=26% Similarity=0.352 Sum_probs=81.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++.+. ..+..|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 468999999999999999999998899999999997655445567889999999999999999999854 467899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||++++++.+++.+
T Consensus 93 lv~e~~~~~~L~~~~~~ 109 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE 109 (297)
T ss_pred EeecccCCCCHHHHHHh
Confidence 99999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-09 Score=111.47 Aligned_cols=95 Identities=21% Similarity=0.340 Sum_probs=77.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|++..+|+.||+|.+... ......++.+|+.++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488889999999999999999999999999998643 223345688999999999999999999987543333345689
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+|||||. +++.+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~ 97 (338)
T cd07859 81 VVFELME-SDLHQVIKAN 97 (338)
T ss_pred EEEecCC-CCHHHHHHhc
Confidence 9999996 6888887643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.3e-10 Score=110.02 Aligned_cols=92 Identities=21% Similarity=0.312 Sum_probs=79.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.++++++||||+++++.+. .....|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 4688999999999999999999889999999988653 2333467899999999999999999999854 478899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+||||++++++.+++...
T Consensus 76 lv~e~~~~~~l~~~~~~~ 93 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGG 93 (286)
T ss_pred EEEeecCCCCHHHHHHhc
Confidence 999999999999888653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=98.99 E-value=7e-10 Score=110.53 Aligned_cols=95 Identities=24% Similarity=0.377 Sum_probs=82.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+.+.|++.+.||+|+||.||+|++..+++.||+|..........+.+.+|+.+++.++||||+++++.+. .....
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeE
Confidence 4467999999999999999999999999999999997765556678899999999999999999999854 36789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||++++++..++.+..
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~ 104 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD 104 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc
Confidence 99999999999988876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.3e-10 Score=110.82 Aligned_cols=93 Identities=28% Similarity=0.470 Sum_probs=80.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+..+|++.+.||+|+||.||+|.+.. ++.+|+|.+..........+.+|+.+++.++||||+++++.+. .....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 45679999999999999999999976 8899999987665545677899999999999999999999854 46788
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
+++|||+++|+|.+++.+.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~ 96 (261)
T cd05148 78 YIITELMEKGSLLAFLRSP 96 (261)
T ss_pred EEEEeecccCCHHHHHhcC
Confidence 9999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.4e-10 Score=116.73 Aligned_cols=116 Identities=23% Similarity=0.382 Sum_probs=93.5
Q ss_pred ccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeee
Q 042887 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSS 116 (628)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 116 (628)
+.+.....+.+.|++.++||+|.||.||++..+++++.+|+|+....... .+....|..+++.. .|||++.+++++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44566667788999999999999999999999999999999998776443 35567788888877 49999999999876
Q ss_pred ccccccceeeeeecccccCCchhhhhcc-ccccccccCC
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQS-NDKLEAGNLG 154 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~ 154 (628)
.+--..+..|+|||||.+|+..+.++.- +..+.+.+..
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~Ia 126 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIA 126 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHH
Confidence 5555678999999999999999998644 3445544444
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=98.98 E-value=9.5e-10 Score=111.28 Aligned_cols=89 Identities=22% Similarity=0.400 Sum_probs=73.0
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHH---hhcCCCCcccccceeeeccccccc
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEAL---SNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
|++.+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|++++ +.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 677889999999999999999999999999997542 23345677776654 566799999999984 4478
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..|+||||+++|++..++..
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~ 95 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT 95 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc
Confidence 89999999999999887753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-10 Score=82.73 Aligned_cols=59 Identities=39% Similarity=0.616 Sum_probs=34.6
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeeccccc
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENN 221 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 221 (628)
+|++|++++|+++...++.|.++++|++|++++|.++.+.+++|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45556666666655555555566666666666666655555555666666666665554
|
... |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.3e-09 Score=110.51 Aligned_cols=86 Identities=20% Similarity=0.231 Sum_probs=72.7
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++..+ +||||+++++++ ......|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997642 23345678899999988 699999999984 4478899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
|||++|+|.+++...
T Consensus 76 e~~~~g~L~~~~~~~ 90 (329)
T cd05588 76 EFVSGGDLMFHMQRQ 90 (329)
T ss_pred eCCCCCCHHHHHHHc
Confidence 999999998887644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.4e-09 Score=106.83 Aligned_cols=91 Identities=20% Similarity=0.363 Sum_probs=78.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc------cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ------KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 4788899999999999999999999999999987532 123567899999999999999999999854 46
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++|+||+++++|.+++.+.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~ 97 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY 97 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh
Confidence 7889999999999999988643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.3e-09 Score=110.30 Aligned_cols=86 Identities=26% Similarity=0.313 Sum_probs=73.1
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+++++.++||||+++++++ ......|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997542 23445678899999999999999998884 44788999999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|++.+++...
T Consensus 76 ~~~~~~L~~~l~~~ 89 (325)
T cd05594 76 YANGGELFFHLSRE 89 (325)
T ss_pred CCCCCcHHHHHHhc
Confidence 99999998887643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.9e-10 Score=117.83 Aligned_cols=90 Identities=24% Similarity=0.437 Sum_probs=75.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCC-Cc--EEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGET-GT--TVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~-~~--~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++..+.+.||+|+||+|++|.|..- |+ .||||++...... ....|.+|+.+|.+|+|||+|++|++.. +.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQ 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cc
Confidence 4455668899999999999999643 33 4899999776543 6788999999999999999999999943 36
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
...||||.+++|+|.+.+++
T Consensus 184 p~mMV~ELaplGSLldrLrk 203 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRK 203 (1039)
T ss_pred hhhHHhhhcccchHHHHHhh
Confidence 78899999999999999987
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.7e-09 Score=107.86 Aligned_cols=92 Identities=25% Similarity=0.357 Sum_probs=81.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.+.||||+++++.+. .....+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEE
Confidence 467999999999999999999998899999999997765555677899999999999999999999854 367899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||++++++.+++.+
T Consensus 94 lv~e~~~~~~L~~~~~~ 110 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE 110 (296)
T ss_pred EeecccCCCCHHHHHHh
Confidence 99999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.97 E-value=9e-10 Score=109.27 Aligned_cols=93 Identities=22% Similarity=0.322 Sum_probs=80.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+++++.++||||+++++.+. .....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence 356888899999999999999998899999999886543 334567899999999999999999999864 36789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|++.+++...
T Consensus 79 ~lv~e~~~~~~L~~~~~~~ 97 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG 97 (284)
T ss_pred EEEEecCCCCCHHHHHHhc
Confidence 9999999999999888653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-09 Score=107.06 Aligned_cols=93 Identities=19% Similarity=0.316 Sum_probs=79.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++.......||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++++. .....+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 81 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFK 81 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEE
Confidence 444555578999999999999998899999999987665556678999999999999999999999854 367899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+++||+++++|.+++...
T Consensus 82 lv~e~~~~~~L~~~l~~~ 99 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK 99 (268)
T ss_pred EEEecCCCCCHHHHHHHh
Confidence 999999999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.4e-09 Score=108.19 Aligned_cols=92 Identities=22% Similarity=0.325 Sum_probs=79.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++.+. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 46889999999999999999999999999999986532 234567889999999999999999999854 4778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||++++++.+++...
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~ 95 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS 95 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc
Confidence 99999999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-09 Score=109.71 Aligned_cols=88 Identities=17% Similarity=0.198 Sum_probs=69.4
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECC-CCcEEEEEEeecc-----ccchhhhHHHHHHHHhhcCCCCcccccceeee
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGE-TGTTVAVKVMNLK-----QKGAAKSFVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
.....++|.+.+.||+|+||+||+|++.. +++.||||..... .....+.|.+|+++|++++|+|++..+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 34456789999999999999999999876 6778899987532 12234568999999999999999853322
Q ss_pred ccccccceeeeeecccccCCch
Q 042887 117 IDFKGVDFKALIYEYMKCGSSE 138 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~ 138 (628)
....|+||||++|++|.
T Consensus 90 -----~~~~~LVmE~~~G~~L~ 106 (365)
T PRK09188 90 -----TGKDGLVRGWTEGVPLH 106 (365)
T ss_pred -----cCCcEEEEEccCCCCHH
Confidence 23469999999999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-09 Score=106.50 Aligned_cols=94 Identities=27% Similarity=0.379 Sum_probs=82.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.+|+|+||.||+|.+..+++.+|+|.+........+.+.+|++++++++||||+++++.+. .....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEE
Confidence 468999999999999999999998889999999998765555678899999999999999999998854 467899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
++|||++++++.+++....
T Consensus 77 l~~e~~~~~~l~~~~~~~~ 95 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR 95 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc
Confidence 9999999999999887653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.1e-11 Score=120.87 Aligned_cols=93 Identities=26% Similarity=0.388 Sum_probs=83.6
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++++|+...++|.|+||.||+|++..+++..|+|+++.....+.....+|+-+++..+|||||.+++.+. ..+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-----r~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-----RRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-----hhcC
Confidence 45688999999999999999999999999999999999887777788889999999999999999999854 4788
Q ss_pred eeeeecccccCCchhhhh
Q 042887 125 KALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~ 142 (628)
.++.||||.+|++.+...
T Consensus 87 lwicMEycgggslQdiy~ 104 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYH 104 (829)
T ss_pred cEEEEEecCCCcccceee
Confidence 999999999999987543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-09 Score=105.88 Aligned_cols=87 Identities=26% Similarity=0.467 Sum_probs=73.9
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 46999999999999998899999999876432 334567899999999999999999999864 367789999999
Q ss_pred ccCCchhhhhccc
Q 042887 133 KCGSSEDWMHQSN 145 (628)
Q Consensus 133 ~~g~L~~~l~~~~ 145 (628)
+++++.+++....
T Consensus 76 ~~~~L~~~~~~~~ 88 (252)
T cd05084 76 QGGDFLTFLRTEG 88 (252)
T ss_pred cCCcHHHHHHhCC
Confidence 9999999986543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-09 Score=106.53 Aligned_cols=91 Identities=24% Similarity=0.376 Sum_probs=79.5
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++. +.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 4888899999999999999998899999999997542 2345778999999999999999999988 4457889
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++|+||+++++|.+++...
T Consensus 76 ~lv~e~~~~~~L~~~l~~~ 94 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK 94 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc
Confidence 9999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.1e-09 Score=105.47 Aligned_cols=94 Identities=23% Similarity=0.350 Sum_probs=77.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.+|++.+.||+|+||.||.|.+..+|+.||+|.+.... ....+.+.+|+.++++++||||+++++.+.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 57899999999999999999999999999999886421 2234678899999999999999999987542 123
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...+++|||+++++|.+++...
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~ 100 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY 100 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc
Confidence 5788999999999999988643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.3e-09 Score=105.97 Aligned_cols=88 Identities=24% Similarity=0.277 Sum_probs=75.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+.++++++||||+++++.+.. ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 46888899999999999999999999999999986542 3344678899999999999999999998653 67889
Q ss_pred eeecccccCCchhh
Q 042887 127 LIYEYMKCGSSEDW 140 (628)
Q Consensus 127 lv~e~~~~g~L~~~ 140 (628)
+||||+++|++..+
T Consensus 76 lv~e~~~~~~l~~~ 89 (279)
T cd06619 76 ICTEFMDGGSLDVY 89 (279)
T ss_pred EEEecCCCCChHHh
Confidence 99999999988654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.6e-09 Score=109.55 Aligned_cols=91 Identities=21% Similarity=0.279 Sum_probs=75.5
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCC-Ccccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHR-NLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~~ 124 (628)
+|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++..+.|+ +|+++++++ .....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 588899999999999999999999999999999754 233456788899999999765 577787774 34678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+++|+|.+++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~ 95 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV 95 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc
Confidence 99999999999999888644
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.1e-09 Score=116.61 Aligned_cols=91 Identities=19% Similarity=0.236 Sum_probs=78.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCC-CcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGET-GTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++|||||++++.+. ..+..|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence 3489999999999999999999877 7889999876555445566788999999999999999999854 478899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||+++|+|.+++.+
T Consensus 142 lv~E~~~gg~L~~~l~~ 158 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQ 158 (478)
T ss_pred EEEECCCCCCHHHHHHH
Confidence 99999999999988764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.6e-10 Score=118.97 Aligned_cols=93 Identities=27% Similarity=0.477 Sum_probs=77.3
Q ss_pred CcCceeecCCceeEEEEEECCCCc----EEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGT----TVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~----~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.-.++||+|+||+||+|.+.-.|+ +||+|++... ......++..|+-+|.+++|||+++++++|.. +..
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------STL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------chH
Confidence 345789999999999999865554 4888887554 34456789999999999999999999999873 448
Q ss_pred eeeecccccCCchhhhhccccccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
.+|++|+++|.|.+|++.+++.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~ig 796 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIG 796 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhcccc
Confidence 899999999999999998876664
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-09 Score=106.85 Aligned_cols=88 Identities=30% Similarity=0.554 Sum_probs=71.5
Q ss_pred cCceeecCCceeEEEEEEC----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 52 ASNMIGQGSFGFVYKGKLG----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+.+.||.|+||.||+|.+. ..+..|+||.++... ....+.|.+|++.+++++||||+++++++.. ....+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 4578999999999999997 335679999996543 3346789999999999999999999999763 55689
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+|+|||++|+|.+++...
T Consensus 78 lv~e~~~~g~L~~~L~~~ 95 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK 95 (259)
T ss_dssp EEEE--TTEBHHHHHHHT
T ss_pred cccccccccccccccccc
Confidence 999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-09 Score=105.84 Aligned_cols=91 Identities=23% Similarity=0.450 Sum_probs=75.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 45888899999999999999885 45689999876432 23467889999999999999999999854 4677899
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
+|||+++|++.+++....
T Consensus 77 v~e~~~~~~L~~~~~~~~ 94 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ 94 (256)
T ss_pred EEEcCCCCcHHHHHHhCc
Confidence 999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-09 Score=105.30 Aligned_cols=91 Identities=24% Similarity=0.369 Sum_probs=79.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .....+.+.+|++++++++|++|+++++.+. ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 5799999999999999999999889999999988643 2334567899999999999999999999854 4678
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.+++|||+++|+|.+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~ 95 (267)
T cd08224 77 LNIVLELADAGDLSRMIKH 95 (267)
T ss_pred EEEEEecCCCCCHHHHHHH
Confidence 8999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.7e-09 Score=106.17 Aligned_cols=94 Identities=26% Similarity=0.452 Sum_probs=78.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCC---CcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.+.||+|+||.||+|.+..+ ...||+|.++... ......|.+|+.++++++||||+++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 5688999999999999999998644 4579999986543 334567899999999999999999999854 467
Q ss_pred eeeeeecccccCCchhhhhcccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
..+++|||+++++|.+++.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~ 101 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDG 101 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccC
Confidence 78999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-09 Score=107.09 Aligned_cols=93 Identities=25% Similarity=0.464 Sum_probs=78.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCc---EEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGT---TVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+... .....+.|.+|+.+++.++||||+++++.+ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 458888999999999999999876665 5999998754 334457899999999999999999999884 3467
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++||||+++|++.+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~ 100 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND 100 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC
Confidence 7899999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=98.94 E-value=2e-09 Score=105.62 Aligned_cols=91 Identities=23% Similarity=0.332 Sum_probs=78.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+++++.++||||+++++.+. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 57899999999999999999999899999999886432 234457889999999999999999999854 3678
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.++++||+++|++.+++..
T Consensus 77 ~~~v~e~~~~~~L~~~~~~ 95 (267)
T cd08228 77 LNIVLELADAGDLSQMIKY 95 (267)
T ss_pred EEEEEEecCCCcHHHHHHH
Confidence 8999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.4e-09 Score=106.63 Aligned_cols=92 Identities=27% Similarity=0.382 Sum_probs=80.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++||||+++++.+.. ....|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence 4689999999999999999999988899999999876554455778999999999999999999998543 67889
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|+||++++++.+++.+
T Consensus 93 lv~e~~~~~~L~~~~~~ 109 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE 109 (293)
T ss_pred EEEecCCCCcHHHHHhh
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.2e-10 Score=125.99 Aligned_cols=131 Identities=19% Similarity=0.238 Sum_probs=77.8
Q ss_pred CcCcccEEEccCCccccccchhhhCCCCCCEEecccCc--CcccccccccCCCCCCEeecccccCcccCCcCccCCCCCC
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANM--LGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 237 (628)
+....+...+-+|.+. .++... ..++|+.|-+..|. +..+..+.|..++.|++|||++|.=-+.+|..++++.+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3445555666566554 222222 23356666666664 4433344466677777777776654446677777777777
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccccc
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH 294 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 294 (628)
+|++++..+. .+|..+.. +.+|.+|++..+.-....|.....+++|++|.+....
T Consensus 599 yL~L~~t~I~-~LP~~l~~-Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGN-LKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHH-HHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 7777777766 66666654 6666666666665544445555566666666665543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-09 Score=106.18 Aligned_cols=90 Identities=21% Similarity=0.310 Sum_probs=76.0
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++|++|+.+++.+. .....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 3677789999999999999999999999999986542 222345788999999999999999988854 46789
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
++||||+++|+|.+++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~ 93 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH 93 (285)
T ss_pred EEEEEecCCCcHHHHHHH
Confidence 999999999999988854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.6e-09 Score=104.09 Aligned_cols=90 Identities=18% Similarity=0.276 Sum_probs=78.0
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
+|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++||||+++++.+. +....|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 478889999999999999999999999999998653 2334567889999999999999999999854 4788999
Q ss_pred eecccccCCchhhhhc
Q 042887 128 IYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~ 143 (628)
+|||+++|++.+++..
T Consensus 76 v~e~~~~~~l~~~~~~ 91 (255)
T cd08219 76 VMEYCDGGDLMQKIKL 91 (255)
T ss_pred EEeeCCCCcHHHHHHh
Confidence 9999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-09 Score=106.27 Aligned_cols=93 Identities=25% Similarity=0.468 Sum_probs=76.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCC---cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETG---TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.+.||+|+||.||+|++..++ ..+|+|.++... ....+.+.+|+.++++++||||+++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 46888999999999999999986444 369999886542 234567899999999999999999999854 467
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..+++|||+++|+|.+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~ 100 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD 100 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC
Confidence 8899999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-09 Score=107.66 Aligned_cols=93 Identities=22% Similarity=0.455 Sum_probs=77.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|.+.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.++++++||||+++++++. ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeE
Confidence 467999999999999999999999899999999987543 233456789999999999999999999854 46789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+++ ++.+++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~ 98 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCG 98 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcC
Confidence 999999985 7877776543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.3e-09 Score=106.20 Aligned_cols=88 Identities=20% Similarity=0.308 Sum_probs=72.7
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccccc---hhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG---AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
..||+|++|.||+|.+ +|+.||+|.++..... ..+.|.+|+.+|++++||||+++++++.+. .+.....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEE
Confidence 5799999999999999 7899999999764322 246788999999999999999999986531 123457899999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|+|.+++...
T Consensus 103 y~~~g~L~~~l~~~ 116 (283)
T PHA02988 103 YCTRGYLREVLDKE 116 (283)
T ss_pred eCCCCcHHHHHhhC
Confidence 99999999998754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.1e-09 Score=106.33 Aligned_cols=83 Identities=22% Similarity=0.292 Sum_probs=70.5
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||+|+||.||+|.+..+|+.||+|.+.... ....+.+..|+++++.++||||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999986542 22345678899999999999999998884 4577899999999
Q ss_pred ccCCchhhhhc
Q 042887 133 KCGSSEDWMHQ 143 (628)
Q Consensus 133 ~~g~L~~~l~~ 143 (628)
++|+|.+++..
T Consensus 76 ~~g~L~~~~~~ 86 (280)
T cd05608 76 NGGDLRYHIYN 86 (280)
T ss_pred CCCCHHHHHHh
Confidence 99999887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-09 Score=107.98 Aligned_cols=86 Identities=22% Similarity=0.305 Sum_probs=71.3
Q ss_pred ceeecCCceeEEEEEEC---CCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 54 NMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
+.||+|+||.||+++.. .+|+.||+|++.... ......+.+|++++++++||||+++++++ ......|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 57999999999998863 578999999997643 22345677899999999999999999885 447889999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
|||+++|+|.+++.+.
T Consensus 77 ~e~~~~~~L~~~l~~~ 92 (318)
T cd05582 77 LDFLRGGDLFTRLSKE 92 (318)
T ss_pred EcCCCCCcHHHHHHHc
Confidence 9999999999888543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-09 Score=107.63 Aligned_cols=86 Identities=22% Similarity=0.313 Sum_probs=71.4
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++. +.+..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999997642 23345667788888765 8999999998854 477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|+|.+++...
T Consensus 76 ey~~~g~L~~~l~~~ 90 (316)
T cd05619 76 EYLNGGDLMFHIQSC 90 (316)
T ss_pred eCCCCCcHHHHHHHc
Confidence 999999999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1e-09 Score=122.11 Aligned_cols=207 Identities=17% Similarity=0.207 Sum_probs=133.2
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEeeccccc--CcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCC
Q 042887 184 NFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENN--FSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261 (628)
Q Consensus 184 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~--i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L 261 (628)
+....+...+-+|.+. .++.+.. .++|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..++. +-+|
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~-Li~L 597 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGE-LVHL 597 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhh-hhhh
Confidence 4467788888888876 3444333 3379999999986 55455556788999999999988765689999985 9999
Q ss_pred cEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCce
Q 042887 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341 (628)
Q Consensus 262 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~ 341 (628)
++|++++..++ .+|..++++..|.+|++..+.-....+.....+++|++|.+..-.... +......+.++.+|+.
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~----~~~~l~el~~Le~L~~ 672 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSN----DKLLLKELENLEHLEN 672 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecccccc----chhhHHhhhcccchhh
Confidence 99999999999 789999999999999999887655667777779999999987765211 1123334455555555
Q ss_pred eecccCCccc-ccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccc
Q 042887 342 LYLNTNKFGG-VFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399 (628)
Q Consensus 342 L~l~~n~~~~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 399 (628)
+......... ........+....+.+.+.++... ..+..+..+.+|+.|.+.++.+.
T Consensus 673 ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 673 LSITISSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred heeecchhHhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence 5543322100 001111111111222222222221 23345566666666666666654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-09 Score=106.13 Aligned_cols=90 Identities=20% Similarity=0.292 Sum_probs=76.0
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+++++.++|++|+.+.+.+ ...+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 667788999999999999999999999999986542 22345578899999999999999998884 3477899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++|++.+++...
T Consensus 77 lv~e~~~~~~L~~~~~~~ 94 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM 94 (285)
T ss_pred EEEEeccCccHHHHHHHh
Confidence 999999999999888643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-09 Score=108.02 Aligned_cols=86 Identities=28% Similarity=0.371 Sum_probs=72.3
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|++... .....+.+.+|..++..+ +||||+++++++ ......|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4699999999999999999999999999753 233456678888888877 699999999984 4578899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|+|.+++.+.
T Consensus 76 Ey~~~g~L~~~i~~~ 90 (320)
T cd05590 76 EFVNGGDLMFHIQKS 90 (320)
T ss_pred cCCCCchHHHHHHHc
Confidence 999999999888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.5e-09 Score=108.03 Aligned_cols=91 Identities=21% Similarity=0.267 Sum_probs=74.6
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+|+..+.||+|+||.||+|++..+|+.||+|++.... ....+.+..|..++..+. |++|+++++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3677899999999999999999999999999997542 234456788999988886 57777888774 44778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+++|+|.+++...
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~ 95 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV 95 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc
Confidence 99999999999999888653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.7e-09 Score=103.97 Aligned_cols=91 Identities=21% Similarity=0.262 Sum_probs=79.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|+..+.||+|+||.||.++...+++.+++|.+.... ......+.+|++++++++|+||+++++.+. .....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 4888999999999999999999999999999986542 344567889999999999999999999954 467899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++|++.+++.+.
T Consensus 76 ~~~e~~~~~~L~~~~~~~ 93 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ 93 (256)
T ss_pred EEEEecCCCcHHHHHHhc
Confidence 999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.92 E-value=3e-09 Score=105.71 Aligned_cols=93 Identities=19% Similarity=0.262 Sum_probs=78.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|+..+.||.|+||.||+|.+..+++.+|+|.+.... .....++.+|+++++.++||||+++++.+.+ ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 36788899999999999999998899999999987543 2345678999999999999999999998653 2345789
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||+++++|.+++..
T Consensus 78 lv~e~~~~~~L~~~l~~ 94 (287)
T cd06621 78 IAMEYCEGGSLDSIYKK 94 (287)
T ss_pred EEEEecCCCCHHHHHHH
Confidence 99999999999888753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-09 Score=103.41 Aligned_cols=91 Identities=26% Similarity=0.405 Sum_probs=77.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4777899999999999999998889999999986543 224567899999999999999999999854 467
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++++||++++++.+++.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~ 96 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY 96 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc
Confidence 889999999999999998653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.7e-09 Score=107.92 Aligned_cols=87 Identities=22% Similarity=0.337 Sum_probs=71.8
Q ss_pred ceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 54 NMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+.||+|+||.||+++.. .+++.||+|+++... ......+.+|+.+|+.++||||+++++++. ..+..|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 67999999999999864 468899999997532 223456788999999999999999998854 477899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+||||+++|+|.+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~ 95 (323)
T cd05584 77 LILEYLSGGELFMHLEREG 95 (323)
T ss_pred EEEeCCCCchHHHHHHHcC
Confidence 9999999999999886543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=98.92 E-value=3e-09 Score=107.76 Aligned_cols=86 Identities=21% Similarity=0.243 Sum_probs=71.8
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++.++ +||||+++++++. .....|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 46999999999999999999999999997642 23345677888888777 7999999999854 478899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|++..++...
T Consensus 76 E~~~~~~L~~~~~~~ 90 (329)
T cd05618 76 EYVNGGDLMFHMQRQ 90 (329)
T ss_pred eCCCCCCHHHHHHHc
Confidence 999999998887543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-09 Score=108.07 Aligned_cols=96 Identities=23% Similarity=0.405 Sum_probs=77.5
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
...++|++.+.||+|+||.||+|.... .+..||+|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 346789999999999999999997642 34579999886443 223346889999999999999999999854
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++....
T Consensus 80 --~~~~~~lv~e~~~~g~L~~~l~~~~ 104 (288)
T cd05061 80 --KGQPTLVVMELMAHGDLKSYLRSLR 104 (288)
T ss_pred --CCCCcEEEEeCCCCCCHHHHHHHhc
Confidence 3567899999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-09 Score=107.23 Aligned_cols=86 Identities=21% Similarity=0.312 Sum_probs=70.2
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++ ......|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997542 23345566777777655 799999999884 4477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|+|.+++...
T Consensus 76 e~~~gg~L~~~~~~~ 90 (316)
T cd05592 76 EYLNGGDLMFHIQSS 90 (316)
T ss_pred cCCCCCcHHHHHHHc
Confidence 999999999888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.7e-09 Score=107.07 Aligned_cols=94 Identities=29% Similarity=0.524 Sum_probs=79.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+...... ..+.+.+|+++++.++||||+++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 3568888999999999999998743 3578999998765433 4578999999999999999999999854
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....+++|||+++|+|.+++...+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~ 103 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHG 103 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcC
Confidence 3678999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.2e-09 Score=103.44 Aligned_cols=91 Identities=21% Similarity=0.345 Sum_probs=79.1
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|++++++++||||+++++.+. ..+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 478889999999999999999999999999998653 2345567899999999999999999999854 467899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||++++++.+++...
T Consensus 76 lv~e~~~~~~L~~~l~~~ 93 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ 93 (256)
T ss_pred EEEEeCCCCcHHHHHHHh
Confidence 999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.1e-10 Score=105.26 Aligned_cols=91 Identities=27% Similarity=0.414 Sum_probs=71.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
-.|...+++|.|+||.||+|...++++.||||.+-...+ ---+|+.+|+.++|||||++..++.+..-.+.-...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 346777899999999999999999999999998854332 2248999999999999999988876521112335667
Q ss_pred eecccccCCchhhhhc
Q 042887 128 IYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~ 143 (628)
||||++. +|.+.++.
T Consensus 100 VleymP~-tL~~~~r~ 114 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRH 114 (364)
T ss_pred HHHhchH-HHHHHHHH
Confidence 9999995 88888864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.9e-09 Score=107.56 Aligned_cols=86 Identities=24% Similarity=0.310 Sum_probs=72.0
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|++.... ....+.+..|.+++..+ +||||+++++++ ......|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999997542 33445677898888876 799999999985 4477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|++..++...
T Consensus 76 E~~~~~~L~~~l~~~ 90 (321)
T cd05591 76 EYVNGGDLMFQIQRS 90 (321)
T ss_pred eCCCCCcHHHHHHHc
Confidence 999999999888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.9e-09 Score=103.34 Aligned_cols=92 Identities=26% Similarity=0.433 Sum_probs=78.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
++|++.+.||+|+||.||.|....+++.||+|.+.... ......+.+|+.++++++||||+++++.+ +..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 46899999999999999999998899999999986532 12345688999999999999999999985 446
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++++||++++++.+++...
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~ 98 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY 98 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh
Confidence 7999999999999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.2e-09 Score=106.29 Aligned_cols=93 Identities=22% Similarity=0.470 Sum_probs=78.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 467999999999999999999998899999999987543 233456789999999999999999999854 46789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||++ +++.+++.+..
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~ 98 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCG 98 (301)
T ss_pred EEEEeccc-cCHHHHHHhcC
Confidence 99999998 58888876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.9e-09 Score=106.02 Aligned_cols=105 Identities=22% Similarity=0.324 Sum_probs=85.0
Q ss_pred ccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeee
Q 042887 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSS 116 (628)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 116 (628)
+.+.+...+.++|++.+.||+|+||.||+|....+++.+|+|.+..... ....+.+|+.+++++ +|||++++++.+..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3445555668899999999999999999999999999999999865432 345678899999999 79999999998764
Q ss_pred ccccccceeeeeecccccCCchhhhhc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.+.......++||||+++|++.+++..
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~ 117 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKG 117 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHH
Confidence 322234578999999999999988753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.5e-09 Score=104.46 Aligned_cols=88 Identities=28% Similarity=0.550 Sum_probs=75.9
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccc--hhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG--AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|+||.||+|....+++.||+|.+...... ......+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 67789999999999999999999999999999876432 22334669999999999999999999543 788899
Q ss_pred eecccccCCchhhhh
Q 042887 128 IYEYMKCGSSEDWMH 142 (628)
Q Consensus 128 v~e~~~~g~L~~~l~ 142 (628)
+|||++++++.+++.
T Consensus 76 v~~~~~~~~L~~~l~ 90 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ 90 (260)
T ss_dssp EEEEETTEBHHHHHH
T ss_pred ccccccccccccccc
Confidence 999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.5e-09 Score=104.63 Aligned_cols=91 Identities=27% Similarity=0.371 Sum_probs=77.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+-|+..+.||+|+||.||+|.+..+++.||+|...... ....+.+.+|+..+++++||||+++++.+. .....+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence 45778889999999999999998889999999886543 234467889999999999999999999854 477899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||++++++.+++..
T Consensus 79 lv~e~~~~~~l~~~i~~ 95 (277)
T cd06641 79 IIMEYLGGGSALDLLEP 95 (277)
T ss_pred EEEEeCCCCcHHHHHhc
Confidence 99999999999988853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-09 Score=106.96 Aligned_cols=87 Identities=22% Similarity=0.385 Sum_probs=70.2
Q ss_pred eeecCCceeEEEEEECCC------------------------CcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccc
Q 042887 55 MIGQGSFGFVYKGKLGET------------------------GTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~------------------------~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 110 (628)
.||+|+||.||+|....+ ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999985321 13488888866544455678899999999999999999
Q ss_pred cceeeeccccccceeeeeecccccCCchhhhhcccc
Q 042887 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 111 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
++++.+ ....++||||+++|++..++.....
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~ 112 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKG 112 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcCC
Confidence 999754 6688999999999999988865443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-09 Score=107.89 Aligned_cols=93 Identities=27% Similarity=0.467 Sum_probs=76.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC--------------cEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG--------------TTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKII 111 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~--------------~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~ 111 (628)
.++|++.+.||+|+||.||+|++..++ ..||+|.++.. .......|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 357999999999999999999875432 35899998654 233456789999999999999999999
Q ss_pred ceeeeccccccceeeeeecccccCCchhhhhcc
Q 042887 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 112 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+.+. .....++||||++++++.+++...
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~ 111 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQR 111 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhc
Confidence 9854 467889999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.9e-09 Score=105.45 Aligned_cols=91 Identities=24% Similarity=0.402 Sum_probs=78.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
-|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++.+. .....++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 3677889999999999999999899999999987655555677899999999999999999999864 36788999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
+||+++|++.+++...
T Consensus 81 ~e~~~~~~l~~~~~~~ 96 (282)
T cd06643 81 IEFCAGGAVDAVMLEL 96 (282)
T ss_pred EEecCCCcHHHHHHhc
Confidence 9999999998887653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.6e-09 Score=106.15 Aligned_cols=92 Identities=17% Similarity=0.342 Sum_probs=79.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 36888999999999999999999999999999987543 23345788999999999999999999884 34778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||++++++.+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~ 95 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI 95 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc
Confidence 89999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.7e-09 Score=106.66 Aligned_cols=86 Identities=26% Similarity=0.335 Sum_probs=72.4
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++..+ +||||+++++++ ......|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997542 23445678899999888 699999999985 4477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|+|.+++.+.
T Consensus 76 e~~~~~~L~~~~~~~ 90 (318)
T cd05570 76 EYVNGGDLMFHIQRS 90 (318)
T ss_pred cCCCCCCHHHHHHHc
Confidence 999999999888654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.9e-09 Score=107.39 Aligned_cols=92 Identities=25% Similarity=0.462 Sum_probs=76.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcE----EEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTT----VAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.+|+..+.||+|+||.||+|++..+++. ||+|.++... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~------~ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL------T 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc------C
Confidence 4699999999999999999998666554 8999986543 334567889999999999999999999864 2
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++++||+++|++.+++....
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~ 103 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHK 103 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhcc
Confidence 35679999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.4e-09 Score=104.62 Aligned_cols=84 Identities=23% Similarity=0.312 Sum_probs=70.2
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||+|+||.||+++...+|+.||+|.+.... ......+..|++++++++||||+++++.+ +.....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999986432 22234566799999999999999998884 4577899999999
Q ss_pred ccCCchhhhhcc
Q 042887 133 KCGSSEDWMHQS 144 (628)
Q Consensus 133 ~~g~L~~~l~~~ 144 (628)
++|++.+++...
T Consensus 76 ~g~~L~~~~~~~ 87 (277)
T cd05607 76 NGGDLKYHIYNV 87 (277)
T ss_pred CCCCHHHHHHhc
Confidence 999998887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-09 Score=106.72 Aligned_cols=95 Identities=25% Similarity=0.418 Sum_probs=77.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
..++|++.+.||+|+||.||+|.+.. .++.||+|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 45779999999999999999998642 34679999886432 233456889999999999999999998853
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++.+..
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~ 104 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLR 104 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcC
Confidence 4678899999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.1e-09 Score=107.65 Aligned_cols=88 Identities=19% Similarity=0.242 Sum_probs=74.5
Q ss_pred cCceeecC--CceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 52 ASNMIGQG--SFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 52 ~~~~iG~G--~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
+.++||+| +|++||++.+..+|+.||+|.++... ....+.+.+|+++++.++||||+++++++. .....++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45789999 67899999999999999999997542 234456778999999999999999999864 3678999
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
||||+++|++.+++...
T Consensus 77 v~e~~~~~~l~~~~~~~ 93 (327)
T cd08227 77 VTSFMAYGSAKDLICTH 93 (327)
T ss_pred EEeccCCCcHHHHHHhh
Confidence 99999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-09 Score=104.77 Aligned_cols=91 Identities=29% Similarity=0.446 Sum_probs=79.0
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 4888899999999999999998899999999987643 344567899999999999999999999854 478899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+|+||+ ++++.+++....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~ 93 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE 93 (286)
T ss_pred EEeccc-CCCHHHHHHhcC
Confidence 999999 999999886544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-09 Score=105.98 Aligned_cols=92 Identities=25% Similarity=0.499 Sum_probs=79.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|++.+.||+|+||.||+|.+.++++.||+|.+.... .....+.+|+++++.++||||+++++++. .....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcE
Confidence 456888899999999999999999889999999986543 33567899999999999999999999854 367789
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||++++++.+++...
T Consensus 79 lv~e~~~~~~L~~~~~~~ 96 (263)
T cd05052 79 IITEFMTYGNLLDYLREC 96 (263)
T ss_pred EEEEeCCCCcHHHHHHhC
Confidence 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.2e-09 Score=103.86 Aligned_cols=92 Identities=29% Similarity=0.357 Sum_probs=79.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+++++.++|+||+++++.+. +....|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 36888899999999999999999999999999987543 334567889999999999999999999854 367899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+|+||++++++.+++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~ 93 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG 93 (274)
T ss_pred EEEEeeCCCcHHHHHhhc
Confidence 999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=98.89 E-value=4e-09 Score=104.18 Aligned_cols=91 Identities=27% Similarity=0.373 Sum_probs=78.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++++.||||+++++.+.+ ....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEE
Confidence 45777889999999999999998889999999987543 3445678999999999999999999998643 67899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||+++|++.+++..
T Consensus 79 lv~e~~~~~~L~~~i~~ 95 (277)
T cd06640 79 IIMEYLGGGSALDLLRA 95 (277)
T ss_pred EEEecCCCCcHHHHHhc
Confidence 99999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.6e-09 Score=105.51 Aligned_cols=92 Identities=23% Similarity=0.364 Sum_probs=80.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+........+.+.+|+.+++.++||||+++++.+. .....|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEE
Confidence 356999999999999999999998999999999997655445677889999999999999999999854 467899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|+||++++++.+++.+
T Consensus 93 lv~e~~~~~~L~~~~~~ 109 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE 109 (296)
T ss_pred EEEEecCCCcHHHHHHh
Confidence 99999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.1e-09 Score=106.70 Aligned_cols=86 Identities=26% Similarity=0.351 Sum_probs=69.8
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHH-HHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECE-ALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+|+.||+|++.... ......+.+|.. +++.++||||+++++.+ ......|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999997542 233445666665 46778999999999884 4478899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|++.+++...
T Consensus 76 e~~~~~~L~~~l~~~ 90 (325)
T cd05604 76 DFVNGGELFFHLQRE 90 (325)
T ss_pred cCCCCCCHHHHHHHc
Confidence 999999998887643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.1e-09 Score=106.59 Aligned_cols=86 Identities=29% Similarity=0.384 Sum_probs=69.8
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHH-HHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECE-ALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+|+.||+|++.... ......+.+|.. +++.++||||+++++.+ ......|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999997542 223345566655 46788999999999884 4477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|++.+++...
T Consensus 76 e~~~~g~L~~~l~~~ 90 (323)
T cd05575 76 DYVNGGELFFHLQRE 90 (323)
T ss_pred cCCCCCCHHHHHHhc
Confidence 999999999888653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.89 E-value=4e-09 Score=104.98 Aligned_cols=93 Identities=25% Similarity=0.511 Sum_probs=78.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|....+++.||+|.+.... ......+.+|+++++.++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 367999999999999999999998899999999987543 223355778999999999999999999854 47789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+.+ ++.+++.+..
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~ 97 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCG 97 (291)
T ss_pred EEEEecCCC-CHHHHHHhCC
Confidence 999999985 8988876544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.1e-09 Score=105.54 Aligned_cols=91 Identities=29% Similarity=0.444 Sum_probs=77.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46888999999999999999998889999999886532 22345688999999999999999999995 457889
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
|+|+||++++++.++...
T Consensus 76 ~lv~e~~~~~~l~~~~~~ 93 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY 93 (286)
T ss_pred EEEEecCCccHHHHHHhc
Confidence 999999999888877643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=5e-09 Score=108.22 Aligned_cols=94 Identities=19% Similarity=0.260 Sum_probs=75.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+++.+|+++++.++||||+++++++...+.......|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999999889999999998653 223456788999999999999999999986542222223789
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||+. +++.+++..
T Consensus 81 lv~e~~~-~~l~~~~~~ 96 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS 96 (372)
T ss_pred EEeeccc-cCHHHHHhc
Confidence 9999997 577776643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.2e-09 Score=117.34 Aligned_cols=93 Identities=23% Similarity=0.338 Sum_probs=79.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++.+. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 468999999999999999999999899999999997542 233467889999999999999999998754 467
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+.+++|.+++...
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~ 98 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY 98 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc
Confidence 899999999999999988643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.2e-09 Score=106.11 Aligned_cols=86 Identities=19% Similarity=0.286 Sum_probs=71.4
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+|+.||+|.++... ....+.+..|..++... +||+|+++++++ ...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999997642 23345667788888765 799999999884 4478999999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|+|.+++...
T Consensus 76 E~~~~g~L~~~i~~~ 90 (316)
T cd05620 76 EFLNGGDLMFHIQDK 90 (316)
T ss_pred CCCCCCcHHHHHHHc
Confidence 999999999888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.6e-09 Score=102.34 Aligned_cols=91 Identities=20% Similarity=0.367 Sum_probs=78.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|+..+.||+|+||.||+|....+++.+|+|.+.... ....+.+.+|+++++.++||||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5888899999999999999999899999999987542 33456789999999999999999999874 3477899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+||||++++++.+++.+.
T Consensus 76 lv~e~~~~~~L~~~~~~~ 93 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR 93 (256)
T ss_pred EEEecCCCCCHHHHHHHh
Confidence 999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.7e-09 Score=104.10 Aligned_cols=91 Identities=24% Similarity=0.440 Sum_probs=76.4
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc----------chhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK----------GAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
+|...+.||+|+||.||+|....+|+.||+|.+..... ...+.+.+|+.+++.++|||++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 47788999999999999999988999999998864211 12346788999999999999999999854
Q ss_pred ccccceeeeeecccccCCchhhhhcc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|++.+++...
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~ 102 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTY 102 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhc
Confidence 467889999999999999988654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.8e-09 Score=102.21 Aligned_cols=94 Identities=24% Similarity=0.390 Sum_probs=78.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-----ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-----QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.+|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|++++++++||||+++++.+.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 5789999999999999999999999999999987532 12344678899999999999999999998643 224
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++++||++++++.+++...
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~ 100 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY 100 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc
Confidence 5788999999999999888643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=98.88 E-value=5e-09 Score=102.14 Aligned_cols=90 Identities=21% Similarity=0.312 Sum_probs=78.1
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||.+....+|+.||+|.+... .....+.+.+|+.++++++||||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 488889999999999999999999999999998653 233446789999999999999999999884 4577899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|+||++++++.+++..
T Consensus 76 lv~e~~~~~~l~~~~~~ 92 (256)
T cd08218 76 IVMDYCEGGDLYKKINA 92 (256)
T ss_pred EEEecCCCCcHHHHHHh
Confidence 99999999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.6e-09 Score=106.15 Aligned_cols=86 Identities=26% Similarity=0.366 Sum_probs=69.6
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHH-HHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECE-ALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+|+.||+|++.... ......+.+|.. +++.++||||+++++.+ ......|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997532 223345666654 57888999999999884 4477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|++.+++...
T Consensus 76 e~~~~~~L~~~l~~~ 90 (321)
T cd05603 76 DYVNGGELFFHLQRE 90 (321)
T ss_pred cCCCCCCHHHHHHHc
Confidence 999999998877543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.3e-09 Score=102.65 Aligned_cols=91 Identities=25% Similarity=0.445 Sum_probs=76.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---------chhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 47788999999999999999988899999998865321 12356889999999999999999999854
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....+++|||++++++.+++...
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~ 100 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNY 100 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhc
Confidence 367889999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.9e-09 Score=101.82 Aligned_cols=94 Identities=23% Similarity=0.389 Sum_probs=78.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.+|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 36889999999999999999999999999999986432 1234568899999999999999999987542 234
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++++||+++++|.+++...
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~ 100 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY 100 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc
Confidence 6789999999999999988643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.3e-09 Score=102.62 Aligned_cols=91 Identities=30% Similarity=0.508 Sum_probs=78.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++.+. .....+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence 45788999999999999999998 478999999876543 4578999999999999999999999854 367889
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+||||++++++.+++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~ 95 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRG 95 (256)
T ss_pred EEEEecCCCcHHHHHHhcC
Confidence 9999999999999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.6e-09 Score=106.22 Aligned_cols=91 Identities=20% Similarity=0.266 Sum_probs=75.0
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+..|..++..+ .|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4788899999999999999999999999999997542 23345567788888877 488999998884 44778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+++|+|.+++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~ 95 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV 95 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc
Confidence 99999999999999888643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.4e-09 Score=106.12 Aligned_cols=94 Identities=29% Similarity=0.517 Sum_probs=77.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcE--EEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTT--VAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~--~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|.+..++.. +|+|..+.. .....+.+.+|++++.++ +||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 35788899999999999999999777764 577766543 233456788999999999 7999999999854 46
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...|++|||+++|++.+++....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~ 103 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSR 103 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcc
Confidence 78999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.8e-09 Score=102.13 Aligned_cols=91 Identities=27% Similarity=0.421 Sum_probs=79.5
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|+.+++.++|+||+++++.+. .....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 47888999999999999999988999999999976543 35678999999999999999999999853 467899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+|+||++++++.+++...
T Consensus 76 lv~e~~~~~~L~~~~~~~ 93 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG 93 (264)
T ss_pred EEEecCCCCcHHHHHhhc
Confidence 999999999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.2e-09 Score=106.04 Aligned_cols=91 Identities=27% Similarity=0.379 Sum_probs=77.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++.+ ......|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence 34667788999999999999998889999999987543 33456789999999999999999999985 4477899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||++++++.+++..
T Consensus 79 lv~e~~~~~~L~~~~~~ 95 (277)
T cd06642 79 IIMEYLGGGSALDLLKP 95 (277)
T ss_pred EEEEccCCCcHHHHhhc
Confidence 99999999999988753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.5e-09 Score=104.44 Aligned_cols=94 Identities=21% Similarity=0.459 Sum_probs=78.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|+..+.||+|+||.||+|+... +.+.||+|........ ..+.+.+|++++++++||||+++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 78 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR----- 78 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----
Confidence 3678899999999999999999753 3467999988654433 4567999999999999999999999854
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++....
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~ 103 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATK 103 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcc
Confidence 3677899999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.7e-10 Score=113.30 Aligned_cols=89 Identities=22% Similarity=0.381 Sum_probs=79.7
Q ss_pred eeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccccc
Q 042887 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKC 134 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 134 (628)
++|+|.||+||.|++..+...+|||-+........+....|+...+.++|.|||++++.+. .++++-+.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCCC
Confidence 5899999999999999998899999998766666778899999999999999999999954 47789999999999
Q ss_pred CCchhhhhcccccc
Q 042887 135 GSSEDWMHQSNDKL 148 (628)
Q Consensus 135 g~L~~~l~~~~~~~ 148 (628)
|+|...++...+.+
T Consensus 657 GSLSsLLrskWGPl 670 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPL 670 (1226)
T ss_pred CcHHHHHHhccCCC
Confidence 99999998887665
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.1e-09 Score=105.34 Aligned_cols=92 Identities=20% Similarity=0.391 Sum_probs=76.3
Q ss_pred CCCCcCceeecCCceeEEEEEEC----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLG----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.+|++.+.||+|+||.||+|.+. .+++.||+|.+.... ......+.+|++++++++||||+++++.+. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 56888899999999999999853 356789999987533 334467889999999999999999999843 46
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...|++|||+++|++.+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~ 101 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMR 101 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhc
Confidence 7889999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.3e-09 Score=103.68 Aligned_cols=91 Identities=24% Similarity=0.461 Sum_probs=76.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|.. ++++.||+|.+..... ..+.+.+|+.++++++|+||+++++... ....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 75 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPI 75 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCc
Confidence 456799999999999999999987 4678899999875433 3467899999999999999999987632 4568
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
+++|||+++|++.+++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~ 94 (260)
T cd05067 76 YIITEYMENGSLVDFLKTP 94 (260)
T ss_pred EEEEEcCCCCCHHHHHHhc
Confidence 9999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.9e-09 Score=104.90 Aligned_cols=94 Identities=29% Similarity=0.498 Sum_probs=79.0
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.++|.+.+.||+|+||.||++... .++..+|+|.+........+.+.+|++++++++||||+++++.+. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 467889999999999999999852 345669999987655555677999999999999999999999864 3
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....+++|||+++|++.+++....
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~ 102 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHG 102 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcC
Confidence 678899999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-09 Score=104.61 Aligned_cols=92 Identities=25% Similarity=0.450 Sum_probs=77.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+. .....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCc
Confidence 3467899999999999999999974 567899998765332 3567899999999999999999998853 46778
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
+++|||+++|++.+++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~ 95 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSD 95 (261)
T ss_pred EEEEecCCCCcHHHHHHHh
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.2e-09 Score=105.54 Aligned_cols=94 Identities=29% Similarity=0.512 Sum_probs=78.4
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+.... ....+.+.+|+.+++++.||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 467899999999999999999874 256789999987543 233466889999999999999999999854
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....+++|||+++|++.+++....
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~ 103 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRS 103 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcC
Confidence 3667899999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.3e-10 Score=110.01 Aligned_cols=100 Identities=21% Similarity=0.290 Sum_probs=82.9
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-------chhhhHHHHHHHHhhcCCCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-------GAAKSFVTECEALSNVRHRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 114 (628)
+-....+.|-+...+|+|||+.||+|.+..-.++||||+-..... ...+..+||.+|.+.++||-||++++++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 334455678888999999999999999988899999998865432 2345678999999999999999999987
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.- +.+.++-|+|||+|.+|.-|++.+.
T Consensus 537 sl----DtdsFCTVLEYceGNDLDFYLKQhk 563 (775)
T KOG1151|consen 537 SL----DTDSFCTVLEYCEGNDLDFYLKQHK 563 (775)
T ss_pred ee----ccccceeeeeecCCCchhHHHHhhh
Confidence 52 4677899999999999999987664
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-09 Score=109.23 Aligned_cols=99 Identities=22% Similarity=0.376 Sum_probs=79.2
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceee
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCS 115 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 115 (628)
|..+.++|++.+.||+|+||.||+|.... +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 34456789999999999999999997533 45789999986532 23345688999999999 7999999999874
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .....+++|||+++|++.+++....
T Consensus 82 ~----~~~~~~~v~ey~~~~~L~~~i~~~~ 107 (337)
T cd05054 82 K----PGGPLMVIVEYCKFGNLSNYLRSKR 107 (337)
T ss_pred c----CCCCEEEEEecCCCCCHHHHHHhcc
Confidence 3 3567889999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.8e-09 Score=104.23 Aligned_cols=92 Identities=27% Similarity=0.469 Sum_probs=77.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|.+. +++.||+|.++.... ..+.+.+|+.++++++||||+++++.+. .....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence 3567899999999999999999974 457899999865432 3567899999999999999999998854 36778
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
+++|||++++++.+++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~ 95 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGG 95 (261)
T ss_pred eeeeecccCCcHHHHHhcc
Confidence 9999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.6e-09 Score=103.12 Aligned_cols=91 Identities=23% Similarity=0.346 Sum_probs=78.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+++.+|+|.+.... ......+.+|+.+++.+.||||+++++.+.. .+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 46888899999999999999998899999999886532 2344678899999999999999999998543 678
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.+++|||++++++.+++..
T Consensus 77 ~~~v~e~~~~~~L~~~~~~ 95 (267)
T cd08229 77 LNIVLELADAGDLSRMIKH 95 (267)
T ss_pred EEEEEEecCCCCHHHHHHH
Confidence 8999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.9e-09 Score=101.61 Aligned_cols=92 Identities=24% Similarity=0.361 Sum_probs=80.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||+|+||.||+|++..+++.||+|.+..... .....+.+|+..+.+++|+||+++++.+. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368889999999999999999998999999999876543 44577999999999999999999999854 468899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++++|.+++...
T Consensus 76 lv~e~~~~~~L~~~l~~~ 93 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV 93 (264)
T ss_pred EEEEecCCCcHHHHHHHc
Confidence 999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-09 Score=105.66 Aligned_cols=91 Identities=24% Similarity=0.434 Sum_probs=74.9
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
.+++|+|.||.||-|+++++|+.||||++++.+ .....+...|+.||+++.||.||.+.-. +++.+..+.|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 588999999999999999999999999998753 3455788999999999999999998766 678999999999
Q ss_pred ccccCCchhhh-hccccccc
Q 042887 131 YMKCGSSEDWM-HQSNDKLE 149 (628)
Q Consensus 131 ~~~~g~L~~~l-~~~~~~~~ 149 (628)
-+.| |+.++| ....++++
T Consensus 644 Kl~G-DMLEMILSsEkgRL~ 662 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLP 662 (888)
T ss_pred hhcc-hHHHHHHHhhcccch
Confidence 9875 555554 44444444
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.8e-09 Score=101.35 Aligned_cols=90 Identities=21% Similarity=0.476 Sum_probs=75.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc------cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ------KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+|.+.+.||+|+||.||+|.. .+|+.+|+|.+.... ......+.+|++++++++|+||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 478889999999999999987 578899999886432 1223568899999999999999999998653 6
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++++||+++++|.+++.+.
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~ 96 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF 96 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc
Confidence 8899999999999999998654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-09 Score=106.50 Aligned_cols=88 Identities=27% Similarity=0.534 Sum_probs=72.5
Q ss_pred ceeecCCceeEEEEEECCCCcE-------EEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTT-------VAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~-------~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+.||+|+||.||+|.+..++.. +|+|.+........+.+.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 4699999999999998655443 88888765554556778899999999999999999998653 56789
Q ss_pred eeecccccCCchhhhhcccc
Q 042887 127 LIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~ 146 (628)
+||||+++|+|.+++.....
T Consensus 76 lv~e~~~~g~L~~~l~~~~~ 95 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN 95 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC
Confidence 99999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.8e-09 Score=105.98 Aligned_cols=91 Identities=24% Similarity=0.318 Sum_probs=75.3
Q ss_pred CCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcC-CCCcccccceeeecccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFK 120 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 120 (628)
+|++.+.||+|+||.||+++.. .+++.||+|++.... ....+.+.+|+.++..++ ||+|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4888999999999999998864 468899999997532 233456788999999995 99999998874 4
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|++.+++...
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~ 99 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQR 99 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc
Confidence 578899999999999999988654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.7e-09 Score=104.74 Aligned_cols=92 Identities=24% Similarity=0.398 Sum_probs=79.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 368888999999999999999988899999999976432 2456788999999999999999999885 44778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+++|||+.+++|.+++...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~ 95 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ 95 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC
Confidence 99999999999999988653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=98.86 E-value=5e-09 Score=102.12 Aligned_cols=92 Identities=27% Similarity=0.391 Sum_probs=80.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|....+++.+|+|.+..... .+.+.+|++++++++||||+++++.+. .....|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 3679999999999999999999988899999999875433 578999999999999999999999854 468899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+++||++++++.+++....
T Consensus 75 l~~e~~~~~~L~~~l~~~~ 93 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN 93 (256)
T ss_pred EEEecCCCCcHHHHHHhCc
Confidence 9999999999999986544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.5e-09 Score=102.76 Aligned_cols=93 Identities=27% Similarity=0.493 Sum_probs=78.4
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
...++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++|+||+++++.+. ....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEP 75 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCc
Confidence 34678999999999999999999985 567899999875432 3467899999999999999999998843 4677
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+++|||++++++.+++.+.
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~ 95 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSG 95 (261)
T ss_pred eEEEEeccCCCCHHHHHhcc
Confidence 89999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-09 Score=106.16 Aligned_cols=94 Identities=26% Similarity=0.459 Sum_probs=76.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECC----------------CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE----------------TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIK 109 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 109 (628)
.++|++.+.||+|+||.||++.+.. ++..||+|...... ......+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4579999999999999999986432 34469999987542 334567899999999999999999
Q ss_pred ccceeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 110 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+++++. ..+..+++|||+++|++.+++....
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 114 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHE 114 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcC
Confidence 999854 3677899999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.6e-09 Score=101.28 Aligned_cols=93 Identities=19% Similarity=0.373 Sum_probs=78.4
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.+|.|+||.||+|.+..+++.||+|.+... .....+++.+|+.++++++||||+++++.+.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 488889999999999999999999999999998653 23345678899999999999999999887542 3356789
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||++++++.+++...
T Consensus 78 ~~~e~~~~~~L~~~l~~~ 95 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKC 95 (265)
T ss_pred EEehhccCCCHHHHHHHH
Confidence 999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=98.85 E-value=4e-09 Score=102.83 Aligned_cols=91 Identities=22% Similarity=0.448 Sum_probs=75.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|.+.+.||+|+||.||.|.+.. +..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 468888999999999999998843 45699998865432 34678999999999999999999998643 567899
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
+|||+++|++.+++....
T Consensus 77 v~e~~~~~~l~~~i~~~~ 94 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG 94 (256)
T ss_pred EEEcCCCCcHHHHHHhcC
Confidence 999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.2e-09 Score=103.22 Aligned_cols=93 Identities=27% Similarity=0.445 Sum_probs=76.5
Q ss_pred CCCcCceeecCCceeEEEEEE----CCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~----~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
-|++.+.||+|+||.||+|.+ ..+++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence 478889999999999999985 3467889999987543 3345678999999999999999999998653 2246
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||+++++|.+++.+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~ 102 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN 102 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc
Confidence 789999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.8e-09 Score=103.00 Aligned_cols=91 Identities=26% Similarity=0.404 Sum_probs=76.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++.+. .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 46889999999999999999999899999999886542 223456789999999999999999999854 46788
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
++||||++++.+..++..
T Consensus 76 ~~v~e~~~~~~l~~~~~~ 93 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN 93 (286)
T ss_pred EEEEeccCccHHHHHHhC
Confidence 999999999888877643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.2e-09 Score=104.83 Aligned_cols=95 Identities=22% Similarity=0.389 Sum_probs=78.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCC-----cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETG-----TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
..++|++.+.||+|+||.||+|.+...+ +.||+|.+.... ......+.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---- 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc----
Confidence 4568999999999999999999986433 789999986543 234457889999999999999999999854
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....+++|||+++|+|.+++....
T Consensus 80 -~~~~~~~v~e~~~~~~L~~~l~~~~ 104 (277)
T cd05032 80 -TGQPTLVVMELMAKGDLKSYLRSRR 104 (277)
T ss_pred -CCCCcEEEEecCCCCCHHHHHHhcc
Confidence 4678999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.5e-09 Score=103.42 Aligned_cols=91 Identities=25% Similarity=0.483 Sum_probs=76.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-----chhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-----GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+..|++++++++|+||+++++.+. +..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 47888999999999999999988999999999976432 23345778999999999999999999854 367
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++||||+ +|++.+++....
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~ 96 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS 96 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC
Confidence 899999999 899999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.3e-09 Score=110.99 Aligned_cols=99 Identities=21% Similarity=0.278 Sum_probs=79.7
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc---cc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID---FK 120 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~ 120 (628)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+..+..++|+||+++++.+...+ ..
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999999999999999987542 334566889999999999999999887654311 11
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|+|.+++...
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~ 133 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSR 133 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHh
Confidence 223578999999999999998653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.2e-09 Score=101.05 Aligned_cols=91 Identities=19% Similarity=0.339 Sum_probs=78.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|....+|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 4788899999999999999999999999999986542 23445788999999999999999999985 3477899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+++||++++++.+++.+.
T Consensus 76 lv~e~~~~~~L~~~~~~~ 93 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ 93 (257)
T ss_pred EEEecCCCCcHHHHHHhc
Confidence 999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.4e-09 Score=102.68 Aligned_cols=93 Identities=25% Similarity=0.519 Sum_probs=77.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCc---EEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGT---TVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.+|+..+.||+|+||.||+|....+++ .+|+|.+.... ....+.+.+|+.++++++||||+++.+.+. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence 467888999999999999999876654 69999886542 334567899999999999999999999854 467
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++||||+++++|.+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~ 101 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD 101 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC
Confidence 7899999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.3e-09 Score=103.93 Aligned_cols=94 Identities=22% Similarity=0.399 Sum_probs=78.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|++.+.||+|+||.||+|.+.. ++..||+|...... ......|.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 4678999999999999999999976 67889999886443 3334568999999999999999999998543
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....+++|||+++|+|.+++....
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~ 104 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENR 104 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhC
Confidence 567799999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.2e-08 Score=101.58 Aligned_cols=95 Identities=21% Similarity=0.430 Sum_probs=73.7
Q ss_pred CCCCcCceeecCCceeEEEEEECC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhhc---CCCCcccccceeeeccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGE-TGTTVAVKVMNLKQ--KGAAKSFVTECEALSNV---RHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~ 121 (628)
++|++.+.||+|+||.||+|++.. +++.||+|.++... ......+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 46889999986542 22334567888877766 6999999999876433345
Q ss_pred cceeeeeecccccCCchhhhhc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
....++||||+. +++.+++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~ 101 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK 101 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh
Confidence 667899999997 588888754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.5e-09 Score=104.81 Aligned_cols=86 Identities=20% Similarity=0.239 Sum_probs=72.3
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.++.++ .||+|+++++++ ......|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999997642 23445688999999888 599999999984 4477899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|+|.+++...
T Consensus 76 e~~~~~~L~~~~~~~ 90 (327)
T cd05617 76 EYVNGGDLMFHMQRQ 90 (327)
T ss_pred eCCCCCcHHHHHHHc
Confidence 999999998887543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-09 Score=106.68 Aligned_cols=94 Identities=18% Similarity=0.276 Sum_probs=79.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc----cc----hhhhHHHHHHHHhhcC---CCCcccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ----KG----AAKSFVTECEALSNVR---HRNLIKIITVCS 115 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~----~~~~~~~E~~~l~~l~---h~nIv~l~~~~~ 115 (628)
..+|...+.+|+|+||+|+.|.+++....|.+|.+.+.+ .| ....+..|+.||..+. |+||++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-- 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-- 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence 456899999999999999999999888889999997642 22 2345788999999997 9999999999
Q ss_pred eccccccceeeeeecc-cccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEY-MKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~ 145 (628)
|++.+++|++||- -++-+|+++|..+.
T Consensus 638 ---FEddd~yyl~te~hg~gIDLFd~IE~kp 665 (772)
T KOG1152|consen 638 ---FEDDDYYYLETEVHGEGIDLFDFIEFKP 665 (772)
T ss_pred ---eecCCeeEEEecCCCCCcchhhhhhccC
Confidence 7789999999998 46678999987654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-09 Score=103.73 Aligned_cols=91 Identities=27% Similarity=0.485 Sum_probs=75.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..+.|++.+.||+|+||.||+|.+..+ ..||+|.++.... ..+.+.+|+++++.++||||+++++.+. ....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~ 75 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPI 75 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCc
Confidence 346799999999999999999998655 5699999875332 3457899999999999999999988632 3557
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|++.+++.+.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~ 94 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGE 94 (262)
T ss_pred EEEEEcCCCCcHHHHHhhc
Confidence 8999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=98.84 E-value=6e-09 Score=104.01 Aligned_cols=94 Identities=24% Similarity=0.403 Sum_probs=78.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC----------------cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG----------------TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIK 109 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~----------------~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 109 (628)
+++|++.+.||+|+||.||+|.....+ ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 568999999999999999999876543 458999987543 334567899999999999999999
Q ss_pred ccceeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 110 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+++++. .....+++|||++++++.+++.+..
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 114 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHV 114 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcc
Confidence 999854 3578899999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.6e-09 Score=102.15 Aligned_cols=95 Identities=31% Similarity=0.479 Sum_probs=78.3
Q ss_pred CCCCcCceeecCCceeEEEEEECC----CCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGE----TGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+.|++.+.||+|+||.||+|.+.. +++.||+|.+...... ..+.|.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 457788999999999999999743 4788999998765432 45789999999999999999999987543 235
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...+++|||++++++.+++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~ 103 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR 103 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc
Confidence 67899999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.9e-09 Score=107.93 Aligned_cols=86 Identities=20% Similarity=0.241 Sum_probs=73.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++|||||++++++. .....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence 367999999999999999999999999999999643 245679999999999999999999854 467889
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+|+|++. +++.+++...
T Consensus 160 lv~e~~~-~~L~~~l~~~ 176 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK 176 (391)
T ss_pred EEEecCC-CCHHHHHHhc
Confidence 9999986 6788777543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.9e-09 Score=101.36 Aligned_cols=98 Identities=26% Similarity=0.405 Sum_probs=80.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecccc-ccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK-GVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~-~~~ 123 (628)
+.+.|++.+.||+|+||.||+|....+++.||+|.+..... ....+.+|+.++.++ +||||+++++.+...... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45678888999999999999999999999999999875432 345688999999998 699999999987642111 135
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|++|||+++|++.+++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~ 103 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT 103 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc
Confidence 689999999999999988753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.5e-09 Score=101.33 Aligned_cols=91 Identities=23% Similarity=0.446 Sum_probs=75.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+++++.++||||+++++.+. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence 35788899999999999999985 567899998864322 3356889999999999999999998853 4678899
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
||||++++++.+++....
T Consensus 77 v~e~~~~~~L~~~l~~~~ 94 (256)
T cd05059 77 VTEYMANGCLLNYLRERK 94 (256)
T ss_pred EEecCCCCCHHHHHHhcc
Confidence 999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.2e-09 Score=103.72 Aligned_cols=93 Identities=26% Similarity=0.556 Sum_probs=77.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCC-----cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETG-----TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
++|++.+.||+|+||.||+|.....+ +.||+|.+.... ......+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 46888999999999999999976544 679999886543 234467899999999999999999999854 3
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....+++|||+++|++.+++....
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~ 103 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNS 103 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcC
Confidence 677899999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.3e-09 Score=101.53 Aligned_cols=92 Identities=21% Similarity=0.283 Sum_probs=79.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....+++.+|++++++++||||+++++.+. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 36788899999999999999999899999999987653 344567899999999999999999999854 368899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+++||+++++|.+++...
T Consensus 76 lv~e~~~~~~L~~~~~~~ 93 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV 93 (265)
T ss_pred EEEEecCCCcHHHHHHHc
Confidence 999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.4e-09 Score=104.83 Aligned_cols=98 Identities=23% Similarity=0.436 Sum_probs=79.8
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCC-----cEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceee
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETG-----TTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCS 115 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 115 (628)
+....++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... ......+.+|+++++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4445678999999999999999999986433 679999987532 23446688999999999 7999999999854
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..+..+++|||+++|++.+++....
T Consensus 87 -----~~~~~~li~e~~~~~~L~~~l~~~~ 111 (293)
T cd05053 87 -----QEGPLYVVVEYAAHGNLRDFLRARR 111 (293)
T ss_pred -----CCCCeEEEEEeCCCCcHHHHHHhcC
Confidence 4678899999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.9e-09 Score=103.90 Aligned_cols=87 Identities=26% Similarity=0.363 Sum_probs=69.3
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHH-HHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECE-ALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++ ...+..|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999999999999999999997532 222334555554 46778999999999884 4478899999
Q ss_pred cccccCCchhhhhccc
Q 042887 130 EYMKCGSSEDWMHQSN 145 (628)
Q Consensus 130 e~~~~g~L~~~l~~~~ 145 (628)
||+++|++.+++....
T Consensus 76 e~~~~~~L~~~~~~~~ 91 (325)
T cd05602 76 DYINGGELFYHLQRER 91 (325)
T ss_pred eCCCCCcHHHHHHhcC
Confidence 9999999998886543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-10 Score=119.23 Aligned_cols=180 Identities=27% Similarity=0.294 Sum_probs=118.4
Q ss_pred CcCCCCCCCCCeEecccCccccccCccccCC-CCCCeEecCCcccc----------cccCCcccCCcchhcccceEEcCC
Q 042887 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNL-TLLNRLFLGFNNLQ----------GNVPSSLGNCQNLMTLSRLLDLSG 471 (628)
Q Consensus 403 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~----------~~~~~~~~~l~~L~~l~~~L~Ls~ 471 (628)
|-.+..+.+|++|.+.++.+... ..+..+ .+|++| +..|.++ +.+-..+.+ ..| ...+.++
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~ns~~W-n~L----~~a~fsy 173 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKL-ICHNSLDALRHVFASCGGDISNSPVW-NKL----ATASFSY 173 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhh-hhhccHHHHHHHHHHhccccccchhh-hhH----hhhhcch
Confidence 44567788999999999888731 111111 122222 1122221 011111111 123 4567888
Q ss_pred CcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCc
Q 042887 472 NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP 551 (628)
Q Consensus 472 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 551 (628)
|++. .+..++.-++.|+.|||++|+++.. +.+..++.|+.|||++|.+....--...+.. |+.|.+++|.++. -
T Consensus 174 N~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t--L 247 (1096)
T KOG1859|consen 174 NRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT--L 247 (1096)
T ss_pred hhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh--h
Confidence 8887 5666777788899999999998743 3778888999999999998833333334444 8899999998873 3
Q ss_pred hhhhcccCCCeEeccCCcCccc--CCCCCCCCCCCcccccCCCCCcc
Q 042887 552 KYLENLLFLAYLNLSYNHFEGE--VPRKGVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 552 ~~~~~l~~L~~L~ls~N~l~~~--~p~~~~~~~l~~~~~~~n~~~c~ 596 (628)
..+.+|.+|+.||+++|-|.+- +...+.+..+..+++.|||.-|.
T Consensus 248 ~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 248 RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 4578888899999999988763 33345566778888999987774
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.8e-09 Score=104.41 Aligned_cols=96 Identities=22% Similarity=0.407 Sum_probs=78.1
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEE-----CCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceeee
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCSS 116 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 116 (628)
....++|++.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+.+++++ +||||+++++.+..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 34456799999999999999999975 2345679999987543 33456789999999999 79999999998643
Q ss_pred ccccccceeeeeecccccCCchhhhhcc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....+++|||+++|+|.+++...
T Consensus 111 -----~~~~~lv~e~~~~~~L~~~i~~~ 133 (302)
T cd05055 111 -----GGPILVITEYCCYGDLLNFLRRK 133 (302)
T ss_pred -----CCceEEEEEcCCCCcHHHHHHhC
Confidence 66789999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.4e-09 Score=102.33 Aligned_cols=92 Identities=25% Similarity=0.479 Sum_probs=76.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence 467999999999999999999998899999999986543 233346789999999999999999999854 46788
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+. +++.+++...
T Consensus 79 ~lv~e~~~-~~l~~~~~~~ 96 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQH 96 (291)
T ss_pred EEEEeccc-CCHHHHHHhC
Confidence 99999996 6776666543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.8e-09 Score=101.68 Aligned_cols=105 Identities=25% Similarity=0.393 Sum_probs=83.7
Q ss_pred cHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeec
Q 042887 39 SYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSI 117 (628)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 117 (628)
+..+...+.+.|++.+.+|+|+||.||+|++..+++.+|+|....... ....+.+|+.+++++ +||||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344445567889999999999999999999999999999999865432 335688899999998 699999999886431
Q ss_pred c-ccccceeeeeecccccCCchhhhhcc
Q 042887 118 D-FKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 118 ~-~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
. .......+++|||+++|++.+++...
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~ 113 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT 113 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc
Confidence 1 12356789999999999999988653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-08 Score=100.38 Aligned_cols=92 Identities=26% Similarity=0.359 Sum_probs=79.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||.|+||.||+|....++..+|+|++.... ......+.+|+.+++.++|+||+++++.+. .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 47899999999999999999998889999999986543 234567899999999999999999998754 467889
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++||+++++++.+++...
T Consensus 76 iv~e~~~~~~l~~~~~~~ 93 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS 93 (267)
T ss_pred EEEeccCCCcHHHHHHHh
Confidence 999999999999998653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=98.82 E-value=7.1e-09 Score=101.95 Aligned_cols=93 Identities=22% Similarity=0.365 Sum_probs=75.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCC---CcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------E 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------C
Confidence 34688889999999999999997543 3468999886543 345568999999999999999999998754 3
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++||||+++|++.+++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~ 101 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK 101 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC
Confidence 45689999999999999997544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.9e-09 Score=101.76 Aligned_cols=91 Identities=26% Similarity=0.544 Sum_probs=76.7
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
+|+..+.||+|+||.||+|++..+|+.||+|.++... ....+.+.+|+.++++++||||+++++.+.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 4888899999999999999999899999999997653 2334667889999999999999999998653 677899
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
||||+++ ++.+++....
T Consensus 76 v~e~~~~-~l~~~~~~~~ 92 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHG 92 (284)
T ss_pred EEecCCc-cHHHHHHhcC
Confidence 9999985 7888876543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.2e-09 Score=102.04 Aligned_cols=93 Identities=24% Similarity=0.389 Sum_probs=79.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.+.||+|+||.||+|....+|+.||+|+.... .....+.+.+|+.+++++. ||||+++++.+ ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4689999999999999999999989999999998653 2233466889999999998 99999999984 4578
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..+++|||++++++.+++.+..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~ 97 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG 97 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC
Confidence 8999999999999999986543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=101.32 Aligned_cols=94 Identities=23% Similarity=0.455 Sum_probs=74.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhc---CCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNV---RHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+|++.+.||+|+||.||+|++..+|+.||+|.++... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999999999999999987542 22334567788777665 699999999987653334456
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..+++|||+++ ++.+++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~ 99 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK 99 (288)
T ss_pred eEEEEEccccc-CHHHHHHh
Confidence 78999999985 78777754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.6e-09 Score=102.36 Aligned_cols=94 Identities=22% Similarity=0.455 Sum_probs=78.7
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..+|+..++||+|+||.||+|... .++..+|+|............+.+|+++++.++|+||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----E 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----c
Confidence 356788899999999999999753 346689999887665556678999999999999999999998854 3
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....+++|||+++|++.+++....
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~ 102 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHG 102 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcC
Confidence 677899999999999999997554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.2e-09 Score=101.47 Aligned_cols=86 Identities=24% Similarity=0.450 Sum_probs=69.8
Q ss_pred ceeecCCceeEEEEEECC--CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGE--TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~--~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.||+|+||.||+|.+.. ++..+|+|.++... ......+.+|+.++++++||||+++++.+. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 368999999999998643 44679999886543 233457889999999999999999999854 3567899999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|+|.+++...
T Consensus 76 ~~~~g~L~~~l~~~ 89 (269)
T cd05087 76 FCPLGDLKGYLRSC 89 (269)
T ss_pred CCCCCcHHHHHHHh
Confidence 99999999998654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.2e-09 Score=103.17 Aligned_cols=91 Identities=23% Similarity=0.333 Sum_probs=77.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
+.|.....||+|+||.||++....+++.||+|.+........+.+.+|+..++.++||||+++++.+. .....++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence 34455577999999999999998899999999987655455677899999999999999999999854 4678899
Q ss_pred eecccccCCchhhhhc
Q 042887 128 IYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~ 143 (628)
||||++++++.+++..
T Consensus 97 v~e~~~~~~L~~~~~~ 112 (292)
T cd06658 97 VMEFLEGGALTDIVTH 112 (292)
T ss_pred EEeCCCCCcHHHHHhc
Confidence 9999999999988753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-08 Score=100.80 Aligned_cols=95 Identities=27% Similarity=0.528 Sum_probs=75.2
Q ss_pred CCcCceeecCCceeEEEEEECCC---CcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc-ccccc
Q 042887 50 FSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGVD 123 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~ 123 (628)
|++.+.||+|+||.||+|....+ +..||+|.++... ......+.+|++.++.++||||+++++.+.... .....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999997643 3789999987542 234567899999999999999999998865421 12334
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++++||+++|++.+++...
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~ 101 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYS 101 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHh
Confidence 579999999999999888554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=101.32 Aligned_cols=89 Identities=26% Similarity=0.515 Sum_probs=75.5
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+. .....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 5788899999999999999998899999999986542 233467889999999999999999999854 467889
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||++ +++.+++..
T Consensus 76 ~v~e~~~-~~l~~~~~~ 91 (285)
T cd07861 76 LIFEFLS-MDLKKYLDS 91 (285)
T ss_pred EEEecCC-CCHHHHHhc
Confidence 9999998 578888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=98.81 E-value=5e-09 Score=105.19 Aligned_cols=96 Identities=21% Similarity=0.393 Sum_probs=77.8
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECC-------CCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceee
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGE-------TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCS 115 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 115 (628)
...++|.+.+.||+|+||.||+|++.. ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 334679999999999999999998643 23569999987542 23445688999999999 7999999999864
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .+..|+||||+++|+|.+++....
T Consensus 95 ~-----~~~~~lv~e~~~~~~L~~~i~~~~ 119 (307)
T cd05098 95 Q-----DGPLYVIVEYASKGNLREYLRARR 119 (307)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcC
Confidence 3 678899999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=98.81 E-value=9.3e-09 Score=101.96 Aligned_cols=91 Identities=26% Similarity=0.490 Sum_probs=75.7
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|++..+|+.||+|.++... ......+.+|++++++++||||+++++.+ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4788899999999999999999999999999987542 22345678899999999999999999984 4577899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+++||+. +++.+++....
T Consensus 76 lv~e~~~-~~l~~~~~~~~ 93 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCN 93 (284)
T ss_pred EEEecCC-CCHHHHHHhcC
Confidence 9999997 47777775443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.5e-08 Score=99.90 Aligned_cols=97 Identities=26% Similarity=0.375 Sum_probs=81.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccc-cccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDF-KGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~~~~ 123 (628)
+.++|++.+.||+|+||.||+|.+..+++.+|+|.+..... ..+.+.+|+.+++++ .|+||+++++.+..... ....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 46789999999999999999999988899999999876543 346788999999999 69999999998764221 2356
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..+++|||++++++.+++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~ 102 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKG 102 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHH
Confidence 68999999999999988764
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-08 Score=101.42 Aligned_cols=94 Identities=28% Similarity=0.509 Sum_probs=77.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCc----EEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGT----TVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~----~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..+|++.+.||+|+||.||+|.+..+|+ .+|+|...... ......+.+|+..+++++||||+++++.+..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3568889999999999999999876665 58999876543 3345678899999999999999999998642
Q ss_pred cceeeeeecccccCCchhhhhcccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...+++|||+++|++.+++.+...
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~ 104 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKD 104 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccC
Confidence 678999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.4e-09 Score=102.95 Aligned_cols=91 Identities=22% Similarity=0.348 Sum_probs=77.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
..|+....||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.+.||||+++++.+. .....|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEE
Confidence 44555567999999999999998899999999987654445567889999999999999999999854 4678999
Q ss_pred eecccccCCchhhhhc
Q 042887 128 IYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~ 143 (628)
++||++++++.+++..
T Consensus 96 v~e~~~~~~L~~~~~~ 111 (297)
T cd06659 96 LMEFLQGGALTDIVSQ 111 (297)
T ss_pred EEecCCCCCHHHHHhh
Confidence 9999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-08 Score=99.02 Aligned_cols=91 Identities=18% Similarity=0.308 Sum_probs=76.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5889999999999999999999899999999986542 334567889999999999999999987642 1345689
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
++|||++++++.+++..
T Consensus 77 lv~e~~~~~~l~~~l~~ 93 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE 93 (257)
T ss_pred EEecccCCCcHHHHHHH
Confidence 99999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-08 Score=104.99 Aligned_cols=96 Identities=23% Similarity=0.271 Sum_probs=76.3
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~ 121 (628)
...++|++.+.||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.+++.++||||+++++++... .+..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3457899999999999999999999999999999998653 233456788999999999999999999986531 1223
Q ss_pred cceeeeeecccccCCchhhh
Q 042887 122 VDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l 141 (628)
....|+||||+.+ ++.+.+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~ 116 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVI 116 (359)
T ss_pred cceeEEEEeCCCc-CHHHHH
Confidence 3467999999976 455444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-08 Score=100.86 Aligned_cols=90 Identities=30% Similarity=0.430 Sum_probs=76.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcC---CCCcccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVR---HRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.|+..+.||+|+||.||+|.+..+++.||+|.++.. .....+.+.+|+.++++++ |||++++++.+. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 477888999999999999999999999999998654 2334567889999999996 999999999854 4678
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.+++|||+++++|.+++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~ 95 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA 95 (277)
T ss_pred EEEEEecCCCCcHHHHHHc
Confidence 8999999999999988754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.3e-09 Score=101.24 Aligned_cols=90 Identities=28% Similarity=0.486 Sum_probs=75.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|+.++++++|++++++++.+. ....
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~ 75 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPI 75 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCc
Confidence 3567999999999999999999875 567799999875433 3467899999999999999999988742 3457
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
+++|||++++++.+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~ 93 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKD 93 (260)
T ss_pred EEEEEecCCCcHHHHHHh
Confidence 899999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-08 Score=102.23 Aligned_cols=93 Identities=24% Similarity=0.510 Sum_probs=76.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCc--EEEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGT--TVAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~--~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.+.||+|+||.||+|....++. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 578999999999999999999877764 4788887642 333456789999999999 6999999999854 467
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++++||+++|++.+++....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~ 98 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSR 98 (297)
T ss_pred cceEEEEecCCCcHHHHHHhcc
Confidence 7899999999999999996543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.9e-09 Score=104.50 Aligned_cols=96 Identities=22% Similarity=0.411 Sum_probs=78.1
Q ss_pred HHhCCCCcCceeecCCceeEEEEEEC-------CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceee
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLG-------ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCS 115 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 115 (628)
...++|.+.+.||+|+||.||+|++. .++..||+|...... ....+.+.+|+.+++.+ +||||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567899999999999999999853 234579999886532 33456789999999999 7999999999854
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....|++|||+++|+|.+++.+..
T Consensus 92 -----~~~~~~lv~e~~~~~~L~~~l~~~~ 116 (304)
T cd05101 92 -----QDGPLYVIVEYASKGNLREYLRARR 116 (304)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcC
Confidence 3678899999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-08 Score=100.60 Aligned_cols=89 Identities=28% Similarity=0.548 Sum_probs=75.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|+..+.||+|+||.||+|++..+|+.||+|.+.... ......+.+|++++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4788899999999999999999899999999886542 23345788999999999999999999984 4577899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+||||+. +++.+++..
T Consensus 76 ~v~e~~~-~~l~~~~~~ 91 (284)
T cd07860 76 LVFEFLH-QDLKKFMDA 91 (284)
T ss_pred EEeeccc-cCHHHHHHh
Confidence 9999996 578877754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.5e-08 Score=100.66 Aligned_cols=95 Identities=26% Similarity=0.375 Sum_probs=82.6
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
...+.|+..+.+|+|+||.||+|.+..+++.||+|.+..... ..+.+.+|++.++.++|+||+++++.+.. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCE
Confidence 345678888999999999999999988899999999976544 45678899999999999999999998653 688
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+++||+++++|.+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~ 110 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF 110 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc
Confidence 999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.6e-09 Score=100.75 Aligned_cols=92 Identities=25% Similarity=0.426 Sum_probs=76.3
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+. . ..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~ 74 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP 74 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CC
Confidence 45678999999999999999999874 45679999886533 23467899999999999999999988743 2 66
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+++|||+++|++.+++...
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~ 94 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSD 94 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhC
Confidence 79999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-08 Score=101.60 Aligned_cols=91 Identities=32% Similarity=0.457 Sum_probs=74.6
Q ss_pred CCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+|++.+.||+|+||.||+|.... ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47888999999999999998743 23568998886543 234567899999999999999999999854 36
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++++||+.+|++.+++...
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~ 97 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRES 97 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhc
Confidence 7789999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.9e-09 Score=105.08 Aligned_cols=96 Identities=21% Similarity=0.389 Sum_probs=77.0
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCC-------CcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGET-------GTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
.....+|.+.+.||+|+||.||+|++... +..||+|...... ....+.+.+|+.+++++ +||||+++++.+
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 33345689999999999999999986432 2368999886432 33456789999999999 799999999986
Q ss_pred eeccccccceeeeeecccccCCchhhhhcc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.. ....++++||+++|+|.+++.+.
T Consensus 88 ~~-----~~~~~lv~e~~~~g~L~~~l~~~ 112 (334)
T cd05100 88 TQ-----DGPLYVLVEYASKGNLREYLRAR 112 (334)
T ss_pred cc-----CCceEEEEecCCCCcHHHHHHhc
Confidence 43 56789999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-08 Score=99.68 Aligned_cols=94 Identities=26% Similarity=0.547 Sum_probs=74.0
Q ss_pred CCcCceeecCCceeEEEEEECCCCc--EEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccce
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGT--TVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVDF 124 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~--~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~~ 124 (628)
|.+.+.||+|+||.||+|++..++. .+|+|.++.. .....+.+.+|+.+++.++||||+++++.+... .......
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567889999999999999876665 5899988653 334467789999999999999999999876431 1122345
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.+++|||+++|++.+++..
T Consensus 81 ~~~v~e~~~~~~l~~~~~~ 99 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLY 99 (272)
T ss_pred cEEEEEeCCCCcHHHHHHH
Confidence 7899999999999988753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-08 Score=100.04 Aligned_cols=85 Identities=21% Similarity=0.306 Sum_probs=71.9
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+++++.++||||+++++.+ +..+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 699999999999999899999999986532 22345678899999999999999998884 4467899999999
Q ss_pred ccCCchhhhhccc
Q 042887 133 KCGSSEDWMHQSN 145 (628)
Q Consensus 133 ~~g~L~~~l~~~~ 145 (628)
++++|.+++....
T Consensus 76 ~~~~L~~~l~~~~ 88 (277)
T cd05577 76 NGGDLKYHIYNVG 88 (277)
T ss_pred CCCcHHHHHHHcC
Confidence 9999999886544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-08 Score=98.26 Aligned_cols=86 Identities=28% Similarity=0.498 Sum_probs=71.2
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
+.||+|+||.||+|... +++.+|+|...... ......+.+|+++++.++||||+++++.+.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 46899999999999874 68899999886543 2234568899999999999999999998653 56789999999
Q ss_pred ccCCchhhhhccc
Q 042887 133 KCGSSEDWMHQSN 145 (628)
Q Consensus 133 ~~g~L~~~l~~~~ 145 (628)
++|++.+++....
T Consensus 75 ~~~~L~~~~~~~~ 87 (250)
T cd05085 75 PGGDFLSFLRKKK 87 (250)
T ss_pred CCCcHHHHHHhcC
Confidence 9999999886543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-08 Score=102.57 Aligned_cols=95 Identities=20% Similarity=0.351 Sum_probs=78.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999999999999999998643 23345668899999999999999999998765445555678
Q ss_pred eeeecccccCCchhhhh
Q 042887 126 ALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~ 142 (628)
|+++||+.+ ++.+.+.
T Consensus 84 ~lv~e~~~~-~l~~~~~ 99 (336)
T cd07849 84 YIVQELMET-DLYKLIK 99 (336)
T ss_pred EEEehhccc-CHHHHHh
Confidence 999999974 7766664
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.6e-08 Score=106.53 Aligned_cols=92 Identities=24% Similarity=0.360 Sum_probs=72.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc---ccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF---KGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~~ 122 (628)
..++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++|||||++++++....+ +..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999999999999999885432 234579999999999999999887543111 223
Q ss_pred ceeeeeecccccCCchhhhh
Q 042887 123 DFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~ 142 (628)
.+.++||||+++ ++.+++.
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~ 158 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMK 158 (440)
T ss_pred eEEEEEEecCCc-cHHHHHH
Confidence 457799999985 6766664
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-08 Score=98.46 Aligned_cols=91 Identities=27% Similarity=0.563 Sum_probs=77.1
Q ss_pred CCcCceeecCCceeEEEEEECCCC----cEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETG----TTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+++.+.||.|+||.||+|.+...+ ..||+|.+...... ..+.+.+|++.++.+.|+||+++++.+. ....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence 356788999999999999998766 88999999765432 5678999999999999999999999854 3578
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.+++|||++++++.+++....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~ 96 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR 96 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh
Confidence 999999999999999987544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-08 Score=98.76 Aligned_cols=91 Identities=23% Similarity=0.503 Sum_probs=75.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
.+|++.+.||+|+||.||+|.+. .++.+|+|.+..... ....+.+|+++++++.||+|+++++.+. .....++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence 46888899999999999999885 467899998864332 2357899999999999999999998843 4678899
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
+|||+++++|.+++....
T Consensus 77 v~e~~~~~~L~~~~~~~~ 94 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR 94 (256)
T ss_pred EEEcCCCCcHHHHHHhCc
Confidence 999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.8e-09 Score=102.20 Aligned_cols=94 Identities=28% Similarity=0.486 Sum_probs=78.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..+|.+.+.||+|+||.||+|++.. ++..+|+|.+........+.+.+|++++++++||||+++++.+. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----D 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----c
Confidence 3468888999999999999998642 44568999887655555577899999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++||||++++++.+++....
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~ 102 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHG 102 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcC
Confidence 678899999999999999997644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.5e-09 Score=103.51 Aligned_cols=97 Identities=22% Similarity=0.401 Sum_probs=77.8
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECC-------CCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGE-------TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
....++|.+.+.||+|+||.||+|++.. ....+|+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3445678899999999999999998632 34569999987532 33456788999999999 599999999986
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .....|++|||+++|+|.+++....
T Consensus 88 ~-----~~~~~~lv~e~~~~g~L~~~i~~~~ 113 (314)
T cd05099 88 T-----QEGPLYVIVEYAAKGNLREFLRARR 113 (314)
T ss_pred c-----cCCceEEEEecCCCCcHHHHHHhcC
Confidence 4 3667899999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.8e-08 Score=102.92 Aligned_cols=97 Identities=18% Similarity=0.244 Sum_probs=76.7
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc-ccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~ 121 (628)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999999999999999986532 233456789999999999999999998864311 122
Q ss_pred cceeeeeecccccCCchhhhh
Q 042887 122 VDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~ 142 (628)
....|+++|++ ++++.+++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~ 111 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK 111 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh
Confidence 34578999987 678877764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.7e-09 Score=107.09 Aligned_cols=86 Identities=26% Similarity=0.423 Sum_probs=71.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
+...-.+-+|.|+-|-||.|+. .++.||||.++.-.+ .+|.-|++++||||+.+.++|+. ...+++
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtq-----sPcyCI 189 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQ-----SPCYCI 189 (904)
T ss_pred HHhhhhhhhccCcccceeeeec--cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecC-----CceeEE
Confidence 3334456799999999999999 678999998864332 46777999999999999999975 688999
Q ss_pred eecccccCCchhhhhccccc
Q 042887 128 IYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~~~ 147 (628)
|||||+.|-|.+.++..+.-
T Consensus 190 iMEfCa~GqL~~VLka~~~i 209 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPI 209 (904)
T ss_pred eeeccccccHHHHHhccCcc
Confidence 99999999999999876643
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-08 Score=98.54 Aligned_cols=85 Identities=24% Similarity=0.465 Sum_probs=69.2
Q ss_pred eeecCCceeEEEEEEC--CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecc
Q 042887 55 MIGQGSFGFVYKGKLG--ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEY 131 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~--~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 131 (628)
.||+|+||.||+|.+. .++..||+|+..... ....+.+.+|+.++++++||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999875 345679999986543 334467899999999999999999998753 3567999999
Q ss_pred cccCCchhhhhccc
Q 042887 132 MKCGSSEDWMHQSN 145 (628)
Q Consensus 132 ~~~g~L~~~l~~~~ 145 (628)
+++|+|.+++....
T Consensus 76 ~~~~~L~~~l~~~~ 89 (257)
T cd05115 76 ASGGPLNKFLSGKK 89 (257)
T ss_pred CCCCCHHHHHHhCC
Confidence 99999999886543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-08 Score=99.94 Aligned_cols=90 Identities=18% Similarity=0.236 Sum_probs=71.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHH-HhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEA-LSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|++..+|+.||+|.++... .....++..|+.. ++...||||+++++.+. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 46888999999999999999999999999999987542 2233456667665 56668999999999854 36789
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
|++|||++ |++.+++..
T Consensus 76 ~lv~e~~~-~~l~~~l~~ 92 (283)
T cd06617 76 WICMEVMD-TSLDKFYKK 92 (283)
T ss_pred EEEhhhhc-ccHHHHHHH
Confidence 99999997 577777654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-08 Score=99.23 Aligned_cols=87 Identities=21% Similarity=0.370 Sum_probs=69.3
Q ss_pred ceeecCCceeEEEEEECC--CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGE--TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~--~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.||+|+||.||+|.... ....+|+|.+.... ......+.+|+.+++.++||||+++++.+. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 359999999999997533 33468888775432 233456889999999999999999999854 3677899999
Q ss_pred ccccCCchhhhhccc
Q 042887 131 YMKCGSSEDWMHQSN 145 (628)
Q Consensus 131 ~~~~g~L~~~l~~~~ 145 (628)
|+++|+|.+++....
T Consensus 76 ~~~~g~L~~~l~~~~ 90 (269)
T cd05042 76 FCPLGDLKNYLRSNR 90 (269)
T ss_pred eCCCCcHHHHHHhcc
Confidence 999999999997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.8e-08 Score=98.07 Aligned_cols=90 Identities=24% Similarity=0.345 Sum_probs=77.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|++++++++|+||+++++.+. .....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4788899999999999999999999999999987542 334567789999999999999999998843 468899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|+||++++++.+++.+
T Consensus 76 ~v~e~~~~~~L~~~~~~ 92 (256)
T cd08530 76 IVMEYAPFGDLSKAISK 92 (256)
T ss_pred EEehhcCCCCHHHHHHH
Confidence 99999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-08 Score=100.10 Aligned_cols=93 Identities=22% Similarity=0.388 Sum_probs=73.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcE----EEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTT----VAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
++|++.+.||+|+||.||+|.+..+++. +|+|.+.... ......+..|+.+++++.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 5688889999999999999999777764 6777764332 223456778888899999999999999853 3
Q ss_pred ceeeeeecccccCCchhhhhcccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...++++||+++|++.+++.....
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~ 104 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD 104 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc
Confidence 457899999999999999976443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.8e-08 Score=99.92 Aligned_cols=91 Identities=29% Similarity=0.433 Sum_probs=73.8
Q ss_pred CCcCceeecCCceeEEEEEE----CCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 50 FSASNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~----~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
|+..+.||+|+||.||++.+ ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 37889999999999987653 3467889999987543 2345678899999999999999999988653 23456
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.+++|||+++|++.+++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~ 101 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK 101 (283)
T ss_pred EEEEecCCCCCCHHHHHHH
Confidence 8999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-08 Score=100.79 Aligned_cols=90 Identities=23% Similarity=0.399 Sum_probs=76.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|+++++.++|+||+++++.+.. .+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 36889999999999999999999899999999886532 3345678999999999999999999999643 6789
Q ss_pred eeeecccccCCchhhhh
Q 042887 126 ALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~ 142 (628)
+++|||++++.+..+..
T Consensus 76 ~iv~e~~~~~~l~~~~~ 92 (288)
T cd07833 76 YLVFEYVERTLLELLEA 92 (288)
T ss_pred EEEEecCCCCHHHHHHh
Confidence 99999999877665543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-08 Score=103.26 Aligned_cols=97 Identities=20% Similarity=0.255 Sum_probs=77.1
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~ 121 (628)
...++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++... .+..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3467899999999999999999999889999999998753 233456788999999999999999999986531 1233
Q ss_pred cceeeeeecccccCCchhhhh
Q 042887 122 VDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~ 142 (628)
....|+||||+++ ++.+.+.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~ 113 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ 113 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh
Confidence 4568999999975 5555553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.1e-08 Score=100.64 Aligned_cols=92 Identities=28% Similarity=0.363 Sum_probs=75.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+.+.|+..+.||+|+||.||+|....+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++.+ .
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~ 87 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----E 87 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----C
Confidence 3456889999999999999999998899999999986432 2334568899999999999999999999654 6
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...|+|+||+. |++.+++..
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~ 107 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEV 107 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHH
Confidence 77899999997 566666543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-08 Score=97.01 Aligned_cols=91 Identities=22% Similarity=0.358 Sum_probs=79.0
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+++++.++|||++++.+.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 47888999999999999999988899999999976432 45567889999999999999999998854 358899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+++||++++++.+++...
T Consensus 76 lv~e~~~~~~L~~~l~~~ 93 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQ 93 (258)
T ss_pred EEEEecCCCcHHHHHHHh
Confidence 999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.8e-08 Score=99.09 Aligned_cols=96 Identities=23% Similarity=0.419 Sum_probs=76.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|.+..+|+.||+|...... ......+.+|+.+++.+. ||||+++++.+...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999999999999999986542 223467889999999995 699999998865422222334
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|++|||+++ ++.+++...
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~ 99 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSN 99 (295)
T ss_pred EEEEeeccCc-CHHHHHHHh
Confidence 8999999985 788887643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.8e-08 Score=96.61 Aligned_cols=91 Identities=36% Similarity=0.553 Sum_probs=79.0
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|++++.+++|||++++++.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 47888999999999999999988999999999976543 45577999999999999999999998854 367889
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||++++++.+++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~ 93 (254)
T cd06627 76 IILEYAENGSLRQIIKKF 93 (254)
T ss_pred EEEecCCCCcHHHHHHhc
Confidence 999999999999988654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-08 Score=98.65 Aligned_cols=91 Identities=29% Similarity=0.493 Sum_probs=76.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+|++.+.||+|+||.||+|.. .|+.||+|..+... ..+.+.+|+.++++++|++++++++++. ......+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceE
Confidence 45789999999999999999988 57889999886432 3467899999999999999999998753 3456789
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
++|||+++|++.+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~ 95 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRG 95 (256)
T ss_pred EEEECCCCCcHHHHHHhcC
Confidence 9999999999999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.7e-08 Score=100.40 Aligned_cols=86 Identities=23% Similarity=0.354 Sum_probs=74.4
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
...||+|+||.||+|....+|+.||+|.+..........+.+|+.+++.++|+||+++++.+. .....+++|||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecC
Confidence 367999999999999999899999999986554445567899999999999999999999854 477899999999
Q ss_pred ccCCchhhhhc
Q 042887 133 KCGSSEDWMHQ 143 (628)
Q Consensus 133 ~~g~L~~~l~~ 143 (628)
+++++.+++..
T Consensus 100 ~~~~L~~~~~~ 110 (292)
T cd06657 100 EGGALTDIVTH 110 (292)
T ss_pred CCCcHHHHHhc
Confidence 99999887743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-08 Score=102.83 Aligned_cols=96 Identities=19% Similarity=0.243 Sum_probs=77.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-ccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~ 122 (628)
..++|++.+.||+|+||.||+|.+..+++.||||.+... .......+.+|+.+++.++||||+++++++... .+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999999999999998653 233456788999999999999999999876531 12334
Q ss_pred ceeeeeecccccCCchhhhh
Q 042887 123 DFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~ 142 (628)
...|+||||+++ ++.+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~ 120 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ 120 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH
Confidence 568999999975 5665553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.4e-08 Score=96.23 Aligned_cols=94 Identities=23% Similarity=0.402 Sum_probs=79.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|+..+.||+|+||.||+|....+++.|++|.+..... ...+.+.+|++++++++||||+++++.+.+ ......+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD---EEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec---CCCCeEE
Confidence 47778999999999999999988999999999876542 446778999999999999999999988643 1127889
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+++||++++++.+++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~ 96 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG 96 (260)
T ss_pred EEEEecCCCcHHHHHHHcC
Confidence 9999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.4e-08 Score=97.01 Aligned_cols=86 Identities=33% Similarity=0.497 Sum_probs=73.0
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
+.||+|+||.||+|.+.. ++.||+|.+...... ..+.+.+|++++++++|+||+++++.+. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 469999999999999976 899999998765332 4567899999999999999999998854 467889999999
Q ss_pred ccCCchhhhhccc
Q 042887 133 KCGSSEDWMHQSN 145 (628)
Q Consensus 133 ~~g~L~~~l~~~~ 145 (628)
+++++.+++.+..
T Consensus 75 ~~~~l~~~l~~~~ 87 (251)
T cd05041 75 PGGSLLTFLRKKK 87 (251)
T ss_pred CCCcHHHHHHhcC
Confidence 9999999986544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.2e-08 Score=98.99 Aligned_cols=94 Identities=24% Similarity=0.461 Sum_probs=76.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCc----EEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGT----TVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~----~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..+|++.+.||+|+||.||+|.+..+|+ .||+|.+.... ....+.+.+|+.+++.+.||||+++++.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------ 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc------
Confidence 3568888999999999999999877776 48999886542 334567889999999999999999998864
Q ss_pred cceeeeeecccccCCchhhhhcccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
....++++||+++|++.+++....+
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~~~ 104 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVRENKD 104 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhccC
Confidence 3456799999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.3e-08 Score=99.38 Aligned_cols=95 Identities=27% Similarity=0.468 Sum_probs=76.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|.++... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCC
Confidence 3568999999999999999999999999999999987543 2223456789999999999999999988643 2235
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||+.+ ++.+++...
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~ 101 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNM 101 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhc
Confidence 68999999974 777777643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.1e-08 Score=99.14 Aligned_cols=95 Identities=22% Similarity=0.420 Sum_probs=78.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECC----CCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGE----TGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---- 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE---- 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 35679999999999999999999865 2578999988643 23345678899999999999999999998642
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++++||+++|++.+++...
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~ 103 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQC 103 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhc
Confidence 356788999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.7e-08 Score=99.22 Aligned_cols=90 Identities=26% Similarity=0.496 Sum_probs=75.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 57899999999999999999998899999999986542 233456889999999999999999999854 46789
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
|+||||++ +++.+++..
T Consensus 77 ~lv~e~~~-~~l~~~~~~ 93 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDS 93 (294)
T ss_pred EEEEeccc-ccHHHHHHh
Confidence 99999996 577777654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.8e-08 Score=98.53 Aligned_cols=98 Identities=26% Similarity=0.467 Sum_probs=77.3
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc----
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID---- 118 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 118 (628)
...++|++.+.+|+|+||.||+|.+..+|+.||+|.++... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999999899999999997542 233456788999999999999999998865411
Q ss_pred -ccccceeeeeecccccCCchhhhhc
Q 042887 119 -FKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 119 -~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.+.....++++||+++ ++...+..
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~ 108 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES 108 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc
Confidence 1123478999999986 66665543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.8e-08 Score=101.12 Aligned_cols=97 Identities=24% Similarity=0.352 Sum_probs=77.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..+|.+.+.||+|+||.||+|++..+++.||+|.+... .......+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999999999999999998653 2334456788999999999999999999865422223346
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+++||+. +++.+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~ 102 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS 102 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC
Confidence 899999996 6788777543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.8e-08 Score=100.21 Aligned_cols=89 Identities=16% Similarity=0.209 Sum_probs=73.8
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
....+|++.+.||+|+||.||+|.+..+++.||+|+... .....|+.++++++||||+++++++.. ...
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-----CCe
Confidence 345679999999999999999999998899999997533 234579999999999999999998653 678
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||||+. |++.+++....
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~ 151 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRS 151 (357)
T ss_pred eEEEEEccC-CcHHHHHHhcc
Confidence 899999996 58888876544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.4e-08 Score=100.74 Aligned_cols=97 Identities=21% Similarity=0.269 Sum_probs=76.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc-cccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~ 122 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.... ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3567999999999999999999999999999999986432 223456889999999999999999998865311 1122
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
..+++||||+ ++++.+++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~ 112 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH 112 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc
Confidence 4568999998 6788877753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.1e-08 Score=96.61 Aligned_cols=86 Identities=24% Similarity=0.446 Sum_probs=70.7
Q ss_pred ceeecCCceeEEEEEECCCC---cEEEEEEeecccc-chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETG---TTVAVKVMNLKQK-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|.+...+ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++.+. ....+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 46999999999999876554 7899999875432 34567899999999999999999998743 34679999
Q ss_pred cccccCCchhhhhccc
Q 042887 130 EYMKCGSSEDWMHQSN 145 (628)
Q Consensus 130 e~~~~g~L~~~l~~~~ 145 (628)
||+++|++.+++....
T Consensus 75 e~~~~~~L~~~l~~~~ 90 (257)
T cd05060 75 ELAPLGPLLKYLKKRR 90 (257)
T ss_pred EeCCCCcHHHHHHhCC
Confidence 9999999999987544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.3e-08 Score=97.77 Aligned_cols=87 Identities=20% Similarity=0.424 Sum_probs=69.6
Q ss_pred ceeecCCceeEEEEEECCC------------CcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 54 NMIGQGSFGFVYKGKLGET------------GTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~------------~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
+.||+|+||.||+|..... ...+|+|.+..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 3689999999999985321 23588888766555555678899999999999999999998653
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....+++|||+++|++..++....
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~ 99 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS 99 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC
Confidence 567799999999999988876544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.7e-08 Score=97.06 Aligned_cols=86 Identities=27% Similarity=0.439 Sum_probs=71.9
Q ss_pred ceeecCCceeEEEEEECC-CCc--EEEEEEeecccc-chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGE-TGT--TVAVKVMNLKQK-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~-~~~--~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|.+.. .++ .||+|.+..... ...+.+.+|+..+++++||||+++++.+. . ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999865 333 699999976554 56678999999999999999999998843 3 7889999
Q ss_pred cccccCCchhhhhccc
Q 042887 130 EYMKCGSSEDWMHQSN 145 (628)
Q Consensus 130 e~~~~g~L~~~l~~~~ 145 (628)
||+++|++.+++.+..
T Consensus 75 e~~~~~~L~~~l~~~~ 90 (257)
T cd05040 75 ELAPLGSLLDRLRKDA 90 (257)
T ss_pred EecCCCcHHHHHHhcc
Confidence 9999999999987644
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.9e-08 Score=100.75 Aligned_cols=84 Identities=23% Similarity=0.284 Sum_probs=67.8
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc---CCCCcccccceeeeccccccceeeeee
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV---RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
||+|+||.||+|++..+++.||+|++.... ......+.+|..++... .||+|+++++.+ +.....|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 699999999999999999999999996532 22334456677777665 699999999884 4578899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++|++.+++.+.
T Consensus 76 e~~~~g~L~~~l~~~ 90 (330)
T cd05586 76 DYMSGGELFWHLQKE 90 (330)
T ss_pred cCCCCChHHHHHHhc
Confidence 999999999888643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.4e-08 Score=98.20 Aligned_cols=91 Identities=21% Similarity=0.315 Sum_probs=75.3
Q ss_pred CCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
+|++.+.||+|+||.||.|+.. .+|+.||+|++.... ....+.+.+|+.++.++ +|++|+.+++.+ +
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999874 478999999987532 23346688899999999 599999998884 4
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....|+||||++++++.+++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~ 99 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQR 99 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHc
Confidence 467889999999999999988653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.1e-08 Score=101.04 Aligned_cols=95 Identities=20% Similarity=0.329 Sum_probs=77.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecc--------
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSID-------- 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 118 (628)
..+|++.+.||.|+||.||+|....+|+.||+|.+........+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999999999999999997665555677889999999999999999988754311
Q ss_pred -ccccceeeeeecccccCCchhhhh
Q 042887 119 -FKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 119 -~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
+......+++|||++ +++.+++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~ 107 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE 107 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH
Confidence 112246789999997 58877764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.4e-08 Score=97.06 Aligned_cols=90 Identities=26% Similarity=0.517 Sum_probs=75.8
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|++|.||+|.+..+|+.||+|++.... ....+.+.+|++++++++|||++++++++. +....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 677889999999999999999899999999987543 233467889999999999999999999854 4688999
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
+|||++ +++.+++....
T Consensus 76 v~e~~~-~~l~~~~~~~~ 92 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSP 92 (283)
T ss_pred EEeccC-cCHHHHHhhCC
Confidence 999995 68888876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.71 E-value=3e-08 Score=97.54 Aligned_cols=87 Identities=30% Similarity=0.553 Sum_probs=71.5
Q ss_pred ceeecCCceeEEEEEECCCCc--EEEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGT--TVAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~--~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|+...++. .+|+|..... .....+.+.+|++++.++ +||||+++++.+. .....+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 368999999999999987775 4688887643 234456788999999999 7999999999864 366789999
Q ss_pred cccccCCchhhhhccc
Q 042887 130 EYMKCGSSEDWMHQSN 145 (628)
Q Consensus 130 e~~~~g~L~~~l~~~~ 145 (628)
||+++|+|.+++....
T Consensus 76 e~~~~~~L~~~i~~~~ 91 (270)
T cd05047 76 EYAPHGNLLDFLRKSR 91 (270)
T ss_pred EeCCCCcHHHHHHhcc
Confidence 9999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-08 Score=98.30 Aligned_cols=90 Identities=27% Similarity=0.460 Sum_probs=73.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|||++++++.+. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIY 76 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcE
Confidence 45688999999999999999998544 569999876433 23467889999999999999999987742 35678
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++|++.+++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~ 94 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG 94 (260)
T ss_pred EEEEcCCCCCHHHHHhhC
Confidence 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.3e-08 Score=98.51 Aligned_cols=94 Identities=22% Similarity=0.445 Sum_probs=77.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|.+..+++.+|+|.++... ......+.+|+.++++++||||+++++++.. ......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 57899999999999999999999899999999997543 2233457889999999999999999998653 123789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
|+|+||+.+ ++.+++....
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~ 100 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMK 100 (293)
T ss_pred EEEehhcCc-CHHHHHHhcc
Confidence 999999984 8888876544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.6e-08 Score=96.47 Aligned_cols=84 Identities=21% Similarity=0.337 Sum_probs=72.6
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||.|+||.||+|++..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+. .....++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 699999999999998889999999997542 234567899999999999999999999854 477899999999
Q ss_pred ccCCchhhhhcc
Q 042887 133 KCGSSEDWMHQS 144 (628)
Q Consensus 133 ~~g~L~~~l~~~ 144 (628)
++++|.+++.+.
T Consensus 76 ~~~~L~~~l~~~ 87 (262)
T cd05572 76 LGGELWTILRDR 87 (262)
T ss_pred CCCcHHHHHhhc
Confidence 999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-08 Score=97.63 Aligned_cols=85 Identities=28% Similarity=0.585 Sum_probs=69.7
Q ss_pred ceeecCCceeEEEEEECCCC----------cEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 54 NMIGQGSFGFVYKGKLGETG----------TTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+.||+|+||.||+|.+..++ ..+++|........ ...+.+|+.++++++||||+++++.+. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV-----R-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEe-----c-C
Confidence 46899999999999997666 34777876544332 678899999999999999999999864 2 5
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++||||+++|+|.+++....
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~ 95 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK 95 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc
Confidence 6789999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.6e-08 Score=96.24 Aligned_cols=86 Identities=34% Similarity=0.616 Sum_probs=74.1
Q ss_pred ceeecCCceeEEEEEECCC---CcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|..... +..||+|.+...... ..+.+.+|++.++.++|+||+++++++. .....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4699999999999999765 889999999765432 3678899999999999999999999854 478899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||++++++.+++...
T Consensus 76 e~~~~~~L~~~l~~~ 90 (262)
T cd00192 76 EYMEGGDLLDYLRKS 90 (262)
T ss_pred EeccCCcHHHHHhhc
Confidence 999999999998765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.3e-08 Score=96.80 Aligned_cols=84 Identities=24% Similarity=0.382 Sum_probs=72.4
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||+|+||.||+|++..+|+.+|+|.+..... ...+.+.+|++++++++||||+++++.+ ......|+++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999988899999999865432 3456788999999999999999999884 4578899999999
Q ss_pred ccCCchhhhhcc
Q 042887 133 KCGSSEDWMHQS 144 (628)
Q Consensus 133 ~~g~L~~~l~~~ 144 (628)
+++++.+++.+.
T Consensus 76 ~~~~L~~~l~~~ 87 (265)
T cd05579 76 PGGDLASLLENV 87 (265)
T ss_pred CCCcHHHHHHHc
Confidence 999999988654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.8e-08 Score=94.71 Aligned_cols=91 Identities=30% Similarity=0.474 Sum_probs=79.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
+|+..+.||+|+||.||+|.+..+++.+++|............+.+|++.++.++|++|+++++.+. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4788899999999999999998889999999997655445678999999999999999999999854 36788999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
+||++++++.+++...
T Consensus 76 ~e~~~~~~L~~~~~~~ 91 (253)
T cd05122 76 MEFCSGGSLKDLLKST 91 (253)
T ss_pred EecCCCCcHHHHHhhc
Confidence 9999999999988664
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.1e-08 Score=99.19 Aligned_cols=93 Identities=28% Similarity=0.528 Sum_probs=74.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCc----EEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGT----TVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~----~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.++|+..+.||+|+||.||+|.+..+|+ .||+|.+.... ......+.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3568888999999999999999877776 46888876543 2233468899999999999999999998642
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++++||+++|++.+++....
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~ 103 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK 103 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc
Confidence 34678999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.9e-08 Score=96.85 Aligned_cols=91 Identities=26% Similarity=0.526 Sum_probs=75.8
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ......+.+|+++++.++|||++++++++.. ...+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS---KGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEec---CCCCcEEE
Confidence 677889999999999999998889999999997653 3345678899999999999999999998654 11378999
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
|+||+++ ++.+++...
T Consensus 78 v~e~~~~-~l~~~~~~~ 93 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP 93 (287)
T ss_pred Eeccccc-cHHHHHhcc
Confidence 9999985 888877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.3e-08 Score=100.17 Aligned_cols=94 Identities=23% Similarity=0.312 Sum_probs=76.7
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
...++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+++++.++||||+++.+++.. ..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~ 82 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----PL 82 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----CC
Confidence 3567899999999999999999999999999999988643 22345678899999999999999999988532 24
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...++++||+ ++++.+++..
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~ 102 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS 102 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc
Confidence 5688999998 4678777653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.9e-08 Score=100.10 Aligned_cols=97 Identities=22% Similarity=0.266 Sum_probs=77.6
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeee-ccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSS-IDFKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 121 (628)
...++|+..+.||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.+++.++||||+++++++.. ..+.+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3457899999999999999999999999999999998643 23344667899999999999999999988653 11233
Q ss_pred cceeeeeecccccCCchhhhh
Q 042887 122 VDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~ 142 (628)
....|+||||+.+ ++.+.+.
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~ 112 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQ 112 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHh
Confidence 4567999999974 7777664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.8e-08 Score=96.87 Aligned_cols=90 Identities=23% Similarity=0.332 Sum_probs=76.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
.|...+.||+|++|.||+|.+..+++.+|+|.+........+.+.+|+.+++.+.||||+++++.+. .....+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3444578999999999999998899999999987654445567889999999999999999999843 46788999
Q ss_pred ecccccCCchhhhhc
Q 042887 129 YEYMKCGSSEDWMHQ 143 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~ 143 (628)
+||++++++.+++..
T Consensus 95 ~e~~~~~~L~~~~~~ 109 (285)
T cd06648 95 MEFLEGGALTDIVTH 109 (285)
T ss_pred EeccCCCCHHHHHHh
Confidence 999999999998865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.3e-08 Score=97.28 Aligned_cols=88 Identities=26% Similarity=0.521 Sum_probs=73.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|++.+.||+|+||.||+|.. +++.||+|..+... ..+.+.+|+.++++++||||+++++.+. ....++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL------HNGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEc------CCCcEE
Confidence 5688999999999999999976 78889999986432 3457889999999999999999998854 234689
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
+|||+++|++.+++....
T Consensus 76 v~e~~~~~~L~~~l~~~~ 93 (254)
T cd05083 76 VMELMSKGNLVNFLRTRG 93 (254)
T ss_pred EEECCCCCCHHHHHHhcC
Confidence 999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.3e-08 Score=103.00 Aligned_cols=85 Identities=18% Similarity=0.219 Sum_probs=72.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
.+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++|+|||++++++.. .+..++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~l 237 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCL 237 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEE
Confidence 46999999999999999999999999999999632 2346789999999999999999998653 678899
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
+||++. +++.+++...
T Consensus 238 v~e~~~-~~L~~~l~~~ 253 (461)
T PHA03211 238 VLPKYR-SDLYTYLGAR 253 (461)
T ss_pred EEEccC-CCHHHHHHhc
Confidence 999995 6888887654
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.7e-08 Score=98.58 Aligned_cols=92 Identities=26% Similarity=0.333 Sum_probs=75.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+.|+..+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+++++.++|||++++++++.+ ...
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCe
Confidence 45788889999999999999998899999999987542 2234568899999999999999999998643 678
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||||+.+ ++.+.+....
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~ 119 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHK 119 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhc
Confidence 8999999974 7777665433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.9e-08 Score=98.43 Aligned_cols=90 Identities=22% Similarity=0.417 Sum_probs=74.2
Q ss_pred CCCcCceeecCCceeEEEEEECC--CCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGE--TGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~--~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+.+ ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 47888999999999999999988 78999999997632 3445678899999999999999999998654 2237
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..++||||+++ ++.+.+.
T Consensus 78 ~~~lv~e~~~~-~l~~~~~ 95 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIK 95 (316)
T ss_pred eEEEEEeCCCc-CHHHHHH
Confidence 89999999975 5666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.68 E-value=6e-08 Score=99.01 Aligned_cols=100 Identities=20% Similarity=0.265 Sum_probs=78.5
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeec-c
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSI-D 118 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~ 118 (628)
+.....++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34456788999999999999999999998899999999987532 22346688999999999999999999886542 1
Q ss_pred ccccceeeeeecccccCCchhhhh
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
+......|++++++ ++++.+++.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~ 113 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVK 113 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHh
Confidence 22334578888876 678877664
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-08 Score=95.73 Aligned_cols=84 Identities=21% Similarity=0.474 Sum_probs=68.9
Q ss_pred eeecCCceeEEEEEE--CCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 55 MIGQGSFGFVYKGKL--GETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~--~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
.||+|+||.||+|.+ ..+++.+|+|+++... ....+.+.+|+.+++.++||||+++++.+. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999975 3567889999986543 234567899999999999999999998753 345689999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+++|++.+++...
T Consensus 76 ~~~~~~L~~~l~~~ 89 (257)
T cd05116 76 LAELGPLNKFLQKN 89 (257)
T ss_pred cCCCCcHHHHHHhc
Confidence 99999999988643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.3e-08 Score=97.31 Aligned_cols=98 Identities=21% Similarity=0.396 Sum_probs=76.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc---cc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID---FK 120 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~ 120 (628)
..++|++.+.||+|+||.||+|....+++.||+|.+.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999999999999999986532 222345678999999999999999999876421 11
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+.+ ++.+++...
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~ 112 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK 112 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc
Confidence 23467999999974 777776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.9e-08 Score=99.70 Aligned_cols=86 Identities=26% Similarity=0.359 Sum_probs=72.0
Q ss_pred ceeecC--CceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQG--SFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G--~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
..||+| +||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....++++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 356666 89999999999999999999987543 233467889999999999999999999954 477889999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+.+|++.+++.+.
T Consensus 79 e~~~~~~l~~~l~~~ 93 (328)
T cd08226 79 PFMAYGSANSLLKTY 93 (328)
T ss_pred ecccCCCHHHHHHhh
Confidence 999999999888654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=98.67 E-value=5e-08 Score=95.82 Aligned_cols=90 Identities=18% Similarity=0.366 Sum_probs=73.0
Q ss_pred CCCcCceeecCCceeEEEEEECC-CCcEEEEEEeeccc----------cchhhhHHHHHHHHhh-cCCCCcccccceeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGE-TGTTVAVKVMNLKQ----------KGAAKSFVTECEALSN-VRHRNLIKIITVCSS 116 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~~avK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 116 (628)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....++.+|+.++.+ ++||||+++++.+.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999977 67889999885421 1233557788888765 68999999999854
Q ss_pred ccccccceeeeeecccccCCchhhhhc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
..+..+++|||++++++.+++..
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~ 102 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNS 102 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHH
Confidence 47889999999999999888743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-08 Score=95.26 Aligned_cols=96 Identities=22% Similarity=0.314 Sum_probs=78.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC----cEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG----TTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
-..|+....||+|.||.||+|...+++ +.+|+|.++..+ .+.....+||+..+++++|||||.+..++.+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~---- 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS---- 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----
Confidence 357999999999999999999776554 368999987543 3556678999999999999999999998643
Q ss_pred ccceeeeeecccccCCchhhhhccccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
.+...++++||.+. ||.+.|+-++..
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~ 124 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRAS 124 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccc
Confidence 27889999999985 888888766543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.3e-09 Score=100.03 Aligned_cols=100 Identities=20% Similarity=0.279 Sum_probs=82.5
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDF 119 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 119 (628)
.....+|....+||+|+||+|.+|..+.+.+.||||++++. ...+.+--+.|.++|+-- +-|.+++++.+ |
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----F 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----F 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----h
Confidence 44456799999999999999999999999999999999764 234445556777777755 47889999988 7
Q ss_pred cccceeeeeecccccCCchhhhhcccccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
++.++.|+||||+.||+|-.+|.+.++..
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~GkFK 448 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGKFK 448 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcccC
Confidence 88999999999999999999988776544
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.9e-08 Score=95.47 Aligned_cols=88 Identities=25% Similarity=0.502 Sum_probs=70.1
Q ss_pred ceeecCCceeEEEEEECC---CCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGE---TGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~---~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|.+.. .+..||+|.+... .....+.+.+|+.+++.++||||+++++.+.. .....+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998753 3457999988543 23445778899999999999999999987642 345678999
Q ss_pred cccccCCchhhhhccc
Q 042887 130 EYMKCGSSEDWMHQSN 145 (628)
Q Consensus 130 e~~~~g~L~~~l~~~~ 145 (628)
||+.+|++.+++....
T Consensus 77 e~~~~~~L~~~~~~~~ 92 (262)
T cd05058 77 PYMKHGDLRNFIRSET 92 (262)
T ss_pred ecCCCCCHHHHHHhcC
Confidence 9999999999986543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.9e-08 Score=95.84 Aligned_cols=85 Identities=21% Similarity=0.395 Sum_probs=67.6
Q ss_pred eeecCCceeEEEEEECCCC--cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecc
Q 042887 55 MIGQGSFGFVYKGKLGETG--TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEY 131 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~--~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 131 (628)
.||+|+||.||+|+...++ ..+++|...... ....+.+.+|+.+++.++||||+++++.+.+ ....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence 5999999999999864332 345666665432 2345689999999999999999999998653 6678999999
Q ss_pred cccCCchhhhhcc
Q 042887 132 MKCGSSEDWMHQS 144 (628)
Q Consensus 132 ~~~g~L~~~l~~~ 144 (628)
+++|+|.+++.+.
T Consensus 77 ~~~~~L~~~l~~~ 89 (268)
T cd05086 77 CELGDLKSYLSQE 89 (268)
T ss_pred CCCCcHHHHHHhh
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.3e-08 Score=99.10 Aligned_cols=91 Identities=20% Similarity=0.366 Sum_probs=73.3
Q ss_pred hCCCCc-CceeecCCceeEEEEEECCCCcEEEEEEeeccccch--------------hhhHHHHHHHHhhcCCCCccccc
Q 042887 47 TNNFSA-SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA--------------AKSFVTECEALSNVRHRNLIKII 111 (628)
Q Consensus 47 ~~~~~~-~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~ 111 (628)
.++|.. .+.||+|+||.||+|.+..+++.||+|.+....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 355654 577999999999999998899999999986532111 12578999999999999999999
Q ss_pred ceeeeccccccceeeeeecccccCCchhhhhc
Q 042887 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 112 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
+++. .....+++|||+. |++.+++..
T Consensus 87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~~ 112 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMA-SDLKKVVDR 112 (335)
T ss_pred EEEe-----cCCcEEEEEeccc-cCHHHHHHh
Confidence 9854 4678999999997 588888754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.9e-08 Score=90.04 Aligned_cols=89 Identities=13% Similarity=0.233 Sum_probs=67.7
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-----CCCCcccccceeeeccccccce-
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-----RHRNLIKIITVCSSIDFKGVDF- 124 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~~~~~~~- 124 (628)
.-.+.||+|+||.||. ++.++.. +||++........+.+.+|+.+++.+ .||||+++++++... .....
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 3457899999999995 7777665 69988765444557799999999999 579999999985431 11124
Q ss_pred eeeeecc--cccCCchhhhhcc
Q 042887 125 KALIYEY--MKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~--~~~g~L~~~l~~~ 144 (628)
+.+|+|| +.+|+|.+++.+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~ 101 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC 101 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc
Confidence 4478999 6689999999653
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-08 Score=98.55 Aligned_cols=93 Identities=23% Similarity=0.365 Sum_probs=75.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCC-----CcEEEEEEeecccc-chhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGET-----GTTVAVKVMNLKQK-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.+|++.+.||+|+||.||+|.+..+ ++.||+|+++.... ...+.+.+|+.++..++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 3577788999999999999987543 47799999975432 33466889999999999999999999854 3
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++++||++++++.+++....
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~ 103 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRS 103 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcC
Confidence 667899999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.7e-08 Score=98.75 Aligned_cols=96 Identities=20% Similarity=0.299 Sum_probs=77.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|....+|+.||+|.+.... ......+.+|+.+++.++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 368999999999999999999999999999999987542 234567788999999999999999998754311 23457
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+. |++.+++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~ 101 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD 101 (334)
T ss_pred EEEEEehhh-hhHHHHhccC
Confidence 899999996 5888877543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-08 Score=97.82 Aligned_cols=86 Identities=30% Similarity=0.524 Sum_probs=70.9
Q ss_pred ceeecCCceeEEEEEECCCC------cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 54 NMIGQGSFGFVYKGKLGETG------TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~------~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+.||+|+||.||+|++.... +.+|+|.+.... ......+.+|+.+++.++||||+++++.+. .....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36899999999999986433 679999886542 234567899999999999999999999854 366789
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++|++.+++.+.
T Consensus 76 ~v~e~~~~~~L~~~l~~~ 93 (269)
T cd05044 76 IIMELMEGGDLLSYLRDA 93 (269)
T ss_pred EEEeccCCCcHHHHHHHh
Confidence 999999999999999754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8e-10 Score=99.76 Aligned_cols=97 Identities=22% Similarity=0.441 Sum_probs=76.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec---cccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI---DFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---~~~~ 121 (628)
...|+-...||+|.||.||+|+.+.+|+.||+|++-.. ..+-.....+|++++..++|+|++.+++.|... ....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34577778899999999999999999999999877432 334455678999999999999999999999762 2223
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...+|+||++|+. +|...+...
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~ 117 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR 117 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc
Confidence 4569999999985 777666544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.5e-08 Score=95.64 Aligned_cols=90 Identities=21% Similarity=0.248 Sum_probs=73.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+|.+.+.||+|+||.||++.+...+..+++|..+... ......+.+|+.++++++||||+++++.+ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 4788899999999999999998777777777765421 22344577899999999999999999984 4467
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..++++||++++++.+++.+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~ 95 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEE 95 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHH
Confidence 78999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.1e-09 Score=100.74 Aligned_cols=95 Identities=21% Similarity=0.331 Sum_probs=82.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.+.|..-++||+|+||.||.++.+.+|+.||+|.+.+.. +........|..++.++..+.||.+..+ |++.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 456788899999999999999999999999999986542 3445567889999999999999998877 77899
Q ss_pred eeeeeecccccCCchhhhhcccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
..++|+..|.||||..+|...+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~ 281 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN 281 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC
Confidence 99999999999999999877663
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-08 Score=93.56 Aligned_cols=93 Identities=22% Similarity=0.382 Sum_probs=79.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----c---chhhhHHHHHHHHhhcC-CCCcccccceeeec
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----K---GAAKSFVTECEALSNVR-HRNLIKIITVCSSI 117 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 117 (628)
..+|...+.+|.|.-+.|.++.++++|+.+|+|++.... + .-.+.-.+|+++|+++. ||+|+++.+.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 467888999999999999999999999999999996532 1 12345678999999995 9999999999
Q ss_pred cccccceeeeeecccccCCchhhhhcc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+++..++++|+|.|+.|+|.+++...
T Consensus 92 -yes~sF~FlVFdl~prGELFDyLts~ 117 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYLTSK 117 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHhhhh
Confidence 67799999999999999999999654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.6e-08 Score=98.97 Aligned_cols=94 Identities=21% Similarity=0.327 Sum_probs=76.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhc-CCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|++.+.||+|+||.||+|.+..+|+.+|+|.+... .......+.+|+.+++++ +||||+++++++.. ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 456799999999999999999999888999999988542 223345678899999999 99999999998642 234
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...|+||||++ +++.+++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~ 101 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA 101 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc
Confidence 56899999998 588887754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.1e-08 Score=95.14 Aligned_cols=90 Identities=29% Similarity=0.432 Sum_probs=73.9
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-chhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|+||.||+|....+++.||+|.+..... .......+|+..+++++ ||||+++++.+ ......++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6778899999999999999988899999999865422 22334567999999999 99999999985 44788999
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
||||+ +|++.+++....
T Consensus 76 v~e~~-~~~l~~~~~~~~ 92 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK 92 (283)
T ss_pred EEecC-CCCHHHHHHhcc
Confidence 99999 788988876543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.8e-08 Score=95.16 Aligned_cols=91 Identities=24% Similarity=0.309 Sum_probs=74.5
Q ss_pred CCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+.+|+.++.++ .||+|+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4778899999999999999864 457889999987532 23445688999999999 599999999884 4
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|++.+++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~ 99 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQR 99 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc
Confidence 577899999999999999888643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.4e-08 Score=97.39 Aligned_cols=95 Identities=21% Similarity=0.297 Sum_probs=77.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+.+++.++|+||+++.+++...........|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999998889999999987643 34456789999999999999999999986542212334789
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
++|||+++ ++.+++...
T Consensus 81 lv~e~~~~-~l~~~l~~~ 97 (330)
T cd07834 81 IVTELMET-DLHKVIKSP 97 (330)
T ss_pred EEecchhh-hHHHHHhCC
Confidence 99999984 788877643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.2e-08 Score=109.55 Aligned_cols=72 Identities=24% Similarity=0.403 Sum_probs=62.8
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeee
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
.-..+|+..+.+|+||||.||+++.+-+|+.||||++... +...-..+.||+..++++.|||||+++.++.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 3456788899999999999999999999999999999765 33445678899999999999999999999764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.7e-07 Score=94.24 Aligned_cols=89 Identities=29% Similarity=0.388 Sum_probs=73.1
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
|...+.||+|+||.||+|....+|+.||+|.+.... ....+.+.+|+++++.++|||++++++++.+ ....|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 666678999999999999998899999999986532 2234568899999999999999999998643 67889
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+||||+. |++.+++...
T Consensus 98 lv~e~~~-~~l~~~l~~~ 114 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH 114 (313)
T ss_pred EEEecCC-CCHHHHHHhc
Confidence 9999996 5677666543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-07 Score=94.18 Aligned_cols=91 Identities=24% Similarity=0.341 Sum_probs=71.9
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|+||.||+|.+..+++.||+|.++... ........+|+.++.++. |+||+++++++.+ ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 677889999999999999999899999999986542 222234568999999885 9999999998653 12267899
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
||||++ |++.+++...
T Consensus 78 v~e~~~-~~l~~~l~~~ 93 (282)
T cd07831 78 VFELMD-MNLYELIKGR 93 (282)
T ss_pred EEecCC-ccHHHHHHhc
Confidence 999997 4777777653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1e-07 Score=93.78 Aligned_cols=94 Identities=27% Similarity=0.457 Sum_probs=72.4
Q ss_pred CCcCceeecCCceeEEEEEECC---CCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeecccc-ccc
Q 042887 50 FSASNMIGQGSFGFVYKGKLGE---TGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK-GVD 123 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~---~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~ 123 (628)
|.+.+.||+|+||.||+|.+.. +++.||+|.+... .....+++.+|+.+++.++||||+++++.+...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677899999999999998653 4688999998653 233456788999999999999999999986531111 112
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..++++||+++|++.+++..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~ 100 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLM 100 (273)
T ss_pred ceEEEEecCCCCcHHHHHHH
Confidence 45788999999999888753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.7e-09 Score=87.35 Aligned_cols=85 Identities=25% Similarity=0.291 Sum_probs=43.0
Q ss_pred cCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEe
Q 042887 485 LRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564 (628)
Q Consensus 485 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 564 (628)
...|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..++.|+.|+++.|++. ..|+.+..+.+|-.||
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 344444555555555322222223345555555555555 34444555555555555555555 4445444455555555
Q ss_pred ccCCcCc
Q 042887 565 LSYNHFE 571 (628)
Q Consensus 565 ls~N~l~ 571 (628)
..+|.+.
T Consensus 130 s~~na~~ 136 (177)
T KOG4579|consen 130 SPENARA 136 (177)
T ss_pred CCCCccc
Confidence 5555543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-07 Score=92.06 Aligned_cols=84 Identities=26% Similarity=0.369 Sum_probs=72.4
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
||+|+||.||++.+..+++.+|+|.+.... ......+.+|+.++++++||||+++++.+ +.....+++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999998889999999987543 22456788999999999999999999884 4578899999999
Q ss_pred ccCCchhhhhcc
Q 042887 133 KCGSSEDWMHQS 144 (628)
Q Consensus 133 ~~g~L~~~l~~~ 144 (628)
+++++.+++...
T Consensus 76 ~~~~L~~~l~~~ 87 (250)
T cd05123 76 PGGELFSHLSKE 87 (250)
T ss_pred CCCcHHHHHHhc
Confidence 999999998654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.4e-09 Score=110.49 Aligned_cols=198 Identities=25% Similarity=0.276 Sum_probs=129.9
Q ss_pred cccEEEccCCcceeeC-chhhhccCCcCeeeeccccccccCCcCCCCC-CCCCeEecccCcccc---cc---CccccC--
Q 042887 363 KITVIGMGDNQISGTI-PSEIKNLVNINAFGVEYNQLTGTIPHAIGEL-KNLQGLALVRNSLRG---TI---PDTLGN-- 432 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~---~~---~~~~~~-- 432 (628)
+.+.+.+-.-.-.+.. |-.+....+|+.|.+.++.+.. ...+..+ ..|++|- -+|.+.. .+ ...+++
T Consensus 85 kt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~ 161 (1096)
T KOG1859|consen 85 KTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSP 161 (1096)
T ss_pred hheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccch
Confidence 4455544433322222 4456778899999999998862 1111111 1233332 2232221 00 011111
Q ss_pred -CCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCC
Q 042887 433 -LTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTT 511 (628)
Q Consensus 433 -l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 511 (628)
...|...+.++|++. .+..++.-++.+ +.|||++|+++.. ..+..++.|++|||++|.+....-....++.
T Consensus 162 ~Wn~L~~a~fsyN~L~-~mD~SLqll~al----e~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~- 233 (1096)
T KOG1859|consen 162 VWNKLATASFSYNRLV-LMDESLQLLPAL----ESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK- 233 (1096)
T ss_pred hhhhHhhhhcchhhHH-hHHHHHHHHHHh----hhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-
Confidence 245777788899987 566666666666 8899999999843 3788899999999999999843323334444
Q ss_pred CCeEECcCceeeeecCccccCCCCCCEEECCCCcccccC-chhhhcccCCCeEeccCCcCccc
Q 042887 512 LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQI-PKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 512 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
|+.|.+++|.++. -..+.++.+|+.||+++|-|.+.- -..+..|..|+.|+|.+|++...
T Consensus 234 L~~L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 234 LQLLNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred heeeeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999999999872 235788999999999999987542 23466778899999999998753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-07 Score=94.61 Aligned_cols=86 Identities=22% Similarity=0.305 Sum_probs=67.8
Q ss_pred CceeecCCceeEEEEEEC--CCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeec
Q 042887 53 SNMIGQGSFGFVYKGKLG--ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
.+.||+|+||.||+|++. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.+ ......+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 367999999999999975 366889999886432 23457899999999999999999988653 33567899999
Q ss_pred ccccCCchhhhhcc
Q 042887 131 YMKCGSSEDWMHQS 144 (628)
Q Consensus 131 ~~~~g~L~~~l~~~ 144 (628)
|+.+ ++.+++...
T Consensus 81 ~~~~-~l~~~~~~~ 93 (317)
T cd07868 81 YAEH-DLWHIIKFH 93 (317)
T ss_pred ccCC-CHHHHHHhc
Confidence 9874 777776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.9e-07 Score=88.73 Aligned_cols=91 Identities=27% Similarity=0.491 Sum_probs=78.3
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
|.+.+.||+|+||.||+|...++++.+|+|........ ..+.+.+|++.+++++|+|++++++.+. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56678999999999999999888999999999765544 5678899999999999999999999854 35788999
Q ss_pred ecccccCCchhhhhccc
Q 042887 129 YEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~~ 145 (628)
+|+++++++.+++....
T Consensus 76 ~e~~~~~~L~~~~~~~~ 92 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG 92 (225)
T ss_pred EeccCCCCHHHHHHhcc
Confidence 99999999999886543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-07 Score=93.14 Aligned_cols=90 Identities=28% Similarity=0.486 Sum_probs=75.5
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|++|.||+|....+++.+|+|.+..... .....+.+|+.++++++|+||+++++.+. .....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 5677899999999999999988999999999875432 34567889999999999999999999854 4688999
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
++||+++ ++.+++....
T Consensus 76 v~e~~~~-~l~~~l~~~~ 92 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQ 92 (283)
T ss_pred EEeccCC-CHHHHHHhhc
Confidence 9999985 8887776543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-07 Score=95.03 Aligned_cols=91 Identities=29% Similarity=0.369 Sum_probs=74.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..|+..+.||+|+||.||+|++..+++.+|+|.+... ......++.+|+++++.++|+|++++.+++.+ ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 4477778899999999999999889999999998643 22334568899999999999999999998543 678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+. |++.+.+...
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~ 108 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH 108 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc
Confidence 899999997 5777766443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-07 Score=91.39 Aligned_cols=94 Identities=22% Similarity=0.228 Sum_probs=70.6
Q ss_pred HHHHHhCCCCcCcee--ecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecc
Q 042887 42 DLSKATNNFSASNMI--GQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSID 118 (628)
Q Consensus 42 ~~~~~~~~~~~~~~i--G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 118 (628)
+.....++|++.+.+ |+|+||.||+++...+++.+|+|.......... |+.....+ +||||+++++.+.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~--- 79 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT--- 79 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe---
Confidence 334445677776666 999999999999999999999999865432111 22222222 6999999999854
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++....
T Consensus 80 --~~~~~~iv~e~~~~~~L~~~l~~~~ 104 (267)
T PHA03390 80 --TLKGHVLIMDYIKDGDLFDLLKKEG 104 (267)
T ss_pred --cCCeeEEEEEcCCCCcHHHHHHhcC
Confidence 3678999999999999999987643
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.7e-07 Score=91.48 Aligned_cols=86 Identities=22% Similarity=0.334 Sum_probs=67.5
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHh-hcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALS-NVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|.+..+|+.||+|.+..... .....+..|..++. ..+|+|++++++.+. .....|+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 569999999999999988999999999865431 22234455555443 447999999999854 467899999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
||+++++|.+++...
T Consensus 77 e~~~~~~L~~~l~~~ 91 (260)
T cd05611 77 EYLNGGDCASLIKTL 91 (260)
T ss_pred eccCCCCHHHHHHHc
Confidence 999999999988643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.2e-07 Score=93.73 Aligned_cols=89 Identities=25% Similarity=0.506 Sum_probs=76.0
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|+..+.||+|+||.||+|+...+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++. .....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 566788999999999999999899999999997653 334567889999999999999999999854 4688999
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
|+||++ +++.+++.+.
T Consensus 76 v~e~~~-~~l~~~i~~~ 91 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR 91 (282)
T ss_pred EecCcC-cCHHHHHHhh
Confidence 999998 5899988765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.5e-08 Score=99.27 Aligned_cols=91 Identities=20% Similarity=0.361 Sum_probs=75.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-C-----CCcccccceeeeccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-H-----RNLIKIITVCSSIDFKG 121 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~ 121 (628)
.+|++.+.||+|+||.|.+|.+.++++.||||+++.... -..+...|+.+|..++ | -|+|++++++ .-
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~f 259 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YF 259 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cc
Confidence 478999999999999999999999999999999975432 3455667899999886 3 4899999994 44
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..+.++|+|... -.|+++++...
T Consensus 260 r~HlciVfELL~-~NLYellK~n~ 282 (586)
T KOG0667|consen 260 RNHLCIVFELLS-TNLYELLKNNK 282 (586)
T ss_pred ccceeeeehhhh-hhHHHHHHhcC
Confidence 889999999886 48999997654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=98.55 E-value=2e-07 Score=92.13 Aligned_cols=85 Identities=25% Similarity=0.314 Sum_probs=64.7
Q ss_pred eeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHH---hhcCCCCcccccceeeeccccccceeeee
Q 042887 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEAL---SNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
.||+|+||.||++....+++.||+|.+.... ......+.+|..++ ....||+|+.+++.+. ..+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999899999999986542 11223344554433 3346999999988843 46788999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
|||+++|+|.+++...
T Consensus 76 ~e~~~~~~L~~~i~~~ 91 (279)
T cd05633 76 LDLMNGGDLHYHLSQH 91 (279)
T ss_pred EecCCCCCHHHHHHhc
Confidence 9999999999888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.1e-07 Score=93.59 Aligned_cols=96 Identities=21% Similarity=0.371 Sum_probs=75.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc---ccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID---FKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 121 (628)
.++|++.+.||+|+||.||+|++..+++.+|+|.+.... ......+.+|+++++.++||||+++++.+.... ...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999986542 223346789999999999999999998764311 123
Q ss_pred cceeeeeecccccCCchhhhhc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
....++|+||+.+ ++.+.+..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~ 107 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN 107 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc
Confidence 4568999999875 56555543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.3e-08 Score=101.06 Aligned_cols=91 Identities=20% Similarity=0.351 Sum_probs=75.0
Q ss_pred cCceeecCCceeEEEEEECCCCcEEEEEEeecc----ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 52 ASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK----QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
...+||+|+|-+||+|.+..+|..||=-.++.. .....++|..|+++|+.|+|||||++++.|.+. ..+..-+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeee
Confidence 457899999999999999888888774433322 234458899999999999999999999998762 2467889
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
|+|.+.+|+|.+|.++.+
T Consensus 121 iTEL~TSGtLr~Y~kk~~ 138 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR 138 (632)
T ss_pred eeecccCCcHHHHHHHhc
Confidence 999999999999998776
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.9e-07 Score=99.51 Aligned_cols=93 Identities=20% Similarity=0.300 Sum_probs=70.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCC------Ccccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHR------NLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~ 119 (628)
..++|++.+.||+|+||.||+|.+..+++.||||+++.... ..+.+.+|+.+++.++|. +++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~--- 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN--- 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc---
Confidence 45789999999999999999999998999999999965322 234456777777777654 46777766432
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++|||++ ++++.+++.+.
T Consensus 203 -~~~~~~iv~~~~-g~~l~~~l~~~ 225 (467)
T PTZ00284 203 -ETGHMCIVMPKY-GPCLLDWIMKH 225 (467)
T ss_pred -CCceEEEEEecc-CCCHHHHHHHc
Confidence 245788999987 67888877654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.7e-07 Score=91.13 Aligned_cols=85 Identities=22% Similarity=0.284 Sum_probs=64.8
Q ss_pred eeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHH---HHhhcCCCCcccccceeeeccccccceeeee
Q 042887 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECE---ALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
.||+|+||.||+|.+..+++.||+|.+..... .....+..|.. .++...||+|+++++.+ ...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 48999999999999988999999999875421 11222344443 34445799999998884 447789999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
|||+++|+|.+++...
T Consensus 76 ~e~~~g~~L~~~l~~~ 91 (278)
T cd05606 76 LDLMNGGDLHYHLSQH 91 (278)
T ss_pred EecCCCCcHHHHHHhc
Confidence 9999999999888643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.4e-08 Score=99.79 Aligned_cols=91 Identities=18% Similarity=0.278 Sum_probs=78.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..|..++.||-|+||+|.+++..++...||+|.+.+.+ +..+.....|-+||.+-+.+.||+++.. |++.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 34677889999999999999998898899999997753 4556667889999999999999999988 677999
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.|+||||++|||+-..+.+
T Consensus 704 LYFVMdYIPGGDmMSLLIr 722 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIR 722 (1034)
T ss_pred eEEEEeccCCccHHHHHHH
Confidence 9999999999998776643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5e-08 Score=89.39 Aligned_cols=92 Identities=18% Similarity=0.330 Sum_probs=78.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+.|.+.+.+|+|.||++-+++++.+...+++|.+..... ..+.|.||..+--.+. |.||+..+++. |++.+..
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 4578899999999999999999999999999999976533 3578999998766774 99999988864 7788999
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
.+++||++.|+|...+..
T Consensus 98 vF~qE~aP~gdL~snv~~ 115 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA 115 (378)
T ss_pred EEeeccCccchhhhhcCc
Confidence 999999999999987754
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.8e-07 Score=93.02 Aligned_cols=94 Identities=23% Similarity=0.300 Sum_probs=73.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc-ccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~ 123 (628)
..+|...+.||+|+||.||+|++..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999998899999999986532 223456889999999999999999999865411 12234
Q ss_pred eeeeeecccccCCchhhh
Q 042887 124 FKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l 141 (628)
..++|+||+.. ++.++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~ 110 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM 110 (342)
T ss_pred eEEEEeccccc-CHHHHH
Confidence 56899999864 555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.4e-07 Score=92.33 Aligned_cols=84 Identities=23% Similarity=0.313 Sum_probs=66.8
Q ss_pred ceeecCCceeEEEEEECC--CCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecc
Q 042887 54 NMIGQGSFGFVYKGKLGE--TGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEY 131 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 131 (628)
..||+|+||.||+|+... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ......+++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 579999999999999753 56789999886432 23467899999999999999999998653 345678999999
Q ss_pred cccCCchhhhhc
Q 042887 132 MKCGSSEDWMHQ 143 (628)
Q Consensus 132 ~~~g~L~~~l~~ 143 (628)
+.+ ++.+++..
T Consensus 82 ~~~-~l~~~~~~ 92 (317)
T cd07867 82 AEH-DLWHIIKF 92 (317)
T ss_pred eCC-cHHHHHHh
Confidence 875 67777643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.4e-07 Score=97.48 Aligned_cols=99 Identities=14% Similarity=0.284 Sum_probs=69.3
Q ss_pred HhCCCCcCceeecCCceeEEEEEEC----------------CCCcEEEEEEeeccccchh--------------hhHHHH
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLG----------------ETGTTVAVKVMNLKQKGAA--------------KSFVTE 95 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~----------------~~~~~~avK~~~~~~~~~~--------------~~~~~E 95 (628)
..++|++.++||+|+||.||+|... ..++.||||.+........ +.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 2456799999865432222 334456
Q ss_pred HHHHhhcCCCCc-----ccccceeeec---cccccceeeeeecccccCCchhhhhcc
Q 042887 96 CEALSNVRHRNL-----IKIITVCSSI---DFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 96 ~~~l~~l~h~nI-----v~l~~~~~~~---~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+.++.+++|.++ ++++++|... ........++|+||+++|+|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~ 279 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGK 279 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhc
Confidence 777777766554 4555555421 011235679999999999999999754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.1e-07 Score=95.01 Aligned_cols=97 Identities=20% Similarity=0.261 Sum_probs=76.3
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccc-ccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF-KGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~ 122 (628)
..++|++.+.||+|+||.||+|++..+++.||+|.+... .....+.+.+|+.+++.++||||+++.+++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 356799999999999999999999989999999988643 22344667889999999999999999887543111 222
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...++|+||+ ++++.+++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~ 112 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC 112 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc
Confidence 3589999998 5688888754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.3e-08 Score=88.29 Aligned_cols=89 Identities=20% Similarity=0.403 Sum_probs=75.6
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccce
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.+++|++.+.+|+|.|+.||.|....+++.++||+++.... +.+.||+.+++.+. ||||++++++..+ ...+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~D---p~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKD---PESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcC---ccccC
Confidence 46789999999999999999999988999999999976543 56889999999997 9999999998765 23456
Q ss_pred eeeeecccccCCchhh
Q 042887 125 KALIYEYMKCGSSEDW 140 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~ 140 (628)
..+++||+.+.+....
T Consensus 110 paLiFE~v~n~Dfk~l 125 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQL 125 (338)
T ss_pred chhHhhhhccccHHHH
Confidence 7899999988776544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.6e-07 Score=89.85 Aligned_cols=94 Identities=23% Similarity=0.408 Sum_probs=72.6
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhc---CCCCcccccceeeeccccccce
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNV---RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++++ .|||++++++.+.+.+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999998889999999997532 22345577888877666 5999999999976533223345
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+++|||+.+ ++.+++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~ 99 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC 99 (287)
T ss_pred eEEEehhccc-CHHHHHHHc
Confidence 8999999985 788877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-07 Score=92.56 Aligned_cols=80 Identities=26% Similarity=0.238 Sum_probs=65.2
Q ss_pred CceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecccccCCc
Q 042887 60 SFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSS 137 (628)
Q Consensus 60 ~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L 137 (628)
++|.||.++...+++.||+|++... .....+.+.+|+++++.++||||+++++++. .....+++|||+++|++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence 4455666666668999999999754 3345567999999999999999999999854 46788999999999999
Q ss_pred hhhhhcc
Q 042887 138 EDWMHQS 144 (628)
Q Consensus 138 ~~~l~~~ 144 (628)
.+++...
T Consensus 87 ~~~l~~~ 93 (314)
T cd08216 87 EDLLKTH 93 (314)
T ss_pred HHHHHHh
Confidence 9998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.1e-07 Score=95.53 Aligned_cols=86 Identities=17% Similarity=0.188 Sum_probs=70.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECC--CCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGE--TGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
...+|++.+.||+|+||.||+|.... +++.||+|.+... ....+|++++++++||||+++++++ ....
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCC
Confidence 34579999999999999999998643 4578999987543 2356899999999999999999884 3477
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..+++||++. +++.+++.
T Consensus 160 ~~~lv~e~~~-~~l~~~l~ 177 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVD 177 (392)
T ss_pred EEEEEehhcC-CCHHHHHH
Confidence 8999999986 57888773
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=7.6e-08 Score=90.57 Aligned_cols=94 Identities=20% Similarity=0.263 Sum_probs=77.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 122 (628)
..+|.+.++||+|+|++|..++.+++.+.||+|++++.- ..+..=...|..+.... .||.+|.++.+ |++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 467999999999999999999999999999999998742 22333345666666555 59999999998 7789
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.+.++|.||++||+|--+|.+.+
T Consensus 324 srlffvieyv~ggdlmfhmqrqr 346 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR 346 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh
Confidence 99999999999999987776554
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.5e-08 Score=106.55 Aligned_cols=94 Identities=27% Similarity=0.396 Sum_probs=80.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.+-+|+....||.|.||.||.|....+|+..|+|-+..+. ....+.+.+|..++..++|||+|+++++... ..
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Re 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----RE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HH
Confidence 3456777888999999999999999999999999886543 3445667899999999999999999999764 67
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++-||||++|+|.+.+...
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~g 1328 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG 1328 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhc
Confidence 789999999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.44 E-value=3e-07 Score=84.48 Aligned_cols=80 Identities=15% Similarity=0.140 Sum_probs=57.1
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccc--h-------hhhH-----------------HHHHHHHhhcCCCC
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG--A-------AKSF-----------------VTECEALSNVRHRN 106 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~-------~~~~-----------------~~E~~~l~~l~h~n 106 (628)
.+.||+|+||.||+|.+. +|+.||+|+++..... . ..+| .+|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 8999999999754210 1 1122 34899999998887
Q ss_pred cccccceeeeccccccceeeeeecccccCCchhh
Q 042887 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDW 140 (628)
Q Consensus 107 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 140 (628)
+....... ....++||||++++++...
T Consensus 81 v~~p~~~~-------~~~~~iVmE~i~g~~l~~~ 107 (190)
T cd05147 81 IPCPEPIL-------LKSHVLVMEFIGDDGWAAP 107 (190)
T ss_pred CCCCcEEE-------ecCCEEEEEEeCCCCCcch
Confidence 74433221 1234899999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.9e-07 Score=91.42 Aligned_cols=86 Identities=20% Similarity=0.215 Sum_probs=69.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++. .....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence 35666788999999999999999999999999987543 234567889999999996 999999999854 36778
Q ss_pred eeeecccccCCchh
Q 042887 126 ALIYEYMKCGSSED 139 (628)
Q Consensus 126 ~lv~e~~~~g~L~~ 139 (628)
+++|||+.. ++.+
T Consensus 79 ~~~~e~~~~-~l~~ 91 (288)
T cd06616 79 WICMELMDI-SLDK 91 (288)
T ss_pred EEEEecccC-CHHH
Confidence 899999874 4443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.2e-07 Score=84.70 Aligned_cols=94 Identities=15% Similarity=0.051 Sum_probs=71.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccch---hhh------HHHHHHHHhhcCCCCcccccceeee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA---AKS------FVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~------~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
..++|+..+++|.|+||.||.+.. ++..+|+|.+....... ... +.+|+..+.++.||+|..+.+....
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 468899999999999999999766 56789999996542211 122 6799999999999999998876443
Q ss_pred cc---ccccceeeeeecccccCCchhhh
Q 042887 117 ID---FKGVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 117 ~~---~~~~~~~~lv~e~~~~g~L~~~l 141 (628)
.. +......+++|||++|.++.++.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~ 134 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP 134 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh
Confidence 11 12245689999999999997763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.9e-07 Score=89.12 Aligned_cols=92 Identities=21% Similarity=0.262 Sum_probs=73.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++.+.. ||||+++++.+. ...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence 4567899999999999999999998889999999997543 223455777887777775 999999999964 367
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..|++|||+. +.+.+.+..
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~ 106 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKR 106 (296)
T ss_pred eEEEEeeccC-cCHHHHHHH
Confidence 8999999985 466655543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.2e-08 Score=90.56 Aligned_cols=104 Identities=20% Similarity=0.250 Sum_probs=82.7
Q ss_pred HHhCCCCc-CceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecccccc
Q 042887 45 KATNNFSA-SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 45 ~~~~~~~~-~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 122 (628)
..+++|.+ .++||-|--|+|..+.++.+|+.+|+|++... ....||++..... .|||||.+++++.. .+...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN-SYQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh-hccCc
Confidence 45788887 47899999999999999999999999988543 3456888876666 59999999998653 35667
Q ss_pred ceeeeeecccccCCchhhhhcccc-ccccccCC
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND-KLEAGNLG 154 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~ 154 (628)
+...+|||+++||+|+..+.+++. ..++...+
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~ 164 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREAS 164 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHH
Confidence 889999999999999999987764 34444333
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.3e-08 Score=88.76 Aligned_cols=224 Identities=21% Similarity=0.266 Sum_probs=125.0
Q ss_pred cCcccEEEccCCccccccc----hhhhCCCCCCEEecccCcCc---cccc-------ccccCCCCCCEeecccccCcccC
Q 042887 161 LLKLEMIDVGDNQLIGKFP----DFIANFSALEAIDISANMLG---GRIP-------DSLCQLRSLNYLSISENNFSCKL 226 (628)
Q Consensus 161 l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~n~l~---~~~~-------~~~~~l~~L~~L~Ls~N~i~~~~ 226 (628)
+..++.+|||+|.|...-. ..+.+-.+|++.++|.-... ..++ .++.++++|+..+||.|.+....
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 5678899999999976544 44556788888888864321 1122 34567888888888888887655
Q ss_pred CcC----ccCCCCCCEEEeecccCcccCC-hhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeeccc
Q 042887 227 PLS----IWNISSLEIISLHSNRFEGSLP-LNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKI 301 (628)
Q Consensus 227 p~~----~~~l~~L~~L~L~~n~l~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 301 (628)
|.. +.+-+.|++|.+++|.+- .+. ..++..+.. |..| +-.++-+.|+......|++......
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rigkal~~-----la~n-------KKaa~kp~Le~vicgrNRlengs~~ 175 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIGKALFH-----LAYN-------KKAADKPKLEVVICGRNRLENGSKE 175 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCC-ccchhHHHHHHHH-----HHHH-------hhhccCCCceEEEeccchhccCcHH
Confidence 543 456677888888888764 221 111110000 1111 1223445677777777766432221
Q ss_pred ----ccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHH----hccccccEEEccCCc
Q 042887 302 ----DFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA----NLSAKITVIGMGDNQ 373 (628)
Q Consensus 302 ----~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~----~~~~~L~~L~l~~n~ 373 (628)
.|..-.+|+++.+..|.|.......+.+ ..+..+.+|+.||+++|.++......++ .++ .++.|.+.+|.
T Consensus 176 ~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~-~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~-~lrEL~lnDCl 253 (388)
T COG5238 176 LSAALLESHENLKEVKIQQNGIRPEGVTMLAF-LGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWN-LLRELRLNDCL 253 (388)
T ss_pred HHHHHHHhhcCceeEEeeecCcCcchhHHHHH-HHHHHhCcceeeeccccchhhhhHHHHHHHhcccc-hhhhccccchh
Confidence 1222256777777777665422221111 2344567778888888877655443333 333 35666666666
Q ss_pred ceeeCchhh------hccCCcCeeeecccccc
Q 042887 374 ISGTIPSEI------KNLVNINAFGVEYNQLT 399 (628)
Q Consensus 374 l~~~~~~~l------~~l~~L~~L~l~~n~l~ 399 (628)
++......+ ...++|..|...+|.+.
T Consensus 254 ls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 254 LSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred hccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 654332221 12345555555555543
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.8e-08 Score=87.81 Aligned_cols=223 Identities=17% Similarity=0.200 Sum_probs=107.0
Q ss_pred hhCCCCCCEEecccCcCccccccc----ccCCCCCCEeecccccCc---ccCC-------cCccCCCCCCEEEeecccCc
Q 042887 182 IANFSALEAIDISANMLGGRIPDS----LCQLRSLNYLSISENNFS---CKLP-------LSIWNISSLEIISLHSNRFE 247 (628)
Q Consensus 182 ~~~l~~L~~L~Ls~n~l~~~~~~~----~~~l~~L~~L~Ls~N~i~---~~~p-------~~~~~l~~L~~L~L~~n~l~ 247 (628)
+..+..+..+|||+|.|......+ +.+-.+|+..+++.--.. +.++ .++.++++|+..+||.|.+.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 445677777777777776544333 334456666665543211 1111 22334444555555555444
Q ss_pred ccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeeccccc-------------ccCCCCCEEEc
Q 042887 248 GSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDF-------------NRLSNLSRLFL 314 (628)
Q Consensus 248 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-------------~~l~~L~~L~L 314 (628)
...|..+. +.++.-+.|++|.+++|.+.-+....+ ..-|.|+....
T Consensus 106 ~~~~e~L~---------------------d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vic 164 (388)
T COG5238 106 SEFPEELG---------------------DLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVIC 164 (388)
T ss_pred cccchHHH---------------------HHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEe
Confidence 33333222 223455666666666665542222211 12355666666
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
..|++...+...+ ...+..-..|+.+.+.+|.|.......+. -..+..+.+|+.||+.
T Consensus 165 grNRlengs~~~~--a~~l~sh~~lk~vki~qNgIrpegv~~L~--------------------~~gl~y~~~LevLDlq 222 (388)
T COG5238 165 GRNRLENGSKELS--AALLESHENLKEVKIQQNGIRPEGVTMLA--------------------FLGLFYSHSLEVLDLQ 222 (388)
T ss_pred ccchhccCcHHHH--HHHHHhhcCceeEEeeecCcCcchhHHHH--------------------HHHHHHhCcceeeecc
Confidence 6666544332211 11122223445555555544322111111 1123445566666666
Q ss_pred ccccccc----CCcCCCCCCCCCeEecccCccccccCccc----c--CCCCCCeEecCCcccc
Q 042887 395 YNQLTGT----IPHAIGELKNLQGLALVRNSLRGTIPDTL----G--NLTLLNRLFLGFNNLQ 447 (628)
Q Consensus 395 ~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~--~l~~L~~L~L~~N~l~ 447 (628)
.|-++-. ...+++.++.|+.|.+.+|-++.....++ . ..++|..|-..+|.+.
T Consensus 223 DNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 223 DNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred ccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 6655421 22345666677777777776664333222 1 2356666666666654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.7e-07 Score=85.83 Aligned_cols=185 Identities=16% Similarity=0.179 Sum_probs=100.7
Q ss_pred CcccEEEccCCcccccc-chhhh-CCCCCCEEecccCcCcc--cccccccCCCCCCEeecccccCcccCCcCccCCCCCC
Q 042887 162 LKLEMIDVGDNQLIGKF-PDFIA-NFSALEAIDISANMLGG--RIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~-~~~~~-~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 237 (628)
+.++.|-+.+..|-..- ...|+ ..+.++++||..|.|+. .+...+.+++.|++|+|+.|.+...+...-..+.+|+
T Consensus 45 ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~ 124 (418)
T KOG2982|consen 45 RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLR 124 (418)
T ss_pred cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceE
Confidence 34445555555443221 12232 45778888888888762 1222346788888888888887743322224667888
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccc--cccccCC-CCCCEEEcccccceee--cccccccCCCCCEE
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL--PHSFSNA-SNLQVLDVYKNHFSGQ--VKIDFNRLSNLSRL 312 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l-~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L 312 (628)
+|-|.+..+...--......+|.++.|.+|.|.+.... ....... +.+++|....|...-- ....-..++++..+
T Consensus 125 ~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv 204 (418)
T KOG2982|consen 125 VLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSV 204 (418)
T ss_pred EEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchhe
Confidence 88888887765444444556777788888877544211 1111111 2444444444422100 00011224677777
Q ss_pred EccCCcCCCcCCCCccccccccCCCCCceeecccCCccc
Q 042887 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351 (628)
Q Consensus 313 ~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~ 351 (628)
.+..|.+.+.... .....++.+..|+|+.|++..
T Consensus 205 ~v~e~PlK~~s~e-----k~se~~p~~~~LnL~~~~ids 238 (418)
T KOG2982|consen 205 FVCEGPLKTESSE-----KGSEPFPSLSCLNLGANNIDS 238 (418)
T ss_pred eeecCcccchhhc-----ccCCCCCcchhhhhccccccc
Confidence 7777777654332 223334455566666666643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.5e-07 Score=98.18 Aligned_cols=99 Identities=23% Similarity=0.403 Sum_probs=81.8
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECC-------CCcEEEEEEeecc-ccchhhhHHHHHHHHhhcC-CCCcccccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGE-------TGTTVAVKVMNLK-QKGAAKSFVTECEALSNVR-HRNLIKIIT 112 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~ 112 (628)
.++...++..+.+.+|+|+||.||+|.... ....||||..+.. ...+.+.+.+|+++|+.+. |+||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 456666677777899999999999998431 1346999998754 3346678999999999994 999999999
Q ss_pred eeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+|+. ....++|+|||..|+|.+|++..+
T Consensus 370 ~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r 397 (609)
T KOG0200|consen 370 ACTQ-----DGPLYVIVEYAEHGDLLEFLRKKR 397 (609)
T ss_pred eecc-----CCceEEEEEeccCCcHHHHHHhcc
Confidence 9875 678899999999999999998777
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-07 Score=88.04 Aligned_cols=112 Identities=17% Similarity=0.199 Sum_probs=54.0
Q ss_pred ccCCCCCCEeecccccCcccCC-cCcc-CCCCCCEEEeecccCcccC-ChhhhhCCCCCcEEecccCcccccccccccCC
Q 042887 206 LCQLRSLNYLSISENNFSCKLP-LSIW-NISSLEIISLHSNRFEGSL-PLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNA 282 (628)
Q Consensus 206 ~~~l~~L~~L~Ls~N~i~~~~p-~~~~-~l~~L~~L~L~~n~l~~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 282 (628)
+..+.-++.|.+.++.|..+.. ..|+ ..+.+++|||.+|.|++-- -..+...+|.|++|+++.|++...+-..-..+
T Consensus 41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~ 120 (418)
T KOG2982|consen 41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL 120 (418)
T ss_pred eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence 3344445556665555542221 1122 3456677777777765200 01122346666666666666653322211345
Q ss_pred CCCCEEEcccccceeecc-cccccCCCCCEEEccCC
Q 042887 283 SNLQVLDVYKNHFSGQVK-IDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 283 ~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n 317 (628)
.+|+.|-|.+..+.-... ..+..+|.+++|+++.|
T Consensus 121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N 156 (418)
T KOG2982|consen 121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDN 156 (418)
T ss_pred cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccc
Confidence 566666666655432211 12334555555555555
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-08 Score=93.76 Aligned_cols=181 Identities=15% Similarity=0.144 Sum_probs=126.5
Q ss_pred CcccEEEccCCccccc-cchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeeccccc-CcccCC-cCccCCCCCCE
Q 042887 162 LKLEMIDVGDNQLIGK-FPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENN-FSCKLP-LSIWNISSLEI 238 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-i~~~~p-~~~~~l~~L~~ 238 (628)
++|+.||||+..|+.. ....+..+++|+.|.|.++++.+.+...++.-.+|+.|+|+.+. ++.... --+.+++.|..
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 4699999999998743 33456789999999999999998888899999999999999864 442211 22578999999
Q ss_pred EEeecccCcccCCh-hhhhCCCCCcEEecccCccc---ccccccccCCCCCCEEEccccc-ceeecccccccCCCCCEEE
Q 042887 239 ISLHSNRFEGSLPL-NIGFNIPNVNFLSVGQNNFT---GSLPHSFSNASNLQVLDVYKNH-FSGQVKIDFNRLSNLSRLF 313 (628)
Q Consensus 239 L~L~~n~l~~~~~~-~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~ 313 (628)
|+|+.|.+....-. .+..--++|+.|+|++..=. ..+.--...+++|.+|||++|. ++......|.+++.|++|.
T Consensus 265 LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lS 344 (419)
T KOG2120|consen 265 LNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLS 344 (419)
T ss_pred cCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeee
Confidence 99999988643321 22223578888999886422 1222234578899999999874 4433444567788899999
Q ss_pred ccCCcCCCcCCCCccccccccCCCCCceeecccC
Q 042887 314 LSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTN 347 (628)
Q Consensus 314 L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n 347 (628)
++.|.. +.++ .+-.+...++|.+|++.+.
T Consensus 345 lsRCY~--i~p~---~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 345 LSRCYD--IIPE---TLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hhhhcC--CChH---HeeeeccCcceEEEEeccc
Confidence 888853 2322 2223455667777776554
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-06 Score=88.60 Aligned_cols=93 Identities=23% Similarity=0.272 Sum_probs=72.4
Q ss_pred CCCcCceeecCCceeEEEEEECCC--CcEEEEEEeecc--ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGET--GTTVAVKVMNLK--QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~--~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 123 (628)
+|++.+.||+|+||.||+|.+..+ ++.||+|.+... .....+.+.+|+++++++ .||||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 889999998643 222346688999999999 499999998875431 12335
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..|+++||+. ++|.+++..
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~ 98 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS 98 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc
Confidence 6788999886 578887754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=5.3e-08 Score=79.90 Aligned_cols=109 Identities=16% Similarity=0.302 Sum_probs=76.1
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
.+|+..+|++|.+....+..-..++.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..+..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 45777888888887554444456668888888888887 66777888888888888888887 57777777888888888
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCccccc
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 274 (628)
.+|.+. .+|.+.+. -.+.-..++.++.+.+.
T Consensus 131 ~~na~~-eid~dl~~-s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 131 PENARA-EIDVDLFY-SSLPALIKLGNEPLGDE 161 (177)
T ss_pred CCCccc-cCcHHHhc-cccHHHHHhcCCccccc
Confidence 888887 77777552 22222233444444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.3e-06 Score=80.07 Aligned_cols=84 Identities=29% Similarity=0.530 Sum_probs=72.2
Q ss_pred eecCCceeEEEEEECCCCcEEEEEEeeccccc-hhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccccc
Q 042887 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG-AAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKC 134 (628)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 134 (628)
||+|++|.||++....+++.+++|+....... ..+.+.+|+..++.++|++|+++++.+. .....++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 68999999999999877999999998765432 3467899999999999999999999854 35789999999999
Q ss_pred CCchhhhhcc
Q 042887 135 GSSEDWMHQS 144 (628)
Q Consensus 135 g~L~~~l~~~ 144 (628)
+++.+++...
T Consensus 76 ~~l~~~~~~~ 85 (215)
T cd00180 76 GSLKDLLKEN 85 (215)
T ss_pred CcHHHHHHhc
Confidence 9999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.7e-07 Score=95.31 Aligned_cols=92 Identities=20% Similarity=0.207 Sum_probs=65.9
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCC-cEEEEEEee--------------c---cccchhhhHHHHHHHHhhcCCCCc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETG-TTVAVKVMN--------------L---KQKGAAKSFVTECEALSNVRHRNL 107 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~-~~~avK~~~--------------~---~~~~~~~~~~~E~~~l~~l~h~nI 107 (628)
..++|++.+.||+|+||.||+|..+... ..++.|.+. + ........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998764332 222222111 0 011234568899999999999999
Q ss_pred ccccceeeeccccccceeeeeecccccCCchhhhhc
Q 042887 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 108 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
|++++++. ..+..|+++|++. +++.+++..
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~ 255 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKYD-FDLYSFMYD 255 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhh
Confidence 99999854 4678899999986 467766643
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5e-07 Score=91.05 Aligned_cols=95 Identities=14% Similarity=0.181 Sum_probs=77.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeec--cccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~ 123 (628)
-..|++.+.||+||-++||++... +.+.||+|.+.. .+.+....|.+|+..|.+++ |-+||+++++... ++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 456999999999999999999984 456677776643 24566788999999999996 9999999999653 88
Q ss_pred eeeeeecccccCCchhhhhcccccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
+.||||||.+ -||..++.+.....
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~ 457 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSID 457 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCC
Confidence 9999999876 48888887766444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.8e-06 Score=78.37 Aligned_cols=79 Identities=18% Similarity=0.196 Sum_probs=57.6
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccc--h------------------------hhhHHHHHHHHhhcCCCC
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG--A------------------------AKSFVTECEALSNVRHRN 106 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n 106 (628)
.+.||+|+||.||+|.+. +|+.||||+++..... . ...+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999986 8999999999754210 0 112357889999999998
Q ss_pred cccccceeeeccccccceeeeeecccccCCchh
Q 042887 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSED 139 (628)
Q Consensus 107 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 139 (628)
|........ ...++||||++|+++..
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~ 106 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPA 106 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchh
Confidence 755444321 12489999999885543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.5e-06 Score=82.04 Aligned_cols=76 Identities=13% Similarity=0.024 Sum_probs=62.1
Q ss_pred CCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecccccCCch
Q 042887 59 GSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSE 138 (628)
Q Consensus 59 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 138 (628)
|.||.||++++..+++.||+|.+.... .+.+|...+....||||+++++.+. .....+++|||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 899999999999999999999987543 2334555555667999999999854 467899999999999999
Q ss_pred hhhhcc
Q 042887 139 DWMHQS 144 (628)
Q Consensus 139 ~~l~~~ 144 (628)
+++.+.
T Consensus 74 ~~l~~~ 79 (237)
T cd05576 74 SHISKF 79 (237)
T ss_pred HHHHHh
Confidence 988654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=5e-07 Score=82.78 Aligned_cols=84 Identities=23% Similarity=0.264 Sum_probs=67.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHH-HhhcCCCCcccccceeeeccccccceee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEA-LSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
+.+-...||.|+||.|++-.++.+|+..|||.++... .....++..|.+. |+.-..||||++++++. .++.-|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCcee
Confidence 3444567999999999999999999999999997653 3456788899885 55557999999999964 367779
Q ss_pred eeecccccCCch
Q 042887 127 LIYEYMKCGSSE 138 (628)
Q Consensus 127 lv~e~~~~g~L~ 138 (628)
+.||.|.- ++.
T Consensus 140 iCMELMd~-SlD 150 (361)
T KOG1006|consen 140 ICMELMDI-SLD 150 (361)
T ss_pred eeHHHHhh-hHH
Confidence 99999974 443
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.4e-08 Score=89.16 Aligned_cols=182 Identities=19% Similarity=0.147 Sum_probs=93.7
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccccc-ceeec-ccccccCCCCCEE
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH-FSGQV-KIDFNRLSNLSRL 312 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~-~~~~~~l~~L~~L 312 (628)
.||+|||+...|+..--..+...+.+|+.|.+.++++.+.+...+++-.+|+.|+++.+. ++... .--+..++.|.+|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 466666666655522122223345666666777777666666667777777777777653 22111 1124566677777
Q ss_pred EccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeee
Q 042887 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFG 392 (628)
Q Consensus 313 ~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 392 (628)
+++++.+...... .....+ -++|..|++++..-. +..+ .+..-...+++|..||
T Consensus 266 NlsWc~l~~~~Vt--v~V~hi--se~l~~LNlsG~rrn------------------l~~s----h~~tL~~rcp~l~~LD 319 (419)
T KOG2120|consen 266 NLSWCFLFTEKVT--VAVAHI--SETLTQLNLSGYRRN------------------LQKS----HLSTLVRRCPNLVHLD 319 (419)
T ss_pred CchHhhccchhhh--HHHhhh--chhhhhhhhhhhHhh------------------hhhh----HHHHHHHhCCceeeec
Confidence 7777665442111 000001 124444444443210 0000 0111234566677777
Q ss_pred ecccc-ccccCCcCCCCCCCCCeEecccCccccccCcc---ccCCCCCCeEecCCc
Q 042887 393 VEYNQ-LTGTIPHAIGELKNLQGLALVRNSLRGTIPDT---LGNLTLLNRLFLGFN 444 (628)
Q Consensus 393 l~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~N 444 (628)
++.|. ++......|..++.|++|.++.|.. .+|.. +...|+|.+|+..++
T Consensus 320 LSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 320 LSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred cccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 76653 2322233456677788888877754 34443 455677888877654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.2e-06 Score=88.17 Aligned_cols=89 Identities=17% Similarity=0.197 Sum_probs=64.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEee-cc-c------cchhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN-LK-Q------KGAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~-~~-~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
...|...+.||+|+||.||+|.+. ++.+++|... +. . ....+++.+|+++++.++|++++.....+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 445567889999999999999984 3344444322 11 1 1123568899999999999998876655432
Q ss_pred ccccceeeeeecccccCCchhhhh
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
....++||||++++++.+++.
T Consensus 408 ---~~~~~lv~E~~~g~~L~~~l~ 428 (535)
T PRK09605 408 ---PEEKTIVMEYIGGKDLKDVLE 428 (535)
T ss_pred ---CCCCEEEEEecCCCcHHHHHH
Confidence 446789999999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.3e-06 Score=78.70 Aligned_cols=80 Identities=28% Similarity=0.429 Sum_probs=68.9
Q ss_pred CceeEEEEEECCCCcEEEEEEeeccccch-hhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecccccCCch
Q 042887 60 SFGFVYKGKLGETGTTVAVKVMNLKQKGA-AKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSE 138 (628)
Q Consensus 60 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 138 (628)
+||.||+|.+..+|+.+|+|+........ .+.+.+|++.+++++|+||+++++.+.. ....++++||++++++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999998889999999997654433 6789999999999999999999998653 57889999999999999
Q ss_pred hhhhcc
Q 042887 139 DWMHQS 144 (628)
Q Consensus 139 ~~l~~~ 144 (628)
+++...
T Consensus 76 ~~~~~~ 81 (244)
T smart00220 76 DLLKKR 81 (244)
T ss_pred HHHHhc
Confidence 988654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.3e-06 Score=77.60 Aligned_cols=83 Identities=16% Similarity=0.189 Sum_probs=64.0
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeecccc--------chhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
+.||+|++|.||+|.+ .|..+++|....... .....+.+|++++..+.|++|.....++.. ....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence 5799999999999998 677899997643221 122457889999999999988766555432 4567
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
+++|||++|+++.+++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~ 92 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS 92 (211)
T ss_pred EEEEEEeCCcCHHHHHHh
Confidence 899999999999988754
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.2e-06 Score=72.38 Aligned_cols=59 Identities=25% Similarity=0.281 Sum_probs=28.1
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCc
Q 042887 187 ALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFE 247 (628)
Q Consensus 187 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~ 247 (628)
+...+||++|.+. .-+.|..++.|.+|.|++|.|+.+.|.--.-+++|+.|.|.+|+|.
T Consensus 43 ~~d~iDLtdNdl~--~l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~ 101 (233)
T KOG1644|consen 43 QFDAIDLTDNDLR--KLDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQ 101 (233)
T ss_pred ccceecccccchh--hcccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchh
Confidence 4445555555543 1223455555555555555555444433333444555555554443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.6e-06 Score=76.23 Aligned_cols=82 Identities=20% Similarity=0.282 Sum_probs=60.4
Q ss_pred eeecCCceeEEEEEECCCCcEEEEEEeeccc-c-------chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-K-------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.||+|+||.||+|.+ +|+.+++|...... . ...+++.+|++++..+.|+++......+. .....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 389999999999996 67889999864321 1 12356788999999998877554433322 245568
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
++|||++|+++.+.+..
T Consensus 74 lv~e~~~g~~l~~~~~~ 90 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE 90 (199)
T ss_pred EEEEEECCccHHHHHhh
Confidence 99999999999887754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.2e-06 Score=72.05 Aligned_cols=106 Identities=15% Similarity=0.238 Sum_probs=65.3
Q ss_pred CCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccc-cccccCCCCCCEE
Q 042887 210 RSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL-PHSFSNASNLQVL 288 (628)
Q Consensus 210 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L 288 (628)
.+...+||++|.+. --+.|..++.|.+|.|.+|.|+ .|...+...+++|+.|.|.+|.|.... -..++.++.|++|
T Consensus 42 d~~d~iDLtdNdl~--~l~~lp~l~rL~tLll~nNrIt-~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~L 118 (233)
T KOG1644|consen 42 DQFDAIDLTDNDLR--KLDNLPHLPRLHTLLLNNNRIT-RIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYL 118 (233)
T ss_pred cccceecccccchh--hcccCCCccccceEEecCCcce-eeccchhhhccccceEEecCcchhhhhhcchhccCCcccee
Confidence 34566777777765 2334666777777777777776 666666555677777777777666321 1235566777777
Q ss_pred Ecccccceeec---ccccccCCCCCEEEccCCc
Q 042887 289 DVYKNHFSGQV---KIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 289 ~L~~N~i~~~~---~~~~~~l~~L~~L~L~~n~ 318 (628)
.+-+|.++... .-.+..+++|+.||...-.
T Consensus 119 tll~Npv~~k~~YR~yvl~klp~l~~LDF~kVt 151 (233)
T KOG1644|consen 119 TLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKVT 151 (233)
T ss_pred eecCCchhcccCceeEEEEecCcceEeehhhhh
Confidence 77777664321 1234567777777776543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.03 E-value=1e-05 Score=77.17 Aligned_cols=87 Identities=14% Similarity=0.080 Sum_probs=61.6
Q ss_pred CCCCcCceeecCCceeEEEEE-ECCCCcEEEEEEeeccccc------------------------hhhhHHHHHHHHhhc
Q 042887 48 NNFSASNMIGQGSFGFVYKGK-LGETGTTVAVKVMNLKQKG------------------------AAKSFVTECEALSNV 102 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~-~~~~~~~~avK~~~~~~~~------------------------~~~~~~~E~~~l~~l 102 (628)
..|++.+.||+|+||.||+|. +..+|+.||+|+++..... ....+.+|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999999 6678999999998753210 012356899999999
Q ss_pred CCCCcccccceeeeccccccceeeeeecccccCCchhhh
Q 042887 103 RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 103 ~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 141 (628)
.+.. +.+..... ....++||||++++++....
T Consensus 108 ~~~~-i~~p~~~~------~~~~~lV~E~~~g~~L~~~~ 139 (237)
T smart00090 108 YEAG-VPVPKPIA------WRRNVLVMEFIGGDGLPAPR 139 (237)
T ss_pred HhcC-CCCCeeeE------ecCceEEEEEecCCcccccc
Confidence 7532 22222211 12358999999998876554
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.3e-05 Score=68.66 Aligned_cols=123 Identities=22% Similarity=0.238 Sum_probs=43.7
Q ss_pred hhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCC
Q 042887 180 DFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIP 259 (628)
Q Consensus 180 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~ 259 (628)
.+|.++++|+.+.+.. .+..+...+|..+++|+.+.+.++ +......+|.++++|+.+.+.. .+. .++...+...+
T Consensus 6 ~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~-~i~~~~F~~~~ 81 (129)
T PF13306_consen 6 NAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLK-SIGDNAFSNCT 81 (129)
T ss_dssp TTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT--EE-TTTTTT-T
T ss_pred HHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccc-ccccccccccc
Confidence 3444555555555543 344444445555555555555443 4434444455554555555543 332 34444444445
Q ss_pred CCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCC
Q 042887 260 NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNL 309 (628)
Q Consensus 260 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 309 (628)
+|+.+++..+ +..+....|.+. +|+.+.+.. .+..+....|.++++|
T Consensus 82 ~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 82 NLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp TECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 5555555443 333344445444 555555443 3333344444444443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.6e-06 Score=56.02 Aligned_cols=16 Identities=31% Similarity=0.567 Sum_probs=5.9
Q ss_pred cCCCCCCEEECCCCcc
Q 042887 531 KTLKSIKELDLSRNNL 546 (628)
Q Consensus 531 ~~l~~L~~L~Ls~N~l 546 (628)
+++++|+.|++++|+|
T Consensus 21 ~~l~~L~~L~l~~N~i 36 (44)
T PF12799_consen 21 SNLPNLETLNLSNNPI 36 (44)
T ss_dssp TTCTTSSEEEETSSCC
T ss_pred hCCCCCCEEEecCCCC
Confidence 3333333333333333
|
... |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.6e-07 Score=81.05 Aligned_cols=94 Identities=21% Similarity=0.301 Sum_probs=72.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+.+..+.||-|+||+||.+.++.+|+.||.|.+... .-...+++.+|+.++...+|.||+..++.-...........
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4566778999999999999999999999999988643 23455789999999999999999999888544222233456
Q ss_pred eeeecccccCCchhhhh
Q 042887 126 ALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~ 142 (628)
|.++|.+. .||+..|-
T Consensus 133 YV~TELmQ-SDLHKIIV 148 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIV 148 (449)
T ss_pred HHHHHHHH-hhhhheec
Confidence 77778775 36665553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.4e-07 Score=88.10 Aligned_cols=95 Identities=16% Similarity=0.274 Sum_probs=79.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..+++....+|-|+||.|=.+........+|+|++++. +....+.+..|-.+|.+.+.|.||++|.. |.+.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccch
Confidence 35667778899999999999888655556899998764 34455678899999999999999999998 56699
Q ss_pred eeeeeecccccCCchhhhhcccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
+.||.||-|-||++...+++++.
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~ 516 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGS 516 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCC
Confidence 99999999999999999987763
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2e-06 Score=93.62 Aligned_cols=200 Identities=20% Similarity=0.223 Sum_probs=114.4
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccc-------------cccc--cCCCCCCEeecccccCcc-cC
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRI-------------PDSL--CQLRSLNYLSISENNFSC-KL 226 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------------~~~~--~~l~~L~~L~Ls~N~i~~-~~ 226 (628)
+++..++.+.......-+.+.... |++|.|.+-...... ...+ ..-.+|++||+++...-. .-
T Consensus 61 ~ltki~l~~~~~~~~~~~~l~~~~-L~sl~LGnl~~~k~~~~~~~~idi~~lL~~~Ln~~sr~nL~~LdI~G~~~~s~~W 139 (699)
T KOG3665|consen 61 NLTKIDLKNVTLQHQTLEMLRKQD-LESLKLGNLDKIKQDYLDDATIDIISLLKDLLNEESRQNLQHLDISGSELFSNGW 139 (699)
T ss_pred eeEEeeccceecchhHHHHHhhcc-ccccCCcchHhhhhhhhhhhhccHHHHHHHHHhHHHHHhhhhcCccccchhhccH
Confidence 466666666666544444444444 677766643221100 0000 112578888887765321 11
Q ss_pred CcCcc-CCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccccccee-ecccccc
Q 042887 227 PLSIW-NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG-QVKIDFN 304 (628)
Q Consensus 227 p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~ 304 (628)
|..++ .+|+|+.|.+++=.+...=-..++.++|+|..||+|+.+++.. ..++.+++|+.|.+.+=.+.. ..-..+.
T Consensus 140 ~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF 217 (699)
T KOG3665|consen 140 PKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLF 217 (699)
T ss_pred HHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHh
Confidence 22232 4788888888876664221234455688888888888888754 567788888888887766543 1223456
Q ss_pred cCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhcccccc
Q 042887 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKIT 365 (628)
Q Consensus 305 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~ 365 (628)
.+++|+.||+|.........-.-.+...-..+|+|+.||.++..+.......+-...++|+
T Consensus 218 ~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~le~ll~sH~~L~ 278 (699)
T KOG3665|consen 218 NLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEILEELLNSHPNLQ 278 (699)
T ss_pred cccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHHHHHHHHhCccHh
Confidence 6888888888877654432111112223344677778887777776655555544333333
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.95 E-value=9.7e-06 Score=53.94 Aligned_cols=36 Identities=36% Similarity=0.541 Sum_probs=16.3
Q ss_pred CCcEEecccCcccccccccccCCCCCCEEEcccccce
Q 042887 260 NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFS 296 (628)
Q Consensus 260 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 296 (628)
+|++|++++|+|+. +|..++++++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence 34444444444442 2333455555555555555544
|
... |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.5e-06 Score=83.85 Aligned_cols=119 Identities=17% Similarity=0.219 Sum_probs=83.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-----C---CCcccccceeeecc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-----H---RNLIKIITVCSSID 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~~~ 118 (628)
...|.+.+.+|.|.|++||+|.+..+.++||+|+++.. ....+....||.+|++++ | .+||++++.+.-.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs- 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS- 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence 36788899999999999999999999999999998754 334567789999999884 2 4799999986531
Q ss_pred ccccceeeeeecccccCCchhhhhccc-cccccccCCccccCCcCcccEEE
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN-DKLEAGNLGLIQRLNLLKLEMID 168 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~l~~L~~L~ 168 (628)
-.....++||+|+.- -.|..+|.... ..++...+-.++..-|..|.+|+
T Consensus 155 GpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH 204 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH 204 (590)
T ss_pred CCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH
Confidence 234578899999863 35666766544 33333333334443334444433
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.3e-05 Score=77.60 Aligned_cols=134 Identities=18% Similarity=0.302 Sum_probs=61.1
Q ss_pred hccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCc-ccccccCCcccCCcchh
Q 042887 383 KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFN-NLQGNVPSSLGNCQNLM 461 (628)
Q Consensus 383 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~ 461 (628)
..+.+++.|++++|.++ .+|. -..+|++|.++++.--...|..+ .++|++|++++| .+. ..|.. |
T Consensus 49 ~~~~~l~~L~Is~c~L~-sLP~---LP~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~-sLP~s------L- 114 (426)
T PRK15386 49 EEARASGRLYIKDCDIE-SLPV---LPNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEIS-GLPES------V- 114 (426)
T ss_pred HHhcCCCEEEeCCCCCc-ccCC---CCCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccc-ccccc------c-
Confidence 33455566666666555 2231 12346666666533222444433 245666666665 333 23322 2
Q ss_pred cccceEEcCCCcCcc--ccchhhhccCCCCEeeCcCCc-Ccc-cCCccccCCCCCCeEECcCceeeeecCccccCCCCCC
Q 042887 462 TLSRLLDLSGNLLGG--SIPLEVGNLRNLAEFDLSENH-FSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIK 537 (628)
Q Consensus 462 ~l~~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 537 (628)
+.|+++++.... .+| ++|+.|.+.+++ ... ..|..+ .++|++|++++|... ..|..+. .+|+
T Consensus 115 ---e~L~L~~n~~~~L~~LP------ssLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i-~LP~~LP--~SLk 180 (426)
T PRK15386 115 ---RSLEIKGSATDSIKNVP------NGLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNI-ILPEKLP--ESLQ 180 (426)
T ss_pred ---ceEEeCCCCCcccccCc------chHhheecccccccccccccccc--CCcccEEEecCCCcc-cCccccc--ccCc
Confidence 445555544321 122 234555553322 110 011111 146677777666654 3343332 4666
Q ss_pred EEECCCC
Q 042887 538 ELDLSRN 544 (628)
Q Consensus 538 ~L~Ls~N 544 (628)
.|+++.|
T Consensus 181 ~L~ls~n 187 (426)
T PRK15386 181 SITLHIE 187 (426)
T ss_pred EEEeccc
Confidence 6666665
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.6e-05 Score=85.87 Aligned_cols=96 Identities=18% Similarity=0.260 Sum_probs=63.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCC----CcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeee-cccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGET----GTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSS-IDFK 120 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~ 120 (628)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .+.+..| .+....+.++..+...+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999888 89999998754321 1112222 1222223333333222111 0013
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++|+||+.+++|.+++....
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~ 230 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKE 230 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcC
Confidence 4678899999999999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=97.88 E-value=3.3e-05 Score=71.78 Aligned_cols=84 Identities=24% Similarity=0.148 Sum_probs=60.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc----------------------chhhhHHHHHHHHhhcCCC
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK----------------------GAAKSFVTECEALSNVRHR 105 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~ 105 (628)
..|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|..++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 34888899999999999999884 799999998764320 0112356788888888777
Q ss_pred Cc--ccccceeeeccccccceeeeeecccccCCchhhh
Q 042887 106 NL--IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 106 nI--v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 141 (628)
++ ...++ ....+++|||++++++.+..
T Consensus 94 ~i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~ 122 (198)
T cd05144 94 GFPVPKPID---------WNRHAVVMEYIDGVELYRVR 122 (198)
T ss_pred CCCCCceee---------cCCceEEEEEeCCcchhhcc
Confidence 43 33322 23458999999998886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.1e-05 Score=79.17 Aligned_cols=93 Identities=27% Similarity=0.378 Sum_probs=78.8
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECC---CCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGE---TGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSID 118 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 118 (628)
.....+.|...+.||+|.|+.||+|.+.. ..+.||+|.+...+. ..++.+|+++|..+. +.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh-----
Confidence 44556789999999999999999999877 678999999976543 467899999999995 8999999998
Q ss_pred ccccceeeeeecccccCCchhhhh
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
+...+...+|+||.+.-+..++..
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~ 127 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR 127 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh
Confidence 667899999999999877776654
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.84 E-value=3.7e-05 Score=65.91 Aligned_cols=124 Identities=19% Similarity=0.206 Sum_probs=76.3
Q ss_pred cccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCC
Q 042887 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISS 235 (628)
Q Consensus 156 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~ 235 (628)
..+.+.++|+.+.+.. .+..+...+|.++++|+.+.+..+ +..+...+|.++++|+.+.+.+ .+.......|..+++
T Consensus 6 ~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~ 82 (129)
T PF13306_consen 6 NAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTN 82 (129)
T ss_dssp TTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TT
T ss_pred HHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccccccccc
Confidence 3456777899999885 677777888999999999999885 7767778899998999999976 555466778888999
Q ss_pred CCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCC
Q 042887 236 LEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQ 286 (628)
Q Consensus 236 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 286 (628)
|+.+++..+ +. .++...+... +|+.+.+.. .++.+....|.++++|+
T Consensus 83 l~~i~~~~~-~~-~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l~ 129 (129)
T PF13306_consen 83 LKNIDIPSN-IT-EIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKLK 129 (129)
T ss_dssp ECEEEETTT--B-EEHTTTTTT--T--EEE-TT-B-SS----GGG------
T ss_pred ccccccCcc-cc-EEchhhhcCC-CceEEEECC-CccEECCccccccccCC
Confidence 999999876 65 7778888776 999999886 55556777888887774
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=8.4e-05 Score=74.71 Aligned_cols=137 Identities=15% Similarity=0.143 Sum_probs=80.4
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccc-cCcccCCcCccCCCCCC
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN-NFSCKLPLSIWNISSLE 237 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~ 237 (628)
..+.+++.|++++|.++. +|. --.+|++|.++++.--...|+.+. ++|++|++++| .+. .+| .+|+
T Consensus 49 ~~~~~l~~L~Is~c~L~s-LP~---LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP------~sLe 115 (426)
T PRK15386 49 EEARASGRLYIKDCDIES-LPV---LPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLP------ESVR 115 (426)
T ss_pred HHhcCCCEEEeCCCCCcc-cCC---CCCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-ccc------cccc
Confidence 345678899999988774 452 224689999987443336666553 57889999888 554 445 3477
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCccc-c-cccccccCCCCCCEEEcccccceeecccccccCCCCCEEEcc
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT-G-SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 315 (628)
.|+++.+... .++. -.++|+.|.+.+++.. . ..|..+ -++|++|++++|.... .|..+. .+|+.|.++
T Consensus 116 ~L~L~~n~~~-~L~~----LPssLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i~-LP~~LP--~SLk~L~ls 185 (426)
T PRK15386 116 SLEIKGSATD-SIKN----VPNGLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNII-LPEKLP--ESLQSITLH 185 (426)
T ss_pred eEEeCCCCCc-cccc----CcchHhheecccccccccccccccc--CCcccEEEecCCCccc-Cccccc--ccCcEEEec
Confidence 7777776643 2221 1235666766443211 0 111111 1568888888777542 233333 477778777
Q ss_pred CCc
Q 042887 316 KNN 318 (628)
Q Consensus 316 ~n~ 318 (628)
.+.
T Consensus 186 ~n~ 188 (426)
T PRK15386 186 IEQ 188 (426)
T ss_pred ccc
Confidence 653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.2e-05 Score=77.78 Aligned_cols=92 Identities=23% Similarity=0.367 Sum_probs=72.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC--CC----Ccccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR--HR----NLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~--h~----nIv~l~~~~~~~~~~ 120 (628)
..+|.+.+.+|+|.||+|..+.+.+++..||+|+++...+ ..++..-|+++++++. .| -+|++.++ |+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 6789999999999999999999999999999999976433 3456678999999994 23 24555555 56
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..+..++|+|.+ |-++.++++.++
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~ 185 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENN 185 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCC
Confidence 688899999987 348889987644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=1e-05 Score=76.85 Aligned_cols=99 Identities=18% Similarity=0.294 Sum_probs=75.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
-.|.+.+.||+|+||+.+.|...-++++||||.-...+ .+.+...|.+..+.+. .+.|.+++.+. .....-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhh
Confidence 47999999999999999999999999999999876543 3456677777777664 68888887763 3466778
Q ss_pred eeecccccCCchhhhhccccccccccCC
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEAGNLG 154 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (628)
||+|.. |-+|++.+.-.+.......+.
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~ 127 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVA 127 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHH
Confidence 899975 568888887766666544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=5.3e-05 Score=68.82 Aligned_cols=96 Identities=21% Similarity=0.306 Sum_probs=71.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCC-CCcccccceeeeccccccce
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRH-RNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~ 124 (628)
...+|.+.+.||.|+||.+|.|....+|+.||||.-+... ...+...|..+..-+++ ..|..+..+ ..+...
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 3578999999999999999999999999999999865432 23567788888777764 455555444 234677
Q ss_pred eeeeecccccCCchhhhhccccccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
..+|||.. |-+|++.+.-.....+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ft 109 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFT 109 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhh
Confidence 78999975 5688887765554444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=4.1e-05 Score=67.91 Aligned_cols=93 Identities=15% Similarity=0.225 Sum_probs=72.0
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
...+.++......||+|+||.|-+-++..+|...|+|.+... ..+..++..+|+++..+. ..|.+|.++++ +.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hh
Confidence 344445556667899999999999999999999999999754 334556788899875544 69999999998 44
Q ss_pred ccceeeeeecccccCCchhhh
Q 042887 121 GVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l 141 (628)
.+...++.||.|.. ++..+-
T Consensus 116 regdvwIcME~M~t-Sldkfy 135 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFY 135 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHH
Confidence 58889999999974 454443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=2.3e-05 Score=83.24 Aligned_cols=83 Identities=28% Similarity=0.365 Sum_probs=66.4
Q ss_pred CcCceeecCCcee-EEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceeeee
Q 042887 51 SASNMIGQGSFGF-VYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 51 ~~~~~iG~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
.-.+++|.|+-|+ ||+|.+ .|+.||||++-... .....||+..++.-+ |||||+++.... +..+.|+.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~-----d~qF~YIa 581 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQ-----DRQFLYIA 581 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeecc-----CCceEEEE
Confidence 3346788888765 599999 78899999875432 345679999998885 999999998754 48899999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
.|.|.+ +|.+++...
T Consensus 582 lELC~~-sL~dlie~~ 596 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESS 596 (903)
T ss_pred ehHhhh-hHHHHHhcc
Confidence 999986 899999775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00011 Score=64.66 Aligned_cols=80 Identities=13% Similarity=0.150 Sum_probs=62.5
Q ss_pred cCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCC--CCcccccceeeeccccccceeeeee
Q 042887 52 ASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRH--RNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.+.+|+|.++.||++... ++.+++|....... ...+.+|+.++..+.| ..+.+++... ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 3577999999999999983 47899998865433 4678899999999976 4777777663 3346789999
Q ss_pred cccccCCchhh
Q 042887 130 EYMKCGSSEDW 140 (628)
Q Consensus 130 e~~~~g~L~~~ 140 (628)
||++++.+..+
T Consensus 73 e~~~g~~~~~~ 83 (155)
T cd05120 73 EWIEGETLDEV 83 (155)
T ss_pred EecCCeecccC
Confidence 99998877643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=3.2e-05 Score=71.48 Aligned_cols=99 Identities=18% Similarity=0.251 Sum_probs=72.8
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
.+....+|.|+.|.||+++++.+|...|||.+.+.. ....+++...++++..-. .|.||+.++++. .+...++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~I 168 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFI 168 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHH
Confidence 344566999999999999999999999999998753 455678888888776664 899999999955 4677888
Q ss_pred eecccccCCchhhhhccccccccccCC
Q 042887 128 IYEYMKCGSSEDWMHQSNDKLEAGNLG 154 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (628)
.||.|.- -.+..+++....+++..+|
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilG 194 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILG 194 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhh
Confidence 9998753 2333444333344443333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=3.4e-05 Score=77.74 Aligned_cols=92 Identities=18% Similarity=0.259 Sum_probs=70.2
Q ss_pred CCCcCceeecCCceeEEEEEECCCC-cEEEEEEeeccccchhhhHHHHHHHHhhcCC----CCcccccceeeeccccccc
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETG-TTVAVKVMNLKQKGAAKSFVTECEALSNVRH----RNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~~~~~~~~~~ 123 (628)
.|.+.+.||+|+||.||.|.+..++ +.+|+|............+..|..++..+.. +++.++++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987664 5789998876544333377888888888863 57778877731 3467
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+.|+||+.+ |.+|.+......
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~ 115 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP 115 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC
Confidence 889999976 568888765444
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00018 Score=71.61 Aligned_cols=93 Identities=16% Similarity=0.274 Sum_probs=58.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCC---CcEEEEEEeeccccch-----------hhhHHHHHHHHhhcCCCCcccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQKGA-----------AKSFVTECEALSNVRHRNLIKIIT 112 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~ 112 (628)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999999777 6677887654332111 011223334556678999999998
Q ss_pred eeeeccccccceeeeeecccccCCchhhh
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 141 (628)
++... .......++++|++.. ++.+.+
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 117 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKLVE-NTKEIF 117 (294)
T ss_pred eeeEe-cCCceEEEEEEehhcc-CHHHHH
Confidence 75431 0111245667776543 344333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00028 Score=64.57 Aligned_cols=80 Identities=10% Similarity=-0.009 Sum_probs=59.1
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEEEEeeccccch----hhhHHHHHHHHhhcC-CCCcccccceeeecccccccee
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA----AKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+...+++|+||+||.+.. .+..++.+.+.....+. ...+.+|+++|+++. |++|++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 3557899999999997766 56777766665433211 125789999999996 5888888775 235
Q ss_pred eeeecccccCCchhhh
Q 042887 126 ALIYEYMKCGSSEDWM 141 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l 141 (628)
+++|||+.|.+|.+..
T Consensus 74 ~lvmeyI~G~~L~~~~ 89 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP 89 (218)
T ss_pred EEEEeeecCccHHhhh
Confidence 8999999998886543
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=6e-05 Score=82.34 Aligned_cols=162 Identities=18% Similarity=0.205 Sum_probs=106.9
Q ss_pred hCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccC--C-----------cCc--cCCCCCCEEEeecccCc
Q 042887 183 ANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKL--P-----------LSI--WNISSLEIISLHSNRFE 247 (628)
Q Consensus 183 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--p-----------~~~--~~l~~L~~L~L~~n~l~ 247 (628)
...-++...++.+.......-....... |+.|.|.+-...... . ..+ ..-.+|++||+++...-
T Consensus 57 ~~~f~ltki~l~~~~~~~~~~~~l~~~~-L~sl~LGnl~~~k~~~~~~~~idi~~lL~~~Ln~~sr~nL~~LdI~G~~~~ 135 (699)
T KOG3665|consen 57 IRKFNLTKIDLKNVTLQHQTLEMLRKQD-LESLKLGNLDKIKQDYLDDATIDIISLLKDLLNEESRQNLQHLDISGSELF 135 (699)
T ss_pred hhhheeEEeeccceecchhHHHHHhhcc-ccccCCcchHhhhhhhhhhhhccHHHHHHHHHhHHHHHhhhhcCccccchh
Confidence 3444667777776665533333344444 777777654322100 0 001 12357999999987643
Q ss_pred -ccCChhhhhCCCCCcEEecccCccccc-ccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCC
Q 042887 248 -GSLPLNIGFNIPNVNFLSVGQNNFTGS-LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTS 325 (628)
Q Consensus 248 -~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 325 (628)
..-|..++..+|+|+.|.+++=.+... ......++++|..||+|+.+++.. ..++.+++|+.|.+.+-.+..
T Consensus 136 s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~---- 209 (699)
T KOG3665|consen 136 SNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFES---- 209 (699)
T ss_pred hccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCc----
Confidence 233556677799999999998766532 234467889999999999999855 457788999999888766643
Q ss_pred CccccccccCCCCCceeecccCCcccc
Q 042887 326 DLDFLTLLTNCSQMEMLYLNTNKFGGV 352 (628)
Q Consensus 326 ~~~~~~~l~~~~~L~~L~l~~n~~~~~ 352 (628)
......+.++++|+.||+|..+....
T Consensus 210 -~~~l~~LF~L~~L~vLDIS~~~~~~~ 235 (699)
T KOG3665|consen 210 -YQDLIDLFNLKKLRVLDISRDKNNDD 235 (699)
T ss_pred -hhhHHHHhcccCCCeeeccccccccc
Confidence 24455677888999999988876443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.45 E-value=7.6e-05 Score=77.28 Aligned_cols=92 Identities=21% Similarity=0.213 Sum_probs=75.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++.|.+...+|.|+|+.|-++.+..+++.+|+|++.+.. ..-.+|+.++... +||||++.++++ ++....
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 578899889999999999999999999999999997652 2234566666555 699999999995 458999
Q ss_pred eeeecccccCCchhhhhccccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
|+|||.+.||.+.+.+......
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~ 413 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEF 413 (612)
T ss_pred eeeehhccccHHHHHHHhcchh
Confidence 9999999999998877655433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00015 Score=76.71 Aligned_cols=35 Identities=26% Similarity=0.405 Sum_probs=30.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeec
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL 83 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~ 83 (628)
..|+. +.+|+|++|.||+|+.+.+|+.||||+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP 154 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRP 154 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCc
Confidence 45666 789999999999999987799999999964
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00026 Score=68.89 Aligned_cols=100 Identities=19% Similarity=0.329 Sum_probs=73.5
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCC-----cEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETG-----TTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCS 115 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 115 (628)
+....+.+++....+-+|.||.||+|.+++-. +.|-+|.++.. ++-+...+.+|.-.+..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 33445667888888999999999999886432 22445555332 3334567889999999999999999999876
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. +....+.++.++.-|.|..|+...+
T Consensus 358 e----~~~~P~V~y~~~~~gNLK~FL~~Cr 383 (563)
T KOG1024|consen 358 E----DYATPFVLYPATGVGNLKSFLQICR 383 (563)
T ss_pred e----ccCcceEEEeccCcchHHHHHHHhc
Confidence 3 4556677778888899999987433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00066 Score=62.36 Aligned_cols=31 Identities=35% Similarity=0.407 Sum_probs=27.0
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeecc
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK 84 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~ 84 (628)
.+.||+|+||.||+|.+. +|+.||||+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~ 32 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTG 32 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecC
Confidence 467999999999999986 7899999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0003 Score=78.22 Aligned_cols=92 Identities=23% Similarity=0.353 Sum_probs=66.9
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC---CCCcccccceeeecc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR---HRNLIKIITVCSSID 118 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 118 (628)
+.+...+.|.+.+.+|+|+||.||+|.... |+.||+|+-+....|. |.--.+++.+|+ -+.|..+..+..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~--- 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV--- 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc---
Confidence 334455789999999999999999999966 9999999987665543 222223455555 245555555532
Q ss_pred ccccceeeeeecccccCCchhhhh
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
..+.-++|+||.+.|+|.+++.
T Consensus 765 --~~~~S~lv~ey~~~Gtlld~~N 786 (974)
T KOG1166|consen 765 --FQNASVLVSEYSPYGTLLDLIN 786 (974)
T ss_pred --cCCcceeeeeccccccHHHhhc
Confidence 2556679999999999999987
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00023 Score=65.94 Aligned_cols=82 Identities=29% Similarity=0.371 Sum_probs=41.6
Q ss_pred hhccCCCCEeeCcCC--cCcccCCccccCCCCCCeEECcCceeeeecCcc---ccCCCCCCEEECCCCcccccCc---hh
Q 042887 482 VGNLRNLAEFDLSEN--HFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS---LKTLKSIKELDLSRNNLSGQIP---KY 553 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N--~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~~---~~ 553 (628)
|..+++|++|.+|.| ++.+..+.....+|+|++|++++|+|+. +.. +..+++|..||+.+|..+...- ..
T Consensus 61 ~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~--lstl~pl~~l~nL~~Ldl~n~~~~~l~dyre~v 138 (260)
T KOG2739|consen 61 FPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKD--LSTLRPLKELENLKSLDLFNCSVTNLDDYREKV 138 (260)
T ss_pred CCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccc--ccccchhhhhcchhhhhcccCCccccccHHHHH
Confidence 334556666666666 4444333334444666666666666652 222 3344556666666666553211 12
Q ss_pred hhcccCCCeEec
Q 042887 554 LENLLFLAYLNL 565 (628)
Q Consensus 554 ~~~l~~L~~L~l 565 (628)
|.-+++|++||-
T Consensus 139 f~ll~~L~~LD~ 150 (260)
T KOG2739|consen 139 FLLLPSLKYLDG 150 (260)
T ss_pred HHHhhhhccccc
Confidence 444555555443
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00037 Score=64.60 Aligned_cols=85 Identities=25% Similarity=0.228 Sum_probs=45.6
Q ss_pred CCcCeeeeccccccccCCcCCCCCCCCCeEecccC--ccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcc
Q 042887 386 VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRN--SLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTL 463 (628)
Q Consensus 386 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l 463 (628)
..|+.+++.+..++. -..|-.+++|+.|.++.| ++.+-++.....+++|+++++++|+|.. +.++..++.|..+
T Consensus 43 ~~le~ls~~n~gltt--~~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~--lstl~pl~~l~nL 118 (260)
T KOG2739|consen 43 VELELLSVINVGLTT--LTNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKD--LSTLRPLKELENL 118 (260)
T ss_pred cchhhhhhhccceee--cccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccc--ccccchhhhhcch
Confidence 344444444444431 123455667777777777 5554444444555777777777777752 4444444444333
Q ss_pred cceEEcCCCcCc
Q 042887 464 SRLLDLSGNLLG 475 (628)
Q Consensus 464 ~~~L~Ls~N~l~ 475 (628)
..|++.+|..+
T Consensus 119 -~~Ldl~n~~~~ 129 (260)
T KOG2739|consen 119 -KSLDLFNCSVT 129 (260)
T ss_pred -hhhhcccCCcc
Confidence 45555555544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0018 Score=65.23 Aligned_cols=88 Identities=28% Similarity=0.460 Sum_probs=71.7
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHhhcCCC-Ccccccceeeecccccccee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNVRHR-NLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~~~ 125 (628)
|.+.+.+|.|+||.||++.+. ..+|+|.+..... .....+.+|+..++.+.|+ +|+++.+... .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 677788999999999999996 7789999976532 2467899999999999988 7999988853 34557
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
+++++++.++++.+++....
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~ 93 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIG 93 (384)
T ss_pred EEEEecCCCCcHHHHHHhcc
Confidence 99999999999997665443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0013 Score=68.85 Aligned_cols=85 Identities=18% Similarity=0.162 Sum_probs=54.0
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccch----------------------------------------hhhH
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA----------------------------------------AKSF 92 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----------------------------------------~~~~ 92 (628)
.+.||.|++|.||+|+. .+|+.||||+.+..-... .-.|
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999998 478999999986431000 0024
Q ss_pred HHHHHHHhhcC----CCCcccccceeeeccccccceeeeeecccccCCchhhhh
Q 042887 93 VTECEALSNVR----HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 93 ~~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
.+|+..+.++. |..-+.+-.++. +.....++||||++|+++.+...
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~ 250 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAA 250 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHH
Confidence 45555555442 222222222221 12445789999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.88 E-value=7.1e-05 Score=69.44 Aligned_cols=82 Identities=17% Similarity=0.301 Sum_probs=40.9
Q ss_pred CCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeeccc-ccccCCCCCE
Q 042887 233 ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKI-DFNRLSNLSR 311 (628)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~ 311 (628)
+.+.+.|++-++.++ . ..+..+|+.|++|.||-|+|+.. ..|..+++|++|+|..|.|.++..- -+.++++|+.
T Consensus 18 l~~vkKLNcwg~~L~-D--Isic~kMp~lEVLsLSvNkIssL--~pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~ 92 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLD-D--ISICEKMPLLEVLSLSVNKISSL--APLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRT 92 (388)
T ss_pred HHHhhhhcccCCCcc-H--HHHHHhcccceeEEeeccccccc--hhHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhh
Confidence 344555666666655 2 23344566666666666666533 2344555555555555555433211 1234444555
Q ss_pred EEccCCcC
Q 042887 312 LFLSKNNL 319 (628)
Q Consensus 312 L~L~~n~l 319 (628)
|+|..|.-
T Consensus 93 LWL~ENPC 100 (388)
T KOG2123|consen 93 LWLDENPC 100 (388)
T ss_pred HhhccCCc
Confidence 55544443
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.68 E-value=7.9e-05 Score=69.13 Aligned_cols=100 Identities=20% Similarity=0.156 Sum_probs=55.6
Q ss_pred CCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCccccccc-ccccCCCCCCE
Q 042887 209 LRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLP-HSFSNASNLQV 287 (628)
Q Consensus 209 l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~ 287 (628)
+.+.+.|+.-++.+.++ .....++.|+.|.||-|+|+ .+... ..+++|++|+|..|.|.+... ..+.++++|+.
T Consensus 18 l~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIs-sL~pl--~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~ 92 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKIS-SLAPL--QRCTRLKELYLRKNCIESLDELEYLKNLPSLRT 92 (388)
T ss_pred HHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccc-cchhH--HHHHHHHHHHHHhcccccHHHHHHHhcCchhhh
Confidence 45566666666666532 22345666777777777766 33221 236667777777776664322 23566666777
Q ss_pred EEcccccceeeccc-----ccccCCCCCEEE
Q 042887 288 LDVYKNHFSGQVKI-----DFNRLSNLSRLF 313 (628)
Q Consensus 288 L~L~~N~i~~~~~~-----~~~~l~~L~~L~ 313 (628)
|.|..|.-.+..+. .+..+|+|+.||
T Consensus 93 LWL~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 93 LWLDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred HhhccCCcccccchhHHHHHHHHcccchhcc
Confidence 77766654433222 233456666554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0034 Score=55.10 Aligned_cols=79 Identities=16% Similarity=0.220 Sum_probs=57.6
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCccc-ccceeeeccccccceeeeee
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIK-IITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~~~~~~lv~ 129 (628)
...+.||+|.+|.||.|.+ .|..+|+|+-...+ ....+..|++++..+.-..+.. ++.+ +..++.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---------g~~~i~m 91 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---------GEDFIRM 91 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---------chhhhhh
Confidence 3457799999999999999 67789999865433 3467889999999887655543 3333 2334569
Q ss_pred cccccCCchhhhh
Q 042887 130 EYMKCGSSEDWMH 142 (628)
Q Consensus 130 e~~~~g~L~~~l~ 142 (628)
||..|-.|.+...
T Consensus 92 e~i~G~~L~~~~~ 104 (201)
T COG2112 92 EYIDGRPLGKLEI 104 (201)
T ss_pred hhhcCcchhhhhh
Confidence 9999877766544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0024 Score=64.70 Aligned_cols=96 Identities=17% Similarity=0.311 Sum_probs=73.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC------CCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR------HRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~~~ 119 (628)
.-..|.+....|+|-|+.|.+|.+...|..||||++..... -.+.=.+|+++|++|. ..|+++++.. |
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence 34567888889999999999999999999999999976432 1233468999999994 2478888777 5
Q ss_pred cccceeeeeecccccCCchhhhhcccccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
......+||+|-.. ..|.+.+++-+.+.
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nv 531 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNV 531 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCccc
Confidence 56788999999764 35777776665443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.011 Score=56.48 Aligned_cols=87 Identities=9% Similarity=0.036 Sum_probs=58.7
Q ss_pred ceee-cCCceeEEEEEECCCCcEEEEEEeeccc-------------cchhhhHHHHHHHHhhcCCCCc--ccccceeeec
Q 042887 54 NMIG-QGSFGFVYKGKLGETGTTVAVKVMNLKQ-------------KGAAKSFVTECEALSNVRHRNL--IKIITVCSSI 117 (628)
Q Consensus 54 ~~iG-~G~~g~V~~~~~~~~~~~~avK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 117 (628)
..+| .|+.|.||.+.. .+..+++|...... .....++.+|++++..+.|++| ++.++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888998887 47789999885311 1223567899999999998775 5555543210
Q ss_pred cccccceeeeeeccccc-CCchhhhhc
Q 042887 118 DFKGVDFKALIYEYMKC-GSSEDWMHQ 143 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~-g~L~~~l~~ 143 (628)
.......++|||+++| .++.+++.+
T Consensus 115 -~~~~~~~~lV~e~l~G~~~L~~~l~~ 140 (239)
T PRK01723 115 -HGLFYRADILIERIEGARDLVALLQE 140 (239)
T ss_pred -cCcceeeeEEEEecCCCCCHHHHHhc
Confidence 0011233599999997 688887753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.014 Score=55.14 Aligned_cols=85 Identities=13% Similarity=0.180 Sum_probs=60.2
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeecccc-chhhhHHHHHHHHhhcCCC--Ccccccceeeeccccccceeeeeec
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVRHR--NLIKIITVCSSIDFKGVDFKALIYE 130 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~~~~~~lv~e 130 (628)
+.+|.|.++.||++... +|+.+++|....... .....+.+|+++++.+.+. .+.+++....... .....+++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 56899999999999884 367899998765332 2345788999999998753 3455655532210 1135689999
Q ss_pred ccccCCchhhh
Q 042887 131 YMKCGSSEDWM 141 (628)
Q Consensus 131 ~~~~g~L~~~l 141 (628)
|++|+++.+.+
T Consensus 81 ~i~G~~l~~~~ 91 (223)
T cd05154 81 RVDGRVLRDRL 91 (223)
T ss_pred EeCCEecCCCC
Confidence 99998887654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.0012 Score=61.08 Aligned_cols=88 Identities=22% Similarity=0.446 Sum_probs=69.1
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
.+.-.+.+..-|..|+|++ .|..+++|++... .....+.|..|...++-..||||..++++|.+ .....++
T Consensus 193 nl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVII 265 (448)
T ss_pred hhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEe
Confidence 3445577888899999999 4555666766432 33455778888888888899999999999865 6778899
Q ss_pred ecccccCCchhhhhccc
Q 042887 129 YEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~~ 145 (628)
..||+.|+|+..++...
T Consensus 266 sq~mp~gslynvlhe~t 282 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQT 282 (448)
T ss_pred eeeccchHHHHHHhcCc
Confidence 99999999999887654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.002 Score=61.33 Aligned_cols=94 Identities=20% Similarity=0.250 Sum_probs=72.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeee-ccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSS-IDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~~~ 123 (628)
...|.-.+.+|.|+= .|..|.+.-.++.||+|.+... .....++..||...|..+.|+||++++.+++. -..+...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999987 7778888888999999988543 23456788999999999999999999998764 1123446
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
.+|+|||+|.. ++.+.+.
T Consensus 95 e~y~v~e~m~~-nl~~vi~ 112 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL 112 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH
Confidence 78999999974 5666554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.019 Score=51.64 Aligned_cols=76 Identities=12% Similarity=0.065 Sum_probs=54.1
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcc-cccceeeeccccccceeeeeeccc
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLI-KIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
+.++.|.++.||++.. .++.|++|....... ....+.+|+.+++.+.+..++ +++... ....++||||+
T Consensus 4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i 73 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFI 73 (170)
T ss_pred eecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEec
Confidence 5689999999999998 478899998754332 223567899999988654443 444331 22357999999
Q ss_pred ccCCchh
Q 042887 133 KCGSSED 139 (628)
Q Consensus 133 ~~g~L~~ 139 (628)
+|.++.+
T Consensus 74 ~G~~l~~ 80 (170)
T cd05151 74 EGSELLT 80 (170)
T ss_pred CCCcccc
Confidence 9988754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0473 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.00044 Score=62.60 Aligned_cols=88 Identities=18% Similarity=0.221 Sum_probs=72.8
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
.+....+.+.||++.|++.. .-..|+-++.+..||++.|.+. ..|..+.++..++.+++..|..+ ..|.+++..+.+
T Consensus 37 ei~~~kr~tvld~~s~r~vn-~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~k~~~~ 113 (326)
T KOG0473|consen 37 EIASFKRVTVLDLSSNRLVN-LGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHS-QQPKSQKKEPHP 113 (326)
T ss_pred hhhccceeeeehhhhhHHHh-hccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchh-hCCccccccCCc
Confidence 45566788899999998763 4455777888889999999887 78888999999999999888887 688889999999
Q ss_pred CEEEeecccCc
Q 042887 237 EIISLHSNRFE 247 (628)
Q Consensus 237 ~~L~L~~n~l~ 247 (628)
+++++-+|.+.
T Consensus 114 k~~e~k~~~~~ 124 (326)
T KOG0473|consen 114 KKNEQKKTEFF 124 (326)
T ss_pred chhhhccCcch
Confidence 99988888765
|
|
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.0012 Score=65.11 Aligned_cols=38 Identities=11% Similarity=0.290 Sum_probs=16.2
Q ss_pred CCCCCceeecccCC-cccccchHHHhccccccEEEccCC
Q 042887 335 NCSQMEMLYLNTNK-FGGVFLRSIANLSAKITVIGMGDN 372 (628)
Q Consensus 335 ~~~~L~~L~l~~n~-~~~~~~~~~~~~~~~L~~L~l~~n 372 (628)
++.+|+.+-+..++ |+......++.-...|+.+++..+
T Consensus 318 ~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~ 356 (483)
T KOG4341|consen 318 HCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEEC 356 (483)
T ss_pred CCCceEEEeccccchhhhhhhhhhhcCChhhhhhccccc
Confidence 44555565555553 333333333322223444444433
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.0086 Score=32.96 Aligned_cols=19 Identities=32% Similarity=0.590 Sum_probs=9.3
Q ss_pred ccEEEccCCccccccchhhh
Q 042887 164 LEMIDVGDNQLIGKFPDFIA 183 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~ 183 (628)
|++|||++|+++ .+|+.|+
T Consensus 2 L~~Ldls~n~l~-~ip~~~~ 20 (22)
T PF00560_consen 2 LEYLDLSGNNLT-SIPSSFS 20 (22)
T ss_dssp ESEEEETSSEES-EEGTTTT
T ss_pred ccEEECCCCcCE-eCChhhc
Confidence 455555555555 3443343
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.0093 Score=32.83 Aligned_cols=12 Identities=58% Similarity=1.077 Sum_probs=4.9
Q ss_pred CCeEECcCceee
Q 042887 512 LEYLHLQGNSFS 523 (628)
Q Consensus 512 L~~L~Ls~N~l~ 523 (628)
|++||+++|+++
T Consensus 2 L~~Ldls~n~l~ 13 (22)
T PF00560_consen 2 LEYLDLSGNNLT 13 (22)
T ss_dssp ESEEEETSSEES
T ss_pred ccEEECCCCcCE
Confidence 334444444444
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.0017 Score=64.04 Aligned_cols=84 Identities=12% Similarity=0.099 Sum_probs=41.6
Q ss_pred CCCCEEecccCcCccccc--ccccCCCCCCEeeccccc-CcccCCcCc-cCCCCCCEEEeecc-cCcccCChhhhhCCCC
Q 042887 186 SALEAIDISANMLGGRIP--DSLCQLRSLNYLSISENN-FSCKLPLSI-WNISSLEIISLHSN-RFEGSLPLNIGFNIPN 260 (628)
Q Consensus 186 ~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~-i~~~~p~~~-~~l~~L~~L~L~~n-~l~~~~~~~~~~~l~~ 260 (628)
..|+.|.+.+++-.+.-+ ..-...+++++|++.++. +++..-..+ ..+++|++|++..+ .++...-..+....++
T Consensus 138 g~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~k 217 (483)
T KOG4341|consen 138 GFLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRK 217 (483)
T ss_pred cccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhh
Confidence 457777777765332211 112456777777777665 111111111 23566677776663 3332222223344566
Q ss_pred CcEEecccC
Q 042887 261 VNFLSVGQN 269 (628)
Q Consensus 261 L~~L~L~~N 269 (628)
|++|+++.+
T Consensus 218 L~~lNlSwc 226 (483)
T KOG4341|consen 218 LKYLNLSWC 226 (483)
T ss_pred HHHhhhccC
Confidence 666666554
|
|
| >KOG4308 consensus LRR-containing protein [Function unknown] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.00018 Score=75.19 Aligned_cols=112 Identities=26% Similarity=0.250 Sum_probs=60.9
Q ss_pred CCCCCCeEecCCcccccccC----CcccCCcchhcccceEEcCCCcCcccc----chhhhcc-CCCCEeeCcCCcCcccC
Q 042887 432 NLTLLNRLFLGFNNLQGNVP----SSLGNCQNLMTLSRLLDLSGNLLGGSI----PLEVGNL-RNLAEFDLSENHFSNEI 502 (628)
Q Consensus 432 ~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~l~~~L~Ls~N~l~~~~----~~~~~~l-~~L~~L~Ls~N~l~~~~ 502 (628)
...++++|.+++|.++.... ..+...+.+ ...|++.+|++.+.. ...+..+ ..+++++++.|.|++..
T Consensus 202 ~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~---~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~ 278 (478)
T KOG4308|consen 202 PLSSLETLKLSRCGVTSSSCALLDEVLASGESL---LRELDLASNKLGDVGVEKLLPCLSVLSETLRVLDLSRNSITEKG 278 (478)
T ss_pred ccccHHHHhhhhcCcChHHHHHHHHHHhccchh---hHHHHHHhcCcchHHHHHHHHHhcccchhhhhhhhhcCCccccc
Confidence 35566666676666552111 112222221 144788888887441 2334444 56788888888887543
Q ss_pred Cc----cccCCCCCCeEECcCceeeeecC----ccccCCCCCCEEECCCCcc
Q 042887 503 PV----TLSACTTLEYLHLQGNSFSGSLP----LSLKTLKSIKELDLSRNNL 546 (628)
Q Consensus 503 ~~----~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l 546 (628)
.. .+..++.+++|.++.|.+....- ........+..+-+.++..
T Consensus 279 ~~~L~~~l~~~~~l~~l~l~~n~l~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 330 (478)
T KOG4308|consen 279 VRDLAEVLVSCRQLEELSLSNNPLTDYGVELLLEALERKTPLLHLVLGGTGK 330 (478)
T ss_pred hHHHHHHHhhhHHHHHhhcccCccccHHHHHHHHHhhhcccchhhhccccCc
Confidence 33 34456778888888888764221 1122234455555554443
|
|
| >KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.0058 Score=65.50 Aligned_cols=36 Identities=17% Similarity=0.128 Sum_probs=18.6
Q ss_pred CCCCCEEEeecccCcccCC-hhhhhCCCCCcEEeccc
Q 042887 233 ISSLEIISLHSNRFEGSLP-LNIGFNIPNVNFLSVGQ 268 (628)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~-~~~~~~l~~L~~L~L~~ 268 (628)
.+.|+.|.+.++.-...-. ..+....++|+.|++++
T Consensus 187 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~ 223 (482)
T KOG1947|consen 187 CPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSG 223 (482)
T ss_pred CchhhHhhhcccccCChhhHHHHHhhCchhheecccC
Confidence 5666777666653221111 12233466666666665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 628 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-22 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-20 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-22 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 628 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-118 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-101 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-45 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-21 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-57 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-47 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-45 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-06 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-62 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-61 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-60 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-62 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-60 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-60 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-58 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-34 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-26 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-19 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-56 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-55 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-51 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-48 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-43 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-35 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-32 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-50 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-47 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-46 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-43 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-26 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-07 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-52 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-49 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-45 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-43 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-35 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-27 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-37 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-28 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-07 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-27 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-34 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-31 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-35 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 8e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-10 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-27 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-27 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-15 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-10 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-32 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-18 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-28 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-08 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-31 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-25 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-09 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-30 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-09 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-30 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-30 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-24 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-17 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-17 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-26 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-17 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-19 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-09 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-09 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-28 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 6e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-24 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-20 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-20 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-09 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-05 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-05 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-13 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-20 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-20 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-04 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-14 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-14 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-07 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-05 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-16 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-07 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-11 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-14 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-12 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-18 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-07 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-06 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-04 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-09 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-07 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-14 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-14 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-08 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-14 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 9e-14 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-12 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-13 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-13 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-13 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-10 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 9e-07 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-04 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-12 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-12 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-12 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-12 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-10 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-06 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-11 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-11 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-07 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-11 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-11 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-11 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-05 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-11 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-11 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-10 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-10 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-10 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-10 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-07 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-10 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-09 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-09 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-09 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-09 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-09 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-09 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-09 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-05 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-09 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-09 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-09 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-09 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-09 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-08 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-08 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-08 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-08 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-08 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-06 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-04 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-08 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-08 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-08 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-08 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-08 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-08 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 8e-08 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-07 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-05 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-06 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-07 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-07 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 6e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 7e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-05 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-07 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-07 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-07 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-07 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-07 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-07 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-07 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-07 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-07 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-07 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-07 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 9e-07 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-06 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-04 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-05 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-06 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-06 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-06 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-06 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-04 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-06 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-06 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 7e-06 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-04 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-05 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-05 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-05 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-05 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-05 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-05 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-05 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-05 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-05 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-05 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-05 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-05 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-05 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-05 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-05 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-05 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-05 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-05 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-04 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-04 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-05 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-05 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-05 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-05 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-04 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-04 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-04 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-04 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-04 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-04 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-04 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-04 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-04 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-04 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-04 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-04 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-04 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-04 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-118
Identities = 132/473 (27%), Positives = 202/473 (42%), Gaps = 42/473 (8%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP-DSLCQLRSLNYLSIS 218
L +D+ N G P F + S LE++ +S+N G +P D+L ++R L L +S
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 219 ENNFSCKLPLSIWNIS-SLEIISLHSNRFEGSLPLNIGFNI-PNVNFLSVGQNNFTGSLP 276
N FS +LP S+ N+S SL + L SN F G + N+ N + L + N FTG +P
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 277 HSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL-GTESTSDLDFLTLLTN 335
+ SN S L L + N+ SG + LS L L L N L G L
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE-------LMY 464
Query: 336 CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395
+E L L+ N G ++N + + I + +N+++G IP I L N+ +
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG 455
N +G IP +G+ ++L L L N GTIP + + + N + G +
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIK 579
Query: 456 NCQNLMTLS----------------------RLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493
N +++ + GG N ++ D+
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY 553
S N S IP + + L L+L N SGS+P + L+ + LDLS N L G+IP+
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 554 LENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
+ L L ++LS N+ G +P G F + N LCG LP C
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPRC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-101
Identities = 119/423 (28%), Positives = 199/423 (47%), Gaps = 25/423 (5%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLC-QLRSLNYLSIS 218
+L+++++ NQ +G P +L+ + ++ N G IPD L +L L +S
Sbjct: 245 TCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N+F +P + S LE ++L SN F G LP++ + + L + N F+G LP S
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 279 FSNAS-NLQVLDVYKNHFSGQV--KIDFNRLSNLSRLFLSKNNL-GTESTSDLDFLTLLT 334
+N S +L LD+ N+FSG + + N + L L+L N G + L+
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT-------LS 415
Query: 335 NCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394
NCS++ L+L+ N G S+ +LS K+ + + N + G IP E+ + + ++
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454
+N LTG IP + NL ++L N L G IP +G L L L L N+ GN+P+ L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
G+C++L LDL+ NL G+IP + ++ N + + V + +
Sbjct: 535 GDCRSL----IWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKE 586
Query: 515 LHLQGN--SFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
H GN F G L L + +++ G +N + +L++SYN G
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646
Query: 573 EVP 575
+P
Sbjct: 647 YIP 649
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 6e-93
Identities = 121/423 (28%), Positives = 197/423 (46%), Gaps = 27/423 (6%)
Query: 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNF 222
+++ N + + + LE++ +S + + G + SL L +S N+
Sbjct: 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112
Query: 223 SCKLP--LSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF- 279
S + S+ + S L+ +++ SN + ++ G + ++ L + N+ +G+ +
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172
Query: 280 --SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCS 337
L+ L + N SG +D +R NL L +S NN T + L +CS
Sbjct: 173 LSDGCGELKHLAISGNKISGD--VDVSRCVNLEFLDVSSNNFSTG-------IPFLGDCS 223
Query: 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397
++ L ++ NK G F R+I+ + ++ ++ + NQ G IP L ++ + N+
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENK 280
Query: 398 LTGTIPHAI-GELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP-SSLG 455
TG IP + G L GL L N G +P G+ +LL L L NN G +P +L
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 456 NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLR-NLAEFDLSENHFSNEIPVTLSAC--TTL 512
+ L ++LDLS N G +P + NL +L DLS N+FS I L TL
Sbjct: 341 KMRGL----KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396
Query: 513 EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
+ L+LQ N F+G +P +L + L LS N LSG IP L +L L L L N EG
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456
Query: 573 EVP 575
E+P
Sbjct: 457 EIP 459
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-45
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
++ + LS L ++ L LT +E L+L+ + G + + +T
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTG---LESLFLSNSHINGS-VSGFKCSA-SLTS 104
Query: 367 IGMGDNQISGTIPS--EIKNLVNINAFGVEYNQLTGTIP-HAIGELKNLQGLALVRNSLR 423
+ + N +SG + + + + + V N L +L +L+ L L NS+
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 424 GTIPDTL---GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480
G L L + N + G+V + C NL LD+S N IP
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNL----EFLDVSSNNFSTGIP- 217
Query: 481 EVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELD 540
+G+ L D+S N S + +S CT L+ L++ N F G +P LKS++ L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLS 275
Query: 541 LSRNNLSGQIPKYLE-NLLFLAYLNLSYNHFEGEVP 575
L+ N +G+IP +L L L+LS NHF G VP
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-21
Identities = 33/160 (20%), Positives = 67/160 (41%), Gaps = 1/160 (0%)
Query: 140 WMHQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLG 199
+ + + I+ + K + G + + S +I++ + G
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 200 GRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIP 259
G + S+ +L +S N S +P I ++ L I++L N GS+P +G ++
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG-DLR 680
Query: 260 NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQV 299
+N L + N G +P + S + L +D+ N+ SG +
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 6e-85
Identities = 81/276 (29%), Positives = 126/276 (45%), Gaps = 11/276 (3%)
Query: 333 LTNCSQMEMLYLNTNKFGGVFL--RSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINA 390
T ++ L L+ + S+ANL + G N + G IP I L ++
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
+ + ++G IP + ++K L L N+L GT+P ++ +L L + N + G +
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
P S G+ L T + +S N L G IP NL NLA DLS N + V +
Sbjct: 166 PDSYGSFSKLFT---SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDK 221
Query: 511 TLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHF 570
+ +HL NS + L + K++ LDL N + G +P+ L L FL LN+S+N+
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 571 EGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
GE+P+ G N+ LCG LP+C
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGS----PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 6e-57
Identities = 81/341 (23%), Positives = 126/341 (36%), Gaps = 47/341 (13%)
Query: 177 KFPDFIANFSAL----EAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS--CKLPLSI 230
+ + N + L D G + D+ Q +N L +S N +P S+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 231 WNISSLEIISLHS-NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLD 289
N+ L + + N G +P I + +++L + N +G++P S L LD
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 290 VYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF 349
N SG + + L NL + N +
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRI------------------------------ 161
Query: 350 GGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGEL 409
G S + S T + + N+++G IP NL N+ + N L G G
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSD 220
Query: 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDL 469
KN Q + L +NSL + +G LN L L N + G +P L + L L++
Sbjct: 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL----HSLNV 275
Query: 470 SGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
S N L G IP + GNL+ + N P L ACT
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGT--IPDTLGNLTLLNRLFL-GFNNLQGNVPS 452
G + + + L L +L IP +L NL LN L++ G NNL G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 453 SLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTL 512
++ L L ++ + G+IP + ++ L D S N S +P ++S+ L
Sbjct: 96 AIAKLTQL----HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 513 EYLHLQGNSFSGSLPLSLKTLKS-IKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+ GN SG++P S + + +SRN L+G+IP NL LA+++LS N E
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210
Query: 572 GEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHF 608
G+ L G+ +++HL
Sbjct: 211 GDASV-----------LFGS---DKNTQKIHLAKNSL 233
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 4e-45
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 37/264 (14%)
Query: 160 NLLKLEMIDVGD-NQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
NL L + +G N L+G P IA + L + I+ + G IPD L Q+++L L S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N S LP SI ++ +L I+ NR G++P + G +++ +N TG +P +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL-GTESTSDLDFLTLLTNCS 337
F+N NL +D+ +N G + F N ++ L+KN+L L +
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD--------LGKVGLSK 244
Query: 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397
+ L L +N+I GT+P + L +++ V +N
Sbjct: 245 NLNGLDLR-------------------------NNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 398 LTGTIPHAIGELKNLQGLALVRNS 421
L G IP G L+ A N
Sbjct: 280 LCGEIP-QGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 7e-06
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ--IPKYLENLLFLAYLNLS-YNHFE 571
++ G L + + LDLS NL IP L NL +L +L + N+
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 572 GEVP 575
G +P
Sbjct: 91 GPIP 94
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-62
Identities = 65/447 (14%), Positives = 142/447 (31%), Gaps = 56/447 (12%)
Query: 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSI 217
LK I N + + + L + + + + Y
Sbjct: 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT----- 272
+ L N+ L + +++ LP + +P + ++V N
Sbjct: 238 YKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQL 291
Query: 273 ---GSLPHSFSNASNLQVLDVYKNHF-SGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
+Q++ + N+ + V+ ++ L L N L + +
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA--- 348
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS--EIKNLV 386
+ ++ L L N+ + + + ++ + N++ IP+ + K++
Sbjct: 349 ----FGSEIKLASLNLAYNQITEI-PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402
Query: 387 NINAFGVEYNQLTG-------TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439
++A YN++ + + N+ + L N + + + L+ +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 440 FLGFNNLQG-------NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP-LEVGNLRNLAEF 491
L N L + + N L + +DL N L L L
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTS----IDLRFNKLTKLSDDFRATTLPYLVGI 518
Query: 492 DLSENHFSNEIPVTLSACTTLEYLHLQ------GNSFSGSLPLSLKTLKSIKELDLSRNN 545
DLS N FS + P +TL+ ++ GN P + S+ +L + N+
Sbjct: 519 DLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 546 LSGQIPKYLENLLFLAYLNLSYNHFEG 572
+ K N ++ L++ N
Sbjct: 578 IRKVNEKITPN---ISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-61
Identities = 67/452 (14%), Positives = 132/452 (29%), Gaps = 75/452 (16%)
Query: 160 NLLKLEMIDVGDNQLIGK-------------------FPDFIANFSALEAIDISANMLGG 200
L KL +G++ + + N L +++
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 201 RIPDSLCQLRSLNYLSISENNF--------SCKLPLSIWNISSLEIISLHSNRF-EGSLP 251
++P L L + ++++ N + ++II + N +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 252 LNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSR 311
++ + + L N G LP +F + L L++ N + +
Sbjct: 324 TSLQ-KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVEN 381
Query: 312 LFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGD 371
L + N L + + + S M + + N+ G V ++
Sbjct: 382 LSFAHNKL-----KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP------------ 424
Query: 372 NQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG------- 424
+ +N+++ + NQ++ L + L+ N L
Sbjct: 425 ------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 425 TIPDTLGNLTLLNRLFLGFNNLQGNVPS-SLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483
+ N LL + L FN L L +DLS N P +
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYL----VGIDLSYNSFSK-FPTQPL 533
Query: 484 NLRNLAEFDLSE------NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIK 537
N L F + N E P ++ C +L L + N + + +I
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNIS 590
Query: 538 ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
LD+ N Y+ + L Y+
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-60
Identities = 65/473 (13%), Positives = 151/473 (31%), Gaps = 71/473 (15%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFI------------------------------ANFSALE 189
L +LE++ +G + F +FS L
Sbjct: 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162
Query: 190 AIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGS 249
I+++ I S + NN + + ++ ++ L + ++ F
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAE 221
Query: 250 LPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNL 309
+ + + N +L ++VY ++ L +
Sbjct: 222 NICEAW------ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 310 SRLFLSKNNL--GTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFL-RSIANLSAKITV 366
+ ++ N G + D L +++++Y+ N + S+ + K+ +
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGM 334
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI 426
+ NQ+ G +P + + + + + YNQ+T + G + ++ L+ N L+ I
Sbjct: 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YI 392
Query: 427 PDTL--GNLTLLNRLFLGFNNLQG-------NVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477
P+ ++++++ + +N + + + N+ ++LS N +
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV----SSINLSNNQISKF 448
Query: 478 IPLEVGNLRNLAEFDLSENHFS-------NEIPVTLSACTTLEYLHLQGNSFSGSLP-LS 529
L+ +L N + + L + L+ N +
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508
Query: 530 LKTLKSIKELDLSRNNLSGQIP------KYLENLLFLAYLNLSYNHFEGEVPR 576
TL + +DLS N+ S P L+ + N E P
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-57
Identities = 59/412 (14%), Positives = 128/412 (31%), Gaps = 42/412 (10%)
Query: 184 NFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC----KLPLSIWNISSLEII 239
+ + + + GR+PD++ QL L L++ + P I S E
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 240 SLHSNRFEGSLPLNIGF-NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQ 298
++ + + ++ + + S+ S + N+ +
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF- 197
Query: 299 VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA 358
V RL+ L + ++ + E+ C E +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAEN-----------ICEAWENENSEYAQQYKTEDLKWD 246
Query: 359 NLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT--------GTIPHAIGELK 410
NL +T + + + +P+ +K L + V N+ +
Sbjct: 247 NLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 411 NLQGLALVRNSLR-GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDL 469
+Q + + N+L+ + +L + L L +N L+G + G+ L + L+L
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLAS----LNL 360
Query: 470 SGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA--CTTLEYLHLQGNSFSG--- 524
+ N + G + + N IP A + + + N
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 525 ----SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
L + ++ ++LS N +S + L+ +NL N
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-53
Identities = 62/413 (15%), Positives = 133/413 (32%), Gaps = 42/413 (10%)
Query: 192 DISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLP 251
+ +M G + SL + LS+ S ++P +I ++ LE+++L S+ + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 252 LNIGFNIPNVNFLSV---GQNNFTGSLPHSFSNA--SNLQVLDVYKNHFSGQVKIDFNRL 306
L I + ++ + S+L + + +K
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
+++ NN+ S + + +++ Y+ + F +
Sbjct: 183 LKDTQIGQLSNNITFVSKA-------VMRLTKLRQFYMGNSPFVAENICEAWENEN---- 231
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR--- 423
Q T + NL ++ V +P + L +Q + + N
Sbjct: 232 --SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 424 -----GTIPDTLGNLTLLNRLFLGFNNLQ-GNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477
+ +++G+NNL+ V +SL + L +L+ N L G
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL----GMLECLYNQLEGK 345
Query: 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG-SLPLSLKTLKSI 536
+P G+ LA +L+ N + +E L N K++ +
Sbjct: 346 LP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVM 404
Query: 537 KELDLSRNNLSG-------QIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
+D S N + + + ++ +NLS N +F
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK--ELFST 455
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 27/211 (12%), Positives = 57/211 (27%), Gaps = 32/211 (15%)
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN- 449
F E + ++ + GL+L G +PD +G LT L L LG + + N
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 450 ---VPSSLGNCQNLMTLSRL----------------------LDLSGNLLGGSIPLEVGN 484
P + + ++ ++ + SI
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 485 LRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544
+ N+ + + + T L ++ + F +
Sbjct: 182 TLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYA 235
Query: 545 NLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575
+NL L + + ++P
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-62
Identities = 84/441 (19%), Positives = 146/441 (33%), Gaps = 27/441 (6%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L +DVG N + P+ L+ +++ N L + +L L +
Sbjct: 47 RYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMS 106
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N+ +L + L N S L + N+ L + N
Sbjct: 107 NSIQKIKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 280 SNASN--LQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCS 337
+N L+ L++ N F+ + L LFL+ L S + L L +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL---GPSLTEKLCLELANT 222
Query: 338 QMEMLYLNTNKFGGVFLRSIANLSA-KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYN 396
+ L L+ ++ + L +T++ + N ++ L + F +EYN
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 397 QLTGTIPHAIGELKNLQGLALVRN---------SLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
+ H++ L N++ L L R+ SL + L L L + N++
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLA-----EFDLSENHFSNEI 502
G + NL + L LS + L +LA +L++N S
Sbjct: 343 GIKSNMFTGLINL----KYLSLSNSFTSL-RTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 503 PVTLSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLSGQIPKYLENLLFLA 561
S LE L L N L + L++I E+ LS N + L
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 562 YLNLSYNHFEGEVPRKGVFGN 582
L L + F
Sbjct: 458 RLMLRRVALKNVDSSPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-60
Identities = 94/464 (20%), Positives = 164/464 (35%), Gaps = 34/464 (7%)
Query: 154 GLIQRLNLLKLEMIDVGDNQLIGKFPDFIAN--FSALEAIDISANMLGGRIPDSLCQLRS 211
L L + + + ++QL ++ L +D+S N L DS L
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 212 LNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNF 271
L Y + NN S+ + ++ ++L + + S+ L +
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA----------------SL 317
Query: 272 TGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLT 331
SF L+ L++ N G F L NL L LS + + ++ F++
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377
Query: 332 LLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIP-SEIKNLVNINA 390
L S + +L L NK + + + L + V+ +G N+I + E + L NI
Sbjct: 378 L--AHSPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG--TIPDTLGNLTLLNRLFLGFNNLQG 448
+ YN+ ++ + +LQ L L R +L+ + P L L L L NN+
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 449 NVPSSLGNCQNLMTLS----RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV 504
L + L L L L + G + L +L +L N F
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL-FLAYL 563
L+ + L N+ + S+K L+L +N ++ K L L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 564 NLSYNHFEGEVPRKGVF-----GNRTGIHLIGNERLCGGLEELH 602
++ +N F+ F T I + + LC H
Sbjct: 615 DMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-60
Identities = 85/460 (18%), Positives = 164/460 (35%), Gaps = 39/460 (8%)
Query: 144 SNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP 203
SN+K++A + L+ +++ NQ+ P L + ++ LG +
Sbjct: 153 SNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT 212
Query: 204 DSLC---QLRSLNYLSISENNFSCKLPLSIWN--ISSLEIISLHSNRFEGSLPLNIGFNI 258
+ LC S+ LS+S + S + ++L ++ L N + +
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA-WL 271
Query: 259 PNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKI---------DFNRLSNL 309
P + + + NN HS N++ L++ ++ + + F L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 310 SRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA---NLSAKITV 366
L + N++ ++ + T ++ L L+ + L + + + +
Sbjct: 332 EHLNMEDNDIPGIKSN------MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIP-HAIGELKNLQGLALVRNSLRGT 425
+ + N+IS L ++ + N++ + L+N+ + L N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 426 IPDTLGNLTLLNRLFLGFNNLQG--NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483
++ + L RL L L+ + PS +NL +LDLS N + +
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL----TILDLSNNNIANINDDMLE 501
Query: 484 NLRNLAEFDLSENHFS--------NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKS 535
L L DL N+ + L + L L+L+ N F K L
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 536 IKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575
+K +DL NNL+ N + L LNL N
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-58
Identities = 82/429 (19%), Positives = 150/429 (34%), Gaps = 31/429 (7%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
+ ++++ NQL +S L ++D+ N + P+ +L L L++ N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNAS 283
+ ++L + L SN + N+ L + N + + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV-KQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 284 NLQVLDVYKNHFSGQVKIDFN--RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341
NLQ L + N + + S+L +L LS N + S ++
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH------AIGRLFG 199
Query: 342 LYLNTNKFGGVFLRSIANLSA--KITVIGMGDNQISGTIPSEIKNL--VNINAFGVEYNQ 397
L+LN + G + A I + + ++Q+S T + L N+ + YN
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG---------FNNLQG 448
L + L L+ L N+++ +L L + L L +L
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
Query: 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS- 507
S + L L++ N + G L NL LS + S +
Sbjct: 320 IDDFSFQWLKCLEH----LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 508 ---ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYL 563
A + L L+L N S + L ++ LDL N + ++ L + +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 564 NLSYNHFEG 572
LSYN +
Sbjct: 436 YLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 53/241 (21%), Positives = 83/241 (34%), Gaps = 12/241 (4%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L + +L ITV+ + NQ+ + + + V +N ++ P +L L
Sbjct: 16 LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
+ L L N L T T L L L N++Q + +NL LDLS N
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL----ITLDLSHN 131
Query: 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSAC--TTLEYLHLQGNSFSGSLPLSL 530
L + L NL E LS N L ++L+ L L N P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 531 KTLKSIKELDLSRNNLSGQIPKYL---ENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIH 587
+ + L L+ L + + L + L+LS + F +
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN--TTFLGLKWTN 249
Query: 588 L 588
L
Sbjct: 250 L 250
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 45/190 (23%), Positives = 66/190 (34%), Gaps = 11/190 (5%)
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454
+ +LT +P + N+ L L N LR + L L +GFN + P
Sbjct: 13 HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
L ++L+L N L NL E L N L
Sbjct: 70 QKLPML----KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE--NLLFLAYLNLSYNHFEG 572
L L N S + + L++++EL LS N + + L+ L L LS N +
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 573 EVPRKGVFGN 582
P G F
Sbjct: 186 FSP--GCFHA 193
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 42/162 (25%), Positives = 56/162 (34%), Gaps = 7/162 (4%)
Query: 411 NLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLS 470
+ + L +PD L T + L L N L+ ++ L LD+
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQL----TSLDVG 57
Query: 471 GNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSL 530
N + P L L +L N S T + CT L LHL NS
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 531 KTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
K++ LDLS N LS L L L LS N +
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-19
Identities = 30/147 (20%), Positives = 44/147 (29%), Gaps = 9/147 (6%)
Query: 436 LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSE 495
L VP L N+ +L+L+ N L L D+
Sbjct: 6 HEVADCSHLKLT-QVPDDLPT--NI----TVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE 555
N S P L+ L+LQ N S + ++ EL L N++
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 556 NLLFLAYLNLSYNHFEGEVPRKGVFGN 582
L L+LS+N G
Sbjct: 119 KQKNLITLDLSHNGLSSTKL--GTQVQ 143
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 5e-56
Identities = 78/443 (17%), Positives = 161/443 (36%), Gaps = 37/443 (8%)
Query: 160 NLLKLEMIDVGDNQLIG-KFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNY---- 214
+L L+ ++V N + K P++ +N + LE +D+S+N + L L +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 215 LSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSV------GQ 268
L +S N + + + L ++L +N ++ + + + +
Sbjct: 182 LDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNH---FSGQVKIDFNRLSNLSRLFLSKNNLGTEST- 324
N + NL + + + + + FN L+N+S L +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300
Query: 325 ---SDLDFLTLLTN-------CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQI 374
L L+ + L G S +L + + + N +
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP-SLEFLDLSRNGL 359
Query: 375 S--GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTLG 431
S G ++ + +N + T+ L+ L+ L ++L+
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 432 NLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAE 490
+L L L + + + +L +L ++GN + ++ LRNL
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSL----EVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 491 FDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQI 550
DLS+ P ++ ++L+ L++ N+F K L S++ LD S N++
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 551 PKYLENLL-FLAYLNLSYNHFEG 572
+ L++ LA+LNL+ N F
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-55
Identities = 73/449 (16%), Positives = 151/449 (33%), Gaps = 44/449 (9%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANML-GGRIPDSLCQLRSLNYLSIS 218
L L+ + + L I + L+ ++++ N++ ++P+ L +L +L +S
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 219 ENNFSCKLPLSIWNISSLEI----ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274
N + + + + + L N P F ++ L++ N + +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA--FKEIRLHKLTLRNNFDSLN 215
Query: 275 LP-HSFSNASNLQVLDVYKNHFSGQVKI---DFNRLSNLSRLFLSKNNLGTESTSDLDFL 330
+ + L+V + F + + D + L L L + + L D +
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 331 TLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINA 390
L + + L + ++ + + + + + ++K+L +
Sbjct: 276 DLFNCLTNVSSFSLVSVTIER--VKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLT- 331
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSL--RGTIPDTLGNLTLLNRLFLGFNNLQG 448
+ G + +L +L+ L L RN L +G + T L L L FN +
Sbjct: 332 ----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 449 NVPSSLGNCQNLMTLS---------------------RLLDLSGNLLGGSIPLEVGNLRN 487
+ S+ + L L LD+S + L +
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 488 LAEFDLSENHFSNEI-PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
L ++ N F P + L +L L P + +L S++ L++S NN
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
Query: 547 SGQIPKYLENLLFLAYLNLSYNHFEGEVP 575
+ L L L+ S NH
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-51
Identities = 70/431 (16%), Positives = 141/431 (32%), Gaps = 33/431 (7%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+ +L+++D+ ++ + S L + ++ N + + L SL L E
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N + I ++ +L+ +++ N + N+ N+ L + N
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 280 SNASNLQV----LDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTN 335
+ + LD+ N + F + L +L L N +
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT-----CIQG 223
Query: 336 CSQMEMLYLNTNKFGGV--FLRSIANLSAKITVIGMGDNQIS------GTIPSEIKNLVN 387
+ +E+ L +F + + + + + + +++ I L N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
+++F + + + Q L LV L +L L F + +
Sbjct: 284 VSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNK 336
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLG--GSIPLEVGNLRNLAEFDLSENHFSNEIPVT 505
G S + +L LDLS N L G +L DLS N +
Sbjct: 337 GGNAFSEVDLPSL----EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 506 LSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
LE+L Q ++ S +L+++ LD+S + L L L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 565 LSYNHFEGEVP 575
++ N F+
Sbjct: 452 MAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-48
Identities = 79/425 (18%), Positives = 139/425 (32%), Gaps = 35/425 (8%)
Query: 185 FSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244
+ + +D+S N L S L L +S + ++S L + L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHF-SGQVKIDF 303
+ + ++ L + N + L+ L+V N S ++ F
Sbjct: 87 PIQSLALGAFS-GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 304 NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK 363
+ L+NL L LS N + + +DL L + L L+ N + + +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSLDLSLNPMNFIQPGAFKEIR-- 201
Query: 364 ITVIGMGDNQISGTIPSEI-------KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLA 416
+ + + +N S + + + L A+ L NL
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 417 LVRNSL---RGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS-LGNCQNL------------ 460
L I D LT ++ L ++ S Q+L
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 461 MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENH--FSNEIPVTLSACTTLEYLHLQ 518
+ L L L+ G +L +L DLS N F + T+L+YL L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 519 GNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLSYNHFEGEVPRK 577
N + + L+ ++ LD +NL +L L YL++S+ H
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN-- 438
Query: 578 GVFGN 582
G+F
Sbjct: 439 GIFNG 443
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-43
Identities = 67/423 (15%), Positives = 134/423 (31%), Gaps = 34/423 (8%)
Query: 159 LNLLKLEMIDVGDNQLIGKFP-DFIANFSALEAIDISANMLGGRI---PDSLCQLRSLNY 214
++L + + +N I + LE + L L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 215 LSISENNFSC------KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQ 268
L+I E + + ++++ SL S E + L +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVN 313
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
F + L G L +L L LS+N L +
Sbjct: 314 CKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVN 387
+ ++ L L+ N + + L ++ + + + + +L N
Sbjct: 369 DF----GTTSLKYLDLSFNGVITMS-SNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI-PDTLGNLTLLNRLFLGFNNL 446
+ + + L +L+ L + NS + PD L L L L L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL 506
+ P++ + +L ++L++S N L +L D S NH L
Sbjct: 483 EQLSPTAFNSLSSL----QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 507 SAC-TTLEYLHLQGNSFSGSLPLS--LKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYL 563
++L +L+L N F+ + L+ +K ++L + + P + + L+ L
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-L 597
Query: 564 NLS 566
N++
Sbjct: 598 NIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-35
Identities = 57/332 (17%), Positives = 107/332 (32%), Gaps = 24/332 (7%)
Query: 249 SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSN 308
+P N+ + L + N +SF + LQVLD+ + + LS+
Sbjct: 21 KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 309 LSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIG 368
LS L L+ N + + + L+ L L + I +L + +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQK------LVAVETNLASLENFPIGHLK-TLKELN 130
Query: 369 MGDNQI-SGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQ----GLALVRNSLR 423
+ N I S +P NL N+ + N++ + L + L L N +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483
P + L++L L N NV + + + RL+ G +
Sbjct: 191 FIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 484 NLRNLAEFDLSENHFS------NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIK 537
L L + E + ++I + T + L + S +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQ 307
Query: 538 ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
L+L L++L L + + +
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-32
Identities = 45/227 (19%), Positives = 77/227 (33%), Gaps = 12/227 (5%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
I NL + + N + + + + ++ A L +L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L L N ++ L+ L +L NL +G+ + L + L+++ N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL----KELNVAHN 134
Query: 473 LL-GGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY----LHLQGNSFSGSLP 527
L+ +P NL NL DLS N + L + L L N + P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 528 LSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLSYNHFEGE 573
+ K + + +L L N S + K ++ L L L F E
Sbjct: 195 GAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 8/244 (3%)
Query: 144 SNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP 203
S + L L+ +D+ N +I +F+ LE +D + L
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSE 413
Query: 204 DS-LCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVN 262
S LR+L YL IS + +SSLE++ + N F+ + +I + N+
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 263 FLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTE 322
FL + Q P +F++ S+LQVL++ N+F + L++L L S N++
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI--- 530
Query: 323 STSDLDFLTLLTNCSQMEMLYLNTNKF-GGVFLRSIANLSAKITVIGMGDNQISGTIPSE 381
L S + L L N F +S + + ++ PS+
Sbjct: 531 --MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
Query: 382 IKNL 385
+ +
Sbjct: 589 KQGM 592
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-55
Identities = 69/459 (15%), Positives = 149/459 (32%), Gaps = 58/459 (12%)
Query: 144 SNDKLEAGNLGLIQRLNLLKLEMIDVGD-NQLIGKFPDFIANFSALEAIDISANMLGGRI 202
+ + I++ + + L+ +G+ I I + L+ I + +
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 203 PDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVN 262
+ + +Y EN LS N+ L + L++ LP + ++P +
Sbjct: 465 IAVDWEDANSDYAKQYEN-----EELSWSNLKDLTDVELYNCPNMTQLPDFLY-DLPELQ 518
Query: 263 FLSVGQNNFTG---------SLPHSFSNASNLQVLDVYKNHFSG-QVKIDFNRLSNLSRL 312
L++ N L +Q+ + N+ ++ L L
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578
Query: 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372
N + L ++ L L+ N+ + + ++ +G N
Sbjct: 579 DCVHNKVRH--------LEAFGTNVKLTDLKLDYNQIEEIP-EDFCAFTDQVEGLGFSHN 629
Query: 373 QISGTIPS--EIKNLVNINAFGVEYNQLTGTIPHA-----IGELKNLQGLALVRNSLRGT 425
++ IP+ K++ + + YN++ + + N + L N ++
Sbjct: 630 KLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKF 688
Query: 426 IPDTLGNLTLLNRLFLGFNNLQ-------GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478
+ + ++ + L N + + N L +DL N L S+
Sbjct: 689 PTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL----TTIDLRFNKLT-SL 743
Query: 479 P--LEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQ------GNSFSGSLPLSL 530
L L+ D+S N FS P + L+ ++ GN P +
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
Query: 531 KTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
T S+ +L + N++ K L L+++ N
Sbjct: 803 TTCPSLIQLQIGSNDIRKVDEKLTPQ---LYILDIADNP 838
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-50
Identities = 60/434 (13%), Positives = 120/434 (27%), Gaps = 51/434 (11%)
Query: 151 GNLGLIQRLNL-----------LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLG 199
L +Q + + E + + +N L +++
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504
Query: 200 GRIPDSLCQLRSLNYLSISENNFS---------CKLPLSIWNISSLEIISLHSNRFEGSL 250
++PD L L L L+I+ N +L ++I + N E
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EF 563
Query: 251 PLNIGF-NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNL 309
P + + + L N +F L L + N + +
Sbjct: 564 PASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQV 621
Query: 310 SRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA----KIT 365
L S N L + + + M + + NK G ++ +
Sbjct: 622 EGLGFSHNKL-----KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676
Query: 366 VIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT-------GTIPHAIGELKNLQGLALV 418
+ + N+I I+ + N +T L + L
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 419 RNSLRGTIPDTL--GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTL--SRLLDLSGNLL 474
N L ++ D L L+ + + +N P+ N L D GN +
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794
Query: 475 GGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF-SGSLPLSLKTL 533
P + +L + + N ++ L L L + N S + +
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYI 851
Query: 534 KS-IKELDLSRNNL 546
++ + L +
Sbjct: 852 EAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-47
Identities = 53/415 (12%), Positives = 115/415 (27%), Gaps = 46/415 (11%)
Query: 181 FIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIIS 240
+ N + + ++ GR+PD++ QL L LS ++ + L + ++
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 241 LHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG--- 297
+R +N + Q+ + + +
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTN 435
Query: 298 ---QVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFL 354
+ RL+ L ++ + + T E + K
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPF-----------TYDNIAVDWEDANSDYAKQYENEE 484
Query: 355 RSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG---------TIPHA 405
S +NL +T + + + +P + +L + + + N+ +
Sbjct: 485 LSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 406 IGELKNLQGLALVRNSLRG-TIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLS 464
+Q + N+L +L + L L N + + G L
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKL---- 597
Query: 465 RLLDLSGNLLGGSIPLEVG-NLRNLAEFDLSENHFSNEIP--VTLSACTTLEYLHLQGNS 521
L L N + IP + + S N IP + + + N
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655
Query: 522 FSG-----SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
S + + + LS N + + ++ + LS N
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-46
Identities = 54/457 (11%), Positives = 127/457 (27%), Gaps = 52/457 (11%)
Query: 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYL 215
+ N ++ + + G+ PD I + L+ + + + + +
Sbjct: 317 VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 216 SISENNFSCKL-PLSIWNISSLEIISLHSNRFE-----GSLPLNIGFNIPNVNFLSVGQN 269
++ + + L + L + + + ++ +
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIG--NLT 434
Query: 270 NFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF 329
N + + + LQ++ + F+ +N +N +
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS-------- 486
Query: 330 LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISG---------TIPS 380
+N + + L + +L ++ + + N+ +
Sbjct: 487 ---WSNLKDLTDVELYNCPNMTQLPDFLYDLP-ELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 381 EIKNLVNINAFGVEYNQLTG-TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439
+ I F + YN L ++ ++ L L V N + + G L L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDL 600
Query: 440 FLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP--LEVGNLRNLAEFDLSENH 497
L +N ++ +P + + L S N L IP ++ + D S N
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQV---EGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNK 655
Query: 498 FSNEIPVTLSA-----CTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS----- 547
+E + + L N T I + LS N ++
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 548 --GQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
+N L ++L +N +
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-43
Identities = 62/410 (15%), Positives = 131/410 (31%), Gaps = 36/410 (8%)
Query: 191 IDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSL 250
+ +M G + L + LS++ ++P +I ++ L+++S ++ S
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 251 PLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLS 310
L + L + D+ ++ + ++ + S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP--IKKDS 421
Query: 311 RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMG 370
R+ L +G + + ++++++Y + F N++
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYD------NIAVDWEDANSD 475
Query: 371 DNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG------ 424
+ NL ++ + +P + +L LQ L + N
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535
Query: 425 ---TIPDTLGNLTLLNRLFLGFNNLQG-NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480
+ D + ++G+NNL+ +SL L LLD N +
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL----GLLDCVHNKV--RHLE 589
Query: 481 EVGNLRNLAEFDLSENHFSNEIPVTLSACTT-LEYLHLQGNSFSGSLP--LSLKTLKSIK 537
G L + L N EIP A T +E L N +P + K++ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG 647
Query: 538 ELDLSRNNLSGQIPKYLE-----NLLFLAYLNLSYNHFEGEVPRKGVFGN 582
+D S N + + + + + LSYN + +F
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPT--ELFAT 695
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-26
Identities = 34/257 (13%), Positives = 77/257 (29%), Gaps = 23/257 (8%)
Query: 359 NLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALV 418
+ + ++T + + G +P I L + + T + E
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 419 RNSLR-------GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471
++ +R L LL ++ S + ++ +
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-----IGNLT 434
Query: 472 NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLK 531
N + I + L L + + F+ + E + + LS
Sbjct: 435 NRIT-FISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWS 488
Query: 532 TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGN 591
LK + +++L Q+P +L +L L LN++ N K + L +
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR-----LADD 543
Query: 592 ERLCGGLEELHLPSCHF 608
E ++ ++ +
Sbjct: 544 EDTGPKIQIFYMGYNNL 560
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 16/117 (13%), Positives = 35/117 (29%), Gaps = 1/117 (0%)
Query: 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
L + LD + N F+ + + ++ V L + L L G
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAG 332
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576
G +P ++ L +K L ++ + + + L + +
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-52
Identities = 80/418 (19%), Positives = 141/418 (33%), Gaps = 14/418 (3%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
L+ L +D+ Q+ D + L+ + ++AN L +L ++L +L +
Sbjct: 55 RLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
S + + N +LE + L SN S+ L GF + L N
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 280 SNASNLQVLDVYKNH-FSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
S+ L + N ++ + L L T + +
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST-IQSLWL 232
Query: 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398
++ + +S + I + + + + + L
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMS--VESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPS-SLGNC 457
+ +P + L L+ L L N + N L L + N + + + L N
Sbjct: 291 S-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349
Query: 458 QNLMTLSRLLDLSGNLLGGS--IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYL 515
+NL LDLS + + S L++ NL +L +LS N + C LE L
Sbjct: 350 ENLRE----LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 516 HLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
L S + L +K L+LS + L + + L L +LNL NHF
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-49
Identities = 85/427 (19%), Positives = 160/427 (37%), Gaps = 24/427 (5%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS- 218
N LE + +G N + L+ +D N + + + L+ LS++
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFN-IPNVNFLSVGQNNFTGSLPH 277
N + ++ + + ++ + + + + I ++ + + P
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 278 SFSN--ASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTN 335
F +++ +++ K++F F+ S L L L+ +L + L
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-------LPSGLVG 299
Query: 336 CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSE-IKNLVNINAFGVE 394
S ++ L L+ NKF + S +N +T + + N + + ++NL N+ +
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 395 YNQLT--GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP- 451
++ + + L +LQ L L N + L L L F L+
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 452 SSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV---TLSA 508
S N L ++L+LS +LL S L L +L NHF +L
Sbjct: 419 SPFQNLHLL----KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 509 CTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
LE L L S + +LK + +DLS N L+ + L +L + YLNL+ N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533
Query: 569 HFEGEVP 575
H +P
Sbjct: 534 HISIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 9e-48
Identities = 75/405 (18%), Positives = 133/405 (32%), Gaps = 20/405 (4%)
Query: 185 FSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244
++ E ++ S N+L + +L +L +L ++ + + L+ + L +N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN 304
+ + L Q + N L+ L + NH S
Sbjct: 92 PLI-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKI 364
L L N + S D+ L TN S L LN N G+ + +
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS----LNLNGNDIAGIEPGAFDSAV--F 204
Query: 365 TVIGMGDNQISGTIPSEIKN--LVNINAFGVEYNQLTGTIPHAIGELK--NLQGLALVRN 420
+ G Q I +KN + ++ E P L +++ + L ++
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 421 SLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480
+T + L L L +L +PS L L + L LS N +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL----KKLVLSANKFENLCQI 319
Query: 481 EVGNLRNLAEFDLSENHFSNEI-PVTLSACTTLEYLHLQGN--SFSGSLPLSLKTLKSIK 537
N +L + N E+ L L L L + S L L+ L ++
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 538 ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
L+LS N + + L L+L++ + + F N
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-45
Identities = 77/428 (17%), Positives = 142/428 (33%), Gaps = 22/428 (5%)
Query: 154 GLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSL--CQLRS 211
+ L +++ N I + + ++++ I L ++S
Sbjct: 171 EDMSSLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
Query: 212 LNYLSISENNFSCKLPLSIWNIS--SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQN 269
L + + + P + S+E I+L + F ++ N + L +
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQELDLTAT 288
Query: 270 NFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF 329
+ + LP S L+ L + N F +I + +L+ L + N E +
Sbjct: 289 HLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC-- 345
Query: 330 LTLLTNCSQMEMLYLNTNKFGGVFL--RSIANLSAKITVIGMGDNQISGTIPSEIKNLVN 387
L N + L L+ + + NLS + + + N+ K
Sbjct: 346 ---LENLENLRELDLSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKTEAFKECPQ 401
Query: 388 INAFGVEYNQLTGTIPH-AIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446
+ + + +L L L+ L L + L + L L L L N+
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL 506
+ Q L L +L LS L +L+ + DLS N ++ L
Sbjct: 462 PKGNIQKTNSLQTLGRL-EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
Query: 507 SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566
S + YL+L N S LP L L + ++L +N L N+ FL + +
Sbjct: 521 SHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKEN 575
Query: 567 YNHFEGEV 574
E
Sbjct: 576 MQKLEDTE 583
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 38/223 (17%), Positives = 57/223 (25%), Gaps = 10/223 (4%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L I L + N + + L+N+ + Q+ L
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L L N L L L LF + L N + L L L N
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL----ESLYLGSN 139
Query: 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT--TLEYLHLQGNSFSGSLPLSL 530
+ + L D N +S+ T L+L GN + +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGA 198
Query: 531 KTLKSIKELDLSRNNLSGQIPKYLENLLF--LAYLNLSYNHFE 571
+ L+ I K L+N L E
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 41/209 (19%), Positives = 65/209 (31%), Gaps = 9/209 (4%)
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454
L IP + + + L N L T L L L L + +
Sbjct: 21 NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
+ L TL L+ N L + + L + S+ + L TLE
Sbjct: 78 QSQHRLDTL----VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL--LFLAYLNLSYNHFEG 572
L+L N S + +K LD N + + + +L LNL+ N G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 573 EVPRKGVFGNRTGIHLIGNERLCGGLEEL 601
P ++ G + L + L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 30/134 (22%), Positives = 43/134 (32%), Gaps = 7/134 (5%)
Query: 439 LFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHF 498
L +P +L N + L+ S N+L L NL DL+
Sbjct: 17 YNCENLGLN-EIPGTLPN--ST----ECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI 69
Query: 499 SNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
T + L+ L L N +L K++K L + +S L N
Sbjct: 70 YWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK 129
Query: 559 FLAYLNLSYNHFEG 572
L L L NH
Sbjct: 130 TLESLYLGSNHISS 143
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-44
Identities = 73/441 (16%), Positives = 148/441 (33%), Gaps = 39/441 (8%)
Query: 160 NLLKLEMIDVGDNQLIG-KFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLN----Y 214
L+ L+ ++V N + K P + +N + L +D+S N + + L LR
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS 185
Query: 215 LSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274
L +S N + + L ++L N ++ N+ ++ + F
Sbjct: 186 LDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 275 L------PHSFSNASNLQV--LDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT----E 322
P ++ + + + + F+ L+N+S + L+ ++
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP 304
Query: 323 STSDLDFLTLLTN---------CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQ 373
L+++ ++ L L NK F L ++ + + N
Sbjct: 305 KHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISF--KKVALP-SLSYLDLSRNA 361
Query: 374 ISGTIPSEIKNL--VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTL 430
+S + +L ++ + +N + L+ LQ L ++L+
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 431 GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLA 489
+L L L + + N + + +L L ++GN + V N NL
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSL----NTLKMAGNSFKDNTLSNVFANTTNLT 476
Query: 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ 549
DLS+ L+ L++ N+ L S+ LD S N +
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 550 IPKYLENLLFLAYLNLSYNHF 570
LA+ NL+ N
Sbjct: 537 KGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-43
Identities = 78/443 (17%), Positives = 147/443 (33%), Gaps = 39/443 (8%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
L L + + N + P + ++LE + L + QL +L L+++
Sbjct: 78 GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH 137
Query: 220 NNF-SCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVG---QNNFTGSL 275
N SCKLP N+++L + L N + ++ +N + +++ N +
Sbjct: 138 NFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMSLNPIDFI 196
Query: 276 PHSFSNASNLQVLDVYKNHFSGQV-KIDFNRLSNLSRLFLSKNNL-GTESTSDLDFLTLL 333
L L + N S + K L+ L L + + +
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
Query: 334 TNCS-QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFG 392
C ++ L + L+ ++ + + I ++ +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLA-NVSAMSLAGVSI--KYLEDVPKHFKWQSLS 313
Query: 393 VEYNQLT-------------------GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNL 433
+ QL G+I L +L L L RN+L + + +L
Sbjct: 314 IIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 434 TL--LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAE 490
L L L FN + ++ + L LD + L +L L
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQH----LDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 491 FDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLSGQ 549
D+S + + T+L L + GNSF + + ++ LDLS+ L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 550 IPKYLENLLFLAYLNLSYNHFEG 572
+ L L LN+S+N+
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLF 511
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-40
Identities = 83/425 (19%), Positives = 149/425 (35%), Gaps = 36/425 (8%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
+ ID+ N L +NFS L+ +D+S + + L L+ L ++ N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTG-SLPHSFSNA 282
P S ++SLE + + IG + + L+V N LP FSN
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIG-QLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLS----RLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
+NL +D+ N+ D L L +S N + + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE---- 208
Query: 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGM------GDNQISGTIPSEIKNLVNI--NA 390
L L N +++ A + V + + + PS ++ L ++ +
Sbjct: 209 ---LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
F + Y L N+ ++L S+ + + L + L+
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFP 323
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS--A 508
L ++ L L+ N SI + L +L+ DLS N S + S
Sbjct: 324 TLDLPFLKS-------LTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 509 CTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLSY 567
+L +L L N + + L+ ++ LD + L +L L YL++SY
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433
Query: 568 NHFEG 572
+ +
Sbjct: 434 TNTKI 438
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-35
Identities = 72/414 (17%), Positives = 133/414 (32%), Gaps = 48/414 (11%)
Query: 201 RIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPN 260
++PD + S + +S N S N S L+ + L E + +
Sbjct: 25 KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH-GLHH 81
Query: 261 VNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320
++ L + N P SFS ++L+ L + + +L L +L ++ N +
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI- 140
Query: 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV---FLRSIANLSAKITVIGMGDNQISGT 377
+N + + + L+ N + L+ + + M N I
Sbjct: 141 ----HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIP-HAIGELKNLQGLALVRNSLRGTI------PDTL 430
I + + ++ + N + I + L L L+ + P +
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 431 GNLTLL--NRLFLGFNNLQGNVPSSLGNCQNLMTLS------------------RLLDLS 470
L + + L + N + N+ +S + L +
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSII 315
Query: 471 GNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGN--SFSGSLPL 528
L +L L L+ N S I A +L YL L N SFSG
Sbjct: 316 RCQLKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSY 370
Query: 529 SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
S S++ LDLS N + L L +L+ ++ + V F +
Sbjct: 371 SDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 69/346 (19%), Positives = 116/346 (33%), Gaps = 33/346 (9%)
Query: 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQ 298
+ +P +I + + + N +SFSN S LQ LD+ +
Sbjct: 16 YQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 299 VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA 358
++ L +LS L L+ N + + S LT L N L K + I
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN------LVAVETKLASLESFPIG 125
Query: 359 NLSAKITVIGMGDNQISG-TIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLAL 417
L + + + N I +P+ NL N+ + YN + + + L+ + L
Sbjct: 126 QLI-TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184
Query: 418 V----RNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473
N + + L L L N N+ + QNL L + L
Sbjct: 185 SLDMSLNPIDFIQDQAFQGIKLH-ELTLRGNFNSSNIMKTC--LQNLAGL-HVHRLILGE 240
Query: 474 LGGSIPLEV------GNLRNLA--EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS 525
LE+ L ++ EF L+ + ++ V + + L G S
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY- 299
Query: 526 LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+ + L + R L Q P +L FL L L+ N
Sbjct: 300 -LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-39
Identities = 94/415 (22%), Positives = 161/415 (38%), Gaps = 46/415 (11%)
Query: 154 GLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLN 213
+ + +L ++ + + K D + + L I+ S N L P L L L
Sbjct: 38 DTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 93
Query: 214 YLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTG 273
+ ++ N + PL+ N+++L ++L +N+ PL N+ N+N L + N +
Sbjct: 94 DILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTISD 148
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
+ S ++LQ L L+ L RL +S N + SD+ L L
Sbjct: 149 --ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV-----SDISVLAKL 198
Query: 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV 393
TN +E L N+ + + L+ + + + NQ+ + +L N+ +
Sbjct: 199 TN---LESLIATNNQISD--ITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDL 250
Query: 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS 453
NQ++ P + L L L L N + P L LT L L L N L+ S
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISP 304
Query: 454 LGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLE 513
+ N +NL L L N + P+ +L L N S+ +L+ T +
Sbjct: 305 ISNLKNL----TYLTLYFNNISDISPV--SSLTKLQRLFFYNNKVSD--VSSLANLTNIN 356
Query: 514 YLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
+L N S PL+ L I +L L+ + Y N ++ N N
Sbjct: 357 WLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPVNYKAN---VSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-37
Identities = 100/416 (24%), Positives = 161/416 (38%), Gaps = 42/416 (10%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL KL I + +NQ+ +AN + L + + N + D L L +LN L +S
Sbjct: 88 NLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSS 143
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N S LS ++SL+ +S N+ PL N+ + L + N +
Sbjct: 144 NTISDISALS--GLTSLQQLSF-GNQVTDLKPLA---NLTTLERLDISSNKVSD--ISVL 195
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
+ +NL+ L N S L+NL L L+ N L + L + + +
Sbjct: 196 AKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQLKD--------IGTLASLTNL 245
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
L L N+ L ++ L+ K+T + +G NQIS P + L + + NQL
Sbjct: 246 TDLDLANNQISN--LAPLSGLT-KLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
P I LKNL L L N++ P + +LT L RLF N + SSL N N
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTN 354
Query: 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
+ L N + PL NL + + L++ ++N + + +
Sbjct: 355 I----NWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575
+ P ++ S E D++ N S + + F G V
Sbjct: 409 GAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 35/312 (11%)
Query: 261 VNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320
+ ++ Q+ + + + + + K + + + L ++ L + +
Sbjct: 3 LGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI- 58
Query: 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS 380
+D + L N + + + N+ + + NL+ K+ I M +NQI+ P
Sbjct: 59 ----KSIDGVEYLNN---LTQINFSNNQLTD--ITPLKNLT-KLVDILMNNNQIADITP- 107
Query: 381 EIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF 440
+ NL N+ + NQ+T P + L NL L L N++ L LT L +L
Sbjct: 108 -LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 441 LGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN 500
G N + L N L LD+S N + S + L NL + N S+
Sbjct: 163 FG-NQVTD--LKPLANLTTL----ERLDISSNKV--SDISVLAKLTNLESLIATNNQISD 213
Query: 501 EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFL 560
P L T L+ L L GN +L +L ++ +LDL+ N +S P L L L
Sbjct: 214 ITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 267
Query: 561 AYLNLSYNHFEG 572
L L N
Sbjct: 268 TELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 70/365 (19%), Positives = 134/365 (36%), Gaps = 46/365 (12%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L +++ N + ++ ++L+ + + L L +L L IS
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISS 186
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N S + +++LE + +N+ PL + N++ LS+ N +
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKD--IGTL 239
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLT----- 334
++ +NL LD+ N S + L+ L+ L L N + + S L LT LT
Sbjct: 240 ASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQI--SNISPLAGLTALTNLELN 295
Query: 335 -----------NCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIK 383
N + L L N + +++L+ K+ + +N++S S +
Sbjct: 296 ENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLT-KLQRLFFYNNKVSD--VSSLA 350
Query: 384 NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGF 443
NL NIN +NQ++ P + L + L L + + N+++ N +
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
Query: 444 NNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIP 503
L P+++ + + D++ NL FS +
Sbjct: 409 GAL--IAPATISDGGSY----TEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
Query: 504 VTLSA 508
L A
Sbjct: 462 QPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 15/111 (13%), Positives = 37/111 (33%), Gaps = 8/111 (7%)
Query: 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521
L + L + L + + ++ + + + L
Sbjct: 2 PLGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
S+ ++ L ++ +++ S N L+ P L+NL L + ++ N
Sbjct: 58 IK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 80/384 (20%), Positives = 154/384 (40%), Gaps = 39/384 (10%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
+ + FPD A+ + + + + +L S+ L ++ +
Sbjct: 2 AATLATLPAPINQIFPD--ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNAS 283
+ I +++LE ++L+ N+ PL+ N+ + L +G N T + N +
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 284 NLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLY 343
NL+ L + +++ S L+ + L L N+ SDL L+ +T + L
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN----LSDLSPLSNMTG---LNYLT 161
Query: 344 LNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIP 403
+ +K + IANL+ + + + NQI P + +L +++ F NQ+T P
Sbjct: 162 VTESKVKD--VTPIANLT-DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
Query: 404 HAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTL 463
+ + L L + N + P L NL+ L L +G N + +++ + L
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKL--- 267
Query: 464 SRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523
++L++ N + L NL L L+ N NE + T L L L N +
Sbjct: 268 -KMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 524 GSLPLSLKTLKSIKELDLSRNNLS 547
PL+ +L + D + +
Sbjct: 325 DIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 75/361 (20%), Positives = 136/361 (37%), Gaps = 37/361 (10%)
Query: 212 LNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNF 271
L+ + P + +++ L + + ++ L V
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56
Query: 272 TGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLT 331
S+ +NL+ L++ N + + L L+ L++ N + +D+ L
Sbjct: 57 A-SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI-----TDISALQ 107
Query: 332 LLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAF 391
LTN + LYLN + + +ANL+ K+ + +G N + S + N+ +N
Sbjct: 108 NLTN---LRELYLNEDNISD--ISPLANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYL 160
Query: 392 GVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP 451
V +++ P I L +L L+L N + P L +LT L+ N +
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--I 214
Query: 452 SSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTT 511
+ + N L L + N + PL NL L ++ N S+ + T
Sbjct: 215 TPVANMTRL----NSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTK 266
Query: 512 LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L+ L++ N S L+ L + L L+ N L + + + L L L LS NH
Sbjct: 267 LKMLNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 572 G 572
Sbjct: 325 D 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-31
Identities = 63/320 (19%), Positives = 124/320 (38%), Gaps = 34/320 (10%)
Query: 257 NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316
++ + + + T + ++ L V + L+NL L L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNG 75
Query: 317 NNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISG 376
N + +D+ L+ L + LY+ TNK + ++ NL+ + + + ++ IS
Sbjct: 76 NQI-----TDISPLSNLVK---LTNLYIGTNKI--TDISALQNLT-NLRELYLNEDNISD 124
Query: 377 TIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLL 436
S + NL + + + N + + + L L + + ++ P + NLT L
Sbjct: 125 --ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 437 NRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSEN 496
L L +N ++ S L + +L N + P+ N+ L + N
Sbjct: 180 YSLSLNYNQIED--ISPLASLTSLHYF----TAYVNQITDITPV--ANMTRLNSLKIGNN 231
Query: 497 HFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556
++ P L+ + L +L + N S + ++K L +K L++ N +S L N
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 557 LLFLAYLNLSYNHFEGEVPR 576
L L L L+ N E
Sbjct: 286 LSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/288 (20%), Positives = 125/288 (43%), Gaps = 27/288 (9%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL+KL + +G N++ + N + L + ++ + + L L + L++
Sbjct: 86 NLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGA 141
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N+ + N++ L +++ ++ + P+ N+ ++ LS+ N P
Sbjct: 142 NHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIA---NLTDLYSLSLNYNQIEDISP--L 195
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
++ ++L Y N + ++ L+ L + N + +DL L N SQ+
Sbjct: 196 ASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNKI-----TDLSP---LANLSQL 245
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
L + TN+ + ++ +L+ K+ ++ +G NQIS S + NL +N+ + NQL
Sbjct: 246 TWLEIGTNQISD--INAVKDLT-KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
IG L NL L L +N + P L +L+ ++ ++
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 53/309 (17%), Positives = 102/309 (33%), Gaps = 22/309 (7%)
Query: 273 GSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTL 332
GS H ++S + L S ++ + LS R + + N
Sbjct: 2 GSSHHHHHHSSGRENLYF---QGSTALRPYHDVLSQWQRHYNADRNR-------WHSAWR 51
Query: 333 LTNCSQMEMLYLNTNKFGGVFLRSIANL-SAKITVIGMGDNQISGTIPSEIKNLVNINAF 391
N + ++ + + + + + P + L ++
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 392 GVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP 451
++ L +P + + L+ L L RN LR +P ++ +L L L + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 452 SSLGNCQNLMTLSRL-----LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL 506
L + L L L + S+P + NL+NL + + S + +
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 507 SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566
LE L L+G + + P +K L L + +P + L L L+L
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285
Query: 567 YNHFEGEVP 575
+P
Sbjct: 286 GCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 52/304 (17%), Positives = 104/304 (34%), Gaps = 28/304 (9%)
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
S D + H + + +N + L + L+ T
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTGRAL-KATADLLEDATQP 81
Query: 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV 393
L L + F LS + + + + +P ++ + +
Sbjct: 82 ----GRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTL 134
Query: 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTL---------LNRLFLGFN 444
N L +P +I L L+ L++ +P+ L + L L L +
Sbjct: 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 445 NLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV 504
++ ++P+S+ N QNL + L + + L ++ + +L L E DL P
Sbjct: 194 GIR-SLPASIANLQNL----KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP 247
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
L+ L L+ S +LPL + L +++LDL ++P + L +
Sbjct: 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307
Query: 565 LSYN 568
+ +
Sbjct: 308 VPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 52/360 (14%), Positives = 115/360 (31%), Gaps = 40/360 (11%)
Query: 175 IGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNIS 234
+G + S E + + D L Q + + N +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA----DRNRWHSAWRQANSN 56
Query: 235 SLEIISLHSNRFEGSLPLNIGF-NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN 293
+ +I + + + + P L + P S+LQ + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 294 HFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVF 353
++ + + L L L++N L S + + +++ L +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLRALPAS-------IASLNRLRELSIRACPELTEL 166
Query: 354 LRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQ 413
+A+ E + LVN+ + +E+ + ++P +I L+NL+
Sbjct: 167 PEPLASTD----------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 414 GLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473
L + + L + + +L L L L N P G L + L L
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL----KRLILKDCS 264
Query: 474 LGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG---SLPLSL 530
++PL++ L L + DL + +P ++ + + + + P++
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/301 (16%), Positives = 94/301 (31%), Gaps = 55/301 (18%)
Query: 155 LIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNY 214
L++ +++ L +FPD S L+ + I A L +PD++ Q L
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLET 131
Query: 215 LSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274
L+++ N LP SI +++ L +S+ + LP + +
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA----------------STD 174
Query: 275 LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLT 334
NLQ L + + L NL L + + L + +
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPA-------IH 226
Query: 335 NCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV- 393
+ ++E L L G + P + +
Sbjct: 227 HLPKLEELDLR------------------------GCTALR-NYPPIFGGRAPLKRLILK 261
Query: 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS 453
+ + L T+P I L L+ L L +P + L + + +LQ +
Sbjct: 262 DCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQH 319
Query: 454 L 454
Sbjct: 320 R 320
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 91/472 (19%), Positives = 168/472 (35%), Gaps = 46/472 (9%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRI--PDSLCQLRSLNYLSI 217
NL L ++D+G +++ PD L + + L + L++L L +
Sbjct: 71 NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130
Query: 218 SENNFSC-KLPLSIWNISSLEIISLHSNRFEGSLPLNI-GFNIPNVNFLSVGQNNFTGSL 275
S+N L S ++SL+ I SN+ + ++F S+ N+ +
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV 190
Query: 276 PHSFSNASN------LQVLDVYKNHFSGQVKIDFNR------------LSNLSRLFLSKN 317
+ N L++LDV N ++ + +F+ ++ +
Sbjct: 191 SVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250
Query: 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT 377
N+ + L S + L L+ + R L + V+ + N+I+
Sbjct: 251 NIKDPDQNTFAGLAR----SSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKI 305
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
L N+ + YN L L + + L +N + T L L
Sbjct: 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365
Query: 438 RLFLGFNNLQ-----GNVPSSLGNCQNLMTLSRL------LDLSGNLLGG-SIPLEVGNL 485
L L N L ++P + L+TL ++ + LS N L I + +
Sbjct: 366 TLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV 425
Query: 486 RNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSL-----KTLKSIKEL 539
+L L++N FS+ T S +LE L L N + L + L ++ L
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485
Query: 540 DLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGN 591
L+ N L+ P +L L L+L+ N + + N + + N
Sbjct: 486 YLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 66/367 (17%), Positives = 132/367 (35%), Gaps = 18/367 (4%)
Query: 209 LRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQ 268
L + L +S N S + L+++ L S ++ N+PN+ L +G
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID--FNRLSNLSRLFLSKNNLGTESTSD 326
+ P +F +L L +Y S V D F L L+RL LSKN +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI-----RS 137
Query: 327 LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK-ITVIGMGDNQISGTIPSEIKNL 385
L + ++ + ++N+ V + L K ++ + N + + +
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 386 VN-INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFN 444
+N +E ++G + N++ + +L + GF+
Sbjct: 198 MNPFRNMVLEILDVSGN-------GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250
Query: 445 NLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV 504
N++ ++ ++ R LDLS + L++L +L+ N +
Sbjct: 251 NIKDPDQNTFAGLARS-SV-RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
L+ L+L N + L + +DL +N+++ + + L L L+
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
Query: 565 LSYNHFE 571
L N
Sbjct: 369 LRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-25
Identities = 59/319 (18%), Positives = 108/319 (33%), Gaps = 27/319 (8%)
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
+L + + L + N+ F L L L L +
Sbjct: 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE-----AF 69
Query: 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTI--PSEIKNLVNINAF 391
N + +L L ++K + + L + + + +S + +NL +
Sbjct: 70 RNLPNLRILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128
Query: 392 GVEYNQLTGTIPH-AIGELKNLQGLALVRNSLRGTIPDTLGNLTL--LNRLFLGFNNLQG 448
+ NQ+ H + G+L +L+ + N + L L L+ L N+L
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188
Query: 449 NVPSSLGNCQNLMTLSRL--LDLSGN------------LLGGSIPLEVGNLRNLAEFDLS 494
V G C N L LD+SGN + S + ++
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
Query: 495 ENHFSNEIPVTLS--ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPK 552
++ + T + A +++ +L L +TLK +K L+L+ N ++ +
Sbjct: 249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 553 YLENLLFLAYLNLSYNHFE 571
L L LNLSYN
Sbjct: 309 AFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 68/427 (15%), Positives = 138/427 (32%), Gaps = 49/427 (11%)
Query: 144 SNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP 203
++ + L + +D+ + L+ ++++ N +
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD 307
Query: 204 DSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNF 263
++ L +L L++S N + + + + I L N + + +
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQT 366
Query: 264 LSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTES 323
L + N T + ++ + + N KI+ + + LS+N L
Sbjct: 367 LDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRL---- 413
Query: 324 TSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIK 383
+LD L L +++L LN N+F + + + + +G+N + +E+
Sbjct: 414 -ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC 472
Query: 384 NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGF 443
L +LQ L L N L P +LT L L L
Sbjct: 473 -------------------WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
Query: 444 NNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIP 503
N L + L + L +LD+S N L +L+ D++ N F E
Sbjct: 514 NRL-----TVLSHNDLPANL-EILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECE 564
Query: 504 ----VTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
+ T + + + P S S+ L + + +L
Sbjct: 565 LSTFINWLNHTNVTIAGPPADIYCVY-PDSFS-GVSLFSLSTEGCDEEEVLKSLKFSLFI 622
Query: 560 LAYLNLS 566
+ + L+
Sbjct: 623 VCTVTLT 629
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 23/120 (19%), Positives = 40/120 (33%), Gaps = 5/120 (4%)
Query: 464 SRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523
R+ L +P L LS N+ + L+ L L
Sbjct: 6 GRIAFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 524 GSL-PLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
++ + + L +++ LDL + + P + L L L L + V + G F N
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 69/427 (16%), Positives = 152/427 (35%), Gaps = 25/427 (5%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
L+++ + +++ D + +LE +D+S N L L SL YL++
Sbjct: 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107
Query: 220 NNFSC-KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N + + N+++L+ + + + + + ++N L + + S
Sbjct: 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
+ ++ L ++ + + ++I + LS++ L L NL S L + + +
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIK-----------NLVN 387
+ L + +++ + D ++G V
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
I + L + L+ ++ + + + + +L L L L N +
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG---NLRNLAEFDLSENHFSNEIPV 504
+ +L + L LS N L S+ L+NL D+S N F +P
Sbjct: 348 EEYLKNSACKGAWPSL-QTLVLSQNHL-RSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
+ + +L+L + + ++++ LD+S NNL +L L L
Sbjct: 405 SCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQ---ELY 457
Query: 565 LSYNHFE 571
+S N +
Sbjct: 458 ISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 75/427 (17%), Positives = 159/427 (37%), Gaps = 29/427 (6%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
++ +D+ N++ + + L+ + + ++ + D+ L SL +L +S+N+ S
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGF-NIPNVNFLSVGQNNFTGSLP-HSFSN 281
+SSL+ ++L N ++ +L + F N+ N+ L +G + F+
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 282 ASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341
++L L++ + ++ L L + D L+ + ++
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR-YLELRD 205
Query: 342 LYLNTNKFG----GVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397
L +F + L+ + +V+ + I L + N
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 398 LTGTIPHAIG--------ELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN 449
L P E ++ L + + L + L + R+ + + +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-L 324
Query: 450 VPSSLGNCQNLMTLSRLLDLSGNLLGGSI---PLEVGNLRNLAEFDLSENHFSN--EIPV 504
VP S Q+L +L LDLS NL+ G +L LS+NH + +
Sbjct: 325 VPCSF--SQHLKSL-EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
L L L + N+F +P S + + ++ L+LS + + + L L+
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLD 437
Query: 565 LSYNHFE 571
+S N+ +
Sbjct: 438 VSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 60/406 (14%), Positives = 134/406 (33%), Gaps = 30/406 (7%)
Query: 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNR 245
A D + IP L ++ L +S N + + ++L+++ L S+R
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 246 FEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG-QVKIDFN 304
++ + +++ ++ L + N+ + F S+L+ L++ N + V F
Sbjct: 62 IN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKI 364
L+NL L + +DF L + + L + +S+ ++ I
Sbjct: 121 NLTNLQTLRIGNVET-FSEIRRIDFAGL----TSLNELEIKALSLRNYQSQSLKSIR-DI 174
Query: 365 TVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG 424
+ + ++ + + L ++ + L + + + +
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 425 TIPDTLGNLTLLNRL-------------FLGFNNLQGNVPSSLGNCQNLMTLS-RLLDLS 470
++ L L R G + + + + T++ R L +
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 471 GNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL---P 527
L + L + + + +LE+L L N
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 528 LSLKTLKSIKELDLSRNNLS--GQIPKYLENLLFLAYLNLSYNHFE 571
S++ L LS+N+L + + L L L L++S N F
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-27
Identities = 60/362 (16%), Positives = 120/362 (33%), Gaps = 25/362 (6%)
Query: 234 SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN 293
+ + S F S+P + + L + N T +NLQVL + +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 294 HFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVF 353
+ F L +L L LS N+L + S+S L+ L L L N + +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK------YLNLMGNPYQTLG 114
Query: 354 LRSIANLSAKITVIGMGDNQISGTIPSE-IKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
+ S+ + + +G+ + I L ++N ++ L ++ ++++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L L + + L+ + L L NL S L + + +L
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 473 LLGGSI--------------PLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQ 518
L S +E + D + + + T+ LH+
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 519 GNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKG 578
L L+ +K + + + + + ++L L +L+LS N E +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 579 VF 580
Sbjct: 355 AC 356
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-27
Identities = 65/413 (15%), Positives = 142/413 (34%), Gaps = 50/413 (12%)
Query: 160 NLLKLEMIDVGDNQLIGKFP-DFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
NL L+ + +G+ + + A ++L ++I A L SL +R +++L++
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEG--SLPLNIGFNIPNVNFLSVGQNNFT---- 272
+ + L + +SS+ + L PL + + L+ + T
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 273 GSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN-----------RLSNLSRLFLSKNNLGT 321
L L ++ +G + + + RL + + L
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTI--- 378
+ ++ + + +++ + + +K V +L + + + +N +
Sbjct: 301 DLST------VYSLLEKVKRITVENSKVFLVPCSFSQHLK-SLEFLDLSENLMVEEYLKN 353
Query: 379 PSEIKNLVNINAFGVEYNQLT--GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLL 436
+ ++ + N L + LKNL L + RN+ +PD+ +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 437 NRLFLGFNNLQ---GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493
L L ++ +P +L +LD+S N L S L + L+ L +
Sbjct: 413 RFLNLSSTGIRVVKTCIPQTL----------EVLDVSNNNLD-SFSLFLPRLQEL---YI 458
Query: 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
S N +P S L + + N L S++++ L N
Sbjct: 459 SRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 48/259 (18%), Positives = 90/259 (34%), Gaps = 16/259 (6%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
SI + L+A + + + N+I+ +++ N+ ++ +++ A L +L
Sbjct: 17 FTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL--LDLS 470
+ L L N L G L+ L L L N +LG L+ L L +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY-----QTLGVTSLFPNLTNLQTLRIG 131
Query: 471 GNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS 529
I L +L E ++ N +L + + +L L + + L +
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 530 LKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLI 589
L S++ L+L NL+ L + + R V + + L+
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF-------RGSVLTDESFNELL 244
Query: 590 GNERLCGGLEELHLPSCHF 608
R L E+ C
Sbjct: 245 KLLRYILELSEVEFDDCTL 263
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 45/276 (16%), Positives = 99/276 (35%), Gaps = 30/276 (10%)
Query: 208 QLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVG 267
+ ++ L I + L + ++ I++ +++ +P + ++ ++ FL +
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342
Query: 268 QNNFTGSLPHS---FSNASNLQVLDVYKNHFS--GQVKIDFNRLSNLSRLFLSKNNLGTE 322
+N + +LQ L + +NH + L NL+ L +S+N
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HP 401
Query: 323 STSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI 382
+ + L L++ V + + V+ + +N + + +
Sbjct: 402 MPDSCQWPEKMRF------LNLSSTGIRVVK----TCIPQTLEVLDVSNNNLD-SFSLFL 450
Query: 383 KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442
L + + N+L T+P L + + RN L+ LT L +++L
Sbjct: 451 PRLQELY---ISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478
N +C + LSR L+ + GS
Sbjct: 506 TNPWD-------CSCPRIDYLSRWLNKNSQKEQGSA 534
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 32/116 (27%), Positives = 49/116 (42%), Gaps = 4/116 (3%)
Query: 467 LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL 526
D SIP + + DLS N + L AC L+ L L+ + +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 527 PLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
+ +L S++ LDLS N+LS + L L YLNL N ++ + +F N
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 71/440 (16%), Positives = 147/440 (33%), Gaps = 36/440 (8%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLG-GRIPDSLCQLRSLNYLSIS 218
L L+ + + L I + L+ ++++ N++ ++P+ L +L +L +S
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 219 ENNFSCKLPLSIWNISSLEI----ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274
N + + + + + L N + F ++ L++ N + +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA-FKEIRLHKLTLRNNFDSLN 215
Query: 275 LPH-SFSNASNLQVLDVYKNHFSGQVKI---DFNRLSNLSRLFLSKNNLGTESTSDLDFL 330
+ + L+V + F + + D + L L L + + L D +
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 331 TLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLV---- 386
L + + L + V S + ++ Q +K L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335
Query: 387 ---NINAFG---------VEYNQLT--GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGN 432
N + + N L+ G + +L+ L L N + T+
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 433 LTLLNRLFLGFNNLQGNVPSS-LGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEF 491
L L L +NL+ S + +NL+ L D+S + L +L
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL----DISHTHTRVAFNGIFNGLSSLEVL 450
Query: 492 DLSENHFSNEI-PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQI 550
++ N F P + L +L L P + +L S++ L+++ N L
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 551 PKYLENLLFLAYLNLSYNHF 570
+ L L + L N +
Sbjct: 511 DGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-33
Identities = 87/449 (19%), Positives = 145/449 (32%), Gaps = 40/449 (8%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
+ +D+ N L +F L+ +D+S + + L L+ L ++ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT-GSLPHSFSNA 282
+ +SSL+ + SL ++ + L+V N LP FSN
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLS----RLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
+NL+ LD+ N D L + L LS N + + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHK---- 204
Query: 339 MEMLYLNTNKFGG----VFLRSIANLSAKITVIG--MGDNQISGTIPSEIKNLVNINAFG 392
L L N ++ +A L V+G + + S ++ L N+
Sbjct: 205 ---LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 393 VEYNQLTG---TIPHAIGELKNLQGLALVRNSLRGTIPDT-LGNLTLLNRLFLGFNNLQG 448
L I L N+ +LV ++ + L + F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 449 NVPSSL----------GNCQNLMTLSRL--LDLSGNLLG--GSIPLEVGNLRNLAEFDLS 494
SL GN + + L L LDLS N L G +L DLS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 495 ENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLSGQIPKY 553
N + LE+L Q ++ S +L+++ LD+S +
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 554 LENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
L L L ++ N F+ +F
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLP-DIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 71/419 (16%), Positives = 150/419 (35%), Gaps = 40/419 (9%)
Query: 160 NLLKLEMIDVGDNQL-IGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
+L L+ ++V N + K P++ +N + LE +D+S+N + L L + L++S
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 219 ---ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS------VGQN 269
N + + L ++L +N ++ + + +
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 270 NFTGSLPHSFSNASNLQVLDVYKNH---FSGQVKIDFNRLSNLSRLFLSKNNLGT----E 322
N + NL + + + + + FN L+N+S L +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
Query: 323 STSDLDFLTLLTNC---------SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQ 373
L L+ ++ L +NK G F S +L + + + N
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLP-SLEFLDLSRNG 358
Query: 374 IS--GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTL 430
+S G ++ + +N + T+ L+ L+ L ++L+
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 431 GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLA 489
+L L L + + + +L +L ++GN + ++ LRNL
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSL----EVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLS 547
DLS+ P ++ ++L+ L++ N S+P L S++++ L N
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 79/425 (18%), Positives = 140/425 (32%), Gaps = 28/425 (6%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L L + + N + + S+L+ + L + L++L L+++
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 220 NNF-SCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVG---QNNFTGSL 275
N S KLP N+++LE + L SN+ + S+ + + L++ N +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 276 PHSFSNASNLQVLDVYKNHFSGQV-KIDFNRLSNLSRLFLSKN---NLGTESTSDLDFLT 331
L L + N S V K L+ L L N G D L
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 332 LLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIP-SEIKNLVNINA 390
L N +E L + + + N ++ + I S ++
Sbjct: 253 GLCN-LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ--G 448
++ Q +LK+L+ L N + +L L L L N L G
Sbjct: 312 VNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKG 363
Query: 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV-TLS 507
S +L + LDLS N + ++ L L D ++
Sbjct: 364 CCSQSDFGTTSL----KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 508 ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLS 566
+ L YL + + L S++ L ++ N+ L L +L+LS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 567 YNHFE 571
E
Sbjct: 479 QCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 75/411 (18%), Positives = 144/411 (35%), Gaps = 43/411 (10%)
Query: 202 IPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
IPD+L S L +S N S ++ L+++ L + ++ ++ ++
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321
+ L + N +FS S+LQ L + + + L L L ++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI-- 136
Query: 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVF---LRSIANLSAKITVIGMGDNQISGTI 378
+N + +E L L++NK ++ LR + + + + N ++ I
Sbjct: 137 ---QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 379 PSEIKNLVNINAFGVEYNQLTGTIPH-AIGELKNLQGLALVRNSLRGTI------PDTLG 431
+ ++ + N + + I L L+ LV R L
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 432 NLTLLNRLFLGFNNLQG---NVPSSLGNCQNL-------MTLSRLLDLSGNLLGGSI--- 478
L L L ++ N+ +T+ R+ D S N +
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312
Query: 479 -----PLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGN--SFSGSLPLSLK 531
L++L + N N + +LE+L L N SF G S
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 532 TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
S+K LDLS N + + L L +L+ +++ + ++ VF +
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 66/397 (16%), Positives = 128/397 (32%), Gaps = 35/397 (8%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEA----IDISANMLGGRIPDSLCQLRSLNYL 215
NL LE +D+ N++ + + + +D+S N + I + L+ L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 216 SISENNFSCKLP-LSIWNISSLEIISLHSNRFEG-----SLPLNIGFNIPNVNFLS---V 266
++ N S + I ++ LE+ L F + + N+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 267 GQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNR-LSNLSRLFLSKNNLGTESTS 325
+ + + F+ +N+ + +N +L + T
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 326 DLDFLTLLTN----------CSQMEMLYLNTNKFGGVFLRSIANLS-AKITVIGMGDNQI 374
L LT +N +E L L+ N S ++ + + + N +
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 375 SGTIPSEIKNLVNINAFGVEYNQLTGTIPH-AIGELKNLQGLALVRNSLRGTIPDTLGNL 433
T+ S L + +++ L L+NL L + R L
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 434 TLLNRLFLGFNNLQGNVPS-SLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEF 491
+ L L + N+ Q N +NL LDLS L + +L +L
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNL----TFLDLSQCQLE-QLSPTAFNSLSSLQVL 499
Query: 492 DLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL 528
+++ N + T+L+ + L N + S P
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 42/226 (18%), Positives = 73/226 (32%), Gaps = 12/226 (5%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
I NL + + N + + + + ++ A L +L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L L N ++ L+ L +L NL +G+ + L + L+++ N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL----KELNVAHN 134
Query: 473 LLG-GSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY----LHLQGNSFSGSLP 527
L+ +P NL NL DLS N + L + L L N + +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 528 LSLKTLKSIKELDLSRNNLSGQIPK-YLENLLFLAYLNLSYNHFEG 572
+ +L L N S + K ++ L L L F
Sbjct: 194 PGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 61/342 (17%), Positives = 119/342 (34%), Gaps = 28/342 (8%)
Query: 142 HQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIG-KFPDFIANFSALEAIDISANMLGG 200
++ LE + ++ L L +E + D + + + + + +
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296
Query: 201 RIPDS-LCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIP 259
S + L ++ F + SL+ ++ SN+ + ++P
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS---EVDLP 347
Query: 260 NVNFLSVGQNNFT--GSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317
++ FL + +N + G S ++L+ LD+ N + +F L L L +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406
Query: 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT 377
NL + ++ + + L ++ F LS + V+ M N
Sbjct: 407 NL-----KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQEN 460
Query: 378 IPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLL 436
+I L N+ + QL P A L +LQ L + N L+ LT L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 437 NRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478
+++L N +C + LSR L+ + GS
Sbjct: 521 QKIWLHTNPWD-------CSCPRIDYLSRWLNKNSQKEQGSA 555
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 50/398 (12%), Positives = 110/398 (27%), Gaps = 30/398 (7%)
Query: 178 FPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237
+ N + + ++ + L + ++ L +S N S + + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG 297
+++L SN +L L ++ + L + N +++ L N+ S
Sbjct: 62 LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 298 QVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI 357
++ +R ++L+ N + D + + L L N+ V +
Sbjct: 113 --RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY------LDLKLNEIDTVNFAEL 164
Query: 358 ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLAL 417
A S + + + N I + ++ + + N+L + + ++L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 418 VRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477
N L I L L L N R+ ++ +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVKKL 275
Query: 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS----LPLSLKTL 533
+ L+ S GS L +
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 534 KSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+E+D + I + L +
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 61/421 (14%), Positives = 125/421 (29%), Gaps = 41/421 (9%)
Query: 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
N + ++ V D+ L + ++ +D+S N L L L L++S
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N + + ++S+L + L++N + L P++ L NN +
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSR 118
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
+ + + N + +D S + L L N + ++F L +
Sbjct: 119 G---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAASSDT 170
Query: 339 MEMLYLNTNKF----GGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394
+E L L N G V + L + N+++ + E ++ + +
Sbjct: 171 LEHLNLQYNFIYDVKGQVVFAKLKTLD-------LSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLR-GTIPDTLGNLTLLNRLFL-GFNNLQGNVPS 452
N+L I A+ +NL+ L N GT+ D + + L G
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 453 SLGNCQNL-MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTT 511
DL I L+ L + +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL---SGQGSETE-RLECERENQAR 337
Query: 512 LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+ + + ++ L+ + L + A+ L +
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD-----EQVSNGRRAHAELDGTLQQ 392
Query: 572 G 572
Sbjct: 393 A 393
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-28
Identities = 47/298 (15%), Positives = 101/298 (33%), Gaps = 27/298 (9%)
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
++ N + ++ V + + N+ L LS N L S +DL T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV 393
E+L L++N + +LS + + + +N + E+ +I
Sbjct: 61 ------ELLNLSSNVLYE--TLDLESLS-TLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG-NVPS 452
N ++ + + + + L N + G + + L L N + N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 453 SLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTL 512
+ L L+L N + + +V L DLS N + + + +
Sbjct: 164 LAASSDTL----EHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 513 EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS-GQIPKYLENLLFLAYLNLSYNH 569
++ L+ N + +L+ ++++ DL N G + + + +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 43/352 (12%), Positives = 105/352 (29%), Gaps = 11/352 (3%)
Query: 152 NLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGG-RIPDSLCQLR 210
N+ + + I + +N++ S ++ +D+ N + +
Sbjct: 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNN 270
+L +L++ N + + + L+ + L SN+ + + V ++S+ N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNK 225
Query: 271 FTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFL 330
+ + + NL+ D+ N F DF N ++K + + + +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 331 TLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINA 390
T+ T F + L K + G + + E +N
Sbjct: 284 TVPT---LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
Q I + L + +L + + L+ +
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-EL 399
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEI 502
+ L L ++ + ++ +R+ + E + E
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEEN 451
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 477 SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSI 536
+I N ++++ + + ++ L L GN S L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 537 KELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+ L+LS N L + LE+L L L+L+ N+ +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 74/339 (21%), Positives = 128/339 (37%), Gaps = 30/339 (8%)
Query: 209 LRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQ 268
L + ++ + + + +E+++L+ + E + + L +G
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
N PH F N L VL + +N S + F+ L+ L +S NNL ++
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-----ERIE 157
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNI 388
T + ++ L L++N+ V L I +L + N +S + + +
Sbjct: 158 DDTF-QATTSLQNLQLSSNRLTHVDLSLIPSL----FHANVSYNLLS-----TLAIPIAV 207
Query: 389 NAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448
+N + + + L L L N+L T L N L + L +N L+
Sbjct: 208 EELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEK 262
Query: 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA 508
+ Q L L +S N L ++ L + L DLS NH +
Sbjct: 263 IMYHPFVKMQRL----ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
Query: 509 CTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547
LE L+L NS +L LS T ++K L LS N+
Sbjct: 317 FDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 52/331 (15%), Positives = 106/331 (32%), Gaps = 28/331 (8%)
Query: 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKI 301
+ N+ ++ + + + +N +++ +
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYD-VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 63
Query: 302 DFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLS 361
+ + L L+ + T + + + LY+ N + N+
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTI------QKLYMGFNAIRYLPPHVFQNVP 117
Query: 362 AKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRN 420
+TV+ + N +S ++P I N + + N L +LQ L L N
Sbjct: 118 -LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 421 SLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480
L + L + L + +N L S+L + LD S N + +
Sbjct: 176 RLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAV----EELDASHNSINV---V 220
Query: 481 EVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELD 540
L L N+ + + L L + L N + ++ ++ L
Sbjct: 221 RGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278
Query: 541 LSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+S N L + Y + + L L+LS+NH
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 48/241 (19%), Positives = 81/241 (33%), Gaps = 23/241 (9%)
Query: 371 DNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTL 430
E L N + + + + + ++ L L +
Sbjct: 30 MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF 89
Query: 431 GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLA 489
+ +L++GFN ++ P N L +L L N L S+P + N L
Sbjct: 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLL----TVLVLERNDL-SSLPRGIFHNTPKLT 144
Query: 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ 549
+S N+ T A T+L+ L L N + + L + S+ ++S N LS
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-- 199
Query: 550 IPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNE-------RLCGGLEELH 602
L + + L+ S+N V V T + L N GL E+
Sbjct: 200 ---TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHNNLTDTAWLLNYPGLVEVD 254
Query: 603 L 603
L
Sbjct: 255 L 255
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 49/290 (16%), Positives = 99/290 (34%), Gaps = 50/290 (17%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
N+ L ++ + N L + + L LS+S
Sbjct: 115 NVPLLTVLVLERNDL----------------SSLPRGIFHN--------TPKLTTLSMSN 150
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
NN + +SL+ + L SNR + L+ IP++ +V N + +
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLLS-----TL 201
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
+ ++ LD N + + L+ L L NNL + L N +
Sbjct: 202 AIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTDTAW--------LLNYPGL 250
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
+ L+ N+ + + ++ + + +N++ + + + + + +N L
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN 449
+ + L+ L L NS+ T+ L L L L N+ N
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 26/140 (18%), Positives = 46/140 (32%), Gaps = 4/140 (2%)
Query: 445 NLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP--LEVGNLRNLAEFDLSENHFSNEI 502
N++ P NL D+ ++ + E L N +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 61
Query: 503 PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAY 562
L + +E L+L + +I++L + N + P +N+ L
Sbjct: 62 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121
Query: 563 LNLSYNHFEGEVPRKGVFGN 582
L L N +PR G+F N
Sbjct: 122 LVLERNDLS-SLPR-GIFHN 139
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 44/298 (14%), Positives = 101/298 (33%), Gaps = 27/298 (9%)
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
++ N + ++ V + + N+ L LS N L S + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54
Query: 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV 393
+++E+L L++N + +LS + + + +N + E+ +I
Sbjct: 55 APFTKLELLNLSSNVLYE--TLDLESLS-TLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG-NVPS 452
N ++ + + + + L N + G + + L L N + N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 453 SLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTL 512
+ L L+L N + + +V L DLS N + + + +
Sbjct: 164 LAASSDTL----EHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 513 EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS-GQIPKYLENLLFLAYLNLSYNH 569
++ L+ N + +L+ ++++ DL N G + + + +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/345 (16%), Positives = 108/345 (31%), Gaps = 39/345 (11%)
Query: 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
N + ++ V D+ L + ++ +D+S N L L L L++S
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N + + ++S+L + L++N + L P++ L NN + +
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS-RVS-- 115
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338
S + + + N + +D S + L L N + ++F L +
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAASSDT 170
Query: 339 MEMLYLNTNKF----GGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394
+E L L N G V + L + N+++ + E ++ + +
Sbjct: 171 LEHLNLQYNFIYDVKGQVVFAKLKTLD-------LSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454
N+L I A+ +NL+ L N G L + L
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGF------HCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
L G +P L +H
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLP----APFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 50/372 (13%), Positives = 104/372 (27%), Gaps = 59/372 (15%)
Query: 202 IPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
I + +++++ L + +++ + L N +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS---------- 50
Query: 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321
+ + L++L++ N +D LS L L L+ N
Sbjct: 51 --------------AADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNY--- 91
Query: 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSE 381
+ L +E L+ N V I + +N+I+ +
Sbjct: 92 --------VQELLVGPSIETLHAANNNISRVSCSRGQGK----KNIYLANNKITMLRDLD 139
Query: 382 IKNLVNINAFGVEYNQLTG-TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF 440
+ ++ N++ L+ L L N + + + L L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLD 197
Query: 441 LGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS- 499
L N L + + + + L N L I + +NL FDL N F
Sbjct: 198 LSSNKLA-FMGPEFQSAAGV----TWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHC 251
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
+ S ++ + Q L + ++ L +P
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPA----PFA 304
Query: 560 LAYLNLSYNHFE 571
+ L ++H
Sbjct: 305 DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/364 (14%), Positives = 109/364 (29%), Gaps = 50/364 (13%)
Query: 179 PDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238
+ N + + ++ + L + ++ L +S N S + + LE+
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQ 298
++L SN +L L ++ + L + N +++ L N+ S
Sbjct: 63 LNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-- 112
Query: 299 VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA 358
++ +R ++L+ N + DLD S+++ L L N
Sbjct: 113 -RVSCSRGQGKKNIYLANNKI--TMLRDLDEGCR----SRVQYLDLKLN----------- 154
Query: 359 NLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALV 418
+I + + + ++YN + + + L+ L L
Sbjct: 155 ----EIDTV---------NFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLS 199
Query: 419 RNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478
N L + + + + L N L + +L QNL DL GN
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL----EHFDLRGNGF-HCG 252
Query: 479 PLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKE 538
L +N +++ CT H L ++
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGH 312
Query: 539 LDLS 542
Sbjct: 313 HHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 477 SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSI 536
+I N ++++ + + ++ L L GN S L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 537 KELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
+ L+LS N L + LE+L L L+L+ N+ +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 73/379 (19%), Positives = 130/379 (34%), Gaps = 61/379 (16%)
Query: 201 RIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFN--- 257
+P ++S + + + P + + L + L +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 258 -----IPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRL 312
P++ L N+ T LP + +L V + S L L
Sbjct: 85 SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL-------PPLLEYL 136
Query: 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372
+S N L L L N S ++++ ++ N L+ + +L + I G+N
Sbjct: 137 GVSNNQLEK--------LPELQNSSFLKIIDVDNNS-----LKKLPDLPPSLEFIAAGNN 183
Query: 373 QISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGN 432
Q+ E++NL + A + N L +P +L+ + N L L N
Sbjct: 184 QL--EELPELQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNIL--EELPELQN 235
Query: 433 LTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFD 492
L L ++ N L+ +P + + L++ N L +P +L L +
Sbjct: 236 LPFLTTIYADNNLLK-TLPDLPPSLEA-------LNVRDNYL-TDLPELPQSLTFLDVSE 286
Query: 493 LSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPK 552
+ S P L YL+ N SL +L +EL++S N L ++P
Sbjct: 287 NIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPSL---EELNVSNNKLI-ELPA 334
Query: 553 YLENLLFLAYLNLSYNHFE 571
L L S+NH
Sbjct: 335 LPPRLE---RLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-30
Identities = 80/445 (17%), Positives = 155/445 (34%), Gaps = 89/445 (20%)
Query: 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYL 215
++ + +++ + L P+ + LE++ S N L +P+ L+SL
Sbjct: 65 LRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 216 SISENNFSCKLPL---------------SIWNISSLEIISLHSNRFEGSLPLNIGFNIPN 260
+ + S PL + N S L+II + +N + LP P+
Sbjct: 120 NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP----DLPPS 174
Query: 261 VNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320
+ F++ G N LP N L + N +K + +L + N L
Sbjct: 175 LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNN----SLKKLPDLPLSLESIVAGNNILE 228
Query: 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS 380
L L N + +Y + N L+++ +L + + + DN ++ +P
Sbjct: 229 E--------LPELQNLPFLTTIYADNNL-----LKTLPDLPPSLEALNVRDNYLT-DLPE 274
Query: 381 EIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF 440
++L ++ ++ L+ P NL L N +R ++ D +L LN
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPSLEELN--- 323
Query: 441 LGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN 500
+ N L +P+ + L S N L +P NL+ L + N
Sbjct: 324 VSNNKLI-ELPALPPRLERL-------IASFNHLA-EVPELPQNLKQL---HVEYNPLR- 370
Query: 501 EIPVTLSACTT----------------LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544
E P + L+ LH++ N P ++++ +L ++
Sbjct: 371 EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE---DLRMNSE 426
Query: 545 NLSGQIPKYLENLLFLAYLNLSYNH 569
+ E L ++H
Sbjct: 427 RVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 71/340 (20%), Positives = 123/340 (36%), Gaps = 57/340 (16%)
Query: 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISEN 220
LE I G+NQL + P+ N L AI N L ++PD L S+ N
Sbjct: 172 PPSLEFIAAGNNQLE-ELPELQ-NLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNN 225
Query: 221 NFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS 280
+LP + N+ L I +N + +LP ++ L+V N T LP
Sbjct: 226 ILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPP----SLEALNVRDNYLT-DLPELPQ 277
Query: 281 NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQME 340
+ + L V + + S NL L S N + + L +E
Sbjct: 278 SLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIRS----------LCDLPPSLE 320
Query: 341 MLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400
L ++ NK L + L ++ + N ++ +P +NL ++ VEYN L
Sbjct: 321 ELNVSNNK-----LIELPALPPRLERLIASFNHLA-EVPELPQNLKQLH---VEYNPLR- 370
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
P +++L+ NS +P+ NL L+ + N L+ P + ++L
Sbjct: 371 EFPDIPESVEDLR-----MNSHLAEVPELPQNLKQLH---VETNPLR-EFPDIPESVEDL 421
Query: 461 MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN 500
++ + L + +H +
Sbjct: 422 -------RMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 73/362 (20%), Positives = 137/362 (37%), Gaps = 59/362 (16%)
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
S + + + ++++ + +LP + ++ L + NN T SLP
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA 78
Query: 278 SFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCS 337
L+ L+V N + + + L LS +L L +
Sbjct: 79 LPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA----------LPSG-- 122
Query: 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397
+ L++ N+ L S+ L + + + DNQ++ ++P+ L + A+ NQ
Sbjct: 123 -LCKLWIFGNQ-----LTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKLWAYN---NQ 172
Query: 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNC 457
LT ++P LQ L++ N L ++P L L +L P+
Sbjct: 173 LT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL----PALPSGL 223
Query: 458 QNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHL 517
+ L +SGN L S+P+ L+ L +S N + +P+ + L L +
Sbjct: 224 KEL-------IVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLP---SGLLSLSV 268
Query: 518 QGNSFSGSLPLSLKTLKSIKELDLSRNNLS---GQIPKYLENLLFLAYLNLSYNHFEGEV 574
N + LP SL L S ++L N LS Q + + + + + ++
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASA 327
Query: 575 PR 576
PR
Sbjct: 328 PR 329
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-29
Identities = 68/340 (20%), Positives = 124/340 (36%), Gaps = 59/340 (17%)
Query: 207 CQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSV 266
C L++ E+ + LP + + + + N SLP + L V
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP----ELRTLEV 88
Query: 267 GQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSD 326
N T SLP L + H S L +L++ N L +
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLTS----- 135
Query: 327 LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLV 386
L ++ L ++ N+ L S+ L +++ + +NQ++ ++P L
Sbjct: 136 -----LPVLPPGLQELSVSDNQ-----LASLPALPSELCKLWAYNNQLT-SLPMLPSGLQ 184
Query: 387 NINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446
++ V NQL ++P EL L N L ++P L L + N L
Sbjct: 185 ELS---VSDNQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLK---ELIVSGNRL 233
Query: 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL 506
++P + L +SGN L S+P+ L +L + N + +P +L
Sbjct: 234 T-SLPVLPSELKEL-------MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESL 280
Query: 507 SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
++ ++L+GN S +L+ L+ I +
Sbjct: 281 IHLSSETTVNLEGNPLS---ERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 74/411 (18%), Positives = 139/411 (33%), Gaps = 61/411 (14%)
Query: 138 EDWMHQSNDKLEAGNLGLIQRLNLL---KLEMIDVGDNQLIGKFPDFIANFSALEAIDIS 194
W + + G ++Q++ +++VG++ L PD + + + + I
Sbjct: 13 SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIP 69
Query: 195 ANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNI 254
N L +P +LR+L +S N + LP+ + L I S
Sbjct: 70 DNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS--- 121
Query: 255 GFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314
+ L + N T SLP LQ L V N + + S L +L+
Sbjct: 122 -----GLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA---SLP-ALPSELCKLWA 168
Query: 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQI 374
N L + L S ++ L ++ N+ L S+ L +++ + +N++
Sbjct: 169 YNNQLTS----------LPMLPSGLQELSVSDNQ-----LASLPTLPSELYKLWAYNNRL 213
Query: 375 SGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLT 434
+ ++P+ L + V N+LT ++P ELK L + N L ++P L
Sbjct: 214 T-SLPALPSGLKELI---VSGNRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLL 264
Query: 435 LLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLS 494
L + N L +P SL + + ++L GN L + + + +
Sbjct: 265 ---SLSVYRNQLT-RLPESLIHLSSE----TTVNLEGNPLSERTLQALREITSAPGYSGP 316
Query: 495 ENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNN 545
F L + + N
Sbjct: 317 IIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 65/314 (20%), Positives = 111/314 (35%), Gaps = 15/314 (4%)
Query: 259 PNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318
L +G+N F++ +L+ L++ +N S FN L NL L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 319 LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTI 378
L L+ LT L ++ NK + +L + + +GDN + I
Sbjct: 92 LKLIPLGVFTGLSNLTK------LDISENKIVILLDYMFQDLY-NLKSLEVGDNDLV-YI 143
Query: 379 PSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
L ++ +E LT A+ L L L L ++ + L L
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSEN 496
L + + + NL L ++ L ++P +L L +LS N
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNL----TSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYN 258
Query: 497 HFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556
S L L+ + L G + P + + L ++ L++S N L+ +
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318
Query: 557 LLFLAYLNLSYNHF 570
+ L L L N
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 13/290 (4%)
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
+ ++LD+ KN + +F +L L L++N + S ++ N + L
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-----SAVEPGAF-NNLFNLRTL 85
Query: 343 YLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGT 401
L +N+ + L LS +T + + +N+I + + ++L N+ + V N L
Sbjct: 86 GLRSNRLKLIPLGVFTGLS-NLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLM 461
A L +L+ L L + +L + L +L L L L N+ S L
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL- 202
Query: 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521
++L++S ++ NL ++ + + + + L +L+L N
Sbjct: 203 ---KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
S L L ++E+ L L+ P L +L LN+S N
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 69/340 (20%), Positives = 114/340 (33%), Gaps = 38/340 (11%)
Query: 185 FSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244
+ +D+ N + D L L ++EN S P + N+ +L + L SN
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN 304
R + +PL + + N+ L + +N L + F + NL+ L+V N F+
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149
Query: 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKI 364
L++L +L L K NL + T L L L L L
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIV------LRLR------------------- 184
Query: 365 TVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG 424
I+ K L + + + T+ NL L++ +L
Sbjct: 185 ------HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 425 TIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-G 483
+ +L L L L +N + S L L + L G L +
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQE----IQLVGGQL-AVVEPYAFR 293
Query: 484 NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523
L L ++S N + + LE L L N +
Sbjct: 294 GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 53/265 (20%), Positives = 97/265 (36%), Gaps = 10/265 (3%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L + + N+L S L +DIS N + + L +L L + +
Sbjct: 78 NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N+ + ++SLE ++L S+P ++ + L + N +SF
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
L+VL++ + + + NL+ L ++ NL + L L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR----- 251
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQL 398
L L+ N + + L ++ I + Q++ + + L + V NQL
Sbjct: 252 -FLNLSYNPISTIEGSMLHELL-RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
Query: 399 TGTIPHAIGELKNLQGLALVRNSLR 423
T + NL+ L L N L
Sbjct: 309 TTLEESVFHSVGNLETLILDSNPLA 333
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-28
Identities = 76/413 (18%), Positives = 135/413 (32%), Gaps = 79/413 (19%)
Query: 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLS 216
+ + L +++ ++ + + +F +E ++++ + + ++ L
Sbjct: 46 EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLY 105
Query: 217 ISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLP 276
+ N P N+ L ++ L N SLP I N P + LS+ NN
Sbjct: 106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIED 164
Query: 277 HSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNC 336
+F ++LQ L + N + +D + + +L +S N L+ L
Sbjct: 165 DTFQATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNL-----------LSTLAIP 210
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYN 396
+E L + N I+ + +
Sbjct: 211 IAVEELDAS-------------------------HNSIN-VVRGPV-------------- 230
Query: 397 QLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGN 456
L L L N+L T L N L + L +N L+ +
Sbjct: 231 ------------NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 457 CQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLH 516
Q L L +S N L ++ L + L DLS NH + LE L+
Sbjct: 277 MQRL----ERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG-QIPKYLENLLFLAYLNLSYN 568
L NS L L T ++K L LS N+ + N+ A + +
Sbjct: 331 LDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 77/428 (17%), Positives = 151/428 (35%), Gaps = 33/428 (7%)
Query: 202 IPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
I +L + I +++ +I++ ++ LP + + V
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321
L++ ++F+ A +Q L + N F + L+ L L +N+L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-- 135
Query: 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSE 381
S L + N ++ L ++ N + + + + + + N+++ S
Sbjct: 136 ---SSLP-RGIFHNTPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLTHVDLSL 190
Query: 382 IKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFL 441
I +L + N V YN L+ + ++ L NS+ LT+L L
Sbjct: 191 IPSLFHAN---VSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK---L 239
Query: 442 GFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSN 500
NNL + L N L +DLS N L I ++ L +S N
Sbjct: 240 QHNNLTD--TAWLLNYPGL----VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA 292
Query: 501 EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFL 560
+ + TL+ L L N + + ++ L L N++ + L L
Sbjct: 293 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347
Query: 561 AYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRITLLK 620
L LS+N ++ + +F N + ++ C +L C + LL+
Sbjct: 348 KNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 621 VVIPVAVI 628
+ +V+
Sbjct: 407 YIALTSVV 414
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 4e-19
Identities = 66/309 (21%), Positives = 106/309 (34%), Gaps = 32/309 (10%)
Query: 268 QNNFTGSLPHSFSNASNLQVLDVYKN----HFSGQVKIDFN--RLSNLSRLFLSKNNLGT 321
+ N P SNLQ V+ + + V F L+N + + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSE 381
+ LD + E+L LN + + + A I + MG N I +P
Sbjct: 66 LPAALLDSFRQV------ELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPH 117
Query: 382 I-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF 440
+ +N+ + +E N L+ L L++ N+L DT T L L
Sbjct: 118 VFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177
Query: 441 LGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN 500
L N L S + + + ++S NLL + + E D S N +
Sbjct: 178 LSSNRLTHVDLSLIPSLFHA-------NVSYNLLS-----TLAIPIAVEELDASHNSINV 225
Query: 501 EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFL 560
V L L LQ N+ + L + E+DLS N L + + L
Sbjct: 226 ---VRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 280
Query: 561 AYLNLSYNH 569
L +S N
Sbjct: 281 ERLYISNNR 289
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 5e-15
Identities = 52/271 (19%), Positives = 94/271 (34%), Gaps = 39/271 (14%)
Query: 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSE 381
E L + + + + G ++ N ++ ++ + +P+
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQ----KIVTFKNSTMR-KLPAA 69
Query: 382 I-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF 440
+ + + + Q+ +A +Q L + N++R P N+ LL L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 441 LGFNNLQGNVPSSLGNCQNLMTLS--------------------RLLDLSGNLLGGSIPL 480
L N+L N L TLS + L LS N L +
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---V 186
Query: 481 EVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELD 540
++ + +L ++S N S TL+ +E L NS + + + L
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVELTILK 238
Query: 541 LSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L NNL+ +L N L ++LSYN E
Sbjct: 239 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELE 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 57/416 (13%), Positives = 107/416 (25%), Gaps = 33/416 (7%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+ +E +D N I L + + N L L L + +S
Sbjct: 209 IPIAVEELDASHNS-INVVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSY 263
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N + + LE + + +NR +L L IP + L + N+ + +
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQ 320
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
L+ L + N + + L L LS N+ L N ++
Sbjct: 321 PQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW-----DCNSLRALFRNVARP 372
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
+ + + L D + I + + +
Sbjct: 373 AVDDADQHCKIDYQLEHGL-------CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
T I +++L + + + L +N L L Q
Sbjct: 426 AT--DTINSVQSLSHYITQQGGVPLQGNEQL--EAEVNELRAEVQQLTNEQIQQEQLLQG 481
Query: 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL-----SACTTLEY 514
L L + NL + F + E
Sbjct: 482 LHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETED 541
Query: 515 LHLQGNSFSGSLPL-SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
L + + L K + +E L R + K N + ++H
Sbjct: 542 LEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHHH 597
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 26/141 (18%), Positives = 46/141 (32%), Gaps = 4/141 (2%)
Query: 444 NNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP--LEVGNLRNLAEFDLSENHFSNE 501
N++ P NL D+ ++ + E L N +
Sbjct: 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 66
Query: 502 IPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLA 561
L + +E L+L + +I++L + N + P +N+ L
Sbjct: 67 PAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126
Query: 562 YLNLSYNHFEGEVPRKGVFGN 582
L L N +PR G+F N
Sbjct: 127 VLVLERNDLS-SLPR-GIFHN 145
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 39/107 (36%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 39 SYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEA 98
DL +ATNNF +IG G FG VYKG L G VA+K + + F TE E
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 99 LSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
LS RH +L+ +I C + LIY+YM+ G+ + ++ S+
Sbjct: 89 LSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSD 130
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 7/109 (6%)
Query: 39 SYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECE 97
S +L A++NFS N++G+G FG VYKG+L GT VAVK + + +G F TE E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 98 ALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146
+S HRNL+++ C + + L+Y YM GS + + +
Sbjct: 80 MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPE 123
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 70/320 (21%), Positives = 118/320 (36%), Gaps = 32/320 (10%)
Query: 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH 294
L ++ E +P ++ P+ L + N T F N NL L + N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 295 FSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFL 354
S F L L RL+LSKN L E + TL + L ++ N+ V
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQL-KELPEKM-PKTL-------QELRVHENEITKVRK 138
Query: 355 RSIANLSAKITVIGMGDNQI-SGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L+ ++ V+ +G N + S I + + + ++ + +T TIP G +L
Sbjct: 139 SVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSL 194
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L L N + +L L L +L L FN++ SL N +L R L L+ N
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL----RELHLNNN 250
Query: 473 LLGGSIPLEVGNLRNLAEFDLSENHFSN------EIPVTLSACTTLEYLHLQGNSFSGSL 526
L +P + + + + L N+ S P + + + L N
Sbjct: 251 KL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
Query: 527 --PLSLKTLKSIKELDLSRN 544
P + + + + L
Sbjct: 310 IQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 14/235 (5%)
Query: 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398
+L L NK + NL + + + +N+IS P LV + + NQL
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV--PSSLGN 456
+P K LQ L + N + L + + LG N L+ + +
Sbjct: 113 K-ELP--EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 457 CQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLH 516
+ L + ++ + +IP G +L E L N + +L L L
Sbjct: 170 MKKL----SYIRIADTNIT-TIP--QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L NS S SL ++EL L+ N L ++P L + ++ + L N+
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 60/276 (21%), Positives = 97/276 (35%), Gaps = 36/276 (13%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
+ + L L N + D L L L L NK + + A L K+
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHT------LILINNKISKISPGAFAPLV-KLER 104
Query: 367 IGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGT 425
+ + NQ+ +P ++ K L + V N++T L + + L N L+ +
Sbjct: 105 LYLSKNQLK-ELPEKMPKTLQELR---VHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 426 I--PDTLGNLTLLNRLFLGFNNL---QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480
+ L+ + + N+ +P SL L L GN + +
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL----------TELHLDGNKIT-KVDA 209
Query: 481 EV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKEL 539
L NLA+ LS N S +L+ L LHL N +P L K I+ +
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268
Query: 540 DLSRNNLSG------QIPKYLENLLFLAYLNLSYNH 569
L NN+S P Y + ++L N
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 49/293 (16%), Positives = 102/293 (34%), Gaps = 45/293 (15%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L + + +N++ P A LE + +S N L +P+ + ++L L + E
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHE 130
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N + ++ + ++ L +N + S I +F
Sbjct: 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSS-------GIE----------------NGAF 167
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
L + + + + I +L+ L L N + + L L L
Sbjct: 168 QGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL------ 218
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
L L+ N V S+AN + + + +N++ +P + + I + N ++
Sbjct: 219 AKLGLSFNSISAVDNGSLANTP-HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
Query: 400 G------TIPHAIGELKNLQGLALVRNSLRGTI--PDTLGNLTLLNRLFLGFN 444
P + + G++L N ++ P T + + + LG
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 32/195 (16%), Positives = 62/195 (31%), Gaps = 39/195 (20%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+ KL I + D I P + +L + + N + SL L +L L +S
Sbjct: 169 GMKKLSYIRIADTN-ITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N+ S S+ N L + L++N+ +P
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV--------------------------KVPGGL 259
Query: 280 SNASNLQVLDVYKNHFSG------QVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
++ +QV+ ++ N+ S + ++ S + L N + F +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV- 318
Query: 334 TNCSQMEMLYLNTNK 348
+ L K
Sbjct: 319 ---YVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 5/106 (4%)
Query: 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
+L S+ ++P L T L LQ N + K LK++ L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 547 SGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNE 592
S P L+ L L LS N + E+P + + + NE
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE-KMPKTLQELRVHENE 132
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 24/107 (22%), Positives = 37/107 (34%), Gaps = 10/107 (9%)
Query: 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG 524
R++ S L +P ++ + A DL N + L L L N S
Sbjct: 34 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 525 SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF--LAYLNLSYNH 569
P + L ++ L LS+N L L + L L + N
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-----ELPEKMPKTLQELRVHENE 132
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 69/416 (16%), Positives = 139/416 (33%), Gaps = 53/416 (12%)
Query: 152 NLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRS 211
I L L +D ++ + I + L + ++N + + L Q +
Sbjct: 32 ATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQNTN 86
Query: 212 LNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNF 271
L YL+ N + L + ++ L ++ +N+ L ++ P + +L+ +N
Sbjct: 87 LTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT-KLDVS---QNPLLTYLNCARNTL 139
Query: 272 TGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLT 331
T + S+ + L LD + N K+D + L+ L S N + ++LD
Sbjct: 140 T-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI-----TELDV-- 187
Query: 332 LLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAF 391
+ + L +TN + L L T + N+++ I + L + F
Sbjct: 188 --SQNKLLNRLNCDTNNITKLDLNQNIQL----TFLDCSSNKLT-EID--VTPLTQLTYF 238
Query: 392 GVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP 451
N LT + + L L L ++ L I L + T L +
Sbjct: 239 DCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA--EGCRKIKE 290
Query: 452 SSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTT 511
+ + L LLD + L++ L L+ + + +S T
Sbjct: 291 LDVTHNTQL----YLLDCQAAGI---TELDLSQNPKLVYLYLNNTELTE---LDVSHNTK 340
Query: 512 LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSY 567
L+ L S+ + ++ + + L N ++
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-22
Identities = 71/394 (18%), Positives = 142/394 (36%), Gaps = 56/394 (14%)
Query: 178 FPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237
FPD NF++ A S QL +L L ++ + + I ++ L
Sbjct: 15 FPD--DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLT 67
Query: 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG 297
+ SN +L L+ N+ +L+ N T +L + + L L+ N +
Sbjct: 68 KLICTSNNIT-TLDLS---QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT- 119
Query: 298 QVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI 357
K+D ++ L+ L ++N L +++D +++ +Q+ L + NK + +
Sbjct: 120 --KLDVSQNPLLTYLNCARNTL-----TEID----VSHNTQLTELDCHLNKK--ITKLDV 166
Query: 358 ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLAL 417
+ ++T + N+I+ ++ +N + N +T + + + L L
Sbjct: 167 TPQT-QLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDC 219
Query: 418 VRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477
N L I + LT L N L + L TL L
Sbjct: 220 SSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTL----HCIQTDL--- 266
Query: 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIK 537
+ +++ + L F E+ ++ T L L Q + L L +
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLV 321
Query: 538 ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L L+ L+ ++ + + L L+ H +
Sbjct: 322 YLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 36/314 (11%), Positives = 92/314 (29%), Gaps = 57/314 (18%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L +D N++ ++ L ++ N + ++ L Q L +L S
Sbjct: 168 PQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSS 221
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N + + + ++ L N L ++ + + L Q + +
Sbjct: 222 NKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVS---TLSKLTTLHCIQTDLL-EID--L 271
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQM 339
++ + L ++D + L L + ++LD + ++
Sbjct: 272 THNTQLIYFQAEGCRKIK--ELDVTHNTQLYLLDCQAAGI-----TELDL----SQNPKL 320
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
LYLN + +++ + + + + + +
Sbjct: 321 VYLYLN-------------------------NTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
++G++ L +TL N +L + + GN +
Sbjct: 353 -DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
Query: 460 LMTLSRLLDLSGNL 473
+ + NL
Sbjct: 411 VYDQATNTITWENL 424
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 81/398 (20%), Positives = 144/398 (36%), Gaps = 37/398 (9%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQ-LRSLNYLSISENNF 222
+ +D+ N + + L+ + + G I ++ + L SL L + N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 223 SCKLPLSI-WNISSLEIISLHSNRFEGS-LPLNIGFNIPNVNFLSVGQNNFTGSLPHS-F 279
+L +++LE+++L +G+ L N + ++ L + NN P S F
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRL--SNLSRLFLSKNNLGTESTSDLDFLT--LLTN 335
N VLD+ N + D + + L LS L + L +
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 336 CSQMEMLYLNTNKFG----GVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAF 391
+ + L L+ N F F +IA + ++ N S + K+ N
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 392 GVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP 451
G+E + + L ++ + + + T L +L L N +
Sbjct: 271 GLEASGVKT--------------CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD 316
Query: 452 SSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPV-TLSAC 509
++ +L L+LS N LG SI + NL L DLS NH + +
Sbjct: 317 NAFWGLTHL----LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGL 370
Query: 510 TTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNL 546
L+ L L N S+P L S++++ L N
Sbjct: 371 PNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 72/400 (18%), Positives = 137/400 (34%), Gaps = 44/400 (11%)
Query: 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNN 270
+NY+ +S N+ + S + L+ + + + N + ++ L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 271 FTGSLPHSFSNASNLQVLDVYKNHFSGQV--KIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
F +F+ +NL+VL + + + G V F L++L L L NN+ +
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-----KKIQ 145
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK-ITVIGMGDNQISGTIPSEIKNLVN 387
+ N + +L L NK + + N K T++ + + +
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
N F ++ L L N + ++ + ++ +
Sbjct: 206 GNPFK----------------NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 448 GNVPSSLGNCQNLMTLSRL------------LDLSGNLLGGSIPLEV-GNLRNLAEFDLS 494
N+ SS G N DLS + + ++ V + +L + L+
Sbjct: 250 YNMGSSFG-HTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLA 307
Query: 495 ENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYL 554
+N + T L L+L N + L ++ LDLS N++ +
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367
Query: 555 ENLLFLAYLNLSYNHFEGEVPRKGVF---GNRTGIHLIGN 591
L L L L N + VP G+F + I L N
Sbjct: 368 LGLPNLKELALDTNQLK-SVPD-GIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 70/342 (20%), Positives = 118/342 (34%), Gaps = 35/342 (10%)
Query: 257 NIP-NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFL 314
+P +VN++ + N+ SFS +LQ L V + ++ + F LS+L L L
Sbjct: 27 ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA--NLSAKITVIGMGDN 372
N T + L L L L G L L+ + ++ + DN
Sbjct: 87 DYNQFLQLETGAFNGLANLEV------LTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDN 139
Query: 373 QISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAI-----------GELKNLQGLALVRN 420
I P+ N+ + + +N++ +I L ++ +
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEY 198
Query: 421 SLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL-LDLSGNLLGGSIP 479
L T + L L N + ++ + + L L S N+
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 480 LEVGNLRNLA----------EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS 529
+ N DLS++ + S T LE L L N + +
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 530 LKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L + +L+LS+N L + ENL L L+LSYNH
Sbjct: 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 52/267 (19%), Positives = 79/267 (29%), Gaps = 23/267 (8%)
Query: 354 LRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPH-AIGELKNL 412
L + L A + + + N I+ + L ++ VE I + L +L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV--PSSLGNCQNLMTLSRLLDLS 470
L L N L L L L NL G V + +L +L L
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL----EMLVLR 137
Query: 471 GNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACT--TLEYLHLQGN------- 520
N + P N+R DL+ N + L L L
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 521 -SFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF---LAYLNLSYNHFEGEVPR 576
+ SI LDLS N + K + + + L LS ++ G
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 577 KGVFGNRTGIHLIGNERLCGGLEELHL 603
F + G E G++ L
Sbjct: 258 HTNFKDPDNFTFKGLEA--SGVKTCDL 282
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 56/341 (16%), Positives = 115/341 (33%), Gaps = 62/341 (18%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRI--PDSLCQLRSLNYLSI 217
L L ++ + NQ + + LE + ++ L G + + L SL L +
Sbjct: 77 GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 218 SENNFSCKLPLSIW-NISSLEIISLHSNRFEGSLPLNI----------GFNIPNVNFLSV 266
+NN P S + N+ ++ L N+ + S+ + ++ +
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 267 GQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRL-------------F 313
+ + +++ LD+ N F + F +++
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 314 LSKNNLGTES--------TSDLDFLTL------------LTNCSQMEMLYLNTNKF---- 349
N S + L ++ + +E L L N+
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID 315
Query: 350 GGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPH-AIG 407
F + +L + + N + +I S + +NL + + YN + + +
Sbjct: 316 DNAF-WGLTHL----LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368
Query: 408 ELKNLQGLALVRNSLRGTIPD-TLGNLTLLNRLFLGFNNLQ 447
L NL+ LAL N L+ ++PD LT L +++L N
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 85/437 (19%), Positives = 153/437 (35%), Gaps = 27/437 (6%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+L KL ++ + N++ LE +D+S N L +L +L +S
Sbjct: 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSF 99
Query: 220 NNFSC-KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N F + N+S L+ + L + E S L I + L +G+ P
Sbjct: 100 NAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159
Query: 279 FSN--ASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNC 336
+ +L ++ F + + ++NL + + + L L L
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITV--IGMGDNQISGTIPSEI-----KNLVNIN 389
++ L LN + I L TV + + ++ G + +L ++
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 390 AFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN 449
V + + N+ + R ++ L N L
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 450 VPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG---NLRNLAEFDLSENHFSNEIP-VT 505
V NC +L L L L N L + +++L + D+S+N S +
Sbjct: 340 VF---ENCGHLTELET-LILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
Query: 506 LSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNL 565
S +L L++ N + ++ L IK LDL N + IPK + L L LN+
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451
Query: 566 SYNHFEGEVPRKGVFGN 582
+ N + VP G+F
Sbjct: 452 ASNQLK-SVPD-GIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-20
Identities = 66/404 (16%), Positives = 131/404 (32%), Gaps = 28/404 (6%)
Query: 160 NLLKLEMIDVGDNQL--IGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSI 217
+ L+ +D+ N + +F N S L+ + +S L + L L +
Sbjct: 88 PTVNLKHLDLSFNAFDALPICKEF-GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 218 SENNFSCKLP---LSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS 274
+ K L +N SL I+ + F + + N+ ++
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH-FILDVSVKTVANLELSNIKCVLEDNK 205
Query: 275 LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRL---------SNLSRLFLSKNNLGTESTS 325
+ S + LQ N ++ +N + + +S L +
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 326 DLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNL 385
DF T+ + + + ++ FG S + + + +
Sbjct: 266 R-DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS-NMNIKNFTVSGTRMVHMLCPSKI 323
Query: 386 VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLG---NLTLLNRLFLG 442
N LT T+ G L L+ L L N L+ + + L +L +
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDIS 382
Query: 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEI 502
N++ + G+C +L L++S N+L +I + + DL N I
Sbjct: 383 QNSVSYDEKK--GDCSWTKSL-LSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SI 436
Query: 503 PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
P + L+ L++ N L S++++ L N
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-18
Identities = 69/404 (17%), Positives = 138/404 (34%), Gaps = 18/404 (4%)
Query: 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNR 245
++IS N + + L L L IS N LE + L N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 246 FEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS--FSNASNLQVLDVYKNHFSGQVKIDF 303
+ + N+ L + N F +LP F N S L+ L + H +
Sbjct: 81 LV-KISCH---PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 304 NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK 363
L+ L + G + + + + + V ++++ANL
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 364 ITVIGMGDNQISG--TIPSEIKNLVNINAFGVEYNQLTGTIPHAIGEL---KNLQGLALV 418
+ DN+ S +I ++++ ++ + + T I +L + ++
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 419 RNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNC-QNLMTLSRLLDLSGNLLGGS 477
L+G + + + + L + + +V + + + + + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS---LKTLK 534
L + D S N ++ + T LE L LQ N L +K
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374
Query: 535 SIKELDLSRNNLSGQIPK-YLENLLFLAYLNLSYNHFEGEVPRK 577
S+++LD+S+N++S K L LN+S N + R
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 57/361 (15%), Positives = 108/361 (29%), Gaps = 21/361 (5%)
Query: 234 SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN 293
I+++ N L + ++ + L + N F L+ LD+ N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 294 HFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVF 353
KI + NL L LS N L N SQ++ L L+T
Sbjct: 80 KLV---KISCHPTVNLKHLDLSFNAF-----DALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 354 LRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV--EYNQLTGTIPHAIGELKN 411
+ IA+L+ ++ +G+ P +++ + V + + ++ + N
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNR------LFLGFNNLQGNVPSSLGNCQNLMTLSR 465
L+ + L L L L L N + T+
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 466 L----LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521
+ L G L +L+ L+ + + F + + + +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFG 581
L + LD S N L+ + + +L L L L N + +
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371
Query: 582 N 582
Sbjct: 372 Q 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 12/239 (5%)
Query: 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNI-PNVNFLSVGQN 269
S++ + + S ++ +L I + S+ F P + + I N+N + +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS 310
Query: 270 NFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF 329
S S LD N + V + L+ L L L N L S
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 330 LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNIN 389
+ ++ L ++ N + + + + + M N ++ TI + I
Sbjct: 371 TQM----KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIK 424
Query: 390 AFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPD-TLGNLTLLNRLFLGFNNLQ 447
+ N++ +IP + +L+ LQ L + N L+ ++PD LT L +++L N
Sbjct: 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 45/262 (17%), Positives = 80/262 (30%), Gaps = 15/262 (5%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L + +LS K T++ + N IS S+I +L + + +N++ + L
Sbjct: 12 LIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL--LDLS 470
+ L L N L NL L+ L FN +L C+ +S+L L LS
Sbjct: 72 EYLDLSHNKLVKISCHPTVNLKHLD---LSFNAFD-----ALPICKEFGNMSQLKFLGLS 123
Query: 471 GNLLGGSIPLEVGNLRNLAEF-DLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS 529
L S L + +L L E + E P L L +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ---DFNTESLHIVFPTNKEFHF 180
Query: 530 LKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLI 589
+ + +L +N+ + + L N + + I
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 590 GNERLCGGLEELHLPSCHFGRP 611
+ + +
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQ 262
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 36/160 (22%), Positives = 57/160 (35%), Gaps = 4/160 (2%)
Query: 459 NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQ 518
+L + +L++S N + ++ +L L +S N LEYL L
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 519 GNSFSGSLPLSLKTLKSIKELDLSRNNL-SGQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577
N +S ++K LDLS N + I K N+ L +L LS H E
Sbjct: 78 HNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 578 GVFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRIT 617
N + + L+ E + L + I T
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 64/305 (20%), Positives = 111/305 (36%), Gaps = 46/305 (15%)
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
S+ +N +L Y N SG F+ + L N + ++LL
Sbjct: 2 SIMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRN-------EAVSLL 53
Query: 334 TNC--SQMEMLYLNTNKFGGVFLRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINA 390
C +Q L LN L S+ NL +ITV+ + N + ++P +L ++
Sbjct: 54 KECLINQFSELQLNRLN-----LSSLPDNLPPQITVLEITQNALI-SLPELPASLEYLD- 106
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
N+L+ T+P LK+L + N L +P+ L +N N L +
Sbjct: 107 --ACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYIN---ADNNQLT-ML 155
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
P + L +L + N L +P +L L D+S N +P
Sbjct: 156 PELPTS------L-EVLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNH 203
Query: 511 TLE----YLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566
E + + N + +P ++ +L + L N LS +I + L +
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
Query: 567 YNHFE 571
+F
Sbjct: 263 RIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 62/353 (17%), Positives = 116/353 (32%), Gaps = 62/353 (17%)
Query: 209 LRSLNYLSISENNFSCKLPLSIWNI----SSLEIISLHSNRFEGSLPLNIGFNIPNVNFL 264
L N S+S+N+F + + + E +L ++ L I + L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 265 SVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTEST 324
+ + N + SLP + + VL++ +N + ++L L N L T
Sbjct: 65 QLNRLNLS-SLPDNL--PPQITVLEITQNALI---SLP-ELPASLEYLDACDNRLST--- 114
Query: 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKN 384
L + ++ L ++ +NQ++ +P
Sbjct: 115 -------LPELPASLKHLDVD-------------------------NNQLT-MLPELPAL 141
Query: 385 LVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFN 444
L IN + NQLT +P +L+ L++ N L +P+ +L L+ + N
Sbjct: 142 LEYIN---ADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLPELPESLEALD---VSTN 190
Query: 445 NLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV 504
L+ ++P+ + N + IP + +L L +N S+ I
Sbjct: 191 LLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557
+LS T H FS S D + +
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-20
Identities = 73/438 (16%), Positives = 146/438 (33%), Gaps = 55/438 (12%)
Query: 155 LIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISA---NMLGGRIPDSLCQLRS 211
++ N L + N + G + D+ + + E + N + + C +
Sbjct: 4 MLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQ 60
Query: 212 LNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNF 271
+ L ++ N S LP ++ + ++ + N SLP ++ +L N
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA----SLEYLDACDNRL 112
Query: 272 TGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLT 331
+ +LP ++L+ LDV N + + + L + N L
Sbjct: 113 S-TLPELP---ASLKHLDVDNNQLT---MLP-ELPALLEYINADNNQLT----------M 154
Query: 332 LLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVN---- 387
L + +E+L + N+ L + L + + + N + ++P+ +
Sbjct: 155 LPELPTSLEVLSVRNNQ-----LTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEET 208
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
F N++T IP I L + L N L I ++L T + G
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ-PDYHGPRIYF 266
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS 507
+ + N +V + + E + N FS +
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPEN-----KQSDVSQIWHAFEHEEHANTFSAFLD---R 318
Query: 508 ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSY 567
T+ + G F + L+ L + EL ++ + E+ + L + NL
Sbjct: 319 LSDTVSARNTSG--FREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRK 376
Query: 568 NHFEGEVPRKGVFGNRTG 585
+G+F N TG
Sbjct: 377 TLLV-HQASEGLFDNDTG 393
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 34/218 (15%), Positives = 64/218 (29%), Gaps = 23/218 (10%)
Query: 163 KLEMIDVGDNQLIGKFPDFIANFSALE----AIDISANMLGGRIPDSLCQLRSLNYLSIS 218
LE +DV N L P E N + IP+++ L + +
Sbjct: 181 SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE 238
Query: 219 ENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQN--------- 269
+N S ++ S+ ++ F S + P + ++
Sbjct: 239 DNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
Query: 270 --NFTGSLPHS---FSNASNLQVLDVYKNH--FSGQVKIDFNRLSNLSRLFLSKNNLGTE 322
+ H+ + L +N F QV +LS + L + +
Sbjct: 299 IWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAAD 358
Query: 323 STSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL 360
+T + LT + + L G+F L
Sbjct: 359 ATESCEDRVALTW-NNLRKTLLVHQASEGLFDNDTGAL 395
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 35/119 (29%), Positives = 53/119 (44%), Gaps = 17/119 (14%)
Query: 39 SYADLSKATNNFS------ASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--- 89
S+ +L TNNF N +G+G FG VYKG + TTVAVK +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEEL 73
Query: 90 -KSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
+ F E + ++ +H NL++++ S D L+Y YM GS D + +
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGT 127
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 51/284 (17%), Positives = 93/284 (32%), Gaps = 44/284 (15%)
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
T S+P S+ L++ N F++L+ L++L LS N L +
Sbjct: 17 KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNI 388
+ ++ L L+ N + T+ S L +
Sbjct: 74 DFGT----TSLKYLDLS-------------------------FNGVI-TMSSNFLGLEQL 103
Query: 389 NAFGVEYNQLTGTIPH-AIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
+++ L L+NL L + R L+ L L + N+ Q
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 448 GNVPS-SLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVT 505
N +NL LDLS L + +L +L ++S N+F +
Sbjct: 164 ENFLPDIFTELRNL----TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218
Query: 506 LSACTTLEYLHLQGNSFSGSLPLSL--KTLKSIKELDLSRNNLS 547
+L+ L N + S+ L+L++N+ +
Sbjct: 219 YKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 41/269 (15%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
S+ +RL L N L + D LT L L L++N ++
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQL------TKLSLSSNG---------------LSF 66
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI 426
G G ++ + +N + T+ L+ L+ L ++L+ +
Sbjct: 67 KGCCSQSDFG--------TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QM 116
Query: 427 PD--TLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-G 483
+ +L L L + + + +L +L ++GN + ++
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL----EVLKMAGNSFQENFLPDIFT 172
Query: 484 NLRNLAEFDLSENHFSNEIPVTLSACTT-LEYLHLQGNSFSGSLPLSLKTLKSIKELDLS 542
LRNL DLS+ ++ T + L+ L++ N+F K L S++ LD S
Sbjct: 173 ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231
Query: 543 RNNLSGQIPKYLENLL-FLAYLNLSYNHF 570
N++ + L++ LA+LNL+ N F
Sbjct: 232 LNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 51/276 (18%), Positives = 91/276 (32%), Gaps = 33/276 (11%)
Query: 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH 294
S I +S S+P I + L + N F + L L + N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 295 FSGQ--VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV 352
S + ++L L LS N + +S+ L L + L +
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEH------LDFQHSN---- 112
Query: 353 FLRSIANLSA-----KITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTI-PHA 405
L+ ++ S + + + + I L ++ + N P
Sbjct: 113 -LKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
Query: 406 IGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSR 465
EL+NL L L + L P +L+ L L + NN +L +
Sbjct: 171 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL----Q 226
Query: 466 LLDLSGNLLGGSIPLEV--GNLRNLAEFDLSENHFS 499
+LD S N + + + +LA +L++N F+
Sbjct: 227 VLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 47/247 (19%), Positives = 87/247 (35%), Gaps = 16/247 (6%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT--GTIPHAIGELK 410
L S+ + + T + + N++ L + + N L+ G +
Sbjct: 19 LTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 411 NLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL-GNCQNLMTLSRLLDL 469
+L+ L L N + T+ L L L +NL+ S+ + +NL LD+
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL----IYLDI 133
Query: 470 SGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEI-PVTLSACTTLEYLHLQGNSFSGSLP 527
S + L +L ++ N F P + L +L L P
Sbjct: 134 SHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192
Query: 528 LSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR---KGVFGNRT 584
+ +L S++ L++S NN + L L L+ S NH + + +
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLA 251
Query: 585 GIHLIGN 591
++L N
Sbjct: 252 FLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 37/178 (20%), Positives = 60/178 (33%), Gaps = 8/178 (4%)
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG 455
LT ++P I + L L N L+ LT L +L L N L
Sbjct: 17 KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQ 72
Query: 456 NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV-TLSACTTLEY 514
+ +L + LDLS N + ++ L L D ++ + L Y
Sbjct: 73 SDFGTTSL-KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLSYNHFE 571
L + + L S++ L ++ N+ L L +L+LS E
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 7/207 (3%)
Query: 144 SNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP 203
S++ L L+ +D+ N +I +F LE +D + L
Sbjct: 60 SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNF-LGLEQLEHLDFQHSNLKQMSE 118
Query: 204 DSLCQ-LRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVN 262
S+ LR+L YL IS + +SSLE++ + N F+ + +I + N+
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178
Query: 263 FLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTE 322
FL + Q P +F++ S+LQVL++ N+F + L++L L S N++ T
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 323 STSDLDFLTLLTNCSQMEMLYLNTNKF 349
+L S + L L N F
Sbjct: 239 KKQELQHFP-----SSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 39/233 (16%), Positives = 86/233 (36%), Gaps = 22/233 (9%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGR--IPDSLCQLRSLNYLSISENN 221
+++ N+L + L + +S+N L + S SL YL +S N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 222 FSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSN 281
+ + + LE + + + ++ ++ N+ +L + + + F+
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 282 ASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLT------ 334
S+L+VL + N F D F L NL+ L LS+ L S + + L+ L
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 335 ------------NCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
+ +++L + N + + + + + + + N +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 7/108 (6%)
Query: 39 SYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE- 97
+ ++ S +N +IG+G +G VYKG L VAVKV + + ++F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR---QNFINEKNI 58
Query: 98 -ALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144
+ + H N+ + I + G L+ EY GS ++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH 106
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 57/290 (19%), Positives = 100/290 (34%), Gaps = 39/290 (13%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
+ + L L N++ D L L L L NK + ++ + L K+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYA------LVLVNNKISKIHEKAFSPLR-KLQK 106
Query: 367 IGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGT 425
+ + N + IP + +LV + + N++ L+N+ + + N L +
Sbjct: 107 LYISKNHLV-EIPPNLPSSLVELR---IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 426 I--PDTLGNLTLLNRLFLGFNNL---QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480
P L L L + L ++P +L L L N + +I L
Sbjct: 163 GFEPGAFDGLKLN-YLRISEAKLTGIPKDLPETL----------NELHLDHNKIQ-AIEL 210
Query: 481 EV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKEL 539
E L L N +LS TL LHL N S +P L LK ++ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
Query: 540 DLSRNNLSGQIP-------KYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
L NN++ ++ + + ++L N + F
Sbjct: 270 YLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 53/327 (16%), Positives = 107/327 (32%), Gaps = 47/327 (14%)
Query: 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH 294
L ++ + ++P I P+ L + N+ + F +L L + N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 295 FSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL---------------TNCSQM 339
S + F+ L L +L++SKN+L + L L + M
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 340 EMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
+ + N A K+ + + + +++ IP ++ +N +++N++
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ 206
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
+ L L L N +R +L L L L L N L VP+ L + +
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
L +++ L N N+ + D F + + L
Sbjct: 266 L----QVVYLHTN-----------NITKVGVNDFCPVGFGVKRA-------YYNGISLFN 303
Query: 520 N--SFSGSLPLSLKTLKSIKELDLSRN 544
N + P + + + +
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 53/318 (16%), Positives = 102/318 (32%), Gaps = 46/318 (14%)
Query: 185 FSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244
+D+ N + D L+ L L + N I +H
Sbjct: 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK----------------ISKIHEK 96
Query: 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN 304
F + + L + +N+ P+ S+L L ++ N K F+
Sbjct: 97 AFSP---------LRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFS 144
Query: 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI-ANLSAK 363
L N++ + + N L F L ++ L ++ K L I +L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGL-----KLNYLRISEAK-----LTGIPKDLPET 194
Query: 364 ITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSL 422
+ + + N+I I E + G+ +NQ+ ++ L L+ L L N L
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 423 RGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL--LDLSGNLLG-GSIP 479
+P L +L LL ++L NN+ + + + + L N + +
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 480 LEV-GNLRNLAEFDLSEN 496
+ +
Sbjct: 313 PATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 36/187 (19%), Positives = 65/187 (34%), Gaps = 6/187 (3%)
Query: 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLG-GRIPDSLCQLRSLNYLSISENN 221
L + + DN++ + + I++ N L LNYL ISE
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 222 FSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSN 281
+ +P + +L + L N+ + ++ L + L +G N S S
Sbjct: 184 LT-GIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 282 ASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341
L+ L + N S +V L L ++L NN+ +D + +
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298
Query: 342 LYLNTNK 348
+ L N
Sbjct: 299 ISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 23/169 (13%), Positives = 58/169 (34%), Gaps = 17/169 (10%)
Query: 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD-SLCQLRSLNYLSI 217
+ LKL + + + +L P + L + + N + I L + L L +
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
N S+ + +L + L +N+ +P + ++ + + + NN T +
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL-PDLKLLQVVYLHTNNITKVGVN 282
Query: 278 SFS------NASNLQVLDVYKNHFSGQVKID---FNRLSNLSRLFLSKN 317
F + + ++ N ++ F +++ +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 27/106 (25%), Positives = 40/106 (37%), Gaps = 5/106 (4%)
Query: 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
+L S+ +P +S TT L LQ N S K L+ + L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTT--LLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 547 SGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNE 592
S K L L L +S NH E+P + + + + N
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIP-PNLPSSLVELRIHDNR 134
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 8/217 (3%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
LR + +S ++ + +NQI + K+L ++ + N + A L NL
Sbjct: 55 LREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L L N L L+ L L+L N ++ + +L R LDL
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSL----RRLDLGEL 170
Query: 473 LLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLK 531
I L NL +L+ + EIP L+ L+ L L GN S P S +
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQ 228
Query: 532 TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
L +++L + ++ + +NL L +NL++N
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 10/234 (4%)
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEY 395
+ +L L+ N+ + + S +L + ++ + N I TI L N+N +
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPS-SL 454
N+LT A L L+ L L N + + L RL LG + +
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
NL R L+L+ L IP + L L E DLS NH S P + L+
Sbjct: 182 EGLSNL----RYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
L + + + L+S+ E++L+ NNL+ L L ++L +N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 55/282 (19%), Positives = 97/282 (34%), Gaps = 47/282 (16%)
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
N +P S +N ++L++++N F L +L L LS+N++ T
Sbjct: 53 KNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG--- 106
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVN 387
+ + L L DN+++ TIP+ L
Sbjct: 107 ---AFNGLANLNTLELF-------------------------DNRLT-TIPNGAFVYLSK 137
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVR-NSLRGTIPDTLGNLTLLNRLFLGFNNL 446
+ + N + +A + +L+ L L L L+ L L L NL
Sbjct: 138 LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
Query: 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVT 505
+ N L+ L L DLSGN L +I L +L + + ++
Sbjct: 198 -----REIPNLTPLIKLDEL-DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250
Query: 506 LSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNL 546
+L ++L N+ + LP L ++ + L N
Sbjct: 251 FDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 12/178 (6%)
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG 455
L +P I N + L L N ++ ++ +L L L L N+++ +
Sbjct: 53 KNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFN 109
Query: 456 NCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
NL L+L N L +IP L L E L N + + +L
Sbjct: 110 GLANL----NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRR 164
Query: 515 LHLQGNSFSGSLPL-SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L L + + + L +++ L+L+ NL +IP L L+ L L+LS NH
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS 220
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 50/247 (20%), Positives = 93/247 (37%), Gaps = 11/247 (4%)
Query: 201 RIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPN 260
+PD + + L++ EN S ++ LEI+ L N ++ + + N
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 261 VNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320
+N L + N T +F S L+ L + N FNR+ +L RL L +
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS 380
+ + S + L L + ++ L K+ + + N +S P
Sbjct: 174 SYISEGA-----FEGLSNLRYLNLAMCNL--REIPNLTPLI-KLDELDLSGNHLSAIRPG 225
Query: 381 EIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF 440
+ L+++ + +Q+ +A L++L + L N+L D L L R+
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIH 285
Query: 441 LGFNNLQ 447
L N
Sbjct: 286 LHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 43/221 (19%), Positives = 91/221 (41%), Gaps = 14/221 (6%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
++++ +NQ+ + + LE + +S N + + L +LN L + +N +
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 224 CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLP-HSFSNA 282
+ +S L+ + L +N E S+P IP++ L +G+ + +F
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 283 SNLQVLDVYKNHFSGQVKI-DFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341
SNL+ L++ + +I + L L L LS N+L L L
Sbjct: 185 SNLRYLNLAMCNLR---EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK------ 235
Query: 342 LYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI 382
L++ ++ + + NL + I + N ++ +P ++
Sbjct: 236 LWMIQSQIQVIERNAFDNLQ-SLVEINLAHNNLT-LLPHDL 274
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 31/154 (20%), Positives = 44/154 (28%), Gaps = 23/154 (14%)
Query: 464 SRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522
+ L +P + N R L +L EN + LE L L N
Sbjct: 45 FSKVICVRKNLR-EVPDGISTNTRLL---NLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582
+ L ++ L+L N L+ L L L L N E +P F
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIP-SYAFNR 158
Query: 583 RTGIHLIGNERLCGGLEELHLPSCHFGRPRITRI 616
L L L R++ I
Sbjct: 159 ------------IPSLRRLDLGEL----KRLSYI 176
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 8/218 (3%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L+++ + A I + N+IS + + N+ + N L A L L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 413 QGLALVRNSLRGTIP-DTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471
+ L L N+ ++ T L L+ L L LQ P L + L L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL----QYLYLQD 138
Query: 472 NLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSL 530
N L ++P + +L NL L N S+ +L+ L L N + P +
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 531 KTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
+ L + L L NNLS + L L L YL L+ N
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 57/281 (20%), Positives = 89/281 (31%), Gaps = 67/281 (23%)
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
++P + Q + ++ N S F NL+ L+L N L +
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNI 388
L LL L L+ N Q+ ++
Sbjct: 78 GLALLEQ------LDLSDN------------------------AQLR-SVD--------- 97
Query: 389 NAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTLGNLTLLNRLFLGFNNLQ 447
P L L L L R L+ + L L L+L N LQ
Sbjct: 98 --------------PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTL 506
+ + NL L L GN + S+P L +L L +N ++ P
Sbjct: 143 ALPDDTFRDLGNL----THLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 507 SACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNL 546
L L+L N+ S +LP L L++++ L L+ N
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 44/211 (20%), Positives = 63/211 (29%), Gaps = 22/211 (10%)
Query: 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS 453
L +P I Q + L N + + L L+L N L ++
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 454 LGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTL 512
L LDLS N S+ L L L P L
Sbjct: 76 FTGLALL----EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 513 EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
+YL+LQ N+ + + L ++ L L N +S + L L L L N
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA- 190
Query: 573 EVPRKGVFGNRTGIHLIGNERLCGGLEELHL 603
V F + G L L+L
Sbjct: 191 HVHP-HAFRD------------LGRLMTLYL 208
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 50/216 (23%), Positives = 82/216 (37%), Gaps = 11/216 (5%)
Query: 234 SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN 293
++ + I LH NR +P N+ L + N +F+ + L+ LD+ N
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 294 HFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV 352
V F+ L L L L + L L L LYL N +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY------LYLQDNALQAL 144
Query: 353 FLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKN 411
+ +L +T + + N+IS ++P + L +++ + N++ PHA +L
Sbjct: 145 PDDTFRDLGN-LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
L L L N+L + L L L L L N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 38/210 (18%), Positives = 74/210 (35%), Gaps = 9/210 (4%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
+ I + N++ L + + +N+L + L L L +S+N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 224 CKLPLSIW-NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNA 282
+ + + + L + L + L + + + +L + N +F +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
NL L ++ N S + F L +L RL L +N + L L L
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL------MTL 206
Query: 343 YLNTNKFGGVFLRSIANLSAKITVIGMGDN 372
YL N + ++A L + + + DN
Sbjct: 207 YLFANNLSALPTEALAPLR-ALQYLRLNDN 235
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 10/234 (4%)
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEY 395
S L L N + + +L + V+ +G N I I L ++N +
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG-FNNLQGNVPSSL 454
N LT A L L+ L L N + + L RL LG L+ +
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
NL + L+L + +P + L L E ++S NHF P + ++L+
Sbjct: 193 EGLFNL----KYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
L + + S + L S+ EL+L+ NNLS L +L L+L +N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 57/282 (20%), Positives = 94/282 (33%), Gaps = 47/282 (16%)
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD 328
+ +P SN + L++ +N+ F L +L L L +N++ +
Sbjct: 64 RGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN 120
Query: 329 FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVN 387
L L L L DN ++ IPS + L
Sbjct: 121 GLASL------NTLELF-------------------------DNWLT-VIPSGAFEYLSK 148
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVR-NSLRGTIPDTLGNLTLLNRLFLGFNNL 446
+ + N + +A + +L L L L L L L LG N+
Sbjct: 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208
Query: 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVT 505
+ ++P+ L L L++SGN I L +L + + + S
Sbjct: 209 K-DMPN-LTPLVGL----EELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261
Query: 506 LSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNL 546
+L L+L N+ S SLP L+ + EL L N
Sbjct: 262 FDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 14/189 (7%)
Query: 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG 455
L+ +P I N + L L+ N+++ DT +L L L LG N+++ +
Sbjct: 64 RGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN 120
Query: 456 NCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514
+L TL +L N L IP L L E L N + + +L
Sbjct: 121 GLASLNTL----ELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMR 175
Query: 515 LHLQGNSFSGSLPL-SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573
L L + + + L ++K L+L N+ +P L L+ L L +S NHF E
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-E 232
Query: 574 VPRKGVFGN 582
+ G F
Sbjct: 233 IRP-GSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 49/250 (19%), Positives = 87/250 (34%), Gaps = 17/250 (6%)
Query: 201 RIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPN 260
+P + + YL++ ENN + ++ LE++ L N + + + +
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 261 VNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLSRLFLSKN 317
+N L + N T +F S L+ L + N I FNR+ +L RL L +
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGEL 181
Query: 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT 377
+ ++ L L + ++ L + + M N
Sbjct: 182 KKLEYISEGA-----FEGLFNLKYLNLGMCNI--KDMPNLTPLVG-LEELEMSGNHFPEI 233
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
P L ++ V +Q++ +A L +L L L N+L D L L
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293
Query: 438 RLFLGFNNLQ 447
L L N
Sbjct: 294 ELHLHHNPWN 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 56/297 (18%), Positives = 104/297 (35%), Gaps = 22/297 (7%)
Query: 234 SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN 293
I S S+P + V L + N T NLQ L + N
Sbjct: 31 DRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 294 HFSGQVKID---FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFG 350
+ I+ F+ L +L L LS N L S+S L+ LT L L N +
Sbjct: 87 GIN---TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTF------LNLLGNPYK 137
Query: 351 GVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGEL 409
+ S+ + K+ ++ +G+ I + L + ++ + L P ++ +
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197
Query: 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL--GNCQNLMTLSRL- 466
+N+ L L + + + + L L +L S L G +L+
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257
Query: 467 -LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522
+ ++ L + + + L E + S N + T+L+ + L N +
Sbjct: 258 NVKITDESL-FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 46/256 (17%), Positives = 90/256 (35%), Gaps = 12/256 (4%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L SI + L+ + + + +N+I+ S+++ VN+ A + N + + L +L
Sbjct: 43 LNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
+ L L N L L+ L L L N + +SL +L L L + +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLF--SHLTKLQILRVGNMD 160
Query: 473 LLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLK 531
I + L L E ++ + + P +L + + +L L L + +
Sbjct: 161 TFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 532 TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGN 591
S++ L+L +L L + + R + + ++
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF-------RNVKITDESLFQVMKL 272
Query: 592 ERLCGGLEELHLPSCH 607
GL EL
Sbjct: 273 LNQISGLLELEFSRNQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 45/286 (15%), Positives = 97/286 (33%), Gaps = 27/286 (9%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFS 223
++ +D+ +N++ + L+A+ +++N + DS L SL +L +S N S
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 224 CKLPLSI-WNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH-SFSN 281
L S +SSL ++L N ++ ++ ++ + L VG + + F+
Sbjct: 114 -NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 282 ASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341
+ L+ L++ + + N+S L L +D + +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE------C 226
Query: 342 LYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGT 401
L L ++ + + + L
Sbjct: 227 LELRDTDLDTFHFSELSTGET-----------------NSLIKKFTFRNVKITDESLF-Q 268
Query: 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
+ + ++ L L RN L+ LT L +++L N
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 38/240 (15%), Positives = 88/240 (36%), Gaps = 10/240 (4%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
+ L+ + + N + D ++ +LE +D+S N L L SL +L++
Sbjct: 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLG 133
Query: 220 NNFSCKLPLSI-WNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS 278
N + S+ +++ L+I+ + + + + + L + ++ P S
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193
Query: 279 FSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLT--LLTNC 336
+ N+ L ++ ++I + S++ L L +L T S+L L
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI----KNLVNINAFG 392
+ + + + N + + + NQ+ ++P I +L I
Sbjct: 254 FTFRNVKITDESLFQ--VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 29/127 (22%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 17 GRRKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTV 76
G H S L E +L + + +G FG V+K +L V
Sbjct: 2 GHHHHHHSSGVDLGTE---------NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYV 50
Query: 77 AVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
AVK+ Q + E +L ++H N+++ I VD LI + + GS
Sbjct: 51 AVKIFP-IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGS 108
Query: 137 SEDWMHQ 143
D++
Sbjct: 109 LSDFLKA 115
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 55/261 (21%), Positives = 97/261 (37%), Gaps = 33/261 (12%)
Query: 306 LSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--K 363
L+N ++ K+N+ T + + L + +I +
Sbjct: 18 LANAIKIAAGKSNVTDTVT--------QADLDGITTLSAFGTG-----VTTIEGVQYLNN 64
Query: 364 ITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR 423
+ + + DNQI T + +KNL I + N L I L++++ L L +
Sbjct: 65 LIGLELKDNQI--TDLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120
Query: 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483
P L L+ L L+L N + S L NL + L + + PL
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQIT--NISPLAGLTNL----QYLSIGNAQVSDLTPLA-- 170
Query: 484 NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSR 543
NL L +N S+ P L++ L +HL+ N S PL+ ++ + L+
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226
Query: 544 NNLSGQIPKYLENLLFLAYLN 564
++ Q Y NL+ +
Sbjct: 227 QTITNQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 20/208 (9%)
Query: 362 AKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNS 421
A I G + ++ T+ +L I +T TI + L NL GL L N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74
Query: 422 LRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481
+ P L NLT + L L N L S++ Q++ + LDL+ + PL
Sbjct: 75 ITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSI----KTLDLTSTQITDVTPLA 126
Query: 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDL 541
L NL L N +N P L+ T L+YL + S L L L + L
Sbjct: 127 --GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKA 180
Query: 542 SRNNLSGQIPKYLENLLFLAYLNLSYNH 569
N +S P L +L L ++L N
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 37/294 (12%)
Query: 257 NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLS 315
+ N ++ G++N T ++ ++ + L + + I+ L+NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLELK 71
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLS--AKITVIGMGDNQ 373
N + +DL L LT + L L+ N L++++ ++ I + + Q
Sbjct: 72 DNQI-----TDLAPLKNLTK---ITELELSGNP-----LKNVSAIAGLQSIKTLDLTSTQ 118
Query: 374 ISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNL 433
I+ P + L N+ ++ NQ+T P + L NLQ L++ + P L NL
Sbjct: 119 ITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANL 172
Query: 434 TLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493
+ L L N + S L + NL + L N + PL N NL L
Sbjct: 173 SKLTTLKADDNKISDI--SPLASLPNL----IEVHLKNNQISDVSPLA--NTSNLFIVTL 224
Query: 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547
+ +N+ + ++G S + P ++ + +L+ N S
Sbjct: 225 TNQTITNQPVFYNNNLVVPNV--VKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/271 (17%), Positives = 98/271 (36%), Gaps = 32/271 (11%)
Query: 178 FPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237
FPD + I + + + L + LS + + +++L
Sbjct: 13 FPD--PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQ--YLNNLI 66
Query: 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG 297
+ L N+ PL N+ + L + N + + +++ LD+ +
Sbjct: 67 GLELKDNQITDLAPLK---NLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITD 121
Query: 298 QVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI 357
LSNL L+L N + +++ L LTN ++ L + + + +
Sbjct: 122 V--TPLAGLSNLQVLYLDLNQI-----TNISPLAGLTN---LQYLSIGNAQ-----VSDL 166
Query: 358 ANLSA--KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGL 415
L+ K+T + DN+IS S + +L N+ ++ NQ++ P + NL +
Sbjct: 167 TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 416 ALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446
L ++ NL + N +
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 16/162 (9%)
Query: 408 ELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLL 467
L N +A ++++ T T +L + L + + NL L
Sbjct: 17 ALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVTT--IEGVQYLNNL----IGL 68
Query: 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLP 527
+L N + PL+ NL + E +LS N N ++ +++ L L + P
Sbjct: 69 ELKDNQITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
Query: 528 LSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
L+ L +++ L L N ++ P L L L YL++
Sbjct: 125 LA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 31/174 (17%), Positives = 69/174 (39%), Gaps = 13/174 (7%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL K+ +++ N L IA +++ +D+++ + L L +L L +
Sbjct: 83 NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDL 138
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
N + PL+ +++L+ +S+ + + PL N+ + L N + +
Sbjct: 139 NQITNISPLA--GLTNLQYLSIGNAQVSDLTPLA---NLSKLTTLKADDNKIS-DIS-PL 191
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
++ NL + + N S SNL + L+ + + + L +
Sbjct: 192 ASLPNLIEVHLKNNQIS--DVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 14/162 (8%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
L ++ +D+ Q+ P +A S L+ + + N + L L +L YLSI
Sbjct: 105 GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGN 160
Query: 220 NNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSF 279
S PL+ N+S L + N+ PL ++PN+ + + N + P
Sbjct: 161 AQVSDLTPLA--NLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP--L 213
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321
+N SNL ++ + + +NL + K G
Sbjct: 214 ANTSNLFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSGA 252
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 34/180 (18%), Positives = 67/180 (37%), Gaps = 14/180 (7%)
Query: 369 MGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPD 428
+G + + +++ +L I + LTG I N++ L + P
Sbjct: 30 LGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATNYNP- 83
Query: 429 TLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNL 488
+ L+ L RL + ++ + +L +L LLD+S + SI ++ L +
Sbjct: 84 -ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL----TLLDISHSAHDDSILTKINTLPKV 138
Query: 489 AEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG 548
DLS N +I L L+ L++Q + + + +L + G
Sbjct: 139 NSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 22/198 (11%), Positives = 62/198 (31%), Gaps = 25/198 (12%)
Query: 306 LSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--K 363
L +++ + + ++ LT + L + + +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYI---------TLANIN-----VTDLTGIEYAHN 67
Query: 364 ITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR 423
I + + + + + I L N+ + +T + L +L L + ++
Sbjct: 68 IKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483
+I + L +N + L +N ++ L L + L++ + + +E
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPEL----KSLNIQFDGVHDYRGIE-- 178
Query: 484 NLRNLAEFDLSENHFSNE 501
+ L + +
Sbjct: 179 DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 12/162 (7%)
Query: 408 ELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLL 467
K L ++S + +LT + + +L G + N+ + L
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNI----KDL 71
Query: 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLP 527
++ P+ L NL + +++ LS T+L L + ++ S+
Sbjct: 72 TINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 528 LSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
+ TL + +DLS N I L+ L L LN+ ++
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 28/144 (19%), Positives = 55/144 (38%), Gaps = 13/144 (9%)
Query: 425 TIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGN 484
IPD+ LG ++ + + + + L+ + +E
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTANITEAQMNSLTYI-------TLANINVTDLTGIE--Y 64
Query: 485 LRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544
N+ + ++ H +N P +S + LE L + G + +L L S+ LD+S +
Sbjct: 65 AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 545 NLSGQIPKYLENLLFLAYLNLSYN 568
I + L + ++LSYN
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 33/212 (15%), Positives = 79/212 (37%), Gaps = 20/212 (9%)
Query: 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC 224
E + +Q PD + F A + + + Q+ SL Y++++ N +
Sbjct: 4 EQTGLKASQDNVNIPD--STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD 58
Query: 225 KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASN 284
+ +++ +++++ P++ + N+ L + + T + S ++
Sbjct: 59 LTGIE--YAHNIKDLTINNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTS 113
Query: 285 LQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYL 344
L +LD+ + + N L ++ + LS N +D+ L L ++ L +
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA----ITDIMPLKTLPE---LKSLNI 166
Query: 345 NTNKFGGVFLRSIANLSAKITVIGMGDNQISG 376
+ R I + K+ + I G
Sbjct: 167 QFDGVHD--YRGIEDFP-KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 22/169 (13%), Positives = 58/169 (34%), Gaps = 12/169 (7%)
Query: 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD--SLCQLRSLN 213
I + L I + + + I ++ + I+ + + L +L
Sbjct: 38 ITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNI----HATNYNPISGLSNLE 91
Query: 214 YLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTG 273
L I + + ++ ++SL ++ + + + S+ I +P VN + + N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAIT 150
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTE 322
+ L+ L++ + L++L+ +G +
Sbjct: 151 DIM-PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 36/171 (21%), Positives = 58/171 (33%), Gaps = 10/171 (5%)
Query: 411 NLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN-VPSSLGNCQNLMTLS-RLLD 468
LQ L L + GT P L T + L N+ + L Q + ++L
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 469 LSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSAC-------TTLEYLHLQGNS 521
++ +V L+ DLS+N E + + C L + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF-LAYLNLSYNHFE 571
SG ++ LDLS N+L + L LNLS+ +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 49/315 (15%), Positives = 91/315 (28%), Gaps = 32/315 (10%)
Query: 270 NFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF 329
NF+ P S + L DV + L + + + D
Sbjct: 16 NFSDPKPDWSSAFNCLGAADV-----------ELYGGGRSLEYLLKRVDTEADLGQFTDI 64
Query: 330 LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--KITVIGMGDNQISGTIPSEIKNLVN 387
+ L+ ++ L + + L + + + + + +++GT P +
Sbjct: 65 IKSLS----LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 388 INAFGVEYNQLTGTIPHAI------GELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFL 441
+ + ++ A L+ L++ + + + L+ L L
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 442 GFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL---LGGSIPLEVGNLRNLAEFDLSENHF 498
N G C ++L L G L DLS N
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 499 SNEIPVTL-SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557
+ + L L+L +P L + LDLS N L P + L
Sbjct: 241 RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPS-PDEL 295
Query: 558 LFLAYLNLSYNHFEG 572
+ L+L N F
Sbjct: 296 PQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 43/302 (14%), Positives = 80/302 (26%), Gaps = 39/302 (12%)
Query: 256 FNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315
F+ P ++ S + S +L D + +L RL +
Sbjct: 17 FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK-ITVIGMGDNQI 374
+ + L + S ++ L L + G + + + ++ + +
Sbjct: 77 AARI---PSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 375 SG--TIPSEIKNLV--NINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI---- 426
+ +E++ + + + + L L L N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 427 ---PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV- 482
P L +L G G + L + LDLS N L +
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQL----QGLDLSHNSLRDAAGAPSC 249
Query: 483 GNLRNLAEFDLSENHFS---NEIPVTL----------------SACTTLEYLHLQGNSFS 523
L +LS +P L + L L+GN F
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFL 309
Query: 524 GS 525
S
Sbjct: 310 DS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 30/174 (17%), Positives = 56/174 (32%), Gaps = 12/174 (6%)
Query: 153 LGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP--DSLC--Q 208
L +Q+ L+++ + + + + F AL +D+S N G +LC +
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 209 LRSLNYLSISENNFSC---KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265
+L L++ L+ + L N + +N L+
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 266 VGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL 319
+ +P + L VLD+ N D L + L L N
Sbjct: 260 LSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDE--LPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 36/230 (15%), Positives = 74/230 (32%), Gaps = 19/230 (8%)
Query: 205 SLCQLRSLNYLSISENNFSCKLPLSI--WNISSLEIISLHSNRFEG---SLPLNIGFNIP 259
+ + L L++ + P + L I++L + + L + P
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 260 NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID----FNRLSNLSRLFLS 315
+ LS+ Q + L LD+ N G+ + + L L L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
+ T L Q++ L L+ N + +++ + + +
Sbjct: 210 NAGM---ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 376 GTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG 424
+P + L ++ + YN+L P + EL + L+L N
Sbjct: 267 -QVPKGLPAKLSVLD---LSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 70/424 (16%), Positives = 136/424 (32%), Gaps = 25/424 (5%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLC--QLRSLNYLSI 217
LE +DV N+L ++L +D+S N +P L L +L +
Sbjct: 98 FNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
S F +L L L I L + IPN L + + +
Sbjct: 154 SAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 278 SFSNASNLQVLDVYKNHFSGQVKIDFNRLS-----NLSRLFLSKNNLGTESTSDLDFLTL 332
+ + L L + + + + L ++ ++ T +
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 333 LTNCSQMEMLYLNTNKFGGVFLRSIANLS----AKITVIGMGDNQISGTIPSEIKNLVNI 388
+E L + R S + + + + + + +
Sbjct: 273 F-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 389 NAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448
N + + + L +N ++ L L L L N L+
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK- 390
Query: 449 NVPSSLGNCQNLMTLSRLLDLSGNLLG-GSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS 507
N +N+ +L LD+S N L + ++ +LS N + + L
Sbjct: 391 NFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 508 ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPK-YLENLLFLAYLNLS 566
++ L L N S+P + L++++EL+++ N L +P + L L Y+ L
Sbjct: 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLH 505
Query: 567 YNHF 570
N +
Sbjct: 506 DNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 63/400 (15%), Positives = 134/400 (33%), Gaps = 38/400 (9%)
Query: 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNN 270
LS+S+N+ S I +S L ++ L NR SL ++ ++ +L V N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 271 FTGSLPHSFSNASNLQVLDVYKNHF-SGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF 329
++ ++L+ LD+ N F V +F L+ L+ L LS +
Sbjct: 112 LQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 330 LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLS-----------------AKITVIGMGDN 372
L L + ++ + + + + L + + + +
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 373 QISGTIPSEIKNLVNINAFGVEYNQLTGTIPH----------AIGELKNLQGLALVRNSL 422
+++ + ++ G +T + ++ L + ++
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 423 RGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNC-QNLMTLSRLLDLSGNLLGGSIPLE 481
I + L +++ V ++ + LS + +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLP---LSLKTLKSIKE 538
+ + + ++N F++ + S L+ L LQ N + L K + S++
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLET 407
Query: 539 LDLSRNNLSGQIPKYLENLLF-LAYLNLSYNHFEGEVPRK 577
LD+S N+L+ + LNLS N G V R
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 56/366 (15%), Positives = 107/366 (29%), Gaps = 35/366 (9%)
Query: 257 NIP-NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLSRL 312
++P LS+ QN+ + S S L+VL + N +D F +L L
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR---SLDFHVFLFNQDLEYL 105
Query: 313 FLSKNNLGTESTSDLDFLTLL----------------TNCSQMEMLYLNTNKFGGVFLRS 356
+S N L S + L L N +++ L L+ KF + L
Sbjct: 106 DVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165
Query: 357 IANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLA 416
+A+L ++ + I G ++ N + ++ + + L L
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 417 LVRNSLRGTIPDTLGNLT-------LLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL--- 466
L L L L + L L + L
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284
Query: 467 -LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS 525
L ++ + L++L + F S + L +
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 526 LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTG 585
+ + S L+ ++N + + + L L L L N + + N +
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404
Query: 586 IHLIGN 591
+ +
Sbjct: 405 LETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 6e-13
Identities = 51/303 (16%), Positives = 105/303 (34%), Gaps = 27/303 (8%)
Query: 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD--SLCQLRSLN 213
+ L L +++ D +L+ + + L R +
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 214 YLSISENNFSCKLPLSIWNIS-----SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQ 268
YL+I + ++ + S SL I + + F + +N +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSI 338
Query: 269 NNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL-----GTES 323
++ + S+ L+ +N F+ V + L L L L +N L
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 324 TSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIK 383
T ++ L L LN++ + + I V+ + N ++G++ +
Sbjct: 399 TKNMSSLETLDVSLNS----LNSHAYDRTC-----AWAESILVLNLSSNMLTGSVFRCL- 448
Query: 384 NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPD-TLGNLTLLNRLFLG 442
+ + N++ +IP + L+ LQ L + N L+ ++PD LT L ++L
Sbjct: 449 -PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 443 FNN 445
N
Sbjct: 506 DNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 42/346 (12%), Positives = 104/346 (30%), Gaps = 30/346 (8%)
Query: 142 HQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGR 201
+ ++ G +Q N L ++ ++ + + L+ +I N +
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236
Query: 202 IPDSL-------CQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNI 254
+ L ++ I + +E +++++ +
Sbjct: 237 RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREE 296
Query: 255 GFN----IPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLS 310
+ ++ V F S +S + + + + + + S+ +
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
Query: 311 RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMG 370
L ++N L L L L N +A ++ ++ +
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQ------TLILQRNGL--KNFFKVALMTKNMSSLETL 408
Query: 371 DNQISGTIPSEIKNLV----NINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI 426
D ++ +I + N LTG++ + ++ L L N + +I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SI 465
Query: 427 PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
P + +L L L + N L+ +L + + L N
Sbjct: 466 PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSL----QYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 34/246 (13%), Positives = 83/246 (33%), Gaps = 32/246 (13%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAI-GELKN 411
L + +L + + + N IS +I L + + +N++ ++ + ++
Sbjct: 43 LTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLN----------------------RLFLGFNNLQGN 449
L+ L + N L+ + +L L+ L L +
Sbjct: 102 LEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ- 160
Query: 450 VPSSLGNCQNLMTLSRLLDLSGNLLGGSIP--LEVGNLRNLAEFDLSENHFSNEIPVTLS 507
L +L LLDL + G L++ N L + FS ++ ++++
Sbjct: 161 --LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218
Query: 508 ACTTLE--YLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNL 565
A L+ + L + + + + L+++ ++ ++ F +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 566 SYNHFE 571
Y +
Sbjct: 279 EYLNIY 284
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 58/325 (17%), Positives = 99/325 (30%), Gaps = 39/325 (12%)
Query: 283 SNLQVLDVYKNHFSGQ-VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEM 341
++Q LD+ S L + L L D+ L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60
Query: 342 LYLNTNKFGGVFLRSIA----NLSAKITVIGMGDNQISGT----IPSEIKNLVNINAFGV 393
L L +N+ G V + + S KI + + + ++G + S ++ L + +
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 394 EYNQLTGTIPHAIGEL-----KNLQGLALVRNSLRGT----IPDTLGNLTLLNRLFLGFN 444
N L + E L+ L L SL + L L + N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 445 NLQGNVPSSLGNCQNLMTLS-RLLDLSGNLLG----GSIPLEVGNLRNLAEFDLSENHFS 499
++ L L L + + V + +L E L N
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 500 NE-----IPVTLSACTTLEYLHLQGNSFS----GSLPLSLKTLKSIKELDLSRNNLSGQI 550
+ P L + L L + + G L L+ +S+KEL L+ N L +
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 551 PKYLENLLF-----LAYLNLSYNHF 570
+ L L L L + F
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 74/441 (16%), Positives = 137/441 (31%), Gaps = 58/441 (13%)
Query: 188 LEAIDISANMLGGRIPDSLCQ-LRSLNYLSISENNFS---CK-LPLSIWNISSLEIISLH 242
++++DI L L L+ + + + + CK + ++ +L ++L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 243 SNRF--EGSLPLNIGFNIPNVN--FLSVGQNNFT----GSLPHSFSNASNLQVLDVYKNH 294
SN G + G P+ LS+ T G L + LQ L + N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 295 FSGQ-VKIDFNRL----SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF 349
+++ L L +L L +L S L ++L + L ++ N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL--ASVLRAKPDFKELTVSNNDI 182
Query: 350 GGVFLRSIA----NLSAKITVIGMGDNQIS----GTIPSEIKNLVNINAFGVEYNQLTGT 401
+R + + ++ + + ++ + + + ++ + N+L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 402 IPHAIGE-----LKNLQGLALVRNSLR----GTIPDTLGNLTLLNRLFLGFNNLQGNVPS 452
+ L+ L + + G + L L L L N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 453 SLGN--CQNLMTLSRLLDLSGNLLGG----SIPLEVGNLRNLAEFDLSENHFSNEIPVTL 506
L + L L + + R L E +S N + L
Sbjct: 303 LLCETLLEPGCQLESL-WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361
Query: 507 SA-----CTTLEYLHLQGNSFS----GSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557
+ L L L S SL +L S++ELDLS N L L
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421
Query: 558 L-----FLAYLNLSYNHFEGE 573
+ L L L ++ E
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 75/455 (16%), Positives = 157/455 (34%), Gaps = 76/455 (16%)
Query: 153 LGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQL--- 209
L L+Q+ +++L+ + + + + AL +++ +N LG + Q
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82
Query: 210 --RSLNYLSISENNFSCK----LPLSIWNISSLEIISLHSNRF--EGSLPLNIGFNIPN- 260
+ LS+ + L ++ + +L+ + L N G L G P
Sbjct: 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142
Query: 261 -VNFLSVGQNNFT----GSLPHSFSNASNLQVLDVYKNHFSGQV-----KIDFNRLSNLS 310
+ L + + + L + + L V N + + + L
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 311 RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA----NLSAKITV 366
L L + +++ DL ++ + + + L L +NK G V + + + S+++
Sbjct: 203 ALKLESCGVTSDNCRDLC--GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGT- 425
+ + + I+ G + + ++L+ L+L N L
Sbjct: 261 LWIWECGITAK--------------GCGD------LCRVLRAKESLKELSLAGNELGDEG 300
Query: 426 ---IPDTLGN-LTLLNRLFLGFNNLQG----NVPSSLGNCQNLMTLSRLLDLSGNLLG-- 475
+ +TL L L++ + + S L + L+ L +S N L
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL----QISNNRLEDA 356
Query: 476 GSIPLEVG---NLRNLAEFDLSENHFSNE----IPVTLSACTTLEYLHLQGNSFSGS--- 525
G L G L L++ S+ + TL A +L L L N +
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416
Query: 526 -LPLSLKTLKS-IKELDLSRNNLSGQIPKYLENLL 558
L S++ +++L L S ++ L+ L
Sbjct: 417 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 451
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 22/135 (16%), Positives = 42/135 (31%), Gaps = 22/135 (16%)
Query: 486 RNLAEFDLSENHFSNE-IPVTLSACTTLEYLHLQGNSFS----GSLPLSLKTLKSIKELD 540
++ D+ S+ L + + L + + +L+ ++ EL+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 541 LSRNNLSGQIPKYLENLL-----FLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNE-RL 594
L N L + L + L+L G G ++ + R
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA-----------GCGVLSSTLRT 111
Query: 595 CGGLEELHLPSCHFG 609
L+ELHL G
Sbjct: 112 LPTLQELHLSDNLLG 126
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 14/102 (13%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA-------KSFVTECEALSNVRHRN 106
IG+G FG V+KG+L + + VA+K + L + F E +SN+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
++K+ + + ++ E++ CG + +
Sbjct: 85 IVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPI 119
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 5e-15
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 27/230 (11%)
Query: 342 LYLNTNKFGGVFLRSIANLS--AKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399
+ ++ I A+ + ++ + L +I+ + +
Sbjct: 4 TITVSTP-----IKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQN 459
++ I L N+ L L N L P L NL L LFL N + SSL + +
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI--KDLSSLKDLKK 110
Query: 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
L + L L N + L +L L L N ++ LS T L+ L L+
Sbjct: 111 L----KSLSLEHNGISDINGLV--HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLED 162
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
N S + L L ++ L LS+N++S + L L L L L
Sbjct: 163 NQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQE 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 2e-14
Identities = 48/283 (16%), Positives = 91/283 (32%), Gaps = 30/283 (10%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
+ +L ++ N + +++ + ++ S+ N+ L +
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLN 73
Query: 292 KNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFG 350
N + I L NL LFL +N + DL L L ++ L L N
Sbjct: 74 GNKLT---DIKPLTNLKNLGWLFLDENKI-----KDLSSLKDLKK---LKSLSLEHNG-- 120
Query: 351 GVFLRSIANLS--AKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGE 408
+ I L ++ + +G+N+I T + + L ++ +E NQ++ I +
Sbjct: 121 ---ISDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAG 173
Query: 409 LKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLD 468
L LQ L L +N + + L L L+ L L + N T+
Sbjct: 174 LTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 469 LSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTT 511
S + N S ++
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 5e-14
Identities = 58/301 (19%), Positives = 103/301 (34%), Gaps = 30/301 (9%)
Query: 206 LCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265
++ + + + + + ++S++ I +++ + + +PNV L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLF 71
Query: 266 VGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTEST 324
+ N T P +N NL L + +N + L L L L N +
Sbjct: 72 LNGNKLTDIKP--LTNLKNLGWLFLDENKIK---DLSSLKDLKKLKSLSLEHNGI----- 121
Query: 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--KITVIGMGDNQISGTIPSEI 382
SD++ L + Q+E LYL NK + I LS K+ + + DNQIS I +
Sbjct: 122 SDINGLV---HLPQLESLYLGNNK-----ITDITVLSRLTKLDTLSLEDNQIS-DI-VPL 171
Query: 383 KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442
L + + N ++ + LKNL L L + NL + N +
Sbjct: 172 AGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229
Query: 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEI 502
+L S + L N + V + A F E+
Sbjct: 230 DGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEV 289
Query: 503 P 503
Sbjct: 290 Y 290
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 6e-14
Identities = 50/277 (18%), Positives = 106/277 (38%), Gaps = 35/277 (12%)
Query: 257 NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLS 315
++ + + T ++ + +++ + + + L N+++LFL+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK---SVQGIQYLPNVTKLFLN 73
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--KITVIGMGDNQ 373
N L +D+ LT L N + L+L+ NK ++ +++L K+ + + N
Sbjct: 74 GNKL-----TDIKPLTNLKN---LGWLFLDENK-----IKDLSSLKDLKKLKSLSLEHNG 120
Query: 374 ISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNL 433
IS I + +L + + + N++T + L L L+L N + I L L
Sbjct: 121 IS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGL 174
Query: 434 TLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493
T L L+L N++ +L +NL +L+L NL
Sbjct: 175 TKLQNLYLSKNHIS--DLRALAGLKNL----DVLELFSQECLNKPINHQSNLVVPNTVKN 228
Query: 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSL 530
++ P +S E +++ + + +S
Sbjct: 229 TDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 27/233 (11%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD--SLCQLRSLNYLSI 217
L ++ I ++ I I + + ++ N ++ D L L++L +L +
Sbjct: 41 ELNSIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGN----KLTDIKPLTNLKNLGWLFL 94
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
EN L ++ L+ +SL N L ++P + L +G N T
Sbjct: 95 DENKIKDLSSLK--DLKKLKSLSLEHNGISDINGLV---HLPQLESLYLGNNKITD--IT 147
Query: 278 SFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNC 336
S + L L + N S I L+ L L+LSKN++ SDL L L N
Sbjct: 148 VLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNLYLSKNHI-----SDLRALAGLKN- 198
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNIN 389
+++L L + + + +NL TV + ++ I S+ + N
Sbjct: 199 --LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 249
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 28/260 (10%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD--SLCQLRSLNYLSI 217
L + + + N+L P + N L + + N +I D SL L+ L LS+
Sbjct: 63 YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSL 116
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
N S + + ++ LE + L +N+ L+ + ++ LS+ N + +
Sbjct: 117 EHNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLS---RLTKLDTLSLEDNQIS-DIV- 169
Query: 278 SFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNC 336
+ + LQ L + KNH S + L NL L L + + L +
Sbjct: 170 PLAGLTKLQNLYLSKNHIS---DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT- 225
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN---QISGTIPSEIKNLVNINAFGV 393
+ + S K V ++S + F
Sbjct: 226 -----VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280
Query: 394 EYNQLTGTIPHAIGELKNLQ 413
Q + ++
Sbjct: 281 RVTQPLKEVYTVSYDVDGTV 300
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 25/238 (10%)
Query: 333 LTNCSQMEMLYLNTNKFGGVFLRSIANLS--AKITVIGMGDNQISGTIPSEIKNLVNINA 390
++ L + + I I ++ I ++ I+ L N+
Sbjct: 20 DDAFAETIKDNLKKKS-----VTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
+ N+LT P + LKNL L L N ++ L +L L L L N + +
Sbjct: 73 LFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI--SD 126
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
+ L + L L L N + L L L L +N S+ +P L+ T
Sbjct: 127 INGLVHLPQL----ESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLT 178
Query: 511 TLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
L+ L+L N S L +L LK++ L+L + + NL+ + +
Sbjct: 179 KLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 47/266 (17%), Positives = 96/266 (36%), Gaps = 33/266 (12%)
Query: 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA-- 362
+ + L K ++ T + ++ + N + ++S+ +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--------QNELNSIDQIIANNSD-----IKSVQGIQYLP 68
Query: 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSL 422
+T + + N+++ + NL N+ ++ N++ + +LK L+ L+L N +
Sbjct: 69 NVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI 124
Query: 423 RGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV 482
I L +L L L+LG N + + L L L L N + +PL
Sbjct: 125 S-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKL----DTLSLEDNQISDIVPLA- 175
Query: 483 GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLS 542
L L LS+NH S+ L+ L+ L L L + +
Sbjct: 176 -GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232
Query: 543 RNNLSGQIPKYLENLLFLAYLNLSYN 568
+L P+ + + N+ ++
Sbjct: 233 DGSLVT--PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 30/244 (12%)
Query: 206 LCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265
++ + + + + + ++S++ I +++ + + +PNV L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLF 74
Query: 266 VGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTEST 324
+ N T P +N NL L + +N + L L L L N +
Sbjct: 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVK---DLSSLKDLKKLKSLSLEHNGI----- 124
Query: 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--KITVIGMGDNQISGTIPSEI 382
SD++ L L +E LYL NK + I LS K+ + + DNQIS I +
Sbjct: 125 SDINGLVHLPQ---LESLYLGNNK-----ITDITVLSRLTKLDTLSLEDNQIS-DI-VPL 174
Query: 383 KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442
L + + N ++ + LKNL L L + NL + N +
Sbjct: 175 AGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232
Query: 443 FNNL 446
+L
Sbjct: 233 DGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 43/190 (22%), Positives = 70/190 (36%), Gaps = 18/190 (9%)
Query: 380 SEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439
++ +T + EL ++ + + ++ ++ + L + +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 440 FLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
FL N L + + NL L L L N + L+ +L+ L L N S
Sbjct: 74 FLNGNKL-----TDIKPLANLKNL-GWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS 125
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
+ L LE L+L N + LS L + L L N +S +P L L
Sbjct: 126 DING--LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTK 179
Query: 560 LAYLNLSYNH 569
L L LS NH
Sbjct: 180 LQNLYLSKNH 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD--SLCQLRSLNYLSI 217
L ++ I ++ + K I + + ++ N ++ D L L++L +L +
Sbjct: 44 ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGN----KLTDIKPLANLKNLGWLFL 97
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
EN L ++ L+ +SL N L ++P + L +G N T
Sbjct: 98 DENKVKDLSSLK--DLKKLKSLSLEHNGISDINGLV---HLPQLESLYLGNNKITD--IT 150
Query: 278 SFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNC 336
S + L L + N S I L+ L L+LSKN++ SDL L L N
Sbjct: 151 VLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNLYLSKNHI-----SDLRALAGLKN- 201
Query: 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYN 396
+++L L + + + +NL TV + S P I + + V+++
Sbjct: 202 --LDVLELFSQECLNKPINHQSNLVVPNTVK---NTDGSLVTPEIISDDGDYEKPNVKWH 256
Query: 397 QLTGT 401
T
Sbjct: 257 LPEFT 261
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 22/118 (18%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITV 113
++G+G+FG V K K VA+K ++ + K+F+ E LS V H N++K
Sbjct: 14 EVVGRGAFGVVCKAKW--RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK---- 65
Query: 114 CSSIDFKGVDFKAL--IYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMIDV 169
G + + EY + GS + +H + ++ +
Sbjct: 66 -----LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSW----CLQC 111
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 27/111 (24%), Positives = 53/111 (47%), Gaps = 9/111 (8%)
Query: 54 NMIGQGSFGFVYKGKL---GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNVRHRN 106
++G+G FG V +G L T VAVK +K +++ F++E + + H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQ 157
+I+++ VC + +G+ +I +MK G ++ S + ++ L
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 27/108 (25%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--KSFVTECEALSNVRHRNLIKIITV 113
IG GSFG V++ + G+ VAVK++ + A F+ E + +RH N++ +
Sbjct: 45 IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNL 161
+ + + +++ EY+ GS +H+S + + L +RL++
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSM 142
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 4e-14
Identities = 51/337 (15%), Positives = 97/337 (28%), Gaps = 17/337 (5%)
Query: 208 QLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVG 267
+ ++S E S + S + + L + S+ + + +
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 268 QNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDL 327
+ + +K S
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 328 DFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVN 387
+ L +C +++ L L +I L + + + + + +
Sbjct: 363 VLQSELESCKELQELEPENK----WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
++ E +++ L L L T+ L L L+ L L N L+
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR 476
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN-EIPVTL 506
+P +L + L +L S N L ++ V NL L E L N L
Sbjct: 477 -ALPPALAALRCL----EVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPL 529
Query: 507 SACTTLEYLHLQGNSFSGSLPLSLK---TLKSIKELD 540
+C L L+LQGNS + + L S+ +
Sbjct: 530 VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 6e-08
Identities = 32/193 (16%), Positives = 57/193 (29%), Gaps = 13/193 (6%)
Query: 379 PSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNR 438
+ + + + T + + K LQ L TI + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 439 LFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHF 498
S+L + S L + ++ L+
Sbjct: 401 EKETLQYF-----STLKAVDPMRAAYLDDLRSKFL--LENSVLKMEYADVRVLHLAHKDL 453
Query: 499 SNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
+ + L + +L L N +LP +L L+ ++ L S N L + + NL
Sbjct: 454 T-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLP 508
Query: 559 FLAYLNLSYNHFE 571
L L L N +
Sbjct: 509 RLQELLLCNNRLQ 521
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+G+FG V + TG VAVK + + + F E E L +++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
VC S + + LI EY+ GS D++ + ++++ L
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL 147
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+G+FG V + TG VAVK + + + F E E L +++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
VC S + + LI EY+ GS D++ + ++++ L
Sbjct: 78 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL 116
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 7/96 (7%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--KSFVTECEALSNVRHRNLIKII 111
+ + G ++KG+ G + VKV+ ++ + F EC L H N++ ++
Sbjct: 16 TKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
C S LI +M GS + +H+ +
Sbjct: 74 GACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNF 106
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 25/224 (11%)
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
+P KNL + +N L ++ LQ L L R ++ +L+ L+
Sbjct: 26 LPFSTKNLD------LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSEN 496
L L N +Q + +L + L L S+ G+L+ L E +++ N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSL----QKLVAVETNL-ASLENFPIGHLKTLKELNVAHN 134
Query: 497 HFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPL----SLKTLKSIK-ELDLSRNNLSGQI 550
+ ++P S T LE+L L N S+ L + + LDLS N ++ I
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 551 PKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTG---IHLIGN 591
+ L L L N + VP G+F T I L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPD-GIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 56/269 (20%), Positives = 87/269 (32%), Gaps = 64/269 (23%)
Query: 257 NIP-NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLSRL 312
N+P + L + N +SF + LQVLD+ + I+ + LS+LS L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ---TIEDGAYQSLSHLSTL 81
Query: 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372
L+ N + + + L+ L L L S+
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQK------LVAVETN-----LASLE-------------- 116
Query: 373 QISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG-TIPDTLG 431
IG LK L+ L + N ++ +P+
Sbjct: 117 ------------------------------NFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 432 NLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEF 491
NLT L L L N +Q + L + L+ LDLS N + I L E
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKEL 205
Query: 492 DLSENHFSNEIPVTLSACTTLEYLHLQGN 520
L N + T+L+ + L N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 38/183 (20%), Positives = 71/183 (38%), Gaps = 11/183 (6%)
Query: 203 PDSLCQLRSLNYLSISENNFSCKLPLSI-WNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
S L L +S + ++S L + L N + SL L + ++
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
Query: 262 NFLSVGQNNFTGSLPH-SFSNASNLQVLDVYKNHF-SGQVKIDFNRLSNLSRLFLSKNNL 319
L + N SL + + L+ L+V N S ++ F+ L+NL L LS N +
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 320 GTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIP 379
+ +DL L + L L+ N + + + ++ + + NQ+ ++P
Sbjct: 162 QSIYCTDLRVLHQMP--LLNLSLDLSLNPMNFIQPGAFKEI--RLKELALDTNQLK-SVP 216
Query: 380 SEI 382
I
Sbjct: 217 DGI 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 11/104 (10%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKG--AAKSFVTECEALSNVRHRNLIK 109
+G+G+FG V + TG VAVK L+ G + F E + L + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
V + + L+ EY+ G D++ + +L+A L
Sbjct: 89 YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRL 129
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 25/92 (27%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE--ALSNVRHRNLIKII 111
IG+G FG V++GK G VAVK+ + +++ +S+ E E +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ + L+ +Y + GS D++++
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR 133
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 25/108 (23%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G+G FG K ETG + +K + + ++F+ E + + + H N++K I V
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLK 163
K I EY+K G+ + + + QR++ K
Sbjct: 78 ----KDKRL-NFITEYIKGGTLRGIIKSMDSQYP-----WSQRVSFAK 115
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 11/93 (11%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLK----QKGAAKSFVTECEALSNVRHRNLIK 109
+IG G FG VY+ G VAVK ++ E + + ++H N+I
Sbjct: 13 EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMH 142
+ VC K + L+ E+ + G +
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLS 98
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 35/221 (15%), Positives = 69/221 (31%), Gaps = 11/221 (4%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIP-HAIGELKN 411
+ I ++L + ++ ++ + N + I L
Sbjct: 21 VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 412 LQGLALVR-NSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLS 470
L + + + N+L P+ NL L L + ++ ++P + + + LLD+
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD--VHKIHSLQK-VLLDIQ 136
Query: 471 GNLLGGSIPLEV--GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL 528
N+ +I G L++N + E N+
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 529 SLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLSYN 568
LD+SR + +P Y LENL L +
Sbjct: 197 VFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 45/293 (15%), Positives = 89/293 (30%), Gaps = 51/293 (17%)
Query: 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH 294
S + ++ +P ++ N L +FS +L+ +++ +N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 295 FSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVF 353
++ D F+ L L + + K N + N ++ L ++
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPE-----AFQNLPNLQYLLISNTG----- 115
Query: 354 LRSIANL----SAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGEL 409
++ + ++ S + ++ + DN TI N+F G
Sbjct: 116 IKHLPDVHKIHSLQKVLLDIQDNINIHTIER--------NSFV--------------GLS 153
Query: 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDL 469
L L +N ++ L NNL+ + LD+
Sbjct: 154 FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI----LDI 209
Query: 470 SGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521
S + S+P NL+ L ++P TL L L S
Sbjct: 210 SRTRI-HSLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 32/195 (16%), Positives = 65/195 (33%), Gaps = 15/195 (7%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFI-ANFSALEAIDIS-ANMLGGRIPDSLCQLRSLNYLSI 217
LE I++ N ++ + +N L I I AN L P++ L +L YL I
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIP-NVNFLSVGQNNFTGSLP 276
S + + ++ + N ++ N + L + +N
Sbjct: 112 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 171
Query: 277 HSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333
+F+ ++ N+ ++ F+ S L +S+ + + + L+ L L
Sbjct: 172 SAFNGTQLDELNLSDNNNLE---ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 228
Query: 334 TNCSQMEMLYLNTNK 348
K
Sbjct: 229 R------ARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 37/267 (13%), Positives = 76/267 (28%), Gaps = 46/267 (17%)
Query: 185 FSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSI-WNISSLEIISL-H 242
+ L + L + IS+N+ + + N+ L I +
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID 302
+N + P +F N NLQ L + +
Sbjct: 89 ANNLL-YIN------------------------PEAFQNLPNLQYLLISNTGIKHLPDVH 123
Query: 303 FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA---- 358
L + N + F+ L + +L+LN N ++ I
Sbjct: 124 KIHSLQKVLLDIQDNIN-IHTIERNSFVGL---SFESVILWLNKNG-----IQEIHNSAF 174
Query: 359 NLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLAL 417
N + + +N + +P+++ + ++ + + LK L+ +
Sbjct: 175 NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233
Query: 418 VRNSLRGTIPDTLGNLTLLNRLFLGFN 444
+P TL L L L +
Sbjct: 234 YNLK---KLP-TLEKLVALMEASLTYP 256
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 8/92 (8%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE--ALSNVRHRNLIKII 111
+G+G +G V++G G VAVK+ + + + KS+ E E +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ LI Y + GS D++
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL 99
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 54 NMIGQGSFGFVYKGKL---GETGTTVAVKVM--NLKQKGAAKSFVTECEALSNVRHRNLI 108
M+G+G FG V + +L + VAVK++ ++ + F+ E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 109 KIITVCSSIDFKGVDFKAL-IYEYMKCGS 136
K++ V KG + I +MK G
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 57/305 (18%), Positives = 98/305 (32%), Gaps = 53/305 (17%)
Query: 306 LSNLS--RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL--- 360
++ S L + + TE + +L ++ + L+ N G R ++
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 361 SAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRN 420
+ + D E + + A+ + L + L N
Sbjct: 59 KKDLEIAEFSDIFT--------------GRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 104
Query: 421 SLRGT----IPDTLGNLTLLNRLFLGFNNLQ-------GNVPSSLGNCQNLMTLSRL--L 467
+ T + D L T L L+L N L L + L +
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164
Query: 468 DLSGNLLG--GSIPL--EVGNLRNLAEFDLSENHFSNE-----IPVTLSACTTLEYLHLQ 518
N L + R L + +N E + L+ C L+ L LQ
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224
Query: 519 GNSFS--GSLPLS--LKTLKSIKELDLSRNNLSGQ----IPKYLENLLF--LAYLNLSYN 568
N+F+ GS L+ LK+ +++EL L+ LS + + L L L L YN
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284
Query: 569 HFEGE 573
E +
Sbjct: 285 EIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 47/291 (16%), Positives = 81/291 (27%), Gaps = 54/291 (18%)
Query: 307 SNLSRLFLSKNNLGTESTSDLD----FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL-- 360
+L S G + L L C ++ + L+ N FG + +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 361 -SAKITVIGMGDNQIS-------------GTIPSEIKNLVNINAFGVEYNQLTG----TI 402
+ + + +N + + + KN + + N+L
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 403 PHAIGELKNLQGLALVRNSLR-----GTIPDTLGNLTLLNRLFLGFNNL--QG--NVPSS 453
+ L + +V+N +R + + L L L L N G + +
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 454 LGNCQNLMTLSRLLDLSGNLLGG------SIPLEVGNLRNLAEFDLSENHFSNEIPVTLS 507
L + NL R L L+ LL L L N + TL
Sbjct: 240 LKSWPNL----RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295
Query: 508 A-----CTTLEYLHLQGNSFS------GSLPLSLKTLKSIKELDLSRNNLS 547
L +L L GN FS + T + +L
Sbjct: 296 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 30/224 (13%), Positives = 61/224 (27%), Gaps = 55/224 (24%)
Query: 412 LQGLALVRNSLRG----TIPDTLGNLTLLNRLFLGFNNLQGN----VPSSLGNCQNLMTL 463
++G +L +++ ++ L + + L N + + ++ + ++L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL--- 62
Query: 464 SRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523
+ + S G LR L + L C L + L N+F
Sbjct: 63 -EIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNAFG 107
Query: 524 --GSLPLS--LKTLKSIKELDLSRNNLS-------------GQIPKYLENLLFLAYLNLS 566
PL L ++ L L N L + K +N L +
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 567 YNHFEGEVPRKGVFGNRTGIHLIGNE-RLCGGLEELHLPSCHFG 609
N E + + L + +
Sbjct: 168 RNRLENG-----------SMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 39/268 (14%), Positives = 70/268 (26%), Gaps = 64/268 (23%)
Query: 156 IQRLNLLKLEMIDVGDNQLIG--KFPDFIANFSALEAIDISANMLGGR----IPDSLCQL 209
++ + V D + L + +S N G + D L +
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 210 RSLNYLSISENNFS-------------CKLPLSIWNISSLEIISLHSNRF--EGSLPLNI 254
L +L + N + N L I NR
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181
Query: 255 GF-NIPNVNFLSVGQNNFT-----GSLPHSFSNASNLQVLDVYKNHFSGQ---------- 298
F + ++ + + QN L + L+VLD+ N F+
Sbjct: 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241
Query: 299 -------VKIDFNRLSN-----------------LSRLFLSKNNLGTESTSDLDFLTLLT 334
+ ++ LS L L L N + ++ L +
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT-VIDE 300
Query: 335 NCSQMEMLYLNTNKFG--GVFLRSIANL 360
+ L LN N+F + I +
Sbjct: 301 KMPDLLFLELNGNRFSEEDDVVDEIREV 328
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE--ALSNVRHRNLIKII 111
IG+G +G V+ GK G VAVKV ++ S+ E E +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
LI +Y + GS D++
Sbjct: 98 AADIKGTGSWTQL-YLITDYHENGSLYDYLKS 128
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 12/105 (11%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKS---FVTECEALSNVRHRNLI 108
+G+G FG V + TG VAVK LK + E E L N+ H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
K +C+ G+ LI E++ GS ++++ ++ +K+
Sbjct: 87 KYKGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 8/81 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG+G FG V G G VAVK +K A++F+ E ++ +RH NL++++ V
Sbjct: 29 IGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 116 SIDFKGVDFKALIYEYMKCGS 136
+ ++ EYM GS
Sbjct: 85 ----EEKGGLYIVTEYMAKGS 101
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 13/97 (13%)
Query: 56 IGQGSFGFVYKGKL-GETGTTVAVKVMNLKQKGAA--KSFVTECEALSNVRHRNLIKIIT 112
IG GSFG VYKGK G+ VAVK++N+ ++F E L RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
++ A++ ++ + S +H S K E
Sbjct: 88 YSTAPQL------AIVTQWCEGSSLYHHLHASETKFE 118
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 24/99 (24%), Positives = 45/99 (45%), Gaps = 12/99 (12%)
Query: 54 NMIGQGSFGFVYKGKL-GETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKI 110
+IG+G FG VY G+ GE VA++++++++ + K+F E A RH N++
Sbjct: 39 ELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+ C A+I K + + + L+
Sbjct: 95 MGACM----SPPHL-AIITSLCKGRTLYSVVRDAKIVLD 128
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 45/219 (20%), Positives = 75/219 (34%), Gaps = 27/219 (12%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
++S ++ +LP ++ + L + +N + + L L++
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF-- 349
+ L L L LS N L L LT L ++ N+
Sbjct: 64 RAEL--TKLQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTV------LDVSFNRLTS 114
Query: 350 --GGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAI 406
G R + L + + N++ T+P + + + N LT +P +
Sbjct: 115 LPLGAL-RGLGEL----QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL 167
Query: 407 -GELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFN 444
L+NL L L NSL TIP LL FL N
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 47/215 (21%), Positives = 70/215 (32%), Gaps = 41/215 (19%)
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
+ +L + +N + L++L L + L L +L L
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT------L 82
Query: 343 YLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTI 402
L+ NQ+ ++P + L + V +N+LT ++
Sbjct: 83 DLS-------------------------HNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 403 PHAI-GELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLM 461
P L LQ L L N L+ P L L +L L NNL L +NL
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSEN 496
T L L N L +IP L L N
Sbjct: 176 T----LLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 52/217 (23%), Positives = 75/217 (34%), Gaps = 45/217 (20%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
+ + L LS+N L T S + L T LT L L+ + +T
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQ------LNLDRAE---------------LTK 69
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI 426
+ + L + + +NQL ++P L L L + N L
Sbjct: 70 LQVDGT------------LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 427 PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL--LDLSGNLLGGSIPLEV-G 483
L L L L+L N L+ +P L L +L L L+ N L +P +
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGL-----LTPTPKLEKLSLANNNL-TELPAGLLN 169
Query: 484 NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGN 520
L NL L EN IP L + L GN
Sbjct: 170 GLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 43/214 (20%), Positives = 63/214 (29%), Gaps = 44/214 (20%)
Query: 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNN 270
L +SEN ++ + L ++L L + +P + L + N
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK---LQVDGTLPVLGTLDLSHNQ 88
Query: 271 FTGSLPHSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLSRLFLSKNNLGTESTSDL 327
SLP L VLDV N + + L L L+L N L T L
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT---SLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 328 DFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLV 386
L L L N L +P+ + L
Sbjct: 145 TPTPKLEK------LSLANNN-----LTE---------------------LPAGLLNGLE 172
Query: 387 NINAFGVEYNQLTGTIPHAIGELKNLQGLALVRN 420
N++ ++ N L TIP L L N
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 30/105 (28%), Positives = 42/105 (40%), Gaps = 3/105 (2%)
Query: 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG 524
+L LS NLL + L + +L + ++ V L L L N
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ- 90
Query: 525 SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
SLPL +TL ++ LD+S N L+ L L L L L N
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 12/88 (13%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKS---FVTECEALSNVRHRNLI 108
+G+G FG V TG VAVK LK + + E + L + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCGS 136
K C + L+ EY+ GS
Sbjct: 97 KYKGCCEDAGAASL---QLVMEYVPLGS 121
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 13/114 (11%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G+FG VYK K ETG A KV+ K + + ++ E E L+ H ++K
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK------ 80
Query: 116 SIDFKGVDFKA----LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLE 165
G + ++ E+ G+ + M + + L + ++ R L L
Sbjct: 81 ---LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 8/81 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG+G FG V G G VAVK +K A++F+ E ++ +RH NL++++ V
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 116 SIDFKGVDFKALIYEYMKCGS 136
+ ++ EYM GS
Sbjct: 257 ----EEKGGLYIVTEYMAKGS 273
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 24/197 (12%)
Query: 257 NIP-NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLSRL 312
NIP + L + N + +F + L++L + N + F L NL L
Sbjct: 34 NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ---TLPAGIFKELKNLETL 90
Query: 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF----GGVFLRSIANLSAKITVIG 368
+++ N L D L L L L+ N+ VF +L+ K+T +
Sbjct: 91 WVTDNKLQALPIGVFDQLVNLAE------LRLDRNQLKSLPPRVF----DSLT-KLTYLS 139
Query: 369 MGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP 427
+G N++ ++P + L ++ + NQL A +L L+ L L N L+
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 428 DTLGNLTLLNRLFLGFN 444
+L L L L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 23/196 (11%)
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
++ + LD+ N S F+RL+ L L+L+ N L T L L L
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET------L 90
Query: 343 YLNTNKF----GGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQ 397
++ NK GVF L + + + NQ+ ++P + +L + + YN+
Sbjct: 91 WVTDNKLQALPIGVF----DQLV-NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 398 LTGTIPH-AIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGN 456
L ++P +L +L+ L L N L+ LT L L L N L+ VP G
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPE--GA 200
Query: 457 CQNLMTLSRLLDLSGN 472
+L L L L N
Sbjct: 201 FDSLEKLKM-LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 52/194 (26%), Positives = 76/194 (39%), Gaps = 16/194 (8%)
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
IP++ K L ++ N+L+ A L L+ L L N L+ L L
Sbjct: 35 IPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSEN 496
L++ N LQ +P G L+ L+ L L N L S+P V +L L L N
Sbjct: 89 TLWVTDNKLQ-ALPI--GVFDQLVNLAE-LRLDRNQL-KSLPPRVFDSLTKLTYLSLGYN 143
Query: 497 HFSNEIPVTL-SACTTLEYLHLQGNSFSGSLPLSL-KTLKSIKELDLSRNNLSGQIPKYL 554
+ +P + T+L+ L L N +P L +K L L N L
Sbjct: 144 ELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 555 ENLLFLAYLNLSYN 568
++L L L L N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 52/198 (26%), Positives = 75/198 (37%), Gaps = 17/198 (8%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAI-GELKN 411
L +I +N+ A + + N++S L + + N+L T+P I ELKN
Sbjct: 28 LTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 412 LQGLALVRNSLRGTIP-DTLGNLTLLNRLFLGFNNLQ---GNVPSSLGNCQNLMTLSRLL 467
L+ L + N L+ +P L L L L N L+ V SL L
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY-------L 138
Query: 468 DLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL 526
L N L S+P V L +L E L N T L+ L L N
Sbjct: 139 SLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 527 PLSLKTLKSIKELDLSRN 544
+ +L+ +K L L N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 18/170 (10%)
Query: 208 QLRSLNYLSISENNFSCKLPLSIWN-ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSV 266
+L L L +++N LP I+ + +LE + + N+ + +LP+ + + N+ L +
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 267 GQNNFTGSLPHS-FSNASNLQVLDVYKNHFS---GQVKIDFNRLSNLSRLFLSKNNLGTE 322
+N SLP F + + L L + N V F++L++L L L N L
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGV---FDKLTSLKELRLYNNQLKRV 172
Query: 323 STSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372
D LT L L L+ N+ V + +L K+ ++ + +N
Sbjct: 173 PEGAFDKLTELK------TLKLDNNQLKRVPEGAFDSLE-KLKMLQLQEN 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 21/114 (18%), Positives = 48/114 (42%), Gaps = 9/114 (7%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR 103
+ ++F ++GQG+FG V K + A+K + + + ++E L+++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 104 HRNLIKIITV-----CSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLE 149
H+ +++ V K+ ++ EY + G+ D +H N +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 24/107 (22%), Positives = 49/107 (45%), Gaps = 15/107 (14%)
Query: 54 NMIGQGSFGFVYKGKL----GETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRN 106
++G G+FG VYKG + VA+K L+ A K + E +++V + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 78
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
+ +++ +C + + LI + M G D++ + D + + L
Sbjct: 79 VCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL 119
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 19/90 (21%), Positives = 40/90 (44%), Gaps = 14/90 (15%)
Query: 54 NMIGQGSFGFVYKGKL---GETGTTVAVKVMNLKQKGAA----KSFVTECEALSNVRHRN 106
+IG+G FG VY G+ + A+K ++ + ++F+ E + + H N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
++ +I + +G+ ++ YM G
Sbjct: 84 VLALIGIML--PPEGLPH--VLLPYMCHGD 109
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 12/104 (11%)
Query: 56 IGQGSFGFVYKGKL---GETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIK 109
+G GSFG V +G+ +VAVK + L Q A F+ E A+ ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
+ V + K ++ E GS D + + G L
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTL 123
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+GSF VYKG ET VA + ++ K + F E E L ++H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD- 92
Query: 114 CSSIDFKGVDFKALIY-EYMKCGS 136
S ++ E M G+
Sbjct: 93 -SWESTVKGKKCIVLVTELMTSGT 115
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 54 NMIGQGSFGFVYKGKL---GETGTTVAVKVMN-LKQKGAAKSFVTECEALSNVRHRNLIK 109
+IG+G FG VY G L AVK +N + G F+TE + + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
++ +C + + ++ YMK G +++ +L
Sbjct: 91 LLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL 130
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 25/105 (23%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 56 IGQGSFGFVYKGKLGETG-------TTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLI 108
+GQG+F ++KG E G T V +KV++ + ++SF +S + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
VC G + L+ E++K GS + ++ ++ + +
Sbjct: 76 LNYGVCV----CGDEN-ILVQEFVKFGSLDTYLKKNKNCINILWK 115
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 45/199 (22%), Positives = 72/199 (36%), Gaps = 19/199 (9%)
Query: 362 AKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNS 421
A +G + T K L + F + + + + NL+ L L N
Sbjct: 19 ANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQ 74
Query: 422 LRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481
+ P L +LT L L + N L +L + L L L N L + L
Sbjct: 75 ISDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSA-CL-SRLFLDNNELRDTDSLI 125
Query: 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDL 541
+L+NL + N + + L + LE L L GN + + L+ LK + +DL
Sbjct: 126 --HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDL 179
Query: 542 SRNNLSGQIPKYLENLLFL 560
+ + KY L
Sbjct: 180 TGQKCVNEPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 37/164 (22%), Positives = 60/164 (36%), Gaps = 17/164 (10%)
Query: 406 IGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSR 465
L N L + S+ T + L+ + +N+Q + + NL +
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNL----K 66
Query: 466 LLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS 525
L LS N + PL+ +L L E ++ N N + L L L N +
Sbjct: 67 ELHLSHNQISDLSPLK--DLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDT 121
Query: 526 LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569
L LK+++ L + N L + L L L L+L N
Sbjct: 122 DSLI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 43/245 (17%), Positives = 90/245 (36%), Gaps = 34/245 (13%)
Query: 330 LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA--KITVIGMGDNQISGTIPSEIKNLVN 387
+ + L + + + + ++ I ++ + ++ N
Sbjct: 12 VFPDPGLANAVKQNLGKQS-----VTDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTN 64
Query: 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
+ + +NQ++ P + +L L+ L++ RN L + + + L +RLFL N L+
Sbjct: 65 LKELHLSHNQISDLSP--LKDLTKLEELSVNRNRL--KNLNGIPSACL-SRLFLDNNELR 119
Query: 448 GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS 507
SL + +NL +L + N L + L L L DL N +N L+
Sbjct: 120 D--TDSLIHLKNL----EILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGG--LT 169
Query: 508 ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN--NLSGQI--PKYLENLLFLAYL 563
+ ++ L G + +K EL ++ + G+ P Y+ N
Sbjct: 170 RLKKVNWIDLTGQ------KCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDG 223
Query: 564 NLSYN 568
+ +
Sbjct: 224 CVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 33/211 (15%), Positives = 75/211 (35%), Gaps = 29/211 (13%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
+++ +L + + V + +N SL +NL+ L +
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLS 71
Query: 292 KNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFG 350
N S + L+ L L +++N L +L+ + + L+L+ N+
Sbjct: 72 HNQIS---DLSPLKDLTKLEELSVNRNRL-----KNLNGIPSAC----LSRLFLDNNE-- 117
Query: 351 GVFLRSIANLSA--KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGE 408
LR +L + ++ + +N++ +I + L + + N++T T +
Sbjct: 118 ---LRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTR 170
Query: 409 LKNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439
LK + + L L + N +
Sbjct: 171 LKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 33/178 (18%), Positives = 67/178 (37%), Gaps = 18/178 (10%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPD--SLCQLRSLNYLSI 217
L ++ + ++ + + + F+ L+ + +S N +I D L L L LS+
Sbjct: 39 ELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHN----QISDLSPLKDLTKLEELSV 92
Query: 218 SENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH 277
+ N + + L + L +N + L ++ N+ LS+ N S+
Sbjct: 93 NRNRLKNLNGIPS---ACLSRLFLDNNELRDTDSLI---HLKNLEILSIRNNKLK-SIV- 144
Query: 278 SFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTN 335
S L+VLD++ N + RL ++ + L+ E L +
Sbjct: 145 MLGFLSKLEVLDLHGNEIT--NTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 29/153 (18%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRN 106
F +G+GS+G VYK ETG VA+K + ++ + + E + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 107 LIKIITVCSSIDFKGVDFKA----LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLL 162
++K + G FK ++ EY GS D + N L + I + L
Sbjct: 86 VVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 163 KLEMI--------DV-GDNQLIG-----KFPDF 181
LE + D+ N L+ K DF
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 15/105 (14%)
Query: 56 IGQGSFGFVYKGKLGETG----TTVAVKVMNLKQKGAAKS---FVTECEALSNVRHRNLI 108
+G G FG V+KG G V +KV ++ K +S A+ ++ H +++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
+++ +C + L+ +Y+ GS D + Q L L
Sbjct: 79 RLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL 117
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV 102
S + + + S+++GQG+ V++G+ +TG A+KV N + E E L +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 103 RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
H+N++K+ + + K LI E+ CGS
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGS 95
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 22/132 (16%), Positives = 48/132 (36%), Gaps = 16/132 (12%)
Query: 16 TGRRKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTT 75
+ + +V D + IG+GS G V + +G
Sbjct: 16 ENLYFQSGVVTHEQFKAALRMVVDQGDPRL---LLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 76 VAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA----LIYEY 131
VAVK+M+L+++ + E + + +H N+++ ++ E+
Sbjct: 73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEELWVLMEF 123
Query: 132 MKCGSSEDWMHQ 143
++ G+ D + Q
Sbjct: 124 LQGGALTDIVSQ 135
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 13/98 (13%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIK 109
++ IGQG+ G VY TG VA++ MNL+Q+ + + E + ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 110 IITVCSSIDFKGVDFKA----LIYEYMKCGSSEDWMHQ 143
+ ++ EY+ GS D + +
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 35/163 (21%), Positives = 60/163 (36%), Gaps = 23/163 (14%)
Query: 16 TGRRKHTQKSSRTLPMEQQFPMVSYADLSKATNN------FSASNMIGQGSFGFVYKGKL 69
T + Q + +P + + D+++ FS IG GSFG VY +
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARD 75
Query: 70 GETGTTVAVKVMNLKQKGAA---KSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126
VA+K M+ K + + + E L +RH N I+ ++G +
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLRE 126
Query: 127 ----LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLE 165
L+ EY GS+ D + L+ + + L L
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 24/107 (22%), Positives = 49/107 (45%), Gaps = 15/107 (14%)
Query: 54 NMIGQGSFGFVYKGKL----GETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRN 106
++G G+FG VYKG + VA+K L+ A K + E +++V + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 78
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
+ +++ +C + + LI + M G D++ + D + + L
Sbjct: 79 VCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL 119
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 44/181 (24%), Positives = 63/181 (34%), Gaps = 15/181 (8%)
Query: 395 YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDT-LGNLTLLNRLFLGFNNLQGNVPSS 453
QL +P ++ L L N+L + LT L+ L L N+L +
Sbjct: 27 KQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA 83
Query: 454 LGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTL 512
NL R LDLS N L ++ + +L+ L L NH L
Sbjct: 84 FVPVPNL----RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL 138
Query: 513 EYLHLQGNSFSGSLP----LSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
+ L+L N S P L + LDLS N L L+ L L +
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 569 H 569
+
Sbjct: 198 N 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 39/200 (19%), Positives = 63/200 (31%), Gaps = 48/200 (24%)
Query: 257 NIP-NVNFLSVGQNNFTGSLP--HSFSNASNLQVLDVYKNHFSGQVKID---FNRLSNLS 310
++P L + NN + L + + +NL L + NH + I F + NL
Sbjct: 36 SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN---FISSEAFVPVPNLR 91
Query: 311 RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMG 370
L LS N+L T L L L L
Sbjct: 92 YLDLSSNHLHTLDEFLFSDLQALEV------LLLY------------------------- 120
Query: 371 DNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIP----HAIGELKNLQGLALVRNSLRGT 425
+N I + +++ + + NQ++ P +L L L L N L+
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 426 IPDTLGNLTLLNRLFLGFNN 445
L L + L +N
Sbjct: 179 PLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 35/135 (25%), Positives = 54/135 (40%), Gaps = 11/135 (8%)
Query: 458 QNLMTLSRLLDLSGNLLGGSIPLEV--GNLRNLAEFDLSENHFSNEIPV-TLSACTTLEY 514
Q+L + + LLDLS N L + E L NL LS NH + I L Y
Sbjct: 35 QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRY 92
Query: 515 LHLQGNSFSGSLP-LSLKTLKSIKELDLSRNNLSGQIPKY-LENLLFLAYLNLSYNHFEG 572
L L N +L L++++ L L N++ + + E++ L L LS N
Sbjct: 93 LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS- 149
Query: 573 EVPRKGVFGNRTGIH 587
P + + +
Sbjct: 150 RFPV-ELIKDGNKLP 163
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 32/164 (19%), Positives = 58/164 (35%), Gaps = 13/164 (7%)
Query: 337 SQMEMLYLNTNKF-----GGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINA 390
S +L L+ N L+ + + + N ++ I SE + N+
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTP----TRLT-NLHSLLLSHNHLN-FISSEAFVPVPNLRY 92
Query: 391 FGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
+ N L +L+ L+ L L N + + ++ L +L+L N +
Sbjct: 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLS 494
+ + L L LLDLS N L ++ L + L
Sbjct: 153 VELIKDGNKLPKL-MLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 188 LEAIDISANMLGGRIPD-SLCQLRSLNYLSISENNFSCKLPLSIW-NISSLEIISLHSNR 245
+D+S N L + + +L +L+ L +S N+ + + + + +L + L SN
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99
Query: 246 FEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH---FSGQVKID 302
+L + ++ + L + N+ ++F + + LQ L + +N F ++ D
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD 158
Query: 303 FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTN 347
N+L L L LS N L +DL L LYL+ N
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK----NGLYLHNN 199
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 16/86 (18%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA--AKSFVTECEALSNVRHRNLIKIITV 113
+G G +G VY+G + TVAVK + + + F+ E + ++H NL++++ V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CSSIDFKGVDFKALIY---EYMKCGS 136
C+ + Y E+M G+
Sbjct: 78 CTR--------EPPFYIITEFMTYGN 95
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 54 NMIGQGSFGFVYKGKL---GETGTTVAVKVMN-LKQKGAAKSFVTECEALSNVRHRNLIK 109
+IG+G FG VY G L AVK +N + G F+TE + + H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
++ +C + + ++ YMK G +++ +L
Sbjct: 155 LLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL 194
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 12/84 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G +G VY+G + TVAVK + + + F+ E + ++H NL++++ VC+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 116 SIDFKGVDFKALIY---EYMKCGS 136
+ Y E+M G+
Sbjct: 287 R--------EPPFYIITEFMTYGN 302
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 21/105 (20%), Positives = 42/105 (40%), Gaps = 16/105 (15%)
Query: 56 IGQGSFGFVYKGKL---GETGTTVAVKVMNL-KQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+G FG VY+G VAVK + F++E + N+ H +++K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 112 TVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
+ + + E G ++ ++ + L+ L
Sbjct: 80 GIIE---------EEPTWIIMELYPYGELGHYLERNKNSLKVLTL 115
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN-LKQKGAAKSFVTECEALSNV 102
S + + + S+++GQG+ V++G+ +TG A+KV N + + E E L +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 103 RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
H+N++K+ + + K LI E+ CGS
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGS 95
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 22/109 (20%)
Query: 56 IGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGA----AKSFVTECEALSNVRHRNL 107
IG G FG VYKG L G+ VA+K + G F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 108 IKIITVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
I++ V S + EYM+ G+ + ++ + + + L
Sbjct: 109 IRLEGVISKYK--------PMMIITEYMENGALDKFLREKDGEFSVLQL 149
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 26/107 (24%), Positives = 43/107 (40%), Gaps = 19/107 (17%)
Query: 56 IGQGSFGFVYKGKLGETG---TTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIK 109
IG G G V G+L G VA+K LK + + F++E + H N+I+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 110 IITVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
+ V + L EYM+ GS + ++ + + L
Sbjct: 115 LEGVVTR--------GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 21/102 (20%), Positives = 44/102 (43%), Gaps = 11/102 (10%)
Query: 56 IGQGSFGFVYKGKL--GETGTTVAVKVM--NLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G G+FG V KG + TVAVK++ + E + + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
+C + + L+ E + G ++ Q N ++ N+
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYL-QQNRHVKDKNI 119
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 18/106 (16%)
Query: 56 IGQGSFGFVYKGKL---GETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKII 111
IG+G FG V++G VA+K + F+ E + H +++K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 112 TVCSS----IDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
V + I I E G ++ L+ +L
Sbjct: 83 GVITENPVWI----------IMELCTLGELRSFLQVRKYSLDLASL 118
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 22/86 (25%), Positives = 45/86 (52%), Gaps = 10/86 (11%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G+FG V+ + + VAVK + + A + F E E L+ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGS 136
VC+ +G +++EYM+ G
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGD 129
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 36/146 (24%), Positives = 58/146 (39%), Gaps = 12/146 (8%)
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
+P I + +E N + P A K L+ + L N + PD L LN
Sbjct: 30 LPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSEN 496
L L N + +P + L +L +LL L+ N + + ++ +L NL L +N
Sbjct: 84 SLVLYGNKIT-ELPK--SLFEGLFSL-QLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDN 138
Query: 497 HFSNEIPVTLSACTTLEYLHLQGNSF 522
T S ++ +HL N F
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 36/167 (21%)
Query: 257 NIP-NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315
N+P + + + QN P +FS L+ +D+ N S F L +L+ L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
N + S + L L +L LN NK +
Sbjct: 89 GNKITELPKSLFEGLFSLQ------LLLLNANK-----INC------------------- 118
Query: 376 GTIPSEI-KNLVNINAFGVEYNQLTGTIPH-AIGELKNLQGLALVRN 420
+ + ++L N+N + N+L TI L+ +Q + L +N
Sbjct: 119 --LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 28/136 (20%), Positives = 51/136 (37%), Gaps = 8/136 (5%)
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSEN 496
+ L N ++ P + + L R +DLS N + + + LR+L L N
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKL----RRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 497 HFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL-SLKTLKSIKELDLSRNNLSGQIPKYLE 555
+ +L+ L L N + L + + + L ++ L L N L
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 556 NLLFLAYLNLSYNHFE 571
L + ++L+ N F
Sbjct: 150 PLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 5/117 (4%)
Query: 203 PDSLCQLRSLNYLSISENNFSCKLPLSI-WNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
P + + L + +S N S +L + SL + L+ N+ LP ++ + ++
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL 106
Query: 262 NFLSVGQNNFTGSLPH-SFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317
L + N L +F + NL +L +Y N K F+ L + + L++N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 35/133 (26%), Positives = 67/133 (50%), Gaps = 5/133 (3%)
Query: 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC 224
I + N + P + + L ID+S N + PD+ LRSLN L + N +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 225 KLPLSIW-NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH-SFSNA 282
+LP S++ + SL+++ L++N+ L ++ ++ N+N LS+ N ++ +FS
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 283 SNLQVLDVYKNHF 295
+Q + + +N F
Sbjct: 152 RAIQTMHLAQNPF 164
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 14/88 (15%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G+FG V+ + + VAVK + A K F E E L+N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 111 ITVCSSID--FKGVDFKALIYEYMKCGS 136
VC D +++EYMK G
Sbjct: 83 YGVCGDGDPLI-------MVFEYMKHGD 103
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 19/101 (18%), Positives = 43/101 (42%), Gaps = 9/101 (8%)
Query: 56 IGQGSFGFVYKGKLGETG--TTVAVKVM-NLKQKGAAKSFVTECEALSNVRHRNLIKIIT 112
+G G+FG V +G VA+KV+ +K + + E + + + + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
VC + L+ E G ++ +++ N+
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNV 438
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 13/103 (12%)
Query: 56 IGQGSFGFVYKGKLGETG--TTVAVKVMNLKQKGAAKS---FVTECEALSNVRHRNLIKI 110
+G G+FG V +G VA+KV LKQ + E + + + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
I VC + L+ E G ++ +++ N+
Sbjct: 76 IGVCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNV 112
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 11/87 (12%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIK 109
+G G+FG VY+G++ + VAVK + + F+ E +S H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGS 136
I V + + ++ E M G
Sbjct: 98 CIGVSL----QSLPR-FILMELMAGGD 119
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 29/92 (31%), Positives = 40/92 (43%), Gaps = 21/92 (22%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNVRHRN 106
+G+G FG V K TTVAVK++ + A+ S ++E L V H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 107 LIKIITVCSSID--FKGVDFKALIYEYMKCGS 136
+IK+ CS LI EY K GS
Sbjct: 88 VIKLYGACSQDGPLL-------LIVEYAKYGS 112
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 24/127 (18%), Positives = 50/127 (39%), Gaps = 11/127 (8%)
Query: 31 MEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK 90
M + + ++ +++ +IG G+ V VA+K +NL++ +
Sbjct: 1 MSEDSSALPWSINR---DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 91 S-FVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA-LIYEYMKCGSSEDWMHQSNDKL 148
+ E +A+S H N++ S + V + L+ + + GS D + K
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYY--TSFV----VKDELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 149 EAGNLGL 155
E + L
Sbjct: 112 EHKSGVL 118
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 12/85 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVC 114
IG+G+FG V+ G+L T VAVK F+ E L H N++++I VC
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 115 SSIDFKGVDFKALIY---EYMKCGS 136
+ K IY E ++ G
Sbjct: 182 TQ--------KQPIYIVMELVQGGD 198
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 16/115 (13%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIKIITVC 114
IG+GSFG V+KG T VA+K+++L++ E LS + K
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK----- 84
Query: 115 SSIDFKGVDFKA----LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLE 165
+ G K +I EY+ GS+ D + L+ + I R L L+
Sbjct: 85 ----YYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLD 133
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 21/92 (22%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNVRHRN 106
+GQGSFG VY+G E T VA+K +N + A+ F+ E + +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 107 LIKIITVCSSID--FKGVDFKALIYEYMKCGS 136
+++++ V S +I E M G
Sbjct: 90 VVRLLGVVSQGQPTL-------VIMELMTRGD 114
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 24/103 (23%), Positives = 46/103 (44%), Gaps = 17/103 (16%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA--AKSFVTECEALSNVRHRNLIKIITV 113
+G G FG V GK VA+K++ +G+ F+ E + + N+ H L+++ V
Sbjct: 32 LGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 114 CSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
C+ + I+ EYM G +++ + + + L
Sbjct: 88 CTK--------QRPIFIITEYMANGCLLNYLREMRHRFQTQQL 122
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 21/102 (20%), Positives = 40/102 (39%), Gaps = 10/102 (9%)
Query: 56 IGQGSFGFVYKGKL---GETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIKII 111
IG+G FG V++G VA+K + + F+ E + H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNL 153
V + + +I E G ++ L+ +L
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASL 493
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 15/102 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIKIITVC 114
IG G FG V+ G VA+K +++ ++ F+ E E + + H L+++ VC
Sbjct: 16 IGSGQFGLVHLGYWLNK-DKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 115 SSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
+A I E+M+ G D++ A L
Sbjct: 73 LE--------QAPICLVTEFMEHGCLSDYLRTQRGLFAAETL 106
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 21/90 (23%), Positives = 41/90 (45%), Gaps = 17/90 (18%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNVRHRN 106
+G G+FG VY+G++ + VAVK + + ++ F+ E +S H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
+++ I V + + ++ E M G
Sbjct: 136 IVRCIGVSL----QSLPR-FILLELMAGGD 160
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 14/82 (17%), Positives = 35/82 (42%), Gaps = 3/82 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G+G F +V + G A+K + ++ + E + H N+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94
Query: 116 SIDFKGVDFKALIY-EYMKCGS 136
+ +G +A + + K G+
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGT 116
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 17/90 (18%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNVRHRN 106
IG+G+FG V++ + E T VAVK++ + A+ F E ++ + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
++K++ VC+ G L++EYM G
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGD 136
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 24/107 (22%), Positives = 45/107 (42%), Gaps = 19/107 (17%)
Query: 56 IGQGSFGFVYKGKL---GETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIK 109
+G G FG V G+L + +VA+K LK + + F+ E + H N+I+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 110 IITVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
+ V + + EYM+ GS + ++ + + + L
Sbjct: 111 LEGVVTKSK--------PVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 32/223 (14%)
Query: 232 NIS-SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDV 290
+ +L N + + N+ S+ N++ L +
Sbjct: 16 DAFAETIKANLKKKSVT-DAVTQNELNSIDQIIAN---NSDIKSVQ-GIQYLPNVRYLAL 70
Query: 291 YKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF 349
N I L+NL+ L L+ N L + D LT L L L N+
Sbjct: 71 GGNKLH---DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE------LVLVENQL 121
Query: 350 ----GGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPH 404
GVF + NL T + + NQ+ ++P + L N+ + YNQL ++P
Sbjct: 122 QSLPDGVF-DKLTNL----TYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
Query: 405 AI-GELKNLQGLALVRNSLRGTIPD-TLGNLTLLNRLFLGFNN 445
+ +L L+ L L +N L+ ++PD LT L ++L +N
Sbjct: 175 GVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWL-HDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 35/149 (23%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 303 FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFG--GVFLRSIANL 360
N L+++ ++ + +++ +S + +L + L L NK + + NL
Sbjct: 37 QNELNSIDQIIANNSDI--KSVQGIQYLPNVRY------LALGGNKLHDISAL-KELTNL 87
Query: 361 SAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAI-GELKNLQGLALV 418
T + + NQ+ ++P+ + L N+ + NQL ++P + +L NL L L
Sbjct: 88 ----TYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 419 RNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
N L+ LT L L L +N LQ
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 28/122 (22%), Positives = 55/122 (45%), Gaps = 21/122 (17%)
Query: 28 TLPMEQQFPMVSYADLSK---ATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVK 79
LP+++ + Y D SK + +G+G+FG V + T TVAVK
Sbjct: 5 ELPLDEHCERLPY-DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 80 VMNLKQKGA----AKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKC 134
++ +GA ++ ++E + L ++ H N++ ++ C+ +I E+ K
Sbjct: 64 MLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKF 116
Query: 135 GS 136
G+
Sbjct: 117 GN 118
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 15/89 (16%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS-FVTECEALSNVRHRNLIK 109
+G+ FG VYKG L GE VA+K + K +G + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 110 IITVCSSID--FKGVDFKALIYEYMKCGS 136
++ V + +I+ Y G
Sbjct: 77 LLGVVTKDQPLS-------MIFSYCSHGD 98
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLI 108
F ++G G++G VYKG+ +TG A+KVM++ + E L HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 84
Query: 109 KIITVCSSIDFKGVDFKA-LIYEYMKCGSSEDWMHQSNDK 147
+ G+D + L+ E+ GS D + +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 124
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 22/81 (27%), Positives = 38/81 (46%), Gaps = 8/81 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G FG V+ + T VAVK M + ++F+ E + ++H L+K+ V +
Sbjct: 196 LGAGQFGEVWMATYNKH-TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 116 SIDFKGVDFKALIYEYMKCGS 136
+ +I E+M GS
Sbjct: 254 K------EPIYIITEFMAKGS 268
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-09
Identities = 28/103 (27%), Positives = 42/103 (40%), Gaps = 17/103 (16%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA--AKSFVTECEALSNVRHRNLIKIITV 113
+G G FG V GK VAVK++ +G+ F E + + + H L+K V
Sbjct: 16 LGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 114 CSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLEAGNL 153
CS + IY EY+ G +++ LE L
Sbjct: 72 CSK--------EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL 106
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 18/86 (20%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA--AKSFVTECEALSNVRHRNLIKIITV 113
+G G FG V+ G T VAVK + +G+ +F+ E + ++H+ L+++ V
Sbjct: 21 LGAGQFGEVWMGYYNGH-TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 114 CSSIDFKGVDFKALIY---EYMKCGS 136
+ + IY EYM+ GS
Sbjct: 77 VT---------QEPIYIITEYMENGS 93
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 17/99 (17%), Positives = 42/99 (42%), Gaps = 13/99 (13%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVC 114
++G+G++G VY G+ +A+K + + ++ E +++H+N+++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83
Query: 115 SSIDFKGVDFKA---LIY-EYMKCGSSEDWMHQSNDKLE 149
+ G + I+ E + GS + L+
Sbjct: 84 ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 4/66 (6%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR 103
+ +F +IG G FG V+K K G T +K + + A + E +AL+ +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 104 HRNLIK 109
H N++
Sbjct: 63 HVNIVH 68
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNV 102
++ + +G G FG+V + +TG VA+K + + + E + + +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 103 RHRNLIKIITVC-SSIDFKGVDFKALIYEYMKCGS 136
H N++ V D L EY + G
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGD 104
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 26/151 (17%), Positives = 47/151 (31%), Gaps = 15/151 (9%)
Query: 20 KHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQG--SFGFVYKGKLGETGTTVA 77
H Q M S+ + +IG+G V + TG V
Sbjct: 2 AHHHHHHMENLYFQG--MSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVT 56
Query: 78 VKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
V+ +NL+ E H N++ F + ++ +M G
Sbjct: 57 VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYG 111
Query: 136 SSEDWMHQS-NDKLEAGNLGLIQRLNLLKLE 165
S++D + D + + I + L L+
Sbjct: 112 SAKDLICTHFMDGMNELAIAYILQGVLKALD 142
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 17/126 (13%)
Query: 20 KHTQKSSRTLPMEQQFPMVSYADLSKATNNF---------SASNMIGQGSFGFVYKGKLG 70
+ K + L + ++ +GQG FG V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 71 ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYE 130
T T VA+K + + ++F+ E + + +RH L+++ V S ++ E
Sbjct: 207 GT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIVTE 258
Query: 131 YMKCGS 136
YM GS
Sbjct: 259 YMSKGS 264
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 15/90 (16%)
Query: 54 NMIGQGSFGFVYKGKL--GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNV-RHRN 106
++IG+G+FG V K ++ A+K M + A+K F E E L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
+I ++ C +G + L EY G+
Sbjct: 88 IINLLGACEH---RGYLY--LAIEYAPHGN 112
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 20/103 (19%), Positives = 45/103 (43%), Gaps = 8/103 (7%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK-SFVTECEALSNVRHRNLIK---- 109
+G+G FG V++ K A+K + L + A+ + E +AL+ + H +++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 110 IITVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQSNDKLE 149
+ ++ + K +Y + + + +DWM+ E
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 42/246 (17%), Positives = 81/246 (32%), Gaps = 45/246 (18%)
Query: 306 LSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKIT 365
+ L L + +L T + L ++ +Y++ +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISR------IYVSID------------------ 65
Query: 366 VIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPH-AIGELKNLQGLALVRNSLR 423
+ + S NL + + + I A+ EL L+ L + L+
Sbjct: 66 ------VTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 424 GTIPDT--LGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481
PD + + + L + N ++P + Q L + L L N S+
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA--FQGLCNETLTLKLYNNGF-TSVQGY 174
Query: 482 VGNLRNLAEFDLSENHFSNEIPVTL--SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKEL 539
N L L++N + I + L + S + +LP L+ +KEL
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKEL 231
Query: 540 DLSRNN 545
++RN
Sbjct: 232 -IARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 28/164 (17%), Positives = 56/164 (34%), Gaps = 12/164 (7%)
Query: 411 NLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPS-SLGNCQNLMTLSRLLDL 469
+ Q L L+ LR NL ++R+++ + + S S N + +++
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV----THIEI 87
Query: 470 SGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIP--VTLSACTTLEYLHLQGNSFSGSL 526
I + L L + P + + L + N + S+
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 527 PL-SLKTLKS-IKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
P+ + + L + L L N + + Y N L + L+ N
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 39/232 (16%), Positives = 77/232 (33%), Gaps = 33/232 (14%)
Query: 259 PNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKN 317
P+ L + + + H+FSN N+ + V + Q++ F LS ++ + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT 377
T D L ++ L + + + ++ + DN +
Sbjct: 91 RNLTYIDPD-----ALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
IP NAF G L L N ++ N T L+
Sbjct: 146 IPV--------NAF--------------QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNL 488
++L N + + + LLD+S + ++P + +L+ L
Sbjct: 183 AVYLNKNKYLTVIDKDA--FGGVYSGPSLLDVSQTSV-TALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 33/220 (15%), Positives = 81/220 (36%), Gaps = 27/220 (12%)
Query: 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSI-WNISSLEIISLHSN 244
+ + + + L + L +++ + +S + +L +N+S + I + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH--SFSNASNLQVLDVYKNHFSGQVKID 302
R + + +P + FL + P + +L++ N + + ++
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 303 -FNRLSNLSR-LFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI--- 357
F L N + L L N + + L +YLN NK +L I
Sbjct: 150 AFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDA-------VYLNKNK----YLTVIDKD 198
Query: 358 --ANLSAKITVIGMGDNQISGTIPSE----IKNLVNINAF 391
+ + +++ + ++ +PS+ +K L+ N +
Sbjct: 199 AFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/201 (14%), Positives = 69/201 (34%), Gaps = 31/201 (15%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP-DSLCQLRSLNYLSISENNF 222
+ + + + L +N + I +S ++ ++ S L + ++ I
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 223 SCKLPLSI-WNISSLEIISLHSNRFEGSLPLNIGFNIPNVNF-LSVGQNNFTGSLP-HSF 279
+ + L+ + + + + P ++ F L + N + S+P ++F
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 280 SNASN-LQVLDVYKNH--------FSG----QVKIDFNRL-------------SNLSRLF 313
N L +Y N F+G V ++ N+ S S L
Sbjct: 152 QGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 314 LSKNNLGTESTSDLDFLTLLT 334
+S+ ++ + L+ L L
Sbjct: 212 VSQTSVTALPSKGLEHLKELI 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 8/81 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+GQG FG V+ G T T VA+K + + ++F+ E + + +RH L+++ V S
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 116 SIDFKGVDFKALIYEYMKCGS 136
++ EYM GS
Sbjct: 333 EEPI------YIVTEYMSKGS 347
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 24/95 (25%)
Query: 56 IGQGSFGFVYKGKL-------GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNV-R 103
+G+G+FG V + + TVAVK++ A + V+E E + + +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 104 HRNLIKIITVCSSID--FKGVDFKALIYEYMKCGS 136
H+N+I ++ C+ + +I EY G+
Sbjct: 100 HKNIINLLGACTQDGPLY-------VIVEYASKGN 127
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 24/95 (25%)
Query: 56 IGQGSFGFVYKGKL-------GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNV-R 103
+G+G FG V + + TVAVK++ A + V+E E + + +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 104 HRNLIKIITVCSSID--FKGVDFKALIYEYMKCGS 136
H+N+I ++ C+ + +I EY G+
Sbjct: 146 HKNIINLLGACTQDGPLY-------VIVEYASKGN 173
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 9/62 (14%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+G F ++ +T A K++ L + + E ++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 112 TV 113
Sbjct: 82 GF 83
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 11/89 (12%), Positives = 27/89 (30%), Gaps = 5/89 (5%)
Query: 25 SSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK 84
++ P + + S LS+ + G V+ + E A+KV +
Sbjct: 41 TATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG 98
Query: 85 QK---GAAKSFVTECEALSNVRHRNLIKI 110
+ + A + + + +
Sbjct: 99 AENSRSELERLHEATFAAARLLGESPEEA 127
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 22/93 (23%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNV-RHR 105
+G G+FG V + + TVAVK++ A + ++E + LS + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 106 NLIKIITVCSSID--FKGVDFKALIYEYMKCGS 136
N++ ++ C+ +I EY G
Sbjct: 88 NIVNLLGACTIGGPTL-------VITEYCCYGD 113
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 9/62 (14%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+G F ++ +T A K++ L + + E ++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 112 TV 113
Sbjct: 108 GF 109
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 21/93 (22%), Positives = 41/93 (44%), Gaps = 20/93 (21%)
Query: 56 IGQGSFGFVYKGKL-------GETGTTVAVKVMNLKQKGAAKS----FVTECEALSNV-R 103
+G+G+FG V + T VAVK++ A + ++E E + + +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 104 HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
H+N+I ++ C+ + +I EY G+
Sbjct: 134 HKNIINLLGACT----QDGPL-YVIVEYASKGN 161
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 23/87 (26%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRN 106
+++ + +IG GSFG VY+ KL ++G VA+K K + E + + + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCN 108
Query: 107 LIKIITV-CSSIDFKGVDFKALIYEYM 132
++++ SS + K + L+ +Y+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV 135
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 19/81 (23%), Positives = 35/81 (43%), Gaps = 10/81 (12%)
Query: 39 SYADLSKATNNFSASNM--------IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA- 89
+ + T N +M IG+GSFG K E G +K +N+ + +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 90 -KSFVTECEALSNVRHRNLIK 109
+ E L+N++H N+++
Sbjct: 67 REESRREVAVLANMKHPNIVQ 87
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 19/93 (20%), Positives = 39/93 (41%), Gaps = 22/93 (23%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGA----AKSFVTECEALSNV-RHR 105
+G G+FG V VAVK++ + A ++ ++E + ++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 106 NLIKIITVCSSID--FKGVDFKALIYEYMKCGS 136
N++ ++ C+ + LI+EY G
Sbjct: 110 NIVNLLGACTLSGPIY-------LIFEYCCYGD 135
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 18 RRKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVA 77
R+H + + + +S +S IG G V++ L E A
Sbjct: 26 ERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYA 84
Query: 78 VKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKII 111
+K +NL++ S+ E L+ ++ + KII
Sbjct: 85 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 119
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 23/123 (18%), Positives = 52/123 (42%), Gaps = 18/123 (14%)
Query: 56 IGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQKGA----AKSFVTECEALSNV-RHR 105
+G G+FG V + + VAVK++ A ++ ++E + +S++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLE 165
N++ ++ C+ G +I EY G +++ + + LE I +
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 166 MID 168
++
Sbjct: 166 LLH 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 22/92 (23%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVK-VMNLKQKGAAKSFVTECEALSNV 102
K + F M GQG+FG V GK TG +VA+K V ++ + + L+ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQDPRFRNRELQIMQDLAVL 76
Query: 103 RHRNLIKIITVCSSIDFKGVD--FKALIYEYM 132
H N++++ + ++ + + ++ EY+
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 13/90 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVT-ECEALSNVRHRNLIKII 111
+G+GS+G V + ET AVK++ L++ ++ V E + L +RH+N+I+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 112 TVCSSIDFKGVDFKALIY---EYMKCGSSE 138
V + + K +Y EY CG E
Sbjct: 73 DVLYN------EEKQKMYMVMEYCVCGMQE 96
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 14/167 (8%)
Query: 189 EAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWN-ISSLEIISLHSNRFE 247
E +D+ + L + L L +L++ N L +++ ++ L + L +N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 248 GSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS-FSNASNLQVLDVYKNHFSGQVKIDFNRL 306
SLPL + ++ ++ L +G N SLP F + L+ L + N F++L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLT---------NCSQMEMLYL 344
+NL L LS N L + D L L +CS+ E+LYL
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYL 201
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 44/169 (26%), Positives = 62/169 (36%), Gaps = 14/169 (8%)
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
IP++ + L ++ L L L L L N L+ +LT L
Sbjct: 33 IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV-GNLRNLAEFDLSEN 496
L L N L ++P G +L L + L L GN L S+P V L L E L+ N
Sbjct: 87 TLGLANNQLA-SLPL--GVFDHLTQLDK-LYLGGNQL-KSLPSGVFDRLTKLKELRLNTN 141
Query: 497 HFSNEIPV-TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544
IP T L+ L L N + L ++ + L N
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 15/173 (8%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L S+ + + A + + ++ + + L + ++YNQL +L L
Sbjct: 26 LDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPS----SLGNCQNLMTLSRLLD 468
L L N L +LT L++L+LG N L+ +PS L + L
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKE-------LR 137
Query: 469 LSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGN 520
L+ N L SIP L NL LS N + L+ + L GN
Sbjct: 138 LNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 14/96 (14%), Positives = 42/96 (43%), Gaps = 3/96 (3%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITV 113
++ +G F FVY+ + +G A+K + ++ ++ + E + + H N+++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 114 CSSI--DFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
S + + L+ + G +++ + +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 76/488 (15%), Positives = 147/488 (30%), Gaps = 144/488 (29%)
Query: 97 EALSNVR-HRNLI--------K---IITVCSSIDFKGV-DFKALIYEYMKCGSSEDWMHQ 143
+AL +R +N++ K + VC S + DFK I+ W+
Sbjct: 142 QALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK--IF----------WL-- 187
Query: 144 SNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKF-PDFIANFSALEAIDISANMLGGRI 202
NL + LEM+ +L+ + P++ + I + + + +
Sbjct: 188 --------NLKNCNSPETV-LEML----QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 203 ---------PDSLCQLRSLNYLSISEN-NFSCKLPLSIWNISSLEIISLHSNRFEGSLPL 252
+ L L ++ N SCK+ L+ + +S +
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 253 NIGFNIPNV-----NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLS 307
++ V +L LP +N + L + + ++
Sbjct: 295 SMTLTPDEVKSLLLKYLDCR----PQDLPRE-VLTTNPRRLSI----IAESIRDGLATWD 345
Query: 308 NLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKIT-- 365
N + K L T S L+ L ++ ++ ++ VF SA I
Sbjct: 346 NWKHVNCDK--LTTIIESSLNVL----EPAEYRKMF---DRLS-VF-----PPSAHIPTI 390
Query: 366 VIGMGDNQISGTIPSEI------KNLVNINAFGVEYNQLTGTIPHAIGELK----NLQGL 415
++ + + + + +LV + T +IP ELK N L
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----PKESTISIPSIYLELKVKLENEYAL 445
Query: 416 --ALVR--NSLRGTIPDTLG-----------------------NLTLLNRLFLGFNNLQG 448
++V N + D L +TL +FL F L+
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA 508
+ R + N G + + L+ + + +N E V
Sbjct: 506 KI--------------RHDSTAWNASGSILNT-LQQLKFYKPY-ICDNDPKYERLV---- 545
Query: 509 CTTLEYLH 516
L++L
Sbjct: 546 NAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 72/433 (16%), Positives = 131/433 (30%), Gaps = 141/433 (32%)
Query: 287 VLDVYKNHFSGQVKIDF-----NRLSNLSRLF---LSKNN------LGTESTSDLDFLT- 331
V D+ K+ S + +ID + +S RLF LSK + + FL
Sbjct: 38 VQDMPKSILSKE-EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 332 -LLTNCSQMEM---LYL-------NTNKFGGVF-------------LRS-IANL--SAKI 364
+ T Q M +Y+ N N+ VF LR + L + +
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQ---VFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 365 TVIGMGDNQISG--TIPSEI---KNLVNINAFGVEYNQLT-G--TIPHAIGELKNLQGLA 416
+ G+ SG + ++ + F + + L P + L+ LQ L
Sbjct: 154 LIDGVLG---SGKTWVALDVCLSYKVQCKMDFKIFW--LNLKNCNSPETV--LEMLQKLL 206
Query: 417 LVRNSLRGTIPDTLGNLTL--------LNRLFLGFNNLQGNVPSSL-------------- 454
+ + D N+ L L RL + L
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK-----SKPYENCLLVLLNVQNAKAWNA 261
Query: 455 --GNCQNLMTLSR---LLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN--------- 500
+C+ L+T +R + D I L+ + L D ++
Sbjct: 262 FNLSCKILLT-TRFKQVTDFLSAATTTHISLD-HHSMTLTP-DEVKSLLLKYLDCRPQDL 318
Query: 501 --EI----PVTLS---------ACTTLEYLHLQGNSFSGSLPLSLKTLKS--IKEL--DL 541
E+ P LS T + H+ + + + SL L+ +++ L
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 542 S--RNNLSGQIPKYLENLLFLAYLNLSYN---HFEGEVPRKGV-----FGNRTGIHLI-- 589
S + IP LL L + ++ + ++ + + + I I
Sbjct: 379 SVFPPSA--HIP---TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 590 GNERLCGGLEELH 602
+ LH
Sbjct: 434 ELKVKLENEYALH 446
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 8e-06
Identities = 51/345 (14%), Positives = 98/345 (28%), Gaps = 104/345 (30%)
Query: 99 LSNVRHRNLIK---------IITVCSSI-DF-KGVDFKALIYEYMKCGSSED-------- 139
L NV++ + T + DF + ++ + D
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 140 WMHQSNDKL--EA--GN---LGLI--------------QRLNLLKL-EMIDVGDNQLIGK 177
++ L E N L +I + +N KL +I+ N L +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--E 367
Query: 178 FPDFIANFSAL----EAIDISANMLG-----------GRIPDSLCQLRSLNYLSISENNF 222
++ F L + I +L + + L + SL +
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK-YSL--VEKQPKES 424
Query: 223 SCKLP---LSIWNISSLEIISLHSN-----RFEGSLPLN--------------IGFNIP- 259
+ +P L + + +LH + + + IG ++
Sbjct: 425 TISIPSIYLEL-KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 260 ---------------NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN 304
+ FL + + + S S + LQ L YK + +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYE 542
Query: 305 RLSNLSRLFLSKNNLGTESTSDLDFLTL-LTNCSQMEMLYLNTNK 348
RL N FL K + D L + L + E ++ +K
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIALMA--EDEAIFEEAHK 585
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 20/65 (30%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK---SFVTECEALSNVRH 104
NF IG+G F VY+ G VA+K + + AK + E + L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 105 RNLIK 109
N+IK
Sbjct: 92 PNVIK 96
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 64/433 (14%), Positives = 133/433 (30%), Gaps = 58/433 (13%)
Query: 150 AGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQL 209
+ I+ L + + + L + + ++LE ++ P L +
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLH----ELAQHNTSLEVLNFYMTEFAKISPKDLETI 215
Query: 210 ----RSLNYLSISENNFS--CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGF--NIPNV 261
RSL + + + + N+ SL+ + +N+ F + +
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275
Query: 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLG 320
+G N +P F A+ ++ LD+ + + NL L
Sbjct: 276 GLSYMGPN----EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN---- 327
Query: 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS 380
D L C Q++ L + G + + + ++ G+ +
Sbjct: 328 --VIGDRGLEVLAQYCKQLKRLRIE----RGADEQGMEDEEGLVSQRGLI------ALAQ 375
Query: 381 EIKNLVNINAFGVEYNQLTGTIPHAIGE-LKNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439
+ L + + + +T +IG LKNL L + L
Sbjct: 376 GCQELEYMAVYV---SDITNESLESIGTYLKNLCDFRL---------------VLLDREE 417
Query: 440 FLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
+ L V S L C+ L + G L + N+ L S
Sbjct: 418 RITDLPLDNGVRSLLIGCKKLRRFA-FYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476
Query: 500 NE-IPVTLSACTTLEYLHLQGNSFS-GSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE-- 555
+E + C L+ L ++G FS ++ ++ L S++ L + S ++
Sbjct: 477 DEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMA 536
Query: 556 -NLLFLAYLNLSY 567
+ +
Sbjct: 537 RPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 51/408 (12%), Positives = 116/408 (28%), Gaps = 50/408 (12%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT-GSLPH-SFSNASNLQVLD 289
+ +I + + I N+ + + + + L + + A +L+ L
Sbjct: 85 RAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144
Query: 290 VYK-NHFSGQVKIDF-NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTN 347
+ K + F+ + + L + +++ + L + + +E+L
Sbjct: 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKD--GKWLHELAQHNTSLEVLNFYMT 202
Query: 348 KFGGV---FLRSIANLSAKITVIGMGDNQIS--GTIPSEIKNLVNINAFGVEYNQLTGTI 402
+F + L +IA + + +GD +I NL + +
Sbjct: 203 EFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEK 262
Query: 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN-VPSSLGNCQNLM 461
+ + L L L +P + +L L + L+ + + C NL
Sbjct: 263 YMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL- 320
Query: 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA------------C 509
+L+ + + + + L + + C
Sbjct: 321 ---EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC 377
Query: 510 TTLEYLHLQGNSFS----GSLPLSLKTLKSIKELDLSRNN------LSGQIPKYLENLLF 559
LEY+ + + + S+ LK L + + L R L + L
Sbjct: 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKK 437
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCH 607
L G+ IG + + + L
Sbjct: 438 LRRFAFYLR---------QGGLTDLGLSYIG--QYSPNVRWMLLGYVG 474
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 64/413 (15%), Positives = 130/413 (31%), Gaps = 55/413 (13%)
Query: 228 LSIWNISSLEIISLHSNRFEG--SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNA-SN 284
+++ + L RF SL L N + + SN
Sbjct: 55 VTMALCYTATPDRLSR-RFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQ 113
Query: 285 LQVLDVYKNHFS--GQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
L+ + + S ++ R +L L L + L+++T+C +++ L
Sbjct: 114 LKSVHFRRMIVSDLDLDRLAKARADDLETLKLD----KCSGFTTDGLLSIVTHCRKIKTL 169
Query: 343 YLNTNKF---GGVFLRSIANLSAKITVIGMGDNQISG-------TIPSEIKNLVNINAFG 392
+ + F G +L +A + + V+ + + TI ++LV++
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGD 229
Query: 393 VEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRL-FLGFNNLQGN-V 450
E +L G A NL+ + +P+ NL +L LG + + N +
Sbjct: 230 FEILELVGFFKAA----ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM 285
Query: 451 PSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE-VGNLRNLAEFDLSENHFSNEIPVTLSAC 509
P + R LDL LL + NL + + V C
Sbjct: 286 PILFPFAAQI----RKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYC 341
Query: 510 TTLEYLHLQGNSFSGSLPLSLKTL------------KSIKELDLSRNNLSGQ----IPKY 553
L+ L ++ + + + + ++ + + ++++ + I Y
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401
Query: 554 LENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
L+NL + L R G+ + C L
Sbjct: 402 LKNLCDFRLVLLDR------EERITDLPLDNGVRSLL--IGCKKLRRFAFYLR 446
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 47/341 (13%), Positives = 104/341 (30%), Gaps = 43/341 (12%)
Query: 303 FNRLSNLSRLFLSKNNLGTESTSDLD--FLTL----LTNCSQMEMLYLNTNKFGGVFLRS 356
+ ++ + +R ++ T + L F L L + M L +GG
Sbjct: 44 WFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPW 103
Query: 357 IANLSAKITVI--------GMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGE 408
+ +S + + + D + + +L + + T +I
Sbjct: 104 VTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKC--SGFTTDGLLSIVT 161
Query: 409 -LKNLQGLALVRNSLR-------GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG-NCQN 459
+ ++ L + +S + +L +LN F + ++ NC++
Sbjct: 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRS 221
Query: 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQG 519
L+++ + L NL L+E+ E + L L L L
Sbjct: 222 LVSVK--VGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSG-QIPKYLENLLFLAYLNLSYNHFEGEVPRKG 578
+ +P+ I++LDL L ++ L L +
Sbjct: 280 MGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD------- 331
Query: 579 VFGNRTGIHLIGNERLCGGLEELHLPSCHFGRPRITRITLL 619
G+ ++ + C L+ L + + L+
Sbjct: 332 -----RGLEVLA--QYCKQLKRLRIERGADEQGMEDEEGLV 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHR 105
+S IG G V++ L E A+K +NL++ S+ E L+ ++
Sbjct: 28 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 106 N 106
+
Sbjct: 87 S 87
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 52/292 (17%), Positives = 97/292 (33%), Gaps = 45/292 (15%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL----SA 362
++ L LS NNL + ST +L + + L L+ N G + + A
Sbjct: 22 HGVTSLDLSLNNLYSISTVEL-IQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 363 KITVIGMGDNQISGTIPSEI-KNLVNINA----FGVEYNQLTGTIPHAIGEL-----KNL 412
+T + + N +S E+ K L I + +N + + ++
Sbjct: 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140
Query: 413 QGLALVRNSLRGT----IPDTLGNL-TLLNRLFLGFNNLQGNVPSSLG-----NCQNLMT 462
L L N L + L + +N L L NNL + L ++
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV-- 198
Query: 463 LSRLLDLSGNLLG--GSIPLE---VGNLRNLAEFDLSENHFSNE----IPVTLSACTTLE 513
LDLS NLLG L ++ +L N + + + L+
Sbjct: 199 --TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 514 YLHLQGNSFSG-------SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
++L + +L + ++ I +D + + + NL+
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLI 308
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 44/311 (14%), Positives = 99/311 (31%), Gaps = 48/311 (15%)
Query: 280 SNASNLQVLDVYKNHFSGQVKIDFNRL-----SNLSRLFLSKNNLGTESTSDLDFLTLLT 334
+ +++ L++ N + + ++ +N++ L LS N L +S+ +L TL
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL-VKTLAA 106
Query: 335 NCSQMEMLYLNTNKFGGVFLRSIA----NLSAKITVIGMGDNQISGT--------IPSEI 382
+ +L L N F NL A IT + + N + + +
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166
Query: 383 KNLVNINAFGVEYNQLTGTIPHAIGEL-----KNLQGLALVRNSLRGT----IPDTL-GN 432
N+ ++N + N L + + ++ L L N L +
Sbjct: 167 ANVNSLN---LRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 433 LTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGG-------SIPLEVGNL 485
+ L L N L G +L ++ + + + L +++ ++ N+
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 486 RNLAEFDLSENHFSNEIPVTLSA-----CTTLEYLHLQGNSFS-----GSLPLSLKTLKS 535
+ + D + + +S + L + L
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDE 343
Query: 536 IKELDLSRNNL 546
++E + L
Sbjct: 344 LRESIQTCKPL 354
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 17/104 (16%), Positives = 37/104 (35%), Gaps = 1/104 (0%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA-KSFVTECEALSNV 102
S+ +F +G+G FG V++ K A+K + L + A + + E +AL+ +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 103 RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146
H +++ + + + S
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM 105
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 13/55 (23%), Positives = 24/55 (43%), Gaps = 3/55 (5%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRN 106
IG G V++ L E A+K +NL++ S+ E L+ ++ +
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 14/56 (25%), Positives = 24/56 (42%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G G+F V+ K TG A+K + S E L ++H N++ +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 18/80 (22%), Positives = 31/80 (38%), Gaps = 5/80 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G+FG V++ TG K +N + E ++ + H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 116 SIDFKGVDFKALIYEYMKCG 135
F+ LI E++ G
Sbjct: 117 ---FEDKYEMVLILEFLSGG 133
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 18/66 (27%), Positives = 36/66 (54%), Gaps = 3/66 (4%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRH 104
++F +G+G FG VY + + +A+KV+ L+++G E E S++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 105 RNLIKI 110
N++++
Sbjct: 74 PNILRM 79
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 18/69 (26%), Positives = 35/69 (50%), Gaps = 3/69 (4%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRH 104
+F +G+G FG VY + ++ +A+KV+ L++ G E E S++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 105 RNLIKIITV 113
N++++
Sbjct: 69 PNILRLYGY 77
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 28/133 (21%), Positives = 60/133 (45%), Gaps = 21/133 (15%)
Query: 29 LPMEQQFPMVSYADLSK---ATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKV 80
LP+++ + Y D SK + +G+G+FG V + T TVAVK+
Sbjct: 1 LPLDEHCERLPY-DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 59
Query: 81 MNLKQKGA----AKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
+ +GA ++ ++E + L ++ H N++ ++ C+ + +I E+ K G
Sbjct: 60 LK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM----VIVEFCKFG 112
Query: 136 SSEDWMHQSNDKL 148
+ ++ ++
Sbjct: 113 NLSTYLRSKRNEF 125
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 12/83 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG G+FG + T VAVK + + ++ E ++RH N+++ V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 116 SIDFKGVDFKALIY---EYMKCG 135
+ + EY G
Sbjct: 87 T--------PTHLAIIMEYASGG 101
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 14/61 (22%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIKIIT 112
+G+GSF VY+ + TG VA+K+++ + + G + E + ++H +++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 113 V 113
Sbjct: 79 Y 79
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 21/87 (24%), Positives = 40/87 (45%), Gaps = 5/87 (5%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLI 108
S + ++G G FG V+K + TG +A K++ + + E ++ + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCG 135
++ F+ + L+ EY+ G
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGG 171
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 27/109 (24%), Positives = 52/109 (47%), Gaps = 10/109 (9%)
Query: 31 MEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK 90
M +Q+ V + + + IGQG+FG V+K + +TG VA+K + ++ +
Sbjct: 1 MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKE 57
Query: 91 SF-VT---ECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY---EYM 132
F +T E + L ++H N++ +I +C + K IY ++
Sbjct: 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 14/86 (16%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIKIIT 112
+G G+FG V G+ TG VAVK++N ++ E + L RH ++IK+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 113 VCSSIDFKGVDFKALIY---EYMKCG 135
V S+ + EY+ G
Sbjct: 79 VIST--------PTDFFMVMEYVSGG 96
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 14/57 (24%), Positives = 26/57 (45%), Gaps = 2/57 (3%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--KSFVTECEALSNVRHRNLIK 109
IG GS+G K + G + K ++ A + V+E L ++H N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-07
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 12/84 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT-ECEALSNVRHRNLIKIITVC 114
+G+G++G V T VAVK++++K+ + E + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 SSIDFKGVDFKALIY---EYMKCG 135
+ Y EY G
Sbjct: 75 RE--------GNIQYLFLEYCSGG 90
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 19/92 (20%), Positives = 40/92 (43%), Gaps = 6/92 (6%)
Query: 18 RRKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVA 77
R + + + + ++ V Y + + + + +G+GSFG V++ K +TG A
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87
Query: 78 VKVMNLKQKGAAKSFVTECEALSNVRHRNLIK 109
VK + L+ V E A + + ++
Sbjct: 88 VKKVRLE-----VFRVEELVACAGLSSPRIVP 114
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 23/131 (17%), Positives = 49/131 (37%), Gaps = 21/131 (16%)
Query: 18 RRKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVA 77
+ ++ L +Q+ + D K + +G G+ G V+K +G +A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMA 62
Query: 78 VKVMNLKQKGAA-KSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA----LIYEYM 132
K+++L+ K A + E + L ++ F G + + E+M
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---------FYGAFYSDGEISICMEHM 113
Query: 133 KCGSSEDWMHQ 143
GS + + +
Sbjct: 114 DGGSLDQVLKK 124
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 31/133 (23%), Positives = 54/133 (40%), Gaps = 13/133 (9%)
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENH 497
L ++ + ++L + + L LS N + L + NL L N
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKAC----KHLALSTNNIEKISSLS--GMENLRILSLGRNL 81
Query: 498 FSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS--GQIPKYLE 555
+I + TLE L + N + SL ++ L +++ L +S N ++ G+I L
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEI-DKLA 137
Query: 556 NLLFLAYLNLSYN 568
L L L L+ N
Sbjct: 138 ALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 25/124 (20%), Positives = 55/124 (44%), Gaps = 13/124 (10%)
Query: 225 KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASN 284
K+ ++ + + + ++L +N E L+ + N+ LS+G+N + + + A
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEKISSLS---GMENLRILSLGRNLIK-KIENLDAVADT 94
Query: 285 LQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLY 343
L+ L + N + + +L NL L++S N + ++ + L ++E L
Sbjct: 95 LEELWISYNQIA---SLSGIEKLVNLRVLYMSNNKI-----TNWGEIDKLAALDKLEDLL 146
Query: 344 LNTN 347
L N
Sbjct: 147 LAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 17/74 (22%), Positives = 30/74 (40%), Gaps = 9/74 (12%)
Query: 501 EIPVTLSACTTLEYLHLQGNSFS---GSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557
++ TLS ++L L N+ L +++++ L L RN + +I
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 558 LFLAYLNLSYNHFE 571
L L +SYN
Sbjct: 93 DTLEELWISYNQIA 106
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 12/84 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT-ECEALSNVRHRNLIKIITVC 114
+G+G++G V T VAVK++++K+ + E + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 SSIDFKGVDFKALIY---EYMKCG 135
+ Y EY G
Sbjct: 75 RE--------GNIQYLFLEYCSGG 90
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 28/120 (23%), Positives = 39/120 (32%), Gaps = 12/120 (10%)
Query: 452 SSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPV--TLSAC 509
+ N R LDL G + I L D S+N EI
Sbjct: 13 AQYTNAVRD----RELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLL 63
Query: 510 TTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG-QIPKYLENLLFLAYLNLSYN 568
L+ L + N + L + EL L+ N+L L +L L YL + N
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 27/132 (20%), Positives = 43/132 (32%), Gaps = 9/132 (6%)
Query: 430 LGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLA 489
N L +L+G + N + +D S N + LR L
Sbjct: 15 YTNAVRDREL-----DLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLK 67
Query: 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS-LKTLKSIKELDLSRNNLSG 548
++ N A L L L NS L L +LKS+ L + RN ++
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT- 126
Query: 549 QIPKYLENLLFL 560
Y +++
Sbjct: 127 NKKHYRLYVIYK 138
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 18/105 (17%), Positives = 32/105 (30%), Gaps = 5/105 (4%)
Query: 467 LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL 526
+ L+ L+ + N E DL I + + + N L
Sbjct: 2 VKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 527 PLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
L+ +K L ++ N + + L L L L+ N
Sbjct: 58 D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 10/67 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT---------ECEALSNVRHRN 106
+G G+FGFV+ E V VK + K+K ++ E LS V H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 107 LIKIITV 113
+IK++ +
Sbjct: 91 IIKVLDI 97
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 2e-06
Identities = 27/159 (16%), Positives = 52/159 (32%), Gaps = 18/159 (11%)
Query: 417 LVRNSLRGTIPDTLGNLTL--LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL-LDLSGNL 473
L ++GT ++G L L + L +V + +L L +L L +
Sbjct: 174 LNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS-DLPNLEKLVLYVGVED 232
Query: 474 LGGSIP-------LEVGNLRNLAEFDLSENHFSNEIPVTLSAC---TTLEYLHLQGNSFS 523
G NL + + N + LE + + +
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 524 GS----LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558
L + +K +K +++ N LS ++ K L+ L
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 3e-05
Identities = 19/127 (14%), Positives = 48/127 (37%), Gaps = 18/127 (14%)
Query: 465 RLLDLSGNLLGGSIPLEVG--NLRNLAEFDL---SENHFSNEIPVTLSA------CTTLE 513
+ L++ L S+ ++ +L NL + L E++ + L+
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255
Query: 514 YLHLQGNSFSGSLPLSL---KTLKSIKELDLSRNNLSG----QIPKYLENLLFLAYLNLS 566
+L + + L ++ +D+S L+ + +++ + L ++N+
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 567 YNHFEGE 573
YN+ E
Sbjct: 316 YNYLSDE 322
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 16/87 (18%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT----ECEALSNVRHRNLIKII 111
+G G+FG V GK TG VAVK++N +QK + V E + L RH ++IK+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 112 TVCSSIDFKGVDFKALIY---EYMKCG 135
V S+ + I+ EY+ G
Sbjct: 83 QVIST--------PSDIFMVMEYVSGG 101
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 25/140 (17%), Positives = 47/140 (33%), Gaps = 9/140 (6%)
Query: 234 SSLEIISLHSNRFEGSLPLNIGF-NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYK 292
+ L++N F L F +P + ++ N T +F AS + + +
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 293 NHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV 352
N F L +L L L N + L+ + +L L N+ V
Sbjct: 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR------LLSLYDNQITTV 144
Query: 353 FLRSIANLSAKITVIGMGDN 372
+ L ++ + + N
Sbjct: 145 APGAFDTLH-SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 28/148 (18%), Positives = 50/148 (33%), Gaps = 8/148 (5%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIPHAIGELKN 411
L I ++ + + +N+ + + I K L + N++T A
Sbjct: 23 LNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471
+ + L N L L L L L N + S ++ RLL L
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV----RLLSLYD 138
Query: 472 NLLGGSIPLEV-GNLRNLAEFDLSENHF 498
N + ++ L +L+ +L N F
Sbjct: 139 NQI-TTVAPGAFDTLHSLSTLNLLANPF 165
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 44/167 (26%), Positives = 62/167 (37%), Gaps = 41/167 (24%)
Query: 283 SNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
+N Q+L ++ N + F+ L NL L+L N LG D LT LT L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV------L 93
Query: 343 YLNTNKF----GGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398
L TN+ VF R LV++ + N+L
Sbjct: 94 DLGTNQLTVLPSAVFDR-----------------------------LVHLKELFMCCNKL 124
Query: 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNN 445
T +P I L +L LAL +N L+ L+ L +L F N
Sbjct: 125 T-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 39/145 (26%), Positives = 57/145 (39%), Gaps = 17/145 (11%)
Query: 358 ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAI-GELKNLQGLA 416
A + ++ + DNQI+ P +L+N+ + NQL +P + L L L
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94
Query: 417 LVRNSLRGTIP----DTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L N L +P D L +L LF+ N L +P + +L L L N
Sbjct: 95 LGTNQLT-VLPSAVFDRLVHLK---ELFMCCNKLT-ELPRGIERLTHLTH----LALDQN 145
Query: 473 LLGGSIPLEV-GNLRNLAEFDLSEN 496
L SIP L +L L N
Sbjct: 146 QL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 24/113 (21%), Positives = 44/113 (38%), Gaps = 18/113 (15%)
Query: 35 FPMVSYADLSKATNNFSA----SNMIGQGSFGFVYKGKLGETGTTVAVKVMN-------- 82
F ++ D S S +G G+ G V +T VA+++++
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 83 LKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
++ A + TE E L + H +IKI + D+ ++ E M+ G
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGG 224
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 7/87 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHR 105
+ IG+GS+G V+K + +TG VA+K + K + E L ++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYM 132
NL+ ++ V K L++EY
Sbjct: 63 NLVNLLEVFRR---KRRLH--LVFEYC 84
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHR 105
+ ++G+GS+G V K + +TG VA+K K K + E + L +RH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYM 132
NL+ ++ VC K + L++E++
Sbjct: 85 NLVNLLEVCKK---KKRWY--LVFEFV 106
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVRHRN 106
+ + +G+G++ VYKGK T VA+K + L+ + GA + + E L +++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 107 ---LIKIITVCSSIDFKGVDFKALIYEYM 132
L II S+ L++EY+
Sbjct: 62 IVTLHDIIHTEKSL--------TLVFEYL 82
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 14/55 (25%), Positives = 27/55 (49%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G G+FG V++ TG A K + + ++ E + +S +RH L+ +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 30/130 (23%), Positives = 43/130 (33%), Gaps = 10/130 (7%)
Query: 419 RNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478
S G I L L L L S+ N L L +L +LS N + G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKL-ELSENRIFGGL 87
Query: 479 PLEVGNLRNLAEFDLSENHFSNEIPVT-LSACTTLEYLHLQGN---SFSGSLPLSLKTLK 534
+ L NL +LS N + + L L+ L L + + K L
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP 147
Query: 535 SIKELDLSRN 544
+ LD
Sbjct: 148 QLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 484 NLRNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLS 542
+ E L ++ +I + LE+L L S+ +L L +K+L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 543 RNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
N + G + E L L +LNLS N +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 29/117 (24%), Positives = 51/117 (43%), Gaps = 10/117 (8%)
Query: 21 HTQKSSRTLPMEQQFPMVSYADLSKAT---NNFSASNMIGQGSFGFVYKGKLGETGTTVA 77
H TL + Q P + + + + +G+G++G VYK T TVA
Sbjct: 4 HHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVA 63
Query: 78 VKVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132
+K + L+ + G + + E L ++HRN+I++ +V LI+EY
Sbjct: 64 IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH---NHRLH--LIFEYA 115
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 51/452 (11%), Positives = 135/452 (29%), Gaps = 42/452 (9%)
Query: 152 NLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIA-NFSALEAIDISANMLGGRIPDSLCQL- 209
++ L + + ++ G + + + ++ +++ LE I + + D +L
Sbjct: 70 SVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLK----RMVVTDDCLELI 125
Query: 210 ----RSLNYLSISE-NNFSCKLPLSI-WNISSLEIISLHSNRFEGSLPLNIGFNIPNVNF 263
++ L +S FS +I +L+ + L + + +
Sbjct: 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185
Query: 264 L-----SVGQNNFT-GSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317
L S + + +L + NL+ L + + ++ R L L
Sbjct: 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245
Query: 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT 377
L+ C ++ L + +L ++ ++ +++T + + +
Sbjct: 246 TAEVRPDVYSGLSVALSGCKELRCLSGFWD-AVPAYLPAVYSVCSRLTTLNLSYATVQSY 304
Query: 378 -IPSEIKNLVNINAFGVEYNQLTGTIPHAIGE-LKNLQGLALVRNSLRGTIPDT------ 429
+ + + V + + + K+L+ L + + P+
Sbjct: 305 DLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363
Query: 430 ----LGNLTLLNRLFLGFNNLQGNVPSSLG-NCQNLMTLS-------RLLDLSGNLLGGS 477
L + + ++ N N+ L+ L
Sbjct: 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIG 423
Query: 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG-SLPLSLKTLKSI 536
V + ++L LS + +E L + S + L S+
Sbjct: 424 FGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSL 483
Query: 537 KELDLSRNNLSGQ-IPKYLENLLFLAYLNLSY 567
++L++ + + L + L +S
Sbjct: 484 RKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 51/407 (12%), Positives = 119/407 (29%), Gaps = 40/407 (9%)
Query: 228 LSIWNISSLEIISLHSNRFEG--SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNA-SN 284
+ I N ++ ++ RF S+ L + + N + G + + S++ +
Sbjct: 48 VFIGNCYAVSPATVIR-RFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106
Query: 285 LQVLDVYKNHFS-GQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLY 343
L+ + + + + +++ N L LS E S + C ++ L
Sbjct: 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLS----SCEGFSTDGLAAIAATCRNLKELD 162
Query: 344 LNTNKFGGVFLRSIANLSAKIT-----VIGMGDNQISGT-IPSEIKNLVNINAFGVEYNQ 397
L + V +++ T I +++S + + + N+ + +
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 398 LTGTIPHAIGELKNLQGLAL------VRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP 451
+ + L+ L VR + + L L L ++ + +P
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282
Query: 452 SSLGNCQNLMTLSRLLDLSG-NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510
+ C L L+LS + + + L + + + V S C
Sbjct: 283 AVYSVCSRL----TTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCK 338
Query: 511 TLEYLHLQGNSFSGSLPLSLKT----------LKSIKELDLSRNNLSGQIPKYL-ENLLF 559
L L + + P T ++ + ++ + N
Sbjct: 339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPN 398
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
+ L + + ++ C L L L
Sbjct: 399 MTRFRLCIIEPKAPDYLTLEPLDIGFGAIV---EHCKDLRRLSLSGL 442
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 49/352 (13%), Positives = 98/352 (27%), Gaps = 52/352 (14%)
Query: 303 FNRLSNLSRLFLSKNNLGTESTSDLDF---------LTLLTNCSQMEMLYLNTNKFGGVF 353
+ + R + N S + + L + + ++ + +
Sbjct: 37 WYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPW 96
Query: 354 LRSIANLSAKITVIGMGDNQIS----GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGE- 408
+ ++++ + I + ++ I KN + + AI
Sbjct: 97 IEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC--EGFSTDGLAAIAAT 154
Query: 409 LKNLQGLALVRNSLRGTIPDTLGNLTLLNRLF--LGFNNLQGNVPSS-----LGNCQNLM 461
+NL+ L L + + L + L + L V S + C NL
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214
Query: 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLS------ENHFSNEIPVTLSACTTLEYL 515
+L L+ + + + L E + + V LS C L L
Sbjct: 215 SL----KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270
Query: 516 HLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ-IPKYLENLLFLAYLNLSYNHFEGEV 574
++ LP + L+LS + + K L L L +
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY------ 324
Query: 575 PRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHF----GRPRITRITLLKVV 622
G+ ++ C L EL + +T L+ V
Sbjct: 325 ------IEDAGLEVLA--STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 49/410 (11%), Positives = 114/410 (27%), Gaps = 54/410 (13%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT-GSLPHSFSNASNLQVLDV 290
+ + ++ + + + + + + + T L + N +VL +
Sbjct: 78 HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137
Query: 291 YK-NHFSGQ-VKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLN--T 346
FS + NL L L ++++ + S + + L ++
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDV--DDVSGHWLSHFPDTYTSLVSLNISCLA 195
Query: 347 NKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY------NQLTG 400
++ L + + + + + + ++ + G +
Sbjct: 196 SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYS 255
Query: 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN-VPSSLGNCQN 459
+ A+ K L+ L+ +++ +P + L L L + +Q + L C
Sbjct: 256 GLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPK 315
Query: 460 LMTL---SRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVT-------LSAC 509
L L + D +L + +LR L F + +T C
Sbjct: 316 LQRLWVLDYIEDAGLEVLASTCK----DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGC 371
Query: 510 TTLEYLHLQGNSFSG-SLPLSLKTLKSIKELDLSRNNLSGQ-----------IPKYLENL 557
LE + + +L + ++ L +E+
Sbjct: 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC 431
Query: 558 LFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCH 607
L L+LS IG +E L +
Sbjct: 432 KDLRRLSLSGLL------------TDKVFEYIG--TYAKKMEMLSVAFAG 467
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 17/69 (24%), Positives = 31/69 (44%), Gaps = 3/69 (4%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--KSFVTECEALSN 101
S+ T F IG G FG V+K G A+K G+ ++ + E A +
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 102 V-RHRNLIK 109
+ +H ++++
Sbjct: 67 LGQHSHVVR 75
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 14/100 (14%), Positives = 29/100 (29%), Gaps = 10/100 (10%)
Query: 42 DLSKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQKGAAKSFVTEC 96
+ + +++G+G+F VY+ G + +KV
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 97 EALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGS 136
E L +K + + L+ E G+
Sbjct: 119 ERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGT 153
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 14/88 (15%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN--------LKQKGAAKSFVTECEALSNVRHRNL 107
+G G+ G V +T VA+K+++ ++ A + TE E L + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCG 135
IKI + D+ ++ E M+ G
Sbjct: 78 IKIKNFFDAEDY------YIVLELMEGG 99
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 13/55 (23%), Positives = 24/55 (43%), Gaps = 1/55 (1%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKI 110
+G+G FG V++ + T K + + E L+ RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHL 66
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 8/97 (8%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL-KQKGAAKSF-------VTE 95
S AT+ + IG G++G VYK + +G VA+K + + G V
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 96 CEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132
L H N+++++ VC++ L++E++
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-06
Identities = 29/138 (21%), Positives = 46/138 (33%), Gaps = 11/138 (7%)
Query: 408 ELKNLQGLAL-VRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL 466
+++ L L S G + L L L +S+ N L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKL-KK 68
Query: 467 LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGN---SF 522
L+LS N + G + + NL +LS N + L L+ L L +
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128
Query: 523 SGSLPLSLKTLKSIKELD 540
+ K L + LD
Sbjct: 129 NDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 484 NLRNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLS 542
++ E L + + ++ LE+L + S+ +L L +K+L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 543 RNNLSGQIPKYLENLLFLAYLNLSYNHFE 571
N +SG + E L +LNLS N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 456 NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYL 515
++ L LD S + G + L + I L L+ L
Sbjct: 15 TPSDVKELV--LDNSRSNEG-KLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKL 69
Query: 516 HLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG-QIPKYLENLLFLAYLNLSYN 568
L N SG L + + ++ L+LS N + + L+ L L L+L
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 24/116 (20%), Positives = 46/116 (39%), Gaps = 7/116 (6%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
S ++ + L ++R + + FLS T S+ + + L+ L++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTN 347
N SG +++ + NL+ L LS N + DL + L ++ L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 1/65 (1%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN-LKQKGAAKSFVTECEALSNVRHR 105
+ F +G G+FG V+ + +G +K +N + + + E E L ++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 106 NLIKI 110
N+IKI
Sbjct: 81 NIIKI 85
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+GSFG V K TG AVKV++ +KQK +S + E + L + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 5/80 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG+GS+G V T A K + F E E + ++ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 116 SIDFKGVDFKALIYEYMKCG 135
F+ L+ E G
Sbjct: 75 ---FEDNTDIYLVMELCTGG 91
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 15/86 (17%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRHRNLIKIIT 112
IG+G+F V + TG VA+K+++ L K F E + + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 113 VCSSIDFKGVDFKALIY---EYMKCG 135
V + + +Y EY G
Sbjct: 82 VIET--------EKTLYLIMEYASGG 99
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 5/65 (7%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT----ECEALSNVRHRNLIKII 111
+G+GSFG V +T VA+K ++ +Q E L +RH ++IK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 112 TVCSS 116
V ++
Sbjct: 76 DVITT 80
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 16/101 (15%), Positives = 33/101 (32%), Gaps = 7/101 (6%)
Query: 18 RRKHTQKSSRTLP-MEQQFPMVSYADLSKATNNFSA----SNMIGQGSFGFVYKGKLGET 72
H S R + ++ + S +G G++G V + T
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 73 GTTVAVKVMNLKQKGAAK--SFVTECEALSNVRHRNLIKII 111
A+K++ + + E L + H N++K+
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 25/106 (23%), Positives = 48/106 (45%), Gaps = 8/106 (7%)
Query: 30 PMEQQFPMVSYADLSKATNNFSASNM-IGQGSFGFVYKG--KLGETGTTVAVKVMNLKQK 86
M+ F + ++ + + F +G+G++G VYK K G+ A+K ++
Sbjct: 2 KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK--QIEGT 59
Query: 87 GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132
G + S E L ++H N+I + V S + V L+++Y
Sbjct: 60 GISMSACREIALLRELKHPNVISLQKVFLSHADRKV---WLLFDYA 102
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRN 106
++ +IG GSFG V++ KL E+ VA+K K + E + + V+H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIK----KVLQDKRFKNRELQIMRIVKHPN 93
Query: 107 LIKIITV-CSSIDFKGVDFKALIYEYM 132
++ + S+ D K F L+ EY+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV 120
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 11/86 (12%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFV------TECEALSNVRHRNLIK 109
+G G F V K + TG A K + ++ +++ V E L ++H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCG 135
+ V ++ LI E + G
Sbjct: 79 LHEV-----YENKTDVILILELVAGG 99
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 20/58 (34%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKII 111
+G+GSFG V K K T AVKV+N + + E E L + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 21/88 (23%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVRH 104
+++ F +G G++ VYKG TG VA+K + L + G + + E + ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 105 RNLIKIITVCSSIDFKGVDFKALIYEYM 132
N++++ V + + L++E+M
Sbjct: 63 ENIVRLYDVIHT---ENKLT--LVFEFM 85
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 2/85 (2%)
Query: 25 SSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK 84
S+ Q F + S +L + ++GQ + ETG + V V
Sbjct: 52 STSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 109
Query: 85 QKGAAKSFVTECEALSNVRHRNLIK 109
++ + + E + +R IK
Sbjct: 110 ERPPSNAIKQMKEEVLRLRLLRGIK 134
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--KSFVTECEALSNVRH 104
++ M+G+GSFG V K K T AVKV+N + + E E L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 105 RNLIKI 110
N++K+
Sbjct: 81 PNIMKL 86
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 10/103 (9%)
Query: 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSF 92
L + + IGQGS+G V +T A+K+MN + +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 93 VTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
TE + + H N+ ++ V ++ + L+ E G
Sbjct: 76 KTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGG 113
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 17/68 (25%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVK-VMNLKQKGAAKSFVTECEALSNVRHR 105
+ +S +G GSFG V + E+G A+K V+ + E + + + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHV 60
Query: 106 NLIKIITV 113
N+IK++
Sbjct: 61 NIIKLVDY 68
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 17/83 (20%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK---SFVTECEALSNVRHRNLIKIIT 112
+G+G+F V + TG A K++N +K +A+ E ++H N++++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 113 VCSSIDFKGVDFKALIYEYMKCG 135
+ F L+++ + G
Sbjct: 73 S-----IQEESFHYLVFDLVTGG 90
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 11/86 (12%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFV------TECEALSNVRHRNLIK 109
+G G F V K + TG A K + ++ +++ V E L +RH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCG 135
+ + F+ LI E + G
Sbjct: 73 LHDI-----FENKTDVVLILELVSGG 93
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 11/86 (12%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFV------TECEALSNVRHRNLIK 109
+G G F V K + TG A K + +Q A++ V E L V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCG 135
+ V ++ LI E + G
Sbjct: 80 LHDV-----YENRTDVVLILELVSGG 100
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 17/69 (24%), Positives = 29/69 (42%), Gaps = 3/69 (4%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA--KSFVTECEALSN 101
S +F + +G GS+G V+K + E G AVK +G + E +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 102 V-RHRNLIK 109
V +H ++
Sbjct: 113 VGQHPCCVR 121
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 17/90 (18%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNL--KQKGAAKSFVTECEALSNVRH 104
+ + ++IG GS+G V + VA+K + + K + E L+ + H
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 105 RNLIKIITVCSSIDFKGVDFKA--LIYEYM 132
+++K++ + D + F ++ E
Sbjct: 112 DHVVKVLDIVIPKDVE--KFDELYVVLEIA 139
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 18/86 (20%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT------ECEALSNVRHRNLIK 109
IG+G F V + ETG AVK+++ K + ++ E ++H ++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCG 135
++ SS +++E+M
Sbjct: 91 LLETYSS-----DGMLYMVFEFMDGA 111
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFV-TECEALSNVR-HRNLIKIIT 112
++G+G+ V T AVK++ KQ G +S V E E L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 113 VCSSIDFKGVDFKALIYEYMKCGS 136
F+ D L++E M+ GS
Sbjct: 79 F-----FEEEDRFYLVFEKMRGGS 97
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 11/86 (12%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFV------TECEALSNVRHRNLIK 109
+G G F V K + TG A K + +Q A++ V E L V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCG 135
+ V ++ LI E + G
Sbjct: 80 LHDV-----YENRTDVVLILELVSGG 100
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 31/122 (25%), Positives = 50/122 (40%), Gaps = 19/122 (15%)
Query: 257 NIP-NVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315
IP +V L + N FT +P SN +L ++D+ N S F+ ++ L L LS
Sbjct: 28 GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI-----ANLSAKITVIGMG 370
N L D L L +L L+ N + + +LS ++ + +G
Sbjct: 87 YNRLRCIPPRTFDGLKSLR------LLSLHGND-----ISVVPEGAFNDLS-ALSHLAIG 134
Query: 371 DN 372
N
Sbjct: 135 AN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 12/102 (11%)
Query: 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN 437
IP ++ L ++ NQ T +P + K+L + L N + + N+T L
Sbjct: 29 IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 438 RLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP 479
L L +N L+ +P L +L RLL L GN + +P
Sbjct: 82 TLILSYNRLR-CIPP--RTFDGLKSL-RLLSLHGNDI-SVVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 23/99 (23%), Positives = 44/99 (44%), Gaps = 10/99 (10%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L+ + + +T + + NQ + +P E+ N ++ + N+++ + + L
Sbjct: 22 LKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 413 QGLALVRNSLRGTIP----DTLGNLTLLNRLFLGFNNLQ 447
L L N LR IP D L +L LL+ L N++
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLS---LHGNDIS 115
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 17/83 (20%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK---SFVTECEALSNVRHRNLIKIIT 112
+G+G+F V + TG A K++N +K +A+ E ++H N++++
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 113 VCSSIDFKGVDFKALIYEYMKCG 135
+ F L+++ + G
Sbjct: 96 S-----IQEESFHYLVFDLVTGG 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 18/95 (18%), Positives = 27/95 (28%), Gaps = 2/95 (2%)
Query: 477 SIPLEVGNLRNLAEFDLSENHFSNEIP-VTLSACTTLEYLHLQGNSFSGSLPLSLKTLKS 535
+ NL E + + L L L + + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 536 IKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHF 570
+ L+LS N L + L L L LS N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 21/92 (22%), Positives = 32/92 (34%), Gaps = 8/92 (8%)
Query: 259 PNVNFLSVGQNNFTGSLP-HSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317
N+ L + L L+ L + K+ F+ LSRL LS N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKF 349
L + S + L+L + L L+ N
Sbjct: 91 ALESLSWKTVQGLSL-------QELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 6/97 (6%)
Query: 377 TIPSEIKNLVNINAFGVEYNQLTGTIP-HAIGELKNLQGLALVRNSLRGTIPDTLGNLTL 435
+ N+ +E Q + + L L+ L +V++ LR PD
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 436 LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
L+RL L FN L+ ++ ++L L LSGN
Sbjct: 82 LSRLNLSFNALESLSWKTVQG----LSLQE-LVLSGN 113
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 10/28 (35%), Positives = 16/28 (57%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNL 83
IG+G++G V K +G +AVK +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRS 57
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 12/66 (18%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
+G+G+F V + G A ++N K+ + E ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 114 CSSIDF 119
S
Sbjct: 79 ISEEGH 84
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 9/28 (32%), Positives = 17/28 (60%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNL 83
+G+G++G V K + +G +AVK +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRA 42
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 25 SSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK 84
S+ Q F + S L + ++GQ + ETG + V V
Sbjct: 57 STSLWNTGQPFRVESE--LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114
Query: 85 QKGAAKSFVTECEALSNVRHRNLIK 109
++ + + E + +R IK
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIK 139
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 17/108 (15%)
Query: 20 KHTQKSSRTLPMEQQFPMVSYADLSKATNNFSA----SNMIGQGSFGFVYKGKLGETGTT 75
H S R Q + + K +G G++G V K +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 76 VAVKVMNLKQ-------------KGAAKSFVTECEALSNVRHRNLIKI 110
A+KV+ Q + + E L ++ H N+IK+
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 19/102 (18%), Positives = 41/102 (40%), Gaps = 16/102 (15%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVK-VMNLKQKGA-AKSFVTECEALSNVRHRNLIKIITV 113
IG+GS+G+VY T VA+K V + + K + E L+ ++ +I++ +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 114 C---SSIDFKGVDFKALIYEYMKCGSSEDWMHQ---SNDKLE 149
+ F + ++ E + + + + L
Sbjct: 94 IIPDDLLKFDEL---YIVLEIA-----DSDLKKLFKTPIFLT 127
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 24/87 (27%), Positives = 45/87 (51%), Gaps = 7/87 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHR 105
NF IG+G++G VYK + TG VA+K + L + G + + E L + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYM 132
N++K++ V + + + L++E++
Sbjct: 63 NIVKLLDVIHT---ENKLY--LVFEFL 84
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 21/97 (21%), Positives = 39/97 (40%), Gaps = 13/97 (13%)
Query: 49 NFSASNMIGQGSFG-FVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRN 106
+F +++G G+ G VY+G VAVK + + A E + L H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+I+ K F+ + E + ++++ Q
Sbjct: 80 VIRYFCT-----EKDRQFQYIAIELCA-ATLQEYVEQ 110
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 23/96 (23%), Positives = 42/96 (43%), Gaps = 10/96 (10%)
Query: 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFV--T---EC 96
D+ + + +G+G F VYK + T VA+K + L + AK + T E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 97 EALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132
+ L + H N+I ++ K L++++M
Sbjct: 64 KLLQELSHPNIIGLLDAFGH---KSNIS--LVFDFM 94
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA-AKSFVTECEALSNVRHRNLIK---II 111
+G+G++G V TG VA+K + K A + E + L + +H N+I I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 112 TVCSSIDFKGVDFKALIYEYMKC 134
S +F V +I E M+
Sbjct: 79 RPDSFENFNEV---YIIQELMQT 98
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--GAAKSFVTECEALSNVRHR 105
+ IG+G++G V+K K ET VA+K + L G S + E L ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYM 132
N++++ V S L++E+
Sbjct: 62 NIVRLHDVLHS---DKKLT--LVFEFC 83
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 19/116 (16%), Positives = 39/116 (33%), Gaps = 16/116 (13%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAA-KSFVTECEAL-SNVRHRNLIKIITV 113
+G G+ G V+K + +TG +AVK M K + + + + + +++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88
Query: 114 CSSIDFKGVDFKA----LIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLE 165
G + E M +E + + LG + + L
Sbjct: 89 -----CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 16/88 (18%), Positives = 36/88 (40%), Gaps = 9/88 (10%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITV-- 113
+G G G V+ + VA+K + L + K + E + + + H N++K+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 114 -----CSSIDFKGVDFKA--LIYEYMKC 134
+ + + ++ EYM+
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMET 106
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 8/83 (9%), Positives = 25/83 (30%), Gaps = 19/83 (22%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT------------- 94
N++ + QG F + + + A+K + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 95 ----ECEALSNVRHRNLIKIITV 113
E + ++++++ + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGI 111
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 15/67 (22%), Positives = 25/67 (37%), Gaps = 10/67 (14%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT-------ECEALSNVRHR--N 106
+G G FG VY G VA+K + K + + + E L V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 107 LIKIITV 113
+I+++
Sbjct: 110 VIRLLDW 116
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 13/67 (19%), Positives = 22/67 (32%), Gaps = 12/67 (17%)
Query: 25 SSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK 84
+P P K IG+G FG V++ T VA+K++ ++
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEK----------IGEGVFGEVFQTIA--DHTPVAIKIIAIE 54
Query: 85 QKGAAKS 91
Sbjct: 55 GPDLVNG 61
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 22/106 (20%), Positives = 40/106 (37%), Gaps = 29/106 (27%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN----LKQKGAAKSFVT----------------- 94
IG+GS+G V T A+KV++ ++Q G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 95 -----ECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
E L + H N++K++ V +D D +++E + G
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQG 123
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 21/106 (19%), Positives = 44/106 (41%), Gaps = 19/106 (17%)
Query: 44 SKATNNFSA----SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---------KGAAK 90
S +T+ F ++G+G V + T AVK++++ + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 91 SFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
+ + E + L V H N+I++ ++ F L+++ MK G
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKG 109
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKII 111
+G+G+ VY+ K T A+KV+ K TE L + H N+IK+
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLK 114
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 23/129 (17%), Positives = 47/129 (36%), Gaps = 14/129 (10%)
Query: 16 TGRRKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTT 75
+ ++ M + + +A + + ++IG+G V + TG
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 76 VAVKVMNLKQ--------KGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKA 126
AVK+M + + ++ E L V H ++I +I S F
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----SSFMF 176
Query: 127 LIYEYMKCG 135
L+++ M+ G
Sbjct: 177 LVFDLMRKG 185
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 7/74 (9%)
Query: 48 NNFSASNMIGQGSFG-FVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALS-NVRHR 105
N + ++G GS G V++G G VAVK M + A E + L+ + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALM---EIKLLTESDDHP 69
Query: 106 NLIKIITVCSSIDF 119
N+I+ ++ F
Sbjct: 70 NVIRYYCSETTDRF 83
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 17/79 (21%), Positives = 34/79 (43%), Gaps = 9/79 (11%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKII-TV 113
+G+G + V++ V VK++ +K K E + L N+R N+I + V
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 114 CSSIDFKGVDFKALIYEYM 132
+ L++E++
Sbjct: 101 KDPVSRTPA----LVFEHV 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 38/280 (13%), Positives = 79/280 (28%), Gaps = 83/280 (29%)
Query: 306 LSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKIT 365
LS+L +L L+ + + + + L + ++ + L + + LR++ + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAV-LGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129
Query: 366 VIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGT 425
+G+ N + + + + L+ +
Sbjct: 130 KLGLQLNSLGPE--------------ACK----------DLRD-------LLLHDQ---- 154
Query: 426 IPDTLGNLTLLNRLFLGFNNLQGN----VPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481
+ L L N L + L ++ L L LG +
Sbjct: 155 --------CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH----LSLLHTGLG-----D 197
Query: 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF--SGSLPLS--LKTLKSIK 537
G L LA L L+ L++ N + +L L+ + S++
Sbjct: 198 EG-LELLAA--------------QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLE 242
Query: 538 ELDLSRNNLS-------GQIPKYLENLLFLAYLNLSYNHF 570
L L N LS + E +
Sbjct: 243 LLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV 282
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 7/92 (7%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGA-AKSFVTECEALSNVRHR 105
++ + IG+G++G V VA+K ++ + + + E + L RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 106 NLIK---IITVCSSIDFKGVDFKALIYEYMKC 134
N+I II + K V ++ + M+
Sbjct: 86 NIIGINDIIRAPTIEQMKDV---YIVQDLMET 114
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 12/70 (17%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVT-------ECEALSNVR---- 103
++G+G FG V+ G VA+KV+ + + S ++ E L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 104 HRNLIKIITV 113
H +I+++
Sbjct: 97 HPGVIRLLDW 106
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 31/116 (26%), Positives = 49/116 (42%), Gaps = 18/116 (15%)
Query: 19 RKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAV 78
H SS + Q M Y L K +G+G++G VYK K G VA+
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAK-DSQGRIVAL 50
Query: 79 KVMNLKQK--GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132
K + L + G + + E L + H N++ +I V S + L++E+M
Sbjct: 51 KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS---ERCLT--LVFEFM 101
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 24/104 (23%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGK-LGETGTTVAVKVMNLKQKGAAKSFVTECE----- 97
+A + IG+G++G V+K + L G VA+K + ++ E
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLS 57
Query: 98 ---------ALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132
L H N++++ VC+ L++E++
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 628 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.7 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.66 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.65 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.64 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.63 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.62 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.61 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.58 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.57 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.57 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.54 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.54 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.53 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.53 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.51 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.51 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.4 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.39 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.36 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.35 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.32 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.31 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.3 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.29 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.28 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.27 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.27 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.27 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.26 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.26 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.26 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.25 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.24 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.24 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.24 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.23 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.23 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.23 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.23 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.23 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.22 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.22 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.22 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.22 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.22 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.22 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.21 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.21 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.2 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.2 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.2 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.2 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.19 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.19 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.19 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.19 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.18 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.18 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.18 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.18 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.17 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.17 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.17 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.16 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.16 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.16 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.16 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.16 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.15 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.15 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.15 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.15 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.15 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.15 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.15 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.15 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.15 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.14 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.14 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.14 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.14 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.14 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.14 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.14 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.13 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.13 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.13 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.13 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.13 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.13 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.13 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.13 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.13 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.13 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.12 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.12 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.12 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.12 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.12 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.12 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.12 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.12 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.12 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.11 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.11 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.11 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.11 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.1 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.1 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.1 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.1 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.1 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.09 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.09 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.09 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.08 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.08 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.08 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.08 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.08 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.07 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.07 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.07 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.06 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.06 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.05 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.05 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.05 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.05 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.05 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.05 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.05 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.05 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.05 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.04 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.04 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.04 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.04 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.04 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.04 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.03 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.03 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.03 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.03 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.02 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.02 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.02 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.02 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.02 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.02 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.01 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.01 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.01 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.01 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.01 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 98.99 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 98.99 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 98.99 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 98.99 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 98.99 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 98.99 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 98.99 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 98.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 98.98 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 98.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 98.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 98.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 98.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 98.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 98.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 98.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 98.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 98.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 98.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 98.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 98.94 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 98.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 98.93 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 98.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 98.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 98.92 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 98.92 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 98.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 98.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 98.9 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 98.9 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 98.9 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 98.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 98.87 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 98.87 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 98.86 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 98.86 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 98.85 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 98.84 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 98.84 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 98.83 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 98.83 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 98.82 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 98.81 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 98.81 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 98.8 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 98.78 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 98.78 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 98.76 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 98.76 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 98.76 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 98.73 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 98.72 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 98.71 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 98.69 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.68 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 98.67 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 98.67 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 98.63 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.59 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.59 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.55 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 98.31 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.14 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.11 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 97.97 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 97.92 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.54 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.17 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.14 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 95.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 93.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.12 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 88.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 84.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 83.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 80.61 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-58 Score=513.67 Aligned_cols=441 Identities=34% Similarity=0.544 Sum_probs=365.1
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCC-CCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNI-SSL 236 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l-~~L 236 (628)
++++++|++|++++|.+++.+|..|..+++|++|++++|.+++..|.. .+++|++|++++|.+++.+|..+... ++|
T Consensus 219 l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L 296 (768)
T 3rgz_A 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296 (768)
T ss_dssp CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTC
T ss_pred cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcC
Confidence 678899999999999999999999999999999999999988766654 67777777777777776677766654 777
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCccccccccc-ccCCCCCCEEEcccccceeecccccccCC-CCCEEEc
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS-FSNASNLQVLDVYKNHFSGQVKIDFNRLS-NLSRLFL 314 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L 314 (628)
++|++++|.+++.+|..+. .+++|++|++++|++++.+|.. +.++++|++|++++|++++..|..+..++ +|++|++
T Consensus 297 ~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~L 375 (768)
T 3rgz_A 297 TGLDLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375 (768)
T ss_dssp SEEECCSSEEEECCCGGGG-GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEEC
T ss_pred CEEECcCCcCCCccchHHh-cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEc
Confidence 7777777777766666554 3777777777777776555544 67777777777777777666666666665 6666666
Q ss_pred cCCcCCCcCCCCc--------------------cccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcc
Q 042887 315 SKNNLGTESTSDL--------------------DFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQI 374 (628)
Q Consensus 315 ~~n~l~~~~~~~~--------------------~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l 374 (628)
++|++++..+..+ ..+..+.++++|+.|++++|.+++..+..+..+. +|+.|++++|.+
T Consensus 376 s~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l 454 (768)
T 3rgz_A 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNML 454 (768)
T ss_dssp CSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCC
T ss_pred cCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcc
Confidence 6666543211110 2334567788888999999888888888888776 889999999998
Q ss_pred eeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcc
Q 042887 375 SGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454 (628)
Q Consensus 375 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 454 (628)
.+.+|..+..+++|+.|++++|++.+.+|..+..+++|++|++++|++++..|.++..+++|++|++++|++++..|..+
T Consensus 455 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 534 (768)
T 3rgz_A 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGG
T ss_pred cCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHH
Confidence 88888888889999999999999988888888899999999999999988889999999999999999999998899888
Q ss_pred cCCcchhcccceEEcCCCcCccccchhh----------------------------------------------------
Q 042887 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEV---------------------------------------------------- 482 (628)
Q Consensus 455 ~~l~~L~~l~~~L~Ls~N~l~~~~~~~~---------------------------------------------------- 482 (628)
..+++| +.|++++|++.+.+|..+
T Consensus 535 ~~l~~L----~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (768)
T 3rgz_A 535 GDCRSL----IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610 (768)
T ss_dssp GGCTTC----CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGT
T ss_pred cCCCCC----CEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccc
Confidence 888888 888999998887666433
Q ss_pred ------------------hccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC
Q 042887 483 ------------------GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544 (628)
Q Consensus 483 ------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (628)
+.+++|++|||++|++++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|||++|
T Consensus 611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N 690 (768)
T 3rgz_A 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690 (768)
T ss_dssp CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence 34578999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCcccCCCCCCCCCCCCC
Q 042887 545 NLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCHFGR 610 (628)
Q Consensus 545 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~~l~l~~c~~~~ 610 (628)
++++.+|+.+..+++|++||+++|+++|.+|..+.+.++....+.|||.+||.. +++|....
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~----l~~C~~~~ 752 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP----LPRCDPSN 752 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT----SCCCCSCC
T ss_pred cccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC----CcCCCCCc
Confidence 999999999999999999999999999999999999999999999999999863 45898544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=484.76 Aligned_cols=434 Identities=32% Similarity=0.498 Sum_probs=372.4
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
+..++++|++|++++|.+++.+|. ++++++|++|++++|.+++..|.+|+.+++|++|++++|.+++..|.. .+++|
T Consensus 195 ~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L 271 (768)
T 3rgz_A 195 DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSL 271 (768)
T ss_dssp BCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTC
T ss_pred CcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCC
Confidence 447889999999999999988887 999999999999999999999999999999999999999999877765 89999
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccc-cccCCCCCEEEcc
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLS 315 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~ 315 (628)
++|++++|.+++.+|..++..+++|++|++++|++++..|..|+++++|++|++++|++++..|.. |..+++|++|+++
T Consensus 272 ~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls 351 (768)
T 3rgz_A 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351 (768)
T ss_dssp CEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECC
T ss_pred CEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCc
Confidence 999999999999999998875699999999999999999999999999999999999999777655 9999999999999
Q ss_pred CCcCCCcCCCCccc-------------------cccccC--CCCCceeecccCCcccccchHHHhccccccEEEccCCcc
Q 042887 316 KNNLGTESTSDLDF-------------------LTLLTN--CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQI 374 (628)
Q Consensus 316 ~n~l~~~~~~~~~~-------------------~~~l~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l 374 (628)
+|.+++..+..+.. +..+.. +++|+.|++++|.+++..+..+..+. +|+.|++++|.+
T Consensus 352 ~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l 430 (768)
T 3rgz_A 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYL 430 (768)
T ss_dssp SSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEE
T ss_pred CCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcc
Confidence 99987433322211 111222 56788888888888777777777776 788888888888
Q ss_pred eeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcc
Q 042887 375 SGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSL 454 (628)
Q Consensus 375 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 454 (628)
++..|..+..+++|+.|++++|.+.+.+|..+..+++|++|++++|++++..|..+..+++|++|++++|++++..|.++
T Consensus 431 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 510 (768)
T 3rgz_A 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510 (768)
T ss_dssp ESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred cCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHH
Confidence 88888888888888888888888888888888888888888888888888888888888889999999998888888888
Q ss_pred cCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccc----------------------------
Q 042887 455 GNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTL---------------------------- 506 (628)
Q Consensus 455 ~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---------------------------- 506 (628)
+.+++| +.|++++|++.+.+|..++.+++|++|++++|++++.+|..+
T Consensus 511 ~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (768)
T 3rgz_A 511 GRLENL----AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 586 (768)
T ss_dssp GGCTTC----CEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTT
T ss_pred hcCCCC----CEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccc
Confidence 888888 888999999988888889899999999999998877666543
Q ss_pred ------------------------------------------cCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC
Q 042887 507 ------------------------------------------SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544 (628)
Q Consensus 507 ------------------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (628)
..+++|++|||++|++++.+|..++.+++|+.|+|++|
T Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N 666 (768)
T 3rgz_A 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666 (768)
T ss_dssp CCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCC
Confidence 23467888999999999999999999999999999999
Q ss_pred cccccCchhhhcccCCCeEeccCCcCcccCCCC-CCCCCCCcccccCCCCCcccCC
Q 042887 545 NLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK-GVFGNRTGIHLIGNERLCGGLE 599 (628)
Q Consensus 545 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~~ 599 (628)
++++.+|+.|.++++|+.||+++|+++|.+|.. +.++.++.+++++|+ +.|.+|
T Consensus 667 ~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~-l~g~iP 721 (768)
T 3rgz_A 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN-LSGPIP 721 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE-EEEECC
T ss_pred ccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc-ccccCC
Confidence 999999999999999999999999999988853 567788889998885 444444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=452.21 Aligned_cols=425 Identities=24% Similarity=0.266 Sum_probs=326.7
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 237 (628)
+.++++|++|||++|++++..|++|+++++|++|+|++|.+++..|.+|+.+++|++|++++|.+++..|..++++++|+
T Consensus 53 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~ 132 (606)
T 3t6q_A 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132 (606)
T ss_dssp STTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCC
T ss_pred hccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCccc
Confidence 44556666666666666666666666666666666666666666666666666666666666666654455566666666
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCC--EEEcccccceeec----------------
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQ--VLDVYKNHFSGQV---------------- 299 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~i~~~~---------------- 299 (628)
+|++++|.+++ ++...+..+++|++|++++|.+++..+..|+.+++|+ +|++++|.+++..
T Consensus 133 ~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~ 211 (606)
T 3t6q_A 133 SLYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG 211 (606)
T ss_dssp EEECCSSCCCC-CCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTT
T ss_pred EEECCCCcccc-cCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCC
Confidence 66666666652 2211111266666666666666655555566666555 5555555554443
Q ss_pred -----------------------------------------------------------ccccccCCCCCEEEccCCcCC
Q 042887 300 -----------------------------------------------------------KIDFNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 300 -----------------------------------------------------------~~~~~~l~~L~~L~L~~n~l~ 320 (628)
+..|..+++|++|++++|.++
T Consensus 212 ~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 291 (606)
T 3t6q_A 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291 (606)
T ss_dssp CSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS
T ss_pred chhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC
Confidence 333555667777777777666
Q ss_pred CcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCch-hhhccCCcCeeeecccccc
Q 042887 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS-EIKNLVNINAFGVEYNQLT 399 (628)
Q Consensus 321 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~l~~n~l~ 399 (628)
.+ +..+..+++|+.|++++|.+.+..+..+..++ +|+.|++++|.+.+.++. .+..+++|++|++++|.+.
T Consensus 292 ~l-------p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 363 (606)
T 3t6q_A 292 EL-------PSGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363 (606)
T ss_dssp CC-------CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCC
T ss_pred CC-------ChhhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccc
Confidence 43 23466778899999999998888777777776 899999999988865554 4889999999999999998
Q ss_pred ccC--CcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCc-ccCCcchhcccceEEcCCCcCcc
Q 042887 400 GTI--PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS-LGNCQNLMTLSRLLDLSGNLLGG 476 (628)
Q Consensus 400 ~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~l~~~L~Ls~N~l~~ 476 (628)
+.. +..+..+++|++|++++|.+.+..|..|..+++|++|++++|++++..+.. +..+++| +.|++++|.+.+
T Consensus 364 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L----~~L~l~~n~l~~ 439 (606)
T 3t6q_A 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL----KVLNLSHSLLDI 439 (606)
T ss_dssp EEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTC----CEEECTTCCCBT
T ss_pred cccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccC----CEEECCCCccCC
Confidence 765 778899999999999999999888889999999999999999998776544 7888888 899999999998
Q ss_pred ccchhhhccCCCCEeeCcCCcCccc---CCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchh
Q 042887 477 SIPLEVGNLRNLAEFDLSENHFSNE---IPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY 553 (628)
Q Consensus 477 ~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 553 (628)
..|..+..+++|++|++++|++++. .+..+..+++|++|++++|++++..|..|..+++|++|++++|++++..|+.
T Consensus 440 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (606)
T 3t6q_A 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519 (606)
T ss_dssp TCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred cCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence 8888999999999999999999863 3367889999999999999999988999999999999999999999999999
Q ss_pred hhcccCCCeEeccCCcCcccCCCC-CCCCCCCcccccCCCCCcc
Q 042887 554 LENLLFLAYLNLSYNHFEGEVPRK-GVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 554 ~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~ 596 (628)
+.+++.| +|++++|++++.+|.. +.+++++.++++|||+.|.
T Consensus 520 l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 520 LSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp GTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred hCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 9999999 9999999999877753 5567899999999999984
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=440.91 Aligned_cols=423 Identities=19% Similarity=0.189 Sum_probs=285.1
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
..+++||+++|.+++..|..|.++++|++|+|++|.++++.|++|+++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 36899999999999999999999999999999999999999999999999999999999999888999999999999999
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCC--EEEccCCcC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLS--RLFLSKNNL 319 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~--~L~L~~n~l 319 (628)
++|.++ .++...+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|+ +|++++|.+
T Consensus 113 ~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 113 IQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp TTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred cccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999 45433445699999999999999986655666699999999999999999899999999999 999999999
Q ss_pred CCcCCCCcccc---------------------------------------------------------------------
Q 042887 320 GTESTSDLDFL--------------------------------------------------------------------- 330 (628)
Q Consensus 320 ~~~~~~~~~~~--------------------------------------------------------------------- 330 (628)
+...+..+...
T Consensus 192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 87765543211
Q ss_pred ccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCC-cCCCCC
Q 042887 331 TLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIP-HAIGEL 409 (628)
Q Consensus 331 ~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l 409 (628)
..+..+++|+.|++++|.++.. +..+..+. +|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.+| ..+..+
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~~l-p~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 349 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLSEL-PSGLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCSCC-CSSCCSCT-TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTC
T ss_pred HHhccccCCCEEeccCCccCCC-Chhhcccc-cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhcc
Confidence 0123344455555555544422 22233332 45555555555554444455555555555555555443332 235555
Q ss_pred CCCCeEecccCcccccc--CccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccch-hhhccC
Q 042887 410 KNLQGLALVRNSLRGTI--PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL-EVGNLR 486 (628)
Q Consensus 410 ~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~-~~~~l~ 486 (628)
++|++|++++|.+++.. +..+..+++|++|++++|++++..|..+..+++| +.|++++|++.+..+. .+..++
T Consensus 350 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~l~~n~l~~~~~~~~~~~l~ 425 (606)
T 3t6q_A 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL----ELLDLAFTRLKVKDAQSPFQNLH 425 (606)
T ss_dssp TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTC----SEEECTTCCEECCTTCCTTTTCT
T ss_pred CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccC----CeEECCCCcCCCcccchhhhCcc
Confidence 55555555555555443 4455555566666666665555555555555555 5556666665544333 255566
Q ss_pred CCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeee---cCccccCCCCCCEEECCCCcccccCchhhhcccCCCeE
Q 042887 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS---LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYL 563 (628)
Q Consensus 487 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 563 (628)
+|++|++++|.+++..|..+..+++|++|++++|++++. .+..+..+++|++|++++|++++..|..|..+++|++|
T Consensus 426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 505 (606)
T 3t6q_A 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505 (606)
T ss_dssp TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence 666666666666555555566666666666666665541 22345556666666666666665556666666666666
Q ss_pred eccCCcCcccCCC-CCCCCCCCcccccCCC
Q 042887 564 NLSYNHFEGEVPR-KGVFGNRTGIHLIGNE 592 (628)
Q Consensus 564 ~ls~N~l~~~~p~-~~~~~~l~~~~~~~n~ 592 (628)
++++|++++..|. ...++.+ .+++++|.
T Consensus 506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~ 534 (606)
T 3t6q_A 506 DLSHNRLTSSSIEALSHLKGI-YLNLASNH 534 (606)
T ss_dssp ECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred ECCCCccCcCChhHhCccccc-EEECcCCc
Confidence 6666666655442 2333444 55555553
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=441.73 Aligned_cols=425 Identities=18% Similarity=0.164 Sum_probs=281.4
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
.++++|++||+++|.+++..|.+|.++++|++|+|++|.+++..|.+|+++++|++|++++|.+++..+..++++++|++
T Consensus 53 ~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 132 (606)
T 3vq2_A 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132 (606)
T ss_dssp TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCE
T ss_pred cCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCE
Confidence 34444555555555554444444455555555555555554444444555555555555555544433344455555555
Q ss_pred EEeecccCcc-cCChhhhhCCCCCcEEecccCcccccccccccCCCCCC----EEEcccccceeecccccccCCCCCEEE
Q 042887 239 ISLHSNRFEG-SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQ----VLDVYKNHFSGQVKIDFNRLSNLSRLF 313 (628)
Q Consensus 239 L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L~ 313 (628)
|++++|.+++ .+|..+. ++++|++|++++|++++..+..|+.+++|+ +|++++|.++++.+..|... +|++|+
T Consensus 133 L~L~~n~l~~~~lp~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~ 210 (606)
T 3vq2_A 133 LNVAHNFIHSCKLPAYFS-NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELT 210 (606)
T ss_dssp EECCSSCCCCCCCCGGGG-TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEE
T ss_pred EeCCCCcccceechHhHh-hcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeee
Confidence 5555554442 2343333 245555555555555444444444433332 45555555444444333322 455555
Q ss_pred ccCCcCCCc--------------------------------------------------CCCC-----------------
Q 042887 314 LSKNNLGTE--------------------------------------------------STSD----------------- 326 (628)
Q Consensus 314 L~~n~l~~~--------------------------------------------------~~~~----------------- 326 (628)
+++|.+.+. ....
T Consensus 211 L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L 290 (606)
T 3vq2_A 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290 (606)
T ss_dssp EESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEE
T ss_pred ccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEE
Confidence 555543200 0000
Q ss_pred ------ccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccc
Q 042887 327 ------LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400 (628)
Q Consensus 327 ------~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 400 (628)
+.....+..+++|+.|++++|.+... + .+ .++ +++.|++++|...+.. .+..+++|+.|++++|.+.+
T Consensus 291 ~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~l-p-~~-~l~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 364 (606)
T 3vq2_A 291 SLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF-P-TL-DLP-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSF 364 (606)
T ss_dssp EEESCCCCCCCCCCTTCCCSEEEEESCCCSSC-C-CC-CCS-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEE
T ss_pred EecCccchhhhhccccccCCEEEcccccCccc-c-cC-CCC-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCC
Confidence 00000233344555555555555222 2 22 332 5666666666444333 45677888888888888876
Q ss_pred c--CCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccC-CcccCCcchhcccceEEcCCCcCccc
Q 042887 401 T--IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP-SSLGNCQNLMTLSRLLDLSGNLLGGS 477 (628)
Q Consensus 401 ~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~l~~~L~Ls~N~l~~~ 477 (628)
. .|..+..+++|++|++++|.+++ .|..+..+++|+.|++++|++.+..| ..+..+++| +.|++++|++.+.
T Consensus 365 ~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L----~~L~l~~n~l~~~ 439 (606)
T 3vq2_A 365 SGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL----LYLDISYTNTKID 439 (606)
T ss_dssp EEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC----CEEECTTSCCEEC
T ss_pred CcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccC----CEEECcCCCCCcc
Confidence 5 36778888899999999998885 56788899999999999999987777 678888888 8999999999988
Q ss_pred cchhhhccCCCCEeeCcCCcCcc-cCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhc
Q 042887 478 IPLEVGNLRNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556 (628)
Q Consensus 478 ~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 556 (628)
.|..+.++++|++|++++|++++ ..|..+..+++|++|++++|++++..|..+..+++|++|++++|++++..|..|.+
T Consensus 440 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 519 (606)
T 3vq2_A 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519 (606)
T ss_dssp CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTT
T ss_pred chhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccC
Confidence 89999999999999999999997 47888999999999999999999999999999999999999999999988999999
Q ss_pred ccCCCeEeccCCcCcccCCCCCCCC-CCCcccccCCCCCcc
Q 042887 557 LLFLAYLNLSYNHFEGEVPRKGVFG-NRTGIHLIGNERLCG 596 (628)
Q Consensus 557 l~~L~~L~ls~N~l~~~~p~~~~~~-~l~~~~~~~n~~~c~ 596 (628)
+++|++|++++|+++..++....++ +++.+++.+||+.|.
T Consensus 520 l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence 9999999999999996555545555 599999999999994
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=442.85 Aligned_cols=434 Identities=22% Similarity=0.222 Sum_probs=285.4
Q ss_pred CcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCcc--CCCCCC
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIW--NISSLE 237 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~--~l~~L~ 237 (628)
++++|++|++++|++++..|..|+++++|++|++++|.+++..|..|+++++|++|++++|.+++..+..+. .+++|+
T Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 174 (680)
T 1ziw_A 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174 (680)
T ss_dssp TCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEES
T ss_pred cCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhcccccccc
Confidence 344444444444444444444444444444444444444444444444444444444444444433333222 234444
Q ss_pred EEEeecccCcccCChhhhh--------------------------CCCCCcEEecccCcccccccccccCCCC--CCEEE
Q 042887 238 IISLHSNRFEGSLPLNIGF--------------------------NIPNVNFLSVGQNNFTGSLPHSFSNASN--LQVLD 289 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~--------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~ 289 (628)
+|++++|.+++..|..+.. ..++|+.|++++|.+++..|..|.+++. |++|+
T Consensus 175 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~ 254 (680)
T 1ziw_A 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254 (680)
T ss_dssp EEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEE
T ss_pred EEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEE
Confidence 4444444444222221110 0123344444444444444444544433 77777
Q ss_pred cccccceeecccccccCCCCCEEEccCCcCCCcCCCCccc-----------------------c----ccccCCCCCcee
Q 042887 290 VYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF-----------------------L----TLLTNCSQMEML 342 (628)
Q Consensus 290 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----------------------~----~~l~~~~~L~~L 342 (628)
+++|++++..+..|..+++|++|++++|.+....+..+.. + ..+..+++|+.|
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L 334 (680)
T 1ziw_A 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334 (680)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEE
T ss_pred CCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEE
Confidence 7777777666667777777777777777766544322211 0 034556777777
Q ss_pred ecccCCcccccchHHHhcc---------------------------ccccEEEccCCcceeeCchhhhccCCcCeeeecc
Q 042887 343 YLNTNKFGGVFLRSIANLS---------------------------AKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395 (628)
Q Consensus 343 ~l~~n~~~~~~~~~~~~~~---------------------------~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 395 (628)
++++|.+.+..+..+..+. .+++.|++++|++++..|..+..+++|+.|++++
T Consensus 335 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 414 (680)
T 1ziw_A 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414 (680)
T ss_dssp ECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCC
Confidence 7777777766555444432 2455556666666666677777777777777777
Q ss_pred ccccccCC-cCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccc--cccCCcccCCcchhcccceEEcCCC
Q 042887 396 NQLTGTIP-HAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ--GNVPSSLGNCQNLMTLSRLLDLSGN 472 (628)
Q Consensus 396 n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~l~~~L~Ls~N 472 (628)
|.+.+.+| ..|..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..+.++++| +.|++++|
T Consensus 415 N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L----~~L~Ls~N 490 (680)
T 1ziw_A 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL----TILDLSNN 490 (680)
T ss_dssp SCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC----CEEECCSS
T ss_pred CcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC----CEEECCCC
Confidence 77765444 56777777777777777777777777777777888888777775 4567778888888 88999999
Q ss_pred cCccccchhhhccCCCCEeeCcCCcCcccCC--------ccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC
Q 042887 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIP--------VTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544 (628)
Q Consensus 473 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (628)
++++..+..|.++++|++|++++|++++..+ ..+.++++|++|++++|+++...+..|.++++|+.|+|++|
T Consensus 491 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 570 (680)
T 1ziw_A 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570 (680)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCC
Confidence 9998778889999999999999999986422 23788899999999999999655567999999999999999
Q ss_pred cccccCchhhhcccCCCeEeccCCcCcccCCCC-C-CCCCCCcccccCCCCCccc
Q 042887 545 NLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK-G-VFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 545 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~-~~~~l~~~~~~~n~~~c~~ 597 (628)
++++.++..|.++++|+.|++++|++++..|.. + .+++++.+++++||+.|..
T Consensus 571 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred CCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 999888888999999999999999999876643 2 4788999999999999964
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=431.88 Aligned_cols=429 Identities=20% Similarity=0.214 Sum_probs=271.6
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
+++++||+++|.+++..+..|.++++|++|++++|.+++..|.+|+++++|++|+|++|.++...+..|.++++|++|++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 46777888888877777777777788888888888777777777777888888888888777555556777888888888
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccc--cCCCCCEEEccCCcC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN--RLSNLSRLFLSKNNL 319 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~n~l 319 (628)
++|.++ .++...+..+++|++|++++|.+++..|..++++++|++|++++|.+++..+..+. .+++|++|++++|.+
T Consensus 105 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 105 MSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 888776 45544444577888888888877777777777778888888888877766665554 346777888887777
Q ss_pred CCcCCCCcccccccc---------------------CCCCCceeecccCCcccccchHHHhcc-ccccEEEccCCcceee
Q 042887 320 GTESTSDLDFLTLLT---------------------NCSQMEMLYLNTNKFGGVFLRSIANLS-AKITVIGMGDNQISGT 377 (628)
Q Consensus 320 ~~~~~~~~~~~~~l~---------------------~~~~L~~L~l~~n~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~ 377 (628)
++..+..+.....+. ..++|+.|++++|.+.+..+..+..+. ++++.|++++|.+.+.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 766554332221111 125677777777777776666666554 2477777777777777
Q ss_pred CchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCcccc-----ccC----ccccCCCCCCeEecCCccccc
Q 042887 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRG-----TIP----DTLGNLTLLNRLFLGFNNLQG 448 (628)
Q Consensus 378 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----~~~----~~~~~l~~L~~L~L~~N~l~~ 448 (628)
.|..+..+++|+.|++++|++.+..|..|..+++|+.|++++|...+ .+| ..|..+++|++|++++|++++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 77777777777777777777776666555555555555555443221 111 134444444444444444444
Q ss_pred ccCCcccCCcchhc------------------------ccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCC-
Q 042887 449 NVPSSLGNCQNLMT------------------------LSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIP- 503 (628)
Q Consensus 449 ~~~~~~~~l~~L~~------------------------l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~- 503 (628)
..+..+.++++|+. -++.|++++|++++..|..|..+++|++|++++|.+++.+|
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 423 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence 44444443333310 01445555555555555556666666666666666654333
Q ss_pred ccccCCCCCCeEECcCceeee--------------------------ecCccccCCCCCCEEECCCCcccccCchhhhcc
Q 042887 504 VTLSACTTLEYLHLQGNSFSG--------------------------SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557 (628)
Q Consensus 504 ~~~~~l~~L~~L~Ls~N~l~~--------------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 557 (628)
..+.++++|++|++++|++.+ ..|..+..+++|+.|++++|++++..+..|.++
T Consensus 424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l 503 (680)
T 1ziw_A 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503 (680)
T ss_dssp GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccc
Confidence 455555666666666665543 345556666677777777777776666667777
Q ss_pred cCCCeEeccCCcCcccCC---------CCCCCCCCCcccccCC
Q 042887 558 LFLAYLNLSYNHFEGEVP---------RKGVFGNRTGIHLIGN 591 (628)
Q Consensus 558 ~~L~~L~ls~N~l~~~~p---------~~~~~~~l~~~~~~~n 591 (628)
++|++|++++|++++..+ ....+++++.+++++|
T Consensus 504 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 546 (680)
T 1ziw_A 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546 (680)
T ss_dssp TTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSS
T ss_pred cccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCC
Confidence 777777777777665321 1234456666777666
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=447.60 Aligned_cols=426 Identities=18% Similarity=0.159 Sum_probs=236.7
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccc-cccccCCCCCCEeecccccCcccCCcCccCCCCCCEEE
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRI-PDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIIS 240 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 240 (628)
+++++|||++|.|++..|..|.++++|++|+|++|...+.+ |.+|+++++|++|+|++|.+++..|.+|.++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 34555555555555555555555555555555555322222 44555555555555555555544455555555555555
Q ss_pred eecccCcccCChh-hhhCCCCCcEEecccCccccccc-ccccCCCCCCEEEcccccceeecccccccC--CC--------
Q 042887 241 LHSNRFEGSLPLN-IGFNIPNVNFLSVGQNNFTGSLP-HSFSNASNLQVLDVYKNHFSGQVKIDFNRL--SN-------- 308 (628)
Q Consensus 241 L~~n~l~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~-------- 308 (628)
|++|.+++.+|.. .+..+++|++|+|++|.+++..+ ..|+++++|++|++++|.+++..+..+..+ ++
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 5555555333322 22335555555555555554333 345555555555555555554444444443 44
Q ss_pred ----------------------CCEEEccCCcCCCcCCCCcccc------------------------------ccccC-
Q 042887 309 ----------------------LSRLFLSKNNLGTESTSDLDFL------------------------------TLLTN- 335 (628)
Q Consensus 309 ----------------------L~~L~L~~n~l~~~~~~~~~~~------------------------------~~l~~- 335 (628)
|++|++++|.++......+... ..+..
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 5555555554433221111000 00111
Q ss_pred -CCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCe
Q 042887 336 -CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQG 414 (628)
Q Consensus 336 -~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 414 (628)
.++|+.|++++|.+.+..+..+..+. +++.|++++|.+.+..|..|..+++|+.|++++|.+.+..|..|..+++|+.
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp TTSCCCEEECTTCCCCEECSCCSSSCC-CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred ccCCccEEECCCCcccccChhhhhcCC-CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 14566666666666555555555444 5666666666666666666666666666666666666555666666666666
Q ss_pred EecccCccccccCccccCCCCCCeEecCCcccccccC------------------Cc----------------------c
Q 042887 415 LALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP------------------SS----------------------L 454 (628)
Q Consensus 415 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------------~~----------------------~ 454 (628)
|++++|.+.+..+..|..+++|++|++++|.+++... .. +
T Consensus 343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~ 422 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFL 422 (844)
T ss_dssp EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHH
T ss_pred EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhh
Confidence 6666666665555566666666666666666553210 00 0
Q ss_pred cCCcchhcccceEEcCCCcCccccch-hhhccCCCCEeeCcCCcCc-----ccCCccccCCCCCCeEECcCceeeeecCc
Q 042887 455 GNCQNLMTLSRLLDLSGNLLGGSIPL-EVGNLRNLAEFDLSENHFS-----NEIPVTLSACTTLEYLHLQGNSFSGSLPL 528 (628)
Q Consensus 455 ~~l~~L~~l~~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 528 (628)
..+++| +.|++++|++++..+. .+..+++|++|++++|.++ +..+..|.++++|+.|+|++|++++..|.
T Consensus 423 ~~l~~L----~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 498 (844)
T 3j0a_A 423 LRVPHL----QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498 (844)
T ss_dssp TTCTTC----CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred hcCCcc----ceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence 011111 3333333333322111 1223344444444444443 22234466677788888888888777777
Q ss_pred cccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCcc
Q 042887 529 SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 529 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~ 596 (628)
.|..+++|+.|+|++|++++.++..+. ++|+.|++++|++++.+|.. +.+++.++++|||+.|.
T Consensus 499 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 499 VFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE 562 (844)
T ss_dssp SSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred HccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence 788888888888888888876666665 67888888888888877743 67899999999999994
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=419.72 Aligned_cols=420 Identities=22% Similarity=0.197 Sum_probs=311.6
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
.++.||+++|.+++..+.+|.++++|++|+|++|.++++.+..|+++++|++|+|++|.++...|.+|.++++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 56777777777776666677777777777777777776666677777777777777777776666777777777777777
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCccccc-ccccccCCCCCCEEEcccccceeecccccccCCCC----CEEEccCC
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS-LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNL----SRLFLSKN 317 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L----~~L~L~~n 317 (628)
+|.++ .++...+..+++|++|++++|.+++. .|..|+++++|++|++++|++++..+..|..+++| +.|++++|
T Consensus 109 ~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred ccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 77776 44443344577777777777777653 46677777777777777777776666666666666 67777777
Q ss_pred cCCCcCCCCccc--------------------------------------------------------------------
Q 042887 318 NLGTESTSDLDF-------------------------------------------------------------------- 329 (628)
Q Consensus 318 ~l~~~~~~~~~~-------------------------------------------------------------------- 329 (628)
.++.+.+..+..
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred CceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 666544332211
Q ss_pred -------cccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccC
Q 042887 330 -------LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTI 402 (628)
Q Consensus 330 -------~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 402 (628)
+..+..+++|+.|++++|.+... +..+... +++.|++++|.+. .+|. ..+++|+.|++++|.+.+..
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l-~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERV-KDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEECSC-CBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred hhhhhhchhhhcCcCcccEEEecCccchhh-hhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 11223345556666666655432 2222222 5666666666655 2332 35566666666666665444
Q ss_pred CcCCCCCCCCCeEecccCcccccc--CccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccc-
Q 042887 403 PHAIGELKNLQGLALVRNSLRGTI--PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP- 479 (628)
Q Consensus 403 ~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~- 479 (628)
+. ..+++|++|++++|.+++.. |..+..+++|++|++++|++++..+. +..+++| +.|++++|.+.+..+
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L----~~L~l~~n~l~~~~~~ 414 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQL----EHLDFQHSNLKQMSEF 414 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTC----CEEECTTSEEESCTTS
T ss_pred cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCC----CEEEccCCccccccch
Confidence 33 67889999999999988654 67788999999999999999865554 8888888 889999999987655
Q ss_pred hhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceee-eecCccccCCCCCCEEECCCCcccccCchhhhccc
Q 042887 480 LEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS-GSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558 (628)
Q Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (628)
..+..+++|++|++++|.+.+..|..+.++++|++|++++|+++ +.+|..+..+++|++|++++|++++..|..|..++
T Consensus 415 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 494 (570)
T 2z63_A 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494 (570)
T ss_dssp CTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhccc
Confidence 56889999999999999999888999999999999999999997 57889999999999999999999988899999999
Q ss_pred CCCeEeccCCcCcccCCC-CCCCCCCCcccccCCCCCcc
Q 042887 559 FLAYLNLSYNHFEGEVPR-KGVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 559 ~L~~L~ls~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c~ 596 (628)
+|++|++++|++++.+|. ...+++++.+++++|++.|.
T Consensus 495 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 999999999999987764 35678899999999999885
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=420.28 Aligned_cols=406 Identities=19% Similarity=0.187 Sum_probs=342.5
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcc-cCCcCccCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC-KLPLSIWNISS 235 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~ 235 (628)
.+.++++|++|+|++|.+++..|+.|+++++|++|++++|.+++..+..|+++++|++|++++|.+++ .+|..|+++++
T Consensus 75 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~ 154 (606)
T 3vq2_A 75 AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154 (606)
T ss_dssp TTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTT
T ss_pred HhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCC
Confidence 36788999999999999999989999999999999999999998888899999999999999999986 56999999999
Q ss_pred CCEEEeecccCcccCChhhhhCCCCC----cEEecccCcccccccccccCCCCCCEEEccccccee--------------
Q 042887 236 LEIISLHSNRFEGSLPLNIGFNIPNV----NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG-------------- 297 (628)
Q Consensus 236 L~~L~L~~n~l~~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-------------- 297 (628)
|++|++++|.+++..|..+. .+.+| .+|++++|.+++..+..+... +|++|++++|.+++
T Consensus 155 L~~L~Ls~n~l~~~~~~~~~-~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~ 232 (606)
T 3vq2_A 155 LVHVDLSYNYIQTITVNDLQ-FLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLH 232 (606)
T ss_dssp CCEEECCSSCCCEECTTTTH-HHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCE
T ss_pred CCEEEccCCcceecChhhhh-hhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccc
Confidence 99999999999955454443 35555 489999999997777766655 89999988886531
Q ss_pred --------------------------------------------ecccccccCCCCCEEEccCCcCCCcCCCC-------
Q 042887 298 --------------------------------------------QVKIDFNRLSNLSRLFLSKNNLGTESTSD------- 326 (628)
Q Consensus 298 --------------------------------------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------- 326 (628)
..+. +..+++|+.|++++|.+..++.-.
T Consensus 233 ~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~ 311 (606)
T 3vq2_A 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLEDVPKHFKWQS 311 (606)
T ss_dssp EEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCCCCCTTCCCSE
T ss_pred cccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhhhccccccCCE
Confidence 1111 334445555555555444332000
Q ss_pred -------c-cccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceee--CchhhhccCCcCeeeeccc
Q 042887 327 -------L-DFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT--IPSEIKNLVNINAFGVEYN 396 (628)
Q Consensus 327 -------~-~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~--~~~~l~~l~~L~~L~l~~n 396 (628)
+ ..+ .+ .+++|+.|++++|...+.. .+..++ +++.|++++|.+++. .+..+..+++|+.|++++|
T Consensus 312 L~l~~n~l~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n 386 (606)
T 3vq2_A 312 LSIIRCQLKQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALP-SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386 (606)
T ss_dssp EEEESCCCSSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCT-TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSC
T ss_pred EEcccccCcccc-cC-CCCccceeeccCCcCccch--hhccCC-CCCEEECcCCccCCCcchhhhhccCCcccEeECCCC
Confidence 0 111 23 7789999999999654433 333444 899999999999977 4889999999999999999
Q ss_pred cccccCCcCCCCCCCCCeEecccCccccccC-ccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCc
Q 042887 397 QLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLG 475 (628)
Q Consensus 397 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~ 475 (628)
.+.+ .|..+..+++|+.|++++|++.+..| ..+..+++|++|++++|++++..|..+.++++| +.|++++|++.
T Consensus 387 ~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~l~~n~l~ 461 (606)
T 3vq2_A 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL----NTLKMAGNSFK 461 (606)
T ss_dssp SEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC----CEEECTTCEEG
T ss_pred cccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC----CEEECCCCcCC
Confidence 9985 56889999999999999999998877 689999999999999999999999999999998 89999999999
Q ss_pred c-ccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhh
Q 042887 476 G-SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYL 554 (628)
Q Consensus 476 ~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 554 (628)
+ ..|..++.+++|++|++++|++++..|..+..+++|++|++++|++++..|..+..+++|++|++++|+++ .+|..+
T Consensus 462 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~ 540 (606)
T 3vq2_A 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGIL 540 (606)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCG
T ss_pred CcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhH
Confidence 7 47888999999999999999999999999999999999999999999988999999999999999999999 566669
Q ss_pred hccc-CCCeEeccCCcCcccCCC
Q 042887 555 ENLL-FLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 555 ~~l~-~L~~L~ls~N~l~~~~p~ 576 (628)
..++ +|++|++++|++.+..+.
T Consensus 541 ~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 541 QHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp GGSCTTCCEEECCSCCCCCSSTT
T ss_pred hhhcccCcEEEccCCCcccCCcc
Confidence 9987 599999999999987775
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=426.63 Aligned_cols=418 Identities=18% Similarity=0.235 Sum_probs=344.6
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCc------c---------------------------ccccccc-
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLG------G---------------------------RIPDSLC- 207 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~------~---------------------------~~~~~~~- 207 (628)
.+++.|+|++|++.|.+|.+|+++++|++|+|++|.+. + .+|..+.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 57999999999999999999999999999999999762 1 1111111
Q ss_pred ------------------CCCCCCEeecc--cccCcccCCcCccCCCCCCEEEeecccCccc-----------------C
Q 042887 208 ------------------QLRSLNYLSIS--ENNFSCKLPLSIWNISSLEIISLHSNRFEGS-----------------L 250 (628)
Q Consensus 208 ------------------~l~~L~~L~Ls--~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~ 250 (628)
....++.+.+. +|++++ +|..++++++|++|+|++|.+++. +
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 11123333332 578887 899999999999999999999964 8
Q ss_pred Chhhh-hCCCCCcEEecccCcccccccccccCCCCCCEEEccccc-cee-ecccccccC------CCCCEEEccCCcCCC
Q 042887 251 PLNIG-FNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH-FSG-QVKIDFNRL------SNLSRLFLSKNNLGT 321 (628)
Q Consensus 251 ~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~L~~n~l~~ 321 (628)
|..++ ..+++|++|++++|++.+.+|..|+++++|++|++++|+ +++ ..|..+..+ ++|++|++++|+++.
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ 319 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSS
T ss_pred chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCc
Confidence 88876 149999999999999999999999999999999999998 887 678777776 899999999999874
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCC-cCeeeeccccccc
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVN-INAFGVEYNQLTG 400 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~-L~~L~l~~n~l~~ 400 (628)
++. ...+.++++|+.|++++|.+++..+ .+..+. +|+.|++++|.++ .+|..+..+++ |+.|++++|.+.
T Consensus 320 ip~-----~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~- 390 (636)
T 4eco_A 320 FPV-----ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK- 390 (636)
T ss_dssp CCC-----HHHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-
T ss_pred cCc-----hhhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-
Confidence 321 0157788899999999999987666 666665 8999999999999 77888999999 999999999998
Q ss_pred cCCcCCCCCC--CCCeEecccCccccccCcccc-------CCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCC
Q 042887 401 TIPHAIGELK--NLQGLALVRNSLRGTIPDTLG-------NLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471 (628)
Q Consensus 401 ~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~ 471 (628)
.+|..+..++ +|++|++++|.+++..|..+. .+++|++|++++|++++..+..+..+++| +.|++++
T Consensus 391 ~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L----~~L~Ls~ 466 (636)
T 4eco_A 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL----SSINLMG 466 (636)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCC----SEEECCS
T ss_pred ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCC----CEEECCC
Confidence 6788777655 899999999999998888888 78899999999999995444445567888 8899999
Q ss_pred CcCccccchhhhcc-------CCCCEeeCcCCcCcccCCcccc--CCCCCCeEECcCceeeeecCccccCCCCCCEEEC-
Q 042887 472 NLLGGSIPLEVGNL-------RNLAEFDLSENHFSNEIPVTLS--ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDL- 541 (628)
Q Consensus 472 N~l~~~~~~~~~~l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L- 541 (628)
|+++...+..+... ++|++|++++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus 467 N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls 544 (636)
T 4eco_A 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544 (636)
T ss_dssp SCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECC
T ss_pred CCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECC
Confidence 99994433334433 38999999999999 6777776 89999999999999996 8888999999999999
Q ss_pred -----CCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCccc
Q 042887 542 -----SRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 542 -----s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~ 597 (628)
++|++.+.+|..+..+++|++|++++|++ +.+|.. ..++++.+++++|+..|-.
T Consensus 545 ~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp SCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred CCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence 56788889999999999999999999999 667754 3488999999999988743
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=405.74 Aligned_cols=417 Identities=19% Similarity=0.209 Sum_probs=313.8
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
++|++||+++|.+++..|+.|.++++|++|+|++|++++..|++|+++++|++|+|++|+++ .+|.. .+++|++|++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 67888888888888888888888888888888888888887888888888888888888888 45555 7888888888
Q ss_pred ecccCcc-cCChhhhhCCCCCcEEecccCcccccccccccCCCCC--CEEEcccccc--eeecccccccCC-CCCEEEcc
Q 042887 242 HSNRFEG-SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNL--QVLDVYKNHF--SGQVKIDFNRLS-NLSRLFLS 315 (628)
Q Consensus 242 ~~n~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~l~-~L~~L~L~ 315 (628)
++|.+++ .+|..+. .+++|++|++++|++++ ..+..+++| ++|++++|.+ .+..+..+..+. +...++++
T Consensus 98 ~~N~l~~~~~p~~~~-~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 98 SFNAFDALPICKEFG-NMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CSSCCSSCCCCGGGG-GCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred cCCccccccchhhhc-cCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 8888874 3555555 48888888888888875 356677777 8888888888 555665555433 12233444
Q ss_pred CCcCCCcCCCC-------------------------ccccccccCCCCCceeecccCCcccccchHHHhc--cccccEEE
Q 042887 316 KNNLGTESTSD-------------------------LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL--SAKITVIG 368 (628)
Q Consensus 316 ~n~l~~~~~~~-------------------------~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~--~~~L~~L~ 368 (628)
+|.+.+..... ......+..+++|+.|++++|.+++..+..+... ..+++.|+
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~ 253 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence 44332211000 0011234455666666666666554433332211 12677788
Q ss_pred ccCCcceeeCchhh-----hccCCcCeeeeccccccccCC-cCCCCC---CCCCeEecccCccccccCccccCCCCCCeE
Q 042887 369 MGDNQISGTIPSEI-----KNLVNINAFGVEYNQLTGTIP-HAIGEL---KNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439 (628)
Q Consensus 369 l~~n~l~~~~~~~l-----~~l~~L~~L~l~~n~l~~~~~-~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 439 (628)
+++|.+.+.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|
T Consensus 254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L 329 (520)
T 2z7x_B 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHL 329 (520)
T ss_dssp EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEE
T ss_pred eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEE
Confidence 88887777777776 7777778888877777 233 333333 56888888888776322 12688999999
Q ss_pred ecCCcccccccCCcccCCcchhcccceEEcCCCcCcc--ccchhhhccCCCCEeeCcCCcCcccCCc-cccCCCCCCeEE
Q 042887 440 FLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGG--SIPLEVGNLRNLAEFDLSENHFSNEIPV-TLSACTTLEYLH 516 (628)
Q Consensus 440 ~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~ 516 (628)
++++|++++..|..+..+++| +.|++++|++++ ..|..+..+++|++|++++|++++.+|. .+..+++|++|+
T Consensus 330 ~Ls~n~l~~~~~~~~~~l~~L----~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 330 DFSNNLLTDTVFENCGHLTEL----ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp ECCSSCCCTTTTTTCCCCSSC----CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred EeECCccChhhhhhhccCCCC----CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 999999998899999999988 899999999996 4567899999999999999999974554 588899999999
Q ss_pred CcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC-CCCCCCCCcccccCCCCCc
Q 042887 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR-KGVFGNRTGIHLIGNERLC 595 (628)
Q Consensus 517 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c 595 (628)
+++|++++..|..+. ++|+.|++++|+++ .+|..+..+++|++|++++|++++..+. ...+++++.+++++|++.|
T Consensus 406 Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 406 MSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp CCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence 999999887777664 79999999999999 6777777999999999999999964443 4567889999999999998
Q ss_pred c
Q 042887 596 G 596 (628)
Q Consensus 596 ~ 596 (628)
.
T Consensus 483 ~ 483 (520)
T 2z7x_B 483 S 483 (520)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=406.82 Aligned_cols=402 Identities=19% Similarity=0.209 Sum_probs=338.2
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
.+.++++|++||+++|++++..|..|+++++|++|+|++|.+++..|.+|+++++|++|++++|.++...+..++++++|
T Consensus 47 ~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 126 (570)
T 2z63_A 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126 (570)
T ss_dssp TTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTC
T ss_pred HhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccc
Confidence 35677888888888888888778888888888888888888887777888888888888888888886655678888888
Q ss_pred CEEEeecccCcc-cCChhhhhCCCCCcEEecccCcccccccccccCCCCC----CEEEcccccceeecccc---------
Q 042887 237 EIISLHSNRFEG-SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNL----QVLDVYKNHFSGQVKID--------- 302 (628)
Q Consensus 237 ~~L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~i~~~~~~~--------- 302 (628)
++|++++|.+++ .+|..+. ++++|++|++++|++++..+..++.+++| +.|++++|.+++..+..
T Consensus 127 ~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L 205 (570)
T 2z63_A 127 KELNVAHNLIQSFKLPEYFS-NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 205 (570)
T ss_dssp CEEECCSSCCCCCCCCGGGG-GCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred cEEecCCCccceecChhhhc-ccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeE
Confidence 888888888874 3566665 48888888888888887777777777777 77788777766554433
Q ss_pred ------------------------------------------------------------------------cccCCCCC
Q 042887 303 ------------------------------------------------------------------------FNRLSNLS 310 (628)
Q Consensus 303 ------------------------------------------------------------------------~~~l~~L~ 310 (628)
|..+++|+
T Consensus 206 ~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~ 285 (570)
T 2z63_A 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285 (570)
T ss_dssp EEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCS
T ss_pred ecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCccc
Confidence 34456677
Q ss_pred EEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCe
Q 042887 311 RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINA 390 (628)
Q Consensus 311 ~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 390 (628)
+|++++|.++.+ +..+..+ +|+.|++++|.+...... .+ ++++.|++++|.+.+..+. ..+++|+.
T Consensus 286 ~L~l~~~~l~~l-------~~~~~~~-~L~~L~l~~n~~~~l~~~---~l-~~L~~L~l~~n~~~~~~~~--~~~~~L~~ 351 (570)
T 2z63_A 286 SFSLVSVTIERV-------KDFSYNF-GWQHLELVNCKFGQFPTL---KL-KSLKRLTFTSNKGGNAFSE--VDLPSLEF 351 (570)
T ss_dssp EEEEESCEECSC-------CBCCSCC-CCSEEEEESCBCSSCCBC---BC-SSCCEEEEESCBSCCBCCC--CBCTTCCE
T ss_pred EEEecCccchhh-------hhhhccC-CccEEeeccCcccccCcc---cc-cccCEEeCcCCcccccccc--ccCCCCCE
Confidence 777777766543 2345566 899999999999855442 23 3899999999999877665 78999999
Q ss_pred eeeccccccccC--CcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccC-CcccCCcchhcccceE
Q 042887 391 FGVEYNQLTGTI--PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP-SSLGNCQNLMTLSRLL 467 (628)
Q Consensus 391 L~l~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~l~~~L 467 (628)
|++++|++.+.. +..+..+++|++|++++|.+.+..+. +..+++|++|++++|.+++..+ ..+..+++| +.|
T Consensus 352 L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L----~~L 426 (570)
T 2z63_A 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL----IYL 426 (570)
T ss_dssp EECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC----CEE
T ss_pred EeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCC----CEE
Confidence 999999998654 67788999999999999999965554 9999999999999999997766 567888888 899
Q ss_pred EcCCCcCccccchhhhccCCCCEeeCcCCcCc-ccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcc
Q 042887 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS-NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546 (628)
Q Consensus 468 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 546 (628)
++++|.+.+..|..+.++++|++|++++|.++ +.+|..+..+++|++|++++|++++..|..+..+++|++|++++|++
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 99999999989999999999999999999998 57889999999999999999999998899999999999999999999
Q ss_pred cccCchhhhcccCCCeEeccCCcCcccCCCCC
Q 042887 547 SGQIPKYLENLLFLAYLNLSYNHFEGEVPRKG 578 (628)
Q Consensus 547 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 578 (628)
++.+++.|..+++|+.|++++|++++.+|...
T Consensus 507 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 99888899999999999999999999988653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=409.64 Aligned_cols=421 Identities=19% Similarity=0.196 Sum_probs=290.6
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcc-cCCcCccCCCCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC-KLPLSIWNISSL 236 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L 236 (628)
+.++++|++|++++|++++..|+.|.++++|++|++++|.+++..|..|+++++|++|++++|.+++ ..|..+.++++|
T Consensus 46 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L 125 (549)
T 2z81_A 46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125 (549)
T ss_dssp TSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTC
T ss_pred hhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCc
Confidence 4566777777777777777777777777777777777777776666667777777777777777764 245667777777
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccC
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 316 (628)
++|++++|.+.+.+|...+..+++|++|++++|++++..|..++++++|++|++++|.+.......+..+++|++|++++
T Consensus 126 ~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~ 205 (549)
T 2z81_A 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205 (549)
T ss_dssp CEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEES
T ss_pred cEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccC
Confidence 77777777744466654455577777777777777777777777777777777777776544443445677888888888
Q ss_pred CcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhc---cccccEEEccCCcceeeCc--------------
Q 042887 317 NNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL---SAKITVIGMGDNQISGTIP-------------- 379 (628)
Q Consensus 317 n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~---~~~L~~L~l~~n~l~~~~~-------------- 379 (628)
|++++...... .....+++|+.|++++|.+++..+..+... ..+++.+++++|.+.+...
T Consensus 206 n~l~~~~~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~ 282 (549)
T 2z81_A 206 TNLARFQFSPL---PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282 (549)
T ss_dssp CBCTTCCCCCC---SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTT
T ss_pred Ccccccccccc---chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcc
Confidence 87766432211 122345678888888887776555544322 1367777777777654210
Q ss_pred ---------------------hhhhccCCcCeeeeccccccccCCcCC-CCCCCCCeEecccCccccccC---ccccCCC
Q 042887 380 ---------------------SEIKNLVNINAFGVEYNQLTGTIPHAI-GELKNLQGLALVRNSLRGTIP---DTLGNLT 434 (628)
Q Consensus 380 ---------------------~~l~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~---~~~~~l~ 434 (628)
..+....+|+.+++++|++. .+|..+ ..+++|++|++++|++++..| ..+..++
T Consensus 283 L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~ 361 (549)
T 2z81_A 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361 (549)
T ss_dssp CCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSST
T ss_pred cccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccc
Confidence 11122345667777777765 344444 467788888888888776553 2366777
Q ss_pred CCCeEecCCcccccccC--CcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCC
Q 042887 435 LLNRLFLGFNNLQGNVP--SSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTL 512 (628)
Q Consensus 435 ~L~~L~L~~N~l~~~~~--~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 512 (628)
+|++|++++|++++..+ ..+..+++| +.|++++|+++ .+|..+..+++|++|++++|++++ +|..+ .++|
T Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~L----~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L 433 (549)
T 2z81_A 362 SLQTLVLSQNHLRSMQKTGEILLTLKNL----TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTL 433 (549)
T ss_dssp TCCEEECTTSCCCCHHHHHHHGGGCTTC----CEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTC
T ss_pred cCcEEEccCCcccccccchhhhhcCCCC----CEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCc
Confidence 88888888888765432 346666666 77788888887 566677777888888888888763 33332 2578
Q ss_pred CeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC-CCCCCCCCcccccCC
Q 042887 513 EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR-KGVFGNRTGIHLIGN 591 (628)
Q Consensus 513 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~l~~~~~~~n 591 (628)
++|++++|++++.. ..+++|++|+|++|+++ .+|+ ...+++|++|++++|++++.+|. ...+++++.+++++|
T Consensus 434 ~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 507 (549)
T 2z81_A 434 EVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507 (549)
T ss_dssp SEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred eEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCC
Confidence 88888888877532 47789999999999998 4555 46788999999999999987775 466788899999999
Q ss_pred CCCcc
Q 042887 592 ERLCG 596 (628)
Q Consensus 592 ~~~c~ 596 (628)
++.|.
T Consensus 508 ~~~~~ 512 (549)
T 2z81_A 508 PWDCS 512 (549)
T ss_dssp CBCCC
T ss_pred CccCC
Confidence 98885
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=417.79 Aligned_cols=411 Identities=19% Similarity=0.249 Sum_probs=212.6
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEec-ccCcCcccccccc----------------------------------
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDI-SANMLGGRIPDSL---------------------------------- 206 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L-s~n~l~~~~~~~~---------------------------------- 206 (628)
.+++.|+|++|++.|.+|++|+++++|+.|+| ++|.+.+..|-.-
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 8886654411100
Q ss_pred -----------------cCCCCCCEeeccc--ccCcccCCcCccCCCCCCEEEeecccCcc-----------------cC
Q 042887 207 -----------------CQLRSLNYLSISE--NNFSCKLPLSIWNISSLEIISLHSNRFEG-----------------SL 250 (628)
Q Consensus 207 -----------------~~l~~L~~L~Ls~--N~i~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~ 250 (628)
.....++.+.+.. |++++ +|..|+++++|++|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0111222222222 44544 45555555555555555555554 14
Q ss_pred Chhhh-hCCCCCcEEecccCcccccccccccCCCCCCEEEccccc-cee-ecccccccCC-------CCCEEEccCCcCC
Q 042887 251 PLNIG-FNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH-FSG-QVKIDFNRLS-------NLSRLFLSKNNLG 320 (628)
Q Consensus 251 ~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l~-------~L~~L~L~~n~l~ 320 (628)
|..+. ..+++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ ..|..+..++ +|++|++++|.++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 54442 235555555555555555555555555555555555554 544 3444333332 5555555555554
Q ss_pred CcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCC-cCeeeecccccc
Q 042887 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVN-INAFGVEYNQLT 399 (628)
Q Consensus 321 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~-L~~L~l~~n~l~ 399 (628)
.++. ...+.++++|+.|++++|.++. .+ .+..+. +|+.|++++|.+. .+|..+..+++ |+.|++++|.+.
T Consensus 562 ~ip~-----~~~l~~L~~L~~L~Ls~N~l~~-lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~ 632 (876)
T 4ecn_A 562 EFPA-----SASLQKMVKLGLLDCVHNKVRH-LE-AFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632 (876)
T ss_dssp BCCC-----HHHHTTCTTCCEEECTTSCCCB-CC-CCCTTS-EESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred ccCC-----hhhhhcCCCCCEEECCCCCccc-ch-hhcCCC-cceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC
Confidence 2211 0134445555555555555542 22 333333 4555555555555 44555555555 555555555555
Q ss_pred ccCCcCCCCCCC--CCeEecccCccccccCccc---c--CCCCCCeEecCCcccccccCCcc-cCCcchhcccceEEcCC
Q 042887 400 GTIPHAIGELKN--LQGLALVRNSLRGTIPDTL---G--NLTLLNRLFLGFNNLQGNVPSSL-GNCQNLMTLSRLLDLSG 471 (628)
Q Consensus 400 ~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~l~~~L~Ls~ 471 (628)
.+|..+..++. |+.|++++|++.+.+|... . .+++|+.|++++|+++ .+|..+ ..+++| +.|+|++
T Consensus 633 -~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L----~~L~Ls~ 706 (876)
T 4ecn_A 633 -YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPI----STIILSN 706 (876)
T ss_dssp -SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCC----SEEECCS
T ss_pred -cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCC----CEEECCC
Confidence 44444444432 5555555555554333211 1 2235555555555555 233222 244444 4555555
Q ss_pred CcCccccchh-hh-------ccCCCCEeeCcCCcCcccCCcccc--CCCCCCeEECcCceeeeecCccccCCCCCCEEEC
Q 042887 472 NLLGGSIPLE-VG-------NLRNLAEFDLSENHFSNEIPVTLS--ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDL 541 (628)
Q Consensus 472 N~l~~~~~~~-~~-------~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 541 (628)
|+++ .+|.. +. ++++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 707 N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~L 783 (876)
T 4ecn_A 707 NLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783 (876)
T ss_dssp CCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEEC
T ss_pred CcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEEC
Confidence 5555 22222 11 1125555555555555 3444444 55555555555555553 4555555555555555
Q ss_pred CC------CcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCC
Q 042887 542 SR------NNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNER 593 (628)
Q Consensus 542 s~------N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~ 593 (628)
++ |++.+.+|..|.++++|+.|++++|++ +.+|.. ..++++.+++++|+.
T Consensus 784 s~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l 839 (876)
T 4ecn_A 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPN 839 (876)
T ss_dssp CCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTT
T ss_pred CCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCC
Confidence 44 445555555555555555555555555 444433 224555555555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=400.03 Aligned_cols=402 Identities=19% Similarity=0.245 Sum_probs=325.7
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCccc-ccccccCCCCCCEeeccccc-CcccCCcCccCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGR-IPDSLCQLRSLNYLSISENN-FSCKLPLSIWNIS 234 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l~ 234 (628)
.+.++++|++||+++|.+++..|..|+++++|++|++++|.+++. .|..|+.+++|++|++++|. +....+..|.+++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 367889999999999999998888899999999999999999864 56789999999999999998 5544457899999
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeec---ccccccCCCCCE
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQV---KIDFNRLSNLSR 311 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~l~~L~~ 311 (628)
+|++|++++|.+++.+|..+. .+++|++|++++|.+....+..+..+++|++|++++|++++.. ......+++|+.
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~ 227 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLK-SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTT-TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred ccCeeeccCCcccccChhhhh-ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence 999999999999977777776 4999999999999998544444577999999999999998752 223345789999
Q ss_pred EEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccc------------------------------c----chHH
Q 042887 312 LFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV------------------------------F----LRSI 357 (628)
Q Consensus 312 L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~------------------------------~----~~~~ 357 (628)
|++++|.+++.... .....+..+++|+.+++++|.+.+. . ...+
T Consensus 228 L~l~~n~l~~~~~~--~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~ 305 (549)
T 2z81_A 228 LAFRGSVLTDESFN--ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305 (549)
T ss_dssp EEEESCEEEHHHHH--HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHH
T ss_pred eeccccccchhHHH--HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhh
Confidence 99999987642211 1112223334444444444443321 1 1111
Q ss_pred HhccccccEEEccCCcceeeCchhh-hccCCcCeeeeccccccccCC---cCCCCCCCCCeEecccCccccccC--cccc
Q 042887 358 ANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTGTIP---HAIGELKNLQGLALVRNSLRGTIP--DTLG 431 (628)
Q Consensus 358 ~~~~~~L~~L~l~~n~l~~~~~~~l-~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~L~~n~l~~~~~--~~~~ 431 (628)
.....+++.+++++|.+. .+|..+ ..+++|+.|++++|++.+..| ..++.+++|++|++++|++++..+ ..+.
T Consensus 306 ~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 384 (549)
T 2z81_A 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384 (549)
T ss_dssp HHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGG
T ss_pred hhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhh
Confidence 222348999999999998 455555 689999999999999987653 457889999999999999986543 5688
Q ss_pred CCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCC
Q 042887 432 NLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTT 511 (628)
Q Consensus 432 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 511 (628)
.+++|++|++++|+++ .+|..+..+++| +.|++++|+++. +|..+ .++|++|++++|++++.. ..+++
T Consensus 385 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L----~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~ 452 (549)
T 2z81_A 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKM----RFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPR 452 (549)
T ss_dssp GCTTCCEEECTTCCCC-CCCSCCCCCTTC----CEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTT
T ss_pred cCCCCCEEECCCCCCc-cCChhhcccccc----cEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCCh
Confidence 9999999999999999 678888888888 899999999984 44433 368999999999998643 57899
Q ss_pred CCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC
Q 042887 512 LEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 512 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 576 (628)
|++|++++|+++ .+|. ...+++|++|+|++|++++.+|+.+..+++|+.|++++|++++.+|.
T Consensus 453 L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 453 LQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred hcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 999999999998 6665 46799999999999999999999999999999999999999998774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=404.11 Aligned_cols=360 Identities=18% Similarity=0.252 Sum_probs=282.2
Q ss_pred cCcCcccccccccCCCCCCEeecccccCccc-----------------CCcCcc--CCCCCCEEEeecccCcccCChhhh
Q 042887 195 ANMLGGRIPDSLCQLRSLNYLSISENNFSCK-----------------LPLSIW--NISSLEIISLHSNRFEGSLPLNIG 255 (628)
Q Consensus 195 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-----------------~p~~~~--~l~~L~~L~L~~n~l~~~~~~~~~ 255 (628)
+|++++ +|.+|+++++|++|+|++|.+++. +|..++ ++++|++|++++|.+.+.+|..+.
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 466776 677777777788888887777764 777777 777788888887777777776665
Q ss_pred hCCCCCcEEecccCc-ccc-cccccccCC------CCCCEEEcccccceeeccc--ccccCCCCCEEEccCCcCCCcCCC
Q 042887 256 FNIPNVNFLSVGQNN-FTG-SLPHSFSNA------SNLQVLDVYKNHFSGQVKI--DFNRLSNLSRLFLSKNNLGTESTS 325 (628)
Q Consensus 256 ~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~ 325 (628)
++++|++|++++|+ +++ .+|..++++ ++|++|++++|+++ ..|. .+..+++|++|++++|++++
T Consensus 271 -~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g---- 344 (636)
T 4eco_A 271 -ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEG---- 344 (636)
T ss_dssp -TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEE----
T ss_pred -cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCcc----
Confidence 47778888888777 776 677766665 77788888887777 4555 67777778888887777763
Q ss_pred CccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccC--CcCeeeeccccccccCC
Q 042887 326 DLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLV--NINAFGVEYNQLTGTIP 403 (628)
Q Consensus 326 ~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~--~L~~L~l~~n~l~~~~~ 403 (628)
..+ .+..+++|+.|++++|.++ ..+..+..+..+|+.|++++|.++ .+|..+..++ +|+.|++++|.+.+..|
T Consensus 345 --~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p 419 (636)
T 4eco_A 345 --KLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419 (636)
T ss_dssp --ECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTT
T ss_pred --chh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcch
Confidence 112 3455667777788877776 444556666523888888888888 6677776654 89999999999999888
Q ss_pred cCCC-------CCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCc-ccCCc----chhcccceEEcCC
Q 042887 404 HAIG-------ELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS-LGNCQ----NLMTLSRLLDLSG 471 (628)
Q Consensus 404 ~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~----~L~~l~~~L~Ls~ 471 (628)
..+. .+++|++|++++|++++..+..+..+++|++|++++|+++ .+|.. +.... ++..+ +.|++++
T Consensus 420 ~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L-~~L~Ls~ 497 (636)
T 4eco_A 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLL-TSIDLRF 497 (636)
T ss_dssp CSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGC-CEEECCS
T ss_pred hhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCc-cEEECcC
Confidence 8888 7889999999999999655556677999999999999999 55544 33222 12222 8999999
Q ss_pred CcCccccchhhh--ccCCCCEeeCcCCcCcccCCccccCCCCCCeEEC------cCceeeeecCccccCCCCCCEEECCC
Q 042887 472 NLLGGSIPLEVG--NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHL------QGNSFSGSLPLSLKTLKSIKELDLSR 543 (628)
Q Consensus 472 N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (628)
|+++ .+|..+. .+++|++|+|++|++++ +|..+..+++|++|++ ++|++.+.+|..+..+++|++|+|++
T Consensus 498 N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 575 (636)
T 4eco_A 498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575 (636)
T ss_dssp SCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCS
T ss_pred CcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCC
Confidence 9999 6777776 89999999999999997 8889999999999999 56888889999999999999999999
Q ss_pred CcccccCchhhhcccCCCeEeccCCcCccc
Q 042887 544 NNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 544 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
|+++ .+|..+. ++|+.||+++|++...
T Consensus 576 N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 576 NDIR-KVNEKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp SCCC-BCCSCCC--TTCCEEECCSCTTCEE
T ss_pred CcCC-ccCHhHh--CcCCEEECcCCCCccc
Confidence 9995 6777655 7999999999998753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=417.06 Aligned_cols=402 Identities=21% Similarity=0.235 Sum_probs=299.9
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCccccccc--ccCCCCCCEeecccccCcccCC-cCccCCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDS--LCQLRSLNYLSISENNFSCKLP-LSIWNIS 234 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~ 234 (628)
+.++++|++|+|++|.+++..|+.|+++++|++|+|++|.+++..|.. |+.+++|++|+|++|.+++..+ ..|++++
T Consensus 69 f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~ 148 (844)
T 3j0a_A 69 FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148 (844)
T ss_dssp TSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCS
T ss_pred hcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCC
Confidence 345555555555555555555555555555555555555555433333 5555555555555555554333 3455555
Q ss_pred CCCEEEeecccCcccCChhhhhCC--CCCcEEecccCcccccccccccCCCC------CCEEEcccccceeeccccccc-
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNI--PNVNFLSVGQNNFTGSLPHSFSNASN------LQVLDVYKNHFSGQVKIDFNR- 305 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~N~i~~~~~~~~~~- 305 (628)
+|++|++++|.+++..+..+.. + ++|+.|++++|.+.+..|..++.+.+ |++|++++|.+++..+..+..
T Consensus 149 ~L~~L~Ls~N~i~~~~~~~l~~-l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~ 227 (844)
T 3j0a_A 149 SLKSIDFSSNQIFLVCEHELEP-LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227 (844)
T ss_dssp SCCEEEEESSCCCCCCSGGGHH-HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGT
T ss_pred CCCEEECCCCcCCeeCHHHccc-ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhh
Confidence 5555555555555444443332 3 55555666666555555555554444 788888888776544433322
Q ss_pred -------------------------------------CCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCC
Q 042887 306 -------------------------------------LSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNK 348 (628)
Q Consensus 306 -------------------------------------l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~ 348 (628)
.++|++|++++|.+....+ ..+..+++|+.|++++|.
T Consensus 228 l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~ 301 (844)
T 3j0a_A 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS------RVFETLKDLKVLNLAYNK 301 (844)
T ss_dssp SCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS------CCSSSCCCCCEEEEESCC
T ss_pred cCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccCh------hhhhcCCCCCEEECCCCc
Confidence 2679999999999876433 456778899999999999
Q ss_pred cccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccC-
Q 042887 349 FGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP- 427 (628)
Q Consensus 349 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~- 427 (628)
+++..+..+..+. +|+.|++++|.+.+..|..+..+++|+.|++++|.+.+..+..|..+++|++|++++|.+++...
T Consensus 302 i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~ 380 (844)
T 3j0a_A 302 INKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFI 380 (844)
T ss_dssp CCEECTTTTTTCS-SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSC
T ss_pred CCCCChHHhcCCC-CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCC
Confidence 9999888888877 89999999999999989999999999999999999998888889999999999999998874211
Q ss_pred ---------------------------------------ccccCCCCCCeEecCCcccccccCC-cccCCcchhcccceE
Q 042887 428 ---------------------------------------DTLGNLTLLNRLFLGFNNLQGNVPS-SLGNCQNLMTLSRLL 467 (628)
Q Consensus 428 ---------------------------------------~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~l~~~L 467 (628)
..+..+++|+.|++++|++++..+. .+..+++| +.|
T Consensus 381 ~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L----~~L 456 (844)
T 3j0a_A 381 PSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL----EQL 456 (844)
T ss_dssp CSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC----CBC
T ss_pred CCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc----ccc
Confidence 1134678999999999999865443 35556677 889
Q ss_pred EcCCCcCc-----cccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECC
Q 042887 468 DLSGNLLG-----GSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLS 542 (628)
Q Consensus 468 ~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 542 (628)
++++|.++ +..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..+. ++|+.|+|+
T Consensus 457 ~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls 534 (844)
T 3j0a_A 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDIS 534 (844)
T ss_dssp EEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEE
T ss_pred cCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECC
Confidence 99999997 34456788999999999999999999999999999999999999999977776665 899999999
Q ss_pred CCcccccCchhhhcccCCCeEeccCCcCcccCCC
Q 042887 543 RNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 543 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 576 (628)
+|++++..|+.| .+|+.|++++|++.+..+.
T Consensus 535 ~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 535 RNQLLAPNPDVF---VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp EECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred CCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence 999999888775 4789999999999987764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=395.71 Aligned_cols=426 Identities=19% Similarity=0.166 Sum_probs=329.1
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
..+++|||++|+|++..+.+|.++++|++|||++|+|+++.+++|.++++|++|+|++|++++..+.+|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36899999999999988899999999999999999999888999999999999999999999877788999999999999
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCccccc-ccccccCCCCCCEEEcccccceeecccccccCCCCC----EEEccC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS-LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLS----RLFLSK 316 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~L~~ 316 (628)
++|+++ .+|...+.++++|++|++++|+++.. .|..++.+++|++|++++|++++..+..|..+.+++ .++++.
T Consensus 132 s~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 132 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 999998 67777667799999999999999864 578889999999999999999999888887665543 677888
Q ss_pred CcCCCcCCCCccccc------------------cccCCC-----------------------------------------
Q 042887 317 NNLGTESTSDLDFLT------------------LLTNCS----------------------------------------- 337 (628)
Q Consensus 317 n~l~~~~~~~~~~~~------------------~l~~~~----------------------------------------- 337 (628)
|.+..+....+.... .+..+.
T Consensus 211 n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 211 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred CcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 877655443221100 001111
Q ss_pred ----------------CCceeecccCCcccccchHHHhccccccEEEccCCcceeeCch-------------------hh
Q 042887 338 ----------------QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS-------------------EI 382 (628)
Q Consensus 338 ----------------~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-------------------~l 382 (628)
+++.+.+..+.+.... .+... ..++.|++.+|.+.+..+. ..
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~-~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~ 367 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 367 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSC-CCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCC
T ss_pred hcccccchhhhhhhhccccccccccccccccc--ccccc-hhhhhhhcccccccCcCcccchhhhhcccccccCCCCccc
Confidence 2222222222221111 11111 2566777777766543222 12
Q ss_pred hccCCcCeeeeccccccc--cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccC-CcccCCcc
Q 042887 383 KNLVNINAFGVEYNQLTG--TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVP-SSLGNCQN 459 (628)
Q Consensus 383 ~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~ 459 (628)
..+++|+.+++++|.+.. ..+..+..+.+|+.++++.|.+.. .+..+..+++|+.++++.|......+ ..+..+.+
T Consensus 368 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~ 446 (635)
T 4g8a_A 368 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 446 (635)
T ss_dssp CBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTT
T ss_pred ccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccc
Confidence 345566666666666542 233444556666777776666653 44567778888888888777654443 34566666
Q ss_pred hhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCc-ccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCE
Q 042887 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS-NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKE 538 (628)
Q Consensus 460 L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 538 (628)
+ +.+++++|.+.+..+..+..++.|++|++++|.+. +..|..|..+++|++|+|++|++++..|..|.++++|++
T Consensus 447 l----~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~ 522 (635)
T 4g8a_A 447 L----IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 522 (635)
T ss_dssp C----CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred c----ccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence 6 88999999999888999999999999999999854 457888999999999999999999999999999999999
Q ss_pred EECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCC-CCC-CCCCcccccCCCCCcc
Q 042887 539 LDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK-GVF-GNRTGIHLIGNERLCG 596 (628)
Q Consensus 539 L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~-~~l~~~~~~~n~~~c~ 596 (628)
|+|++|+|++..|..|.++++|++||+++|+|++..|.. ..+ .+++.+++++||+.|.
T Consensus 523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999999999999999999999999999988754 233 6799999999999995
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=405.14 Aligned_cols=409 Identities=18% Similarity=0.229 Sum_probs=332.3
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEeec-ccccCcccCCcCc----------------------------------
Q 042887 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSI-SENNFSCKLPLSI---------------------------------- 230 (628)
Q Consensus 186 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L-s~N~i~~~~p~~~---------------------------------- 230 (628)
..++.|+|++|.+.+.+|.+|++|++|++|+| ++|.+.+..|...
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 8898766533210
Q ss_pred -----------------cCCCCCCEEEeec--ccCcccCChhhhhCCCCCcEEecccCcccc-----------------c
Q 042887 231 -----------------WNISSLEIISLHS--NRFEGSLPLNIGFNIPNVNFLSVGQNNFTG-----------------S 274 (628)
Q Consensus 231 -----------------~~l~~L~~L~L~~--n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------~ 274 (628)
.....++.+.+.. |.+++ +|..+. ++++|++|+|++|++++ .
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~-~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHh-cCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence 1122344444443 88886 898876 49999999999999998 3
Q ss_pred cccccc--CCCCCCEEEcccccceeecccccccCCCCCEEEccCCc-CCC-cCCCCccccc-cccCCCCCceeecccCCc
Q 042887 275 LPHSFS--NASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN-LGT-ESTSDLDFLT-LLTNCSQMEMLYLNTNKF 349 (628)
Q Consensus 275 ~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~~~-~l~~~~~L~~L~l~~n~~ 349 (628)
+|..++ ++++|++|+|++|++.+..|..|..+++|++|++++|+ +++ .-+..+..+. .+..+++|+.|++++|.+
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 888877 99999999999999999999999999999999999998 764 1111112121 455667999999999999
Q ss_pred ccccch--HHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCC-CCeEecccCcccccc
Q 042887 350 GGVFLR--SIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKN-LQGLALVRNSLRGTI 426 (628)
Q Consensus 350 ~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~ 426 (628)
+ ..+. .+..+. +|+.|++++|.++ .+| .+..+++|+.|++++|++. .+|..+..+++ |+.|++++|.++ .+
T Consensus 561 ~-~ip~~~~l~~L~-~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l 634 (876)
T 4ecn_A 561 E-EFPASASLQKMV-KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI 634 (876)
T ss_dssp C-BCCCHHHHTTCT-TCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred C-ccCChhhhhcCC-CCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence 9 4555 788777 8999999999999 777 8999999999999999999 78888999999 999999999999 67
Q ss_pred CccccCCCC--CCeEecCCcccccccCCcccC-----CcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCc
Q 042887 427 PDTLGNLTL--LNRLFLGFNNLQGNVPSSLGN-----CQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499 (628)
Q Consensus 427 ~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~-----l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 499 (628)
|..+..++. |+.|++++|++++..|..... +++| +.|++++|+++...+..+..+++|+.|+|++|+++
T Consensus 635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L----~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~ 710 (876)
T 4ecn_A 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA----STVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710 (876)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCE----EEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS
T ss_pred chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCc----CEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC
Confidence 888877654 999999999999876643322 2355 89999999999544444568999999999999999
Q ss_pred ccCCccccC-C-------CCCCeEECcCceeeeecCcccc--CCCCCCEEECCCCcccccCchhhhcccCCCeEeccC--
Q 042887 500 NEIPVTLSA-C-------TTLEYLHLQGNSFSGSLPLSLK--TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSY-- 567 (628)
Q Consensus 500 ~~~~~~~~~-l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~-- 567 (628)
.+|..+.. . ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|++++
T Consensus 711 -~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 711 -SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp -CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB
T ss_pred -ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC
Confidence 45544333 2 39999999999999 7888887 99999999999999997 788899999999999976
Q ss_pred ----CcCcccCCC-CCCCCCCCcccccCCCC------CcccCCCCCCCCCCCC
Q 042887 568 ----NHFEGEVPR-KGVFGNRTGIHLIGNER------LCGGLEELHLPSCHFG 609 (628)
Q Consensus 568 ----N~l~~~~p~-~~~~~~l~~~~~~~n~~------~c~~~~~l~l~~c~~~ 609 (628)
|++.+.+|. ...+++++.+++++|.. ++..++.|++++|++.
T Consensus 788 ~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCCSSSCEEECCSCTTC
T ss_pred CcccccccccChHHHhcCCCCCEEECCCCCCCccCHhhcCCCCEEECCCCCCC
Confidence 788888874 45688999999999864 2234555677777754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=393.00 Aligned_cols=396 Identities=20% Similarity=0.259 Sum_probs=329.9
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcc-cCCcCccCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC-KLPLSIWNISS 235 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~ 235 (628)
.+.++++|++|++++|++++..|+.|+++++|++|+|++|+++ .+|.. .+++|++|+|++|.+++ ..|..|+++++
T Consensus 40 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~ 116 (520)
T 2z7x_B 40 DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQ 116 (520)
T ss_dssp HHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTT
T ss_pred hccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCc
Confidence 4678899999999999999999999999999999999999999 45555 89999999999999987 46899999999
Q ss_pred CCEEEeecccCcccCChhhhhCCCCC--cEEecccCcc--cccccccccC--------------------------CCCC
Q 042887 236 LEIISLHSNRFEGSLPLNIGFNIPNV--NFLSVGQNNF--TGSLPHSFSN--------------------------ASNL 285 (628)
Q Consensus 236 L~~L~L~~n~l~~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~--------------------------l~~L 285 (628)
|++|++++|.+++ ..+..+++| +.|++++|.+ .+..|..+.. +++|
T Consensus 117 L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L 192 (520)
T 2z7x_B 117 LKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192 (520)
T ss_dssp CCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEE
T ss_pred ceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccce
Confidence 9999999999984 223458888 9999999999 6666666655 6677
Q ss_pred CEEEccccc-------ceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHH-
Q 042887 286 QVLDVYKNH-------FSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI- 357 (628)
Q Consensus 286 ~~L~L~~N~-------i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~- 357 (628)
+.|++++|. +.+..+ .+..+++|+.|++++|.+++..... .... ...++|+.|++++|.+++..+..+
T Consensus 193 ~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~--~~~~-~~~~~L~~L~l~~n~l~~~~p~~~~ 268 (520)
T 2z7x_B 193 ELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIR--ILQL-VWHTTVWYFSISNVKLQGQLDFRDF 268 (520)
T ss_dssp EECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHH--HHHH-HHTSSCSEEEEEEEEEESCCCCCCC
T ss_pred eeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHH--HHHH-hhhCcccEEEeecccccCccccchh
Confidence 777887776 555544 6778888888888888775421110 1111 124589999999999987777766
Q ss_pred ----HhccccccEEEccCCcceeeCc-hhhhcc---CCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCcc
Q 042887 358 ----ANLSAKITVIGMGDNQISGTIP-SEIKNL---VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDT 429 (628)
Q Consensus 358 ----~~~~~~L~~L~l~~n~l~~~~~-~~l~~l---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 429 (628)
..+. +++.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..
T Consensus 269 ~~~~~~l~-~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~ 343 (520)
T 2z7x_B 269 DYSGTSLK-ALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFEN 343 (520)
T ss_dssp CCCSCCCC-EEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred hcccccCc-eeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhh
Confidence 5555 899999999999 445 556555 78999999999987432 2368899999999999999889999
Q ss_pred ccCCCCCCeEecCCccccc--ccCCcccCCcchhcccceEEcCCCcCccccch-hhhccCCCCEeeCcCCcCcccCCccc
Q 042887 430 LGNLTLLNRLFLGFNNLQG--NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL-EVGNLRNLAEFDLSENHFSNEIPVTL 506 (628)
Q Consensus 430 ~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~ 506 (628)
+..+++|++|++++|++++ ..|..+..+++| +.|++++|++++.+|. .+..+++|++|++++|++++..|..+
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L----~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSL----QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC----CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCC----CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence 9999999999999999986 456778888888 8999999999984555 48889999999999999988777666
Q ss_pred cCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 507 SACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 507 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
. ++|++|++++|+++ .+|..+..+++|++|++++|+++...+..|..+++|++|++++|++++..+
T Consensus 420 ~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp C--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred c--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 4 79999999999999 788888899999999999999996555559999999999999999998765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=392.26 Aligned_cols=411 Identities=18% Similarity=0.193 Sum_probs=259.6
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
+++++||+++|.+++..|+.|.++++|++|+|++|.+++..|++|.++++|++|+|++|.++ .+|.. .+++|++|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 46677777777777666667777777777777777777666667777777777777777776 34444 6677777777
Q ss_pred ecccCcccCC--hhhhhCCCCCcEEecccCcccccccccccCCCCC--CEEEcccccc--eeecccccccCC-CCCEEEc
Q 042887 242 HSNRFEGSLP--LNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNL--QVLDVYKNHF--SGQVKIDFNRLS-NLSRLFL 314 (628)
Q Consensus 242 ~~n~l~~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~l~-~L~~L~L 314 (628)
++|.++ .+| ..+ .++++|++|++++|+++.. .+..+++| ++|++++|++ ++..+..|..+. ..-.+++
T Consensus 129 s~N~l~-~l~~p~~~-~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l 203 (562)
T 3a79_B 129 SFNDFD-VLPVCKEF-GNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203 (562)
T ss_dssp CSSCCS-BCCCCGGG-GGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEE
T ss_pred CCCCcc-ccCchHhh-cccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEe
Confidence 777776 333 333 3477777777777776642 34444444 7777777766 555555554432 0112233
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccC----------------------------CcccccchHHHhc--cccc
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTN----------------------------KFGGVFLRSIANL--SAKI 364 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n----------------------------~~~~~~~~~~~~~--~~~L 364 (628)
+.|.+..... ...+..+++|+.+++++| .+.+.....+... ..++
T Consensus 204 ~~n~~~~~~~-----~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L 278 (562)
T 3a79_B 204 HPNSLFSVQV-----NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278 (562)
T ss_dssp CSSSCCCCCC-----EEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSE
T ss_pred cCccchhhhh-----hhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccc
Confidence 3333322100 011223344444554444 3333222111110 1267
Q ss_pred cEEEccCCcceeeCchhh-----hccCCcCeeeeccccccccCC-cCCCC---CCCCCeEecccCccccccCccccCCCC
Q 042887 365 TVIGMGDNQISGTIPSEI-----KNLVNINAFGVEYNQLTGTIP-HAIGE---LKNLQGLALVRNSLRGTIPDTLGNLTL 435 (628)
Q Consensus 365 ~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~l~~n~l~~~~~-~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~ 435 (628)
+.|++++|.+.+.+|..+ .+++.|+.+++..+.+ .+| ..+.. ..+|++|++++|.+.... ....+++
T Consensus 279 ~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~ 354 (562)
T 3a79_B 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSS 354 (562)
T ss_dssp EEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCC
T ss_pred cEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCC
Confidence 777777777776666655 5555555555555544 122 11111 145777777777765322 1256788
Q ss_pred CCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc--cchhhhccCCCCEeeCcCCcCcccCC-ccccCCCCC
Q 042887 436 LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS--IPLEVGNLRNLAEFDLSENHFSNEIP-VTLSACTTL 512 (628)
Q Consensus 436 L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L 512 (628)
|++|++++|++++..|..+.++++| +.|++++|++++. .|..+.++++|++|++++|++++.+| ..+..+++|
T Consensus 355 L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 355 FTFLNFTQNVFTDSVFQGCSTLKRL----QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCEEECCSSCCCTTTTTTCCSCSSC----CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred ceEEECCCCccccchhhhhcccCCC----CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 8888888888887778888888877 7888888888863 34567888888888888888887344 457778888
Q ss_pred CeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC-CCCCCCCCcccccCC
Q 042887 513 EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR-KGVFGNRTGIHLIGN 591 (628)
Q Consensus 513 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~l~~~~~~~n 591 (628)
++|++++|++++..|..+. ++|++|++++|+++ .+|..+..+++|++|++++|++++.++. ...+++++.+++++|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCC
Confidence 8888888888766665543 68888888888888 4555555888888888888888854443 456677888888888
Q ss_pred CCCcc
Q 042887 592 ERLCG 596 (628)
Q Consensus 592 ~~~c~ 596 (628)
|+.|.
T Consensus 508 ~~~c~ 512 (562)
T 3a79_B 508 PWDCT 512 (562)
T ss_dssp CBCCC
T ss_pred CcCCC
Confidence 88874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=373.16 Aligned_cols=385 Identities=18% Similarity=0.193 Sum_probs=309.2
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcc-cCCcCccCCCCCCEEEeec
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC-KLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~L~~ 243 (628)
+.++.+++.++. +|. + .++|++|+|++|.+++..|..|+++++|++|++++|.+.+ ..+..|.++++|++|++++
T Consensus 13 ~~~~c~~~~l~~-lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLHQ-VPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCSS-CCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCccc-CCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 568888888874 554 3 3799999999999998889999999999999999999874 4477899999999999999
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCccccccccc--ccCCCCCCEEEcccccceeecccc-cccCCCCCEEEccCCcCC
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHS--FSNASNLQVLDVYKNHFSGQVKID-FNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~n~l~ 320 (628)
|.+++..|..+. .+++|++|++++|++++..+.. |+++++|++|++++|++++..+.. |..+++|++|++++|.++
T Consensus 89 n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 89 NQFLQLETGAFN-GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp CTTCEECTTTTT-TCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CccCccChhhcc-CcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 999855565554 6999999999999999755554 999999999999999999887766 889999999999999998
Q ss_pred CcCCCCccccccccCCCCCceeecccCCcccccchHHH--------hccccccEEEccCCcceeeCchhhhcc---CCcC
Q 042887 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA--------NLSAKITVIGMGDNQISGTIPSEIKNL---VNIN 389 (628)
Q Consensus 321 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~--------~~~~~L~~L~l~~n~l~~~~~~~l~~l---~~L~ 389 (628)
...+..+... ...+++.|++++|.+.+.....+. .. .+++.|++++|.+.+..|..+... ++|+
T Consensus 168 ~~~~~~l~~l----~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~ 242 (455)
T 3v47_A 168 SICEEDLLNF----QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN-TSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242 (455)
T ss_dssp CCCTTTSGGG----TTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTT-CEEEEEECTTSCCCHHHHHHHHHHTTTCCEE
T ss_pred ccChhhhhcc----ccccccccccccCcccccchhhcccccccccccc-ceeeeEecCCCcccccchhhhhcccccccee
Confidence 7655433221 125788888888888765543322 11 257777777777776666655444 6666
Q ss_pred eeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccC--CCCCCeEecCCcccccccCCcccCCcchhcccceE
Q 042887 390 AFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGN--LTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLL 467 (628)
Q Consensus 390 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L 467 (628)
.+++++|.+.+.. +..+.+.+..+..+.. .++|+.|++++|++++..|..+..+++| +.|
T Consensus 243 ~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L 304 (455)
T 3v47_A 243 SLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL----EQL 304 (455)
T ss_dssp EEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTC----CEE
T ss_pred eEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCC----CEE
Confidence 7777666554321 1111222222222222 3689999999999998888889988888 889
Q ss_pred EcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 468 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
++++|++.+..|..|.++++|++|++++|.+++..|..+..+++|++|++++|++++..|..+..+++|++|++++|+++
T Consensus 305 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 384 (455)
T 3v47_A 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384 (455)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc
Confidence 99999999888889999999999999999999888889999999999999999999888999999999999999999999
Q ss_pred ccCchhhhcccCCCeEeccCCcCcccCCCC
Q 042887 548 GQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577 (628)
Q Consensus 548 ~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 577 (628)
+..++.|..+++|++|++++|++++.+|..
T Consensus 385 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 385 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred cCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 877788899999999999999999998854
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.80 Aligned_cols=372 Identities=18% Similarity=0.188 Sum_probs=320.6
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcc-cccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEE
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGG-RIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIIS 240 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 240 (628)
++|++|||++|.+++..|..|+++++|++|++++|.+.+ +.+..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 579999999999999999999999999999999999974 4477899999999999999999988899999999999999
Q ss_pred eecccCcccCChh-hhhCCCCCcEEecccCccccccccc-ccCCCCCCEEEcccccceeecccccccC--CCCCEEEccC
Q 042887 241 LHSNRFEGSLPLN-IGFNIPNVNFLSVGQNNFTGSLPHS-FSNASNLQVLDVYKNHFSGQVKIDFNRL--SNLSRLFLSK 316 (628)
Q Consensus 241 L~~n~l~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~L~~ 316 (628)
+++|.+++.+|.. .+..+++|++|++++|++++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999998644443 3456999999999999999887876 8999999999999999999988888876 7899999999
Q ss_pred CcCCCcCCCCcc--ccccccCCCCCceeecccCCcccccchHHHhcc--ccccEEEccCCcceeeCchhhhccCCcCeee
Q 042887 317 NNLGTESTSDLD--FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLS--AKITVIGMGDNQISGTIPSEIKNLVNINAFG 392 (628)
Q Consensus 317 n~l~~~~~~~~~--~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~--~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 392 (628)
|.+.......+. ....+..+++|+.|++++|.+++..+..+.... .+++.+++++|.+.+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------------- 255 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------------- 255 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence 999886654322 122344668999999999999988888776652 48999999999865431
Q ss_pred eccccccccCCcCCCC--CCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcC
Q 042887 393 VEYNQLTGTIPHAIGE--LKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLS 470 (628)
Q Consensus 393 l~~n~l~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls 470 (628)
+..+.+.+..+..+.. .++|++|++++|.+++..|..+..+++|++|++++|++++..|..+.++++| +.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L----~~L~Ls 331 (455)
T 3v47_A 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL----LKLNLS 331 (455)
T ss_dssp TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC----CEEECC
T ss_pred cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccC----CEEECC
Confidence 1222222222233333 3689999999999999999999999999999999999998889999999998 899999
Q ss_pred CCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccC
Q 042887 471 GNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQI 550 (628)
Q Consensus 471 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 550 (628)
+|++++..+..+.++++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|++++..
T Consensus 332 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 332 QNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp SSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 99999888899999999999999999999888999999999999999999999877778899999999999999999877
Q ss_pred c
Q 042887 551 P 551 (628)
Q Consensus 551 ~ 551 (628)
|
T Consensus 412 ~ 412 (455)
T 3v47_A 412 P 412 (455)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=373.37 Aligned_cols=398 Identities=18% Similarity=0.207 Sum_probs=307.9
Q ss_pred cccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCccc-CCcCccCCC
Q 042887 156 IQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCK-LPLSIWNIS 234 (628)
Q Consensus 156 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~ 234 (628)
..+.++++|++|++++|++++..|+.|.++++|++|||++|.++ .+|.. .+++|++|+|++|.+++. .|..|++++
T Consensus 70 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~ 146 (562)
T 3a79_B 70 PDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLT 146 (562)
T ss_dssp GGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCT
T ss_pred hhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccC
Confidence 35678999999999999999999999999999999999999999 45555 899999999999999863 468999999
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCC--cEEecccCcc--cccccccccCCC--CCCEEEcccccceeecc-cccccCC
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNV--NFLSVGQNNF--TGSLPHSFSNAS--NLQVLDVYKNHFSGQVK-IDFNRLS 307 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~--~L~~L~L~~N~i~~~~~-~~~~~l~ 307 (628)
+|++|++++|.+++ .. +..+++| +.|++++|.+ ++..|..+..+. .+ .+++++|.+.+..+ ..+..++
T Consensus 147 ~L~~L~L~~n~l~~-~~---~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~ 221 (562)
T 3a79_B 147 KLTFLGLSAAKFRQ-LD---LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALG 221 (562)
T ss_dssp TCCEEEEECSBCCT-TT---TGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEE
T ss_pred cccEEecCCCcccc-Cc---hhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccc
Confidence 99999999999984 22 2235666 9999999999 777787777654 22 34555555543222 2233445
Q ss_pred CCCEEEccCC----------------------------cCCCcCCCCccccccccCCCCCceeecccCCcccccchHH--
Q 042887 308 NLSRLFLSKN----------------------------NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI-- 357 (628)
Q Consensus 308 ~L~~L~L~~n----------------------------~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~-- 357 (628)
+|+.|++++| .+...... ........++|++|++++|.+++..+..+
T Consensus 222 ~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~---~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~ 298 (562)
T 3a79_B 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV---KLFQFFWPRPVEYLNIYNLTITERIDREEFT 298 (562)
T ss_dssp EEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHH---HHHHHHTTSSEEEEEEEEEEECSCCCCCCCC
T ss_pred eEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHH---HHHHhhhcccccEEEEeccEeeccccchhhh
Confidence 5555555554 33221000 00011123489999999999987666655
Q ss_pred ---HhccccccEEEccCCcceeeCc-hhhhcc---CCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccc
Q 042887 358 ---ANLSAKITVIGMGDNQISGTIP-SEIKNL---VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTL 430 (628)
Q Consensus 358 ---~~~~~~L~~L~l~~n~l~~~~~-~~l~~l---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 430 (628)
..+. .+..+++..+.+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|++++|++++..|..+
T Consensus 299 ~~~~~L~-~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~ 373 (562)
T 3a79_B 299 YSETALK-SLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGC 373 (562)
T ss_dssp CCSCSCC-EEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred cccccch-heehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhh
Confidence 3333 566666666666 334 333333 67999999999986332 23788999999999999998899999
Q ss_pred cCCCCCCeEecCCcccccc--cCCcccCCcchhcccceEEcCCCcCccccc-hhhhccCCCCEeeCcCCcCcccCCcccc
Q 042887 431 GNLTLLNRLFLGFNNLQGN--VPSSLGNCQNLMTLSRLLDLSGNLLGGSIP-LEVGNLRNLAEFDLSENHFSNEIPVTLS 507 (628)
Q Consensus 431 ~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 507 (628)
..+++|++|++++|++++. .|..+.++++| +.|++++|++++.+| ..+..+++|++|++++|++++..|..+.
T Consensus 374 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L----~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~ 449 (562)
T 3a79_B 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSL----ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449 (562)
T ss_dssp CSCSSCCEEECCSSCCCBTTHHHHTTTTCTTC----CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC
T ss_pred cccCCCCEEECCCCCcCCcccchhhhcCCCCC----CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc
Confidence 9999999999999999863 34668888888 899999999998444 4588999999999999999877666554
Q ss_pred CCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC
Q 042887 508 ACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 508 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 576 (628)
++|++|++++|+++ .+|..+..+++|++|+|++|+++..++..+..+++|+.|++++|++.+..|.
T Consensus 450 --~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp --TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred --CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 79999999999999 6777777999999999999999955444599999999999999999987663
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=366.21 Aligned_cols=411 Identities=19% Similarity=0.233 Sum_probs=332.7
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
.+.++++|++|||++|+|+++.|++|.++++|++|+|++|++++..+.+|.++++|++|+|++|++++..+..|+++++|
T Consensus 71 ~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L 150 (635)
T 4g8a_A 71 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 150 (635)
T ss_dssp TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred HHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCccc
Confidence 46788999999999999999889999999999999999999998888899999999999999999998777889999999
Q ss_pred CEEEeecccCccc-CChhhhhCCCCCcEEecccCcccccccccccCCCCCC----EEEcccccceeecccccccCCCCCE
Q 042887 237 EIISLHSNRFEGS-LPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQ----VLDVYKNHFSGQVKIDFNRLSNLSR 311 (628)
Q Consensus 237 ~~L~L~~n~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~ 311 (628)
++|++++|.+++. +|..+ ..+++|++|++++|++++..+..|..+.+++ .++++.|.++.+.+..+.. ..++.
T Consensus 151 ~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~ 228 (635)
T 4g8a_A 151 KELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHK 228 (635)
T ss_dssp CEEECCSSCCCCCCCCGGG-GGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEE
T ss_pred CeeccccCccccCCCchhh-ccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhh
Confidence 9999999999743 34444 4599999999999999988888887665543 6778888877655543322 22333
Q ss_pred EEccCCcCC-------------------------------CcCCCC---------------------------c------
Q 042887 312 LFLSKNNLG-------------------------------TESTSD---------------------------L------ 327 (628)
Q Consensus 312 L~L~~n~l~-------------------------------~~~~~~---------------------------~------ 327 (628)
+++.+|... ...... +
T Consensus 229 l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l 308 (635)
T 4g8a_A 229 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNV 308 (635)
T ss_dssp EEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTC
T ss_pred hhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccc
Confidence 333332111 000000 0
Q ss_pred ----------cccccccCCCCCceeecccCCcccccchHHH-------------------hccccccEEEccCCccee--
Q 042887 328 ----------DFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA-------------------NLSAKITVIGMGDNQISG-- 376 (628)
Q Consensus 328 ----------~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~-------------------~~~~~L~~L~l~~n~l~~-- 376 (628)
.....+.....++.|++.+|.+.......+. .+ ++++.+++++|.+..
T Consensus 309 ~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l-~~L~~L~ls~n~l~~~~ 387 (635)
T 4g8a_A 309 SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKG 387 (635)
T ss_dssp SEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC-TTCCEEECCSSCCBEEE
T ss_pred ccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc-cccccchhhcccccccc
Confidence 0011233445677777777765543322111 22 378999999998863
Q ss_pred eCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccC-ccccCCCCCCeEecCCcccccccCCccc
Q 042887 377 TIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTLGNLTLLNRLFLGFNNLQGNVPSSLG 455 (628)
Q Consensus 377 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 455 (628)
..+..+..+.+|+.+++..|.+.. .+..+..+++|+.+++++|......+ ..|..+++++.++++.|.+.+..+..+.
T Consensus 388 ~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~ 466 (635)
T 4g8a_A 388 CCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 466 (635)
T ss_dssp ECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred ccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence 456778889999999999999874 56678899999999999988775544 5678899999999999999999999999
Q ss_pred CCcchhcccceEEcCCCcCc-cccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCC
Q 042887 456 NCQNLMTLSRLLDLSGNLLG-GSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLK 534 (628)
Q Consensus 456 ~l~~L~~l~~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 534 (628)
.++.+ +.|++++|.+. +..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.+++
T Consensus 467 ~~~~L----~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 542 (635)
T 4g8a_A 467 GLSSL----EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 542 (635)
T ss_dssp TCTTC----CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCT
T ss_pred cchhh----hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCC
Confidence 99888 89999999854 45788899999999999999999999999999999999999999999988889999999
Q ss_pred CCCEEECCCCcccccCchhhhcc-cCCCeEeccCCcCcccCC
Q 042887 535 SIKELDLSRNNLSGQIPKYLENL-LFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p 575 (628)
+|++|||++|+|++..|+.+..+ ++|++|++++|++.+...
T Consensus 543 ~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 543 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999999999998 689999999999998765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=338.93 Aligned_cols=347 Identities=26% Similarity=0.355 Sum_probs=224.7
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
..+++++.|+++++.+.. +| .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +.++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 356789999999999875 45 38889999999999999986654 9999999999999999986544 999999999
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
|++++|.++ .++. +..+++|++|++++|.+++. + .+.++++|++|+++ |.+.+.. .+..+++|++|++++|.
T Consensus 117 L~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~ 188 (466)
T 1o6v_A 117 LTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNK 188 (466)
T ss_dssp EECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSC
T ss_pred EECCCCCCC-CChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCc
Confidence 999999998 5554 44699999999999998854 3 58899999999996 4555443 38889999999999998
Q ss_pred CCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccc
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 398 (628)
++.+ ..+..+++|+.|++++|.+.+..+ +..+. +|+.|++++|.+.+. ..+.
T Consensus 189 l~~~--------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~--~~l~--------------- 240 (466)
T 1o6v_A 189 VSDI--------SVLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKDI--GTLA--------------- 240 (466)
T ss_dssp CCCC--------GGGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--GGGG---------------
T ss_pred CCCC--------hhhccCCCCCEEEecCCccccccc--ccccC-CCCEEECCCCCcccc--hhhh---------------
Confidence 8653 235666777777777777665433 22222 455555555554432 2344
Q ss_pred cccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCcccc
Q 042887 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478 (628)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~ 478 (628)
.+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++| +.|++++|++.+..
T Consensus 241 ---------~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L----~~L~L~~n~l~~~~ 303 (466)
T 1o6v_A 241 ---------SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL----TNLELNENQLEDIS 303 (466)
T ss_dssp ---------GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC----SEEECCSSCCSCCG
T ss_pred ---------cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCcc----CeEEcCCCcccCch
Confidence 44455555555555443322 4445555555555555543222 4444444 45555555555332
Q ss_pred chhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhccc
Q 042887 479 PLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558 (628)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (628)
+ +..+++|++|++++|++++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..++
T Consensus 304 ~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~ 375 (466)
T 1o6v_A 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLT 375 (466)
T ss_dssp G--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCT
T ss_pred h--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCC
Confidence 2 4455555555555555554333 44555555555555555532 245555555555555555554444 55555
Q ss_pred CCCeEeccCCcCcc
Q 042887 559 FLAYLNLSYNHFEG 572 (628)
Q Consensus 559 ~L~~L~ls~N~l~~ 572 (628)
+|+.|++++|++++
T Consensus 376 ~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 376 RITQLGLNDQAWTN 389 (466)
T ss_dssp TCCEEECCCEEEEC
T ss_pred CCCEEeccCCcccC
Confidence 55555555555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=338.85 Aligned_cols=346 Identities=25% Similarity=0.353 Sum_probs=287.9
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcE
Q 042887 184 NFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNF 263 (628)
Q Consensus 184 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 263 (628)
.+++++.|+++++.+.. +| .+..+++|++|++++|.+++..+ +.++++|++|++++|.++ .++. +..+++|++
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-cChh--hcCCCCCCE
Confidence 46789999999999984 44 48889999999999999986544 999999999999999998 4554 446999999
Q ss_pred EecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceee
Q 042887 264 LSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLY 343 (628)
Q Consensus 264 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~ 343 (628)
|++++|++++..+ +.++++|++|++++|.+++.. .+..+++|++|+++ |.+.. ...+.++++|+.|+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~--------~~~~~~l~~L~~L~ 183 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTD--------LKPLANLTTLERLD 183 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCC--------CGGGTTCTTCCEEE
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccC--------chhhccCCCCCEEE
Confidence 9999999996543 899999999999999998643 48889999999986 33332 12256667777777
Q ss_pred cccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccc
Q 042887 344 LNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR 423 (628)
Q Consensus 344 l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 423 (628)
+++|.+.+. ..+..+++|+.|++++|.+.+..| ++.+++|++|++++|.++
T Consensus 184 l~~n~l~~~---------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 184 ISSNKVSDI---------------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp CCSSCCCCC---------------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CcCCcCCCC---------------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc
Confidence 777665432 236778888999999998886554 677899999999999998
Q ss_pred cccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCC
Q 042887 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIP 503 (628)
Q Consensus 424 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 503 (628)
+. ..+..+++|+.|++++|++++..+ +..+++| +.|++++|.+++..+ +..+++|++|++++|++++..+
T Consensus 235 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L----~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~ 304 (466)
T 1o6v_A 235 DI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKL----TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304 (466)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC----SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG
T ss_pred cc--hhhhcCCCCCEEECCCCccccchh--hhcCCCC----CEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh
Confidence 53 468899999999999999986655 7788888 899999999996544 8899999999999999996544
Q ss_pred ccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCC
Q 042887 504 VTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNR 583 (628)
Q Consensus 504 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l 583 (628)
+..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| ...++++
T Consensus 305 --~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L 377 (466)
T 1o6v_A 305 --ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRI 377 (466)
T ss_dssp --GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTC
T ss_pred --hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCC
Confidence 7899999999999999997665 78999999999999999965 478999999999999999999888 6678899
Q ss_pred CcccccCCCCCc
Q 042887 584 TGIHLIGNERLC 595 (628)
Q Consensus 584 ~~~~~~~n~~~c 595 (628)
+.+++.+|++..
T Consensus 378 ~~L~l~~n~~~~ 389 (466)
T 1o6v_A 378 TQLGLNDQAWTN 389 (466)
T ss_dssp CEEECCCEEEEC
T ss_pred CEEeccCCcccC
Confidence 999999987654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.65 Aligned_cols=346 Identities=21% Similarity=0.212 Sum_probs=247.5
Q ss_pred CEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccc
Q 042887 213 NYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYK 292 (628)
Q Consensus 213 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 292 (628)
+.++.+++.++ .+|..+. +++++|+|++|.++ .++...+..+++|++|+|++|.+++..|..|.++++|++|++++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 45666666665 3454432 45666666666666 33333333466666666666666665566666666666666666
Q ss_pred ccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCC
Q 042887 293 NHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372 (628)
Q Consensus 293 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n 372 (628)
|+++.+.+..|..+++|++|++++|.+.. ..+..+..+. +|+.|++++|
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------------------~~~~~~~~l~-~L~~L~l~~n 138 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVI------------------------------LLDYMFQDLY-NLKSLEVGDN 138 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCE------------------------------ECTTTTTTCT-TCCEEEECCT
T ss_pred CcCCccCcccccCCCCCCEEECCCCcccc------------------------------CChhHccccc-cCCEEECCCC
Confidence 66665555556666666666666666554 3333333333 5555566666
Q ss_pred cceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCC
Q 042887 373 QISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPS 452 (628)
Q Consensus 373 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 452 (628)
.+.+..+..|.++++|+.|++++|++++..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|...+..|.
T Consensus 139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 218 (477)
T 2id5_A 139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218 (477)
T ss_dssp TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence 66666667777888888888888888766666778888888888888888877777788888888888888777666766
Q ss_pred cccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccC
Q 042887 453 SLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKT 532 (628)
Q Consensus 453 ~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 532 (628)
......+| +.|++++|++++..+..+..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..|..
T Consensus 219 ~~~~~~~L----~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 294 (477)
T 2id5_A 219 NCLYGLNL----TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294 (477)
T ss_dssp TTTTTCCC----SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTT
T ss_pred ccccCccc----cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcC
Confidence 66665666 78888888888655567888899999999999988877888888899999999999998888888888
Q ss_pred CCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCccc
Q 042887 533 LKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~ 597 (628)
+++|+.|+|++|++++..+..|..+++|++|++++|++.+..+....+.......+.++...|..
T Consensus 295 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~ 359 (477)
T 2id5_A 295 LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT 359 (477)
T ss_dssp CTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred cccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCC
Confidence 99999999999999887777888888999999999998876654433334444566677777754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=341.19 Aligned_cols=351 Identities=21% Similarity=0.248 Sum_probs=258.5
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecc
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n 244 (628)
+.++.++++++ .+|..+ .++++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46778888877 455544 358889999999998888888999999999999999998888888999999999999999
Q ss_pred cCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCC
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTEST 324 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 324 (628)
.++ .+|...+..+++|++|+|++|++++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|+++.++.
T Consensus 91 ~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp CCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred cCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 988 6777766678888999998888888888888888899999999998888888888888888888888887765321
Q ss_pred CCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCc
Q 042887 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPH 404 (628)
Q Consensus 325 ~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 404 (628)
..+..++ +|+.|++++|.+.+..+..+..+++|+.|++++|...+.+|.
T Consensus 170 ------~~l~~l~-------------------------~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 218 (477)
T 2id5_A 170 ------EALSHLH-------------------------GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218 (477)
T ss_dssp ------HHHTTCT-------------------------TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred ------hHhcccC-------------------------CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence 1233333 444444445555555556677788888888888877666666
Q ss_pred CCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhc
Q 042887 405 AIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGN 484 (628)
Q Consensus 405 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~ 484 (628)
......+|+.|++++|++++..+..+..+++|+.|++++|++++..+..+.++++| +.|++++|++++..|..|.+
T Consensus 219 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~~~~ 294 (477)
T 2id5_A 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL----QEIQLVGGQLAVVEPYAFRG 294 (477)
T ss_dssp TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTC----CEEECCSSCCSEECTTTBTT
T ss_pred ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccC----CEEECCCCccceECHHHhcC
Confidence 66666688888888888886555677788888888888888887777777777777 77788888887777777777
Q ss_pred cCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhh
Q 042887 485 LRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE 555 (628)
Q Consensus 485 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 555 (628)
+++|++|++++|++++..+..|..+++|++|++++|++...-+ ...-...+..+++.++...-..|..+.
T Consensus 295 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~-~~~~~~~~~~~~~~~~~~~C~~p~~~~ 364 (477)
T 2id5_A 295 LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR-LLWVFRRRWRLNFNRQQPTCATPEFVQ 364 (477)
T ss_dssp CTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG-GHHHHTTTTSSCCTTCCCBEEESGGGT
T ss_pred cccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc-hHhHHhhhhccccCccCceeCCchHHc
Confidence 7888888888888776666667777778888888877764221 111112233344555555444444443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.66 Aligned_cols=368 Identities=22% Similarity=0.274 Sum_probs=212.9
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCC-------------CEEecccCcCcccccccccCCCCCCEeecccccCcc
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSAL-------------EAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSC 224 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-------------~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 224 (628)
++++++|++|++++|.+.+.+|..++.+++| ++|++++|.+++ +|.. .++|++|++++|.+++
T Consensus 30 i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~ 105 (454)
T 1jl5_A 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE 105 (454)
T ss_dssp ----CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS
T ss_pred HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc
Confidence 4566667777777777766666666666553 677777776664 2321 3567777777777764
Q ss_pred cCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccc
Q 042887 225 KLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFN 304 (628)
Q Consensus 225 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 304 (628)
+|.. +++|++|++++|.++ .+|.. .++|++|++++|++++ +| .|+++++|++|++++|+++++ |..
T Consensus 106 -lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~-- 171 (454)
T 1jl5_A 106 -LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL-- 171 (454)
T ss_dssp -CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCC-CCC--
T ss_pred -cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCccc-CCC--
Confidence 4532 366777777777776 34421 2567777777777775 44 477777777777777777653 222
Q ss_pred cCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhc
Q 042887 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKN 384 (628)
Q Consensus 305 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 384 (628)
.++|++|++++|+++.++ .+..+++|+.|++++|.+++... ...+++.|++++|.+. .+| .+..
T Consensus 172 -~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~l~~-----~~~~L~~L~l~~n~l~-~lp-~~~~ 235 (454)
T 1jl5_A 172 -PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKKLPD-----LPLSLESIVAGNNILE-ELP-ELQN 235 (454)
T ss_dssp -CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSSCCC-----CCTTCCEEECCSSCCS-SCC-CCTT
T ss_pred -cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCcCCC-----CcCcccEEECcCCcCC-ccc-ccCC
Confidence 246777777777766532 25566777777777777765321 2236777777777776 445 3677
Q ss_pred cCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhccc
Q 042887 385 LVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLS 464 (628)
Q Consensus 385 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ 464 (628)
+++|+.|++++|++.+ +|.. +++|+.|++++|++++ +|.. .++|++|++++|++++. |.. .++|
T Consensus 236 l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L---- 299 (454)
T 1jl5_A 236 LPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNL---- 299 (454)
T ss_dssp CTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTC----
T ss_pred CCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcC----
Confidence 7777777777777764 3332 3677777777777774 3432 36777777777777652 211 1334
Q ss_pred ceEEcCCCcCccccchhhhcc-CCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCC
Q 042887 465 RLLDLSGNLLGGSIPLEVGNL-RNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSR 543 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (628)
+.|++++|++++. + .+ ++|++|++++|++++ +|.. +++|++|++++|+++ .+|. .+++|++|++++
T Consensus 300 ~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~ 366 (454)
T 1jl5_A 300 YYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEY 366 (454)
T ss_dssp CEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred CEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCC
Confidence 6677777777642 1 22 477778888887775 4433 467778888888777 4554 357778888888
Q ss_pred Ccccc--cCchhhhcc-------------cCCCeEeccCCcCcc--cCCCCCCCCCCCcccccCCCC
Q 042887 544 NNLSG--QIPKYLENL-------------LFLAYLNLSYNHFEG--EVPRKGVFGNRTGIHLIGNER 593 (628)
Q Consensus 544 N~l~~--~~~~~~~~l-------------~~L~~L~ls~N~l~~--~~p~~~~~~~l~~~~~~~n~~ 593 (628)
|++++ .+|.++..+ ++|+.|++++|++++ .+| .+++.+.+.+|..
T Consensus 367 N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP-----~sl~~L~~~~~~~ 428 (454)
T 1jl5_A 367 NPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIP-----ESVEDLRMNSERV 428 (454)
T ss_dssp SCCSSCCCCCTTCCEEECCC-----------------------------------------------
T ss_pred CCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccch-----hhHhheeCcCccc
Confidence 88776 566777666 667777777777776 444 2344455554443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=336.51 Aligned_cols=352 Identities=17% Similarity=0.210 Sum_probs=268.3
Q ss_pred ccccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCC
Q 042887 155 LIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNIS 234 (628)
Q Consensus 155 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~ 234 (628)
...++++++|++||+++|.+++. | .+..+++|++|++++|.+++. | ++.+++|++|++++|.+++. + +++++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence 34567889999999999999975 5 699999999999999999975 3 89999999999999999964 4 89999
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEc
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 314 (628)
+|++|++++|.++ .+| +..+++|++|++++|++++. .++++++|++|++++|+..+.. .+..+++|++|++
T Consensus 107 ~L~~L~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 107 KLTYLNCDTNKLT-KLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177 (457)
T ss_dssp TCCEEECCSSCCS-CCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred cCCEEECCCCcCC-eec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence 9999999999998 465 34699999999999999975 3889999999999999554333 5888999999999
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
++|++++++ +..+++|+.|++++|.+++.. +..++ +++.|++++|++++ +| +..+++|+.|+++
T Consensus 178 s~n~l~~l~---------l~~l~~L~~L~l~~N~l~~~~---l~~l~-~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 178 SFNKITELD---------VSQNKLLNRLNCDTNNITKLD---LNQNI-QLTFLDCSSNKLTE-ID--VTPLTQLTYFDCS 241 (457)
T ss_dssp CSSCCCCCC---------CTTCTTCCEEECCSSCCSCCC---CTTCT-TCSEEECCSSCCSC-CC--CTTCTTCSEEECC
T ss_pred CCCccceec---------cccCCCCCEEECcCCcCCeec---cccCC-CCCEEECcCCcccc-cC--ccccCCCCEEEee
Confidence 999998742 566789999999999998763 44444 78899999999887 44 7788889999999
Q ss_pred cccccccCCcCCCCCC-------CCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceE
Q 042887 395 YNQLTGTIPHAIGELK-------NLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLL 467 (628)
Q Consensus 395 ~n~l~~~~~~~~~~l~-------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L 467 (628)
+|++.+..+..+..+. +|+.|++++|.+.+.+| +..+++|+.|++++|...+.+|... .++ +.|
T Consensus 242 ~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~---~~L----~~L 312 (457)
T 3bz5_A 242 VNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA---AGI----TEL 312 (457)
T ss_dssp SSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT---CCC----SCC
T ss_pred CCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC---Ccc----eEe
Confidence 9988876544433332 33444444444433333 3445555555555555444433211 122 222
Q ss_pred EcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 468 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
+ ++++++|++|++++|++++. .+..+++|+.|++++|++++ ++.|..|++++|.++
T Consensus 313 ~-------------l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~ 368 (457)
T 3bz5_A 313 D-------------LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFE 368 (457)
T ss_dssp C-------------CTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEE
T ss_pred c-------------hhhcccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEE
Confidence 2 33446888899999998874 27888889999999998874 356677788888888
Q ss_pred ccCchhhhcccCCCeEeccCCcCcccCCCC
Q 042887 548 GQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577 (628)
Q Consensus 548 ~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 577 (628)
+. ..+..|+.+++++|+++|.+|..
T Consensus 369 g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 369 AE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp EE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred ec-----ceeeecCccccccCcEEEEcChh
Confidence 65 35667888999999999998853
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.62 Aligned_cols=344 Identities=19% Similarity=0.214 Sum_probs=222.1
Q ss_pred CcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEE
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEII 239 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 239 (628)
.+.+++.|++++|.+....+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46788999999999988888888999999999999999998888899999999999999999998888888999999999
Q ss_pred EeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcC
Q 042887 240 SLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL 319 (628)
Q Consensus 240 ~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l 319 (628)
+|++|.++ .+|..++..+++|++|+|++|.+++..|..|+++++|++|++++|.+++.. +..+++|+.|++++|.+
T Consensus 129 ~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 129 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL 204 (597)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred EeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcc
Confidence 99999998 777777667888888888888888777777888888888888888877542 44556666676666655
Q ss_pred CCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccc
Q 042887 320 GTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399 (628)
Q Consensus 320 ~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 399 (628)
+.+. . .++|+.|++++|.+.
T Consensus 205 ~~l~-----------~-------------------------------------------------~~~L~~L~ls~n~l~ 224 (597)
T 3oja_B 205 STLA-----------I-------------------------------------------------PIAVEELDASHNSIN 224 (597)
T ss_dssp SEEE-----------C-------------------------------------------------CTTCSEEECCSSCCC
T ss_pred cccc-----------C-------------------------------------------------CchhheeeccCCccc
Confidence 3211 0 112333333333333
Q ss_pred ccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccc
Q 042887 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP 479 (628)
Q Consensus 400 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~ 479 (628)
...+.. .++|+.|++++|.+++ +..+..+++|+.|++++|.+++..|..+
T Consensus 225 ~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~------------------------- 274 (597)
T 3oja_B 225 VVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF------------------------- 274 (597)
T ss_dssp EEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGG-------------------------
T ss_pred cccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHh-------------------------
Confidence 221111 1356666666666653 3445555555555555555554444444
Q ss_pred hhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccC
Q 042887 480 LEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559 (628)
Q Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 559 (628)
+.+++|++|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++.. +..+++
T Consensus 275 ---~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~ 346 (597)
T 3oja_B 275 ---VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHT 346 (597)
T ss_dssp ---TTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCC
T ss_pred ---cCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCC
Confidence 444555555555555543 2333444555555555555555 34445555556666666666655332 344556
Q ss_pred CCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCcccCCCCCCCCC
Q 042887 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGLEELHLPSC 606 (628)
Q Consensus 560 L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~~l~l~~c 606 (628)
|+.|++++|++++... ...+..+....+.+++..|+....+....|
T Consensus 347 L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~~~~~~~~~c 392 (597)
T 3oja_B 347 LKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDYQLEHGLC 392 (597)
T ss_dssp CSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCTTCEEETTEE
T ss_pred CCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCcchhccCCcc
Confidence 6666666666655422 122334444455566677765444333333
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=324.33 Aligned_cols=386 Identities=21% Similarity=0.233 Sum_probs=271.6
Q ss_pred cCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCC-------------CEeecccccCcccCC
Q 042887 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSL-------------NYLSISENNFSCKLP 227 (628)
Q Consensus 161 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-------------~~L~Ls~N~i~~~~p 227 (628)
.+.|++|++++|.+ +.+|++++++++|++|++++|.+.+..|..++.+.+| ++|++++|.+++ +|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 46899999999999 7899999999999999999999999999999999875 999999999985 55
Q ss_pred cCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCC
Q 042887 228 LSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLS 307 (628)
Q Consensus 228 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 307 (628)
.. .++|++|++++|.+++ +|.. +++|++|++++|++++. +.. .++|++|++++|++++ .| .|..++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 42 4789999999999994 7752 58999999999999853 221 2799999999999997 45 599999
Q ss_pred CCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCC
Q 042887 308 NLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVN 387 (628)
Q Consensus 308 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~ 387 (628)
+|++|++++|++++++.. .++|+.|++++|.+++.. .+..+. +++.|++++|.+++ +|.. .++
T Consensus 154 ~L~~L~l~~N~l~~lp~~----------~~~L~~L~L~~n~l~~l~--~~~~l~-~L~~L~l~~N~l~~-l~~~---~~~ 216 (454)
T 1jl5_A 154 FLKIIDVDNNSLKKLPDL----------PPSLEFIAAGNNQLEELP--ELQNLP-FLTAIYADNNSLKK-LPDL---PLS 216 (454)
T ss_dssp TCCEEECCSSCCSCCCCC----------CTTCCEEECCSSCCSSCC--CCTTCT-TCCEEECCSSCCSS-CCCC---CTT
T ss_pred CCCEEECCCCcCcccCCC----------cccccEEECcCCcCCcCc--cccCCC-CCCEEECCCCcCCc-CCCC---cCc
Confidence 999999999999875421 248999999999998853 466665 89999999999986 3432 258
Q ss_pred cCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceE
Q 042887 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLL 467 (628)
Q Consensus 388 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L 467 (628)
|+.|++++|.+. .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +|..+ ++| +.|
T Consensus 217 L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~---~~L----~~L 282 (454)
T 1jl5_A 217 LESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP---QSL----TFL 282 (454)
T ss_dssp CCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC---TTC----CEE
T ss_pred ccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCccc---CcC----CEE
Confidence 999999999998 566 48999999999999999985 4543 4899999999999985 55433 455 889
Q ss_pred EcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCC-CCCCeEECcCceeeeecCccccCCCCCCEEECCCCcc
Q 042887 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSAC-TTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546 (628)
Q Consensus 468 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 546 (628)
++++|++++. +. + .++|++|++++|++++. + .+ ++|++|++++|++++ +|.. +++|++|++++|++
T Consensus 283 ~ls~N~l~~l-~~-~--~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l 349 (454)
T 1jl5_A 283 DVSENIFSGL-SE-L--PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHL 349 (454)
T ss_dssp ECCSSCCSEE-SC-C--CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred ECcCCccCcc-cC-c--CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcc
Confidence 9999999863 21 1 26899999999999853 2 23 589999999999995 5654 58999999999999
Q ss_pred cccCchhhhcccCCCeEeccCCcCcc--cCCCC-CCC-------------CCCCcccccCCCCCc-----ccCCCCCCCC
Q 042887 547 SGQIPKYLENLLFLAYLNLSYNHFEG--EVPRK-GVF-------------GNRTGIHLIGNERLC-----GGLEELHLPS 605 (628)
Q Consensus 547 ~~~~~~~~~~l~~L~~L~ls~N~l~~--~~p~~-~~~-------------~~l~~~~~~~n~~~c-----~~~~~l~l~~ 605 (628)
++ +|. .+++|++|++++|++++ .+|.. +.+ ++++.+++++|+... ..+..|.+..
T Consensus 350 ~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~L~~~~ 425 (454)
T 1jl5_A 350 AE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDLRMNS 425 (454)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------------------------------------
T ss_pred cc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhhHhheeCcC
Confidence 95 555 47899999999999999 55532 222 678888888887553 2344556666
Q ss_pred CCCCC
Q 042887 606 CHFGR 610 (628)
Q Consensus 606 c~~~~ 610 (628)
|.+..
T Consensus 426 ~~~~~ 430 (454)
T 1jl5_A 426 ERVVD 430 (454)
T ss_dssp -----
T ss_pred cccCC
Confidence 66533
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.05 Aligned_cols=353 Identities=18% Similarity=0.193 Sum_probs=271.5
Q ss_pred cccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChh
Q 042887 174 LIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLN 253 (628)
Q Consensus 174 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 253 (628)
..+..+..++.+++|++|++++|.+++. | .|+.+++|++|++++|.+++. | ++.+++|++|++++|.++ .+|
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~-~~~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLT-NLD-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS-CCC--
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCc-eee--
Confidence 3445556788999999999999999965 5 799999999999999999964 4 899999999999999998 455
Q ss_pred hhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccc
Q 042887 254 IGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333 (628)
Q Consensus 254 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 333 (628)
+..+++|++|++++|++++. | ++.+++|++|++++|+++++ .+..+++|++|++++|...+. . .+
T Consensus 102 -~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~------~--~~ 166 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITK------L--DV 166 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCC------C--CC
T ss_pred -cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccc------c--cc
Confidence 34699999999999999974 3 89999999999999999975 388899999999999953321 1 35
Q ss_pred cCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCC
Q 042887 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQ 413 (628)
Q Consensus 334 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 413 (628)
..+++|+.|++++|++++.. +..++ +++.|++++|.+++. .+..+++|+.|++++|++++ +| +..+++|+
T Consensus 167 ~~l~~L~~L~ls~n~l~~l~---l~~l~-~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~ 236 (457)
T 3bz5_A 167 TPQTQLTTLDCSFNKITELD---VSQNK-LLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLT 236 (457)
T ss_dssp TTCTTCCEEECCSSCCCCCC---CTTCT-TCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCS
T ss_pred ccCCcCCEEECCCCccceec---cccCC-CCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCC
Confidence 67789999999999988864 44444 788888888888865 37788888888888888886 44 77888888
Q ss_pred eEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeC
Q 042887 414 GLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493 (628)
Q Consensus 414 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 493 (628)
.|++++|++++.. +..+++|+.|++++|++ +.|++++|.+.+.+| ++.+++|+.|++
T Consensus 237 ~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L------------------~~L~l~~n~~~~~~~--~~~l~~L~~L~L 293 (457)
T 3bz5_A 237 YFDCSVNPLTELD---VSTLSKLTTLHCIQTDL------------------LEIDLTHNTQLIYFQ--AEGCRKIKELDV 293 (457)
T ss_dssp EEECCSSCCSCCC---CTTCTTCCEEECTTCCC------------------SCCCCTTCTTCCEEE--CTTCTTCCCCCC
T ss_pred EEEeeCCcCCCcC---HHHCCCCCEEeccCCCC------------------CEEECCCCccCCccc--ccccccCCEEEC
Confidence 8888888888654 34566677777666543 445677776665555 456677777777
Q ss_pred cCCcCcccCCc--------cccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEec
Q 042887 494 SENHFSNEIPV--------TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNL 565 (628)
Q Consensus 494 s~N~l~~~~~~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 565 (628)
++|...+.+|. .+..+++|++|++++|++++. + +..+++|+.|++++|++++ ++.|..|++
T Consensus 294 s~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l 362 (457)
T 3bz5_A 294 THNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPA 362 (457)
T ss_dssp TTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSG
T ss_pred CCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccc
Confidence 77765544432 244557889999999999863 3 7888999999999999885 245667788
Q ss_pred cCCcCcccCCCCCCCCCCCcccccCCCCCcccC
Q 042887 566 SYNHFEGEVPRKGVFGNRTGIHLIGNERLCGGL 598 (628)
Q Consensus 566 s~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~ 598 (628)
++|.++|. +.+..+..++++.|. +.|.+
T Consensus 363 ~~n~l~g~----~~~~~l~~l~l~~N~-l~g~i 390 (457)
T 3bz5_A 363 LNNNFEAE----GQTITMPKETLTNNS-LTIAV 390 (457)
T ss_dssp GGTSEEEE----EEEEECCCBCCBTTB-EEEEC
T ss_pred cCCcEEec----ceeeecCccccccCc-EEEEc
Confidence 99988886 223445566666663 34443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.56 Aligned_cols=312 Identities=23% Similarity=0.239 Sum_probs=228.7
Q ss_pred CcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEE
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEII 239 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 239 (628)
.+.+++.|++++|.++...+..|..+++|++|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46789999999999998777788999999999999999998888899999999999999999998888889999999999
Q ss_pred EeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcC
Q 042887 240 SLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL 319 (628)
Q Consensus 240 ~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l 319 (628)
++++|.++ .+|..++..+++|++|++++|++++..+..|+++++|++|++++|++++. .+..+++|++|++++|.+
T Consensus 123 ~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred ECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 99999998 78888777799999999999999988888899999999999999988754 356677888888888876
Q ss_pred CCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccc
Q 042887 320 GTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399 (628)
Q Consensus 320 ~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 399 (628)
+.+. ..++|+.|++++|. +... |
T Consensus 199 ~~~~-----------~~~~L~~L~l~~n~-------------------------l~~~-~-------------------- 221 (390)
T 3o6n_A 199 STLA-----------IPIAVEELDASHNS-------------------------INVV-R-------------------- 221 (390)
T ss_dssp SEEE-----------CCSSCSEEECCSSC-------------------------CCEE-E--------------------
T ss_pred cccC-----------CCCcceEEECCCCe-------------------------eeec-c--------------------
Confidence 5421 11233344443333 3221 1
Q ss_pred ccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccc
Q 042887 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP 479 (628)
Q Consensus 400 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~ 479 (628)
. ...++|+.|++++|.+++. ..+..+++|++|++++|++++..|..+..+++| +.|++++|++++ ++
T Consensus 222 ----~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L----~~L~L~~n~l~~-~~ 288 (390)
T 3o6n_A 222 ----G--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL----ERLYISNNRLVA-LN 288 (390)
T ss_dssp ----C--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC----CEEECCSSCCCE-EE
T ss_pred ----c--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC----CEEECCCCcCcc-cC
Confidence 0 0123455555555555432 345555555555555555555555555555555 556666666653 34
Q ss_pred hhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccccc
Q 042887 480 LEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ 549 (628)
Q Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (628)
..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++.. + +..+++|+.|++++|+++..
T Consensus 289 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence 44556677777777777777 4555667777888888888887743 3 56778888899999888754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.08 Aligned_cols=335 Identities=19% Similarity=0.200 Sum_probs=262.8
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcE
Q 042887 184 NFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNF 263 (628)
Q Consensus 184 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 263 (628)
.+++++.|++++|.++...+..|..+++|++|++++|.+++..+..|..+++|++|++++|.++ .++...+..+++|++
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCE
Confidence 4689999999999998776677899999999999999999877889999999999999999998 555555556899999
Q ss_pred EecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceee
Q 042887 264 LSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLY 343 (628)
Q Consensus 264 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~ 343 (628)
|++++|+++...+..|+++++|++|++++|++++..+..|..+++|++|++++|+++..+ +.
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------~~--------- 183 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LS--------- 183 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---------GG---------
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---------cc---------
Confidence 999999998666666788999999999999988887777888888888888888775421 11
Q ss_pred cccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccc
Q 042887 344 LNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR 423 (628)
Q Consensus 344 l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 423 (628)
.+++|+.+++++|.+.+. ...++|+.|++++|.+.
T Consensus 184 ----------------------------------------~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~ 218 (390)
T 3o6n_A 184 ----------------------------------------LIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSIN 218 (390)
T ss_dssp ----------------------------------------GCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCC
T ss_pred ----------------------------------------cccccceeeccccccccc-----CCCCcceEEECCCCeee
Confidence 223334444444443321 12346888999999888
Q ss_pred cccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCC
Q 042887 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIP 503 (628)
Q Consensus 424 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 503 (628)
.. |.. ..++|+.|++++|++++. ..+..+++| +.|++++|.+++..|..+..+++|++|++++|++++ +|
T Consensus 219 ~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L----~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~ 288 (390)
T 3o6n_A 219 VV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGL----VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 288 (390)
T ss_dssp EE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTC----SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EE
T ss_pred ec-ccc--ccccccEEECCCCCCccc--HHHcCCCCc----cEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cC
Confidence 54 332 247899999999999853 567777777 889999999998888899999999999999999985 45
Q ss_pred ccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCC
Q 042887 504 VTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNR 583 (628)
Q Consensus 504 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l 583 (628)
..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++... +..+++|+.|++++|++.+... ...+..+
T Consensus 289 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~ 363 (390)
T 3o6n_A 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSL-RALFRNV 363 (390)
T ss_dssp CSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHH-HHHTTTC
T ss_pred cccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccchhH-HHHHHHH
Confidence 66678899999999999998 56777888899999999999998553 6678889999999999987533 2334555
Q ss_pred CcccccCCCCCccc
Q 042887 584 TGIHLIGNERLCGG 597 (628)
Q Consensus 584 ~~~~~~~n~~~c~~ 597 (628)
....+.+++..|..
T Consensus 364 ~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 364 ARPAVDDADQHCKI 377 (390)
T ss_dssp CTTTBCCCCSCCCT
T ss_pred HhhcccccCceecc
Confidence 55566677777753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.56 Aligned_cols=306 Identities=21% Similarity=0.312 Sum_probs=156.8
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
..+++|++|++++|.+... + .+..+++|++|++++|.+++..+ |..+++|++|++++|.++. + ..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~ 114 (347)
T 4fmz_A 41 EELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRE 114 (347)
T ss_dssp HHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSE
T ss_pred hhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCE
Confidence 3455666666666666532 2 25566666666666666654332 6666666666666666553 2 23555555555
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
|++++|.++ .++. +..+++|+.|++++|...... ..+..+++|++|++++|.+.+..+ +..+++|++|++++|.
T Consensus 115 L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 115 LYLNEDNIS-DISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EECcCCccc-Cchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 555555554 2332 223444444444444322111 123333444444444333332211 2223333333333222
Q ss_pred CCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccc
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQL 398 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 398 (628)
+. +.. .+..+++|+.+++++|.+
T Consensus 189 l~-------------------------------------------------------~~~--~~~~l~~L~~L~l~~n~l 211 (347)
T 4fmz_A 189 IE-------------------------------------------------------DIS--PLASLTSLHYFTAYVNQI 211 (347)
T ss_dssp CC-------------------------------------------------------CCG--GGGGCTTCCEEECCSSCC
T ss_pred cc-------------------------------------------------------ccc--cccCCCccceeecccCCC
Confidence 21 111 134445555555555555
Q ss_pred cccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCcccc
Q 042887 399 TGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSI 478 (628)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~ 478 (628)
.+..+ +..+++|++|++++|.+++..+ +..+++|+ .|++++|.+++.
T Consensus 212 ~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~----------------------------~L~l~~n~l~~~- 258 (347)
T 4fmz_A 212 TDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT----------------------------WLEIGTNQISDI- 258 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCC----------------------------EEECCSSCCCCC-
T ss_pred CCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCC----------------------------EEECCCCccCCC-
Confidence 43322 4445555555555555543222 44444444 445555554432
Q ss_pred chhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhccc
Q 042887 479 PLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558 (628)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (628)
..+..+++|++|++++|++++. ..+..+++|++|++++|++++..|..+..+++|++|++++|++++..| +..++
T Consensus 259 -~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~ 333 (347)
T 4fmz_A 259 -NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333 (347)
T ss_dssp -GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCT
T ss_pred -hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhh
Confidence 2455566666666666666643 345666677777777777766666666677777777777777765544 66677
Q ss_pred CCCeEeccCCcCc
Q 042887 559 FLAYLNLSYNHFE 571 (628)
Q Consensus 559 ~L~~L~ls~N~l~ 571 (628)
+|++|++++|+|+
T Consensus 334 ~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 334 KMDSADFANQVIK 346 (347)
T ss_dssp TCSEESSSCC---
T ss_pred ccceeehhhhccc
Confidence 7777777777664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=297.99 Aligned_cols=284 Identities=24% Similarity=0.332 Sum_probs=213.3
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 237 (628)
+..+++|++|++++|.+++..+ +..+++|++|++++|.++.. .+|..+++|++|++++|.+++. +. +..+++|+
T Consensus 62 ~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~ 135 (347)
T 4fmz_A 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDI-SP-LANLTKMY 135 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCC
T ss_pred hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCc-hh-hccCCcee
Confidence 5678899999999999986554 99999999999999999853 4699999999999999999854 43 89999999
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
+|++++|.....++. +..+++|++|++++|.+....+ +..+++|++|++++|.+++..+ +..+++|+.|++++|
T Consensus 136 ~L~l~~n~~~~~~~~--~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 209 (347)
T 4fmz_A 136 SLNLGANHNLSDLSP--LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVN 209 (347)
T ss_dssp EEECTTCTTCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred EEECCCCCCcccccc--hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccC
Confidence 999999976645544 3469999999999999986544 8899999999999999986554 777888888888877
Q ss_pred cCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccc
Q 042887 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397 (628)
Q Consensus 318 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 397 (628)
.+... ..+..+++|+.|++++|.
T Consensus 210 ~l~~~---------------------------------------------------------~~~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 210 QITDI---------------------------------------------------------TPVANMTRLNSLKIGNNK 232 (347)
T ss_dssp CCCCC---------------------------------------------------------GGGGGCTTCCEEECCSSC
T ss_pred CCCCC---------------------------------------------------------chhhcCCcCCEEEccCCc
Confidence 66431 014567788999999999
Q ss_pred ccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc
Q 042887 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477 (628)
Q Consensus 398 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~ 477 (628)
+.+..+ +..+++|++|++++|.+++. +.+..+++|++|++++|++++. ..+..+++| +.|++++|++++.
T Consensus 233 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L----~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 233 ITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL----NSLFLNNNQLGNE 302 (347)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTC----SEEECCSSCCCGG
T ss_pred cCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCC----CEEECcCCcCCCc
Confidence 986544 88999999999999999853 4577788888888888877643 234444444 5555555555555
Q ss_pred cchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 478 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
.+..+..+++|++|++++|++++..| +..+++|++|++++|.|
T Consensus 303 ~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp GHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred ChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 55555555555555555555554333 44455555555555554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=294.61 Aligned_cols=259 Identities=30% Similarity=0.481 Sum_probs=233.4
Q ss_pred CCceeecccCCccc--ccchHHHhccccccEEEccC-CcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCe
Q 042887 338 QMEMLYLNTNKFGG--VFLRSIANLSAKITVIGMGD-NQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQG 414 (628)
Q Consensus 338 ~L~~L~l~~n~~~~--~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 414 (628)
+++.|++++|.+++ ..+..+..+. +|+.|++++ |.+.+.+|..+.++++|++|++++|++.+..|..|..+++|++
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred eEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 56666666666666 5566666665 788888884 8888888999999999999999999999899999999999999
Q ss_pred EecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCc-chhcccceEEcCCCcCccccchhhhccCCCCEeeC
Q 042887 415 LALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQ-NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493 (628)
Q Consensus 415 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 493 (628)
|++++|.+++..|..+..+++|++|++++|++++..|..+..++ +| +.|++++|++++..|..+..++ |++|++
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L----~~L~L~~N~l~~~~~~~~~~l~-L~~L~L 204 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF----TSMTISRNRLTGKIPPTFANLN-LAFVDL 204 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC----CEEECCSSEEEEECCGGGGGCC-CSEEEC
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcC----cEEECcCCeeeccCChHHhCCc-ccEEEC
Confidence 99999999999999999999999999999999999999999887 77 8999999999999999999987 999999
Q ss_pred cCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCccc
Q 042887 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 494 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
++|.+++..|..+..+++|+.|++++|++++.+|. +..+++|++|++++|++++.+|..+..+++|++|++++|+++|.
T Consensus 205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 283 (313)
T 1ogq_A 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred cCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence 99999999999999999999999999999976665 88899999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccccCCCCCcccCCCCCCCCCC
Q 042887 574 VPRKGVFGNRTGIHLIGNERLCGGLEELHLPSCH 607 (628)
Q Consensus 574 ~p~~~~~~~l~~~~~~~n~~~c~~~~~l~l~~c~ 607 (628)
+|..+.+++++.+++.+|+++|+. .++.|.
T Consensus 284 ip~~~~l~~L~~l~l~~N~~lc~~----p~~~C~ 313 (313)
T 1ogq_A 284 IPQGGNLQRFDVSAYANNKCLCGS----PLPACT 313 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEEST----TSSCCC
T ss_pred CCCCccccccChHHhcCCCCccCC----CCCCCC
Confidence 999888999999999999999985 344563
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=332.15 Aligned_cols=380 Identities=16% Similarity=0.155 Sum_probs=228.2
Q ss_pred CcccEEEccCCccccccchh-hhCCCCCCEEecccCcCccc----ccccccCCCCCCEeecccccCcccCCcCcc-CCC-
Q 042887 162 LKLEMIDVGDNQLIGKFPDF-IANFSALEAIDISANMLGGR----IPDSLCQLRSLNYLSISENNFSCKLPLSIW-NIS- 234 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~- 234 (628)
++|++||+++|+++...... +..+++|++|++++|.++.. ++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46788888888887654433 77788888888888887743 355667777788888888777654333322 233
Q ss_pred ---CCCEEEeecccCcc----cCChhhhhCCCCCcEEecccCccccccccccc-----CCCCCCEEEcccccceeecccc
Q 042887 235 ---SLEIISLHSNRFEG----SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS-----NASNLQVLDVYKNHFSGQVKID 302 (628)
Q Consensus 235 ---~L~~L~L~~n~l~~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~i~~~~~~~ 302 (628)
+|++|++++|.+++ .++..+ ..+++|++|++++|.+++..+..+. ..++|++|++++|++++....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l-~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTL-RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHT-TSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHH-ccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH-
Confidence 56666666666652 122222 2355555555555555433222221 133455555555554432211
Q ss_pred cccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHh----ccccccEEEccCCcceee-
Q 042887 303 FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIAN----LSAKITVIGMGDNQISGT- 377 (628)
Q Consensus 303 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~----~~~~L~~L~l~~n~l~~~- 377 (628)
.....+..+++|+.|++++|.++......+.. ..++++.|++++|.+++.
T Consensus 161 -------------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 161 -------------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp -------------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred -------------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 11222333444455555555444433333322 112556666666655542
Q ss_pred ---CchhhhccCCcCeeeeccccccccC-----CcCCCCCCCCCeEecccCccccc----cCccccCCCCCCeEecCCcc
Q 042887 378 ---IPSEIKNLVNINAFGVEYNQLTGTI-----PHAIGELKNLQGLALVRNSLRGT----IPDTLGNLTLLNRLFLGFNN 445 (628)
Q Consensus 378 ---~~~~l~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~ 445 (628)
++..+..+++|+.|++++|.+.+.. +..+..+++|++|++++|.+++. ++..+..+++|++|++++|.
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 3455667778888888888776432 22334577888888888888753 46666778888888888888
Q ss_pred cccccCCcccCC-----cchhcccceEEcCCCcCccc----cchhhhccCCCCEeeCcCCcCcccCCccccC-----CCC
Q 042887 446 LQGNVPSSLGNC-----QNLMTLSRLLDLSGNLLGGS----IPLEVGNLRNLAEFDLSENHFSNEIPVTLSA-----CTT 511 (628)
Q Consensus 446 l~~~~~~~~~~l-----~~L~~l~~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~ 511 (628)
+++..+..+... ++| +.|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. .++
T Consensus 296 i~~~~~~~l~~~l~~~~~~L----~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~ 371 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQL----ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCC----CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred CchHHHHHHHHHhccCCccc----eeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCc
Confidence 765544433322 345 7778888887754 3455666788888888888877654444432 567
Q ss_pred CCeEECcCceeee----ecCccccCCCCCCEEECCCCcccccCchhhh-----cccCCCeEeccCCcCcc
Q 042887 512 LEYLHLQGNSFSG----SLPLSLKTLKSIKELDLSRNNLSGQIPKYLE-----NLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 512 L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~ls~N~l~~ 572 (628)
|++|++++|.+++ .+|..+..+++|++|++++|++++.....+. ....|+.|++.++.+..
T Consensus 372 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred eEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 8888888888775 5667777778888888888887754333332 12357777777766654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.89 Aligned_cols=311 Identities=19% Similarity=0.201 Sum_probs=218.2
Q ss_pred CCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEE
Q 042887 234 SSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLF 313 (628)
Q Consensus 234 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 313 (628)
.+++.|++++|.+. .+|..++..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..+..|+.+++|++|+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 44555555555554 44554444455555555555555555555555666666666666666555555555566666666
Q ss_pred ccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeee
Q 042887 314 LSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGV 393 (628)
Q Consensus 314 L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 393 (628)
+++|.++.++.. .+.++++|+.|++++| .+.+..|..+..+++|+.|++
T Consensus 130 L~~n~l~~l~~~------~~~~l~~L~~L~Ls~N-------------------------~l~~~~~~~~~~l~~L~~L~L 178 (597)
T 3oja_B 130 LERNDLSSLPRG------IFHNTPKLTTLSMSNN-------------------------NLERIEDDTFQATTSLQNLQL 178 (597)
T ss_dssp CCSSCCCCCCTT------TTTTCTTCCEEECCSS-------------------------CCCBCCTTTTTTCTTCCEEEC
T ss_pred eeCCCCCCCCHH------HhccCCCCCEEEeeCC-------------------------cCCCCChhhhhcCCcCcEEEC
Confidence 666655543322 1222333333333333 333344455666667777777
Q ss_pred ccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCc
Q 042887 394 EYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473 (628)
Q Consensus 394 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~ 473 (628)
++|.+.+.. +..+++|+.|++++|.+++ +...++|+.|++++|.++...+... ++| +.|++++|.
T Consensus 179 ~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~~---~~L----~~L~L~~n~ 243 (597)
T 3oja_B 179 SSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPVN---VEL----TILKLQHNN 243 (597)
T ss_dssp TTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSCC---SCC----CEEECCSSC
T ss_pred cCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccccC---CCC----CEEECCCCC
Confidence 777766432 4456777888888887764 2344678888888888875444332 345 788999999
Q ss_pred CccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchh
Q 042887 474 LGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY 553 (628)
Q Consensus 474 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 553 (628)
+++ +..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..
T Consensus 244 l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 319 (597)
T 3oja_B 244 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 319 (597)
T ss_dssp CCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred CCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcc
Confidence 985 4678999999999999999999999999999999999999999995 5777788999999999999999 57788
Q ss_pred hhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCccc
Q 042887 554 LENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 554 ~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~ 597 (628)
+..+++|+.|++++|++++.. ...+++++.+++++|++.|..
T Consensus 320 ~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 320 QPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp HHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred cccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChh
Confidence 899999999999999998753 456789999999999999853
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=283.23 Aligned_cols=288 Identities=22% Similarity=0.259 Sum_probs=215.3
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEc
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 314 (628)
+++.++++++.++ .+|..+ .++|+.|++++|.+++..|..|.++++|++|++++|++++..+..|..+++|++|++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCC---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 4667777777766 666554 356777777777777666777788888888888888887777777888888888888
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
++|+++.++...+ + +++.|++++|.+.+..+..+..+++|+.|+++
T Consensus 110 ~~n~l~~l~~~~~---------~-------------------------~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 110 SKNHLVEIPPNLP---------S-------------------------SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CSSCCCSCCSSCC---------T-------------------------TCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred CCCcCCccCcccc---------c-------------------------cCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence 8887765432210 2 34444445555554455567777888888888
Q ss_pred cccccc--cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCC
Q 042887 395 YNQLTG--TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472 (628)
Q Consensus 395 ~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N 472 (628)
+|.+.. ..+..+..+ +|++|++++|++++ +|..+. ++|++|++++|++++..+..+..+++| +.|++++|
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L----~~L~L~~N 227 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKL----YRLGLGHN 227 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTC----SCCBCCSS
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCC----CEEECCCC
Confidence 887753 566777777 88888888888885 454443 688888888888887777888888887 78888999
Q ss_pred cCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccC------CCCCCEEECCCCcc
Q 042887 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKT------LKSIKELDLSRNNL 546 (628)
Q Consensus 473 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l 546 (628)
++++..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..|.. .++|+.|++++|++
T Consensus 228 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~ 306 (332)
T 2ft3_A 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306 (332)
T ss_dssp CCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSS
T ss_pred cCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcc
Confidence 888777778888899999999999988 67777888899999999999998766666654 36788999999998
Q ss_pred c--ccCchhhhcccCCCeEeccCCc
Q 042887 547 S--GQIPKYLENLLFLAYLNLSYNH 569 (628)
Q Consensus 547 ~--~~~~~~~~~l~~L~~L~ls~N~ 569 (628)
. ...|..|..+++|+.+++++|+
T Consensus 307 ~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 307 PYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccCcccccccchhhhhhccccc
Confidence 7 6778889999999999998885
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=282.41 Aligned_cols=296 Identities=18% Similarity=0.235 Sum_probs=216.5
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
.+++.++++++.++. +|..+. +++++|++++|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|++
T Consensus 31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 368899999999984 555443 68999999999999888889999999999999999999888999999999999999
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccccccee--ecccccccCCCCCEEEccCCcC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG--QVKIDFNRLSNLSRLFLSKNNL 319 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~n~l 319 (628)
++|.++ .+|..++ ++|++|++++|++++..+..|.++++|++|++++|.++. ..+..|..+++|++|++++|.+
T Consensus 108 s~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 108 SKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 999998 7887664 789999999999998888889999999999999999864 5667788889999999998888
Q ss_pred CCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccc
Q 042887 320 GTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLT 399 (628)
Q Consensus 320 ~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 399 (628)
+.++... .+ +++.|++++|.+++..+..+..+++|+.|++++|.+.
T Consensus 184 ~~l~~~~---------~~-------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 184 TTIPQGL---------PP-------------------------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp CSCCSSC---------CT-------------------------TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ccCCccc---------cc-------------------------cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 6543210 01 4555555555555555666667777777777777776
Q ss_pred ccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccc
Q 042887 400 GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP 479 (628)
Q Consensus 400 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~ 479 (628)
+..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..|.....
T Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~-------------------- 288 (330)
T 1xku_A 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY-------------------- 288 (330)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC--------------------
T ss_pred eeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccc--------------------
Confidence 666666667777777777777776 55666666777777777777776554444432210
Q ss_pred hhhhccCCCCEeeCcCCcCcc--cCCccccCCCCCCeEECcCce
Q 042887 480 LEVGNLRNLAEFDLSENHFSN--EIPVTLSACTTLEYLHLQGNS 521 (628)
Q Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~ 521 (628)
....+.|+.|++++|.+.. ..|..|..+.+++.++|++|+
T Consensus 289 --~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 289 --NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp --CTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred --ccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 0112455666666666542 345566666666666666664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=281.56 Aligned_cols=289 Identities=22% Similarity=0.251 Sum_probs=178.6
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEc
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 314 (628)
+++.++++++.++ .+|..+ .+++++|++++|++++..+..|+++++|++|++++|++++..+..|..+++|++|++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccC---CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 3455555555554 444433 245556666666666555555666666666666666666665666666666666666
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
++|+++.++... .++|+.|++++|. +.+..+..+.++++|+.|+++
T Consensus 108 s~n~l~~l~~~~---------~~~L~~L~l~~n~-------------------------l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 108 SKNQLKELPEKM---------PKTLQELRVHENE-------------------------ITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CSSCCSBCCSSC---------CTTCCEEECCSSC-------------------------CCBBCHHHHTTCTTCCEEECC
T ss_pred CCCcCCccChhh---------cccccEEECCCCc-------------------------ccccCHhHhcCCccccEEECC
Confidence 666665433211 0234444444443 333334445555666666666
Q ss_pred cccccc--cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCC
Q 042887 395 YNQLTG--TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472 (628)
Q Consensus 395 ~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N 472 (628)
+|.+.. ..+..+..+++|++|++++|.+++ +|..+. ++|++|++++|++++..|..+..+++| +.|++++|
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~Ls~n 226 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNL----AKLGLSFN 226 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTC----CEEECCSS
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCC----CEEECCCC
Confidence 665542 445556666666677776666663 333332 567777777777776666666666666 66777777
Q ss_pred cCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccC------CCCCCEEECCCCcc
Q 042887 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKT------LKSIKELDLSRNNL 546 (628)
Q Consensus 473 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l 546 (628)
++++..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..|.. .+.|+.|++++|++
T Consensus 227 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~ 305 (330)
T 1xku_A 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305 (330)
T ss_dssp CCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred cCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcc
Confidence 777666666777777777777777777 56666777777777777777777655555543 36778888888887
Q ss_pred cc--cCchhhhcccCCCeEeccCCc
Q 042887 547 SG--QIPKYLENLLFLAYLNLSYNH 569 (628)
Q Consensus 547 ~~--~~~~~~~~l~~L~~L~ls~N~ 569 (628)
.. ..|..|..+..++.+++++|+
T Consensus 306 ~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 306 QYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CGGGSCGGGGTTCCCGGGEEC----
T ss_pred cccccCccccccccceeEEEecccC
Confidence 63 556778888888888888874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=284.53 Aligned_cols=294 Identities=18% Similarity=0.197 Sum_probs=191.7
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
+++.++++++.++ .+|..+ .++|++|++++|.+++..|..|..+++|++|++++|.+++..|..|.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 6889999999987 456544 3689999999999998888889999999999999999998888899999999999999
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccccccee--ecccccccCCCCCEEEccCCcCC
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG--QVKIDFNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~n~l~ 320 (628)
+|.++ .+|..++ ++|++|++++|+++...+..|.++++|++|++++|.++. ..+..|..+ +|++|++++|+++
T Consensus 111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 111 KNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp SSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 99998 7777654 788888888888887766778888888888888888853 455566665 6777777777665
Q ss_pred CcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccc
Q 042887 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400 (628)
Q Consensus 321 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 400 (628)
.++... .+ +++.|++++|.+.+..+..+..+++|+.|++++|++.+
T Consensus 186 ~l~~~~---------~~-------------------------~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 186 GIPKDL---------PE-------------------------TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp SCCSSS---------CS-------------------------SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred ccCccc---------cC-------------------------CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 432210 01 23333333333333334445555555555555555554
Q ss_pred cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccch
Q 042887 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL 480 (628)
Q Consensus 401 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~ 480 (628)
..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..+.....
T Consensus 232 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~--------------------- 289 (332)
T 2ft3_A 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF--------------------- 289 (332)
T ss_dssp CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC---------------------
T ss_pred CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc---------------------
Confidence 44445555555555555555555 34444555555555555555555443333332110
Q ss_pred hhhccCCCCEeeCcCCcCc--ccCCccccCCCCCCeEECcCce
Q 042887 481 EVGNLRNLAEFDLSENHFS--NEIPVTLSACTTLEYLHLQGNS 521 (628)
Q Consensus 481 ~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~ 521 (628)
-...+.|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 290 -~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 290 -GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp -CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred -ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 001245666777777665 4555666667777777777664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.48 Aligned_cols=372 Identities=17% Similarity=0.157 Sum_probs=250.1
Q ss_pred cCCcCcccEEEccCCcccc----ccchhhhCCCCCCEEecccCcCcccccccc-cCCC----CCCEeecccccCcc----
Q 042887 158 RLNLLKLEMIDVGDNQLIG----KFPDFIANFSALEAIDISANMLGGRIPDSL-CQLR----SLNYLSISENNFSC---- 224 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~----~L~~L~Ls~N~i~~---- 224 (628)
+..+++|++|++++|+++. .+++.+..+++|++|++++|.+....+..+ ..++ +|++|+|++|.++.
T Consensus 24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~ 103 (461)
T 1z7x_W 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103 (461)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence 3467789999999999985 356778889999999999999986555444 3455 79999999999984
Q ss_pred cCCcCccCCCCCCEEEeecccCcccCChhhhh----CCCCCcEEecccCcccccc----cccccCCCCCCEEEcccccce
Q 042887 225 KLPLSIWNISSLEIISLHSNRFEGSLPLNIGF----NIPNVNFLSVGQNNFTGSL----PHSFSNASNLQVLDVYKNHFS 296 (628)
Q Consensus 225 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~ 296 (628)
.++..+..+++|++|++++|.+++..+..+.. ..++|++|++++|++++.. +..+..+++|++|++++|.++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 45888999999999999999997544443332 3568999999999999743 566778899999999999997
Q ss_pred eeccccccc-----CCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccC
Q 042887 297 GQVKIDFNR-----LSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGD 371 (628)
Q Consensus 297 ~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~ 371 (628)
......+.. .++|++|++++|.++..... ..+..+..+++|+.|++++|.++......+..
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~------------ 249 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--DLCGIVASKASLRELALGSNKLGDVGMAELCP------------ 249 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH------------
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--HHHHHHHhCCCccEEeccCCcCChHHHHHHHH------------
Confidence 665555442 56999999999988753211 13445666788888888888876654443332
Q ss_pred CcceeeCchhhhccCCcCeeeecccccccc----CCcCCCCCCCCCeEecccCccccccCccccC-----CCCCCeEecC
Q 042887 372 NQISGTIPSEIKNLVNINAFGVEYNQLTGT----IPHAIGELKNLQGLALVRNSLRGTIPDTLGN-----LTLLNRLFLG 442 (628)
Q Consensus 372 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~ 442 (628)
..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. .++|++|+++
T Consensus 250 --------~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 250 --------GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp --------HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred --------HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 1112344455555555554432 2333444555555666655555433322222 2466666666
Q ss_pred Ccccccc----cCCcccCCcchhcccceEEcCCCcCccccchhhhc-----cCCCCEeeCcCCcCcc----cCCccccCC
Q 042887 443 FNNLQGN----VPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGN-----LRNLAEFDLSENHFSN----EIPVTLSAC 509 (628)
Q Consensus 443 ~N~l~~~----~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l 509 (628)
+|.+++. .+..+..+++| +.|++++|.+++..+..+.. .++|++|++++|++++ .+|..+..+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L----~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 397 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFL----LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSC----CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred CCCCchHHHHHHHHHHhhCCCc----cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence 6666543 23334444555 66677777666544444432 5678888888888875 566677777
Q ss_pred CCCCeEECcCceeeeecCccc-----cCCCCCCEEECCCCcccccCchhhh
Q 042887 510 TTLEYLHLQGNSFSGSLPLSL-----KTLKSIKELDLSRNNLSGQIPKYLE 555 (628)
Q Consensus 510 ~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~~~~~ 555 (628)
++|++|++++|++++.....+ ....+|+.|++.++.+....++.+.
T Consensus 398 ~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l~ 448 (461)
T 1z7x_W 398 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ 448 (461)
T ss_dssp CCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHHH
Confidence 888888888888775322111 1245688888888877655554443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.19 Aligned_cols=185 Identities=30% Similarity=0.532 Sum_probs=131.7
Q ss_pred hhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCC-CCCeEecCCcccccccCCcccCCcc
Q 042887 381 EIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLT-LLNRLFLGFNNLQGNVPSSLGNCQN 459 (628)
Q Consensus 381 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~ 459 (628)
.+.++++|++|++++|.+.+..|..+..+++|++|++++|++++..|..+..++ +|++|++++|++++..|..+..++
T Consensus 120 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~- 198 (313)
T 1ogq_A 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN- 198 (313)
T ss_dssp GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-
T ss_pred HHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-
Confidence 344444444444444444444555555555666666666666655666666665 666666666666666666666654
Q ss_pred hhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEE
Q 042887 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKEL 539 (628)
Q Consensus 460 L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 539 (628)
| +.|++++|++++..|..+..+++|++|++++|++++..|. +..+++|++|++++|++++.+|..+..+++|++|
T Consensus 199 L----~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 273 (313)
T 1ogq_A 199 L----AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273 (313)
T ss_dssp C----SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEE
T ss_pred c----cEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEE
Confidence 4 6777777777777777777888888888888888765554 6778888888888888888888888888888888
Q ss_pred ECCCCcccccCchhhhcccCCCeEeccCCc-Ccc
Q 042887 540 DLSRNNLSGQIPKYLENLLFLAYLNLSYNH-FEG 572 (628)
Q Consensus 540 ~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~-l~~ 572 (628)
++++|++++.+|+. ..+++|+.+++++|+ ++|
T Consensus 274 ~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 274 NVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp ECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred ECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 88888888888876 778888899999888 555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=268.64 Aligned_cols=278 Identities=21% Similarity=0.196 Sum_probs=166.9
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEc
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 314 (628)
.....++++|.++ .+|..+ .++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++
T Consensus 32 ~~~~c~~~~~~l~-~iP~~~---~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 32 RNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp TTSEEECCSTTCS-SCCTTC---CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCeEeeCCCCCcc-cccccc---cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 3344555666665 555544 245666666666666555556666666666666666666666666666666666666
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
++|+++.++ +..+.++++|++|+++
T Consensus 108 s~n~l~~~~-------------------------------------------------------~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 108 SYNYLSNLS-------------------------------------------------------SSWFKPLSSLTFLNLL 132 (353)
T ss_dssp CSSCCSSCC-------------------------------------------------------HHHHTTCTTCSEEECT
T ss_pred CCCcCCcCC-------------------------------------------------------HhHhCCCccCCEEECC
Confidence 666554311 1123334444444444
Q ss_pred cccccccCC-cCCCCCCCCCeEecccC-ccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCC
Q 042887 395 YNQLTGTIP-HAIGELKNLQGLALVRN-SLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472 (628)
Q Consensus 395 ~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N 472 (628)
+|++.+..+ ..+..+++|++|++++| .+.+..+..|..+++|++|++++|++++..|..+..+++| +.|++++|
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L----~~L~l~~n 208 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV----SHLILHMK 208 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE----EEEEEECS
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccC----CeecCCCC
Confidence 444443222 24555555555555555 3444445555556666666666666665556666666655 56666666
Q ss_pred cCccccchhhhccCCCCEeeCcCCcCcccCCcccc---CCCCCCeEECcCceeee----ecCccccCCCCCCEEECCCCc
Q 042887 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLS---ACTTLEYLHLQGNSFSG----SLPLSLKTLKSIKELDLSRNN 545 (628)
Q Consensus 473 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~ 545 (628)
++....+..+..+++|++|++++|++++..+..+. ..+.++.+++++|.+.+ .+|..+..+++|++|++++|+
T Consensus 209 ~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~ 288 (353)
T 2z80_A 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQ 288 (353)
T ss_dssp CSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSC
T ss_pred ccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCC
Confidence 66543333344567777777777777654443332 34567777777777764 356677788888888888888
Q ss_pred ccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 546 LSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 546 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
++...+..|..+++|++|++++|++++.+|
T Consensus 289 l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 289 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 885444446788888888888888887766
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=256.70 Aligned_cols=190 Identities=21% Similarity=0.238 Sum_probs=125.5
Q ss_pred hccCCcCeeeeccccccccCC-cCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccccc-ccCCcccCCcch
Q 042887 383 KNLVNINAFGVEYNQLTGTIP-HAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG-NVPSSLGNCQNL 460 (628)
Q Consensus 383 ~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L 460 (628)
..+++|+.|++++|++.+..+ ..+..+++|++|++++|.+.+..+..+..+++|++|++++|.+++ ..|..+..+++|
T Consensus 98 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 177 (306)
T 2z66_A 98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177 (306)
T ss_dssp ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCC
Confidence 334444444444444443332 345556666666666666666666666666667777777776664 456666666666
Q ss_pred hcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCC-CCCEE
Q 042887 461 MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLK-SIKEL 539 (628)
Q Consensus 461 ~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L 539 (628)
+.|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|++++..|..+..++ +|++|
T Consensus 178 ----~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 253 (306)
T 2z66_A 178 ----TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253 (306)
T ss_dssp ----CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEE
T ss_pred ----CEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEE
Confidence 6677777777766677777777888888888888766666777788888888888888877777777774 78888
Q ss_pred ECCCCcccccCc--hhhhcccCCCeEeccCCcCcccCCC
Q 042887 540 DLSRNNLSGQIP--KYLENLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 540 ~Ls~N~l~~~~~--~~~~~l~~L~~L~ls~N~l~~~~p~ 576 (628)
++++|++++..+ .....+...+.+.+..+.+.+..|.
T Consensus 254 ~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 254 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp ECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred EccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 888888875422 2233344455566666666665553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-30 Score=260.76 Aligned_cols=278 Identities=18% Similarity=0.162 Sum_probs=185.1
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
....|.++|+++. +|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+++..|..|.++++|++|++++
T Consensus 33 ~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 3457888888874 555443 4888888888888877777888888888888888888877788888888888888888
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCccccccc-ccccCCCCCCEEEcccc-cceeecccccccCCCCCEEEccCCcCCC
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLP-HSFSNASNLQVLDVYKN-HFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
|.++ .+|...+..+++|++|++++|+++...+ ..|.++++|++|++++| .++...+..|..+++|++|++++|.++.
T Consensus 110 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (353)
T 2z80_A 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188 (353)
T ss_dssp SCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence 8888 6777766678888888888888885544 47888888888888888 4777777788888888888888888876
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccccc
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGT 401 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 401 (628)
.. +..+..+++|+.|++++|.++......+.... +++.|++++|.+++..+..+..
T Consensus 189 ~~------~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~l~~----------------- 244 (353)
T 2z80_A 189 YE------PKSLKSIQNVSHLILHMKQHILLLEIFVDVTS-SVECLELRDTDLDTFHFSELST----------------- 244 (353)
T ss_dssp EC------TTTTTTCSEEEEEEEECSCSTTHHHHHHHHTT-TEEEEEEESCBCTTCCCC---------------------
T ss_pred cC------HHHHhccccCCeecCCCCccccchhhhhhhcc-cccEEECCCCcccccccccccc-----------------
Confidence 43 23455667777777777776544333332232 5666666666555433322211
Q ss_pred CCcCCCCCCCCCeEecccCcccc----ccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc
Q 042887 402 IPHAIGELKNLQGLALVRNSLRG----TIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477 (628)
Q Consensus 402 ~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~ 477 (628)
......++.++++++.+.+ .+|..+..+++|++|++++|+++...+..+..+++| +.|++++|.+.+.
T Consensus 245 ----~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L----~~L~L~~N~~~~~ 316 (353)
T 2z80_A 245 ----GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSL----QKIWLHTNPWDCS 316 (353)
T ss_dssp ------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTC----CEEECCSSCBCCC
T ss_pred ----ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCC----CEEEeeCCCccCc
Confidence 1122334444444444443 244555566666666666666653222224555555 5566666666543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=254.03 Aligned_cols=263 Identities=22% Similarity=0.245 Sum_probs=146.9
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCccccc--ccccccCCCCCCEEEcccccceeecccccccCCCCCEE
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGS--LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRL 312 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 312 (628)
+|++|++++|.++ .+|..++..+++|++|++++|+++.. .+..+..+++|++|++++|.++.. +..+..+++|++|
T Consensus 29 ~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l-~~~~~~l~~L~~L 106 (306)
T 2z66_A 29 SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHL 106 (306)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEE-EEEEETCTTCCEE
T ss_pred CCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccC-hhhcCCCCCCCEE
Confidence 4444444444444 44444433444555555555544422 134444556666666666665532 3335555555555
Q ss_pred EccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeee
Q 042887 313 FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFG 392 (628)
Q Consensus 313 ~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 392 (628)
++++|+++.... ...+..+++|++|+
T Consensus 107 ~l~~n~l~~~~~------------------------------------------------------~~~~~~l~~L~~L~ 132 (306)
T 2z66_A 107 DFQHSNLKQMSE------------------------------------------------------FSVFLSLRNLIYLD 132 (306)
T ss_dssp ECTTSEEESSTT------------------------------------------------------TTTTTTCTTCCEEE
T ss_pred ECCCCccccccc------------------------------------------------------chhhhhccCCCEEE
Confidence 555555443211 01233344444444
Q ss_pred eccccccccCCcCCCCCCCCCeEecccCcccc-ccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCC
Q 042887 393 VEYNQLTGTIPHAIGELKNLQGLALVRNSLRG-TIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471 (628)
Q Consensus 393 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~ 471 (628)
+++|.+.+..+..+..+++|++|++++|.+++ ..|..+..+++|++|++++|++++..|..+..+++| +.|++++
T Consensus 133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L----~~L~L~~ 208 (306)
T 2z66_A 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL----QVLNMSH 208 (306)
T ss_dssp CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC----CEEECTT
T ss_pred CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCC----CEEECCC
Confidence 44444444444555555556666666665554 355556666666666666666665556666666666 6666666
Q ss_pred CcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCC-CCCeEECcCceeeeecC--ccccCCCCCCEEECCCCcccc
Q 042887 472 NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT-TLEYLHLQGNSFSGSLP--LSLKTLKSIKELDLSRNNLSG 548 (628)
Q Consensus 472 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~ 548 (628)
|++++..+..+..+++|++|++++|++++..|..+..++ +|++|++++|++++.-+ .....+...+.+.+..+.+..
T Consensus 209 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C 288 (306)
T 2z66_A 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMEC 288 (306)
T ss_dssp SCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBE
T ss_pred CccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcccccccc
Confidence 666655555667777777777777777777777777763 77777777777764321 111223344455566677776
Q ss_pred cCchhhhcc
Q 042887 549 QIPKYLENL 557 (628)
Q Consensus 549 ~~~~~~~~l 557 (628)
..|+.+.+.
T Consensus 289 ~~p~~~~g~ 297 (306)
T 2z66_A 289 ATPSDKQGM 297 (306)
T ss_dssp EESGGGTTC
T ss_pred CCchhhCCc
Confidence 667666654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=250.72 Aligned_cols=231 Identities=24% Similarity=0.219 Sum_probs=179.3
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCc-cccccCccccCCCCCCeEec
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNS-LRGTIPDTLGNLTLLNRLFL 441 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 441 (628)
+++.|++++|.+++..+..+..+++|++|++++|.+.+..|..|..+++|++|++++|. +++..|..|..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 56667777777776666777888888888888888887777788888888888888886 77666777888888888888
Q ss_pred CCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCce
Q 042887 442 GFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521 (628)
Q Consensus 442 ~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 521 (628)
++|++++..|..+.++++| +.|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|+
T Consensus 113 ~~n~l~~~~~~~~~~l~~L----~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 188 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAAL----QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTC----CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCcCCEECHhHhhCCcCC----CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCc
Confidence 8888887777777777777 778888888886666678888888888888888887666678888888888888888
Q ss_pred eeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCccc
Q 042887 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 522 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~ 597 (628)
+++..|..+..+++|+.|++++|++++..++.+..+++|++|++++|++.+..+.......++......+...|..
T Consensus 189 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~ 264 (285)
T 1ozn_A 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred ccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCC
Confidence 8877788888888888888888888877777788888888888888888876654333333444445556666653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-31 Score=291.60 Aligned_cols=403 Identities=12% Similarity=0.077 Sum_probs=289.6
Q ss_pred CcCcccEEEccCCccc---cccc------------hhhhCCCCCCEEecccCcCcccccccccCC--CCCCEeeccccc-
Q 042887 160 NLLKLEMIDVGDNQLI---GKFP------------DFIANFSALEAIDISANMLGGRIPDSLCQL--RSLNYLSISENN- 221 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~---~~~~------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~N~- 221 (628)
.+++|+.|+++++... +.+| .....+++|++|+|++|.+++..+..+... .+|++|+|++|.
T Consensus 71 ~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~ 150 (592)
T 3ogk_B 71 RFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSG 150 (592)
T ss_dssp HCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEE
T ss_pred hCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCC
Confidence 4567899999774321 1222 223378999999999998887777777664 459999999886
Q ss_pred Ccc-cCCcCccCCCCCCEEEeecccCcccCCh---hhhhCCCCCcEEecccCccc----ccccccccCCCCCCEEEcccc
Q 042887 222 FSC-KLPLSIWNISSLEIISLHSNRFEGSLPL---NIGFNIPNVNFLSVGQNNFT----GSLPHSFSNASNLQVLDVYKN 293 (628)
Q Consensus 222 i~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N 293 (628)
++. .++.....+++|++|+|++|.+++.-.. .+...+++|++|++++|.++ ...+..+.++++|++|++++|
T Consensus 151 ~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~ 230 (592)
T 3ogk_B 151 FTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF 230 (592)
T ss_dssp EEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSC
T ss_pred cCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCc
Confidence 221 1222334789999999999988754221 23345899999999999987 344555678899999999999
Q ss_pred cceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCc
Q 042887 294 HFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQ 373 (628)
Q Consensus 294 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~ 373 (628)
.+.+ .+..+..+++|++|+++........ ......+..+++|+.++++++.. ...+..+...+ +|+.|++++|.
T Consensus 231 ~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~-~L~~L~Ls~~~ 304 (592)
T 3ogk_B 231 EILE-LVGFFKAAANLEEFCGGSLNEDIGM---PEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAA-QIRKLDLLYAL 304 (592)
T ss_dssp BGGG-GHHHHHHCTTCCEEEECBCCCCTTC---TTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGG-GCCEEEETTCC
T ss_pred cHHH-HHHHHhhhhHHHhhcccccccccch---HHHHHHhhccccccccCccccch-hHHHHHHhhcC-CCcEEecCCCc
Confidence 9886 4567888999999999864322111 12334567778999999887532 22333344444 89999999999
Q ss_pred ceeeCc-hhhhccCCcCeeeeccccccc-cCCcCCCCCCCCCeEecc-----------cCcccccc-CccccCCCCCCeE
Q 042887 374 ISGTIP-SEIKNLVNINAFGVEYNQLTG-TIPHAIGELKNLQGLALV-----------RNSLRGTI-PDTLGNLTLLNRL 439 (628)
Q Consensus 374 l~~~~~-~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~-----------~n~l~~~~-~~~~~~l~~L~~L 439 (628)
+++... ..+..+++|+.|+++ +.+.+ ..+..+..+++|++|+++ .|.+++.. +.....+++|++|
T Consensus 305 l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L 383 (592)
T 3ogk_B 305 LETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYM 383 (592)
T ss_dssp CCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEE
T ss_pred CCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEE
Confidence 765433 346889999999998 44433 333444668899999999 36666432 2234568999999
Q ss_pred ecCCcccccccCCcccC-CcchhcccceEEcC----CCcCccc-----cchhhhccCCCCEeeCcCCc--CcccCCcccc
Q 042887 440 FLGFNNLQGNVPSSLGN-CQNLMTLSRLLDLS----GNLLGGS-----IPLEVGNLRNLAEFDLSENH--FSNEIPVTLS 507 (628)
Q Consensus 440 ~L~~N~l~~~~~~~~~~-l~~L~~l~~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~ 507 (628)
+++.|.+++..+..+.. +++| +.|+++ .|.+++. ++..+.++++|++|++++|. +++..+..+.
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L----~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~ 459 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNL----CDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG 459 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSC----CEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHH
T ss_pred EeecCCccHHHHHHHHhhCCCC----cEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHH
Confidence 99999998777666665 7777 788885 7788753 33447779999999998644 6655444443
Q ss_pred -CCCCCCeEECcCceeee-ecCccccCCCCCCEEECCCCccccc-CchhhhcccCCCeEeccCCcCccc
Q 042887 508 -ACTTLEYLHLQGNSFSG-SLPLSLKTLKSIKELDLSRNNLSGQ-IPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 508 -~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
.+++|++|++++|++++ .++..+.++++|++|++++|.+++. .+..+..+++|++|++++|+++..
T Consensus 460 ~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 460 QYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 48899999999999886 3455567889999999999998754 344567899999999999998764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=257.57 Aligned_cols=249 Identities=21% Similarity=0.227 Sum_probs=190.2
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEc
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 314 (628)
....++.+++.++ .+|..+ .+++++|+|++|++++..+..|.++++|++|++++|+++++.+..|.++++|++|++
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 3567888888887 677655 367788888888888777777888888888888888887777777777777777777
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
++|+++. ..+..+..+++|++|+++
T Consensus 131 ~~n~l~~-------------------------------------------------------~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 131 FDNWLTV-------------------------------------------------------IPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp CSSCCSB-------------------------------------------------------CCTTTSSSCTTCCEEECC
T ss_pred CCCcCCc-------------------------------------------------------cChhhhcccCCCCEEECC
Confidence 7766543 223446677888899999
Q ss_pred cccccccCCcCCCCCCCCCeEeccc-CccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCc
Q 042887 395 YNQLTGTIPHAIGELKNLQGLALVR-NSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473 (628)
Q Consensus 395 ~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~ 473 (628)
+|++.+..+..|..+++|+.|++++ |.+....+..|..+++|++|++++|++++. | .+..+++| +.|++++|+
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L----~~L~Ls~N~ 229 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGL----EELEMSGNH 229 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTC----CEEECTTSC
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccc----cEEECcCCc
Confidence 9998877777888899999999988 555555555688888888888888888743 3 35666666 778888888
Q ss_pred CccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccc
Q 042887 474 LGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG 548 (628)
Q Consensus 474 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 548 (628)
+++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++..
T Consensus 230 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 230 FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 887777778888888888888888887777778888888888888888876666677778888888888887763
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=246.61 Aligned_cols=252 Identities=22% Similarity=0.213 Sum_probs=134.1
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccC
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 316 (628)
++++.+++.++ .+|..+ .++|++|++++|.+++..+..|.++++|++|++++|.+++..+..|..+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 45666666665 555433 35666666666666655555666666666666666666665555566666666666655
Q ss_pred Cc-CCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecc
Q 042887 317 NN-LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395 (628)
Q Consensus 317 n~-l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 395 (628)
|. ++.+ .+..+..+++|++|++++
T Consensus 90 n~~l~~~-------------------------------------------------------~~~~~~~l~~L~~L~l~~ 114 (285)
T 1ozn_A 90 NAQLRSV-------------------------------------------------------DPATFHGLGRLHTLHLDR 114 (285)
T ss_dssp CTTCCCC-------------------------------------------------------CTTTTTTCTTCCEEECTT
T ss_pred CCCcccc-------------------------------------------------------CHHHhcCCcCCCEEECCC
Confidence 54 3221 122233334444444444
Q ss_pred ccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCc
Q 042887 396 NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLG 475 (628)
Q Consensus 396 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~ 475 (628)
|.+.+..+..+..+++|++|++++|++++..+..|..+++|+ .|++++|+++
T Consensus 115 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~----------------------------~L~l~~n~l~ 166 (285)
T 1ozn_A 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT----------------------------HLFLHGNRIS 166 (285)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC----------------------------EEECCSSCCC
T ss_pred CcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCcc----------------------------EEECCCCccc
Confidence 444433344444444444444444444433333334444444 4444444444
Q ss_pred cccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhh
Q 042887 476 GSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLE 555 (628)
Q Consensus 476 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 555 (628)
+..+..+..+++|++|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++....+.. .
T Consensus 167 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~ 245 (285)
T 1ozn_A 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-P 245 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-H
T ss_pred ccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-H
Confidence 333334555556666666666666555566666666666666666666544455666666666666666665432211 1
Q ss_pred cccCCCeEeccCCcCcccCCC
Q 042887 556 NLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 556 ~l~~L~~L~ls~N~l~~~~p~ 576 (628)
-...++.+..+.|.+.+..|.
T Consensus 246 ~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 246 LWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHHHHHCCSEECCCBEEESG
T ss_pred HHHHHHhcccccCccccCCch
Confidence 112344455666777666664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=255.67 Aligned_cols=248 Identities=21% Similarity=0.244 Sum_probs=184.5
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEc
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFL 314 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 314 (628)
....++.+++.++ .+|..+ .++++.|+|++|+++...+..|.++++|++|+|++|+++.+.+..|.++++|++|++
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 4567888888887 777765 367788888888888777777888888888888888887777777777777777777
Q ss_pred cCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeec
Q 042887 315 SKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVE 394 (628)
Q Consensus 315 ~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~ 394 (628)
++|+++. ..+..|..+++|+.|+++
T Consensus 120 ~~n~l~~-------------------------------------------------------~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 120 FDNRLTT-------------------------------------------------------IPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp CSSCCSS-------------------------------------------------------CCTTTSCSCSSCCEEECC
T ss_pred CCCcCCe-------------------------------------------------------eCHhHhhccccCceeeCC
Confidence 7776643 222346677888888888
Q ss_pred cccccccCCcCCCCCCCCCeEeccc-CccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCc
Q 042887 395 YNQLTGTIPHAIGELKNLQGLALVR-NSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473 (628)
Q Consensus 395 ~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~ 473 (628)
+|.+.+..+..|..+++|++|++++ |.+....+..|..+++|++|++++|+++ .+| .+..+++| +.|+|++|+
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L----~~L~Ls~N~ 218 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKL----DELDLSGNH 218 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSC----CEEECTTSC
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCccc----CEEECCCCc
Confidence 8888877777888888888888888 4555455556788888888888888887 333 35556666 677777777
Q ss_pred CccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 474 LGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 474 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
+++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 219 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 77766777777777777777777777777777777777777777777777666666777777777777777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=255.45 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=212.6
Q ss_pred CCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEc
Q 042887 211 SLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDV 290 (628)
Q Consensus 211 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 290 (628)
..+.++.+++.++ .+|..+. +++++|+|++|.++ .++...+..+++|++|+|++|+++...+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCC-EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCC-eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 4678999999988 5776664 68999999999998 565555667999999999999999888889999999999999
Q ss_pred ccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEcc
Q 042887 291 YKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMG 370 (628)
Q Consensus 291 ~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~ 370 (628)
++|+++.+.+..|..+++|++|++++|.++.
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~------------------------------------------------- 150 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIES------------------------------------------------- 150 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCE-------------------------------------------------
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccc-------------------------------------------------
Confidence 9999998887788888888888888876643
Q ss_pred CCcceeeCchhhhccCCcCeeeecc-ccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccc
Q 042887 371 DNQISGTIPSEIKNLVNINAFGVEY-NQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN 449 (628)
Q Consensus 371 ~n~l~~~~~~~l~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 449 (628)
..+..|..+++|+.|++++ +.+....+..|..+++|++|++++|.++. +| .+..+++|+.|++++|++++.
T Consensus 151 ------~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 151 ------IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp ------ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEE
T ss_pred ------cCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCcc
Confidence 2234567788899999998 45555556689999999999999999984 45 488899999999999999988
Q ss_pred cCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeee
Q 042887 450 VPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG 524 (628)
Q Consensus 450 ~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 524 (628)
.|..|.++++| +.|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.+..
T Consensus 223 ~~~~~~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 223 RPGSFQGLMHL----QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTTTTTCTTC----CEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred ChhhhccCccC----CEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 89999999988 889999999998888899999999999999999998888888999999999999999873
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=256.49 Aligned_cols=247 Identities=20% Similarity=0.192 Sum_probs=198.0
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
...++.+++.++. +|..+. +++++|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 4678888888874 555443 6899999999999988888999999999999999999988888899999999999999
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccc-ccceeecccccccCCCCCEEEccCCcCCCc
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYK-NHFSGQVKIDFNRLSNLSRLFLSKNNLGTE 322 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 322 (628)
|.++ .+|...+..+++|++|+|++|+++...+..|.++++|++|++++ |.+..+.+..|..+++|++|++++|+++.+
T Consensus 133 n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9998 67777677799999999999999977777899999999999998 566766677788999999999999988754
Q ss_pred CCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccC
Q 042887 323 STSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTI 402 (628)
Q Consensus 323 ~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 402 (628)
+ .+..+++| +.|++++|.+++..|..|.++++|+.|++++|++.+..
T Consensus 212 ~--------~~~~l~~L-------------------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (452)
T 3zyi_A 212 P--------NLTPLVGL-------------------------EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258 (452)
T ss_dssp C--------CCTTCTTC-------------------------CEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC
T ss_pred c--------cccccccc-------------------------cEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC
Confidence 2 23344444 44555555555566677777788888888888888777
Q ss_pred CcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccc
Q 042887 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447 (628)
Q Consensus 403 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 447 (628)
+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 259 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred HHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 778888888888888888888777777778888888888888776
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=257.23 Aligned_cols=266 Identities=17% Similarity=0.192 Sum_probs=161.9
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
..+++.+.+. ..+..++..+++|++|++++|++++..|..|+++++|++|++++|++++..+ |..+++|++|++++|
T Consensus 14 i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred Eeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 3444455444 3344444445566666666666666555666666666666666666665443 566666666666666
Q ss_pred cCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccc
Q 042887 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397 (628)
Q Consensus 318 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 397 (628)
.+++++ ..++|+.|+ +++|.+++..+. .+
T Consensus 91 ~l~~l~-----------~~~~L~~L~-------------------------l~~n~l~~~~~~---~~------------ 119 (317)
T 3o53_A 91 YVQELL-----------VGPSIETLH-------------------------AANNNISRVSCS---RG------------ 119 (317)
T ss_dssp EEEEEE-----------ECTTCCEEE-------------------------CCSSCCSEEEEC---CC------------
T ss_pred cccccc-----------CCCCcCEEE-------------------------CCCCccCCcCcc---cc------------
Confidence 554311 112233333 333332222111 12
Q ss_pred ccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCccc-CCcchhcccceEEcCCCcCcc
Q 042887 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG-NCQNLMTLSRLLDLSGNLLGG 476 (628)
Q Consensus 398 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~~~L~Ls~N~l~~ 476 (628)
++|++|++++|++++..+..+..+++|++|++++|++++..+..+. .+++| +.|++++|++++
T Consensus 120 ------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L----~~L~L~~N~l~~ 183 (317)
T 3o53_A 120 ------------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL----EHLNLQYNFIYD 183 (317)
T ss_dssp ------------SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC----CEEECTTSCCCE
T ss_pred ------------CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcC----CEEECCCCcCcc
Confidence 3344444444444444444444455555555555555544443332 34444 555666666654
Q ss_pred ccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc-ccCchhhh
Q 042887 477 SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS-GQIPKYLE 555 (628)
Q Consensus 477 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~ 555 (628)
. + ....+++|++|++++|++++. |..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++ +..|.++.
T Consensus 184 ~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 184 V-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp E-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred c-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 3 2 222477888888888888854 445888899999999999998 56778889999999999999998 77888999
Q ss_pred cccCCCeEeccC-CcCcccCCCC
Q 042887 556 NLLFLAYLNLSY-NHFEGEVPRK 577 (628)
Q Consensus 556 ~l~~L~~L~ls~-N~l~~~~p~~ 577 (628)
.+++|+.+++++ +.++|..|..
T Consensus 260 ~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 260 KNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp TCHHHHHHHHHHHHHHHSSSSCC
T ss_pred ccccceEEECCCchhccCCchhc
Confidence 999999999994 4566665543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-31 Score=287.06 Aligned_cols=396 Identities=17% Similarity=0.113 Sum_probs=292.5
Q ss_pred CcCcccEEEccCCccccccchhhhCC--CCCCEEecccCc-Ccc-cccccccCCCCCCEeecccccCcccC----CcCcc
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIANF--SALEAIDISANM-LGG-RIPDSLCQLRSLNYLSISENNFSCKL----PLSIW 231 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~----p~~~~ 231 (628)
++++|++|+|++|.+++..+..+... .+|++|+|++|. ++. ..+.....+++|++|+|++|.+++.. +..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 57889999999999988777777764 459999999987 221 12233457899999999999987653 33456
Q ss_pred CCCCCCEEEeecccCcc----cCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccce---eecccccc
Q 042887 232 NISSLEIISLHSNRFEG----SLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFS---GQVKIDFN 304 (628)
Q Consensus 232 ~l~~L~~L~L~~n~l~~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~---~~~~~~~~ 304 (628)
.+++|++|++++|.+++ .++. ++..+++|+.|++++|.+.+ .+..+.++++|++|++++.... ......+.
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~ 267 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLET-IARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHH-HHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHH-HHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence 78999999999999972 2222 23358999999999999985 6788999999999999864332 12334567
Q ss_pred cCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhc
Q 042887 305 RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKN 384 (628)
Q Consensus 305 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 384 (628)
.+++|+.|+++++... ..+..+..+++|+.|++++|.+++.....+....++|+.|+++++...+.++.....
T Consensus 268 ~~~~L~~L~l~~~~~~-------~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~ 340 (592)
T 3ogk_B 268 FPRKLCRLGLSYMGPN-------EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY 340 (592)
T ss_dssp CCTTCCEEEETTCCTT-------TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHH
T ss_pred ccccccccCccccchh-------HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHh
Confidence 7899999999886433 234456678899999999999876655443333348999999944333334445578
Q ss_pred cCCcCeeeecc-----------ccccccC-CcCCCCCCCCCeEecccCccccccCccccC-CCCCCeEecC----Ccccc
Q 042887 385 LVNINAFGVEY-----------NQLTGTI-PHAIGELKNLQGLALVRNSLRGTIPDTLGN-LTLLNRLFLG----FNNLQ 447 (628)
Q Consensus 385 l~~L~~L~l~~-----------n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~ 447 (628)
+++|+.|++++ |.+++.. +.....+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.++
T Consensus 341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~ 420 (592)
T 3ogk_B 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420 (592)
T ss_dssp CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence 89999999993 5665432 222445899999999999998877777765 8999999996 67777
Q ss_pred cc-----cCCcccCCcchhcccceEEcCCCc--Cccccchhhhc-cCCCCEeeCcCCcCccc-CCccccCCCCCCeEECc
Q 042887 448 GN-----VPSSLGNCQNLMTLSRLLDLSGNL--LGGSIPLEVGN-LRNLAEFDLSENHFSNE-IPVTLSACTTLEYLHLQ 518 (628)
Q Consensus 448 ~~-----~~~~~~~l~~L~~l~~~L~Ls~N~--l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls 518 (628)
+. .+..+.++++| +.|++++|. +++..+..+.. +++|++|++++|++++. .+..+.++++|++|+++
T Consensus 421 ~~p~~~~~~~~~~~~~~L----~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~ 496 (592)
T 3ogk_B 421 DLPLDNGVRSLLIGCKKL----RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR 496 (592)
T ss_dssp SCCCHHHHHHHHHHCTTC----CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEE
T ss_pred CchHHHHHHHHHHhCCCC----CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeecc
Confidence 43 23335667777 889997644 66555555544 89999999999999863 45556789999999999
Q ss_pred Cceeeee-cCccccCCCCCCEEECCCCcccccCchhh-hcccCCCeEeccCC
Q 042887 519 GNSFSGS-LPLSLKTLKSIKELDLSRNNLSGQIPKYL-ENLLFLAYLNLSYN 568 (628)
Q Consensus 519 ~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ls~N 568 (628)
+|.+++. ++.....+++|++|++++|+++......+ ..++.+....+..+
T Consensus 497 ~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 497 GCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp SCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 9998754 34445678999999999999986544433 35666666655554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=253.16 Aligned_cols=260 Identities=19% Similarity=0.198 Sum_probs=174.8
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
..++..+++.+.+....+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+ +..+++|++|++
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 346777888888877777777788889999999999988878888999999999999998886544 888888888888
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
++|.++ .++. .++|++|++++|++++..+.. +++|++|++++|++++..+..|..+++|++|++++|.++.
T Consensus 88 s~n~l~-~l~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 88 NNNYVQ-ELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp CSSEEE-EEEE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE
T ss_pred cCCccc-cccC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc
Confidence 888887 3431 467777777777777554433 4566777777777766656566666666666666665543
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhh-hccCCcCeeeeccccccc
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEI-KNLVNINAFGVEYNQLTG 400 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l-~~l~~L~~L~l~~n~l~~ 400 (628)
..+..+ ..+++|++|++++|.+++
T Consensus 159 -------------------------------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 159 -------------------------------------------------------VNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp -------------------------------------------------------EEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred -------------------------------------------------------ccHHHHhhccCcCCEEECCCCcCcc
Confidence 112222 234555555555555554
Q ss_pred cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCc-cccc
Q 042887 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLG-GSIP 479 (628)
Q Consensus 401 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~-~~~~ 479 (628)
.. ....+++|++|++++|++++. |..+..+++|++|++++|+++ .+|..+..+++| +.|++++|.+. +..+
T Consensus 184 ~~--~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L----~~L~l~~N~~~~~~~~ 255 (317)
T 3o53_A 184 VK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL----EHFDLRGNGFHCGTLR 255 (317)
T ss_dssp EE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTC----CEEECTTCCCBHHHHH
T ss_pred cc--cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCC----CEEEccCCCccCcCHH
Confidence 31 122366777777777777643 334666777777777777776 345556666666 66677777666 4555
Q ss_pred hhhhccCCCCEeeCcC
Q 042887 480 LEVGNLRNLAEFDLSE 495 (628)
Q Consensus 480 ~~~~~l~~L~~L~Ls~ 495 (628)
..+..+++|+.|++++
T Consensus 256 ~~~~~~~~L~~l~l~~ 271 (317)
T 3o53_A 256 DFFSKNQRVQTVAKQT 271 (317)
T ss_dssp HHHHTCHHHHHHHHHH
T ss_pred HHHhccccceEEECCC
Confidence 6666666666666663
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=244.78 Aligned_cols=234 Identities=19% Similarity=0.206 Sum_probs=153.2
Q ss_pred cCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEE
Q 042887 161 LLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIIS 240 (628)
Q Consensus 161 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 240 (628)
..+++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..|+.+++|++|+|++|.++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 467888999999988 66777888889999999999888 77888888899999999999888 6788888888999999
Q ss_pred eecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCC
Q 042887 241 LHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 241 L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 320 (628)
+++|.+.+.+|..+.. . ..+..|.++++|++|++++|+++ ..|..+..+++|++|++++|.++
T Consensus 157 L~~n~~~~~~p~~~~~-------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 157 IRACPELTELPEPLAS-------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEETTCCCCCSCSEE-------E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred CCCCCCccccChhHhh-------c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 9988877777765532 0 11223455666666666666666 34455666666666666666554
Q ss_pred CcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccc
Q 042887 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400 (628)
Q Consensus 321 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 400 (628)
.++ ..+..+++|+.|+++ +|.+.+.+|..+..+++|+.|++++|.+.+
T Consensus 220 ~l~-------~~l~~l~~L~~L~Ls-------------------------~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 220 ALG-------PAIHHLPKLEELDLR-------------------------GCTALRNYPPIFGGRAPLKRLILKDCSNLL 267 (328)
T ss_dssp CCC-------GGGGGCTTCCEEECT-------------------------TCTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred cCc-------hhhccCCCCCEEECc-------------------------CCcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence 321 112222222222222 222223344455556666666666666665
Q ss_pred cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccc
Q 042887 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446 (628)
Q Consensus 401 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 446 (628)
.+|..+..+++|++|++++|.+.+.+|..+..+++|+.+++..+.+
T Consensus 268 ~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp BCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred hcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 6666666666666666666666666666666666666666665544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-27 Score=254.38 Aligned_cols=109 Identities=28% Similarity=0.337 Sum_probs=74.3
Q ss_pred CCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCC
Q 042887 434 TLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLE 513 (628)
Q Consensus 434 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 513 (628)
++|+.|++++|.++ .+|.. +++| +.|++++|++++ +| ..+++|++|++++|+++. +|. .+++|+
T Consensus 201 ~~L~~L~L~~N~l~-~l~~~---~~~L----~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~ 264 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPAL---PSGL----KELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLL 264 (622)
T ss_dssp TTCCEEECCSSCCS-SCCCC---CTTC----CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCC
T ss_pred chhhEEECcCCccc-ccCCC---CCCC----CEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCc
Confidence 34555555555554 22221 1333 566677776664 33 345778888888888873 444 567888
Q ss_pred eEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccC
Q 042887 514 YLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559 (628)
Q Consensus 514 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 559 (628)
.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..++.
T Consensus 265 ~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~ 309 (622)
T 3g06_A 265 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309 (622)
T ss_dssp EEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHH
T ss_pred EEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhccc
Confidence 8888888888 67778888888888888888888888887776653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=241.35 Aligned_cols=201 Identities=20% Similarity=0.337 Sum_probs=133.2
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCcccc---------CC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLG---------NL 433 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---------~l 433 (628)
+|++|++++|.++ .+|..+..+++|++|++++|.+. .+|..+..+++|++|++++|.+.+..|..+. .+
T Consensus 105 ~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 3444444444444 44455555666666666666665 4455566666666666666555555555443 36
Q ss_pred CCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCC
Q 042887 434 TLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLE 513 (628)
Q Consensus 434 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 513 (628)
++|++|++++|+++ .+|..+..+++| +.|++++|++++ +|..+..+++|++|++++|++.+.+|..+..+++|+
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L----~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASIANLQNL----KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGGGGCTTC----CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred CCCCEEECcCCCcC-cchHhhcCCCCC----CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 77777777777776 566666666666 667777777774 455677777777777777777777777777777777
Q ss_pred eEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCc
Q 042887 514 YLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571 (628)
Q Consensus 514 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 571 (628)
+|++++|.+.+.+|..+..+++|++|+|++|++.+.+|+.+..+++|+.+++..|.+.
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 7777777777777777777777777777777777777777777777777777766543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=250.75 Aligned_cols=142 Identities=26% Similarity=0.302 Sum_probs=110.2
Q ss_pred CCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCC
Q 042887 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLA 489 (628)
Q Consensus 410 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~ 489 (628)
++|+.|++++|.+++ +| ..+++|+.|++++|++++ +|.. .++| +.|++++|.++. +|. .+++|+
T Consensus 161 ~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L----~~L~L~~N~l~~-l~~---~~~~L~ 224 (622)
T 3g06_A 161 SELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSEL----YKLWAYNNRLTS-LPA---LPSGLK 224 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTC----CEEECCSSCCSS-CCC---CCTTCC
T ss_pred CCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchh----hEEECcCCcccc-cCC---CCCCCC
Confidence 345566666666653 33 335677777777777763 3332 2455 789999999984 443 358899
Q ss_pred EeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCc
Q 042887 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNH 569 (628)
Q Consensus 490 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~ 569 (628)
+|++++|++++ +| ..+++|+.|++++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|++++|+
T Consensus 225 ~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~ 295 (622)
T 3g06_A 225 ELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295 (622)
T ss_dssp EEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred EEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence 99999999995 55 45689999999999999 5665 6789999999999999 678889999999999999999
Q ss_pred CcccCCC
Q 042887 570 FEGEVPR 576 (628)
Q Consensus 570 l~~~~p~ 576 (628)
+++.+|.
T Consensus 296 l~~~~~~ 302 (622)
T 3g06_A 296 LSERTLQ 302 (622)
T ss_dssp CCHHHHH
T ss_pred CCCcCHH
Confidence 9987664
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-29 Score=248.60 Aligned_cols=252 Identities=18% Similarity=0.186 Sum_probs=161.1
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCc-cccccccc-------CCCCCCEeecccccCcccCCcC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLG-GRIPDSLC-------QLRSLNYLSISENNFSCKLPLS 229 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~-------~l~~L~~L~Ls~N~i~~~~p~~ 229 (628)
.+..++|+.|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. .+++|++|+|++|.+++..|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34567788889999988 567666554 888888888884 34555554 7888899999998888777877
Q ss_pred c--cCCCCCCEEEeecccCcccCChhhhhCC-----CCCcEEecccCcccccccccccCCCCCCEEEcccccceeec--c
Q 042887 230 I--WNISSLEIISLHSNRFEGSLPLNIGFNI-----PNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQV--K 300 (628)
Q Consensus 230 ~--~~l~~L~~L~L~~n~l~~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~ 300 (628)
+ ..+++|++|++++|.+++. |..+.. + ++|++|++++|++++..|..|+++++|++|++++|++.+.. +
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~-l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAE-LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHH-HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHH-HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 6 7888888888888888844 655443 4 77888888888877777677777777777777777765431 1
Q ss_pred cc--cccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeC
Q 042887 301 ID--FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTI 378 (628)
Q Consensus 301 ~~--~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 378 (628)
.. +..+++|++|++++|+++.++ . ..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~------------------------------~----------------------~~ 220 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPS------------------------------G----------------------VC 220 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHH------------------------------H----------------------HH
T ss_pred HHHHhccCCCCCEEECCCCcCcchH------------------------------H----------------------HH
Confidence 22 255666666666666554211 0 00
Q ss_pred chhhhccCCcCeeeeccccccccCC-cCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCC
Q 042887 379 PSEIKNLVNINAFGVEYNQLTGTIP-HAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNC 457 (628)
Q Consensus 379 ~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 457 (628)
...+..+++|+.|++++|++.+..| ..+..+++|++|++++|+++ .+|..+. ++|++|++++|++++. |. +..+
T Consensus 221 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l 295 (312)
T 1wwl_A 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDEL 295 (312)
T ss_dssp HHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTS
T ss_pred HHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhC
Confidence 1122344555555555555554442 33444556666666666665 4444444 5666666666666544 43 5555
Q ss_pred cchhcccceEEcCCCcCcc
Q 042887 458 QNLMTLSRLLDLSGNLLGG 476 (628)
Q Consensus 458 ~~L~~l~~~L~Ls~N~l~~ 476 (628)
++| +.|++++|.+++
T Consensus 296 ~~L----~~L~L~~N~l~~ 310 (312)
T 1wwl_A 296 PQV----GNLSLKGNPFLD 310 (312)
T ss_dssp CEE----EEEECTTCTTTC
T ss_pred CCC----CEEeccCCCCCC
Confidence 555 566666666653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=243.82 Aligned_cols=242 Identities=23% Similarity=0.230 Sum_probs=140.8
Q ss_pred CCceeecccCCcccccchHHHhccccccEEEccCCcce-eeCchhhh-------ccCCcCeeeeccccccccCCcCC--C
Q 042887 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS-GTIPSEIK-------NLVNINAFGVEYNQLTGTIPHAI--G 407 (628)
Q Consensus 338 ~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~l~-------~l~~L~~L~l~~n~l~~~~~~~~--~ 407 (628)
+|+.+++++|.+ ..+..+.. .++.|++++|.+. ..+|..+. ++++|++|++++|++.+..|..+ .
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTD---IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHH---HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CceeEeeccccc--ccHHHHHH---HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 444445555544 22333332 2455555555552 23444333 56666666666666666566554 6
Q ss_pred CCCCCCeEecccCccccccCccccCC-----CCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc--cch
Q 042887 408 ELKNLQGLALVRNSLRGTIPDTLGNL-----TLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS--IPL 480 (628)
Q Consensus 408 ~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~--~~~ 480 (628)
.+++|++|++++|++++. |..+..+ ++|++|++++|++++..|..++.+++| +.|++++|++.+. .+.
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL----STLDLSDNPELGERGLIS 193 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC----CEEECCSCTTCHHHHHHH
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC----CEEECCCCCcCcchHHHH
Confidence 666666666666666655 5555555 666666666666666666666666666 6666666665543 222
Q ss_pred hh--hccCCCCEeeCcCCcCcc---cCCccccCCCCCCeEECcCceeeeecC-ccccCCCCCCEEECCCCcccccCchhh
Q 042887 481 EV--GNLRNLAEFDLSENHFSN---EIPVTLSACTTLEYLHLQGNSFSGSLP-LSLKTLKSIKELDLSRNNLSGQIPKYL 554 (628)
Q Consensus 481 ~~--~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 554 (628)
.+ ..+++|++|++++|++++ .....+..+++|++|++++|++++..| ..+..+++|++|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 566666777777766662 112233456666777777776665443 34455666777777777666 445444
Q ss_pred hcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCC
Q 042887 555 ENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNER 593 (628)
Q Consensus 555 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~ 593 (628)
. ++|++||+++|++++. |....+++++.+++++|+.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l 308 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPF 308 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTT
T ss_pred c--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCC
Confidence 3 5666677777766655 4455556666666666653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=277.58 Aligned_cols=398 Identities=17% Similarity=0.157 Sum_probs=263.4
Q ss_pred CcCcccEEEccCCccccccchhhh-CCCCCCEEecccC-cCccc-ccccccCCCCCCEeecccccCcccCCcCcc----C
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIA-NFSALEAIDISAN-MLGGR-IPDSLCQLRSLNYLSISENNFSCKLPLSIW----N 232 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~----~ 232 (628)
.+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 467899999999998887777776 6899999999988 55432 344455789999999999988765544443 6
Q ss_pred CCCCCEEEeeccc--CcccCChhhhhCCCCCcEEecccC-cccccccccccCCCCCCEEEccc-------ccceeecccc
Q 042887 233 ISSLEIISLHSNR--FEGSLPLNIGFNIPNVNFLSVGQN-NFTGSLPHSFSNASNLQVLDVYK-------NHFSGQVKID 302 (628)
Q Consensus 233 l~~L~~L~L~~n~--l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-------N~i~~~~~~~ 302 (628)
+++|++|++++|. +.......+...+++|++|++++| .++ ..+..+..+++|++|+++. +.+.+.. ..
T Consensus 183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~-~~ 260 (594)
T 2p1m_B 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLS-VA 260 (594)
T ss_dssp CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHH-HH
T ss_pred CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHH-HH
Confidence 7799999999887 221111222234799999999988 444 4777788899999998544 3444433 36
Q ss_pred cccCCCCCEE-EccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceee-Cch
Q 042887 303 FNRLSNLSRL-FLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGT-IPS 380 (628)
Q Consensus 303 ~~~l~~L~~L-~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~ 380 (628)
+.++++|+.| .+...... .....+..+++|+.|++++|.+++.....+....++|+.|++++| +.+. ++.
T Consensus 261 l~~~~~L~~Ls~~~~~~~~-------~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~ 332 (594)
T 2p1m_B 261 LSGCKELRCLSGFWDAVPA-------YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEV 332 (594)
T ss_dssp HHTCTTCCEEECCBTCCGG-------GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHH
T ss_pred HhcCCCcccccCCcccchh-------hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHH
Confidence 7788888888 33332211 122233456789999999888765544443333348888888887 4322 222
Q ss_pred hhhccCCcCeeeecc---------ccccccCCcCCC-CCCCCCeEecccCccccccCcccc-CCCCCCeEecC--C----
Q 042887 381 EIKNLVNINAFGVEY---------NQLTGTIPHAIG-ELKNLQGLALVRNSLRGTIPDTLG-NLTLLNRLFLG--F---- 443 (628)
Q Consensus 381 ~l~~l~~L~~L~l~~---------n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~---- 443 (628)
....+++|+.|++.. +.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++ +
T Consensus 333 l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 412 (594)
T 2p1m_B 333 LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP 412 (594)
T ss_dssp HHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCC
T ss_pred HHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCc
Confidence 334578888888833 344432222222 367888888888888765555554 47888888888 3
Q ss_pred cccccc-----cCCcccCCcchhcccceEEcCCCcCccccchhhhc-cCCCCEeeCcCCcCcccCCccc-cCCCCCCeEE
Q 042887 444 NNLQGN-----VPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGN-LRNLAEFDLSENHFSNEIPVTL-SACTTLEYLH 516 (628)
Q Consensus 444 N~l~~~-----~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ 516 (628)
|.+++. .+..+..+++| +.|++++ .+++..+..+.. +++|++|++++|.+++..+..+ .++++|++|+
T Consensus 413 ~~l~~~~~~~~~~~l~~~~~~L----~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~ 487 (594)
T 2p1m_B 413 DYLTLEPLDIGFGAIVEHCKDL----RRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLE 487 (594)
T ss_dssp CTTTCCCTHHHHHHHHHHCTTC----CEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEE
T ss_pred ccccCCchhhHHHHHHhhCCCc----cEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEE
Confidence 455421 11124455666 7788877 666555555554 7888888888888876544444 5678888888
Q ss_pred CcCceeeeecCc-cccCCCCCCEEECCCCcccccCchhh-hcccCCCeEeccCCcCcc
Q 042887 517 LQGNSFSGSLPL-SLKTLKSIKELDLSRNNLSGQIPKYL-ENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 517 Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~~ 572 (628)
+++|.+++.... ....+++|+.|++++|+++......+ ..++.|+...+..+.-..
T Consensus 488 L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~ 545 (594)
T 2p1m_B 488 IRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPD 545 (594)
T ss_dssp EESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred CcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence 888888644333 34457888888888888864444444 456777666666654433
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=251.31 Aligned_cols=235 Identities=17% Similarity=0.190 Sum_probs=143.4
Q ss_pred CCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCC
Q 042887 259 PNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQ 338 (628)
Q Consensus 259 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~ 338 (628)
++|+.|+|++|.+++..|..|+++++|++|+|++|.+++..+ |..+++|++|++++|.+++++ ..++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----------~~~~ 100 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----------VGPS 100 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----------ECTT
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----------CCCC
Confidence 366677777777666666667777777777777777765544 666666666666666554311 0122
Q ss_pred CceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecc
Q 042887 339 MEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALV 418 (628)
Q Consensus 339 L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 418 (628)
|+.|+ +++|.+.+..+. .+++|+.|+++
T Consensus 101 -------------------------L~~L~------------------------L~~N~l~~~~~~---~l~~L~~L~L~ 128 (487)
T 3oja_A 101 -------------------------IETLH------------------------AANNNISRVSCS---RGQGKKNIYLA 128 (487)
T ss_dssp -------------------------CCEEE------------------------CCSSCCCCEEEC---CCSSCEEEECC
T ss_pred -------------------------cCEEE------------------------CcCCcCCCCCcc---ccCCCCEEECC
Confidence 22333 333333222221 12345555555
Q ss_pred cCccccccCccccCCCCCCeEecCCcccccccCCccc-CCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCc
Q 042887 419 RNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG-NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENH 497 (628)
Q Consensus 419 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 497 (628)
+|.+++..|..+..+++|+.|++++|.+++..|..+. .+++| +.|+|++|.+++..+ ...+++|++|+|++|.
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L----~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~ 202 (487)
T 3oja_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL----EHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNK 202 (487)
T ss_dssp SSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC----CEEECTTSCCCEEEC--CCCCTTCCEEECCSSC
T ss_pred CCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcc----cEEecCCCccccccc--cccCCCCCEEECCCCC
Confidence 5555554455555555555555555555554444443 34444 555666666654322 2346778888888888
Q ss_pred CcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc-ccCchhhhcccCCCeEecc
Q 042887 498 FSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS-GQIPKYLENLLFLAYLNLS 566 (628)
Q Consensus 498 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ls 566 (628)
+++..| .+..+++|+.|++++|.+++ +|..+..+++|+.|++++|++. +.+|.++..++.|+.++++
T Consensus 203 l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 203 LAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 875443 47777888888888888874 6667788888888888888887 5667778888888877776
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=250.80 Aligned_cols=242 Identities=17% Similarity=0.159 Sum_probs=179.2
Q ss_pred CCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEe
Q 042887 337 SQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLA 416 (628)
Q Consensus 337 ~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 416 (628)
++|+.|++++|.+++..+..+..+. +|+.|++++|.+++..| +..+++|+.|++++|.+++..+ .++|++|+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3566666666666666555665555 67777777777776655 7788888888888888875432 27888899
Q ss_pred cccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhh-ccCCCCEeeCcC
Q 042887 417 LVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG-NLRNLAEFDLSE 495 (628)
Q Consensus 417 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~ 495 (628)
+++|.+++..+. .+++|+.|++++|.+++..|..++.+++| +.|+|++|.+++..|..+. .+++|++|+|++
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~ 178 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRV----QYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSE----EEEECTTSCCCEEEGGGGGGGTTTCCEEECTT
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCC----CEEECCCCCCCCcChHHHhhhCCcccEEecCC
Confidence 999888866554 35788888999998888888888888887 7888999988887777775 688899999999
Q ss_pred CcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCc-ccC
Q 042887 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE-GEV 574 (628)
Q Consensus 496 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~ 574 (628)
|.+++..+ ...+++|++|+|++|.+++. |..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+
T Consensus 179 N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 179 NFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp SCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred Cccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcch
Confidence 98886532 33578889999999988854 4458888889999999998885 6667888888889999988887 333
Q ss_pred CC-CCCCCCCCccccc-------CCCCCccc
Q 042887 575 PR-KGVFGNRTGIHLI-------GNERLCGG 597 (628)
Q Consensus 575 p~-~~~~~~l~~~~~~-------~n~~~c~~ 597 (628)
|. ...++.+..+++. +++..|..
T Consensus 255 ~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~ 285 (487)
T 3oja_A 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285 (487)
T ss_dssp HHHHTTCHHHHHHHHHHHHHHTSSSSCCCSS
T ss_pred HHHHHhCCCCcEEeccccccccCCCcccccC
Confidence 32 2334444555554 66666654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-28 Score=270.44 Aligned_cols=403 Identities=11% Similarity=0.104 Sum_probs=282.2
Q ss_pred CcCcccEEEccCCcccc---cc------------chhhhCCCCCCEEecccCcCccccccccc-CCCCCCEeecccc-cC
Q 042887 160 NLLKLEMIDVGDNQLIG---KF------------PDFIANFSALEAIDISANMLGGRIPDSLC-QLRSLNYLSISEN-NF 222 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~---~~------------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N-~i 222 (628)
.+++|+.|+++++.... .. +.....+++|++|+|++|.+++..+..+. .+++|++|+|++| .+
T Consensus 64 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~ 143 (594)
T 2p1m_B 64 RFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGF 143 (594)
T ss_dssp HCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEE
T ss_pred hCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCC
Confidence 45678999999875321 11 22345788999999999999877777775 6899999999999 55
Q ss_pred ccc-CCcCccCCCCCCEEEeecccCcccCChhh---hhCCCCCcEEecccCc--ccc-cccccccCCCCCCEEEcccc-c
Q 042887 223 SCK-LPLSIWNISSLEIISLHSNRFEGSLPLNI---GFNIPNVNFLSVGQNN--FTG-SLPHSFSNASNLQVLDVYKN-H 294 (628)
Q Consensus 223 ~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~~l~~L~~L~L~~N~--l~~-~~~~~~~~l~~L~~L~L~~N-~ 294 (628)
+.. ++..+.++++|++|++++|.+++..+..+ ...+++|+.|++++|. ++. ..+..+..+++|++|++++| .
T Consensus 144 ~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~ 223 (594)
T 2p1m_B 144 STDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVP 223 (594)
T ss_dssp EHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSC
T ss_pred CHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCc
Confidence 532 34445589999999999999875443322 2247799999999997 321 12222356799999999998 4
Q ss_pred ceeecccccccCCCCCEEEccCCcCCCcCCCCc-cccccccCCCCCcee-ecccCCcccccchHHHhccccccEEEccCC
Q 042887 295 FSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDL-DFLTLLTNCSQMEML-YLNTNKFGGVFLRSIANLSAKITVIGMGDN 372 (628)
Q Consensus 295 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~~~~l~~~~~L~~L-~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n 372 (628)
+.+ .+..+..+++|++|+++.+...- ....+ .....+.++++|+.+ .+..... ...+..+... ++|+.|++++|
T Consensus 224 ~~~-l~~~~~~~~~L~~L~l~~~~~~~-~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~-~~L~~L~L~~~ 299 (594)
T 2p1m_B 224 LEK-LATLLQRAPQLEELGTGGYTAEV-RPDVYSGLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVC-SRLTTLNLSYA 299 (594)
T ss_dssp HHH-HHHHHHHCTTCSEEECSBCCCCC-CHHHHHHHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHH-TTCCEEECTTC
T ss_pred HHH-HHHHHhcCCcceEcccccccCcc-chhhHHHHHHHHhcCCCcccccCCcccch-hhHHHHHHhh-CCCCEEEccCC
Confidence 444 66678889999999977654210 00000 122356788899988 4443322 1222222233 48999999999
Q ss_pred cceeeCc-hhhhccCCcCeeeecccccccc-CCcCCCCCCCCCeEecc---------cCccccccCcccc-CCCCCCeEe
Q 042887 373 QISGTIP-SEIKNLVNINAFGVEYNQLTGT-IPHAIGELKNLQGLALV---------RNSLRGTIPDTLG-NLTLLNRLF 440 (628)
Q Consensus 373 ~l~~~~~-~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~---------~n~l~~~~~~~~~-~l~~L~~L~ 440 (628)
.+++... ..+..+++|+.|++++| +.+. .+.....+++|++|+++ .+.+++.....+. .+++|+.|.
T Consensus 300 ~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~ 378 (594)
T 2p1m_B 300 TVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVL 378 (594)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHH
Confidence 9775432 23568899999999988 4432 22223357899999994 3556544333333 489999999
Q ss_pred cCCcccccccCCccc-CCcchhcccceEEcC--C----CcCccc-----cchhhhccCCCCEeeCcCCcCcccCCccccC
Q 042887 441 LGFNNLQGNVPSSLG-NCQNLMTLSRLLDLS--G----NLLGGS-----IPLEVGNLRNLAEFDLSENHFSNEIPVTLSA 508 (628)
Q Consensus 441 L~~N~l~~~~~~~~~-~l~~L~~l~~~L~Ls--~----N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 508 (628)
++.|.+++..+..+. .+++| +.|+++ + |.+++. ++..+..+++|++|++++ .+++..+..+..
T Consensus 379 ~~~~~l~~~~~~~l~~~~~~L----~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~ 453 (594)
T 2p1m_B 379 YFCRQMTNAALITIARNRPNM----TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT 453 (594)
T ss_dssp EEESCCCHHHHHHHHHHCTTC----CEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH
T ss_pred HhcCCcCHHHHHHHHhhCCCc----ceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHH
Confidence 999999876655554 47777 788998 4 566632 222367789999999987 777655555555
Q ss_pred -CCCCCeEECcCceeeeecCccc-cCCCCCCEEECCCCcccccCch-hhhcccCCCeEeccCCcCcc
Q 042887 509 -CTTLEYLHLQGNSFSGSLPLSL-KTLKSIKELDLSRNNLSGQIPK-YLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 509 -l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~ 572 (628)
+++|+.|++++|.+++..+..+ ..+++|++|++++|.+++.... ....+++|+.|++++|+++.
T Consensus 454 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 454 YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 8999999999999976555555 6789999999999999755444 44568999999999999854
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=223.16 Aligned_cols=210 Identities=21% Similarity=0.240 Sum_probs=183.7
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
+++.|++++|.+++..+..+.++++|++|++++|++.+..+..|..+++|++|++++|.+++..+..|..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 67788888888887777788999999999999999998888889999999999999999998888889999999999999
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccc-cchhhhccCCCCEeeCcCCcCcccCCccccCCCCCC----eEEC
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS-IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLE----YLHL 517 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L 517 (628)
+|++++..+..+..+++| +.|++++|++++. +|..+..+++|++|++++|++++..+..+..+++|+ .|++
T Consensus 109 ~n~l~~~~~~~~~~l~~L----~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~l 184 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTL----KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184 (276)
T ss_dssp TSCCCCSTTCCCTTCTTC----CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEEC
T ss_pred CCCccccCchhcccCCCC----CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeec
Confidence 999997777788888888 8899999999864 588999999999999999999987777787777777 8999
Q ss_pred cCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCC
Q 042887 518 QGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577 (628)
Q Consensus 518 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 577 (628)
++|++++..+..+.. .+|++|++++|++++..+..|..+++|+.|++++|++++..|..
T Consensus 185 s~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 185 SLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred CCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 999999766655544 58999999999999887778899999999999999999887754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=219.00 Aligned_cols=200 Identities=24% Similarity=0.238 Sum_probs=134.3
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
+++.++++++.++. +|..+. ++++.|++++|.+.+..+..|..+++|++|++++|.+++..+. ..+++|++|+++
T Consensus 11 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls 85 (290)
T 1p9a_G 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLS 85 (290)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECC
T ss_pred CccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECC
Confidence 56777777777763 333332 4667777777777766666677777777777777777654332 566777777777
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|+++ .+|..+..+++| +.|++++|++++..+..|.++++|++|++++|++++..+..|..+++|+.|+|++|++
T Consensus 86 ~N~l~-~l~~~~~~l~~L----~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 86 HNQLQ-SLPLLGQTLPAL----TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp SSCCS-SCCCCTTTCTTC----CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCcCC-cCchhhccCCCC----CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 77776 556666666666 6677777777766666677777777777777777766666666777777777777777
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCccc
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.+++++|++...
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 7555555666777777777777776 4555555666777777777776543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-25 Score=216.01 Aligned_cols=206 Identities=22% Similarity=0.245 Sum_probs=160.1
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
..+.++++++.++. +|..+. ++++.|++++|++.+..+..|..+++|++|++++|.+++..+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 34566666666663 343332 467788888888877666678888888888888888886666667778888888888
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|++++..+..+..+++| +.|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++
T Consensus 94 ~n~l~~~~~~~~~~l~~L----~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNL----AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SSCCCCCCTTTTTTCSSC----CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCCcCCHhHcccccCC----CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 888887666677777777 7888888888877777788888888888888888876666678888888888888888
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++....+
T Consensus 170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 170 KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 87666678888888888888888887777778888888888888888876654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=219.53 Aligned_cols=223 Identities=21% Similarity=0.234 Sum_probs=192.9
Q ss_pred EEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccc
Q 042887 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446 (628)
Q Consensus 367 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 446 (628)
++..+..+. .+|..+. ++++.|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344444444 3444443 5799999999999988888999999999999999999988888999999999999999999
Q ss_pred ccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCccc-CCccccCCCCCCeEECcCceeeee
Q 042887 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNE-IPVTLSACTTLEYLHLQGNSFSGS 525 (628)
Q Consensus 447 ~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~ 525 (628)
++..+..+.++++| +.|++++|.+.+..+..+..+++|++|++++|.+++. +|..+..+++|++|++++|++++.
T Consensus 89 ~~~~~~~~~~l~~L----~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 89 QSLALGAFSGLSSL----QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp CEECTTTTTTCTTC----CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CccChhhhcCCccc----cEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 98888899999999 8999999999987777899999999999999999874 589999999999999999999988
Q ss_pred cCccccCCCCCC----EEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCC-CCCCCCCcccccCCCCCccc
Q 042887 526 LPLSLKTLKSIK----ELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK-GVFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 526 ~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~ 597 (628)
.+..+..+++|+ .|++++|++++..+..+.. .+|++|++++|++++.++.. ..+++++.+++++|++.|..
T Consensus 165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred CHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 888887777777 9999999999776666654 48999999999999776643 56789999999999999863
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-24 Score=213.25 Aligned_cols=204 Identities=26% Similarity=0.254 Sum_probs=182.7
Q ss_pred CcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccce
Q 042887 387 NINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL 466 (628)
Q Consensus 387 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~ 466 (628)
+.+.++++++.++. +|..+. +++++|++++|++++..+..|..+++|++|++++|+++...+..|.++++| +.
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L----~~ 89 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL----ET 89 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTC----CE
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCC----CE
Confidence 56789999999984 565554 689999999999998877899999999999999999997777777889888 89
Q ss_pred EEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcc
Q 042887 467 LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546 (628)
Q Consensus 467 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 546 (628)
|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|.+
T Consensus 90 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 99999999987778889999999999999999988888899999999999999999977777799999999999999999
Q ss_pred cccCchhhhcccCCCeEeccCCcCcccCCC-CCCCCCCCcccccCCCCCccc
Q 042887 547 SGQIPKYLENLLFLAYLNLSYNHFEGEVPR-KGVFGNRTGIHLIGNERLCGG 597 (628)
Q Consensus 547 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c~~ 597 (628)
++..+..|..+++|++|++++|++++..+. ...+++++.+++.+||+.|..
T Consensus 170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 170 KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred cEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 988888899999999999999999976554 355788999999999999863
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-24 Score=209.20 Aligned_cols=204 Identities=20% Similarity=0.191 Sum_probs=179.4
Q ss_pred ccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCC
Q 042887 333 LTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412 (628)
Q Consensus 333 l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 412 (628)
+.++++++.++++++.++.+... +..+++.|++++|.+++..+..+..+++|+.|++++|.+++..+. ..+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~----~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPD----LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSC----CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCCcCCCC----CCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 55678899999999998876432 234899999999999998889999999999999999999865443 788999
Q ss_pred CeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEee
Q 042887 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFD 492 (628)
Q Consensus 413 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 492 (628)
++|++++|+++ .+|..+..+++|++|++++|++++..+..|.++++| +.|++++|++++..+..|..+++|++|+
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL----QELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC----CEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCC----CEEECCCCCCCccChhhcccccCCCEEE
Confidence 99999999998 677888999999999999999998878889999888 8999999999987777889999999999
Q ss_pred CcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccc
Q 042887 493 LSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG 548 (628)
Q Consensus 493 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 548 (628)
|++|+++...+..|..+++|+.|+|++|+++ .+|..+...++|+.|+|++|++..
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 9999999777777888999999999999998 678888888899999999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=209.64 Aligned_cols=200 Identities=27% Similarity=0.242 Sum_probs=162.9
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
+++.|++++|.+... ..+..+++|++|++++|.+.+. ..+..+++|++|++++|.+++..+..|..+++|++|+++
T Consensus 42 ~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 566777777766532 3577888888888888888753 467888888899998888887777778888889999998
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|++++..+..+..+++| +.|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++
T Consensus 118 ~n~l~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNL----TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp TSCCCCCCTTTTTTCTTC----CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCCccCHHHhccCCCC----CEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 888887777778888888 8888999988877777788888999999999998877777788888999999999999
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCC
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRK 577 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 577 (628)
++..+..+..+++|+.|++++|++.+. ++.|+.++++.|.++|.+|..
T Consensus 194 ~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 194 KSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred CccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 877777788889999999999988754 346788888899999888753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=227.09 Aligned_cols=209 Identities=17% Similarity=0.238 Sum_probs=143.8
Q ss_pred EEEccCCccccccchhhhCCCCCCEEecccCcCccccc----ccccCCC-CCCEeecccccCcccCCcCccCC-----CC
Q 042887 166 MIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP----DSLCQLR-SLNYLSISENNFSCKLPLSIWNI-----SS 235 (628)
Q Consensus 166 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l-----~~ 235 (628)
..+++.|++++.+|..+...++|++|||++|.+++..+ +.|..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788999998888877777779999999999987766 7788888 89999999999987777777665 88
Q ss_pred CCEEEeecccCcccCChhhhh---CC-CCCcEEecccCccccccccccc----C-CCCCCEEEcccccceeecccc----
Q 042887 236 LEIISLHSNRFEGSLPLNIGF---NI-PNVNFLSVGQNNFTGSLPHSFS----N-ASNLQVLDVYKNHFSGQVKID---- 302 (628)
Q Consensus 236 L~~L~L~~n~l~~~~~~~~~~---~l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~i~~~~~~~---- 302 (628)
|++|+|++|.+++..+..+.. .+ ++|++|++++|++++..+..+. . .++|++|++++|++++.....
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999988555544332 23 7888888888888876655443 3 358888888888887544333
Q ss_pred cccCC-CCCEEEccCCcCCCcCCCCccccccccCC-CCCceeecccCCcccccchHHH----hccccccEEEccCCccee
Q 042887 303 FNRLS-NLSRLFLSKNNLGTESTSDLDFLTLLTNC-SQMEMLYLNTNKFGGVFLRSIA----NLSAKITVIGMGDNQISG 376 (628)
Q Consensus 303 ~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~l~~~-~~L~~L~l~~n~~~~~~~~~~~----~~~~~L~~L~l~~n~l~~ 376 (628)
+...+ +|++|++++|+++..... .....+..+ ++|+.|++++|.++......++ ....+|+.|++++|.+++
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCA--ELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHH--HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHH--HHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 33444 788888888877653322 122234444 3777777777777664433222 222245555555555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=232.28 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=142.8
Q ss_pred ccccccCCCCCCEEEcccccceeeccc----ccccCCCCCEEEccCCcCCCcCCCCc----cccccccCCCCCceeeccc
Q 042887 275 LPHSFSNASNLQVLDVYKNHFSGQVKI----DFNRLSNLSRLFLSKNNLGTESTSDL----DFLTLLTNCSQMEMLYLNT 346 (628)
Q Consensus 275 ~~~~~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~~----~~~~~l~~~~~L~~L~l~~ 346 (628)
++..+..+++|++|++++|+++...+. .+..+++|++|++++|.+..+..... .....+..+++|+.|++++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 344555566666666666666544332 24456666666666654432211000 0111223444444444444
Q ss_pred CCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCC----C---------CCCC
Q 042887 347 NKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGE----L---------KNLQ 413 (628)
Q Consensus 347 n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~----l---------~~L~ 413 (628)
|.++..... .+|..+..+++|+.|++++|.+++..+..+.. + ++|+
T Consensus 104 n~l~~~~~~---------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~ 162 (386)
T 2ca6_A 104 NAFGPTAQE---------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 162 (386)
T ss_dssp CCCCTTTHH---------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred CcCCHHHHH---------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence 444332211 23455677778888888888776443333332 2 6777
Q ss_pred eEecccCccc-cccC---ccccCCCCCCeEecCCccccc-----ccCCcccCCcchhcccceEEcCCCcCc----cccch
Q 042887 414 GLALVRNSLR-GTIP---DTLGNLTLLNRLFLGFNNLQG-----NVPSSLGNCQNLMTLSRLLDLSGNLLG----GSIPL 480 (628)
Q Consensus 414 ~L~L~~n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~l~~~L~Ls~N~l~----~~~~~ 480 (628)
+|++++|+++ +..+ ..+..+++|++|++++|+++. ..+..+..+++| +.|+|++|.++ ..+|.
T Consensus 163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L----~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL----KVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC----CEEECCSSCCHHHHHHHHHH
T ss_pred EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCc----cEEECcCCCCCcHHHHHHHH
Confidence 7777777776 2233 345566777777777777762 233355556666 66777777764 34555
Q ss_pred hhhccCCCCEeeCcCCcCccc----CCcccc--CCCCCCeEECcCceeee----ecCccc-cCCCCCCEEECCCCccccc
Q 042887 481 EVGNLRNLAEFDLSENHFSNE----IPVTLS--ACTTLEYLHLQGNSFSG----SLPLSL-KTLKSIKELDLSRNNLSGQ 549 (628)
Q Consensus 481 ~~~~l~~L~~L~Ls~N~l~~~----~~~~~~--~l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~ 549 (628)
.+..+++|++|+|++|.+++. ++..+. .+++|++|+|++|.+++ .+|..+ .++++|++|++++|++++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 666667777777777776644 334442 26667777777777665 355555 4466777777777777655
Q ss_pred C
Q 042887 550 I 550 (628)
Q Consensus 550 ~ 550 (628)
.
T Consensus 319 ~ 319 (386)
T 2ca6_A 319 D 319 (386)
T ss_dssp S
T ss_pred h
Confidence 5
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-24 Score=212.54 Aligned_cols=225 Identities=17% Similarity=0.176 Sum_probs=153.7
Q ss_pred CCceeecccCCcccccchHHHhc--cccccEEEccCCcceeeCchhh--hccCCcCeeeeccccccccCC----cCCCCC
Q 042887 338 QMEMLYLNTNKFGGVFLRSIANL--SAKITVIGMGDNQISGTIPSEI--KNLVNINAFGVEYNQLTGTIP----HAIGEL 409 (628)
Q Consensus 338 ~L~~L~l~~n~~~~~~~~~~~~~--~~~L~~L~l~~n~l~~~~~~~l--~~l~~L~~L~l~~n~l~~~~~----~~~~~l 409 (628)
.++.+.+..+.++......+... ..+++.|++++|.+.+..|..+ ..+++|++|++++|.+.+..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 35555555555543322221111 1257888888888877777776 778888888888888876444 334567
Q ss_pred CCCCeEecccCccccccCccccCCCCCCeEecCCcccccc---c-CCcccCCcchhcccceEEcCCCcCccccch----h
Q 042887 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGN---V-PSSLGNCQNLMTLSRLLDLSGNLLGGSIPL----E 481 (628)
Q Consensus 410 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~----~ 481 (628)
++|++|++++|++.+..+..|..+++|++|++++|++.+. . +..+..+++| ++|++++|+++. ++. .
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L----~~L~Ls~N~l~~-l~~~~~~l 219 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAI----QNLALRNTGMET-PTGVCAAL 219 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCC----CSCBCCSSCCCC-HHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCC----CEEECCCCCCCc-hHHHHHHH
Confidence 7888888888888877777788888888888888876542 1 2233566666 777888888863 222 2
Q ss_pred hhccCCCCEeeCcCCcCcccCCccccCC---CCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhccc
Q 042887 482 VGNLRNLAEFDLSENHFSNEIPVTLSAC---TTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLL 558 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (628)
++.+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..++
T Consensus 220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~ 294 (310)
T 4glp_A 220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELP 294 (310)
T ss_dssp HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCC
T ss_pred HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCC
Confidence 4667888888888888877666666655 58888888888887 5566553 6788888888888754 32 56777
Q ss_pred CCCeEeccCCcCcc
Q 042887 559 FLAYLNLSYNHFEG 572 (628)
Q Consensus 559 ~L~~L~ls~N~l~~ 572 (628)
+|+.|++++|+|+.
T Consensus 295 ~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 295 EVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCEECSSTTTSC
T ss_pred CccEEECcCCCCCC
Confidence 88888888887753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-25 Score=223.84 Aligned_cols=265 Identities=18% Similarity=0.227 Sum_probs=160.7
Q ss_pred EEecccCcCcccccccccCCCCCCEeecccccCcccCC----cCccCCC-CCCEEEeecccCcccCChhhhhC----CCC
Q 042887 190 AIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLP----LSIWNIS-SLEIISLHSNRFEGSLPLNIGFN----IPN 260 (628)
Q Consensus 190 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~----l~~ 260 (628)
.+++++|.+++.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..+... .++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788999998888877777779999999999987666 6778888 89999999999985545444431 288
Q ss_pred CcEEecccCccccccccccc----CC-CCCCEEEcccccceeeccccccc-----CCCCCEEEccCCcCCCcCCCCcccc
Q 042887 261 VNFLSVGQNNFTGSLPHSFS----NA-SNLQVLDVYKNHFSGQVKIDFNR-----LSNLSRLFLSKNNLGTESTSDLDFL 330 (628)
Q Consensus 261 L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~~~ 330 (628)
|++|+|++|++++..+..+. .+ ++|++|++++|++++..+..+.. .++|++|++++|.++..... ...
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~--~l~ 159 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD--ELI 159 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH--HHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH--HHH
Confidence 88888888888876665443 34 78888888888887666655433 25788888888877643221 122
Q ss_pred ccccCCC-CCceeecccCCcccccchHHHhc----cccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcC
Q 042887 331 TLLTNCS-QMEMLYLNTNKFGGVFLRSIANL----SAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHA 405 (628)
Q Consensus 331 ~~l~~~~-~L~~L~l~~n~~~~~~~~~~~~~----~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 405 (628)
..+...+ +|+.|++++|.+++..+..+... +.+|+.|++++|.+.+..... ++..
T Consensus 160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~--------------------l~~~ 219 (362)
T 3goz_A 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE--------------------LAYI 219 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH--------------------HHHH
T ss_pred HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHH--------------------HHHH
Confidence 2333343 67777777777666555444322 124455555555444321110 1222
Q ss_pred CCC-CCCCCeEecccCccccccC----ccccCCCCCCeEecCCcccccc-------cCCcccCCcchhcccceEEcCCCc
Q 042887 406 IGE-LKNLQGLALVRNSLRGTIP----DTLGNLTLLNRLFLGFNNLQGN-------VPSSLGNCQNLMTLSRLLDLSGNL 473 (628)
Q Consensus 406 ~~~-l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~l~~~L~Ls~N~ 473 (628)
+.. .++|++|++++|.+++..+ ..+..+++|+.|++++|.+.+. .+..+..+++| +.||+++|.
T Consensus 220 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L----~~LdL~~N~ 295 (362)
T 3goz_A 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI----ILVDKNGKE 295 (362)
T ss_dssp HHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEE----EEECTTSCB
T ss_pred HhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCce----EEEecCCCc
Confidence 222 2355555555555553322 2234445556666655553221 22234444444 666777777
Q ss_pred Cccccch
Q 042887 474 LGGSIPL 480 (628)
Q Consensus 474 l~~~~~~ 480 (628)
+....+.
T Consensus 296 l~~~~~~ 302 (362)
T 3goz_A 296 IHPSHSI 302 (362)
T ss_dssp CCGGGCH
T ss_pred CCCcchH
Confidence 6654443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=201.58 Aligned_cols=199 Identities=19% Similarity=0.180 Sum_probs=109.2
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeecccc-ccccCCcCCCCCCCCCeEeccc-CccccccCccccCCCCCCeEe
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ-LTGTIPHAIGELKNLQGLALVR-NSLRGTIPDTLGNLTLLNRLF 440 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 440 (628)
+++.|++++|++++..+..|.++++|+.|++++|+ +++..+..|..+++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45566666666665555566666666666666665 5555555566666666666665 666655555566666666666
Q ss_pred cCCcccccccCCcccCCcchhcccceEEcCCC-cCccccchhhhccCCCC-EeeCcCCcCcccCCccccCCCCCCeEECc
Q 042887 441 LGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN-LLGGSIPLEVGNLRNLA-EFDLSENHFSNEIPVTLSACTTLEYLHLQ 518 (628)
Q Consensus 441 L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 518 (628)
+++|++++ +|. +..+++|..+ +.|++++| ++++..+..|.++++|+ +|++++|+++...+..+.. ++|+.|+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L-~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIF-FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSE-EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred CCCCCCcc-ccc-cccccccccc-cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 66666653 333 5555555221 25566666 55544444555555555 5555555555333333333 555555555
Q ss_pred Cce-eeeecCccccCC-CCCCEEECCCCcccccCchhhhcccCCCeEeccCC
Q 042887 519 GNS-FSGSLPLSLKTL-KSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568 (628)
Q Consensus 519 ~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N 568 (628)
+|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 553 554444455555 5555555555555533222 3444555555544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-23 Score=199.22 Aligned_cols=178 Identities=20% Similarity=0.208 Sum_probs=86.9
Q ss_pred ccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCC
Q 042887 364 ITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGF 443 (628)
Q Consensus 364 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 443 (628)
.+.++++++.++. +|..+. ++++.|++++|.+.+..+..|..+++|++|++++|.+++..+..|..+++|++|++++
T Consensus 16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 4455555555542 232222 3455555555555544444555555555555555555544444455555555555555
Q ss_pred cccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceee
Q 042887 444 NNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523 (628)
Q Consensus 444 N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 523 (628)
|++++..+..+..+++| +.|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 93 n~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQL----DKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp SCCCCCCTTTTTTCTTC----CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CcccccChhHhcccCCC----CEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 55554444444444444 44455555554443334444555555555555554444434444455555555555554
Q ss_pred eecCccccCCCCCCEEECCCCcccc
Q 042887 524 GSLPLSLKTLKSIKELDLSRNNLSG 548 (628)
Q Consensus 524 ~~~~~~~~~l~~L~~L~Ls~N~l~~ 548 (628)
+..+..+..+++|+.|++++|+++.
T Consensus 169 ~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 169 SVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred ccCHHHHhCCCCCCEEEeeCCceeC
Confidence 4444444444555555555555443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=202.42 Aligned_cols=198 Identities=13% Similarity=0.121 Sum_probs=175.0
Q ss_pred CCcCeeeeccccccccCCcCCCCCCCCCeEecccCc-cccccCccccCCCCCCeEecCC-cccccccCCcccCCcchhcc
Q 042887 386 VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNS-LRGTIPDTLGNLTLLNRLFLGF-NNLQGNVPSSLGNCQNLMTL 463 (628)
Q Consensus 386 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~l 463 (628)
++++.|++++|++++..+..|..+++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|.++++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L--- 107 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL--- 107 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTC---
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCC---
Confidence 389999999999998888899999999999999997 9877777999999999999998 99998888899999998
Q ss_pred cceEEcCCCcCccccchhhhccCCCC---EeeCcCC-cCcccCCccccCCCCCC-eEECcCceeeeecCccccCCCCCCE
Q 042887 464 SRLLDLSGNLLGGSIPLEVGNLRNLA---EFDLSEN-HFSNEIPVTLSACTTLE-YLHLQGNSFSGSLPLSLKTLKSIKE 538 (628)
Q Consensus 464 ~~~L~Ls~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~ 538 (628)
+.|++++|++++ +|. +..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++...+..+.. ++|+.
T Consensus 108 -~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~ 183 (239)
T 2xwt_C 108 -KFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDA 183 (239)
T ss_dssp -CEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEE
T ss_pred -CEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCE
Confidence 899999999996 555 88889998 9999999 99988788899999999 9999999999555555655 89999
Q ss_pred EECCCCc-ccccCchhhhcc-cCCCeEeccCCcCcccCCCCCCCCCCCcccccCCC
Q 042887 539 LDLSRNN-LSGQIPKYLENL-LFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNE 592 (628)
Q Consensus 539 L~Ls~N~-l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~ 592 (628)
|++++|+ ++...+..|..+ ++|+.|++++|++++..+. .+++++.+++.++.
T Consensus 184 L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp EECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC-
T ss_pred EEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCcc
Confidence 9999995 998888899999 9999999999999865443 67888888887664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-23 Score=202.04 Aligned_cols=201 Identities=23% Similarity=0.239 Sum_probs=177.0
Q ss_pred EEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcc
Q 042887 366 VIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNN 445 (628)
Q Consensus 366 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 445 (628)
.+.+..+.+.+. .....+++|+.|++++|.+... ..+..+++|++|++++|.+++. ..+..+++|++|++++|+
T Consensus 23 ~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~ 96 (272)
T 3rfs_A 23 KANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQ 96 (272)
T ss_dssp HHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSC
T ss_pred HHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCc
Confidence 344445544433 3467889999999999998743 4588899999999999999853 478999999999999999
Q ss_pred cccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeee
Q 042887 446 LQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS 525 (628)
Q Consensus 446 l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 525 (628)
+++..+..+..+++| +.|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++.
T Consensus 97 l~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 97 LQSLPNGVFDKLTNL----KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp CCCCCTTTTTTCTTC----CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cCccChhHhcCCcCC----CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 998888888999998 8999999999988888899999999999999999988888889999999999999999988
Q ss_pred cCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCC
Q 042887 526 LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 526 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 576 (628)
.+..+..+++|++|++++|++++..+..+..+++|++|++++|++.+.+|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 888889999999999999999998888899999999999999999987763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.5e-23 Score=196.99 Aligned_cols=183 Identities=22% Similarity=0.217 Sum_probs=164.6
Q ss_pred CCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccc
Q 042887 386 VNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSR 465 (628)
Q Consensus 386 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~ 465 (628)
...+.++++++.+. .+|..+. ++++.|++++|.+++..+..|..+++|++|++++|++++..+..+.++++| +
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~ 86 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL----G 86 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC----C
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcC----C
Confidence 45678999999998 4565554 689999999999998888899999999999999999998888889999888 8
Q ss_pred eEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCc
Q 042887 466 LLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNN 545 (628)
Q Consensus 466 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 545 (628)
.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 87 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 99999999998888889999999999999999997777778999999999999999997777789999999999999999
Q ss_pred ccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 546 LSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 546 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
+++..+..|..+++|+.|++++|++++...
T Consensus 167 l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 167 LQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 998888899999999999999999988744
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=207.84 Aligned_cols=223 Identities=21% Similarity=0.186 Sum_probs=182.7
Q ss_pred cccEEEccCCcceeeCch---hhhccCCcCeeeeccccccccCCcCC--CCCCCCCeEecccCccccccC----ccccCC
Q 042887 363 KITVIGMGDNQISGTIPS---EIKNLVNINAFGVEYNQLTGTIPHAI--GELKNLQGLALVRNSLRGTIP----DTLGNL 433 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~---~l~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l 433 (628)
.++.+.+.++.++...-. .+..+++|++|++++|.+.+..|..+ ..+++|++|++++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 567788888776532111 12345779999999999999988888 899999999999999997555 345679
Q ss_pred CCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc--c--chhhhccCCCCEeeCcCCcCcccCCc----c
Q 042887 434 TLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS--I--PLEVGNLRNLAEFDLSENHFSNEIPV----T 505 (628)
Q Consensus 434 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~--~--~~~~~~l~~L~~L~Ls~N~l~~~~~~----~ 505 (628)
++|++|++++|++++..+..+..+++| ++|++++|++.+. . +..+..+++|++|++++|+++. .+. .
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 219 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPAL----TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAAL 219 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTC----CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCC----CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHH
Confidence 999999999999998888999999998 8999999998652 2 2234789999999999999973 222 3
Q ss_pred ccCCCCCCeEECcCceeeeecCccccCC---CCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCC
Q 042887 506 LSACTTLEYLHLQGNSFSGSLPLSLKTL---KSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGN 582 (628)
Q Consensus 506 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 582 (628)
+..+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|++++|++++. |....+++
T Consensus 220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~ 295 (310)
T 4glp_A 220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPE 295 (310)
T ss_dssp HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCC
T ss_pred HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCC
Confidence 5788999999999999998878777776 69999999999999 5666654 7999999999999974 44566788
Q ss_pred CCcccccCCCCC
Q 042887 583 RTGIHLIGNERL 594 (628)
Q Consensus 583 l~~~~~~~n~~~ 594 (628)
++.+++++|+..
T Consensus 296 L~~L~L~~N~l~ 307 (310)
T 4glp_A 296 VDNLTLDGNPFL 307 (310)
T ss_dssp CSCEECSSTTTS
T ss_pred ccEEECcCCCCC
Confidence 999999999754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-25 Score=227.78 Aligned_cols=44 Identities=14% Similarity=0.216 Sum_probs=26.4
Q ss_pred ccchhhhCCCCCCEEecccCcCcccccc----cccCCCCCCEeecccc
Q 042887 177 KFPDFIANFSALEAIDISANMLGGRIPD----SLCQLRSLNYLSISEN 220 (628)
Q Consensus 177 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~----~~~~l~~L~~L~Ls~N 220 (628)
.++..+..+++|++|+|++|.++...+. .+..+++|++|+|++|
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~ 70 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 70 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCccc
Confidence 3445566666677777777766654332 3556666666666664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-23 Score=210.83 Aligned_cols=251 Identities=17% Similarity=0.189 Sum_probs=177.4
Q ss_pred CCCEEEcccccceeecccccccC--CCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhcc
Q 042887 284 NLQVLDVYKNHFSGQVKIDFNRL--SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLS 361 (628)
Q Consensus 284 ~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~ 361 (628)
.++.+++++|.+. +..+..+ ++++.|++++|.+.+.... +..+++|+.|++++|.+
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-------~~~~~~L~~L~L~~~~l------------ 105 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-------HFSPFRVQHMDLSNSVI------------ 105 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-------CCCCBCCCEEECTTCEE------------
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-------hccCCCCCEEEccCCCc------------
Confidence 3666777766655 3445555 6777777777766553221 22334455555554443
Q ss_pred ccccEEEccCCcceee-CchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccC-ccccc-cCccccCCCCCCe
Q 042887 362 AKITVIGMGDNQISGT-IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRN-SLRGT-IPDTLGNLTLLNR 438 (628)
Q Consensus 362 ~~L~~L~l~~n~l~~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~ 438 (628)
.+. ++..+..+++|++|++++|.+.+..+..++.+++|++|++++| .+++. .+..+..+++|++
T Consensus 106 -------------~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 106 -------------EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp -------------CHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred -------------CHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 322 3445667777888888888777666777777888888888888 56652 5666777888888
Q ss_pred EecCCc-ccccc-cCCcccCCc-chhcccceEEcCCC--cCc-cccchhhhccCCCCEeeCcCCc-CcccCCccccCCCC
Q 042887 439 LFLGFN-NLQGN-VPSSLGNCQ-NLMTLSRLLDLSGN--LLG-GSIPLEVGNLRNLAEFDLSENH-FSNEIPVTLSACTT 511 (628)
Q Consensus 439 L~L~~N-~l~~~-~~~~~~~l~-~L~~l~~~L~Ls~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~ 511 (628)
|++++| .+++. .+..+..++ +| +.|++++| .++ +.++..+..+++|++|++++|. +++..+..+..+++
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L----~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~ 248 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETI----TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTC----CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred EcCCCCCCcChHHHHHHHHhcccCC----CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCC
Confidence 888888 88754 455667777 77 88889988 454 3466778889999999999999 77777888899999
Q ss_pred CCeEECcCce-eeeecCccccCCCCCCEEECCCCcccccCchhhhcc-cCCCeEeccCCcCcccCCCC
Q 042887 512 LEYLHLQGNS-FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL-LFLAYLNLSYNHFEGEVPRK 577 (628)
Q Consensus 512 L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~ 577 (628)
|++|++++|. +.......+..+++|+.|++++| ++. +.+..+ ..+..|++++|++++..|..
T Consensus 249 L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 249 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred CCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 9999999995 33222236788999999999999 443 334444 34778889999999987753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=212.84 Aligned_cols=256 Identities=18% Similarity=0.247 Sum_probs=168.3
Q ss_pred cccEEEccCCccccccchhhhCC--CCCCEEecccCcCcccccccccCCCCCCEeecccccCccc-CCcCccCCCCCCEE
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANF--SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCK-LPLSIWNISSLEII 239 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L 239 (628)
.++.+|+++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3678889888876 5667776 8888999998888866554 55788888888888888755 67777888888888
Q ss_pred EeecccCcccCChhhhhCCCCCcEEecccC-ccccc-ccccccCCCCCCEEEcccc-cceee-cccccccCC-CCCEEEc
Q 042887 240 SLHSNRFEGSLPLNIGFNIPNVNFLSVGQN-NFTGS-LPHSFSNASNLQVLDVYKN-HFSGQ-VKIDFNRLS-NLSRLFL 314 (628)
Q Consensus 240 ~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~-~L~~L~L 314 (628)
++++|.+++..+..+.. +++|++|++++| .+++. .+..+.++++|++|++++| .+++. .+..+..++ +|++|++
T Consensus 124 ~L~~~~l~~~~~~~l~~-~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHTT-CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred eCcCcccCHHHHHHHhc-CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 88888887666665553 788888888888 56652 5556777788888888888 77653 345566777 7777777
Q ss_pred cCCc--CCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeee
Q 042887 315 SKNN--LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFG 392 (628)
Q Consensus 315 ~~n~--l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 392 (628)
++|. ++.. ..+..+..+++|+.|++++|.. +++..+..+..+++|+.|+
T Consensus 203 ~~~~~~~~~~-----~l~~~~~~~~~L~~L~l~~~~~------------------------l~~~~~~~l~~l~~L~~L~ 253 (336)
T 2ast_B 203 SGYRKNLQKS-----DLSTLVRRCPNLVHLDLSDSVM------------------------LKNDCFQEFFQLNYLQHLS 253 (336)
T ss_dssp CSCGGGSCHH-----HHHHHHHHCTTCSEEECTTCTT------------------------CCGGGGGGGGGCTTCCEEE
T ss_pred CCCcccCCHH-----HHHHHHhhCCCCCEEeCCCCCc------------------------CCHHHHHHHhCCCCCCEee
Confidence 7773 3210 1222333444455555444441 3334445566667777777
Q ss_pred ecccc-ccccCCcCCCCCCCCCeEecccCccccccCccccCC-CCCCeEecCCcccccccCCcccC
Q 042887 393 VEYNQ-LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNL-TLLNRLFLGFNNLQGNVPSSLGN 456 (628)
Q Consensus 393 l~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~ 456 (628)
+++|. +.......+..+++|+.|++++| ++. ..+..+ .++..|++++|++++..|..++.
T Consensus 254 l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 254 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 77773 32222224666777788888777 332 223333 23566667888887777766654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-22 Score=199.22 Aligned_cols=190 Identities=24% Similarity=0.334 Sum_probs=150.4
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
+++.|++++|.+... + .+..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++. ..+..+++|++|+++
T Consensus 42 ~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC
Confidence 677777777777643 3 57788888888888888875544 88888888999988888753 368888889999999
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|++++.. .+..+++| +.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++
T Consensus 116 ~n~l~~~~--~l~~l~~L----~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 116 STQITDVT--PLAGLSNL----QVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp TSCCCCCG--GGTTCTTC----CEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred CCCCCCch--hhcCCCCC----CEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 88887532 27777777 888899998885443 7888899999999998885433 78888999999999998
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcc
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 572 (628)
++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 85443 7888899999999999986553 7888899999999998876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-22 Score=201.58 Aligned_cols=152 Identities=14% Similarity=0.135 Sum_probs=81.6
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccC-CcCccCCCCCCE-EEee
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKL-PLSIWNISSLEI-ISLH 242 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~-L~L~ 242 (628)
++++-++++++ .+|..+ .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+ +.+|.+++++++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45666666666 344433 246666666666666555556666666666666666654333 345566665543 4444
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEccc-ccceeecccccccCC-CCCEEEccCCcCC
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYK-NHFSGQVKIDFNRLS-NLSRLFLSKNNLG 320 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~-~L~~L~L~~n~l~ 320 (628)
.|+++ .++...+..+++|++|++++|+++...+..+....++..|++.+ +++..+.+..|..+. .++.|++++|+++
T Consensus 89 ~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 55665 44444444555566666655555544444444445555555533 344444444444432 3444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=198.61 Aligned_cols=76 Identities=21% Similarity=0.160 Sum_probs=32.4
Q ss_pred ceEEcCC-CcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCC
Q 042887 465 RLLDLSG-NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSR 543 (628)
Q Consensus 465 ~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (628)
+.+++++ |.++...+..|.++++|++||+++|+|+...+..+ .+|+.|.+.++.-...+| .+..+++|+.+++++
T Consensus 180 ~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTY 255 (350)
T ss_dssp EEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSC
T ss_pred hHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCC-CchhCcChhhCcCCC
Confidence 3444442 34443333345555555555555555553332222 233333332222112333 244555555555544
Q ss_pred C
Q 042887 544 N 544 (628)
Q Consensus 544 N 544 (628)
+
T Consensus 256 ~ 256 (350)
T 4ay9_X 256 P 256 (350)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.7e-22 Score=196.47 Aligned_cols=206 Identities=27% Similarity=0.340 Sum_probs=173.7
Q ss_pred ccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccccc
Q 042887 369 MGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448 (628)
Q Consensus 369 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 448 (628)
++.+.+.+.. ....+++|+.|++++|.+.. ++ .+..+++|++|++++|.+++..+ +..+++|++|++++|++++
T Consensus 26 l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~ 99 (308)
T 1h6u_A 26 AGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN 99 (308)
T ss_dssp TTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC
T ss_pred hCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC
Confidence 4444444332 35678899999999999985 34 68899999999999999996544 9999999999999999985
Q ss_pred ccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCc
Q 042887 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL 528 (628)
Q Consensus 449 ~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 528 (628)
. ..+..+++| +.|++++|++++. + .+..+++|++|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 100 ~--~~~~~l~~L----~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~- 168 (308)
T 1h6u_A 100 V--SAIAGLQSI----KTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP- 168 (308)
T ss_dssp C--GGGTTCTTC----CEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred c--hhhcCCCCC----CEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-
Confidence 3 367778888 8999999999864 3 38999999999999999986544 8899999999999999996443
Q ss_pred cccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCc
Q 042887 529 SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLC 595 (628)
Q Consensus 529 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c 595 (628)
+..+++|+.|++++|++++..+ +..+++|++|++++|++++..| ...+++++.+++++|+..+
T Consensus 169 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEEC
T ss_pred -hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeec
Confidence 8999999999999999996554 8899999999999999998665 5678899999999998655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8e-21 Score=177.85 Aligned_cols=179 Identities=21% Similarity=0.277 Sum_probs=135.1
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecc
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n 244 (628)
+.++.+++.++. +|..+ .++|++|++++|.+++..+..|..+++|++|++++|+++...+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 466777777764 34332 457888888888888777777888888888888888888666666788888888888888
Q ss_pred cCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCC
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTEST 324 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 324 (628)
.++ .+|...+..+++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|.+..
T Consensus 87 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--- 162 (208)
T 2o6s_A 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--- 162 (208)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred cCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence 887 6666665568888888888888887777778888888888888888887777778888888888888886643
Q ss_pred CCccccccccCCCCCceeecccCCcccccchHHHhc
Q 042887 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL 360 (628)
Q Consensus 325 ~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~ 360 (628)
.++.|+.|+++.|.+++..+..++.+
T Consensus 163 ----------~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 163 ----------TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp ----------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred ----------CCCCHHHHHHHHHhCCceeeccCccc
Confidence 34567777777777776666554443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-21 Score=181.26 Aligned_cols=151 Identities=18% Similarity=0.204 Sum_probs=72.7
Q ss_pred eeeeccccccccCCcCCCCCCCCCeEecccCccccccC-ccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEE
Q 042887 390 AFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIP-DTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLD 468 (628)
Q Consensus 390 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~ 468 (628)
.+++++|.++. +|..+. +.+++|++++|++++..+ ..|..+++|++|++++|+|++..+..|.++++| +.|+
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L----~~L~ 87 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV----NEIL 87 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC----CEEE
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC----CEEE
Confidence 55555555553 333332 234555555555554432 234555555555555555554444444444444 4445
Q ss_pred cCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 469 LSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 469 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|+++
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 5555554444444444444444444444444444444444444444444444444444444444444444444444444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.4e-21 Score=177.73 Aligned_cols=173 Identities=24% Similarity=0.218 Sum_probs=128.9
Q ss_pred eeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEc
Q 042887 390 AFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDL 469 (628)
Q Consensus 390 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~L 469 (628)
.++.+++.++. +|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++| ++|++
T Consensus 11 ~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~L 83 (208)
T 2o6s_A 11 TVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL----TYLNL 83 (208)
T ss_dssp EEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC----CEEEC
T ss_pred EEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCc----CEEEC
Confidence 44555555552 33322 3467777777777776666667777778888888777776666666777777 77888
Q ss_pred CCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccccc
Q 042887 470 SGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQ 549 (628)
Q Consensus 470 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (628)
++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~- 162 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC- 162 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-
Confidence 8888876666667888888888888888887666677888888888888888886666668888888888888887774
Q ss_pred CchhhhcccCCCeEeccCCcCcccCCC
Q 042887 550 IPKYLENLLFLAYLNLSYNHFEGEVPR 576 (628)
Q Consensus 550 ~~~~~~~l~~L~~L~ls~N~l~~~~p~ 576 (628)
.+++|++|+++.|+++|.+|.
T Consensus 163 ------~~~~l~~L~~~~n~~~g~ip~ 183 (208)
T 2o6s_A 163 ------TCPGIRYLSEWINKHSGVVRN 183 (208)
T ss_dssp ------CTTTTHHHHHHHHHCTTTBBC
T ss_pred ------CCCCHHHHHHHHHhCCceeec
Confidence 345788888888988888875
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.3e-21 Score=180.36 Aligned_cols=152 Identities=20% Similarity=0.236 Sum_probs=80.8
Q ss_pred CeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEE
Q 042887 389 NAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLD 468 (628)
Q Consensus 389 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~ 468 (628)
+.++++++.++ .+|..+. ++++.|++++|.+++..+..|..+++|++|++++|++++..|..|.++++| ++|+
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L----~~L~ 86 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL----NSLV 86 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC----CEEE
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC----CEEE
Confidence 34555666555 2333332 455666666666655555555555566666665555555555555555555 5555
Q ss_pred cCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 469 LSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 469 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
|++|+|+...+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 87 Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 87 LYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 5555555444444455555555555555555444555555555555555555555444444555555555555555544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-20 Score=176.31 Aligned_cols=153 Identities=20% Similarity=0.323 Sum_probs=137.8
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecc
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n 244 (628)
+.+++++++++. +|..+. ++|+.|++++|.++++.+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 578999999884 555443 68999999999999888889999999999999999999888999999999999999999
Q ss_pred cCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
.++ .+|..++..+++|++|+|++|++++..|..|.++++|++|+|++|+++++.+..|..+++|++|++++|.+..
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 998 7888887789999999999999998888999999999999999999998888889999999999999998764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=189.50 Aligned_cols=176 Identities=26% Similarity=0.210 Sum_probs=97.5
Q ss_pred eeeeccccccccCCcCCCCCCCCCeEecccCccccccCcccc-CCCCCCeEecCCcccccccCCcccCCcchhcccceEE
Q 042887 390 AFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLG-NLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLD 468 (628)
Q Consensus 390 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~ 468 (628)
.+++++++++. +|..+. +.++.|+|++|++++..+..|. .+++|++|++++|+|++..+..|.++++| +.|+
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L----~~L~ 94 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL----RYLD 94 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTC----CEEE
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCC----CEEE
Confidence 44455555442 333222 2355555555555555555454 55556666666665555555555555555 5556
Q ss_pred cCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccc---cCCCCCCEEECCCCc
Q 042887 469 LSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSL---KTLKSIKELDLSRNN 545 (628)
Q Consensus 469 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~Ls~N~ 545 (628)
|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..| ..+++|+.|+|++|+
T Consensus 95 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~ 174 (361)
T 2xot_A 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSC
T ss_pred CCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCC
Confidence 66666655545555666666666666666665555566666666666666666664333333 345666666666666
Q ss_pred ccccCchhhhcccC--CCeEeccCCcCcc
Q 042887 546 LSGQIPKYLENLLF--LAYLNLSYNHFEG 572 (628)
Q Consensus 546 l~~~~~~~~~~l~~--L~~L~ls~N~l~~ 572 (628)
|+...++.+..++. ++.|++++|++..
T Consensus 175 l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CCccCHHHhhhccHhhcceEEecCCCccC
Confidence 66555555665554 3566666666553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.5e-20 Score=195.78 Aligned_cols=187 Identities=22% Similarity=0.330 Sum_probs=85.4
Q ss_pred CCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEec
Q 042887 338 QMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLAL 417 (628)
Q Consensus 338 ~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 417 (628)
+++.|++++|.+++.... + .++++.|++++|.++ .+| ..+++|+.|++++|++++ +|. +.. +|++|++
T Consensus 60 ~L~~L~Ls~n~L~~lp~~-l---~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDN-L---PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSCCCSC-C---CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCccCHh-H---cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 455555555555542221 1 124555555555554 233 234455555555555543 333 332 4555555
Q ss_pred ccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCc
Q 042887 418 VRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENH 497 (628)
Q Consensus 418 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 497 (628)
++|.+++ +|. .+++|+.|++++|+|++ +|. .+++| +.|+|++|++++ +|. |. ++|++|+|++|+
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L----~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSL----EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNL 191 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTC----CEEECCSSCCSC-CCC-CC--TTCCEEECCSSC
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCc----CEEECCCCCCCC-cch-hh--CCCCEEECcCCC
Confidence 5555553 332 34455555555555543 232 22333 445555555543 333 33 455555555555
Q ss_pred CcccCCccccCCCCC-------CeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcc
Q 042887 498 FSNEIPVTLSACTTL-------EYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557 (628)
Q Consensus 498 l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 557 (628)
|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 192 L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 192 LE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 54 2333 322 34 55555555554 344444445555555555555555445444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.6e-20 Score=172.03 Aligned_cols=153 Identities=21% Similarity=0.236 Sum_probs=135.3
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCccccc-ccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIP-DSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
+.+++++|.++. +|..+ ...+++|+|++|.+++..+ ..|..+++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 589999999985 56544 3467899999999997754 5689999999999999999988888999999999999999
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
|.++ .++...+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|++++|.+..
T Consensus 91 N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 9998 6777766679999999999999998889999999999999999999998888899999999999999998865
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8e-20 Score=180.19 Aligned_cols=173 Identities=29% Similarity=0.331 Sum_probs=109.0
Q ss_pred hhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchh
Q 042887 382 IKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLM 461 (628)
Q Consensus 382 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 461 (628)
+..+++|+.|++++|.+.+. + .+..+++|++|++++|++++..+ +..+++|++|++++|++++. ..+..+++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L- 114 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKL- 114 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTC-
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCC-
Confidence 34556666666666666533 2 35566666666666666664333 66666666666666666532 225555555
Q ss_pred cccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEEC
Q 042887 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDL 541 (628)
Q Consensus 462 ~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 541 (628)
+.|++++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|++
T Consensus 115 ---~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L 185 (291)
T 1h6t_A 115 ---KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (291)
T ss_dssp ---CEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ---CEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence 6667777766643 3566667777777777777643 456667777777777777765433 666777777777
Q ss_pred CCCcccccCchhhhcccCCCeEeccCCcCcc
Q 042887 542 SRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 542 s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 572 (628)
++|.+++. + .+..+++|+.|++++|+++.
T Consensus 186 ~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 186 SKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 77777643 3 36667777777777777654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.7e-20 Score=186.90 Aligned_cols=177 Identities=25% Similarity=0.209 Sum_probs=152.1
Q ss_pred CeEecccCccccccCccccCCCCCCeEecCCcccccccCCccc-CCcchhcccceEEcCCCcCccccchhhhccCCCCEe
Q 042887 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLG-NCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEF 491 (628)
Q Consensus 413 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L 491 (628)
+.++++++.++. +|..+. +.++.|++++|+|++..+..+. ++++| +.|+|++|+|++..+..|.++++|++|
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L----~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNL----HSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTC----CEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhccccc----CEEECCCCcCCccChhhccCCCCCCEE
Confidence 689999999984 665543 4689999999999988888887 88888 899999999998888899999999999
Q ss_pred eCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhh---hcccCCCeEeccCC
Q 042887 492 DLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYL---ENLLFLAYLNLSYN 568 (628)
Q Consensus 492 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~ls~N 568 (628)
+|++|++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|
T Consensus 94 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N 173 (361)
T 2xot_A 94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSS
T ss_pred ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCC
Confidence 999999998888889999999999999999998889999999999999999999997666666 67999999999999
Q ss_pred cCcccCCC-CCCCCC--CCcccccCCCCCcc
Q 042887 569 HFEGEVPR-KGVFGN--RTGIHLIGNERLCG 596 (628)
Q Consensus 569 ~l~~~~p~-~~~~~~--l~~~~~~~n~~~c~ 596 (628)
+|++..+. ...++. ++.+++.+||+.|.
T Consensus 174 ~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 99864432 122333 36789999999985
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-19 Score=170.68 Aligned_cols=153 Identities=24% Similarity=0.242 Sum_probs=82.5
Q ss_pred cCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceE
Q 042887 388 INAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLL 467 (628)
Q Consensus 388 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L 467 (628)
.+.++.+++.+. .+|..+. ++|++|++++|.+++..|..|..+++|++|++++|+++...+..|..+++| +.|
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L----~~L 93 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL----TVL 93 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC----CEE
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc----CEE
Confidence 345566666655 3333332 556666666666665555556666666666666666654444444555555 555
Q ss_pred EcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 468 DLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 468 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..+..+++|+.|++++|++.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 55555555444444555555555555555555 34444555555555555555555444444555555555555555554
Q ss_pred c
Q 042887 548 G 548 (628)
Q Consensus 548 ~ 548 (628)
.
T Consensus 173 c 173 (229)
T 3e6j_A 173 C 173 (229)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-19 Score=177.00 Aligned_cols=175 Identities=22% Similarity=0.347 Sum_probs=142.3
Q ss_pred ccCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCC
Q 042887 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSL 236 (628)
Q Consensus 157 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 236 (628)
....+++|+.|++++|.+... + .+..+++|++|++++|++++..+ +..+++|++|++++|.+++ +| .+..+++|
T Consensus 41 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L 114 (291)
T 1h6t_A 41 TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKL 114 (291)
T ss_dssp CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTC
T ss_pred chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCC
Confidence 345678899999999998855 3 48889999999999999986554 8999999999999999985 33 48899999
Q ss_pred CEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccC
Q 042887 237 EIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316 (628)
Q Consensus 237 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 316 (628)
++|++++|.++ .++ .+ ..+++|+.|++++|++++. ..+..+++|++|++++|++++..+ +..+++|++|++++
T Consensus 115 ~~L~L~~n~i~-~~~-~l-~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~ 187 (291)
T 1h6t_A 115 KSLSLEHNGIS-DIN-GL-VHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187 (291)
T ss_dssp CEEECTTSCCC-CCG-GG-GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CEEECCCCcCC-CCh-hh-cCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCC
Confidence 99999999998 453 33 3589999999999999865 578889999999999999987655 88889999999999
Q ss_pred CcCCCcCCCCccccccccCCCCCceeecccCCcccc
Q 042887 317 NNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV 352 (628)
Q Consensus 317 n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~ 352 (628)
|.++.+ ..+..+++|+.|++++|++...
T Consensus 188 N~i~~l--------~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 188 NHISDL--------RALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp SCCCBC--------GGGTTCTTCSEEEEEEEEEECC
T ss_pred CcCCCC--------hhhccCCCCCEEECcCCcccCC
Confidence 988753 2366777888888888876543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-19 Score=169.10 Aligned_cols=153 Identities=19% Similarity=0.240 Sum_probs=124.3
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
.+.++.++++++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|.++...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 467888888887 4454333 7888999999998888888888888999999999988866667788888889999988
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
|.++ .+|...+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|..+++|+.|++++|.+..
T Consensus 98 N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 8888 677666667888888888888888 667778888888888888888887777778888888888888887764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=191.92 Aligned_cols=181 Identities=21% Similarity=0.294 Sum_probs=126.2
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
+++.|++++|.+++ +|..+ .++|+.|++++|+++ .+| ..+++|++|++++|++++ +|. +.. +|++|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 67788888888776 44444 267788888888877 445 346778888888888875 555 544 78888888
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|++++ +|. .+++| +.|++++|++++ +|. .+++|++|+|++|++++ +|. +. ++|+.|+|++|+|
T Consensus 129 ~N~l~~-lp~---~l~~L----~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L 192 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALL----EYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLL 192 (571)
T ss_dssp SSCCSC-CCC---CCTTC----CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCC
T ss_pred CCcCCC-CCC---cCccc----cEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCC
Confidence 888875 444 45555 777888888875 443 46778888888888875 454 54 7788888888887
Q ss_pred eeecCccccCCCCC-------CEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 523 SGSLPLSLKTLKSI-------KELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 523 ~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|++++|++++.+|
T Consensus 193 ~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 193 E-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp S-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred C-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 7 5555 443 66 78888888887 456666668888888888888877655
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.4e-19 Score=191.56 Aligned_cols=187 Identities=27% Similarity=0.337 Sum_probs=141.1
Q ss_pred EEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccc
Q 042887 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNL 446 (628)
Q Consensus 367 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 446 (628)
+.++.+.+.+.. .+..+++|+.|++++|.+... + .+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++
T Consensus 26 l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l 99 (605)
T 1m9s_A 26 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99 (605)
T ss_dssp HHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred HhccCCCccccc--chhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCC
Confidence 344445544332 256777888888888887743 3 47778888888888888886544 77888888888888888
Q ss_pred ccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeec
Q 042887 447 QGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL 526 (628)
Q Consensus 447 ~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 526 (628)
++ + ..+..+++| +.|+|++|++.+. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+.+..
T Consensus 100 ~~-l-~~l~~l~~L----~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 100 KD-L-SSLKDLKKL----KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp CC-C-TTSTTCTTC----CEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CC-C-hhhccCCCC----CEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 74 2 356777777 7888888888753 4577888888888888888754 56788888888888888888655
Q ss_pred CccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCccc
Q 042887 527 PLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 527 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 5 78888888888888888854 3578888888888888888764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.1e-19 Score=179.60 Aligned_cols=101 Identities=15% Similarity=0.074 Sum_probs=51.0
Q ss_pred CCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccc-eEEcCCCcCccccchhhhccCCC
Q 042887 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSR-LLDLSGNLLGGSIPLEVGNLRNL 488 (628)
Q Consensus 410 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~-~L~Ls~N~l~~~~~~~~~~l~~L 488 (628)
++|+.+++++|+++...+..|.++++|+.+++.+| ++...+..|.+|.+| + .+++.+ .++.+.+..|.++++|
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L----~~~l~l~~-~l~~I~~~aF~~c~~L 299 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRL----AGTLELPA-SVTAIEFGAFMGCDNL 299 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC----CEEEEECT-TCCEECTTTTTTCTTE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhc----cEEEEEcc-cceEEchhhhhCCccC
Confidence 44444444444444444444444444555555444 444444445555444 4 445544 4444444555555555
Q ss_pred CEeeCcCCcCcccCCccccCCCCCCeEE
Q 042887 489 AEFDLSENHFSNEIPVTLSACTTLEYLH 516 (628)
Q Consensus 489 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 516 (628)
+.+++++|+++...+..|.++++|+.++
T Consensus 300 ~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 300 RYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5555555555555555555555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.6e-20 Score=177.05 Aligned_cols=172 Identities=19% Similarity=0.230 Sum_probs=127.2
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
.++.++..+++++|.+++.. .+..+++|++|++++|.++. ++ .++.+++|++|+|++|.+++..+ +..+++|++
T Consensus 16 ~~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 16 PGLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 34566777788888877543 57778888888888888874 44 67788888888888888875433 788888888
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
|++++|+++ .+|.... ++|+.|++++|++++. ..++.+++|++|++++|++++.. .+..+++|++|++++|+
T Consensus 90 L~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 90 LSVNRNRLK-NLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp EECCSSCCS-CCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSC
T ss_pred EECCCCccC-CcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCc
Confidence 888888887 4554322 7888888888888854 35778888888888888887652 57778888888888888
Q ss_pred CCCcCCCCccccccccCCCCCceeecccCCcccc
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV 352 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~ 352 (628)
+++. ..+..+++|+.|++++|.+...
T Consensus 162 i~~~--------~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 162 ITNT--------GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCBC--------TTSTTCCCCCEEEEEEEEEECC
T ss_pred Ccch--------HHhccCCCCCEEeCCCCcccCC
Confidence 8653 3456667777778777776554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.4e-19 Score=162.06 Aligned_cols=154 Identities=14% Similarity=0.251 Sum_probs=119.9
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 56678899999999988 445 5888999999999999775 3347888999999999999998777888888999999
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCc-ccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNN-FTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
|++++|.+++..|..+. .+++|++|++++|. ++. +| .+..+++|++|++++|++++.. .+..+++|++|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~-~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 117 LDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EECCSSBCBGGGHHHHT-TCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC
T ss_pred EEecCCccCcHhHHHHh-hCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCc
Confidence 99999988855555554 58888888888887 653 34 5788888888888888887643 5777888888888888
Q ss_pred cCCC
Q 042887 318 NLGT 321 (628)
Q Consensus 318 ~l~~ 321 (628)
++..
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 7653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=4.8e-19 Score=163.16 Aligned_cols=131 Identities=24% Similarity=0.297 Sum_probs=88.7
Q ss_pred CeEecccCccccccCccccCCCCCCeEecCCcccccccCC-cccCCcchhcccceEEcCCCcCccccchhhhccCCCCEe
Q 042887 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPS-SLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEF 491 (628)
Q Consensus 413 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L 491 (628)
+.+++++|.++ .+|..+. .++++|++++|++++..+. .+..+++| +.|+|++|++++..|..|.++++|++|
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHL----VKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTC----CEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCC----CEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 56777777776 4454443 2677777777777655543 36666666 667777777776666677777777777
Q ss_pred eCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccC
Q 042887 492 DLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQI 550 (628)
Q Consensus 492 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 550 (628)
+|++|++++..+..|..+++|++|+|++|++++..|..+..+++|++|+|++|++++..
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 77777777666666667777777777777777666666777777777777777776543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=160.63 Aligned_cols=153 Identities=16% Similarity=0.220 Sum_probs=75.0
Q ss_pred hccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhc
Q 042887 383 KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMT 462 (628)
Q Consensus 383 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 462 (628)
..+++|+.|++++|.+. .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~------- 109 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLS------- 109 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCT-------
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhc-------
Confidence 44455555555555555 223 3555555555555555443 222445555555555555555444444444
Q ss_pred ccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCce-eeeecCccccCCCCCCEEEC
Q 042887 463 LSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS-FSGSLPLSLKTLKSIKELDL 541 (628)
Q Consensus 463 l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L 541 (628)
.+++|++|++++|++++..+..+..+++|++|++++|+ ++ .+| .+..+++|++|++
T Consensus 110 ---------------------~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l 166 (197)
T 4ezg_A 110 ---------------------GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNI 166 (197)
T ss_dssp ---------------------TCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEEC
T ss_pred ---------------------CCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEEC
Confidence 44444444444444444444444445555555555554 33 222 3455555555555
Q ss_pred CCCcccccCchhhhcccCCCeEeccCCcCc
Q 042887 542 SRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571 (628)
Q Consensus 542 s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 571 (628)
++|++++. + .+..+++|++|++++|++.
T Consensus 167 ~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 167 QFDGVHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TTBCCCCC-T-TGGGCSSCCEEEECBC---
T ss_pred CCCCCcCh-H-HhccCCCCCEEEeeCcccC
Confidence 55555532 2 4555555566666655553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=187.35 Aligned_cols=173 Identities=27% Similarity=0.320 Sum_probs=110.5
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
.|+.|++++|.+... + .+..+++|+.|++++|.+.+..+ +..+++|+.|+|++|.+.+ +| .+..+++|+.|+|+
T Consensus 44 ~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls 117 (605)
T 1m9s_A 44 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLE 117 (605)
T ss_dssp TCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECT
T ss_pred CCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEec
Confidence 444455555554432 2 35666677777777776665433 6666777777777777663 22 56667777777777
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|++++. ..+..+++| +.|+|++|++++. ..+..+++|+.|+|++|.+++..| +..+++|+.|+|++|+|
T Consensus 118 ~N~l~~l--~~l~~l~~L----~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 118 HNGISDI--NGLVHLPQL----ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp TSCCCCC--GGGGGCTTC----SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred CCCCCCC--ccccCCCcc----CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence 7777642 345556655 6677777777653 456677777777777777775544 66777777777777777
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchh
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKY 553 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 553 (628)
++. ..+..+++|+.|+|++|++++.....
T Consensus 188 ~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~ 216 (605)
T 1m9s_A 188 SDL--RALAGLKNLDVLELFSQECLNKPINH 216 (605)
T ss_dssp CBC--GGGTTCTTCSEEECCSEEEECCCCCC
T ss_pred CCC--hHHccCCCCCEEEccCCcCcCCcccc
Confidence 643 34677777777777777776543333
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.9e-19 Score=172.39 Aligned_cols=168 Identities=23% Similarity=0.319 Sum_probs=99.0
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
++..+++++|.+++.. .+..+++|+.|++++|.+.. ++ .+..+++|++|++++|++++..+ +..+++|++|+++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3455566666665443 45666677777777776663 23 46666667777777776664433 6666667777777
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|++++. |.. .. ++| +.|++++|++++. ..+..+++|++|++++|++++. + .+..+++|+.|++++|++
T Consensus 94 ~N~l~~l-~~~-~~-~~L----~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 94 RNRLKNL-NGI-PS-ACL----SRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp SSCCSCC-TTC-CC-SSC----CEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred CCccCCc-Ccc-cc-Ccc----cEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 6666642 221 11 444 5666666666642 2456666666666666666543 2 455566666666666666
Q ss_pred eeecCccccCCCCCCEEECCCCccccc
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQ 549 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (628)
++. ..+..+++|+.|++++|+++..
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cch--HHhccCCCCCEEeCCCCcccCC
Confidence 543 4455666666666666666543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=174.77 Aligned_cols=284 Identities=13% Similarity=0.088 Sum_probs=164.7
Q ss_pred cCcccEEEccCCccccccchhhhC-CCCCCEEecccCcCc--ccccccccCCCCCCEeecccccCcccCCcCccC-----
Q 042887 161 LLKLEMIDVGDNQLIGKFPDFIAN-FSALEAIDISANMLG--GRIPDSLCQLRSLNYLSISENNFSCKLPLSIWN----- 232 (628)
Q Consensus 161 l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~----- 232 (628)
+.+++.|+++++ +.......+.. +++|+.|||++|++. ...+ +.++.++.+.+..|. +.+.+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~---~~~~~~~~~~~~~~~---I~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA---GTYPNGKFYIYMANF---VPAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS---SSSGGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc---ccccccccccccccc---cCHHHhccccccc
Confidence 345677777754 22222233334 667777777777766 2221 122224445554442 23445555
Q ss_pred ---CCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccc----eeeccccccc
Q 042887 233 ---ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHF----SGQVKIDFNR 305 (628)
Q Consensus 233 ---l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i----~~~~~~~~~~ 305 (628)
+++|++|+|.+ .++ .|+...|.++++|+.+++++|.++.+.+..|.++.++..+....+.. ..+...+|..
T Consensus 97 ~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~ 174 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE 174 (329)
T ss_dssp EEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred ccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence 66666666666 555 55555555566666666666655555555555555555444443211 1112223333
Q ss_pred CCCCC-EEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHh---ccccccEEEccCCcceeeCchh
Q 042887 306 LSNLS-RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIAN---LSAKITVIGMGDNQISGTIPSE 381 (628)
Q Consensus 306 l~~L~-~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~---~~~~L~~L~l~~n~l~~~~~~~ 381 (628)
+..|+ .+.+.. ... .+..+.. ...++..+.+.++-.. .....
T Consensus 175 ~~~L~~~i~~~~------------------------------~~~---l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~ 220 (329)
T 3sb4_A 175 GEPLETTIQVGA------------------------------MGK---LEDEIMKAGLQPRDINFLTIEGKLDN-ADFKL 220 (329)
T ss_dssp SCCCEEEEEECT------------------------------TCC---HHHHHHHTTCCGGGCSEEEEEECCCH-HHHHH
T ss_pred ccccceeEEecC------------------------------CCc---HHHHHhhcccCccccceEEEeeeecH-HHHHH
Confidence 33333 222221 100 0011100 0123444444433211 11111
Q ss_pred h-hccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCC-eEecCCcccccccCCcccCCcc
Q 042887 382 I-KNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLN-RLFLGFNNLQGNVPSSLGNCQN 459 (628)
Q Consensus 382 l-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~ 459 (628)
+ ..+++|+.+++++|+++.+.+.+|.++++|+.+++.+| ++...+.+|.++++|+ .+++.. .++...+..|.+|++
T Consensus 221 l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~ 298 (329)
T 3sb4_A 221 IRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDN 298 (329)
T ss_dssp HHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTT
T ss_pred HHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCcc
Confidence 2 23678888888888888777778888888888888887 7767778888888888 888887 777777888888888
Q ss_pred hhcccceEEcCCCcCccccchhhhccCCCCEeeC
Q 042887 460 LMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493 (628)
Q Consensus 460 L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 493 (628)
| +.+++++|++..+.+..|.++++|+.++.
T Consensus 299 L----~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 299 L----RYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp E----EEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred C----CEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 8 77888888888777778888888888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.7e-21 Score=204.62 Aligned_cols=108 Identities=27% Similarity=0.294 Sum_probs=75.2
Q ss_pred ceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC
Q 042887 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (628)
+.|+|++|++++ +|. ++.+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|
T Consensus 444 ~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 444 RVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp SEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred eEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 566777777764 444 677777777777777776 566677777777777777777774 45 6677777777777777
Q ss_pred cccccC-chhhhcccCCCeEeccCCcCcccCCCC
Q 042887 545 NLSGQI-PKYLENLLFLAYLNLSYNHFEGEVPRK 577 (628)
Q Consensus 545 ~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~~p~~ 577 (628)
+|++.. |..+..+++|+.|++++|++++.+|..
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 777665 677777777777777777777665543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.7e-20 Score=198.80 Aligned_cols=165 Identities=21% Similarity=0.183 Sum_probs=132.8
Q ss_pred eeeCchhhhccCCcCeee-eccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCc
Q 042887 375 SGTIPSEIKNLVNINAFG-VEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSS 453 (628)
Q Consensus 375 ~~~~~~~l~~l~~L~~L~-l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 453 (628)
.+..|..+..+++|+.|+ ++.|.+. +|..+.+++|.++...+ ..|+.|++++|+|++ +|.
T Consensus 398 ~~~~~~~l~~l~~L~~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~- 458 (567)
T 1dce_A 398 LLYEKETLQYFSTLKAVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH- 458 (567)
T ss_dssp GGGHHHHHHHHHHHHHHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-
T ss_pred ccCCHHHHHHHHhcccCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-
Confidence 445667777778888777 6666543 35566677777764332 258899999999985 565
Q ss_pred ccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeec-CccccC
Q 042887 454 LGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSL-PLSLKT 532 (628)
Q Consensus 454 ~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~ 532 (628)
++.+++| +.|+|++|+|+ .+|..++.+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++.. |..+..
T Consensus 459 ~~~l~~L----~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~ 531 (567)
T 1dce_A 459 LEQLLLV----THLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 531 (567)
T ss_dssp GGGGTTC----CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGG
T ss_pred ccccccC----cEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhc
Confidence 8888887 88999999998 778899999999999999999996 56 8899999999999999999776 899999
Q ss_pred CCCCCEEECCCCcccccCch---hhhcccCCCeEec
Q 042887 533 LKSIKELDLSRNNLSGQIPK---YLENLLFLAYLNL 565 (628)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~l 565 (628)
+++|+.|+|++|++++.+|. .+..+++|+.|++
T Consensus 532 l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999999999976553 3455889998875
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=6e-19 Score=195.50 Aligned_cols=181 Identities=24% Similarity=0.298 Sum_probs=81.8
Q ss_pred CchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCC
Q 042887 378 IPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNC 457 (628)
Q Consensus 378 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 457 (628)
.+..+..+++|+.|++++|.+. .+|..+..+++|++|+|++|.++ .+|..|..+++|++|+|++|+|+ .+|..++++
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 3445555666666666666665 34444445666666666666666 45555666666666666666666 456566665
Q ss_pred cchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCC-CCCeEECcCceeeeecCccccCCCCC
Q 042887 458 QNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT-TLEYLHLQGNSFSGSLPLSLKTLKSI 536 (628)
Q Consensus 458 ~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L 536 (628)
++| ++|+|++|.|+ .+|..|+.+++|++|+|++|.+++.+|..+..+. .+..|+|++|.+++.+|. .|
T Consensus 293 ~~L----~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l 361 (727)
T 4b8c_D 293 FQL----KYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ER 361 (727)
T ss_dssp TTC----SEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C-
T ss_pred CCC----CEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------cc
Confidence 555 56666666665 4455566666666666666666655555544321 112355666666655543 23
Q ss_pred CEEECCCC--------cccccCchhhhcccCCCeEeccCCcCcc
Q 042887 537 KELDLSRN--------NLSGQIPKYLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 537 ~~L~Ls~N--------~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 572 (628)
+.|++++| .+.+..+..+..+..++...+++|-+.+
T Consensus 362 ~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 362 RFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ----------------------------------------CCCG
T ss_pred ceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 44445554 3333334444555555666666666653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=151.69 Aligned_cols=155 Identities=23% Similarity=0.246 Sum_probs=108.8
Q ss_pred CeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccch-hhhccCCCCEeeCcCCcCcccCCccccCCCCCCeE
Q 042887 437 NRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPL-EVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYL 515 (628)
Q Consensus 437 ~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 515 (628)
+.+++++|+++ .+|..+.. ++ +.|++++|++++..+. .|..+++|++|+|++|++++..|..|.++++|++|
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l----~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HT----TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TC----SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CEEEcCCCCcC-cCccCCCC--CC----CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 67788888876 55554433 44 6778888888765553 37778888888888888887777778888888888
Q ss_pred ECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCc
Q 042887 516 HLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLC 595 (628)
Q Consensus 516 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c 595 (628)
+|++|++++..+..|.++++|++|+|++|++++..|+.|..+++|++|++++|++++..+.......+....+.++...|
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C 163 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCC
Confidence 88888888777777778888888888888888777777888888888888888887766532221122223344455556
Q ss_pred ccC
Q 042887 596 GGL 598 (628)
Q Consensus 596 ~~~ 598 (628)
+..
T Consensus 164 ~~P 166 (192)
T 1w8a_A 164 GAP 166 (192)
T ss_dssp CSS
T ss_pred CCC
Confidence 543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=149.26 Aligned_cols=134 Identities=19% Similarity=0.208 Sum_probs=68.5
Q ss_pred CcccEEEccCCccc-cccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEE
Q 042887 162 LKLEMIDVGDNQLI-GKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIIS 240 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 240 (628)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..|..+++|++|++++|.+++.+|..+..
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-------- 93 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEK-------- 93 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHH--------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhh--------
Confidence 44555555555554 34444455555555555555555433 44445555555555555554334444444
Q ss_pred eecccCcccCChhhhhCCCCCcEEecccCcccccc-cccccCCCCCCEEEcccccceeecc---cccccCCCCCEEEccC
Q 042887 241 LHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSL-PHSFSNASNLQVLDVYKNHFSGQVK---IDFNRLSNLSRLFLSK 316 (628)
Q Consensus 241 L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~ 316 (628)
+++|++|++++|++++.. +..+..+++|++|++++|.+++..+ ..|..+++|++|++++
T Consensus 94 -----------------l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 94 -----------------LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp -----------------CTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred -----------------CCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 445555555555544321 1445555555555555555554433 3455566666666666
Q ss_pred CcCCCc
Q 042887 317 NNLGTE 322 (628)
Q Consensus 317 n~l~~~ 322 (628)
|.+...
T Consensus 157 n~~~~~ 162 (168)
T 2ell_A 157 REDQEA 162 (168)
T ss_dssp TTSCBC
T ss_pred CChhhc
Confidence 655443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=152.28 Aligned_cols=130 Identities=25% Similarity=0.289 Sum_probs=85.8
Q ss_pred CeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEE
Q 042887 437 NRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLH 516 (628)
Q Consensus 437 ~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 516 (628)
+.+++++|.++ .+|..+. +++ +.|++++|+++ .+|..|.++++|++|+|++|.+++..+..|.++++|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l----~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ 84 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDV----TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI 84 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTC----CEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCCC-cCCCCCC--CCC----CEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence 34555555555 3333332 233 56666666666 4556677777777777777777766666677777777777
Q ss_pred CcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccC
Q 042887 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEV 574 (628)
Q Consensus 517 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 574 (628)
|++|++++..|..|..+++|++|+|++|+|+...+..|..+++|+.|++++|++.+..
T Consensus 85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 7777777666666777777777777777777665666777777777777777776543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.3e-17 Score=145.61 Aligned_cols=137 Identities=16% Similarity=0.110 Sum_probs=96.2
Q ss_pred CCCCEeecccccCc-ccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEE
Q 042887 210 RSLNYLSISENNFS-CKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVL 288 (628)
Q Consensus 210 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 288 (628)
++|++|++++|.++ +.+|..+..+++|++|++++|.++ .+ ..+..+++|++|++++|++++..|..+.++++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 44555555555554 344555555555666666666555 23 222346666677777777766677778889999999
Q ss_pred Ecccccceeecc-cccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccc
Q 042887 289 DVYKNHFSGQVK-IDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGV 352 (628)
Q Consensus 289 ~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~ 352 (628)
++++|++++... ..+..+++|++|++++|.++..+.. ....+..+++|+.|++++|.+...
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY---RESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTH---HHHHHTTCSSCCEETTEETTSCBC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHH---HHHHHHhCccCcEecCCCCChhhc
Confidence 999999987643 6889999999999999999864320 013577889999999999987654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.5e-18 Score=186.27 Aligned_cols=187 Identities=19% Similarity=0.173 Sum_probs=71.6
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
+.++.|+|.+|.+... +.. .|+.++|+.|.|.+ ++++.|.+. ..|+.|..+++|++|+|
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~-----~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQA-----LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcc-hhh-----HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 4577888888887753 332 34444555554432 223334433 34445555555555555
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
++|.+. .+|..++ .+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|..+++|++|+|++|.++.
T Consensus 232 s~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp TTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc
Confidence 555554 4555544 2555555555555555 44555555555555555555555 334455555555555555555543
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCch
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPS 380 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 380 (628)
++ ..+..+++|+.|+|++|.+++..+..+.........+++++|.+++.+|.
T Consensus 308 lp-------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 308 LP-------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CC-------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred cC-------hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 22 22444555555555555555555555544322233345556666555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-15 Score=156.84 Aligned_cols=87 Identities=9% Similarity=0.043 Sum_probs=38.4
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
.++.+.+.+ .++.+...+|.+. +|+.+++..+ ++.+...+|.+. +|+.+.+.. .++.+.+.+|.++++|+.++++
T Consensus 114 ~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~ 188 (401)
T 4fdw_A 114 GYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLS 188 (401)
T ss_dssp SCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECT
T ss_pred CccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecC
Confidence 344444433 2333444445443 4555555433 443444444442 355555443 3333444444444444444444
Q ss_pred cccCcccCChhhh
Q 042887 243 SNRFEGSLPLNIG 255 (628)
Q Consensus 243 ~n~l~~~~~~~~~ 255 (628)
+|.++ .++...|
T Consensus 189 ~n~l~-~I~~~aF 200 (401)
T 4fdw_A 189 KTKIT-KLPASTF 200 (401)
T ss_dssp TSCCS-EECTTTT
T ss_pred CCcce-EechhhE
Confidence 44444 3443333
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-15 Score=156.55 Aligned_cols=153 Identities=10% Similarity=0.090 Sum_probs=125.0
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 237 (628)
+.+. +|+.+++..+ ++.+...+|.+. +|+.+++.. .++.+.+.+|.++++|+.+++++|+++.+...+|. ..+|+
T Consensus 132 F~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~ 206 (401)
T 4fdw_A 132 FRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIE 206 (401)
T ss_dssp TTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCS
T ss_pred cccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccC
Confidence 4443 6999999876 777777888884 799999986 67778888999999999999999999976666676 58999
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
.+.+..+ ++ .++...|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.+...+|..+++|+.+++.+|
T Consensus 207 ~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~ 281 (401)
T 4fdw_A 207 EVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS 281 (401)
T ss_dssp EEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred EEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence 9999855 76 788888888999999999875 66677778888 78999998 45677788888888888888888877
Q ss_pred cCC
Q 042887 318 NLG 320 (628)
Q Consensus 318 ~l~ 320 (628)
.+.
T Consensus 282 ~~~ 284 (401)
T 4fdw_A 282 TFN 284 (401)
T ss_dssp CCC
T ss_pred ccc
Confidence 654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.1e-17 Score=141.41 Aligned_cols=128 Identities=23% Similarity=0.296 Sum_probs=79.1
Q ss_pred CCCCeEecCCcccc-cccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCC
Q 042887 434 TLLNRLFLGFNNLQ-GNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTL 512 (628)
Q Consensus 434 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 512 (628)
++++.|++++|.++ +..|..+..+++| +.|++++|.+++. ..++.+++|++|++++|.+++.+|..+..+++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L----~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 90 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEEL----EFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTC----CEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCC----cEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC
Confidence 34445555555554 3444444444444 5555555555533 455566666677777777665556666666777
Q ss_pred CeEECcCceeeee-cCccccCCCCCCEEECCCCcccccCc---hhhhcccCCCeEeccC
Q 042887 513 EYLHLQGNSFSGS-LPLSLKTLKSIKELDLSRNNLSGQIP---KYLENLLFLAYLNLSY 567 (628)
Q Consensus 513 ~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~ls~ 567 (628)
++|++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 91 ~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 7777777777642 23567777777777777777776555 4677777777777763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.8e-15 Score=153.67 Aligned_cols=147 Identities=14% Similarity=0.155 Sum_probs=78.7
Q ss_pred CcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhh
Q 042887 403 PHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEV 482 (628)
Q Consensus 403 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~ 482 (628)
..+|..+..++.+.+..+... .....|..+..++.+....+.+ ....|.++.+| +.+.+.++ +..+....|
T Consensus 246 ~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L----~~i~l~~~-i~~I~~~aF 316 (394)
T 4fs7_A 246 KSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSL----TEVKLLDS-VKFIGEEAF 316 (394)
T ss_dssp SSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTC----CEEEECTT-CCEECTTTT
T ss_pred cccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccc----cccccccc-cceechhhh
Confidence 344555555555555544332 4444555555555555544432 22344555555 44455433 443445556
Q ss_pred hccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCe
Q 042887 483 GNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAY 562 (628)
Q Consensus 483 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 562 (628)
.++.+|+.+++.++ ++......|.++++|+.+++..| ++.....+|.++++|+.+++..+ ++ .+...|.+.++|+.
T Consensus 317 ~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 317 ESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred cCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 66666666666533 54445556666666766666655 55455566666667777666543 22 22345555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=140.83 Aligned_cols=126 Identities=17% Similarity=0.271 Sum_probs=62.7
Q ss_pred CCCEEecccCcCc-ccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEe
Q 042887 187 ALEAIDISANMLG-GRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265 (628)
Q Consensus 187 ~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~ 265 (628)
+|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++.+|..+. .+++|++|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAE-KCPNLTHLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHH-HCTTCCEEE
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhh-hCCCCCEEE
Confidence 3444444444443 33344444444444444444444432 3444455555555555555432333222 255555555
Q ss_pred cccCccccc-ccccccCCCCCCEEEcccccceeecc---cccccCCCCCEEEcc
Q 042887 266 VGQNNFTGS-LPHSFSNASNLQVLDVYKNHFSGQVK---IDFNRLSNLSRLFLS 315 (628)
Q Consensus 266 L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~ 315 (628)
+++|++++. .+..++.+++|++|++++|++++..+ ..+..+++|++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555542 23455666666666666666655444 345566666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.3e-16 Score=144.00 Aligned_cols=127 Identities=20% Similarity=0.270 Sum_probs=82.8
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecc
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n 244 (628)
+.+++++|+++. +|..+ .++|++|++++|.++ .+|..|..+++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 567888887773 44433 257777777777776 55677777777777777777777666667777777777777777
Q ss_pred cCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccce
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFS 296 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 296 (628)
.++ .++...+..+++|++|+|++|+++...+..|..+++|+.|++++|.+.
T Consensus 89 ~l~-~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCC-BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccC-EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 776 444444444666666666666666544445555555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-16 Score=142.05 Aligned_cols=111 Identities=23% Similarity=0.239 Sum_probs=67.1
Q ss_pred ceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC
Q 042887 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (628)
+.|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|
T Consensus 31 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC
Confidence 45555555555444445555666666666666666554555566666666666666666555555566666666666666
Q ss_pred cccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 545 NLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 545 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
++++..+..+..+++|++|++++|++++..|
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 111 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6665555555666666666666666665544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7e-17 Score=160.74 Aligned_cols=94 Identities=19% Similarity=0.301 Sum_probs=77.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++ ++.+.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence 478999999999999999999999999999999997643 34457899999999999999999999995 45789
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||+||+|.+++....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~ 118 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQK 118 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTT
T ss_pred EEEEEeCCCCCcHHHHHHHcC
Confidence 999999999999999997543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=9.5e-17 Score=159.49 Aligned_cols=92 Identities=22% Similarity=0.337 Sum_probs=83.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+.|+..+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.+|++++|||||++++++. +.+..|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 356999999999999999999999999999999998766666678999999999999999999999954 478999
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|||||+||+|.+++..
T Consensus 148 ivmEy~~gg~L~~~l~~ 164 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH 164 (346)
T ss_dssp EEECCCTTEEHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHc
Confidence 99999999999998864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.1e-16 Score=139.99 Aligned_cols=132 Identities=20% Similarity=0.230 Sum_probs=90.8
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
.+.+++++|+++. +|..+ .++|++|++++|++++..+..|+.+++|++|++++|.+++..+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4677888888774 34332 36788888888888766666777788888888888887765566677777777777777
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeec
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQV 299 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 299 (628)
|.++ .+|...+..+++|++|++++|++++..+..|..+++|++|++++|.+.+..
T Consensus 86 N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCcc-ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 7777 455555445677777777777776555555566666666666666665433
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.65 E-value=8.5e-17 Score=157.35 Aligned_cols=93 Identities=18% Similarity=0.319 Sum_probs=83.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||+||+|++..+|+.||||++++. .....+.+.+|+++|++++|||||+++++ +++.+.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence 5799999999999999999999999999999999764 23445779999999999999999999999 456889
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||+||+|.+++.+.+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~ 127 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG 127 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS
T ss_pred EEEEEecCCCCCHHHHHHHcC
Confidence 999999999999999997643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-16 Score=155.99 Aligned_cols=94 Identities=29% Similarity=0.502 Sum_probs=80.0
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
+++|.+.+.||+|+||.||+|++. .+++.||||+++.......+.|.+|+++|++++|||||+++++|.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----- 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE----- 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence 467889999999999999999975 3578899999987666667889999999999999999999999653
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.+..|+|||||++|+|.+++...+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~ 110 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHG 110 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC
Confidence 678999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-16 Score=160.90 Aligned_cols=92 Identities=22% Similarity=0.337 Sum_probs=83.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+.|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++. +.+..|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEE
Confidence 457999999999999999999999999999999998766666678999999999999999999999954 478999
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|||||+||+|.+++..
T Consensus 225 iVmEy~~gG~L~~~i~~ 241 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH 241 (423)
T ss_dssp EEEECCTTEEHHHHHHH
T ss_pred EEEeCCCCCcHHHHHhc
Confidence 99999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=4e-16 Score=155.26 Aligned_cols=95 Identities=22% Similarity=0.457 Sum_probs=81.8
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
+++|.+.+.||+|+||.||+|++. .+++.||||+++.......+.|.+|+++|++++|||||+++++|.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 456778889999999999999975 3578899999987666667889999999999999999999999754
Q ss_pred cceeeeeecccccCCchhhhhcccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
....|+|||||++|+|.+++.....
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~ 139 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGP 139 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCc
Confidence 6789999999999999999986653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=141.27 Aligned_cols=133 Identities=20% Similarity=0.139 Sum_probs=81.6
Q ss_pred ccCCCCCCeEecCCcccccccCCcccCCc-chhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccC
Q 042887 430 LGNLTLLNRLFLGFNNLQGNVPSSLGNCQ-NLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA 508 (628)
Q Consensus 430 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 508 (628)
+..+++|+.|++++|+++. +|. +..+. +| +.|++++|.+++. ..+..+++|++|++++|.+++..+..+..
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L----~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 86 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQF----DAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQA 86 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCC----SEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHH
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCC----CEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhc
Confidence 3344455555555555542 222 22222 34 5556666665543 45666667777777777776554455567
Q ss_pred CCCCCeEECcCceeeeecCc--cccCCCCCCEEECCCCcccccCch----hhhcccCCCeEeccCCcCcc
Q 042887 509 CTTLEYLHLQGNSFSGSLPL--SLKTLKSIKELDLSRNNLSGQIPK----YLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 509 l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~ls~N~l~~ 572 (628)
+++|++|++++|+++ .+|. .+..+++|+.|++++|+++. .|. .+..+++|+.||+++|.+..
T Consensus 87 l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 87 LPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 777777777777775 3444 66777777888888887773 444 37777888888888877654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-14 Score=146.59 Aligned_cols=318 Identities=11% Similarity=0.044 Sum_probs=189.4
Q ss_pred cccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChh
Q 042887 174 LIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLN 253 (628)
Q Consensus 174 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 253 (628)
++.+...+|.++++|+.+.+.. .++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++ .+...
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~ 134 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVE 134 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecce
Confidence 3334444555555565555543 244444555555555665555433 44344455555555555444332 22 23333
Q ss_pred hhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccc
Q 042887 254 IGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLL 333 (628)
Q Consensus 254 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 333 (628)
.|.+...++..... ....+...+|.++++|+.+.+.++. ..+....|..+++|+.+.+..+ ++.
T Consensus 135 aF~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~------------ 198 (394)
T 4fs7_A 135 AFKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKI------------ 198 (394)
T ss_dssp TTTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCE------------
T ss_pred eeecccccccccCc--cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceE------------
Confidence 33322222211111 1111233345555555555554332 2244444444444444444332 111
Q ss_pred cCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCC
Q 042887 334 TNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQ 413 (628)
Q Consensus 334 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 413 (628)
+...+|.++..|+.+.+..+... +.+.+....+|+
T Consensus 199 -------------------------------------------I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~ 233 (394)
T 4fs7_A 199 -------------------------------------------IRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVK 233 (394)
T ss_dssp -------------------------------------------ECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCC
T ss_pred -------------------------------------------eCchhhccccccceeecCCCceE--eehhhcccCCCc
Confidence 12233444455555544443322 122333445777
Q ss_pred eEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeC
Q 042887 414 GLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDL 493 (628)
Q Consensus 414 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 493 (628)
.+.+..+ ++......|..+..++.+.+..+... .....|..+..+ +.+....+.+ ....|.++.+|+.+.+
T Consensus 234 ~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l----~~~~~~~~~i---~~~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 234 NIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL----KKVIYGSVIV---PEKTFYGCSSLTEVKL 304 (394)
T ss_dssp EEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC----CEEEECSSEE---CTTTTTTCTTCCEEEE
T ss_pred eEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccccc----ceeccCceee---cccccccccccccccc
Confidence 7777643 33355667888999999999887554 677788888888 5666665543 3456888999999999
Q ss_pred cCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCC
Q 042887 494 SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568 (628)
Q Consensus 494 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N 568 (628)
.++ ++......|.++++|+.+++..+ ++.....+|.++.+|+.+++..| ++.....+|.++++|+.+++..+
T Consensus 305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred ccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 765 66567788999999999999865 77677889999999999999887 77677889999999999999755
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-17 Score=154.88 Aligned_cols=152 Identities=22% Similarity=0.246 Sum_probs=117.5
Q ss_pred cCcccEEEccCCccccccch------hhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCC
Q 042887 161 LLKLEMIDVGDNQLIGKFPD------FIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNIS 234 (628)
Q Consensus 161 l~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~ 234 (628)
...++.++++.+.+.+..|. .|..+++|++|++++|.+++ +| .+..+++|++|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34566667777777666665 88899999999999999885 55 8888899999999999988 5777777788
Q ss_pred CCCEEEeecccCcccCChhhhhCCCCCcEEecccCccccccc-ccccCCCCCCEEEcccccceeecccc----------c
Q 042887 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLP-HSFSNASNLQVLDVYKNHFSGQVKID----------F 303 (628)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~----------~ 303 (628)
+|++|++++|.++ .+| .+. .+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+.. +
T Consensus 94 ~L~~L~L~~N~l~-~l~-~~~-~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 170 (198)
T 1ds9_A 94 TLEELWISYNQIA-SLS-GIE-KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp HCSEEEEEEEECC-CHH-HHH-HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred cCCEEECcCCcCC-cCC-ccc-cCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence 8999999999988 455 333 48889999999998885443 46888888999999999887665542 6
Q ss_pred ccCCCCCEEEccCCcCC
Q 042887 304 NRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 304 ~~l~~L~~L~L~~n~l~ 320 (628)
..+++|+.|| +|.++
T Consensus 171 ~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 171 KRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHCSSCSEEC--CGGGT
T ss_pred HhCCCcEEEC--CcccC
Confidence 6778888776 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=137.80 Aligned_cols=108 Identities=19% Similarity=0.177 Sum_probs=52.0
Q ss_pred CcCcccEEEccCCccccccchhhhCC-CCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 160 NLLKLEMIDVGDNQLIGKFPDFIANF-SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 160 ~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
++.+|+.|++++|+++.. |. +..+ ++|++|++++|.+++. ..|+.+++|++|++++|.+++..+..|..+++|++
T Consensus 17 ~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 345566666666665532 33 2222 2555555555555543 34555555555555555555333333345555555
Q ss_pred EEeecccCcccCCh-hhhhCCCCCcEEecccCccc
Q 042887 239 ISLHSNRFEGSLPL-NIGFNIPNVNFLSVGQNNFT 272 (628)
Q Consensus 239 L~L~~n~l~~~~~~-~~~~~l~~L~~L~L~~N~l~ 272 (628)
|++++|.++ .+|. ..+..+++|+.|++++|.++
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 555555554 3333 11122444444444444443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=146.59 Aligned_cols=93 Identities=29% Similarity=0.391 Sum_probs=76.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++++.. ....+.+.+|+++|++++|||||++++++ ++.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 468999999999999999999999999999999997542 33456799999999999999999999994 5588
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+||||| +|++.+++.+..
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~ 107 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRD 107 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSC
T ss_pred EEEEEEeCC-CCCHHHHHHHcC
Confidence 999999999 679999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.1e-15 Score=148.15 Aligned_cols=98 Identities=18% Similarity=0.350 Sum_probs=79.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecc-------c
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-------F 119 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------~ 119 (628)
++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+ .
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999999999999999997654 334567999999999999999999999876411 1
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
......|+|||||++|+|.+++....
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~ 110 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC 110 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC
Confidence 12345799999999999999997543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.6e-15 Score=146.12 Aligned_cols=93 Identities=29% Similarity=0.408 Sum_probs=78.7
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.|.+|+++|++++|||||++++++.+. .......|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 66778999999999999999999999999997542 34457799999999999999999999986531 1234678999
Q ss_pred ecccccCCchhhhhcc
Q 042887 129 YEYMKCGSSEDWMHQS 144 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~ 144 (628)
||||++|+|.+++.+.
T Consensus 108 mEy~~gg~L~~~l~~~ 123 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF 123 (290)
T ss_dssp EECCCSCBHHHHHHHH
T ss_pred EeCCCCCCHHHHHHhc
Confidence 9999999999999754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-15 Score=148.36 Aligned_cols=94 Identities=22% Similarity=0.365 Sum_probs=77.6
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
..++++.+.||+|+||.||+|++. .+++.||||+++... ....+.|.+|+.+|++++|||||+++++|.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---- 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK---- 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence 345677889999999999999974 356889999997543 3345789999999999999999999999754
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++|||||++|+|.+++....
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~ 124 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRS 124 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhC
Confidence 678899999999999999997654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.4e-17 Score=151.69 Aligned_cols=161 Identities=24% Similarity=0.290 Sum_probs=86.6
Q ss_pred hhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchh
Q 042887 382 IKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLM 461 (628)
Q Consensus 382 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 461 (628)
+.....++.++++.+.+.+..|. ++ .+|..+..+++|++|++++|++++ +| .+..+++|
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L- 72 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENL- 72 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTC-
T ss_pred HHhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCC-
Confidence 44555666666666666554443 00 111244445555555555555543 33 44444444
Q ss_pred cccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecC-ccccCCCCCCEEE
Q 042887 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLP-LSLKTLKSIKELD 540 (628)
Q Consensus 462 ~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~ 540 (628)
+.|++++|.++ .+|..+..+++|++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|+
T Consensus 73 ---~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T 1ds9_A 73 ---RILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp ---CEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred ---CEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence 45555555554 344445555566666666666654 22 45556666666666666653222 3556666667777
Q ss_pred CCCCcccccCch----------hhhcccCCCeEeccCCcCc
Q 042887 541 LSRNNLSGQIPK----------YLENLLFLAYLNLSYNHFE 571 (628)
Q Consensus 541 Ls~N~l~~~~~~----------~~~~l~~L~~L~ls~N~l~ 571 (628)
+++|++++..|. .+..+++|+.|| +|.++
T Consensus 147 l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 147 LAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 777766654443 366777777776 55554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=130.41 Aligned_cols=108 Identities=21% Similarity=0.251 Sum_probs=58.0
Q ss_pred ceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCC
Q 042887 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRN 544 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (628)
+.+++++|+++. +|..+ .++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 345555555542 33333 245555555555555555555555555555555555555444444555555555555555
Q ss_pred cccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 545 NLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 545 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
+|++..++.|..+++|++|++++|++++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 5555444455555555555555555554443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.1e-15 Score=148.13 Aligned_cols=89 Identities=22% Similarity=0.266 Sum_probs=77.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+.|++.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|++++|||||++++++. +....|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 4567888899999999999999999999999999975422 357999999999999999999954 478899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+|||||+||+|.+++.+.+
T Consensus 127 ivmEy~~gg~L~~~l~~~~ 145 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG 145 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS
T ss_pred EEEeccCCCcHHHHHHHcC
Confidence 9999999999999997543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-15 Score=149.00 Aligned_cols=93 Identities=22% Similarity=0.261 Sum_probs=74.3
Q ss_pred CCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
++|++.+.||+|+||+||+|++. .+++.||+|++++.. .....++.+|+++|++++|||||++++++ ++.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 46999999999999999999974 467899999997642 23345788999999999999999999995 457
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+..|+|||||+||+|.+++.+..
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~ 121 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV 121 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC
Confidence 89999999999999999997643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.53 E-value=8.8e-13 Score=135.89 Aligned_cols=154 Identities=11% Similarity=0.083 Sum_probs=82.7
Q ss_pred ccCCcC-cccEEEccCCccccccchhhhCCCCCCEEecccCc---CcccccccccCCCCCCEeecccccCcccCCcCccC
Q 042887 157 QRLNLL-KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANM---LGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWN 232 (628)
Q Consensus 157 ~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~---l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~ 232 (628)
.+.+.. .|+.+.+..+ ++.+...+|.++++|+.+.++.|. ++.+...+|..+.+|+.+.+..+ ++.+...+|..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~ 135 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH 135 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence 344442 4666666543 555556666666666666666543 44445556666666666666543 44355556666
Q ss_pred CCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEE
Q 042887 233 ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRL 312 (628)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 312 (628)
+.+|+.+.+..+ ++ .++...|....+|+.+.+..+ ++.+....|.+ .+|+.+.+..+- ..+...+|..+.+++..
T Consensus 136 c~~L~~i~lp~~-~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~-~~i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 136 CEELDTVTIPEG-VT-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV-TRIGTNAFSECFALSTI 210 (394)
T ss_dssp CTTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC-CEECTTTTTTCTTCCEE
T ss_pred hcccccccccce-ee-eecccceecccccccccccce-eeEeccccccc-cceeEEEECCcc-cccccchhhhcccccee
Confidence 666666666543 22 455555555566666665543 33344444443 445555555432 22444455555555555
Q ss_pred EccCC
Q 042887 313 FLSKN 317 (628)
Q Consensus 313 ~L~~n 317 (628)
....+
T Consensus 211 ~~~~~ 215 (394)
T 4gt6_A 211 TSDSE 215 (394)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 44433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-14 Score=128.75 Aligned_cols=106 Identities=21% Similarity=0.270 Sum_probs=55.9
Q ss_pred eEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCc
Q 042887 466 LLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNN 545 (628)
Q Consensus 466 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 545 (628)
.+++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4455555554 3333332 455555555555555545555555555555555555554444444555555555555555
Q ss_pred ccccCchhhhcccCCCeEeccCCcCcccC
Q 042887 546 LSGQIPKYLENLLFLAYLNLSYNHFEGEV 574 (628)
Q Consensus 546 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 574 (628)
|++..+..|..+++|++|++++|++....
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccc
Confidence 55444444555555555555555555443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-15 Score=146.36 Aligned_cols=97 Identities=28% Similarity=0.414 Sum_probs=80.1
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
|+...+++++.+.||+|+||+||+|++. ..||||+++... ....+.|.+|+.+|++++|||||++++++.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~----- 102 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT----- 102 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----
Confidence 4455678889999999999999999874 359999987543 345578999999999999999999999864
Q ss_pred ccceeeeeecccccCCchhhhhcccccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
.+..|+|||||++|+|.+++......+
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~~~l 129 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQETKF 129 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSCCCC
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcCCCC
Confidence 345799999999999999997655444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.51 E-value=3e-12 Score=131.83 Aligned_cols=337 Identities=11% Similarity=0.154 Sum_probs=222.3
Q ss_pred cccccchhhhCCC-CCCEEecccCcCcccccccccCCCCCCEeeccccc---CcccCCcCccCCCCCCEEEeecccCccc
Q 042887 174 LIGKFPDFIANFS-ALEAIDISANMLGGRIPDSLCQLRSLNYLSISENN---FSCKLPLSIWNISSLEIISLHSNRFEGS 249 (628)
Q Consensus 174 l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~---i~~~~p~~~~~l~~L~~L~L~~n~l~~~ 249 (628)
++.+...+|.++. .|+.+.+..+ ++.+...+|.++.+|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++ .
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~ 127 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-E 127 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-E
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-e
Confidence 4555567888885 6999999854 777888999999999999998874 77677888999999999888765 55 6
Q ss_pred CChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccc
Q 042887 250 LPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDF 329 (628)
Q Consensus 250 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 329 (628)
++...|....+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++.+...+|.. .+|+.+.+..+-. .+..
T Consensus 128 I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~----- 198 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGT----- 198 (394)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECT-----
T ss_pred ehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc-cccc-----
Confidence 88888888999999999755 45477788999999999999865 56677778865 6799998876532 2221
Q ss_pred cccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCC
Q 042887 330 LTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGEL 409 (628)
Q Consensus 330 ~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 409 (628)
..+..+..++......+......-..+. .+.........+.....+..+.+. +.+......+|.++
T Consensus 199 -~af~~c~~l~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c 264 (394)
T 4gt6_A 199 -NAFSECFALSTITSDSESYPAIDNVLYE------------KSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSC 264 (394)
T ss_dssp -TTTTTCTTCCEEEECCSSSCBSSSCEEE------------ECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTC
T ss_pred -chhhhccccceecccccccccccceeec------------ccccccccccccccccccceEEcC-CcceEcccceeeec
Confidence 2345566676666554433221100000 000000000011112223333332 23333455678888
Q ss_pred CCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCC
Q 042887 410 KNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLA 489 (628)
Q Consensus 410 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~ 489 (628)
.+|+.+.+..+... .....|.++++|+.+.+. +.++......|.+|.+| +.+++..+ ++.+....|.++.+|+
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L----~~i~lp~~-v~~I~~~aF~~C~~L~ 337 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISL----KSIDIPEG-ITQILDDAFAGCEQLE 337 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTC----CEEECCTT-CCEECTTTTTTCTTCC
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCc----CEEEeCCc-ccEehHhHhhCCCCCC
Confidence 88888888765443 566677888888888885 45665667778888888 77788754 5556667888888888
Q ss_pred EeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 490 EFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 490 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
.+.+..+ ++......|.++++|+.+++.++.... ..+....+|+.+.+..|.+.
T Consensus 338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred EEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 8888654 665666788888899998888876541 45667778888888776654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=8.5e-15 Score=146.88 Aligned_cols=103 Identities=18% Similarity=0.344 Sum_probs=85.6
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCC-----CcEEEEEEeeccc-cchhhhHHHHHHHHhhcCC-CCcccccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGET-----GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRH-RNLIKIIT 112 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~l~~ 112 (628)
...|+.++++|++.+.||+|+||+||+|.+..+ ++.||||.+.... ....+.|.+|+.+|+++.| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 346778889999999999999999999998654 3579999997643 3345679999999999975 99999999
Q ss_pred eeeeccccccceeeeeecccccCCchhhhhcccc
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
+|.. .....|+|||||++|+|.++++....
T Consensus 136 ~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~ 165 (353)
T 4ase_A 136 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRN 165 (353)
T ss_dssp EECC----TTSCCEEEEECCTTEEHHHHHHHTGG
T ss_pred EEEe----cCCEEEEEEEcCCCCCHHHHHHhccc
Confidence 9743 34678999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-14 Score=154.92 Aligned_cols=99 Identities=21% Similarity=0.398 Sum_probs=87.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+.+|+.++|||||+++++ +++....|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 3679999999999999999999999999999999987665566788999999999999999999999 45588999
Q ss_pred eeecccccCCchhhhhcccccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEA 150 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~ 150 (628)
+|||||+||+|.+++.+....+++
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e 254 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSE 254 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEH
T ss_pred EEEeecCCCcHHHHHHHhCCCCCH
Confidence 999999999999999765544543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=7.7e-14 Score=125.27 Aligned_cols=105 Identities=17% Similarity=0.220 Sum_probs=55.2
Q ss_pred ccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec
Q 042887 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS 243 (628)
Q Consensus 164 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 243 (628)
.+.+|+++|+++. +|..+ .++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 3556666666653 33333 25566666666666655555555566666666666655544444455555555555555
Q ss_pred ccCcccCChhhhhCCCCCcEEecccCccc
Q 042887 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFT 272 (628)
Q Consensus 244 n~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 272 (628)
|+++ .+|...+..+++|++|+|++|.++
T Consensus 88 N~l~-~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLK-SIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccC-EeCHHHhcCCCCCCEEEeCCCCCC
Confidence 5555 344333333444444444444443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-14 Score=146.54 Aligned_cols=97 Identities=22% Similarity=0.363 Sum_probs=81.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeee-ccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSS-IDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~~~~ 124 (628)
++|++.+.||+|+||+||+|++..+|+.||||+++... ....+++.+|+.+|++++|||||++++++.. ..+.+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999997543 3345678999999999999999999998654 22445678
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||+ |+|.+++.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~ 153 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ 153 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS
T ss_pred EEEEEeCCC-CCHHHHHHhcC
Confidence 999999996 67988886543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=124.31 Aligned_cols=104 Identities=15% Similarity=0.220 Sum_probs=58.7
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecc
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSN 244 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n 244 (628)
+.+++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56666766665 3444332 56666666666666555666666666666666666666444444555666666666666
Q ss_pred cCcccCChhhhhCCCCCcEEecccCccc
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFT 272 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 272 (628)
+++ .+|...+..+++|++|+|++|.+.
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCcc
Confidence 555 444443334555555555555444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=7.1e-14 Score=137.94 Aligned_cols=93 Identities=25% Similarity=0.356 Sum_probs=72.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|.+.+.||+|+||.||+|++ +|+.||||+++.... ....+.+|+..+.+++|||||++++++.+.+ ......|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 4578889999999999999998 689999999875432 1122345566667889999999999986511 12246899
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
|||||++|+|.++++..
T Consensus 79 V~Ey~~~gsL~~~l~~~ 95 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY 95 (303)
T ss_dssp EEECCTTCBHHHHHHHC
T ss_pred EecCCCCCcHHHHHHhC
Confidence 99999999999999754
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.2e-14 Score=144.56 Aligned_cols=62 Identities=16% Similarity=0.107 Sum_probs=27.0
Q ss_pred CCcCeeeeccccccccCCcCCC-----CCCCCCeEecccCccccccCccc-cCCCCCCeEecCCcccc
Q 042887 386 VNINAFGVEYNQLTGTIPHAIG-----ELKNLQGLALVRNSLRGTIPDTL-GNLTLLNRLFLGFNNLQ 447 (628)
Q Consensus 386 ~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~ 447 (628)
+.|+.|++++|.++......+. ..++|++|+|++|.++......+ ..+++|+.|++++|.++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~ 139 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence 4455556665555432222211 12455555555555543222222 12334455555555544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.2e-13 Score=145.46 Aligned_cols=94 Identities=26% Similarity=0.370 Sum_probs=77.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHH---HHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTE---CEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|++.++||+|+||+||+|+++.+|+.||||++++.. ......+.+| +.+++.++|||||+++++ |+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence 367999999999999999999999999999999997642 2222333444 566777899999999999 55
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+....|+|||||+||+|.+++.+.+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~ 287 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHG 287 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC
Confidence 6889999999999999999997643
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.5e-14 Score=146.95 Aligned_cols=172 Identities=11% Similarity=0.145 Sum_probs=99.2
Q ss_pred CCCCCEEecccCcCcccccccccCC-----CCCCEeecccccCcccCCcCc-cCCCCCCEEEeecccCcccCChhhh---
Q 042887 185 FSALEAIDISANMLGGRIPDSLCQL-----RSLNYLSISENNFSCKLPLSI-WNISSLEIISLHSNRFEGSLPLNIG--- 255 (628)
Q Consensus 185 l~~L~~L~Ls~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~~--- 255 (628)
+++|+.|+|++|.++......+... ++|++|+|++|.++......+ ..+++|++|+|++|.+++.....+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4678899999998876554444332 688888888888765433333 2356778888888877633222222
Q ss_pred -hCCCCCcEEecccCccccc----ccccccCCCCCCEEEcccccceeec----ccccccCCCCCEEEccCCcCCCcCCCC
Q 042887 256 -FNIPNVNFLSVGQNNFTGS----LPHSFSNASNLQVLDVYKNHFSGQV----KIDFNRLSNLSRLFLSKNNLGTESTSD 326 (628)
Q Consensus 256 -~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~ 326 (628)
...++|++|+|++|.++.. ++..+..+++|++|+|++|.|+... ...+...++|++|+|++|.++.....
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~- 229 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL- 229 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH-
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH-
Confidence 1246677777777777642 2333456667777777777765432 23344555666666666666532211
Q ss_pred ccccccccCCCCCceeecccCCcccccchHHH
Q 042887 327 LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIA 358 (628)
Q Consensus 327 ~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~ 358 (628)
.....+..+++|+.|++++|.++......+.
T Consensus 230 -~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 230 -ALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp -HHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred -HHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 1122233445555555555555544444433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=6.3e-13 Score=134.19 Aligned_cols=91 Identities=19% Similarity=0.283 Sum_probs=77.5
Q ss_pred HHhCCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
...+.|++.+.||+|+||.||+|+++ .+++.||+|.+.... ...++.+|+++|+.+ .|||||++++++ +
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 44578999999999999999999874 457889999986543 345688999999998 599999999984 4
Q ss_pred ccceeeeeecccccCCchhhhh
Q 042887 121 GVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
+.+..|+|||||++|+|.+++.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~ 112 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN 112 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT
T ss_pred ECCEEEEEEeCCCcccHHHHHc
Confidence 5789999999999999999884
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-13 Score=142.67 Aligned_cols=102 Identities=21% Similarity=0.304 Sum_probs=85.6
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
+.....++|++.+.||+|+||.||+|++..+++.||+|++++.. ......+.+|+.++..++||||+++++++.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~--- 144 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ--- 144 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE---
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe---
Confidence 33445688999999999999999999999999999999997632 233455889999999999999999999854
Q ss_pred ccccceeeeeecccccCCchhhhhcccccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
+....|+|||||++|+|.+++.+....+
T Consensus 145 --~~~~~~lV~Ey~~gg~L~~~l~~~~~~l 172 (437)
T 4aw2_A 145 --DDNNLYLVMDYYVGGDLLTLLSKFEDRL 172 (437)
T ss_dssp --CSSEEEEEECCCTTCBHHHHHHTTTTCC
T ss_pred --eCCEEEEEEecCCCCcHHHHHHHccCCC
Confidence 4788999999999999999997644333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.3e-12 Score=127.24 Aligned_cols=94 Identities=24% Similarity=0.364 Sum_probs=83.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+........+.+.+|+.+++.++||||+++++++.. .+..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEE
Confidence 34689999999999999999999999999999999987655556778999999999999999999998653 6789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 93 ~lv~e~~~~~~L~~~~~~~ 111 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET 111 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS
T ss_pred EEEEECCCCCCHHHHHhhc
Confidence 9999999999999998654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=3e-12 Score=129.62 Aligned_cols=103 Identities=20% Similarity=0.183 Sum_probs=63.9
Q ss_pred eEecCCc-ccccccCCcccCCcchhcccceEEcCC-CcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeE
Q 042887 438 RLFLGFN-NLQGNVPSSLGNCQNLMTLSRLLDLSG-NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYL 515 (628)
Q Consensus 438 ~L~L~~N-~l~~~~~~~~~~l~~L~~l~~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 515 (628)
.++.+++ +++ .+|. +..+++| +.|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L----~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 85 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENL----TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCC----SEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCe----eEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEE
Confidence 4566665 665 3555 6555555 6666664 66665555666666666666666666666666666666666666
Q ss_pred ECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 516 HLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 516 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
+|++|+|++..+..+..++ |+.|+|++|++.
T Consensus 86 ~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 86 NLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp ECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred eCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 6666666654444454444 666666666665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=130.78 Aligned_cols=95 Identities=24% Similarity=0.357 Sum_probs=83.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+++.+|+.+|+.++||||+++++++. ...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 4578999999999999999999999999999999997642 344567889999999999999999999954 478
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+||||+++|++.+++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~ 109 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG 109 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC
T ss_pred EEEEEEECCCCCcHHHHHHHcC
Confidence 8999999999999999986543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.7e-12 Score=127.70 Aligned_cols=96 Identities=22% Similarity=0.375 Sum_probs=84.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++.+ ....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 4578999999999999999999999999999999876666667889999999999999999999999654 67899
Q ss_pred eeecccccCCchhhhhccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~ 147 (628)
+||||+++|+|.+++......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~ 104 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQ 104 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTT
T ss_pred EEEEecCCCcHHHHHHhccCC
Confidence 999999999999999764433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=4.2e-12 Score=128.71 Aligned_cols=93 Identities=25% Similarity=0.332 Sum_probs=81.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.+.|++.+.||+|+||.||+|++..+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++ +
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 4679999999999999999999999999999999976432 1346789999999999999999999995 4
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+....|+||||+++|+|.+++...
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~ 109 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQK 109 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc
Confidence 578899999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.8e-12 Score=133.41 Aligned_cols=96 Identities=18% Similarity=0.301 Sum_probs=82.9
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.+++.++|||||++++++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~---- 139 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ---- 139 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE----
Confidence 3344678999999999999999999999999999999997632 334566889999999999999999999854
Q ss_pred cccceeeeeecccccCCchhhhhc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
+....|+|||||++|+|.+++..
T Consensus 140 -~~~~~~lV~E~~~gg~L~~~l~~ 162 (410)
T 3v8s_A 140 -DDRYLYMVMEYMPGGDLVNLMSN 162 (410)
T ss_dssp -CSSEEEEEECCCTTEEHHHHHHH
T ss_pred -ECCEEEEEEeCCCCCcHHHHHHc
Confidence 57889999999999999998864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=2.2e-12 Score=132.94 Aligned_cols=100 Identities=23% Similarity=0.353 Sum_probs=85.3
Q ss_pred HHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 41 ADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
.+.....++|++.+.||+|+||.||+|++..+|+.||+|++++.. ....+.+.+|..++..++||||+++++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--- 130 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF--- 130 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE---
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE---
Confidence 333445688999999999999999999999999999999997532 33456688999999999999999999985
Q ss_pred cccccceeeeeecccccCCchhhhhccc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
++....|+|||||++|+|.+++.+.+
T Consensus 131 --~~~~~~~lVmE~~~gg~L~~~l~~~~ 156 (412)
T 2vd5_A 131 --QDENYLYLVMEYYVGGDLLTLLSKFG 156 (412)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred --eeCCEEEEEEcCCCCCcHHHHHHhcC
Confidence 45788999999999999999997644
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=9.9e-12 Score=125.75 Aligned_cols=103 Identities=24% Similarity=0.228 Sum_probs=69.1
Q ss_pred eEecccC-ccccccCccccCCCCCCeEecCC-cccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEe
Q 042887 414 GLALVRN-SLRGTIPDTLGNLTLLNRLFLGF-NNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEF 491 (628)
Q Consensus 414 ~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L 491 (628)
.++.+++ ++++ +|. +..+++|+.|+|++ |+|++..+..|.++++| +.|+|++|+|++..|..|.++++|++|
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L----~~L~l~~N~l~~~~~~~~~~l~~L~~L 85 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGEL----RNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCC----SEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCC----CEEECCCCccceeCHHHhcCCcCCCEE
Confidence 4566666 6663 555 66677777777774 77776666667666666 667777777776666667777777777
Q ss_pred eCcCCcCcccCCccccCCCCCCeEECcCceee
Q 042887 492 DLSENHFSNEIPVTLSACTTLEYLHLQGNSFS 523 (628)
Q Consensus 492 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 523 (628)
+|++|+|++..+..+..++ |+.|+|++|.+.
T Consensus 86 ~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 86 NLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp ECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred eCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 7777777755555555554 777777777765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=8.1e-12 Score=124.80 Aligned_cols=103 Identities=21% Similarity=0.328 Sum_probs=86.3
Q ss_pred CcccHHHHHHHhCC----------CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCC
Q 042887 36 PMVSYADLSKATNN----------FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHR 105 (628)
Q Consensus 36 ~~~~~~~~~~~~~~----------~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~ 105 (628)
+.+++.+...+.+. |+..+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45667666655543 66778999999999999999889999999999876655667899999999999999
Q ss_pred CcccccceeeeccccccceeeeeecccccCCchhhhhc
Q 042887 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 106 nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
||+++++++.. ....++||||+++|++.+++..
T Consensus 103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~ 135 (321)
T 2c30_A 103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQ 135 (321)
T ss_dssp TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTT
T ss_pred CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHh
Confidence 99999998654 6789999999999999998764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.27 E-value=3.7e-12 Score=124.89 Aligned_cols=92 Identities=10% Similarity=0.113 Sum_probs=80.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECC
Confidence 367999999999999999999999899999999997643 233467899999999999999999999954 367
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..|+||||+++++|.+++..
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~ 124 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT 124 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT
T ss_pred cEEEEEEecCCCCHHHHHhc
Confidence 89999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=4.3e-12 Score=127.38 Aligned_cols=93 Identities=26% Similarity=0.341 Sum_probs=81.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++++. .....+.+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 46799999999999999999999999999999999764 233456788999999999999999999985 4478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++...
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~ 99 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE 99 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEeCCCCCcHHHHHHhc
Confidence 899999999999999888654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=5.7e-12 Score=128.93 Aligned_cols=97 Identities=20% Similarity=0.270 Sum_probs=84.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+|+.++||||+++++++. .....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 467999999999999999999999999999999997765545567899999999999999999999954 478899
Q ss_pred eeecccccCCchhhhhcccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
+||||+++|+|.+++......+
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l 146 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKM 146 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCB
T ss_pred EEEEcCCCCcHHHHHHhhcCCC
Confidence 9999999999999987654333
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=6.1e-12 Score=125.65 Aligned_cols=93 Identities=18% Similarity=0.289 Sum_probs=81.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++. +....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 468999999999999999999999999999999987543 34466889999999999999999999954 477899
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+|||||++|+|.+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~~ 96 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA 96 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS
T ss_pred EEEEeCCCCCHHHHHHhcC
Confidence 9999999999999987654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.26 E-value=8.3e-10 Score=112.99 Aligned_cols=145 Identities=14% Similarity=0.169 Sum_probs=79.1
Q ss_pred cCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhh
Q 042887 404 HAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVG 483 (628)
Q Consensus 404 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~ 483 (628)
..+....+|+.+.+..+ +.......|..+..|+.+.+..+ ++......|.++.+| +.+.+..+ +.......|.
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l----~~i~l~~~-i~~i~~~aF~ 283 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL----KTLNFYAK-VKTVPYLLCS 283 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC----CEEEECCC-CSEECTTTTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehh----cccccccc-ceeccccccc
Confidence 34444555555555433 22234445555555655555443 443444555555555 44455432 3334445566
Q ss_pred ccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcc
Q 042887 484 NLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557 (628)
Q Consensus 484 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 557 (628)
++++|+.+++.++.++......|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+...+|.+.
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 6666666666666666555566666666776666544 44455556666667776666543 444444555554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.26 E-value=3.8e-12 Score=125.62 Aligned_cols=99 Identities=29% Similarity=0.500 Sum_probs=83.6
Q ss_pred hCCCCcCceeecCCceeEEEEE----ECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGK----LGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|+ ...+++.||+|++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 4679999999999999999999 456789999999987666566789999999999999999999998653 234
Q ss_pred ceeeeeecccccCCchhhhhcccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
...++||||+++|+|.+++......+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~ 111 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERI 111 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGC
T ss_pred CceEEEEEeCCCCCHHHHHHhccccc
Confidence 56899999999999999997655433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.25 E-value=8.4e-12 Score=125.39 Aligned_cols=99 Identities=18% Similarity=0.342 Sum_probs=80.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccc------
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF------ 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 119 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..-
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357999999999999999999999999999999997543 3455779999999999999999999998754110
Q ss_pred ----------------------------------------------cccceeeeeecccccCCchhhhhccc
Q 042887 120 ----------------------------------------------KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ----------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
......++|||||++|+|.+++....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 156 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence 11234899999999999999997654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.25 E-value=5.6e-12 Score=127.66 Aligned_cols=93 Identities=17% Similarity=0.324 Sum_probs=80.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 357999999999999999999999999999999996532 123567899999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+|||||++|+|.+++...
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~ 120 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKR 120 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHH
T ss_pred CCEEEEEEeCCCCCCHHHHHHHh
Confidence 78899999999999998887644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.24 E-value=8.5e-12 Score=123.02 Aligned_cols=93 Identities=20% Similarity=0.352 Sum_probs=81.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 467999999999999999999999999999999986532 334567899999999999999999999854 478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++...
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~ 105 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH 105 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH
T ss_pred eEEEEEeCCCCCCHHHHHHhc
Confidence 899999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=8.7e-12 Score=124.68 Aligned_cols=93 Identities=20% Similarity=0.295 Sum_probs=78.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 468999999999999999999999999999999997543 233467889999999999999999999854 47788
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
|+|||||++|+|.+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~ 99 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPD 99 (323)
T ss_dssp EEEEECCTTEEGGGGSBTT
T ss_pred EEEEEcCCCCcHHHHHhhc
Confidence 9999999999999988644
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=7.9e-12 Score=124.46 Aligned_cols=93 Identities=23% Similarity=0.268 Sum_probs=81.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 467999999999999999999999999999999997642 23456788999999999999999999985 4478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++...
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~ 100 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS 100 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT
T ss_pred EEEEEEeCCCCCCHHHHHHHc
Confidence 899999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=4.7e-12 Score=126.65 Aligned_cols=101 Identities=40% Similarity=0.598 Sum_probs=85.6
Q ss_pred ccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
+++.+.....++|++.+.||+|+||.||+|++ .+|+.||+|.+........+.+.+|+.+++.++||||+++++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 104 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--- 104 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 33444455678999999999999999999997 46899999998776555667899999999999999999999985
Q ss_pred cccccceeeeeecccccCCchhhhhcc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
......++||||+++|+|.+++...
T Consensus 105 --~~~~~~~lv~e~~~~~~L~~~l~~~ 129 (321)
T 2qkw_B 105 --DERNEMILIYKYMENGNLKRHLYGS 129 (321)
T ss_dssp --CCTTCCEEEEECCTTCBTGGGSSSS
T ss_pred --cCCCeEEEEEEcCCCCcHHHHHhcc
Confidence 4477889999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=9e-12 Score=124.87 Aligned_cols=107 Identities=37% Similarity=0.614 Sum_probs=89.9
Q ss_pred CCCCcccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCccccc
Q 042887 33 QQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKII 111 (628)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~ 111 (628)
.....+++.+.....++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 4456788899999999999999999999999999986 468999999997643 23344789999999999999999999
Q ss_pred ceeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 112 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+++. .....++||||+++|+|.+++....
T Consensus 94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (326)
T 3uim_A 94 GFCM-----TPTERLLVYPYMANGSVASCLRERP 122 (326)
T ss_dssp EEEC-----CSSCCEEEEECCTTCBHHHHHHCCS
T ss_pred EEEe-----cCCceEEEEEeccCCCHHHHHHhcc
Confidence 9964 4677899999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.23 E-value=9e-12 Score=126.56 Aligned_cols=93 Identities=18% Similarity=0.353 Sum_probs=81.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 467999999999999999999999999999999997643 334567899999999999999999999854 4788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++...
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~ 122 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAR 122 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTC
T ss_pred EEEEEecCCCCCHHHHHHHc
Confidence 99999999999999888654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=6.2e-12 Score=128.66 Aligned_cols=101 Identities=23% Similarity=0.406 Sum_probs=84.8
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.+....++|.+.+.||+|+||.||+|.+..+++.||+|.++... ....+.|.+|+.+|++++||||+++++++.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----- 182 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT----- 182 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----
Confidence 33445578889999999999999999998899999999987542 334567899999999999999999999964
Q ss_pred ccceeeeeecccccCCchhhhhccccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
.....++||||+++|+|.+++......
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~ 209 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEGAR 209 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHGGG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCC
Confidence 367789999999999999999765433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=8.3e-12 Score=125.69 Aligned_cols=96 Identities=20% Similarity=0.310 Sum_probs=81.0
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDF 119 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 119 (628)
....++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|..++..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~----- 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF----- 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----
Confidence 345688999999999999999999999999999999997642 33456678899999887 899999999985
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
++....|+||||+++|+|.+++...
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~ 112 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSC 112 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 4578899999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=7.3e-12 Score=127.71 Aligned_cols=93 Identities=19% Similarity=0.298 Sum_probs=81.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+|+.++|||||++++++. +..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 467999999999999999999999999999999997542 334567889999999999999999999854 478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~ 109 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN 109 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT
T ss_pred EEEEEEecCCCCcHHHHHHhc
Confidence 899999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=9.7e-12 Score=125.66 Aligned_cols=95 Identities=27% Similarity=0.363 Sum_probs=80.7
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhc-CCCCcccccceeeecccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 120 (628)
...++|++.+.||+|+||.||+|++..+|+.||+|+++.. .....+.+.+|..+++.+ .||||+++++++ .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 3457899999999999999999999999999999999764 233456788999999988 699999999985 4
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+....|+|||||++|+|.+++...
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~ 118 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKS 118 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc
Confidence 578899999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-11 Score=124.19 Aligned_cols=96 Identities=23% Similarity=0.461 Sum_probs=80.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCc---EEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGT---TVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|++..+++ .||||+++.. .....+.+.+|+.++++++||||+++++++. ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 4578889999999999999999986555 4999999764 3344567999999999999999999999954 47
Q ss_pred ceeeeeecccccCCchhhhhccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
...++||||+++|+|.+++......
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~ 147 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQ 147 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccC
Confidence 7889999999999999999655433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-11 Score=125.79 Aligned_cols=92 Identities=22% Similarity=0.269 Sum_probs=80.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++. .....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 4689999999999999999999999999999999975432 3466889999999999999999999954 477899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+|||||++|+|.+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~ 110 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA 110 (361)
T ss_dssp EEEECCCSCBHHHHHHHH
T ss_pred EEEEeCCCCCHHHHHHhc
Confidence 999999999999988653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=122.76 Aligned_cols=96 Identities=26% Similarity=0.458 Sum_probs=81.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+.|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 357999999999999999999999999999999997543 3345678899999999999999999998653 234578
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+++|+|.+++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~ 104 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS 104 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG
T ss_pred EEEEeCCCCCCHHHHHHHhc
Confidence 99999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=122.82 Aligned_cols=93 Identities=22% Similarity=0.338 Sum_probs=80.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 3568999999999999999999999999999999976432 13467899999999999999999999854
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|+|.+++...
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~ 108 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEK 108 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTS
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhc
Confidence 477899999999999999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.22 E-value=9.4e-12 Score=125.81 Aligned_cols=95 Identities=22% Similarity=0.345 Sum_probs=82.5
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-----ccchhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-----QKGAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
....++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--- 98 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE--- 98 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc---
Confidence 44567899999999999999999999999999999999753 2345578999999999999999999999954
Q ss_pred ccccceeeeeecccccCCchhhhhc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.....++|||||++|+|.+++..
T Consensus 99 --~~~~~~lv~e~~~gg~L~~~l~~ 121 (345)
T 3hko_A 99 --DEQYICLVMELCHGGHLLDKLNV 121 (345)
T ss_dssp --CSSEEEEEEECCCSCBHHHHEEE
T ss_pred --cCCeEEEEEeCCCCCcHHHHHHH
Confidence 47889999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=9.8e-12 Score=122.25 Aligned_cols=95 Identities=26% Similarity=0.508 Sum_probs=82.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC-------cEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG-------TTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
.++|++.+.||+|+||.||+|++..++ +.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 467999999999999999999998776 469999997766666788999999999999999999999954
Q ss_pred cccceeeeeecccccCCchhhhhcccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
.....++||||+++|+|.+++.....
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~~~ 108 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKNKN 108 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHTGG
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhCCC
Confidence 46778999999999999999976553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=125.00 Aligned_cols=93 Identities=23% Similarity=0.297 Sum_probs=81.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence 367999999999999999999999999999999997542 23456788999999999999999999985 4478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++.+.
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~ 135 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI 135 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEcCCCCCcHHHHHHHc
Confidence 899999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=124.02 Aligned_cols=93 Identities=20% Similarity=0.253 Sum_probs=80.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++ .+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 357999999999999999999999999999999997642 23456688999999988 799999999985 447
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...|+||||+++|+|.+++...
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~ 104 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ 104 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH
T ss_pred CEEEEEEeCCCCCcHHHHHHHc
Confidence 8899999999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-11 Score=129.09 Aligned_cols=95 Identities=16% Similarity=0.246 Sum_probs=80.6
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++ ....
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 3467999999999999999999999999999999997643 23456789999999999999999999985 4578
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|||||++|+|.+++....
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~ 105 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVARE 105 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCS
T ss_pred EEEEEEEeCCCCCHHHHHHHcC
Confidence 8999999999999999887543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.4e-11 Score=120.40 Aligned_cols=93 Identities=20% Similarity=0.219 Sum_probs=82.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 457999999999999999999999999999999998765556678999999999999999999999854 477899
Q ss_pred eeecccccCCchhhhhcc
Q 042887 127 LIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~ 144 (628)
+||||++++++.+++...
T Consensus 83 lv~e~~~~~~L~~~~~~~ 100 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK 100 (277)
T ss_dssp EEEECCCSCBHHHHHHHH
T ss_pred EEEeccCCCcHHHHHHHc
Confidence 999999999999888654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.4e-11 Score=126.12 Aligned_cols=94 Identities=19% Similarity=0.251 Sum_probs=80.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++++.. ....+.+.+|..++.++ +|||||++++++ .+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 3568999999999999999999999999999999997642 33456688999999887 799999999985 45
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+|||||++|+|.+++.+.
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~ 147 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQ 147 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH
T ss_pred CCEEEEEEEcCCCCcHHHHHHHc
Confidence 78899999999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=9.4e-12 Score=123.58 Aligned_cols=96 Identities=24% Similarity=0.420 Sum_probs=81.5
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
+....++|++.+.||+|+||.||+|++ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 104 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----- 104 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----
Confidence 334567899999999999999999988 68899999987543 334567899999999999999999999854
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++....
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~ 129 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSG 129 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTT
T ss_pred ECCceEEEEecCCCCcHHHHHhhcC
Confidence 4677899999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.5e-11 Score=125.45 Aligned_cols=89 Identities=22% Similarity=0.357 Sum_probs=73.4
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeeccc
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYM 132 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 132 (628)
.+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|+.++++++||||+++++++. .....++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence 567999999999999999999999999998765556678999999999999999999999954 467899999999
Q ss_pred ccCCchhhhhcccc
Q 042887 133 KCGSSEDWMHQSND 146 (628)
Q Consensus 133 ~~g~L~~~l~~~~~ 146 (628)
++|+|.+++.....
T Consensus 169 ~~~~L~~~l~~~~~ 182 (373)
T 2x4f_A 169 DGGELFDRIIDESY 182 (373)
T ss_dssp TTCEEHHHHHHTGG
T ss_pred CCCcHHHHHHhcCC
Confidence 99999998875543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=9.7e-12 Score=126.48 Aligned_cols=103 Identities=19% Similarity=0.372 Sum_probs=85.7
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEE-----ECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGK-----LGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIIT 112 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 112 (628)
...+....++|++.+.||+|+||.||+|+ ...+++.||||+++... ....+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 55666778899999999999999999999 44567899999997643 33456799999999999 7999999999
Q ss_pred eeeeccccccceeeeeecccccCCchhhhhcccc
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
++.+ .....++|||||++|+|.+++.....
T Consensus 94 ~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~ 123 (359)
T 3vhe_A 94 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRN 123 (359)
T ss_dssp EECS----TTSCCEEEEECCTTEEHHHHHHTTTT
T ss_pred eeec----CCCceEEEEEecCCCcHHHHHHhccc
Confidence 8643 34558999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.19 E-value=1.4e-11 Score=125.68 Aligned_cols=95 Identities=24% Similarity=0.487 Sum_probs=79.9
Q ss_pred hCCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|++. .++..||+|.++... ....+.|.+|+.++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 357999999999999999999986 457789999997643 344567999999999999999999999964 46
Q ss_pred ceeeeeecccccCCchhhhhcccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...++||||+++|+|.+++.....
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~ 142 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDA 142 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT
T ss_pred CceEEEEeCCCCCcHHHHHHhCCC
Confidence 788999999999999999976543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.8e-11 Score=121.22 Aligned_cols=95 Identities=24% Similarity=0.397 Sum_probs=80.6
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..+.|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence 45689999999999999999999999999999999977655566789999999999999999999998653 6788
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||++++++.+++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~ 111 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD 111 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT
T ss_pred EEEEEeCCCCcHHHHHHhhc
Confidence 99999999999999886543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.19 E-value=8e-09 Score=105.63 Aligned_cols=311 Identities=11% Similarity=0.046 Sum_probs=164.7
Q ss_pred CcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 162 LKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
.+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|.. .+|+.+.+
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l 120 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF 120 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence 4566666653 455555667777777777777543 555556666665 4666655433 44344444544 35666666
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCC
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT 321 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 321 (628)
..+ ++ .+....|.. .+++.+.+..+ ++.+....|.++.+++.+.+..+.........+. .....
T Consensus 121 p~~-~~-~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~----------- 184 (379)
T 4h09_A 121 PGA-TT-EIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-YNKNK----------- 184 (379)
T ss_dssp CTT-CC-EECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE-EETTS-----------
T ss_pred CCc-cc-ccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeeccccee-ccccc-----------
Confidence 544 22 333333332 23444333322 2223333444444444444433322111110000 00000
Q ss_pred cCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccccccc
Q 042887 322 ESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGT 401 (628)
Q Consensus 322 ~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 401 (628)
.....+..+..+..+. +... ........+....+++.+.+..+ +...
T Consensus 185 ------~~~~~~~~~~~~~~~~-------------------------~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i 231 (379)
T 4h09_A 185 ------TILESYPAAKTGTEFT-------------------------IPST-VKTVTAYGFSYGKNLKKITITSG-VTTL 231 (379)
T ss_dssp ------SEEEECCTTCCCSEEE-------------------------CCTT-CCEECTTTTTTCSSCSEEECCTT-CCEE
T ss_pred ------ceeccccccccccccc-------------------------cccc-eeEEeecccccccccceeeeccc-eeEE
Confidence 0000011111122111 1111 11123344555666666665443 3334
Q ss_pred CCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchh
Q 042887 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481 (628)
Q Consensus 402 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~ 481 (628)
...+|..+..|+.+.+..+ ++......|.++.+|+.+.+..+ +.......|.+|.+| +.+.+.++.++.+....
T Consensus 232 ~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L----~~i~l~~~~i~~I~~~a 305 (379)
T 4h09_A 232 GDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL----TKVVMDNSAIETLEPRV 305 (379)
T ss_dssp CTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC----CEEEECCTTCCEECTTT
T ss_pred ccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc----ccccccccccceehhhh
Confidence 5566777777777777655 55455666777777777777543 554556677777777 66777777777666677
Q ss_pred hhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCC
Q 042887 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLK 534 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 534 (628)
|.++.+|+.+++..+ ++.+....|.++++|+.+.+..+ ++.+...+|.+.+
T Consensus 306 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 306 FMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred hcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 888888888888654 55555667888888888887655 5545566666553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.3e-11 Score=120.15 Aligned_cols=93 Identities=24% Similarity=0.379 Sum_probs=75.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--------------------------chhhhHHHHHHHHh
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--------------------------GAAKSFVTECEALS 100 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------------------~~~~~~~~E~~~l~ 100 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4789999999999999999999999999999999965321 12356899999999
Q ss_pred hcCCCCcccccceeeeccccccceeeeeecccccCCchhhhh
Q 042887 101 NVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 101 ~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
+++||||+++++++.+ ......|+||||+++|++.++..
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~ 130 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT 130 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh
Confidence 9999999999998653 23568899999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.6e-11 Score=120.88 Aligned_cols=93 Identities=23% Similarity=0.304 Sum_probs=80.6
Q ss_pred hCCCCcC-ceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccce
Q 042887 47 TNNFSAS-NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.+.|++. +.||+|+||.||+|++..+++.||+|++........+.+.+|+.++.++ +||||+++++++. ..+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence 3568874 7899999999999999999999999999776555567899999999985 7999999999954 4778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+++|+|.+++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~ 105 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR 105 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhcc
Confidence 99999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.2e-11 Score=125.46 Aligned_cols=96 Identities=26% Similarity=0.458 Sum_probs=81.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+.|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 357999999999999999999999999999999997543 3345678899999999999999999998653 234477
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++|||||++|+|.+++....
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~ 104 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPS 104 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGG
T ss_pred EEEEecCCCCCHHHHHHhhh
Confidence 99999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=124.83 Aligned_cols=94 Identities=22% Similarity=0.280 Sum_probs=78.7
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--------cchhhhHHHHHHHHhhcCCCCcccccceeee
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--------KGAAKSFVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45688999999999999999999999999999999997532 122346889999999999999999999853
Q ss_pred ccccccceeeeeecccccCCchhhhhcc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+||||+++|+|.+++...
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~~~ 233 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVVGN 233 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTSSS
T ss_pred -----cCceEEEEEcCCCCcHHHHHhcc
Confidence 34579999999999999888654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.7e-11 Score=128.64 Aligned_cols=93 Identities=28% Similarity=0.412 Sum_probs=81.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 468999999999999999999999999999999997542 234567899999999999999999999954 477
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+|||||++|+|.+++.+.
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~ 110 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN 110 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS
T ss_pred EEEEEEeCCCCCcHHHHHHhc
Confidence 899999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.18 E-value=2.6e-11 Score=124.68 Aligned_cols=93 Identities=18% Similarity=0.239 Sum_probs=81.9
Q ss_pred hCCCCcCceeecC--CceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQG--SFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G--~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+| +||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++|||||++++++. ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence 4579999999999 99999999999999999999997643 344567889999999999999999999965 47
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...|+|||||++|++.+++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~ 120 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTH 120 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHT
T ss_pred CEEEEEEEccCCCCHHHHHhhh
Confidence 7899999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=119.31 Aligned_cols=93 Identities=22% Similarity=0.287 Sum_probs=81.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence 457999999999999999999999999999999997653 334577899999999999999999999954 47789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|++.+++...
T Consensus 96 ~lv~e~~~~~~L~~~l~~~ 114 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSA 114 (285)
T ss_dssp EEEECCCSCCBHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhh
Confidence 9999999999999988643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.2e-11 Score=120.71 Aligned_cols=94 Identities=19% Similarity=0.291 Sum_probs=79.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|.+.+.||+|+||.||+|++..+|+.||+|++........+.+.+|+.++++++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEE
Confidence 3467999999999999999999999999999999998655445567899999999999999999999854 47789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~ 100 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILER 100 (304)
T ss_dssp EEEECCCCSCBHHHHHHHH
T ss_pred EEEEEcCCCccHHHHHHHc
Confidence 9999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-11 Score=122.58 Aligned_cols=92 Identities=23% Similarity=0.299 Sum_probs=79.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 468999999999999999999999999999999997542 233467899999999999999999999954 477
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||+ +|++.+++...
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~ 102 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEK 102 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHH
T ss_pred EEEEEEECC-CCcHHHHHHHc
Confidence 899999999 67888887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2.9e-11 Score=120.83 Aligned_cols=93 Identities=25% Similarity=0.332 Sum_probs=80.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.+.|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 4569999999999999999999999999999999976432 13467899999999999999999999854
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++++|.+++...
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~ 109 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQK 109 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc
Confidence 477899999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.4e-11 Score=122.81 Aligned_cols=92 Identities=24% Similarity=0.307 Sum_probs=74.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..+.|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.++++++||||+++++++. .....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 3467999999999999999999999999999999997543 3456889999999999999999999954 47789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~~ 142 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK 142 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC
T ss_pred EEEEEeCCCCCHHHHHHhc
Confidence 9999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.7e-11 Score=116.72 Aligned_cols=93 Identities=24% Similarity=0.463 Sum_probs=79.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++. .....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 467999999999999999999996 577899999976433 3467899999999999999999999854 467889
Q ss_pred eeecccccCCchhhhhcccc
Q 042887 127 LIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~ 146 (628)
+||||+++|++.+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~ 101 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG 101 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT
T ss_pred EEEEeCCCCcHHHHHHhcCc
Confidence 99999999999999976543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.2e-11 Score=129.74 Aligned_cols=95 Identities=21% Similarity=0.288 Sum_probs=79.4
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-------------chhhhHHHHHHHHhhcCCCCccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-------------GAAKSFVTECEALSNVRHRNLIKII 111 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~ 111 (628)
...+.|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 346789999999999999999999999999999999975421 2346789999999999999999999
Q ss_pred ceeeeccccccceeeeeecccccCCchhhhhcc
Q 042887 112 TVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 112 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+++. .....|+|||||++|+|.+++...
T Consensus 113 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~ 140 (504)
T 3q5i_A 113 DVFE-----DKKYFYLVTEFYEGGELFEQIINR 140 (504)
T ss_dssp EEEE-----CSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEE-----cCCEEEEEEecCCCCcHHHHHHHc
Confidence 9954 478899999999999999888654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.8e-11 Score=128.89 Aligned_cols=94 Identities=21% Similarity=0.309 Sum_probs=81.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+|+.++|||||++++++ ++..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence 467999999999999999999999999999999997642 23456688999999999999999999985 4578
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+||||++||+|.+++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~ 279 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG 279 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS
T ss_pred EEEEEEEcCCCCcHHHHHHhcC
Confidence 8999999999999999887543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.5e-11 Score=120.01 Aligned_cols=92 Identities=24% Similarity=0.511 Sum_probs=66.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 467999999999999999999999999999999997643 33456788999999999999999999995 447789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||++ |++.+++...
T Consensus 79 ~lv~e~~~-~~L~~~l~~~ 96 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSR 96 (317)
T ss_dssp EEEEECCC-CBHHHHHHHH
T ss_pred EEEEEecC-CCHHHHHHhc
Confidence 99999999 5898888654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.9e-11 Score=117.25 Aligned_cols=95 Identities=17% Similarity=0.311 Sum_probs=82.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.. +....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 468999999999999999999999999999999997543 3345678999999999999999999998653 34678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+++|+|.+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~ 101 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKG 101 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHH
T ss_pred EEEEEeCCCCCCHHHHHHhh
Confidence 89999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.3e-11 Score=123.95 Aligned_cols=94 Identities=22% Similarity=0.432 Sum_probs=79.4
Q ss_pred hCCCCcCceeecCCceeEEEEEEC-------CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceeeec
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG-------ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCSSI 117 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 117 (628)
.++|++.+.||+|+||.||+|++. .++..||+|+++... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 467889999999999999999974 345679999997643 34456799999999999 8999999999954
Q ss_pred cccccceeeeeecccccCCchhhhhccc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....|+||||+++|+|.+++....
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~ 182 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARR 182 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhC
Confidence 4778999999999999999997654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.1e-11 Score=123.09 Aligned_cols=94 Identities=20% Similarity=0.258 Sum_probs=81.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|..++..+ .||+|+++++++ ++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 4578999999999999999999999899999999997642 33456788999999988 799999999984 45
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+||||+++|+|.+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~ 115 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQV 115 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc
Confidence 78899999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=4.4e-11 Score=117.21 Aligned_cols=93 Identities=18% Similarity=0.353 Sum_probs=80.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 468999999999999999999999999999999997543 334567889999999999999999999854 4778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+++|++.+++...
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~ 99 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR 99 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH
T ss_pred EEEEEecCCCCCHHHHHHhc
Confidence 89999999999998887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=3.4e-11 Score=120.68 Aligned_cols=97 Identities=23% Similarity=0.372 Sum_probs=83.1
Q ss_pred hCCCCcCceeecCCceeEEEEEE----CCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|++ ..+++.||+|++........+.+.+|++++++++||||+++++++.. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 35799999999999999999994 56789999999987666566789999999999999999999998653 346
Q ss_pred ceeeeeecccccCCchhhhhcccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...++||||+++|+|.+++.....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~ 122 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA 122 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG
T ss_pred ceEEEEEeecCCCCHHHHHHhccc
Confidence 778999999999999999976443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-11 Score=121.85 Aligned_cols=97 Identities=24% Similarity=0.469 Sum_probs=83.8
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
++....++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++. .
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 80 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----R 80 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----c
Confidence 44445678999999999999999999999889999999987543 34577899999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....++||||+++|+|.+++...
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~ 103 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLREC 103 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhc
Confidence 77889999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=2e-11 Score=124.42 Aligned_cols=95 Identities=23% Similarity=0.404 Sum_probs=79.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEE-----CCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
..++|++.+.||+|+||.||+|++ ..+++.||||+++.. .......+.+|+.++++++||||+++++++.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---- 144 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 144 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence 346789999999999999999994 346778999999654 3344567899999999999999999999954
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++|||||++|+|.+++....
T Consensus 145 -~~~~~~lv~e~~~~g~L~~~l~~~~ 169 (367)
T 3l9p_A 145 -QSLPRFILLELMAGGDLKSFLRETR 169 (367)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHS
T ss_pred -cCCCCEEEEEeCCCCCHHHHHHhhc
Confidence 4677899999999999999997654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=8.1e-11 Score=116.02 Aligned_cols=92 Identities=17% Similarity=0.334 Sum_probs=78.1
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
+|.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence 44555689999999999999999999999999987655556789999999999999999999998653 6789999
Q ss_pred ecccccCCchhhhhccc
Q 042887 129 YEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~~ 145 (628)
|||+++++|.+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~ 114 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKW 114 (295)
T ss_dssp EECCSEEEHHHHHHHTT
T ss_pred EEeCCCCCHHHHHHhhc
Confidence 99999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=2.4e-11 Score=121.72 Aligned_cols=93 Identities=22% Similarity=0.304 Sum_probs=74.1
Q ss_pred hCCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
.++|++.+.||+|+||.||+|++. .+|+.||+|+++... ......+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 467999999999999999999985 678999999997542 234456789999999999999999999854
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....|+||||+++|+|.+++...
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~~ 115 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLERE 115 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHHH
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHhC
Confidence 477899999999999999988654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=3e-11 Score=128.05 Aligned_cols=94 Identities=26% Similarity=0.319 Sum_probs=81.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 3467999999999999999999999999999999996532 334577899999999999999999999954 478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+|||||++|+|.+++...
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~ 115 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKR 115 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHHhc
Confidence 899999999999999888654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.2e-11 Score=119.41 Aligned_cols=99 Identities=22% Similarity=0.417 Sum_probs=79.5
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.+....++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++. .
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 90 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----K 90 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----c
Confidence 34445678999999999999999999985 677899999976543 3467899999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhccccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
....++||||+++|+|.+++......
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~ 116 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHR 116 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGC
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccC
Confidence 77889999999999999999764433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.15 E-value=3.7e-11 Score=122.20 Aligned_cols=93 Identities=18% Similarity=0.291 Sum_probs=81.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 46799999999999999999999999999999999765 33445678999999999999999999998654 6789
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 107 ~lv~e~~~~~~L~~~l~~~ 125 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA 125 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc
Confidence 9999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.4e-11 Score=128.91 Aligned_cols=97 Identities=24% Similarity=0.476 Sum_probs=83.8
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.+....++|++.+.||+|+||.||+|.+..+++.||||.++.... ..+.|.+|+.+|++++|||||++++++. .
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~ 287 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT-----R 287 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEe-----c
Confidence 344556778999999999999999999988899999999976433 4578999999999999999999999964 3
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+|||||++|+|.+++...
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~ 310 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLREC 310 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHS
T ss_pred CCcEEEEEEccCCCCHHHHHHhc
Confidence 67889999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.7e-11 Score=121.90 Aligned_cols=90 Identities=23% Similarity=0.316 Sum_probs=77.6
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccce
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+|++++.++ +||||+++++++ ++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 34679999999999999999999999999999999976432 345788888888 799999999985 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~ 110 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ 110 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC
T ss_pred EEEEEeCCCCCcHHHHHHHc
Confidence 99999999999999988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=3.1e-11 Score=128.21 Aligned_cols=94 Identities=18% Similarity=0.245 Sum_probs=77.6
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..+.|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKR 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 3457999999999999999999999999999999997643 334567899999999999999999999954 478
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+|||||++|+|.+++...
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~ 130 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHR 130 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHH
T ss_pred EEEEEEecCCCCcHHHHHHHc
Confidence 899999999999998888654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.4e-11 Score=117.11 Aligned_cols=91 Identities=24% Similarity=0.455 Sum_probs=76.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 57999999999999999999999999999999997543 334567889999999999999999999954 47889
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++ ++.+++...
T Consensus 77 ~lv~e~~~~-~l~~~~~~~ 94 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSC 94 (292)
T ss_dssp EEEEECCSE-EHHHHHHHT
T ss_pred EEEEecCCC-CHHHHHHhC
Confidence 999999986 555555443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.8e-11 Score=121.77 Aligned_cols=97 Identities=15% Similarity=0.232 Sum_probs=80.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 468999999999999999999999999999999997642 233457889999999999999999999865411 1123
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..|+||||+++|+|.+++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~ 110 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE 110 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH
T ss_pred ccEEEEecCCCCCHHHHHHhc
Confidence 459999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=2.5e-11 Score=121.80 Aligned_cols=97 Identities=26% Similarity=0.456 Sum_probs=78.0
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH----- 103 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----
Confidence 3445678999999999999999999999999999999997543 233567889999999999999999999954
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++ ++.+++....
T Consensus 104 ~~~~~~lv~e~~~~-~L~~~~~~~~ 127 (329)
T 3gbz_A 104 HNHRLHLIFEYAEN-DLKKYMDKNP 127 (329)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHHCT
T ss_pred cCCEEEEEEecCCC-CHHHHHhhcC
Confidence 47889999999985 8988886543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=3.9e-11 Score=117.25 Aligned_cols=95 Identities=21% Similarity=0.438 Sum_probs=82.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 3467999999999999999999999899999999997542 223467899999999999999999999854 47
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++||||++++++.+++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~ 106 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRV 106 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCS
T ss_pred CeEEEEEecCCCCcHHHHHhhcc
Confidence 78999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=3.4e-11 Score=121.08 Aligned_cols=99 Identities=21% Similarity=0.394 Sum_probs=83.3
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCc-----EEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGT-----TVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
.+....++|++.+.||+|+||.||+|.+..+++ .||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 445566889999999999999999999976654 79999997643 33456789999999999 899999999985
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .....++||||+++|+|.+++....
T Consensus 120 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (333)
T 2i1m_A 120 T-----HGGPVLVITEYCCYGDLLNFLRRKS 145 (333)
T ss_dssp C-----SSSSCEEEEECCTTEEHHHHHHHHH
T ss_pred e-----cCCceEEEEecCCCCcHHHHHHHhc
Confidence 4 4678999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-11 Score=121.38 Aligned_cols=97 Identities=26% Similarity=0.464 Sum_probs=82.3
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
....++|++.+.||+|+||.||+|++. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--
Confidence 345688999999999999999999986 345889999997643 334567999999999999999999999954
Q ss_pred cccccceeeeeecccccCCchhhhhccc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++....
T Consensus 121 ---~~~~~~lv~e~~~~~~L~~~l~~~~ 145 (343)
T 1luf_A 121 ---VGKPMCLLFEYMAYGDLNEFLRSMS 145 (343)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred ---cCCceEEEEecCCCCcHHHHHHHhC
Confidence 4678899999999999999997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=4e-11 Score=119.61 Aligned_cols=97 Identities=14% Similarity=0.209 Sum_probs=81.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|++..+|+.||+|++........+.+.+|+.+++.++||||+++++++... .......
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCcee
Confidence 346799999999999999999999999999999999766555667899999999999999999999987531 1234678
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
++||||+++|+|.+++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~ 123 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIER 123 (317)
T ss_dssp EEEEECCTTCBHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHH
Confidence 999999999999998875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=6e-11 Score=117.94 Aligned_cols=93 Identities=24% Similarity=0.369 Sum_probs=79.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 367999999999999999999999999999999986543 233567889999999999999999999965 3778
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||++++++.+++...
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~ 96 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQ 96 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTS
T ss_pred EEEEEEeCCCchHHHHHhhh
Confidence 99999999999998877543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=5.7e-11 Score=115.35 Aligned_cols=93 Identities=23% Similarity=0.393 Sum_probs=79.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++ ......+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 567999999999999999999885 567899999976443 346789999999999999999999985 4477889
Q ss_pred eeecccccCCchhhhhcccc
Q 042887 127 LIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~ 146 (628)
+||||+++|++.+++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~ 99 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK 99 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG
T ss_pred EEEEccCCCcHHHHHHHcCC
Confidence 99999999999999976543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=2e-11 Score=121.56 Aligned_cols=96 Identities=30% Similarity=0.426 Sum_probs=81.2
Q ss_pred HHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSID 118 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 118 (628)
...++|.+.+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 96 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--- 96 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe---
Confidence 34578999999999999999999973 455889999997543 344577899999999999999999999854
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+++|+|.+++....
T Consensus 97 --~~~~~~lv~e~~~~~~L~~~l~~~~ 121 (314)
T 2ivs_A 97 --QDGPLLLIVEYAKYGSLRGFLRESR 121 (314)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTT
T ss_pred --cCCceEEEEeecCCCCHHHHHHHHh
Confidence 4778999999999999999997654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.13 E-value=5e-11 Score=119.22 Aligned_cols=84 Identities=21% Similarity=0.304 Sum_probs=73.8
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccccceeeeeecc
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFKALIYEY 131 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 131 (628)
.+.||+|+||.||+|.+..+|+.||+|++... ....+.+|+.+++.+. ||||+++++++. +....|+||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 37899999999999999999999999998653 3356789999999997 999999999954 47889999999
Q ss_pred cccCCchhhhhcc
Q 042887 132 MKCGSSEDWMHQS 144 (628)
Q Consensus 132 ~~~g~L~~~l~~~ 144 (628)
+++|+|.+++...
T Consensus 88 ~~~~~L~~~l~~~ 100 (325)
T 3kn6_A 88 LNGGELFERIKKK 100 (325)
T ss_dssp CCSCBHHHHHHHC
T ss_pred cCCCcHHHHHHhc
Confidence 9999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.13 E-value=4.6e-11 Score=126.83 Aligned_cols=92 Identities=21% Similarity=0.298 Sum_probs=80.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++++++||||+++++++ ++...
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~~ 259 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKTD 259 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCCE
Confidence 67888899999999999999999999999999997542 23456788999999999999999999984 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||++||+|.+++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~ 279 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNV 279 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTS
T ss_pred EEEEEEeccCCCHHHHHHHh
Confidence 99999999999999988654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=4.5e-11 Score=126.75 Aligned_cols=94 Identities=27% Similarity=0.373 Sum_probs=81.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 457999999999999999999999999999999996542 334577999999999999999999999954 478
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|||||.+|++.+++....
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~ 121 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK 121 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS
T ss_pred EEEEEEecCCCCCHHHHHHhcC
Confidence 8999999999999998886543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.13 E-value=5.6e-11 Score=116.42 Aligned_cols=91 Identities=22% Similarity=0.370 Sum_probs=79.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 568999999999999999999998999999999975421 23567899999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
....++||||+++++|.+++..
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~ 101 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE 101 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH
T ss_pred CCeEEEEEeecCCCcHHHHHHh
Confidence 6789999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=6.5e-11 Score=116.23 Aligned_cols=93 Identities=23% Similarity=0.305 Sum_probs=81.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+..+..+ +||||+++++++.+ .+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 45799999999999999999999989999999999764 233456788999999999 89999999998654 77
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||+++|+|.+++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~ 105 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISEN 105 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHH
T ss_pred eEEEEEEecCCCcHHHHHHhh
Confidence 899999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=115.04 Aligned_cols=104 Identities=35% Similarity=0.543 Sum_probs=87.5
Q ss_pred CCCcccHHHHHHHhCCCCcC------ceeecCCceeEEEEEECCCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcC
Q 042887 34 QFPMVSYADLSKATNNFSAS------NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVR 103 (628)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~~~------~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~ 103 (628)
..+.+++.+....+++|... +.||+|+||.||+|.+ +++.||+|.+.... ....+.+.+|+.+++.++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 35667888888888888766 8999999999999987 68899999986532 234567899999999999
Q ss_pred CCCcccccceeeeccccccceeeeeecccccCCchhhhhcc
Q 042887 104 HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 104 h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
||||+++++++. .....++||||+++|++.+++...
T Consensus 89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~ 124 (307)
T 2nru_A 89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCL 124 (307)
T ss_dssp CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTG
T ss_pred CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhc
Confidence 999999999854 467889999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=5.2e-11 Score=116.92 Aligned_cols=94 Identities=26% Similarity=0.459 Sum_probs=78.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-------chhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-------GAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 93 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH---- 93 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET----
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec----
Confidence 4679999999999999999999999999999999865422 11267899999999999999999999853
Q ss_pred cccceeeeeecccccCCchhhhhccccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
.. .++||||+++|++.+++.+....
T Consensus 94 -~~--~~lv~e~~~~~~L~~~l~~~~~~ 118 (287)
T 4f0f_A 94 -NP--PRMVMEFVPCGDLYHRLLDKAHP 118 (287)
T ss_dssp -TT--TEEEEECCTTCBHHHHHHCTTSC
T ss_pred -CC--CeEEEEecCCCCHHHHHhcccCC
Confidence 22 36999999999999888665433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=2.5e-11 Score=123.46 Aligned_cols=94 Identities=26% Similarity=0.358 Sum_probs=72.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHH-HhhcCCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEA-LSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++++.. ......+.+|..+ ++.++||||+++++++ .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 3467999999999999999999999999999999997643 2334566777776 5778999999999985 45
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+||||+++|+|.+++.+.
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~ 133 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRE 133 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc
Confidence 78999999999999999988654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.12 E-value=4.9e-11 Score=125.51 Aligned_cols=97 Identities=18% Similarity=0.282 Sum_probs=73.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+++.+|+.+|++++|||||++++++....++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999999999999999999653 2344577899999999999999999999976544455678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+. |++.+++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~ 150 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP 150 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS
T ss_pred EEEEEeccc-cchhhhcccC
Confidence 999999985 6888888654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=3.7e-11 Score=116.81 Aligned_cols=94 Identities=22% Similarity=0.459 Sum_probs=79.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++ .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCC
Confidence 46799999999999999999999 58899999997643 3345679999999999999999999998653 22377
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||||+++|+|.+++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~ 104 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGT 104 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCS
T ss_pred eEeeecccCCCcHHHHHhhcc
Confidence 899999999999999997644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.12 E-value=7.3e-11 Score=115.12 Aligned_cols=93 Identities=20% Similarity=0.298 Sum_probs=80.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 467999999999999999999999899999999997543 3345778999999999999999999998643 6788
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++++|.+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~ 99 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPD 99 (276)
T ss_dssp EEEEECCTTEEGGGGSBTT
T ss_pred EEEEEecCCCcHHHHHhhc
Confidence 9999999999999988643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=7.1e-11 Score=115.19 Aligned_cols=93 Identities=27% Similarity=0.396 Sum_probs=81.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 468999999999999999999999899999999997542 234567899999999999999999999854 467
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||+++++|.+++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~ 105 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH 105 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH
T ss_pred eEEEEEeccCCCcHHHHHhcc
Confidence 899999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=6.2e-11 Score=124.15 Aligned_cols=93 Identities=28% Similarity=0.470 Sum_probs=79.7
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
...++|++.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.+|++++||||+++++++.. ....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 261 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 261 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCc
Confidence 3457889999999999999999999 47899999997543 45789999999999999999999998653 3447
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||++|+|.+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~ 282 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRG 282 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHC
T ss_pred eEEEEEecCCCcHHHHHHhcC
Confidence 899999999999999997653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.12 E-value=5.7e-11 Score=118.97 Aligned_cols=97 Identities=30% Similarity=0.497 Sum_probs=80.7
Q ss_pred hCCCCcCceeecCCceeEEEEEE----CCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|++ ..+|+.||+|++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 45689999999999999999994 56789999999987665566789999999999999999999998653 224
Q ss_pred ceeeeeecccccCCchhhhhcccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...++||||+++|+|.+++.....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~ 140 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE 140 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT
T ss_pred CceEEEEECCCCCCHHHHHHhccc
Confidence 578999999999999999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=6.2e-11 Score=119.19 Aligned_cols=94 Identities=13% Similarity=0.204 Sum_probs=81.5
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence 3567999999999999999999999999999999997542 334567899999999999999999999854 47
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...|+||||++++++.+++...
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~ 135 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRR 135 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH
T ss_pred CeEEEEEecCCCCCHHHHHhcc
Confidence 7899999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=6.5e-11 Score=116.68 Aligned_cols=93 Identities=13% Similarity=0.203 Sum_probs=80.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 467999999999999999999999999999999997542 334567889999999999999999999954 477
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||++++++.+++...
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~ 109 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR 109 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEecCCCCCHHHHHHhc
Confidence 899999999999999887643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.12 E-value=5.2e-11 Score=116.40 Aligned_cols=94 Identities=26% Similarity=0.384 Sum_probs=81.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence 3567999999999999999999999999999999996542 233467889999999999999999999954 47
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++||||+++|++.+++...
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~ 103 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKL 103 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH
T ss_pred CEEEEEEecCCCCcHHHHHHhc
Confidence 7899999999999999988654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.12 E-value=7.4e-11 Score=116.71 Aligned_cols=98 Identities=20% Similarity=0.328 Sum_probs=81.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeec--------c
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSI--------D 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~ 118 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999999999999999996532 3456789999999999999999999987541 1
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.......|+||||+++|+|.+++....
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN 110 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc
Confidence 133578899999999999999997544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=7.9e-11 Score=116.29 Aligned_cols=94 Identities=21% Similarity=0.359 Sum_probs=80.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---------cchhhhHHHHHHHHhhcC-CCCcccccceee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---------KGAAKSFVTECEALSNVR-HRNLIKIITVCS 115 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 115 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999999999999999997542 123456889999999996 999999999854
Q ss_pred eccccccceeeeeecccccCCchhhhhcc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|+|.+++...
T Consensus 95 -----~~~~~~lv~e~~~~~~L~~~l~~~ 118 (298)
T 1phk_A 95 -----TNTFFFLVFDLMKKGELFDYLTEK 118 (298)
T ss_dssp -----CSSEEEEEEECCTTCBHHHHHHHH
T ss_pred -----cCCeEEEEEeccCCCcHHHHHhcc
Confidence 478899999999999999998653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=6.3e-11 Score=117.27 Aligned_cols=97 Identities=26% Similarity=0.423 Sum_probs=77.8
Q ss_pred hCCCCcCceeecCCceeEEEEE----ECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGK----LGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~----~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.+.|++.+.||+|+||.||+|+ ...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence 3458899999999999999999 45678999999997543 3345778999999999999999999998753 23
Q ss_pred cceeeeeecccccCCchhhhhcccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
....++||||+++|+|.+++.....
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~ 121 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKN 121 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTT
T ss_pred CceEEEEEEeCCCCcHHHHHHhccc
Confidence 3678999999999999999965443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=7.4e-11 Score=122.95 Aligned_cols=97 Identities=21% Similarity=0.331 Sum_probs=81.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+++.+|+.+|++++||||+++++++....+.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999999999999999999753 2344578899999999999999999999976533334477
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+. |+|.+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~ 123 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP 123 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS
T ss_pred EEEEEecCC-cCHHHHHhcc
Confidence 999999987 5899888654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=3.2e-11 Score=126.36 Aligned_cols=93 Identities=26% Similarity=0.324 Sum_probs=72.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 46799999999999999999999999999999999753 23345678899999999999999999999654 67
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++|||||++|+|.+++...
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~ 242 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE 242 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH
T ss_pred EEEEEEeeCCCCcHHHHHHhc
Confidence 899999999999999888653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=6e-11 Score=118.58 Aligned_cols=95 Identities=22% Similarity=0.286 Sum_probs=77.3
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|++ .++.||||++..... ....+.+|+.++++++||||+++++++.... ......
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceE
Confidence 456899999999999999999998 479999999975432 3345677999999999999999999976421 113457
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++|||||++|+|.+++...
T Consensus 98 ~lv~e~~~~g~L~~~l~~~ 116 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN 116 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC
T ss_pred EEEEecCCCCCHHHHHHhc
Confidence 9999999999999999653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1e-10 Score=116.27 Aligned_cols=93 Identities=23% Similarity=0.335 Sum_probs=79.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 346799999999999999999999989999999999753 23345678999999999999999999998654 6
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...++||||+++|+|.+++..
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~ 125 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKH 125 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHH
T ss_pred CcEEEEEecCCCCCHHHHHHH
Confidence 789999999999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.10 E-value=7.6e-11 Score=115.79 Aligned_cols=91 Identities=23% Similarity=0.464 Sum_probs=77.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|++ .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 5799999999999999999999 678999999996543 233467889999999999999999999954 46789
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+++ ++.+++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~ 94 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCE 94 (288)
T ss_dssp EEEEECCSE-EHHHHHHTST
T ss_pred EEEEEecCC-CHHHHHHhcc
Confidence 999999986 8888876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.10 E-value=9.1e-11 Score=116.50 Aligned_cols=95 Identities=12% Similarity=0.133 Sum_probs=81.0
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----- 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence 34588999999999999999999999899999999997542 2234678999999999999999999998643
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+||||+++++|.+++...
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~ 128 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQ 128 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHH
T ss_pred CCeEEEEEEecCCCCHHHHHHhc
Confidence 67899999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.4e-10 Score=114.83 Aligned_cols=92 Identities=27% Similarity=0.371 Sum_probs=80.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 456999999999999999999999999999999997653 3345778999999999999999999998654 6788
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
++||||++++++.+++..
T Consensus 96 ~lv~e~~~~~~L~~~~~~ 113 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP 113 (303)
T ss_dssp EEEEECCTTEEHHHHHTT
T ss_pred EEEEEeCCCCcHHHHHhc
Confidence 999999999999998864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=113.84 Aligned_cols=96 Identities=28% Similarity=0.393 Sum_probs=80.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++... .......
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 34788889999999999999999999999999987542 34456789999999999999999999986541 2335678
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++||||+++|+|.+++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~ 123 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF 123 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH
T ss_pred EEEEEecCCCCHHHHHHHc
Confidence 9999999999999998653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=9.4e-11 Score=116.48 Aligned_cols=94 Identities=23% Similarity=0.484 Sum_probs=76.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++ ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence 3578999999999999999999994 58999999996542 33456788999999999999999999995 4477
Q ss_pred eeeeeecccccCCchhhhhcccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
..++||||+++ ++.+++.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~ 114 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKT 114 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTT
T ss_pred EEEEEEcCCCC-CHHHHHHhccC
Confidence 89999999985 77777765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.09 E-value=7.7e-11 Score=115.50 Aligned_cols=93 Identities=23% Similarity=0.368 Sum_probs=80.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++. ...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 467999999999999999999999899999999996542 233467899999999999999999999954 477
Q ss_pred eeeeeecccccCCchhhhhcc
Q 042887 124 FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..++||||+++|++.+++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~ 108 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH 108 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH
T ss_pred EEEEEEEeCCCCcHHHHHHhc
Confidence 899999999999999988654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=114.60 Aligned_cols=96 Identities=25% Similarity=0.314 Sum_probs=82.6
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----D 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----C
Confidence 344578999999999999999999999899999999997543 334567899999999999999999999854 4
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....++||||++++++.+++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~ 115 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKR 115 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH
T ss_pred CCeEEEEEEccCCCCHHHHHHhc
Confidence 67899999999999998887643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.09 E-value=5.7e-11 Score=120.01 Aligned_cols=101 Identities=21% Similarity=0.415 Sum_probs=81.9
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
++....++|++.+.||+|+||.||+|.+. .+++.||+|++... .....+.+.+|+.+++++ .||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34455688999999999999999999973 35678999999754 234557899999999999 899999999985
Q ss_pred eeccccccceeeeeecccccCCchhhhhccccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
. .....++||||+++|+|.+++......
T Consensus 119 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~ 146 (344)
T 1rjb_A 119 T-----LSGPIYLIFEYCCYGDLLNYLRSKREK 146 (344)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHTTTTC
T ss_pred e-----eCCccEEEEecCCCCcHHHHHhhcccc
Confidence 4 467899999999999999999876544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=9.5e-11 Score=117.13 Aligned_cols=93 Identities=24% Similarity=0.286 Sum_probs=75.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--------cchhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--------KGAAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 85 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 85 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc--
Confidence 3467999999999999999999999999999999986532 122346889999999999999999999854
Q ss_pred cccccceeeeeecccccCCchhhhhcc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+||||+++|+|.+++...
T Consensus 86 ----~~~~~lv~e~~~~~~L~~~~~~~ 108 (322)
T 2ycf_A 86 ----AEDYYIVLELMEGGELFDKVVGN 108 (322)
T ss_dssp ----SSSEEEEEECCTTEETHHHHSTT
T ss_pred ----CCceEEEEecCCCCcHHHHHhcc
Confidence 23479999999999999988643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=8.5e-11 Score=118.65 Aligned_cols=92 Identities=28% Similarity=0.364 Sum_probs=77.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+.|+..+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 45888999999999999999999999999999997543 2334678999999999999999999998654 678
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||||+. |++.+++....
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~ 148 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHK 148 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHT
T ss_pred EEEEEecCC-CCHHHHHHHhc
Confidence 999999998 57777775433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.08 E-value=1e-10 Score=117.55 Aligned_cols=97 Identities=22% Similarity=0.412 Sum_probs=80.1
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEEC-------CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLG-------ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
....++|++.+.||+|+||.||+|++. .+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 344678999999999999999999975 356789999997543 33456789999999999 899999999985
Q ss_pred eeccccccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
. .....++||||+++|+|.+++....
T Consensus 111 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 136 (334)
T 2pvf_A 111 T-----QDGPLYVIVEYASKGNLREYLRARR 136 (334)
T ss_dssp C-----SSSCCEEEEECCTTCBHHHHHHTTS
T ss_pred c-----cCCceEEEEECCCCCcHHHHHHHhc
Confidence 4 4678899999999999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=7.7e-11 Score=118.11 Aligned_cols=95 Identities=23% Similarity=0.386 Sum_probs=76.4
Q ss_pred HhCCCCcCceeecCCceeEEEEE-----ECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGK-----LGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~-----~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
..++|++.+.||+|+||.||+|+ ...+++.||+|.+... .......+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence 35789999999999999999999 4457789999999654 3344567899999999999999999999854
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....|+||||+++|+|.+++....
T Consensus 104 -~~~~~~lv~e~~~~~~L~~~l~~~~ 128 (327)
T 2yfx_A 104 -QSLPRFILMELMAGGDLKSFLRETR 128 (327)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTS
T ss_pred -CCCCcEEEEecCCCCcHHHHHHhhc
Confidence 4677899999999999999997654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.08 E-value=3.1e-11 Score=120.76 Aligned_cols=101 Identities=25% Similarity=0.399 Sum_probs=83.8
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccce
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITV 113 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 113 (628)
..++....++|++.+.||+|+||.||+|++. .+++.||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455556788999999999999999999875 356789999997543 2344578999999999999999999998
Q ss_pred eeeccccccceeeeeecccccCCchhhhhccc
Q 042887 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+. .....++||||+++|+|.+++....
T Consensus 97 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 123 (322)
T 1p4o_A 97 VS-----QGQPTLVIMELMTRGDLKSYLRSLR 123 (322)
T ss_dssp EC-----SSSSCEEEEECCTTCBHHHHHHHHH
T ss_pred Ec-----cCCccEEEEEeCCCCcHHHHHHHhc
Confidence 54 4678899999999999999997644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2e-10 Score=116.83 Aligned_cols=104 Identities=21% Similarity=0.303 Sum_probs=83.5
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-----------chhhhHHHHHHHHhhcCCCCcc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-----------GAAKSFVTECEALSNVRHRNLI 108 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv 108 (628)
..+.....++|++.+.||+|+||.||+|.+.. |+.||+|++..... ...+.+.+|+.++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 44566778999999999999999999999854 89999999865321 1136789999999999999999
Q ss_pred cccceeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 109 KIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 109 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
++++++...+-......|+||||+. |++.+++....
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 128 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR 128 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc
Confidence 9999976533344567899999998 57888776544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.08 E-value=6.1e-11 Score=124.45 Aligned_cols=96 Identities=24% Similarity=0.403 Sum_probs=81.7
Q ss_pred HHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 41 ADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
..+....++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.|.+|+.+|++++|||||++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----- 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT----- 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----
Confidence 445566788999999999999999999995 46789999997644 34678999999999999999999998853
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....++|||||++|+|.+++...
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~ 276 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSD 276 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSH
T ss_pred -CCccEEEEeecCCCcHHHHHHhc
Confidence 45689999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-10 Score=115.72 Aligned_cols=93 Identities=23% Similarity=0.350 Sum_probs=75.3
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
...+.|++.+.||+|+||.||+|.+..+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence 34578999999999999999999999999999999997643 34678999999999999999999998653 678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+++|+|.+++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~ 118 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR 118 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH
T ss_pred EEEEeecCCCCCHHHHHHhc
Confidence 89999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=4.7e-11 Score=118.85 Aligned_cols=99 Identities=23% Similarity=0.395 Sum_probs=82.6
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEE-----CCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccceee
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVCS 115 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 115 (628)
+....++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 334457899999999999999999985 3567889999997643 23457799999999999 8999999999854
Q ss_pred eccccccceeeeeecccccCCchhhhhcccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
..+..++||||+++|+|.+++.....
T Consensus 98 -----~~~~~~lv~e~~~~~~L~~~l~~~~~ 123 (313)
T 1t46_A 98 -----IGGPTLVITEYCCYGDLLNFLRRKRD 123 (313)
T ss_dssp -----SSSSCEEEEECCTTEEHHHHHHHTTT
T ss_pred -----cCCCcEEEEecCCCCCHHHHHHhccc
Confidence 46788999999999999999976653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.4e-10 Score=113.47 Aligned_cols=94 Identities=23% Similarity=0.441 Sum_probs=79.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc-------
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF------- 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------- 119 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|.+.... +.+.+|++++++++||||+++++++...++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457999999999999999999998899999999987543 467799999999999999999998654221
Q ss_pred ----cccceeeeeecccccCCchhhhhcc
Q 042887 120 ----KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ----~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
......++||||+++|+|.+++...
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 114 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc
Confidence 2345689999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.5e-10 Score=112.17 Aligned_cols=92 Identities=24% Similarity=0.442 Sum_probs=79.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+++++.++||||+++++++. .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence 467899999999999999999995 678899999976543 3467899999999999999999999854 467889
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+||||+++|+|.+++....
T Consensus 80 lv~e~~~~~~L~~~~~~~~ 98 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQR 98 (267)
T ss_dssp EEECCCTTCBHHHHHHHTT
T ss_pred EEEeCCCCCcHHHHHhhCc
Confidence 9999999999999997654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.2e-10 Score=113.36 Aligned_cols=90 Identities=23% Similarity=0.389 Sum_probs=73.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|.+ .|+.||+|++.... ....+.+.+|+++++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 46799999999999999999998 58899999986542 233467889999999999999999999954 46
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...++||||++++++.+++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~ 99 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG 99 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS
T ss_pred CceEEEEEcCCCCCHHHHhhc
Confidence 788999999999999988853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-10 Score=117.30 Aligned_cols=95 Identities=21% Similarity=0.433 Sum_probs=73.3
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 81 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF----- 81 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 34578999999999999999999999999999999997532 12245788999999999999999999985
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
......++||||+++ ++.+++....
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~~~ 106 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKDNS 106 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTTCC
T ss_pred eeCCceEEEEEcCCC-CHHHHHHhcC
Confidence 447789999999996 7888876544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=121.71 Aligned_cols=95 Identities=20% Similarity=0.256 Sum_probs=78.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+++.+|+.+|+.++|||||++++++... .++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999999754 334567789999999999999999999997542 123446
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..|+||||++++ +.+.+.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~ 158 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ 158 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT
T ss_pred eEEEEEeCCCCC-HHHHHh
Confidence 789999999875 555543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.3e-10 Score=116.71 Aligned_cols=92 Identities=26% Similarity=0.440 Sum_probs=79.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence 467999999999999999999999999999999986543 2334568899999999999999999999653 778
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.++||||++++++.++...
T Consensus 99 ~~lv~e~~~~~~l~~~~~~ 117 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF 117 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS
T ss_pred EEEEEecCCcchHHHHHhh
Confidence 9999999999988877543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.06 E-value=3.7e-11 Score=120.91 Aligned_cols=94 Identities=22% Similarity=0.314 Sum_probs=70.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--------cchhhhHHHHHHHHhhcC---------CCCccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--------KGAAKSFVTECEALSNVR---------HRNLIK 109 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~nIv~ 109 (628)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.++++++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999999 78999999997642 123367899999999886 555555
Q ss_pred ccceee-----------------e--------ccccccceeeeeecccccCCchhhhh
Q 042887 110 IITVCS-----------------S--------IDFKGVDFKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 110 l~~~~~-----------------~--------~~~~~~~~~~lv~e~~~~g~L~~~l~ 142 (628)
+.+++. + .++......|+|||||++|++.+.+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~ 154 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR 154 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH
Confidence 544321 1 00113678999999999998766664
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=5e-11 Score=119.23 Aligned_cols=93 Identities=23% Similarity=0.484 Sum_probs=76.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 579999999999999999999999999999999975432 23345678999999999999999999954 477899
Q ss_pred eeecccccCCchhhhhcccc
Q 042887 127 LIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~ 146 (628)
+||||++ |++.+++.....
T Consensus 77 lv~e~~~-~~l~~~~~~~~~ 95 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN 95 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT
T ss_pred EEecccc-cCHHHHHHhcCC
Confidence 9999998 488888876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-10 Score=116.22 Aligned_cols=91 Identities=23% Similarity=0.285 Sum_probs=78.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ..+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence 367999999999999999999999999999999987543 235688999999999 89999999998543 6788
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+ +|+|.+++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~ 99 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD 99 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT
T ss_pred EEEEEeC-CCCHHHHHHHcC
Confidence 9999999 999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.06 E-value=2e-10 Score=116.77 Aligned_cols=95 Identities=22% Similarity=0.392 Sum_probs=80.5
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--------chhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--------GAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
....++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 3345679999999999999999999988999999999875431 1245688999999999 799999999985
Q ss_pred eeccccccceeeeeecccccCCchhhhhc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
. .....++||||+++|+|.+++..
T Consensus 170 ~-----~~~~~~lv~e~~~g~~L~~~l~~ 193 (365)
T 2y7j_A 170 E-----SSSFMFLVFDLMRKGELFDYLTE 193 (365)
T ss_dssp E-----BSSEEEEEECCCTTCBHHHHHHH
T ss_pred e-----eCCEEEEEEEeCCCCcHHHHHHh
Confidence 4 47889999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.6e-10 Score=115.81 Aligned_cols=93 Identities=29% Similarity=0.540 Sum_probs=77.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEE--EEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTV--AVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.+.||+|+||.||+|++..+|+.+ |+|.+... .....+.+.+|+++++++ +||||+++++++. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 57999999999999999999998888765 99988753 334557799999999999 8999999999964 377
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+||||+++|+|.+++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~ 121 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSR 121 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTC
T ss_pred ceEEEEecCCCCCHHHHHHhcc
Confidence 8999999999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.06 E-value=9.4e-11 Score=119.21 Aligned_cols=103 Identities=22% Similarity=0.238 Sum_probs=85.6
Q ss_pred CcccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-----CCCcccc
Q 042887 36 PMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-----HRNLIKI 110 (628)
Q Consensus 36 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l 110 (628)
..+++.+.....++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555555666789999999999999999999999999999999987432 23456788999999986 9999999
Q ss_pred cceeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 111 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
++++.. .+..++||||+ +++|.+++....
T Consensus 102 ~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~ 130 (360)
T 3llt_A 102 HGKFMY-----YDHMCLIFEPL-GPSLYEIITRNN 130 (360)
T ss_dssp EEEEEE-----TTEEEEEECCC-CCBHHHHHHHTT
T ss_pred cceeeE-----CCeeEEEEcCC-CCCHHHHHHhcC
Confidence 998653 67899999999 899999987544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.06 E-value=1.3e-10 Score=118.32 Aligned_cols=96 Identities=23% Similarity=0.308 Sum_probs=73.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~ 123 (628)
.+.|++.+.||+|+||.||+|.+..+|+.||||++... .....+++.+|+.+++.++||||+++++++... ......
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999999999999999998653 233456789999999999999999999987541 112235
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..|+||||+ +++|.+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~ 122 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH 122 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH
T ss_pred eEEEEEecC-CCCHHHHHhc
Confidence 679999999 7899988865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.6e-10 Score=118.48 Aligned_cols=98 Identities=20% Similarity=0.381 Sum_probs=81.4
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECC-------CCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccce
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGE-------TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITV 113 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 113 (628)
+....++|.+.+.||+|+||.||+|++.. .+..||+|++.... ....+.+.+|+++++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 34456789999999999999999999753 33579999997643 34457789999999999 89999999999
Q ss_pred eeeccccccceeeeeecccccCCchhhhhccc
Q 042887 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+. .....++||||+++|+|.+++....
T Consensus 144 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~ 170 (382)
T 3tt0_A 144 CT-----QDGPLYVIVEYASKGNLREYLQARR 170 (382)
T ss_dssp EC-----SSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred ec-----cCCceEEEEEecCCCcHHHHHHHhc
Confidence 54 4778899999999999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=115.96 Aligned_cols=101 Identities=22% Similarity=0.405 Sum_probs=72.1
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCc---EEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGT---TVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
...++|++.+.||+|+||.||+|++..+++ .||+|+++.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999877665 7999999754 33456789999999999999999999998754111
Q ss_pred -cccceeeeeecccccCCchhhhhccc
Q 042887 120 -KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
......++||||+++|+|.+++....
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~ 126 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASR 126 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHH
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhh
Confidence 11123489999999999999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=7.3e-11 Score=118.54 Aligned_cols=94 Identities=24% Similarity=0.402 Sum_probs=80.1
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--------chhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--------GAAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 34679999999999999999999999999999999976421 23456889999999999999999999954
Q ss_pred cccccceeeeeecccccC-Cchhhhhcc
Q 042887 118 DFKGVDFKALIYEYMKCG-SSEDWMHQS 144 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~ 144 (628)
.....++||||+.+| ++.+++...
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~~~ 124 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFIDRH 124 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHHTC
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHHhc
Confidence 478899999999777 888888654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=6.3e-11 Score=115.94 Aligned_cols=94 Identities=20% Similarity=0.323 Sum_probs=78.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCC---CcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|++.+.||+|+||.||+|.+..+ +..||+|...... ....+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 456899999999999999999998654 4569999986543 344567899999999999999999998853
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++||||+++|+|.+++....
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~ 110 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK 110 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT
T ss_pred cCccEEEEecCCCCCHHHHHHhcC
Confidence 456799999999999999997554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=114.92 Aligned_cols=88 Identities=30% Similarity=0.537 Sum_probs=75.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|.+ .++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence 35788999999999999999998 5788999998643 34567899999999999999999998842 3478
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+||||+++|+|.+++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~ 94 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAE 94 (307)
T ss_dssp EEEECCTTCBHHHHHHCSS
T ss_pred EEEEcCCCCCHHHHHhccC
Confidence 9999999999999997543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.05 E-value=9.9e-11 Score=122.70 Aligned_cols=96 Identities=25% Similarity=0.436 Sum_probs=80.5
Q ss_pred HHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 41 ADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
..+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.+|++++||||+++++++.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 249 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS----- 249 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 3455567789999999999999999999954 56799999976432 3467999999999999999999999853
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....++||||+++|+|.+++...
T Consensus 250 -~~~~~iv~e~~~~gsL~~~l~~~ 272 (452)
T 1fmk_A 250 -EEPIYIVTEYMSKGSLLDFLKGE 272 (452)
T ss_dssp -SSSCEEEECCCTTCBHHHHHSHH
T ss_pred -CCceEEEehhhcCCCHHHHHHhc
Confidence 25689999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.7e-10 Score=112.84 Aligned_cols=93 Identities=24% Similarity=0.423 Sum_probs=76.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 478999999999999999999999999999999997542 2345678999999999999999999998642 345
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...++||||+++| +.+++..
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~ 100 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDS 100 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHH
T ss_pred CeEEEEehhccCC-HHHHHHh
Confidence 6889999999987 6666644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-10 Score=116.38 Aligned_cols=103 Identities=19% Similarity=0.375 Sum_probs=83.9
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEE-----CCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIIT 112 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 112 (628)
...+....++|++.+.||+|+||.||+|++ ..+++.||+|++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 345555678899999999999999999985 3467889999997643 33456789999999999 6999999999
Q ss_pred eeeeccccccceeeeeecccccCCchhhhhcccc
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
++.. .....++||||+++|+|.+++.....
T Consensus 99 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~ 128 (316)
T 2xir_A 99 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRN 128 (316)
T ss_dssp EECC----TTSCCEEEEECCTTEEHHHHHHTCTT
T ss_pred EEec----CCCceEEEEEcCCCCcHHHHHHhccc
Confidence 8642 34568999999999999999976553
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-10 Score=116.21 Aligned_cols=95 Identities=25% Similarity=0.462 Sum_probs=77.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC----cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG----TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.++++++||||+++++++ ..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence 356777899999999999999986543 359999997543 33456789999999999999999999985 34
Q ss_pred cceeeeeecccccCCchhhhhcccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
....++||||+++|+|.+++.....
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~ 142 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDG 142 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTT
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCC
Confidence 7789999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.04 E-value=2.6e-10 Score=116.00 Aligned_cols=96 Identities=17% Similarity=0.255 Sum_probs=81.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.....+.....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999999999999999997543 3345778999999999999999999998765444455678
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
|+||||+.+ ++.+++..
T Consensus 106 ~iv~e~~~~-~L~~~l~~ 122 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT 122 (364)
T ss_dssp EEEEECCSE-EHHHHHHH
T ss_pred EEEEcccCc-CHHHHHHh
Confidence 999999985 88888754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=3e-10 Score=112.29 Aligned_cols=91 Identities=26% Similarity=0.451 Sum_probs=74.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhh--cCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSN--VRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++ +|+.||+|++... ....+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 46899999999999999999998 7899999998653 23556677777766 7899999999986541 233567
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.++||||+++|+|.+++..
T Consensus 81 ~~lv~e~~~~g~L~~~l~~ 99 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL 99 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT
T ss_pred eEEehhhccCCCHHHHHhh
Confidence 8999999999999999954
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=4.6e-11 Score=118.30 Aligned_cols=95 Identities=22% Similarity=0.320 Sum_probs=64.5
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
....++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++. ..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 85 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VK 85 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SS
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ec
Confidence 345678999999999999999999998899999999986543 334567889999999999999999999864 36
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...++||||+++|+|.+++..
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~ 106 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKH 106 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHH
T ss_pred CCcEEEehhccCCchHHHHHH
Confidence 788999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.8e-10 Score=114.90 Aligned_cols=96 Identities=18% Similarity=0.336 Sum_probs=76.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeec---------
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSI--------- 117 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------- 117 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46799999999999999999999999999999999876666667899999999999999999999876321
Q ss_pred cccccceeeeeecccccCCchhhhhc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.+......++||||++ |++.+++..
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~ 114 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ 114 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhc
Confidence 1234578899999998 589888854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.04 E-value=3.1e-10 Score=113.78 Aligned_cols=90 Identities=18% Similarity=0.307 Sum_probs=78.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+++.||+|+++... .+.+.+|+.++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 367999999999999999999999999999999987433 367889999999997 9999999998653 235678
Q ss_pred eeeecccccCCchhhhh
Q 042887 126 ALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~ 142 (628)
++||||++++++.+++.
T Consensus 109 ~lv~e~~~~~~l~~~~~ 125 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ 125 (330)
T ss_dssp EEEEECCCCCCHHHHGG
T ss_pred EEEEeccCchhHHHHHH
Confidence 99999999999988874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.04 E-value=1.2e-10 Score=113.87 Aligned_cols=94 Identities=24% Similarity=0.443 Sum_probs=78.6
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+....++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+++++.++||||+++++++. .
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 79 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------Q 79 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc------C
Confidence 3344578999999999999999999984 567899999875432 3567899999999999999999998853 3
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...++||||+++++|.+++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~ 101 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTP 101 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSH
T ss_pred CCcEEEEecCCCCCHHHHHhcC
Confidence 4579999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.04 E-value=2.3e-10 Score=113.00 Aligned_cols=96 Identities=25% Similarity=0.487 Sum_probs=77.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC---cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG---TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
...|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCC
Confidence 356888899999999999999975433 358999987543 344577899999999999999999999863 345
Q ss_pred ceeeeeecccccCCchhhhhcccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...++||||+++|+|.+++.....
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~ 123 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH 123 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC
T ss_pred CceEEEEeCCCCCCHHHHHHhccc
Confidence 678999999999999999976443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.4e-10 Score=117.31 Aligned_cols=88 Identities=17% Similarity=0.241 Sum_probs=76.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccc---h--------------hhhHHHHHHHHhhcCCCCccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKG---A--------------AKSFVTECEALSNVRHRNLIK 109 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~--------------~~~~~~E~~~l~~l~h~nIv~ 109 (628)
.++|++.+.||+|+||.||+|.+ +|+.||+|.+...... . .+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 8999999999754211 1 178999999999999999999
Q ss_pred ccceeeeccccccceeeeeecccccCCchhhh
Q 042887 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 110 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 141 (628)
+++++. ..+..++||||+++|+|.+++
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~ 134 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFD 134 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEES
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHH
Confidence 999964 467899999999999999883
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.9e-10 Score=115.10 Aligned_cols=96 Identities=23% Similarity=0.427 Sum_probs=77.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcE----EEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTT----VAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.++|++.+.||+|+||.||+|++..+++. ||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------ 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence 35799999999999999999999888876 6677664332 334467889999999999999999999853
Q ss_pred cceeeeeecccccCCchhhhhcccccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
....++||||+++|++.+++......+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~ 112 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGAL 112 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccC
Confidence 456889999999999999997654333
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.1e-10 Score=117.04 Aligned_cols=102 Identities=25% Similarity=0.401 Sum_probs=83.9
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccc-
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDF- 119 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~- 119 (628)
+.....+.|++.+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++.....
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 334456889999999999999999999999999999999875432 346789999999999 79999999998754111
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
......++||||+++|+|.+++...
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~ 121 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT 121 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc
Confidence 1146789999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.4e-10 Score=117.13 Aligned_cols=94 Identities=20% Similarity=0.290 Sum_probs=72.7
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc-----
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF----- 119 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 119 (628)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+|+.++||||+++++++....-
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45678999999999999999999999999999999986542 223479999999999999999998754111
Q ss_pred ----------------------------cccceeeeeecccccCCchhhhhc
Q 042887 120 ----------------------------KGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 120 ----------------------------~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
......++||||+++ ++.+.+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~ 130 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKS 130 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHH
Confidence 234568899999995 77766653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.4e-10 Score=117.36 Aligned_cols=95 Identities=21% Similarity=0.362 Sum_probs=72.6
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcC-CCCcccccceeeeccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 121 (628)
...++|++.+.||+|+||.||+|.+..+|+.||+|++... ......++.+|+.+++++. ||||+++++++.. +.
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence 3467899999999999999999999999999999998653 2345567889999999997 9999999998653 33
Q ss_pred cceeeeeecccccCCchhhhhc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
....|+|||||+ |++.+++..
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~ 103 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA 103 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH
T ss_pred CCEEEEEecccC-cCHHHHHHc
Confidence 457899999998 588888864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.8e-10 Score=115.33 Aligned_cols=96 Identities=22% Similarity=0.351 Sum_probs=81.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|.+..+|+.||||.+.... ......+.+|+.++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999999999999999996543 3345678899999999999999999998765445556789
Q ss_pred eeeecccccCCchhhhhc
Q 042887 126 ALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~ 143 (628)
++||||+. |++.+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~ 106 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST 106 (353)
T ss_dssp EEEECCCS-EEHHHHHHH
T ss_pred EEEEeccC-ccHHHHHhh
Confidence 99999998 588888764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.02 E-value=3.1e-10 Score=114.15 Aligned_cols=193 Identities=17% Similarity=0.172 Sum_probs=109.5
Q ss_pred CcccEEEccCCcccc-c-------cchhhhCCCCCCEEecccCcCc---------ccccccccCCCCCCEeecccccCcc
Q 042887 162 LKLEMIDVGDNQLIG-K-------FPDFIANFSALEAIDISANMLG---------GRIPDSLCQLRSLNYLSISENNFSC 224 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~-~-------~~~~~~~l~~L~~L~Ls~n~l~---------~~~~~~~~~l~~L~~L~Ls~N~i~~ 224 (628)
.+++.|.+......+ . +.++...+++|+.|.+..+... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 356666666554331 1 1334556789999988765331 123345567888999999887311
Q ss_pred cCCcCccCCCCCCEEEeecccCcccCChhhh-hCCCCCcEEeccc--Cccccc-----ccccc--cCCCCCCEEEccccc
Q 042887 225 KLPLSIWNISSLEIISLHSNRFEGSLPLNIG-FNIPNVNFLSVGQ--NNFTGS-----LPHSF--SNASNLQVLDVYKNH 294 (628)
Q Consensus 225 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~l~~L~~L~L~~--N~l~~~-----~~~~~--~~l~~L~~L~L~~N~ 294 (628)
..+. + .+++|++|++..|.+.......+. ..+|+|+.|+|+. |...+. +...+ ..+++|++|++.+|.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2233 3 378889999988877633222333 2478888888753 221111 11122 246778888887777
Q ss_pred ceeecccccc---cCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHh
Q 042887 295 FSGQVKIDFN---RLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIAN 359 (628)
Q Consensus 295 i~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~ 359 (628)
++...+..+. .+++|++|+|+.|.+++.... .....+.++++|+.|+++.|.++......+..
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~--~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGAR--LLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH--HHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHH--HHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 7643332232 356777777777776542111 11222344566777777776666554444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.02 E-value=1.2e-10 Score=124.70 Aligned_cols=97 Identities=25% Similarity=0.425 Sum_probs=80.9
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
...+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.+|++++||||+++++++.
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 332 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS---- 332 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEe----
Confidence 34455567789999999999999999999954 56799999976442 3467999999999999999999999853
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....|+|||||++|+|.+++...
T Consensus 333 --~~~~~lv~e~~~~gsL~~~l~~~ 355 (535)
T 2h8h_A 333 --EEPIYIVTEYMSKGSLLDFLKGE 355 (535)
T ss_dssp --SSSCEEEECCCTTEEHHHHHSHH
T ss_pred --eccceEeeehhcCCcHHHHHhhc
Confidence 35689999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=2.7e-10 Score=114.01 Aligned_cols=100 Identities=18% Similarity=0.266 Sum_probs=82.2
Q ss_pred HHHHHHHhCCCCcC-ceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcC-CCCcccccceee
Q 042887 40 YADLSKATNNFSAS-NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVR-HRNLIKIITVCS 115 (628)
Q Consensus 40 ~~~~~~~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 115 (628)
+.......+.|.+. +.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~- 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY- 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-
Confidence 34444445667776 88999999999999999999999999997643 334567899999999995 69999999995
Q ss_pred eccccccceeeeeecccccCCchhhhhcc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
......++||||+++|+|.+++...
T Consensus 99 ----~~~~~~~lv~e~~~~~~L~~~~~~~ 123 (327)
T 3lm5_A 99 ----ENTSEIILILEYAAGGEIFSLCLPE 123 (327)
T ss_dssp ----ECSSEEEEEEECCTTEEGGGGGSSC
T ss_pred ----EeCCeEEEEEEecCCCcHHHHHHHh
Confidence 4478899999999999999988543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.02 E-value=3.2e-10 Score=111.96 Aligned_cols=92 Identities=28% Similarity=0.545 Sum_probs=76.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENK 76 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEec-----CCc
Confidence 367999999999999999999999999999999986543 2344678899999999999999999999653 678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+. |++.+++...
T Consensus 77 ~~lv~e~~~-~~L~~~~~~~ 95 (299)
T 2r3i_A 77 LYLVFEFLH-QDLKKFMDAS 95 (299)
T ss_dssp EEEEEECCS-EEHHHHHHHT
T ss_pred eEEEEEccc-CCHHHHHHhh
Confidence 999999998 5888888654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-10 Score=114.46 Aligned_cols=96 Identities=25% Similarity=0.477 Sum_probs=73.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEE----EEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTV----AVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.++|++.+.||+|+||.||+|++..+++.+ |+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 357999999999999999999998777654 77776543 23445779999999999999999999999753
Q ss_pred cceeeeeecccccCCchhhhhcccccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
...++++||+++|++.+++......+
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~~~ 114 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKDNI 114 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTTSC
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCCCC
Confidence 34789999999999999997655433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=2.2e-10 Score=111.86 Aligned_cols=92 Identities=28% Similarity=0.486 Sum_probs=76.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|.+ +|+.||+|+++... ..+.+.+|+.++++++||||+++++++. +.....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCce
Confidence 356899999999999999999998 58899999987543 4567899999999999999999999853 234578
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
++||||+++|+|.+++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~ 110 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG 110 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHhcc
Confidence 99999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.1e-10 Score=112.78 Aligned_cols=93 Identities=19% Similarity=0.174 Sum_probs=75.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+..+.++ .||||+++++++.+ ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 57999999999999999999999999999999986532 23344566677666666 89999999999654 788
Q ss_pred eeeeecccccCCchhhhhcccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
.++||||+ ++++.+++.....
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~ 152 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA 152 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS
T ss_pred EEEEEecc-CCCHHHHHHhcCC
Confidence 99999999 6688888866543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.8e-10 Score=111.92 Aligned_cols=99 Identities=24% Similarity=0.431 Sum_probs=77.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-----cchhhhHHHHHHHHhhcC---CCCcccccceeeec
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-----KGAAKSFVTECEALSNVR---HRNLIKIITVCSSI 117 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 117 (628)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999999999999999997532 122356778888877775 99999999997653
Q ss_pred cccccceeeeeecccccCCchhhhhccc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
........++||||+. |++.+++....
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~ 113 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP 113 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc
Confidence 2223346899999998 59998887544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=3.2e-10 Score=112.82 Aligned_cols=102 Identities=27% Similarity=0.529 Sum_probs=76.2
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECC---CCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeec
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGE---TGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSI 117 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 117 (628)
.....++|.+.+.||+|+||.||+|.+.. +++.||+|.++... ....+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 33445789999999999999999998765 45589999987542 33456789999999999999999999997653
Q ss_pred cccccceeeeeecccccCCchhhhhcc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
........++||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~ 135 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYS 135 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHT
T ss_pred cccCCcccEEEEecccCCCHHHHHHHh
Confidence 222234569999999999999998543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.01 E-value=2.1e-10 Score=116.82 Aligned_cols=94 Identities=26% Similarity=0.505 Sum_probs=76.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCC---cEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETG---TTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.|++.+.||+|+||.||+|.+..++ ..||+|.++.. .....+.+.+|+.++++++||||+++++++. +....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence 3667789999999999999975432 45899998654 3345678999999999999999999999863 33567
Q ss_pred eeeeecccccCCchhhhhcccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
.++||||+++|+|.+++.....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~ 187 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH 187 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC
T ss_pred eEEEEECCCCCCHHHHHhhccc
Confidence 8999999999999999976543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-10 Score=113.18 Aligned_cols=92 Identities=26% Similarity=0.407 Sum_probs=76.4
Q ss_pred CCcCceeecCCceeEEEEEEC----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 50 FSASNMIGQGSFGFVYKGKLG----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 488999999999999888653 467899999997653 3445678999999999999999999998764 23567
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.++||||+++|+|.+++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~ 129 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH 129 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS
T ss_pred EEEEEecccCCcHHHHHhhC
Confidence 89999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.2e-10 Score=124.51 Aligned_cols=95 Identities=22% Similarity=0.299 Sum_probs=81.7
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|..++..+ .||+|++++++ +++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence 457899999999999999999999999999999999754 234556788999999988 69999999998 556
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....|+||||+++|+|.+++....
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~ 437 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG 437 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC
Confidence 889999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.99 E-value=4.3e-10 Score=110.30 Aligned_cols=94 Identities=20% Similarity=0.418 Sum_probs=77.2
Q ss_pred hCCCCcCc-eeecCCceeEEEEEEC--CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASN-MIGQGSFGFVYKGKLG--ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~-~iG~G~~g~V~~~~~~--~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence 45677766 8999999999999864 467789999997643 345677999999999999999999999863 4
Q ss_pred ceeeeeecccccCCchhhhhcccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
...++||||+++++|.+++.....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~ 105 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKRE 105 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCc
Confidence 568999999999999999865443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=6.2e-10 Score=111.92 Aligned_cols=95 Identities=27% Similarity=0.473 Sum_probs=75.2
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHH--HhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEA--LSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|++ +++.||+|++..... ..+..|.++ +..++||||+++++.+.........
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 457899999999999999999988 789999999975432 344445444 4457999999999876554455566
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++|||||++|+|.+++....
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~ 107 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT 107 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC
T ss_pred eEEEEEecCCCCcHHHHHhhcc
Confidence 7899999999999999996544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=2.7e-10 Score=111.41 Aligned_cols=94 Identities=22% Similarity=0.415 Sum_probs=77.3
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCC---CcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
..++|.+.+.||+|+||.||+|++... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------ 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence 356799999999999999999997533 346999998764 2344577999999999999999999999853
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++||||+++++|.+++....
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~~~ 107 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLERNK 107 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHT
T ss_pred CCCCEEEEecCCCCCHHHHHHhcc
Confidence 345689999999999999997644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.99 E-value=4.7e-10 Score=110.69 Aligned_cols=95 Identities=19% Similarity=0.379 Sum_probs=76.6
Q ss_pred CCCcCceeecCCceeEEEEEECCCCc---EEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGT---TVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~---~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.|...+.||+|+||.||+|.+..+++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 45667899999999999999765554 79999987543 3455788999999999999999999998643 2344
Q ss_pred eeeeecccccCCchhhhhccccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
.+++|||+.+|++.+++......
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~ 120 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRN 120 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCC
T ss_pred cEEEEecccCCCHHHHHhccccC
Confidence 58999999999999999764433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=4.1e-10 Score=122.42 Aligned_cols=86 Identities=21% Similarity=0.413 Sum_probs=72.3
Q ss_pred eeecCCceeEEEEEECC--CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeeecc
Q 042887 55 MIGQGSFGFVYKGKLGE--TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEY 131 (628)
Q Consensus 55 ~iG~G~~g~V~~~~~~~--~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 131 (628)
.||+|+||.||+|.+.. ++..||||+++... ....+.+.+|+.+|++++|||||++++++. ....++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~------~~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AEALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE------SSSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec------cCCeEEEEEe
Confidence 79999999999998753 45679999997643 345678999999999999999999999864 2458999999
Q ss_pred cccCCchhhhhcccc
Q 042887 132 MKCGSSEDWMHQSND 146 (628)
Q Consensus 132 ~~~g~L~~~l~~~~~ 146 (628)
|++|+|.+++.....
T Consensus 417 ~~~g~L~~~l~~~~~ 431 (613)
T 2ozo_A 417 AGGGPLHKFLVGKRE 431 (613)
T ss_dssp CTTCBHHHHHTTCTT
T ss_pred CCCCcHHHHHhhccC
Confidence 999999999975543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=98.99 E-value=3.3e-10 Score=115.16 Aligned_cols=96 Identities=21% Similarity=0.275 Sum_probs=72.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+++.+|+.+++.++||||+++++++... .++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999999999999999999653 233456788999999999999999999987541 223346
Q ss_pred eeeeeecccccCCchhhhhc
Q 042887 124 FKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~ 143 (628)
..|+|+|++ +++|.+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~ 126 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC 126 (367)
T ss_dssp CCEEEEECC-CEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc
Confidence 789999999 6788888754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=2.1e-10 Score=112.85 Aligned_cols=93 Identities=20% Similarity=0.426 Sum_probs=76.2
Q ss_pred HhCCCCcCc-eeecCCceeEEEEEE--CCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 46 ATNNFSASN-MIGQGSFGFVYKGKL--GETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 46 ~~~~~~~~~-~iG~G~~g~V~~~~~--~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
..++|.+.+ .||+|+||.||+|.+ ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 88 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE----- 88 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence 346788887 999999999999954 5567899999997543 233567999999999999999999999862
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
....++||||+++++|.+++...
T Consensus 89 -~~~~~lv~e~~~~~~L~~~l~~~ 111 (291)
T 1xbb_A 89 -AESWMLVMEMAELGPLNKYLQQN 111 (291)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHC
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhC
Confidence 46689999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.98 E-value=2.4e-10 Score=115.75 Aligned_cols=93 Identities=22% Similarity=0.308 Sum_probs=78.6
Q ss_pred hCCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhc-CCCCcccccceeeecc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNV-RHRNLIKIITVCSSID 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 118 (628)
.++|++.+.||+|+||.||+|++. .+|+.||||+++... ....+.+.+|+.+++++ .||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 368999999999999999999984 478999999986532 23446678899999999 6999999999854
Q ss_pred ccccceeeeeecccccCCchhhhhcc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||||+++|+|.+++...
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~~ 153 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQR 153 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHH
T ss_pred --eCceEEEEeecCCCCCHHHHHHHc
Confidence 467899999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=5.3e-10 Score=112.40 Aligned_cols=96 Identities=18% Similarity=0.309 Sum_probs=80.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecc---cccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSID---FKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~---~~~~ 122 (628)
..+|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999999999999999987665556678899999999996 999999999875311 1345
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...+++|||+. |++.+++..
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~ 126 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKK 126 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHH
T ss_pred ceEEEEEEecC-CCHHHHHHH
Confidence 67899999997 688888864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=4e-10 Score=114.76 Aligned_cols=91 Identities=13% Similarity=0.206 Sum_probs=74.6
Q ss_pred HHhCCCCcCceeecCCceeEEEEE-----ECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC---CCCcccccceeee
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGK-----LGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR---HRNLIKIITVCSS 116 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 116 (628)
...++|.+.+.||+|+||.||+|. ...+++.||+|++.... ...+.+|+.+++.++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~- 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL- 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence 345779999999999999999994 56788999999987543 356778888888886 999999999864
Q ss_pred ccccccceeeeeecccccCCchhhhhc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
..+..|+|||||++|+|.+++..
T Consensus 138 ----~~~~~~lv~e~~~~g~L~~~l~~ 160 (365)
T 3e7e_A 138 ----FQNGSVLVGELYSYGTLLNAINL 160 (365)
T ss_dssp ----CSSCEEEEECCCCSCBHHHHHHH
T ss_pred ----cCCCcEEEEeccCCCcHHHHHHH
Confidence 36788999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=98.97 E-value=4.5e-10 Score=115.64 Aligned_cols=93 Identities=15% Similarity=0.238 Sum_probs=74.5
Q ss_pred hCCCCcC-ceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccce
Q 042887 47 TNNFSAS-NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|.+. +.||+|+||.||+|.+..+|+.||||++... ..+.+|+.++.+. +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 3566665 6899999999999999999999999998632 4567888887544 799999999986431 233567
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||++|+|.+++....
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~ 154 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG 154 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-
T ss_pred EEEEEEeCCCCcHHHHHHHhC
Confidence 899999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=98.97 E-value=7.4e-10 Score=112.96 Aligned_cols=95 Identities=19% Similarity=0.246 Sum_probs=78.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++... .++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999999999999999753 233456788999999999999999999987541 123345
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..|+||||+++ ++.+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~ 121 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ 121 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH
T ss_pred ceEEEEEcCCC-CHHHHHh
Confidence 78999999985 6777664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.97 E-value=6.5e-10 Score=111.21 Aligned_cols=96 Identities=25% Similarity=0.477 Sum_probs=78.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEE----EEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTV----AVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
.++|++.+.||+|+||.||+|++..+++.+ |+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 467999999999999999999998888765 55555432 23455779999999999999999999998653
Q ss_pred cceeeeeecccccCCchhhhhcccccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
...++++||+++|++.+++......+
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~~~~ 114 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHKDNI 114 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTTTCC
T ss_pred -CCceEEEEecCCCcHHHHHHhcCCCC
Confidence 34789999999999999997654433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.5e-10 Score=124.60 Aligned_cols=99 Identities=20% Similarity=0.357 Sum_probs=80.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeee-ccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSS-IDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|++++++++||||+++++++.. ..+.....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999999999999998654 33445779999999999999999999988643 11233677
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++|||||++|+|.+++....
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~ 113 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE 113 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS
T ss_pred EEEEEEeCCCCCHHHHHHhcc
Confidence 899999999999999997644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=5.4e-10 Score=113.09 Aligned_cols=98 Identities=21% Similarity=0.419 Sum_probs=77.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc---ccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID---FKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 121 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.... ...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999999999999999986543 233457889999999999999999999876521 111
Q ss_pred cceeeeeecccccCCchhhhhccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++||||+++ ++.+.+....
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~ 118 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL 118 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc
Confidence 4578999999986 6766665543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=9.2e-10 Score=110.92 Aligned_cols=102 Identities=25% Similarity=0.393 Sum_probs=80.6
Q ss_pred cccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhh--cCCCCccccccee
Q 042887 37 MVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSN--VRHRNLIKIITVC 114 (628)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~ 114 (628)
..+........++|++.+.||+|+||.||+|++ +|+.||+|++... ....+.+|++++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 344444455667899999999999999999999 6899999998643 23567889998887 6899999999986
Q ss_pred eeccccccceeeeeecccccCCchhhhhcc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.... ......++||||+++|+|.+++.+.
T Consensus 106 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~ 134 (342)
T 1b6c_B 106 NKDN-GTWTQLWLVSDYHEHGSLFDYLNRY 134 (342)
T ss_dssp ECCC-SSCCCEEEEECCCTTCBHHHHHHHC
T ss_pred cccC-CccceeEEEEeecCCCcHHHHHhcc
Confidence 5411 1113789999999999999999653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.7e-10 Score=114.58 Aligned_cols=85 Identities=18% Similarity=0.236 Sum_probs=48.6
Q ss_pred ccCCCCEeeCcCCcCcccCCcccc---CCCCCCeEECcCceeeee----cCccccCCCCCCEEECCCCcccccCchhhhc
Q 042887 484 NLRNLAEFDLSENHFSNEIPVTLS---ACTTLEYLHLQGNSFSGS----LPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556 (628)
Q Consensus 484 ~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 556 (628)
.+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.|+...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 356777777777776543322222 356777777777776653 2333345677777777777766443334443
Q ss_pred ccCCCeEeccCCc
Q 042887 557 LLFLAYLNLSYNH 569 (628)
Q Consensus 557 l~~L~~L~ls~N~ 569 (628)
.- ...++++.|+
T Consensus 330 al-g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL-PMKIDVSDSQ 341 (362)
T ss_dssp HC-CSEEECCSBC
T ss_pred Hc-CCEEEecCCc
Confidence 11 3456776665
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.1e-10 Score=124.36 Aligned_cols=97 Identities=20% Similarity=0.292 Sum_probs=76.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE-TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999975 68999999986542 334567899999999999999999999876532222233
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.|+||||+++++|.+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~ 177 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ 177 (681)
T ss_dssp EEEEEECCCCEECC----C
T ss_pred eEEEEEeCCCCcHHHHHhC
Confidence 7999999999999887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1.9e-10 Score=117.64 Aligned_cols=97 Identities=15% Similarity=0.121 Sum_probs=72.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHH---HHhhcCCCCcccccceeee--cc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECE---ALSNVRHRNLIKIITVCSS--ID 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~--~~ 118 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+. .+++++|||||++++.+.. ..
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688899999999999999999889999999999743 2345577899994 5556679999999854321 00
Q ss_pred ccccc-----------------eeeeeecccccCCchhhhhcc
Q 042887 119 FKGVD-----------------FKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 119 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~ 144 (628)
++..+ ..|+||||+ +|+|.+++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~ 193 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 193 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence 11111 378999999 57999999754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=8.2e-10 Score=109.02 Aligned_cols=93 Identities=15% Similarity=0.255 Sum_probs=76.1
Q ss_pred hCCCCcC-ceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHH-hhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSAS-NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEAL-SNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +..+||||+++++++... ......
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 4567776 789999999999999999999999999864 24567888887 555899999999986531 223577
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||||+++|+|.+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~ 110 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG 110 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT
T ss_pred EEEEEeecCCCcHHHHHHhcc
Confidence 899999999999999997643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.1e-09 Score=110.04 Aligned_cols=99 Identities=27% Similarity=0.367 Sum_probs=76.2
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc--CCCCcccccceeeec
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV--RHRNLIKIITVCSSI 117 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~ 117 (628)
........++|++.+.||+|+||.||+|++ +|+.||+|++.... ...+.+|.+++... +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 333444567899999999999999999998 48999999986432 24455666666555 899999999987641
Q ss_pred cccccceeeeeecccccCCchhhhhcc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.......++||||+++|+|.+++...
T Consensus 104 -~~~~~~~~lv~e~~~~g~L~~~l~~~ 129 (337)
T 3mdy_A 104 -TGSWTQLYLITDYHENGSLYDYLKST 129 (337)
T ss_dssp -CGGGCEEEEEECCCTTCBHHHHHHHC
T ss_pred -CCCCCceEEEEeccCCCcHHHHhhcc
Confidence 11226789999999999999999643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=98.94 E-value=6e-10 Score=109.41 Aligned_cols=95 Identities=28% Similarity=0.437 Sum_probs=76.4
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
...++|++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|+.++++++||||+++++++ ..
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TA 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CS
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cC
Confidence 34578999999999999999999873 359999997543 34457799999999999999999998864 24
Q ss_pred ceeeeeecccccCCchhhhhcccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
...++||||++++++.+++.......
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~ 117 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKF 117 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---C
T ss_pred CccEEEEEecCCCcHHHHHhhccCCC
Confidence 56899999999999999986554433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=1.3e-09 Score=107.57 Aligned_cols=92 Identities=17% Similarity=0.243 Sum_probs=79.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ..+.+.+|+.+++.+ .|++++++++++. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence 467999999999999999999999999999999986533 345688999999999 6999999998854 47788
Q ss_pred eeeecccccCCchhhhhcccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~ 146 (628)
++||||+ +++|.+++.....
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~ 101 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR 101 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT
T ss_pred EEEEEec-CCCHHHHHHHhcc
Confidence 9999999 9999999976543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.9e-10 Score=112.07 Aligned_cols=97 Identities=19% Similarity=0.285 Sum_probs=72.8
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhc----CCCCcccccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNV----RHRNLIKIIT 112 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l----~h~nIv~l~~ 112 (628)
.....++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34446789999999999999999999999999999999965432 2335577899999998 8999999999
Q ss_pred eeeeccccccceeeeeecc-cccCCchhhhhcc
Q 042887 113 VCSSIDFKGVDFKALIYEY-MKCGSSEDWMHQS 144 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~ 144 (628)
++ ......++|||+ +.+++|.+++...
T Consensus 106 ~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~ 133 (312)
T 2iwi_A 106 WF-----ETQEGFMLVLERPLPAQDLFDYITEK 133 (312)
T ss_dssp EC----------CEEEEECCSSEEEHHHHHHHH
T ss_pred EE-----ecCCeEEEEEEecCCCCCHHHHHHhc
Confidence 84 446788999999 7899999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.1e-10 Score=114.37 Aligned_cols=100 Identities=22% Similarity=0.417 Sum_probs=82.3
Q ss_pred ccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceee
Q 042887 38 VSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCS 115 (628)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 115 (628)
....++....++|++.+.||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 3345555667899999999999999999999843 49999987542 334467889999999999999999999965
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+ ....++||||+++++|.+++....
T Consensus 100 ~-----~~~~~iv~e~~~~~~L~~~l~~~~ 124 (319)
T 2y4i_B 100 S-----PPHLAIITSLCKGRTLYSVVRDAK 124 (319)
T ss_dssp C-----SSCEEEECBCCCSEEHHHHTTSSC
T ss_pred c-----CCceEEEeecccCCcHHHHHHhcC
Confidence 3 677999999999999999997654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-09 Score=110.25 Aligned_cols=95 Identities=20% Similarity=0.296 Sum_probs=76.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc-ccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~ 123 (628)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999999999999999996542 334567899999999999999999999865411 11123
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..|+||||+. |++.+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~ 120 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG 120 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT
T ss_pred eEEEEecccc-CCHHHHhc
Confidence 4699999998 57877764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.1e-09 Score=111.54 Aligned_cols=95 Identities=20% Similarity=0.296 Sum_probs=76.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecc-ccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~ 123 (628)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999999999999997542 334577899999999999999999999975411 11122
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..++||||+. |++.+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~ 138 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG 138 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT
T ss_pred eEEEEEcccc-ccHHHHhh
Confidence 3499999998 57777664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=118.83 Aligned_cols=85 Identities=22% Similarity=0.461 Sum_probs=70.9
Q ss_pred ceeecCCceeEEEEEE--CCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKL--GETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~--~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|+.+|++++|||||++++++. ....++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 3699999999999965 3566889999997643 334578999999999999999999999864 34578999
Q ss_pred cccccCCchhhhhcc
Q 042887 130 EYMKCGSSEDWMHQS 144 (628)
Q Consensus 130 e~~~~g~L~~~l~~~ 144 (628)
|||++|+|.+++...
T Consensus 449 E~~~~g~L~~~l~~~ 463 (635)
T 4fl3_A 449 EMAELGPLNKYLQQN 463 (635)
T ss_dssp ECCTTEEHHHHHHHC
T ss_pred EccCCCCHHHHHhhC
Confidence 999999999999643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=98.91 E-value=9.9e-10 Score=107.85 Aligned_cols=91 Identities=15% Similarity=0.169 Sum_probs=71.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-c-chhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-K-GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... . ...+.+.++...++.+.||||+++++++. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 468999999999999999999999999999999997542 2 22233444455578889999999999964 4678
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.++||||+++ ++.+++..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~ 98 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQ 98 (290)
T ss_dssp EEEEEECCSE-EHHHHHHH
T ss_pred EEEEEehhcc-chHHHHHH
Confidence 8999999985 77777654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=98.90 E-value=1.8e-09 Score=108.04 Aligned_cols=99 Identities=21% Similarity=0.413 Sum_probs=78.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEEC-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhhc---CCCCcccccceeeeccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLG-ETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNV---RHRNLIKIITVCSSIDF 119 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~ 119 (628)
..++|++.+.||+|+||.||+|++. .+|+.||+|++.... ......+.+|+.+++.+ .||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3468999999999999999999995 678899999997543 22345678888888777 89999999998763223
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
......++||||+. |++.+++....
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~ 113 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP 113 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc
Confidence 35678999999998 59998886543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=9.3e-10 Score=120.39 Aligned_cols=96 Identities=20% Similarity=0.312 Sum_probs=78.6
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCC---CcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGET---GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
....++|++.+.||+|+||.||+|.+..+ +..||+|...... ....+.+.+|+.++++++||||+++++++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---- 461 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---- 461 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence 33456788889999999999999998654 4569999986543 344577999999999999999999999853
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.+..|+||||+++|+|.+++....
T Consensus 462 --~~~~~lv~E~~~~g~L~~~l~~~~ 485 (656)
T 2j0j_A 462 --ENPVWIIMELCTLGELRSFLQVRK 485 (656)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTT
T ss_pred --cCceEEEEEcCCCCcHHHHHHhcc
Confidence 356899999999999999997544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.3e-09 Score=111.82 Aligned_cols=91 Identities=16% Similarity=0.266 Sum_probs=76.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcC--CCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVR--HRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~ 123 (628)
..|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.+|++++ ||||+++++++. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 459999999999999999999864 8999999997543 344577999999999997 599999999864 367
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+||| +.+++|.+++....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~ 150 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKK 150 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCS
T ss_pred EEEEEEe-cCCCCHHHHHHhcC
Confidence 7999999 67789999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-09 Score=110.09 Aligned_cols=91 Identities=18% Similarity=0.276 Sum_probs=76.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCC--CCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRH--RNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~ 122 (628)
.+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.++++++| |||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 35699999999999999999998 468999999997543 3345678999999999986 99999999854 47
Q ss_pred ceeeeeecccccCCchhhhhcc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
...|+||| +.+|+|.+++...
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~ 102 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKK 102 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHS
T ss_pred CEEEEEEe-CCCCCHHHHHHhc
Confidence 78999999 5678999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-09 Score=107.36 Aligned_cols=91 Identities=15% Similarity=0.208 Sum_probs=73.4
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHH-HHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECE-ALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+. +++.++||||+++++++. ..+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence 3578999999999999999999999899999999997643 233455666766 677789999999999964 367
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
..++||||+++ ++.+++.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~ 112 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYK 112 (327)
T ss_dssp EEEEEECCCSE-EHHHHHH
T ss_pred ceEEEEeecCC-ChHHHHH
Confidence 88999999996 7776665
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=98.87 E-value=2.9e-09 Score=108.12 Aligned_cols=100 Identities=21% Similarity=0.279 Sum_probs=67.5
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDF 119 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 119 (628)
........++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+..++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3445667789999999999999999999999999999999986543 234567788888899999999999998765211
Q ss_pred --cccceeeeeecccccCCchhhh
Q 042887 120 --KGVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 120 --~~~~~~~lv~e~~~~g~L~~~l 141 (628)
......++||||++++ +.+.+
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~ 116 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCC 116 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHH
T ss_pred ccccceeEEEEeeccccc-HHHHH
Confidence 1233478999999974 44333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=98.87 E-value=1e-09 Score=107.87 Aligned_cols=93 Identities=29% Similarity=0.484 Sum_probs=69.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECC-CCc--EEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE-TGT--TVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~--~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|++.+.||+|+||.||+|++.. +++ .||+|+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4579999999999999999998643 333 5899998654 23445778999999999999999999998642
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...++||||+++|++.+++....
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~~ 115 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKHQ 115 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG
T ss_pred --CCceeeEecccCCCHHHHHHhcc
Confidence 34789999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=98.86 E-value=2.3e-09 Score=111.13 Aligned_cols=90 Identities=23% Similarity=0.392 Sum_probs=71.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~~~~ 126 (628)
..|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++|++++|||||++++++... ...+....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36899999999999999999999999999999986532 2334799999999999999999987542 112334577
Q ss_pred eeecccccCCchhhhh
Q 042887 127 LIYEYMKCGSSEDWMH 142 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~ 142 (628)
+||||+++ ++.+.+.
T Consensus 130 lv~e~~~~-~l~~~~~ 144 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVAR 144 (420)
T ss_dssp EEEECCCE-EHHHHHH
T ss_pred eehhcccc-cHHHHHH
Confidence 99999986 5555543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=98.86 E-value=3.1e-09 Score=104.64 Aligned_cols=93 Identities=25% Similarity=0.349 Sum_probs=77.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ..+.+.+|+.+++.++|++++..+..+. ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 468999999999999999999999999999999986543 2356889999999999988877766553 2467889
Q ss_pred eeecccccCCchhhhhcccc
Q 042887 127 LIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~ 146 (628)
+||||+ +++|.+++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~ 100 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR 100 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT
T ss_pred EEEEec-CCCHHHHHHhhcc
Confidence 999999 8999999875443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.1e-09 Score=104.64 Aligned_cols=95 Identities=25% Similarity=0.353 Sum_probs=75.0
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.++|++++..+..+. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 3578999999999999999999999999999999876543 2356889999999999988888777653 346788
Q ss_pred eeeecccccCCchhhhhccccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
++||||+ +|+|.+++......
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~ 101 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRK 101 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSC
T ss_pred EEEEEcc-CCCHHHHHHHhcCC
Confidence 9999999 89999998754433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.2e-09 Score=109.22 Aligned_cols=100 Identities=14% Similarity=0.202 Sum_probs=75.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCC-----CcEEEEEEeeccccc-----------hhhhHHHHHHHHhhcCCCCcccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGET-----GTTVAVKVMNLKQKG-----------AAKSFVTECEALSNVRHRNLIKI 110 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l 110 (628)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++...... ....+.+|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998764 578999998754311 11234556667788899999999
Q ss_pred cceeeeccccccceeeeeecccccCCchhhhhcccccc
Q 042887 111 ITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 111 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
++++... .......++||||| +|+|.+++......+
T Consensus 114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l 149 (364)
T 3op5_A 114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAKRF 149 (364)
T ss_dssp EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTSCC
T ss_pred Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccCCC
Confidence 9987641 12236689999999 999999997654333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.4e-09 Score=109.76 Aligned_cols=97 Identities=18% Similarity=0.214 Sum_probs=72.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECC---CCcEEEEEEeeccccc-----------hhhhHHHHHHHHhhcCCCCcccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE---TGTTVAVKVMNLKQKG-----------AAKSFVTECEALSNVRHRNLIKIIT 112 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~~ 112 (628)
.++|++.+.||+|+||.||+|.+.. ++..||+|+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3679999999999999999999987 7788999998754311 2234778889999999999999999
Q ss_pred eeeeccccccceeeeeecccccCCchhhhhccc
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
++... +......|+||||+ +++|.+++....
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~ 146 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG 146 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC
Confidence 87541 23467899999999 999999987543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-09 Score=109.92 Aligned_cols=92 Identities=8% Similarity=0.089 Sum_probs=71.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECC--------CCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceee---
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGE--------TGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS--- 115 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--- 115 (628)
.++|++.+.||+|+||.||+|++.. .++.||+|++... +.+.+|++++++++||||+++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999987 3789999998743 46889999999999999998533211
Q ss_pred --------eccccccceeeeeecccccCCchhhhhcc
Q 042887 116 --------SIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 116 --------~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
..........++||||+ +|+|.+++...
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 151 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS 151 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC
Confidence 00012357889999999 99999999765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=4.1e-09 Score=108.85 Aligned_cols=91 Identities=22% Similarity=0.305 Sum_probs=68.3
Q ss_pred CCCCc-CceeecCCceeEEEEEEC--CCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSA-SNMIGQGSFGFVYKGKLG--ETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~-~~~iG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+.|++ .++||+|+||.||+|++. .+++.||+|++.... ....+.+|+.+|++++||||+++++++.. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 44666 458999999999999976 468899999986532 33578899999999999999999999653 34678
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+||||+.+ ++.+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~ 113 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFH 113 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHH
T ss_pred EEEEEeCCCC-CHHHHHHHh
Confidence 9999999985 777777543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=2.5e-09 Score=110.14 Aligned_cols=94 Identities=15% Similarity=0.209 Sum_probs=75.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC--------CCCcccccceeeecc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR--------HRNLIKIITVCSSID 118 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~~~~ 118 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~- 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS- 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence 46899999999999999999999999999999999754 234567889999999986 78899999986521
Q ss_pred ccccceeeeeecccccCCchhhhhc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~ 143 (628)
.......++||||+ ++++.+++..
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~ 137 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIK 137 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHh
Confidence 11356889999999 4566555543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.2e-09 Score=105.70 Aligned_cols=94 Identities=19% Similarity=0.268 Sum_probs=72.0
Q ss_pred HhCCCCcC-ceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHH-HHhhcCCCCcccccceeeeccccccc
Q 042887 46 ATNNFSAS-NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE-ALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 46 ~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
..++|++. +.||+|+||.||+|.+..+|+.||+|++.... ...+|+. .++.+.||||+++++++... .....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCc
Confidence 35678885 46999999999999999999999999986532 2233333 35667899999999986541 12245
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..++|||||++|+|.+++....
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~ 121 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG 121 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-
T ss_pred eEEEEEeccCCCCHHHHHHhcC
Confidence 6899999999999999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=6e-09 Score=108.24 Aligned_cols=92 Identities=17% Similarity=0.282 Sum_probs=75.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc------CCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV------RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~ 120 (628)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 457999999999999999999999999999999997542 2345677888888877 56799999998643
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
....++||||+. +++.+++....
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~ 193 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNK 193 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTT
T ss_pred -CCeEEEEEeccC-CCHHHHHHhcc
Confidence 678999999997 58888886543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=98.80 E-value=1.9e-09 Score=107.54 Aligned_cols=97 Identities=20% Similarity=0.262 Sum_probs=79.8
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhcC--CCCccccccee
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNVR--HRNLIKIITVC 114 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~ 114 (628)
.....++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34456789999999999999999999999999999999976432 13356789999999996 59999999995
Q ss_pred eeccccccceeeeeeccccc-CCchhhhhcc
Q 042887 115 SSIDFKGVDFKALIYEYMKC-GSSEDWMHQS 144 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~ 144 (628)
. .....++|||++.+ +++.+++...
T Consensus 118 ~-----~~~~~~lv~e~~~~~~~L~~~l~~~ 143 (320)
T 3a99_A 118 E-----RPDSFVLILERPEPVQDLFDFITER 143 (320)
T ss_dssp E-----CSSEEEEEEECCSSEEEHHHHHHHH
T ss_pred e-----cCCcEEEEEEcCCCCccHHHHHhcc
Confidence 4 47789999999976 8999988653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=3.9e-09 Score=107.62 Aligned_cols=98 Identities=10% Similarity=-0.009 Sum_probs=64.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---chhhhHHHHHHHHhhc--CCCCccccccee-------
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNV--RHRNLIKIITVC------- 114 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~~~~------- 114 (628)
..+|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458999999999999999999999999999999987432 3445677885544444 699988855332
Q ss_pred eeccc------------cccceeeeeecccccCCchhhhhccc
Q 042887 115 SSIDF------------KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 115 ~~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..... ......|+|||||+ |+|.+++....
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 182 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence 11000 00145899999999 89999997653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=3.8e-09 Score=106.18 Aligned_cols=92 Identities=16% Similarity=0.313 Sum_probs=75.7
Q ss_pred hCCCCcCceeecCCceeEEEEEE-CCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCC------cccccceeeeccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKL-GETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRN------LIKIITVCSSIDF 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 119 (628)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++... ...+.+.+|+.+++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 46899999999999999999998 4578999999987543 34567889999999887665 888888854
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..+..++||||+ ++++.+++....
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~ 111 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENG 111 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTT
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcC
Confidence 477899999999 889999886543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-08 Score=107.46 Aligned_cols=95 Identities=27% Similarity=0.362 Sum_probs=74.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++|++.+..+..+. ......+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 4689999999999999999999999999999998865432 356889999999998755444443332 2367889
Q ss_pred eeecccccCCchhhhhcccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
+||||+ +++|.+++......+
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l 100 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKL 100 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCC
T ss_pred EEEECC-CCCHHHHHHhhcCCC
Confidence 999999 899999987544333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=6e-09 Score=103.52 Aligned_cols=94 Identities=17% Similarity=0.247 Sum_probs=77.9
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcC--CCCcccccceeeeccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVR--HRNLIKIITVCSSIDF 119 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 119 (628)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~---- 98 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI---- 98 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE----
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee----
Confidence 344567999999999999999999985 58999999997543 344577899999999997 599999999854
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.....++||| +.+++|.+++...
T Consensus 99 -~~~~~~lv~e-~~~~~L~~~l~~~ 121 (313)
T 3cek_A 99 -TDQYIYMVME-CGNIDLNSWLKKK 121 (313)
T ss_dssp -CSSEEEEEEC-CCSEEHHHHHHHC
T ss_pred -cCCEEEEEEe-cCCCcHHHHHHhc
Confidence 3678999999 6678999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.76 E-value=6.2e-09 Score=103.59 Aligned_cols=89 Identities=19% Similarity=0.213 Sum_probs=63.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc-chhhh-HHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-GAAKS-FVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~-~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+ +.++..+++.++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 4678999999999999999999999999999999976432 22223 344445678889999999999964 4678
Q ss_pred eeeeecccccCCchhhh
Q 042887 125 KALIYEYMKCGSSEDWM 141 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l 141 (628)
.++||||+ ++.+....
T Consensus 99 ~~lv~e~~-~~~~~~l~ 114 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLK 114 (318)
T ss_dssp EEEEECCC-SEEHHHHH
T ss_pred EEEEEecc-CCcHHHHH
Confidence 99999999 44444444
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=98.73 E-value=8.7e-09 Score=105.12 Aligned_cols=95 Identities=15% Similarity=0.185 Sum_probs=77.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-----------CCCcccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-----------HRNLIKIITVCS 115 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 115 (628)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467999999999999999999999999999999987532 23466889999988886 899999999865
Q ss_pred eccccccceeeeeecccccCCchhhhhcc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
... ......++||||+ ++++.+++...
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~ 123 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKY 123 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHT
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHh
Confidence 411 1234789999999 88999988753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.2e-08 Score=106.33 Aligned_cols=87 Identities=23% Similarity=0.222 Sum_probs=69.9
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
.|...+.||+|+||+||.+.. .+|+.||||++.... .+.+.+|+.+++++ +|||||++++++. .....|+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEEE
Confidence 355568899999999986644 579999999986532 34678999999887 7999999998853 4788999
Q ss_pred eecccccCCchhhhhccc
Q 042887 128 IYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~ 145 (628)
|||||. |+|.+++....
T Consensus 87 v~E~~~-gsL~~~l~~~~ 103 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKN 103 (434)
T ss_dssp EECCCS-EEHHHHHHTC-
T ss_pred EEecCC-CCHHHHHhccC
Confidence 999996 59999997654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=98.71 E-value=8.5e-09 Score=105.89 Aligned_cols=86 Identities=27% Similarity=0.374 Sum_probs=66.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecc-cccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSID-FKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~~~ 125 (628)
..+|++.+.||+|+||.||+|++..+++ ||+|++..... ...+|+.+|+.++||||+++++++.... .......
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3569999999999999999999976655 88888754322 2247999999999999999999876522 1334458
Q ss_pred eeeecccccCCc
Q 042887 126 ALIYEYMKCGSS 137 (628)
Q Consensus 126 ~lv~e~~~~g~L 137 (628)
++||||++++.+
T Consensus 114 ~lv~e~~~~~l~ 125 (394)
T 4e7w_A 114 NLVLEYVPETVY 125 (394)
T ss_dssp EEEEECCSEEHH
T ss_pred EEEeeccCccHH
Confidence 899999997543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=3.5e-08 Score=105.16 Aligned_cols=86 Identities=15% Similarity=0.145 Sum_probs=60.0
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--------cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--------KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
...+.||+|+||.||+|.+ .++.+|+|...... ....+++.+|++++++++||||+++..++.. .
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L 411 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence 4467899999999999965 67889999864321 1123568999999999999999955444332 4
Q ss_pred ceeeeeecccccCCchhhhhc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~ 143 (628)
...|+|||||++|+|.+++.+
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~ 432 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED 432 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT
T ss_pred CccEEEEECCCCCCHHHHHHH
Confidence 566999999999999999876
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.8e-08 Score=96.69 Aligned_cols=84 Identities=17% Similarity=0.169 Sum_probs=65.9
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------------------chhhhHHHHHHHHhhcCCCCc
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------------------GAAKSFVTECEALSNVRHRNL 107 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nI 107 (628)
....|++.+.||+|+||.||+|.+ .+|+.||+|+++.... .....+.+|+.+|++++ |
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred CCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 345566779999999999999999 7899999999964321 13456899999999998 4
Q ss_pred ccccceeeeccccccceeeeeecccccCCchh
Q 042887 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSED 139 (628)
Q Consensus 108 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 139 (628)
+++.+++. ....|+||||++||+|.+
T Consensus 164 ~~v~~~~~------~~~~~lvmE~~~g~~L~~ 189 (282)
T 1zar_A 164 LAVPKVYA------WEGNAVLMELIDAKELYR 189 (282)
T ss_dssp SSSCCEEE------EETTEEEEECCCCEEGGG
T ss_pred CCcCeEEe------ccceEEEEEecCCCcHHH
Confidence 66666532 355699999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.4e-08 Score=105.32 Aligned_cols=88 Identities=18% Similarity=0.255 Sum_probs=70.9
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+|+..+.||+|+||.||.... .+|+.||||++..... ..+.+|+.+++++ +|||||++++++. .....|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~ 94 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQY 94 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEE
T ss_pred EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEE
Confidence 4688889999999999664333 4789999999865332 3467899999999 7999999998854 477889
Q ss_pred eeecccccCCchhhhhccc
Q 042887 127 LIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~ 145 (628)
+|||||. |+|.+++....
T Consensus 95 lv~E~~~-g~L~~~l~~~~ 112 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKD 112 (432)
T ss_dssp EEEECCS-EEHHHHHHSSS
T ss_pred EEEECCC-CCHHHHHHhcC
Confidence 9999997 58999987654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2e-08 Score=102.68 Aligned_cols=94 Identities=21% Similarity=0.287 Sum_probs=75.5
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCC-----cccccceeeecc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRN-----LIKIITVCSSID 118 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~n-----Iv~l~~~~~~~~ 118 (628)
...++|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+. |++ |+++++.+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--- 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence 34678999999999999999999999999999999997532 23456778888888885 554 777777754
Q ss_pred ccccceeeeeecccccCCchhhhhccc
Q 042887 119 FKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++||||+. |++.+++....
T Consensus 127 --~~~~~~lv~e~~~-~~L~~~l~~~~ 150 (382)
T 2vx3_A 127 --FRNHLCLVFEMLS-YNLYDLLRNTN 150 (382)
T ss_dssp --ETTEEEEEEECCC-CBHHHHHHHTT
T ss_pred --cCCceEEEEecCC-CCHHHHHhhcC
Confidence 3678999999997 48998887543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2e-08 Score=101.57 Aligned_cols=91 Identities=13% Similarity=0.252 Sum_probs=72.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCC-cEEEEEEeeccccchhhhHHHHHHHHhhcCCCC------cccccceeeeccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETG-TTVAVKVMNLKQKGAAKSFVTECEALSNVRHRN------LIKIITVCSSIDF 119 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 119 (628)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++... ...+.+.+|+.+++.++|++ ++.+.+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~----- 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----- 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence 478999999999999999999998777 689999997532 34467889999999998766 77777764
Q ss_pred cccceeeeeecccccCCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
......++||||+ ++++.+++...
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~ 115 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKEN 115 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT
T ss_pred eeCCeEEEEEecc-CCChHHHHHhc
Confidence 3467899999999 56666666543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.60 E-value=1.2e-08 Score=97.09 Aligned_cols=102 Identities=22% Similarity=0.199 Sum_probs=63.0
Q ss_pred CcccE--EEccCCccc---cccchhhhCCCCCCEEecccCcCccc--ccccccCCCCCCEeecccccCcccCCcCccCCC
Q 042887 162 LKLEM--IDVGDNQLI---GKFPDFIANFSALEAIDISANMLGGR--IPDSLCQLRSLNYLSISENNFSCKLPLSIWNIS 234 (628)
Q Consensus 162 ~~L~~--L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls~n~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~ 234 (628)
+.|.. ++++.|+.. ...+-...++++|+.|+|++|+|+++ +|..+..+++|++|+|++|.|++. ..+..+.
T Consensus 141 p~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~ 218 (267)
T 3rw6_A 141 PDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIK 218 (267)
T ss_dssp HHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGT
T ss_pred cchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcc
Confidence 34554 666777433 22222234677888888888888763 346667788888888888888753 2233333
Q ss_pred --CCCEEEeecccCcccCCh------hhhhCCCCCcEEe
Q 042887 235 --SLEIISLHSNRFEGSLPL------NIGFNIPNVNFLS 265 (628)
Q Consensus 235 --~L~~L~L~~n~l~~~~~~------~~~~~l~~L~~L~ 265 (628)
+|++|+|++|.+.+.+|. .+...+|+|+.||
T Consensus 219 ~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 219 GLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 778888888877765552 1233455655554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.59 E-value=1.6e-08 Score=91.58 Aligned_cols=87 Identities=21% Similarity=0.286 Sum_probs=43.1
Q ss_pred cCCCCEeeCcCCcCcccC----CccccCCCCCCeEECcCceeeee----cCccccCCCCCCEEEC--CCCcccccC----
Q 042887 485 LRNLAEFDLSENHFSNEI----PVTLSACTTLEYLHLQGNSFSGS----LPLSLKTLKSIKELDL--SRNNLSGQI---- 550 (628)
Q Consensus 485 l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~~---- 550 (628)
.++|++|+|++|.+.+.. ...+...++|++|+|++|.|... +...+...++|++|+| ++|.|....
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 344555555555554321 22233334555555555555432 2334445556666666 556665332
Q ss_pred chhhhcccCCCeEeccCCcCc
Q 042887 551 PKYLENLLFLAYLNLSYNHFE 571 (628)
Q Consensus 551 ~~~~~~l~~L~~L~ls~N~l~ 571 (628)
.+.+...++|++|++++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 233344456666666666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.59 E-value=2.1e-08 Score=95.38 Aligned_cols=96 Identities=23% Similarity=0.336 Sum_probs=59.2
Q ss_pred EEcCCCcCc---cccchhhhccCCCCEeeCcCCcCcc--cCCccccCCCCCCeEECcCceeeeecCccccCCC--CCCEE
Q 042887 467 LDLSGNLLG---GSIPLEVGNLRNLAEFDLSENHFSN--EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLK--SIKEL 539 (628)
Q Consensus 467 L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L 539 (628)
++++.|+.. +..+....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 456666433 1112222457778888888888776 3345566777777888887777743 2233333 77777
Q ss_pred ECCCCcccccCc-------hhhhcccCCCeEe
Q 042887 540 DLSRNNLSGQIP-------KYLENLLFLAYLN 564 (628)
Q Consensus 540 ~Ls~N~l~~~~~-------~~~~~l~~L~~L~ 564 (628)
+|++|++.+..| ..+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 777777775444 2356677777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.55 E-value=1.5e-08 Score=91.91 Aligned_cols=46 Identities=13% Similarity=0.093 Sum_probs=25.8
Q ss_pred cchhhhCCCCCCEEecccC-cCccc----ccccccCCCCCCEeecccccCc
Q 042887 178 FPDFIANFSALEAIDISAN-MLGGR----IPDSLCQLRSLNYLSISENNFS 223 (628)
Q Consensus 178 ~~~~~~~l~~L~~L~Ls~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~i~ 223 (628)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|.|.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 3445556666777777766 66532 2233444555666666666554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.4e-07 Score=99.41 Aligned_cols=87 Identities=10% Similarity=-0.030 Sum_probs=63.7
Q ss_pred ceeecCCceeEEEEEECCCCcEEEEEEeeccc----------cchhhhHHHHHHHHhhc-CCCCcccccceeeecccccc
Q 042887 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ----------KGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 122 (628)
...+.|+.|.+..++....|+.||+|++.... ....+.|.+|+++|+++ .|+||++++++ +++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEEC
Confidence 34667777777766666678999999996531 12345699999999999 69999999999 5668
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
...|||||||+||+|.+++.+.+
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhCC
Confidence 99999999999999999997654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.1e-06 Score=84.31 Aligned_cols=75 Identities=16% Similarity=0.156 Sum_probs=55.9
Q ss_pred CCcCceeecCCceeEEEEEECCCCcE--EEEEEeeccccc------------------------hhhhHHHHHHHHhhcC
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTT--VAVKVMNLKQKG------------------------AAKSFVTECEALSNVR 103 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 103 (628)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998778888 999987543110 1125789999999998
Q ss_pred CCCcc--cccceeeeccccccceeeeeecccc
Q 042887 104 HRNLI--KIITVCSSIDFKGVDFKALIYEYMK 133 (628)
Q Consensus 104 h~nIv--~l~~~~~~~~~~~~~~~~lv~e~~~ 133 (628)
|+++. ..++ ....++||||+.
T Consensus 129 ~~~i~~p~~~~---------~~~~~lVmE~~g 151 (258)
T 1zth_A 129 EAGVSVPQPYT---------YMKNVLLMEFIG 151 (258)
T ss_dssp HTTCCCCCEEE---------EETTEEEEECCE
T ss_pred hCCCCCCeEEE---------cCCCEEEEEecC
Confidence 88652 2222 235689999994
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.14 E-value=4.9e-07 Score=79.55 Aligned_cols=81 Identities=14% Similarity=0.122 Sum_probs=41.1
Q ss_pred ceEEcCCCcCccccchhhhccCCCCEeeCcCCc-CcccCCccccCC----CCCCeEECcCce-eeeecCccccCCCCCCE
Q 042887 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENH-FSNEIPVTLSAC----TTLEYLHLQGNS-FSGSLPLSLKTLKSIKE 538 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~ 538 (628)
+.||++++.++...-..+.++++|++|+|++|. +++..-..+..+ ++|++|+|++|. |++..-..+..+++|++
T Consensus 64 ~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~ 143 (176)
T 3e4g_A 64 QAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKY 143 (176)
T ss_dssp EEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCE
T ss_pred eEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCE
Confidence 556666666554444445555666666666653 444333333332 245555555553 44333333445555555
Q ss_pred EECCCCc
Q 042887 539 LDLSRNN 545 (628)
Q Consensus 539 L~Ls~N~ 545 (628)
|++++|.
T Consensus 144 L~L~~c~ 150 (176)
T 3e4g_A 144 LFLSDLP 150 (176)
T ss_dssp EEEESCT
T ss_pred EECCCCC
Confidence 5555553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.11 E-value=9.3e-07 Score=77.79 Aligned_cols=83 Identities=18% Similarity=0.216 Sum_probs=63.6
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCc-CcccccccccCC----CCCCEeeccccc-CcccCCcCccCCCCC
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANM-LGGRIPDSLCQL----RSLNYLSISENN-FSCKLPLSIWNISSL 236 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~Ls~N~-i~~~~p~~~~~l~~L 236 (628)
+|+.||++++.|+..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. +++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 58899999988887766778888899999999885 665544556665 368888888874 776555567778888
Q ss_pred CEEEeeccc
Q 042887 237 EIISLHSNR 245 (628)
Q Consensus 237 ~~L~L~~n~ 245 (628)
++|+++++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 888888875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.97 E-value=5.8e-06 Score=85.20 Aligned_cols=57 Identities=21% Similarity=0.201 Sum_probs=47.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCC
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRH 104 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h 104 (628)
..|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.+.|
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~ 137 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTT
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhcc
Confidence 34777889999999999999999999999999987432 2335779999999999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=97.92 E-value=5.2e-06 Score=83.07 Aligned_cols=92 Identities=9% Similarity=0.040 Sum_probs=54.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc--------------chhhhHHHHHHHHhhcCCCCcccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK--------------GAAKSFVTECEALSNVRHRNLIKIITV 113 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 113 (628)
.-|++.+.||+|+||.||+|... +|+.||||+++.... ........++++.....|+|+++++..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34899999999999999999984 699999998754210 001112222333333334444444332
Q ss_pred eeec-cccccceeeeeecccccCCchhh
Q 042887 114 CSSI-DFKGVDFKALIYEYMKCGSSEDW 140 (628)
Q Consensus 114 ~~~~-~~~~~~~~~lv~e~~~~g~L~~~ 140 (628)
.... ..-.....++||||++|+.+.+.
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G~~L~~l 201 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDALPMRQV 201 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSCEEGGGC
T ss_pred CCCCCeeeeccCceEEEEecCCccHhhh
Confidence 1110 00012345799999998877654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.54 E-value=5e-05 Score=68.08 Aligned_cols=67 Identities=12% Similarity=0.100 Sum_probs=30.0
Q ss_pred cccCCCCCCEEEcccccceeeccccc----ccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeeccc
Q 042887 278 SFSNASNLQVLDVYKNHFSGQVKIDF----NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNT 346 (628)
Q Consensus 278 ~~~~l~~L~~L~L~~N~i~~~~~~~~----~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~ 346 (628)
.+..-+.|+.|+|++|+|.......+ ..-+.|++|+|++|.|+..... .....+...+.|+.|+|++
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~--ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA--RLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--HHHHHTTTTCCCSEEECCC
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH--HHHHHHhhCCceeEEECCC
Confidence 34444555555555555543332222 2334555555555555432111 1223344444455555543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.53 E-value=6.1e-05 Score=67.54 Aligned_cols=83 Identities=12% Similarity=0.152 Sum_probs=47.5
Q ss_pred CcccEEEccCC-ccccc----cchhhhCCCCCCEEecccCcCccccccc----ccCCCCCCEeecccccCcccCC----c
Q 042887 162 LKLEMIDVGDN-QLIGK----FPDFIANFSALEAIDISANMLGGRIPDS----LCQLRSLNYLSISENNFSCKLP----L 228 (628)
Q Consensus 162 ~~L~~L~Ls~n-~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~----~~~l~~L~~L~Ls~N~i~~~~p----~ 228 (628)
+.|+.|+|++| .|... +.+.+..-+.|+.|+|++|.|...-..+ +..-+.|++|+|++|.|.+... +
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 45777888775 66432 3345556667777777777776433222 3345667777777776664322 2
Q ss_pred CccCCCCCCEEEeecc
Q 042887 229 SIWNISSLEIISLHSN 244 (628)
Q Consensus 229 ~~~~l~~L~~L~L~~n 244 (628)
++..-+.|++|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 3334445666666543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00072 Score=64.56 Aligned_cols=91 Identities=12% Similarity=0.048 Sum_probs=70.6
Q ss_pred HHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecccccc
Q 042887 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~ 122 (628)
.....+|.+....|.|+.+.||++.. .++.+++|+...........+.+|+.+++.+. +..+.++++.+. ..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~ 82 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD 82 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence 34457898888899999999999976 46889999987543233457899999999885 667778887754 35
Q ss_pred ceeeeeecccccCCchhhh
Q 042887 123 DFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l 141 (628)
+..|+||||++|.++.+.+
T Consensus 83 ~~~~lv~e~i~G~~l~~~~ 101 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp TEEEEEEECCSSEEHHHHC
T ss_pred CceEEEEEecCCeehhhcc
Confidence 7789999999999887653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0006 Score=57.02 Aligned_cols=56 Identities=20% Similarity=0.304 Sum_probs=31.4
Q ss_pred EeeCcCCcCc-ccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 490 EFDLSENHFS-NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 490 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5566666664 23343322 34666666666666544555566666666666666554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0012 Score=55.14 Aligned_cols=57 Identities=26% Similarity=0.329 Sum_probs=30.3
Q ss_pred eEECcCceee-eecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcc
Q 042887 514 YLHLQGNSFS-GSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 514 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 572 (628)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...++.|..+++|+.|+|++|++..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 4555555554 12333221 345666666666665555555666666666666665543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.38 E-value=0.015 Score=55.05 Aligned_cols=82 Identities=12% Similarity=-0.005 Sum_probs=57.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCC--cccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRN--LIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~ 125 (628)
.+|.+....+.|..+.||++.. .+|+.+++|..... ....+.+|+.+++.+.+.. +.+++.... ..+..
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~ 90 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRD 90 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCC
Confidence 4455543334566799999975 46778999987543 2356889999999886444 445666532 34568
Q ss_pred eeeecccccCCch
Q 042887 126 ALIYEYMKCGSSE 138 (628)
Q Consensus 126 ~lv~e~~~~g~L~ 138 (628)
++||||++|.++.
T Consensus 91 ~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 91 WLLLGEVPGQDLL 103 (264)
T ss_dssp EEEEECCSSEETT
T ss_pred EEEEEecCCcccC
Confidence 9999999998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=93.13 E-value=0.1 Score=51.93 Aligned_cols=84 Identities=13% Similarity=0.147 Sum_probs=56.4
Q ss_pred cCceeecCCceeEEEEEECCCCcEEEEEEee--ccc-cchhhhHHHHHHHHhhcC--CCCcccccceeeeccccccceee
Q 042887 52 ASNMIGQGSFGFVYKGKLGETGTTVAVKVMN--LKQ-KGAAKSFVTECEALSNVR--HRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+.++.|.++.||+... .+..+++|+.. ... ......+.+|..+++.+. +..+.+++..+.+. ...+..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 356799999999999887 34678888775 332 123457889999999987 45577777775431 1125578
Q ss_pred eeecccccCCchh
Q 042887 127 LIYEYMKCGSSED 139 (628)
Q Consensus 127 lv~e~~~~g~L~~ 139 (628)
+||||++|..+.+
T Consensus 118 ~vme~v~G~~l~~ 130 (359)
T 3dxp_A 118 YIMEFVSGRVLWD 130 (359)
T ss_dssp EEEECCCCBCCCC
T ss_pred EEEEecCCeecCC
Confidence 9999999987743
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.12 E-value=0.15 Score=51.57 Aligned_cols=77 Identities=14% Similarity=0.144 Sum_probs=49.2
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeecccc-------chhhhHHHHHHHHhhcCC--CC-cccccceeeecccccc
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-------GAAKSFVTECEALSNVRH--RN-LIKIITVCSSIDFKGV 122 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-Iv~l~~~~~~~~~~~~ 122 (628)
.+.+|.|.++.||++....+++.+++|....... ....++.+|.++++.+.. +. +.+++.. +.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-------d~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-------DT 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-------ET
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-------cC
Confidence 4579999999999997655678899998653211 134567889998887742 33 3344432 13
Q ss_pred ceeeeeecccccCC
Q 042887 123 DFKALIYEYMKCGS 136 (628)
Q Consensus 123 ~~~~lv~e~~~~g~ 136 (628)
...++|||++++..
T Consensus 108 ~~~~lvmE~l~g~~ 121 (397)
T 2olc_A 108 EMAVTVMEDLSHLK 121 (397)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CccEEEEEeCCCcc
Confidence 34589999997643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=91.37 E-value=0.4 Score=45.87 Aligned_cols=79 Identities=18% Similarity=0.185 Sum_probs=55.4
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCC---Ccccccceeeecccccccee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHR---NLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~~~ 125 (628)
...-.+.+|.|..+.||+.+. .+|+.|.+|+...........|.+|+..|+.+... -+.+++.. +..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETT
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCc
Confidence 445567899999999999987 57899999987654443445688999998888422 23333333 234
Q ss_pred eeeecccccCCc
Q 042887 126 ALIYEYMKCGSS 137 (628)
Q Consensus 126 ~lv~e~~~~g~L 137 (628)
++||||.+++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999887654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.70 E-value=0.029 Score=57.97 Aligned_cols=62 Identities=11% Similarity=0.042 Sum_probs=18.1
Q ss_pred CcCceeecCCceeEEEEEECCCCcEEEE------EEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceee
Q 042887 51 SASNMIGQGSFGFVYKGKLGETGTTVAV------KVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCS 115 (628)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~av------K~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 115 (628)
.+.+.+| ||+||+|.+......||+ |..... .......|.+|..+++..+|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 999999999655567888 655432 2233457889999999999999999988743
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=88.73 E-value=0.93 Score=43.86 Aligned_cols=75 Identities=16% Similarity=0.132 Sum_probs=56.2
Q ss_pred CceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC---CCCcccccceeeeccccccceeeeee
Q 042887 53 SNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR---HRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
.+.++.|....+|+... +++.+.+|+.... ....+.+|.+.|+.+. ..-+.+++..+.. .+..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence 46789999999999876 4677888987543 2466889998888874 2456677666432 46789999
Q ss_pred cccccCCc
Q 042887 130 EYMKCGSS 137 (628)
Q Consensus 130 e~~~~g~L 137 (628)
|++++...
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=84.90 E-value=2 Score=40.27 Aligned_cols=86 Identities=13% Similarity=0.014 Sum_probs=58.7
Q ss_pred CCCCcCceeecCCce-eEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFG-FVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.+|+. +.+..|.-| .||+.....++..+.+|+.... ....+.+|...|+.+. +--|.+++..+.+ .+..
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~ 95 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDA 95 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeE
Confidence 44543 345556554 6898887667778999986543 3456788999888875 3234566666443 5678
Q ss_pred eeeecccccCCchhhhh
Q 042887 126 ALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~ 142 (628)
++|||+++|.++.+...
T Consensus 96 ~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp EEEEECCCSEEHHHHHH
T ss_pred EEEEEeeCCcccccccc
Confidence 99999999988766543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 628 | ||||
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-17 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-17 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-17 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-17 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-08 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-17 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-17 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-16 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-16 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-16 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-16 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-16 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-16 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-16 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-16 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-15 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-15 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-15 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-15 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-15 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-15 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-15 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-15 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-15 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-15 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-15 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-14 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-14 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-14 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-14 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-14 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-14 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-14 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-13 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-13 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-13 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-13 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-13 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-12 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-12 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-12 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-11 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-11 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-11 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-11 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-11 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-11 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-11 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-10 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-10 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-10 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-09 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 |
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 3e-20
Identities = 80/397 (20%), Positives = 133/397 (33%), Gaps = 35/397 (8%)
Query: 178 FPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237
F D + + + + + L + L + + +++L
Sbjct: 16 FTD--TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLT 69
Query: 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFS------NASNLQVLDVY 291
I+ +N+ PL N+ + + + N P + N Q+ D+
Sbjct: 70 QINFSNNQLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351
+ + +S + + S + +T L + + L
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 352 VFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKN 411
V S+ + + +NQIS P I N++ + NQL + L N
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTN 242
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471
L L L N + P L LT L L LG N + P L L+ L +L
Sbjct: 243 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--------LAGLTALTNLEL 292
Query: 472 NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLK 531
N + NL+NL L N+ S+ P +S+ T L+ L N S SL
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 532 TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYN 568
L +I L N +S P L NL + L L+
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 5e-10
Identities = 59/347 (17%), Positives = 111/347 (31%), Gaps = 29/347 (8%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
++ L ++ ++ V L + S+ +NL ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 74
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351
N + L+ L + ++ N + + ++ ++ K
Sbjct: 75 NNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 352 VFLR------SIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHA 405
R +I+++SA + + + ++ + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 406 IGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSR 465
+ +L NL+ L N + P LT L+ L L N L+ +L + NL L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDL-- 246
Query: 466 LLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGS 525
DL+ N + PL L L E L N SN P+ T L+
Sbjct: 247 --DLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED--- 299
Query: 526 LPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEG 572
+ LK++ L L NN+S P + +L L L + N
Sbjct: 300 -ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 9e-07
Identities = 19/85 (22%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 160 NLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISE 219
NL L + + N + P +++ + L+ + + N + SL L ++N+LS
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 220 NNFSCKLPLSIWNISSLEIISLHSN 244
N S PL+ N++ + + L+
Sbjct: 361 NQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 13/122 (10%), Positives = 44/122 (36%), Gaps = 8/122 (6%)
Query: 99 LSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQR 158
L + N+ + + + + + + + + + ++ + + +
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNIS----DISPV 325
Query: 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSIS 218
+L KL+ + +N++ +AN + + + N + P L L + L ++
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381
Query: 219 EN 220
+
Sbjct: 382 DQ 383
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.3 bits (213), Expect = 3e-19
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 18/118 (15%)
Query: 39 SYADLSKATNNFSAS---------NMIGQGSFGFVYKGKL---GETGTTVAVKVMNLKQ- 85
++ D ++A F+ +IG G FG V G L G+ VA+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 86 KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ + F++E + H N+I + V + +I E+M+ GS + ++ Q
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQ 120
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.5 bits (205), Expect = 3e-18
Identities = 62/316 (19%), Positives = 107/316 (33%), Gaps = 30/316 (9%)
Query: 235 SLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNH 294
L ++ E +P ++ P+ L + N T F N NL L + N
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 295 FSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFL 354
S F L L RL+LSKN L ++ L ++ N+ V
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEK---------MPKTLQELRVHENEITKVRK 117
Query: 355 RSIANLSAKITVIGMGD-NQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQ 413
L+ I V + + SG + + ++ + +T TIP + +L
Sbjct: 118 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLT 174
Query: 414 GLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473
L L N + +L L L +L L FN++ SL N +L L N
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-----LNNN 229
Query: 474 LGGSIPLEVGNLRNLAEFDLSENHFSN------EIPVTLSACTTLEYLHLQGN--SFSGS 525
+P + + + + L N+ S P + + + L N +
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289
Query: 526 LPLSLKTLKSIKELDL 541
P + + + + L
Sbjct: 290 QPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 2e-16
Identities = 51/266 (19%), Positives = 101/266 (37%), Gaps = 9/266 (3%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L + +L ++ + +N+I+ + KNL N++ + N+++ P A L L
Sbjct: 22 LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGN 472
+ L L +N L+ L L ++ +V + L + + L SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 473 LLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKT 532
++ L+ +++ + + + +L LHL GN + SLK
Sbjct: 142 -----ENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKG 193
Query: 533 LKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNE 592
L ++ +L LS N++S L N L L+L+ N ++L N
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
Query: 593 RLCGGLEELHLPSCHFGRPRITRITL 618
G + P + + + ++L
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSL 279
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.5 bits (166), Expect = 3e-13
Identities = 52/271 (19%), Positives = 90/271 (33%), Gaps = 22/271 (8%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
+ + L L N + D L L L L NK + + A L K+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHT------LILINNKISKISPGAFAPLV-KLER 83
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI 426
+ + NQ+ K L + E ++ ++ + + ++ ++ L G
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIE 142
Query: 427 PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLR 486
+ L+ + + N+ + L L GN + + L
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL-------HLDGNKITKVDAASLKGLN 195
Query: 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
NLA+ LS N S +L+ L LHL N P L K I+ + L NN+
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNI 254
Query: 547 SG------QIPKYLENLLFLAYLNLSYNHFE 571
S P Y + ++L N +
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 24/153 (15%), Positives = 56/153 (36%), Gaps = 5/153 (3%)
Query: 196 NMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIG 255
G + ++ L+Y+ I++ N + + SL + L N+ ++
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASL- 191
Query: 256 FNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315
+ N+ L + N+ + S +N +L+ L + N + + ++L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD-HKYIQVVYLH 250
Query: 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNK 348
NN+ ++D T + + L +N
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.0 bits (202), Expect = 1e-17
Identities = 17/104 (16%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSN 101
+ ++F + +G G+ G V+K +G +A K+++L+ + + E + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
++ S ++ E+M GS + + ++
Sbjct: 61 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG 99
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 80.5 bits (198), Expect = 2e-17
Identities = 27/117 (23%), Positives = 55/117 (47%), Gaps = 8/117 (6%)
Query: 31 MEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK 90
M+ P +Y + + + +G G +G VY+G + TVAVK + + +
Sbjct: 2 MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 58
Query: 91 SFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
F+ E + ++H NL++++ VC+ +I E+M G+ D++ + N +
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ 110
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 3e-17
Identities = 23/100 (23%), Positives = 44/100 (44%), Gaps = 8/100 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
+G G FG V+ G T VAVK + + + +F+ E + ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
+++ V + + +I EYM+ GS D++ +
Sbjct: 71 VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGI 104
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.0 bits (197), Expect = 3e-17
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 11/104 (10%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHR 105
+ IG GSFG VYKGK VAVK++N+ ++F E L RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
N++ + ++ A++ ++ + S +H K E
Sbjct: 65 NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFE 102
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 4e-17
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 8/100 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
IG+G FG V G G VAVK +K A++F+ E ++ +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNL 62
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
++++ V + ++ EYM GS D++
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRS 98
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 5e-17
Identities = 22/102 (21%), Positives = 45/102 (44%), Gaps = 7/102 (6%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
+ + +G G FG V GK VA+K++ + + F+ E + + N+ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+++ VC+ +I EYM G +++ + + +
Sbjct: 62 VQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQ 98
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (194), Expect = 6e-17
Identities = 49/266 (18%), Positives = 85/266 (31%), Gaps = 14/266 (5%)
Query: 307 SNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITV 366
+ R+FL N + + LT + + L + +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL------EQL 85
Query: 367 IGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTI 426
+ Q+ P+ L ++ ++ L P L LQ L L N+L+
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 427 PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLR 486
DT +L L LFL N + + +L L L N + P +L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL----DRLLLHQNRVAHVHPHAFRDLG 201
Query: 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNL 546
L L N+ S L+ L+YL L N + +++ S + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEV 260
Query: 547 SGQIPKYLENLLFLAYLNLSYNHFEG 572
+P+ L L+ N +G
Sbjct: 261 PCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (157), Expect = 4e-12
Identities = 57/251 (22%), Positives = 89/251 (35%), Gaps = 6/251 (2%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNL 412
L+++ + A I + N+IS + + N+ + N L A L L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 413 QGLALVRNSLRGTI-PDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471
+ L L N+ ++ P T L L+ L L LQ P L L L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL----YLQD 138
Query: 472 NLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLK 531
N L +L NL L N S+ +L+ L L N + P + +
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 532 TLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGN 591
L + L L NNLS + L L L YL L+ N + + + ++ +
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSS 258
Query: 592 ERLCGGLEELH 602
E C + L
Sbjct: 259 EVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 5e-08
Identities = 36/221 (16%), Positives = 73/221 (33%), Gaps = 11/221 (4%)
Query: 131 YMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEA 190
G + +D + ++ L +L + + L P +AL+
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 191 IDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSL 250
+ + N L D+ L +L +L + N S + + SL+ + LH NR
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 251 PLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLS 310
P ++ + L + NN + + + LQ L + N + + + L
Sbjct: 194 PHAF-RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQ 251
Query: 311 RLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351
+ S + + L + ++ L N G
Sbjct: 252 KFRGSSSEVPCSLPQRL---------AGRDLKRLAANDLQG 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 7e-17
Identities = 28/113 (24%), Positives = 51/113 (45%), Gaps = 8/113 (7%)
Query: 31 MEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAK 90
+E+ +VS D K ++ IGQG+ G VY TG VA++ MNL+Q+ +
Sbjct: 6 LEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 91 SFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ E + ++ N++ + D ++ EY+ GS D + +
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE 110
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 8e-17
Identities = 19/107 (17%), Positives = 49/107 (45%), Gaps = 10/107 (9%)
Query: 46 ATNNFSASNM-IGQGSFGFVYKG--KLGETGTTVAVKVMNLK-QKGAAKSFVTECEALSN 101
+N +++ +G G+FG V +G ++ + VA+KV+ +K + + E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+ + ++++I VC + L+ E G ++ +++
Sbjct: 66 LDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEI 106
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.7 bits (191), Expect = 2e-16
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 3/92 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITV 113
IG+GSF VYKG ET VA + ++ K + F E E L ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
S KG L+ E M G+ + ++ +
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK 107
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 77.5 bits (190), Expect = 3e-16
Identities = 17/105 (16%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALS 100
S ++ + ++G G V+ + VAVKV+ + F E + +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 101 NVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
+ H ++ + + G ++ EY+ + D +H
Sbjct: 63 ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG 106
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 78.2 bits (192), Expect = 3e-16
Identities = 20/101 (19%), Positives = 44/101 (43%), Gaps = 5/101 (4%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
+++ +G G+FG V++ TG A K + + ++ E + +S +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+ + + +IYE+M G + + ++K+
Sbjct: 86 VNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKM 121
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.6 bits (188), Expect = 3e-16
Identities = 22/96 (22%), Positives = 42/96 (43%), Gaps = 7/96 (7%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
+ + IG G FG V+ G VA+K + + + + F+ E E + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+++ VC L++E+M+ G D++
Sbjct: 63 VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT 93
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (190), Expect = 3e-16
Identities = 22/93 (23%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G+FG VYK + ET A KV++ K + + ++ E + L++ H N++K++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+ ++ E+ G+ + M + L
Sbjct: 80 Y-----ENNLWILIEFCAGGAVDAVMLELERPL 107
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 4e-16
Identities = 25/100 (25%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLI 108
+++ + +IG GSFG VY+ KL ++G VA+K + + + E + + + H N++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 109 KIITVC-SSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
++ SS + K + L+ +Y+ H S K
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 77.4 bits (190), Expect = 6e-16
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G G+FG V++ TG K +N + E ++ + H LI +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
LI E++ G D + + K+
Sbjct: 97 D-----KYEMVLILEFLSGGELFDRIAAEDYKM 124
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 6e-16
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 12/107 (11%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL---GETGTTVAVKVMN---LKQKGAAKSFVTECEALSN 101
+ +G GSFG V +G+ +VAVK + L Q A F+ E A+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+ HRNLI++ V + K ++ E GS D + +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF 108
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 1e-15
Identities = 24/94 (25%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
IG+G FG V++GK G VAVK+ + ++ + E +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+ L+ +Y + GS D++++ +E
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE 100
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 75.4 bits (185), Expect = 1e-15
Identities = 25/99 (25%), Positives = 35/99 (35%), Gaps = 8/99 (8%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---GAAKSFVTECEALSNVRHRN 106
FS IG GSFG VY + VA+K M+ K + + E L +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
I+ L+ EY +S+
Sbjct: 77 TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK 110
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (184), Expect = 1e-15
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 6/97 (6%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRN 106
++ +G+G++G V T VAVK++++K+ ++ E + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
++K + + L EY G D +
Sbjct: 65 VVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEP 96
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 2e-15
Identities = 19/96 (19%), Positives = 40/96 (41%), Gaps = 10/96 (10%)
Query: 54 NMIGQGSFGFVYKGKL--GETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIK 109
+G G+FG V KG + TVAVK++ + + E + + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
+I +C + L+ E + G ++ Q+
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQNR 102
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 2e-15
Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 10/112 (8%)
Query: 42 DLSKATNNFSASNMIGQGSFGFVYKGKL---GETGTTVAVKVMN-LKQKGAAKSFVTECE 97
S +F+ +IG+G FG VY G L AVK +N + G F+TE
Sbjct: 23 GPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 98 ALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+ + H N++ ++ +C + ++ YMK G +++
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPT 128
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.7 bits (183), Expect = 2e-15
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 8/100 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
+ +GQG FG V+ G T VA+K + + ++F+ E + + +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
+++ V S + ++ EYM GS D++ K
Sbjct: 75 VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGK 108
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.3 bits (182), Expect = 2e-15
Identities = 18/106 (16%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 44 SKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSN 101
S+A ++ IG GS+G K + G + K ++ + + V+E L
Sbjct: 1 SRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
++H N+++ + ++ EY + G + + +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKE 102
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 4e-15
Identities = 26/115 (22%), Positives = 52/115 (45%), Gaps = 16/115 (13%)
Query: 35 FPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKS 91
+P++ + N+ ++IG+G+FG V K ++ + G + + +K+ K +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 92 FVTECEALSNV-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
F E E L + H N+I ++ C + L EY G+ D++ +S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSR 106
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.9 bits (181), Expect = 4e-15
Identities = 17/102 (16%), Positives = 37/102 (36%), Gaps = 8/102 (7%)
Query: 45 KATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSN 101
K +F ++G+GSF V + T A+K++ + ++ E + +S
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ H +K+ + Y K G ++ +
Sbjct: 65 LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRK 101
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 4e-15
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 2/98 (2%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN-LKQKGAAKSFVTECEALSNVRHR 105
++ + IG+G++G V VA+K ++ + + + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
N+I I + + + + + ++ +
Sbjct: 67 NIIGINDIIRAPTIEQMK-DVYLVTHLMGADLYKLLKT 103
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.8 bits (183), Expect = 5e-15
Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 11/109 (10%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK------QKGAAKSFVTECEALSN 101
N+FS +IG+G FG VY + +TG A+K ++ K + A + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150
++ + + D + I + M G + Q EA
Sbjct: 64 GDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSEA 107
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 73.1 bits (179), Expect = 9e-15
Identities = 20/100 (20%), Positives = 40/100 (40%), Gaps = 6/100 (6%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHR 105
+ + +++G G+F V + T VA+K + K +G S E L ++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
N++ + + S LI + + G D + +
Sbjct: 68 NIVALDDIYES-----GGHLYLIMQLVSGGELFDRIVEKG 102
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.2 bits (178), Expect = 1e-14
Identities = 64/270 (23%), Positives = 101/270 (37%), Gaps = 34/270 (12%)
Query: 363 KITVIGMGDNQISG--TIPSEIKNLVNINAFGVEYN-QLTGTIPHAIGELKNLQGLALVR 419
++ + + + IPS + NL +N + L G IP AI +L L L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 420 NSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP 479
++ G IPD L + L L +N L G +P S+ + NL+ + GN + G+IP
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI----TFDGNRISGAIP 166
Query: 480 LEVGNLRNL-----------------------AEFDLSENHFSNEIPVTLSACTTLEYLH 516
G+ L F + L
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 517 LQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPR 576
+ + K++ LDL N + G +P+ L L FL LN+S+N+ GE+P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 577 KGVFGNRTGIHLIGNERLCGGLEELHLPSC 606
G N+ LCG LP+C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 1/62 (1%)
Query: 168 DVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLP 227
D+ +N++ G P + L ++++S N L G IP L+ + + + N C P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 228 LS 229
L
Sbjct: 309 LP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 192 DISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLP 251
D+ N + G +P L QL+ L+ L++S NN ++P N+ ++ + +N+ P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 252 L 252
L
Sbjct: 309 L 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.2 bits (126), Expect = 3e-08
Identities = 35/178 (19%), Positives = 53/178 (29%), Gaps = 23/178 (12%)
Query: 164 LEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENN-- 221
L +D N L G P I++ L I N + G IPDS L N
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 222 --------------------FSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNV 261
+ S+ S +H + + L N+
Sbjct: 187 TGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 262 NFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNL 319
N L + N G+LP + L L+V N+ G++ L + N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 46.7 bits (109), Expect = 5e-06
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 2/70 (2%)
Query: 207 CQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSV 266
++LN L + N LP + + L +++ N G +P G N+ + +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAY 298
Query: 267 GQNNFTGSLP 276
N P
Sbjct: 299 ANNKCLCGSP 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 2e-14
Identities = 18/99 (18%), Positives = 39/99 (39%), Gaps = 2/99 (2%)
Query: 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN--LKQKGAAKSFVTECEALSNVRH 104
+ + +G G++G V +TG VAVK ++ + AK E L +++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 105 RNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
N+I ++ V + + ++ + +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 115
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 2e-14
Identities = 21/106 (19%), Positives = 38/106 (35%), Gaps = 10/106 (9%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL---GETGTTVAVKVM-NLKQKGAAKSFVTECEALSNVR 103
IG+G FG V++G VA+K N + F+ E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 104 HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
H +++K+I V + + +I E G ++ L+
Sbjct: 67 HPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLD 106
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 2e-14
Identities = 26/106 (24%), Positives = 47/106 (44%), Gaps = 10/106 (9%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV 102
+ + +IG G FG VYKG L G+ VA+K + + F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 103 RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
H N+I++ V S +I EYM+ G+ + ++ + + +
Sbjct: 67 SHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEF 107
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.8 bits (175), Expect = 2e-14
Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 11/117 (9%)
Query: 39 SYADLSKATNNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLK-QKGAAKSF 92
L NN IG+G+FG V++ + E T VAVK++ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 93 VTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
E ++ + N++K++ VC+ L++EYM G +++ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTV 115
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 4e-14
Identities = 20/102 (19%), Positives = 42/102 (41%), Gaps = 10/102 (9%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNLK-----QKGAAKSFVTECEALSNVRHRNLI 108
+ +G+G F VYK + T VA+K + L + G ++ + E + L + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 109 KIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEA 150
++ +L++++M+ S +
Sbjct: 64 GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS 100
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.7 bits (172), Expect = 6e-14
Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 11/108 (10%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSN 101
+ S +GQGSFG VY+G E T VA+K +N F+ E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
++++++ V S +I E M G + ++ +
Sbjct: 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMA 122
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 6e-14
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 12/107 (11%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQK-GAAKSFVTECEALSN 101
N S +G G+FG V + + TVAVK++ ++ ++E + LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 102 V-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
+ H N++ ++ C+ +I EY G +++ + D
Sbjct: 83 LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDS 124
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 9e-14
Identities = 23/101 (22%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHR 105
+ + IGQG+FG V+K + +TG VA+K + ++ ++G + + E + L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 106 NLIKIITVCSSIDFKGVDFKALIY---EYMKCGSSEDWMHQ 143
N++ +I +C + K IY ++ + + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 110
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.5 bits (172), Expect = 1e-13
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 6/93 (6%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCS 115
+G+G FG V++ + T K + +K E L+ RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFE 71
Query: 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
S ++ +I+E++ + ++ S +L
Sbjct: 72 S-----MEELVMIFEFISGLDIFERINTSAFEL 99
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.2 bits (169), Expect = 1e-13
Identities = 23/101 (22%), Positives = 44/101 (43%), Gaps = 8/101 (7%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRH 104
+F +G+G FG VY + ++ +A+KV+ L++ G E E S++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 105 RNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
N++++ LI EY G+ + + +
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLS 101
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (171), Expect = 1e-13
Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 11/103 (10%)
Query: 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVM-----NLKQKGAAKSFVTECEALSNVRH 104
F ++G G+FG VYKG G V + V A K + E +++V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 105 RNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
++ +++ +C + + LI + M G D++ + D
Sbjct: 71 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN 107
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (166), Expect = 3e-13
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 11/94 (11%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLK------QKGAAKSFVTECEALSNVRHRNLIK 109
+G G F V K + TG A K + + + + + E L ++H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 110 IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ V + LI E + G D++ +
Sbjct: 78 LHEVYEN-----KTDVILILELVAGGELFDFLAE 106
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (167), Expect = 4e-13
Identities = 26/138 (18%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTT-----VAVKVMNLK-QKGAAKSFVTECEALSN 101
N ++G G+FG V T VAVK++ K ++ ++E + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 102 V-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLN 160
+ H N++ ++ C+ LI+EY G +++ +K + +
Sbjct: 97 LGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 161 LLKLEMIDVGDNQLIGKF 178
L + E ++V + + F
Sbjct: 152 LEEEEDLNVLTFEDLLCF 169
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 67.6 bits (164), Expect = 6e-13
Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
N + IG GSFG +Y G G VA+K+ +K K E + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
I I C + D+ ++ E + + + S
Sbjct: 65 IPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSR 98
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 9e-13
Identities = 22/91 (24%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMN--LKQKGAAKSFVTECEALSNVRHRNLIKIITV 113
+G G++G V G TG VA+K + + + AK E L ++RH N+I ++ V
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 114 CSSID-FKGVDFKALIYEYMKCGSSEDWMHQ 143
+ + L+ +M + H+
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHE 116
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 2e-12
Identities = 26/121 (21%), Positives = 50/121 (41%), Gaps = 7/121 (5%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRN 106
NF IG+G++G VYK + TG VA+K + L +G + + E L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNLLKLEM 166
++K++ V + + L++E++ + + + + L L
Sbjct: 63 IVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 167 I 167
Sbjct: 118 C 118
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.9 bits (160), Expect = 2e-12
Identities = 21/105 (20%), Positives = 39/105 (37%), Gaps = 8/105 (7%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRH 104
+F +G GSFG V+ + G A+KV+ + + + E LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 105 RNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+I++ +I +Y++ G + +S
Sbjct: 64 PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPN 103
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 64.9 bits (157), Expect = 4e-12
Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 9/104 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHR 105
+ IG+G++G VYK + G T A+K + L++ +G + + E L ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
N++K+ V + + ++ + + LE
Sbjct: 61 NIVKLYDVIHT------KKRLVLVFEHLDQDLKKLLDVCEGGLE 98
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (156), Expect = 5e-12
Identities = 24/104 (23%), Positives = 46/104 (44%), Gaps = 7/104 (6%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHR 105
+ IG+G++G V+K K ET VA+K + L +G S + E L ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 106 NLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
N++++ V S L++E+ + + + D
Sbjct: 62 NIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDP 100
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (156), Expect = 9e-12
Identities = 19/103 (18%), Positives = 38/103 (36%), Gaps = 3/103 (2%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN--LKQKGAAKSFVTECEALSNVRHR 105
+ IG G+ G V VA+K ++ + + AK E + V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 106 NLIKIITVCSSID-FKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
N+I ++ V + + L+ E M + + + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 119
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 1e-11
Identities = 25/129 (19%), Positives = 53/129 (41%), Gaps = 6/129 (4%)
Query: 43 LSKATNNFSASNMIGQGSFGFVYKGK-LGETGTTVAVKVMNLK--QKGAAKSFVTECE-- 97
L +A + IG+G++G V+K + L G VA+K + ++ ++G S + E
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 98 -ALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLI 156
L H N++++ VC+ L++E++ + + + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 157 QRLNLLKLE 165
L L+
Sbjct: 122 MFQLLRGLD 130
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 1e-11
Identities = 19/102 (18%), Positives = 37/102 (36%), Gaps = 9/102 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALS-NVR 103
+F M+G+GSFG V+ + +T A+K + + + + E LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 104 HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145
H L + + + + EY+ G + +
Sbjct: 62 HPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCH 98
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 1e-11
Identities = 25/105 (23%), Positives = 40/105 (38%), Gaps = 8/105 (7%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMN---LKQKGAAKSFVTECEALSNVRH 104
N+F ++G+G+FG V + TG A+K++ + K VTE L N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 105 RNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
L + + D + EY G + + E
Sbjct: 65 PFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTE 104
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 1e-11
Identities = 16/94 (17%), Positives = 36/94 (38%), Gaps = 7/94 (7%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITV 113
++G G G V + T A+K++ K E E + ++++I+ V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
++ + G ++ E + G + D+
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ 106
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 64.1 bits (155), Expect = 1e-11
Identities = 18/101 (17%), Positives = 40/101 (39%), Gaps = 7/101 (6%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRN 106
+++ +G+G + V++ V VK++ +K K E + L N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
+I + + + AL++E++ + D
Sbjct: 92 IITLADIVKDPVSRTP---ALVFEHVNNTDFKQLYQTLTDY 129
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 62.0 bits (150), Expect = 4e-11
Identities = 20/105 (19%), Positives = 44/105 (41%), Gaps = 15/105 (14%)
Query: 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---------KGAAKSFVTECEAL 99
N+ ++G+G V + T AVK++++ + ++ + E + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 100 SNVR-HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
V H N+I++ + F L+++ MK G D++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTE 103
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 9e-11
Identities = 20/105 (19%), Positives = 43/105 (40%), Gaps = 14/105 (13%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGET-------GTTVAVKVMNLKQ-KGAAKSFVTECEAL 99
+ +G+G+FG V + T VAVK++ + ++E E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 100 SNV-RHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQ 143
+ +H+N+I ++ C+ +I EY G+ +++
Sbjct: 73 KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQA 112
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 59.8 bits (144), Expect = 2e-10
Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 7/102 (6%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNL 107
++ IG+GSFG +++G VA+K + A E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 62
Query: 108 IKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
I + F ++ + S ED + K
Sbjct: 63 IPNV-----YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS 99
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (140), Expect = 7e-10
Identities = 19/103 (18%), Positives = 30/103 (29%), Gaps = 13/103 (12%)
Query: 55 MIGQGSFGFVYKGKLGETGTTVAVKVMNLK------QKGAAKSFVTECEALSNVR--HRN 106
++G G FG VY G VA+K + + E L V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 107 LIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
+I+++ D LI E + L+
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGALQ 108
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 58.9 bits (141), Expect = 7e-10
Identities = 18/100 (18%), Positives = 38/100 (38%), Gaps = 9/100 (9%)
Query: 56 IGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIK------ 109
+G G F V+ K T VA+K++ K ++ E + L V + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 110 --IITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147
I+ + + KG + ++ + G + + + +
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.0 bits (139), Expect = 9e-10
Identities = 19/107 (17%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 48 NNFSASNMIGQGSFGFVYKGKL-----GETGTTVAVKVMNLKQ-KGAAKSFVTECEALSN 101
+ +G+G+FG V + T TVAVK++ ++ ++E + L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 102 VRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKL 148
+ H + K +I E+ K G+ ++ ++
Sbjct: 73 IGHHL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 58.3 bits (140), Expect = 1e-09
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 12/128 (9%)
Query: 19 RKHTQKSSRTLPMEQQFPMVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAV 78
++ K+ + + P + A L + F +G GSFG V K E+G A+
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 79 KVMN---LKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCG 135
K+++ + + + + E L V L+K+ + + EY+ G
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VMEYVAGG 126
Query: 136 SSEDWMHQ 143
+ +
Sbjct: 127 EMFSHLRR 134
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 3e-09
Identities = 22/109 (20%), Positives = 44/109 (40%), Gaps = 11/109 (10%)
Query: 48 NNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMN----LKQKGAAKSFVTECEALS 100
NF ++G G++G V+ + +TG A+KV+ +++ + TE + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 101 NVRHRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149
++R + + F+ LI +Y+ G + Q E
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTE 128
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 35/216 (16%), Positives = 62/216 (28%), Gaps = 15/216 (6%)
Query: 232 NISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVY 291
++S ++ +LP ++ + L + +N + + L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL--- 60
Query: 292 KNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG 351
+ L L + + L TL T+ G
Sbjct: 61 --NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 352 VFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKN 411
++ + + N++ P + + + N LT + L+N
Sbjct: 119 AL-----RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQ 447
L L L NSL TIP LL FL N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 51/216 (23%), Positives = 77/216 (35%), Gaps = 13/216 (6%)
Query: 380 SEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRL 439
S++ + + +N + LT +P + K+ L L N L TL T L +L
Sbjct: 7 SKVASHLEVN---CDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 440 FLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFS 499
L + + G L TL + + +PL L L D+S N +
Sbjct: 61 NL--DRAELTKLQVDGTLPVLGTLDLSHNQLQS-----LPLLGQTLPALTVLDVSFNRLT 113
Query: 500 NEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF 559
+ L L+ L+L+GN P L +++L L+ NNL+ L L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 560 LAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLC 595
L L L N L GN LC
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 7e-04
Identities = 15/66 (22%), Positives = 22/66 (33%), Gaps = 3/66 (4%)
Query: 505 TLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
+S + ++ + + +LP L K L LS N L L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 565 LSYNHF 570
L
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.001
Identities = 18/75 (24%), Positives = 30/75 (40%), Gaps = 1/75 (1%)
Query: 172 NQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIW 231
N+L P + LE + ++ N L L L +L+ L + EN+ +P +
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFF 192
Query: 232 NISSLEIISLHSNRF 246
L LH N +
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (84), Expect = 0.004
Identities = 11/63 (17%), Positives = 18/63 (28%), Gaps = 4/63 (6%)
Query: 172 NQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCK---LPL 228
N L + L+ + + N IP L + + N + C L
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYF 216
Query: 229 SIW 231
W
Sbjct: 217 RRW 219
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 1e-08
Identities = 13/94 (13%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 487 NLAEFDLSENHFSNE-IPVTLSACTTLEYLHLQGNSFSG----SLPLSLKTLKSIKELDL 541
++ D+ S+ L + + L + + +L+ ++ EL+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 542 SRNNLSGQIPKYLENLLF-----LAYLNLSYNHF 570
N L + L + L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 4e-07
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 484 NLRNLAEFDLSENHFSNE----IPVTLSACTTLEYLHLQGNSFSGSLPLSL-----KTLK 534
L L++ S+ + TL A +L L L N + L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 535 SIKELDLSRNNLSGQIPKYLENLL 558
+++L L S ++ L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 5e-07
Identities = 20/77 (25%), Positives = 28/77 (36%), Gaps = 9/77 (11%)
Query: 509 CTTLEYLHLQGNSFSG----SLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF----- 559
+ L L L S SL +L S++ELDLS N L L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 560 LAYLNLSYNHFEGEVPR 576
L L L ++ E+
Sbjct: 428 LEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 15/67 (22%), Positives = 23/67 (34%), Gaps = 5/67 (7%)
Query: 512 LEYLHLQGNSFSGS-LPLSLKTLKSIKELDLSRNNLSGQ----IPKYLENLLFLAYLNLS 566
++ L +Q S + L L+ + + L L+ I L LA LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 567 YNHFEGE 573
N
Sbjct: 64 SNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 13/92 (14%), Positives = 25/92 (27%), Gaps = 5/92 (5%)
Query: 467 LDLSGNLLGGSIPLEV-GNLRNLAEFDLSENHFSNE----IPVTLSACTTLEYLHLQGNS 521
LD+ L + E+ L+ L + + I L L L+L+ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 522 FSGSLPLSLKTLKSIKELDLSRNNLSGQIPKY 553
+ + + +L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 1e-05
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 3/78 (3%)
Query: 284 NLQVLDVYKNHFS-GQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEML 342
++Q LD+ S + L + L L D+ + L + L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 343 YLNTNKFGGVFLRSIANL 360
L +N+ G V + +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 9/87 (10%)
Query: 457 CQNLMTLSRLLDLSGNLLGG----SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA---- 508
++ R+L L+ + S+ + +L E DLS N + + L
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 509 -CTTLEYLHLQGNSFSGSLPLSLKTLK 534
LE L L +S + L+ L+
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 6/91 (6%)
Query: 303 FNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGG----VFLRSIA 358
S L L+L+ ++ S S L L + L L+ N G + S+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 359 NLSAKITVIGMGDNQISGTIPSEIKNLVNIN 389
+ + + D S + ++ L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 17/92 (18%), Positives = 25/92 (27%), Gaps = 5/92 (5%)
Query: 276 PHSFSNASNLQVLDVYKNHFSGQVKID----FNRLSNLSRLFLSKNNLGTESTSDLDFLT 331
S L+VL + S +L L LS N LG L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VES 420
Query: 332 LLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK 363
+ +E L L + + L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 11/100 (11%), Positives = 33/100 (33%), Gaps = 8/100 (8%)
Query: 308 NLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANL---SAKI 364
++ L + L SD + LL Q +++ L+ + I++ + +
Sbjct: 3 DIQSLDIQCEEL-----SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 365 TVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPH 404
+ + N++ + + + ++ L
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 51.7 bits (123), Expect = 4e-08
Identities = 19/145 (13%), Positives = 41/145 (28%), Gaps = 21/145 (14%)
Query: 54 NMIGQGSFGFVYKGKLGETGTTVAVKVMNL----------KQKGAAKSFVTECEALSNVR 103
++G+G V+ E VK + K+ F +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 104 HRNLIKIITVCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLEAGNLGLIQRLNL-- 161
R L K+ + + A++ E + ++ D++ L + +
Sbjct: 65 FRALQKLQGLA-VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 162 -----LKLEMIDVGDNQLIGKFPDF 181
L + V + + DF
Sbjct: 124 IVHGDLSQYNVLVSEEGI--WIIDF 146
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 8e-08
Identities = 46/277 (16%), Positives = 91/277 (32%), Gaps = 8/277 (2%)
Query: 215 LSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTG- 273
L ++ N P + S +I+ R PL F+ V + + +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 274 SLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN-NLGTESTSDLDFLTL 332
+L S S LQ L + S + + SNL RL LS + L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 333 LTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFG 392
+ + + T K V + ++ ++ + G N + + ++ N+
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 393 VEYNQL-TGTIPHAIGELKNLQGLALVR-NSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450
+ + + +L LQ L+L R + LG + L L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 451 PSSLGNCQNL-MTLSRLLDLSGNLLGGSIPLEVGNLR 486
+L + S ++ +G E+ ++
Sbjct: 242 QLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 38/277 (13%), Positives = 78/277 (28%), Gaps = 17/277 (6%)
Query: 286 QVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLN 345
Q LD+ + V RL + + + F + +++ + L+
Sbjct: 3 QTLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHF-----SPFRVQHMDLS 54
Query: 346 TNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHA 405
+ L I + +K+ + + ++S I + + N+ +
Sbjct: 55 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ 114
Query: 406 IGE-----LKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNL 460
L L + + + +L L +
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174
Query: 461 MTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSE-NHFSNEIPVTLSACTTLEYLHLQG 519
L L +L E L L LS E + L TL+ L + G
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234
Query: 520 NSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLEN 556
G+L L + L L ++ ++ + + N
Sbjct: 235 IVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 11/86 (12%), Positives = 27/86 (31%), Gaps = 3/86 (3%)
Query: 492 DLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSG-QI 550
DL+ + ++ L + + + L + ++ +DLS + + +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTL 63
Query: 551 PKYLENLLFLAYLNLSYNHFEGEVPR 576
L L L+L +
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 3e-06
Identities = 29/110 (26%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG 524
R+L L+ L ++ + L + DLS N P L+A LE L N+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 525 SLPLSLKTLKSIKELDLSRNNL-SGQIPKYLENLLFLAYLNLSYNHFEGE 573
+ L ++EL L N L + L + L LNL N E
Sbjct: 58 --VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 9e-06
Identities = 30/123 (24%), Positives = 41/123 (33%), Gaps = 11/123 (8%)
Query: 439 LFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHF 498
L L +L V L + LDLS N L P + LR L S+N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLV----THLDLSHNRLRALPP-ALAALRCLEVLQASDNAL 55
Query: 499 SNEIPVTLSACTTLEYLHLQGNSF-SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557
N V L+ L L N + L + + L+L N+L E L
Sbjct: 56 ENVDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERL 112
Query: 558 LFL 560
+
Sbjct: 113 AEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 4e-05
Identities = 29/126 (23%), Positives = 45/126 (35%), Gaps = 10/126 (7%)
Query: 415 LALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLL 474
L L L T+ L L L+ L L N L+ P+ L + L L + N+
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 475 GGSIPLEVGNLRNLAEFDLSENHFSN-EIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTL 533
G + + L L N L +C L L+LQGNS + +
Sbjct: 60 GVANLPRLQEL------LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 534 KSIKEL 539
+ + +
Sbjct: 114 EMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 22/127 (17%), Positives = 48/127 (37%), Gaps = 10/127 (7%)
Query: 191 IDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSL 250
+ ++ L + L QL + +L +S N P ++ + LE++ N E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--- 56
Query: 251 PLNIGFNIPNVNFLSVGQNNFTG-SLPHSFSNASNLQVLDVYKNHFSGQVKID---FNRL 306
++ N+P + L + N + + L +L++ N + I L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 307 SNLSRLF 313
++S +
Sbjct: 117 PSVSSIL 123
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 4e-06
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 469 LSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL 528
N I +L E ++S N E+P LE L N + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 320
Query: 529 SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLN 564
+ +++K+L + N L + P E++ L +N
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 4e-05
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 12/88 (13%)
Query: 451 PSSLGNCQNLMTLSRL--LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSA 508
SS L L++S N L +P L L S NH + E+P
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP---EL 322
Query: 509 CTTLEYLHLQGNSFSG--SLPLSLKTLK 534
L+ LH++ N +P S++ L+
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 46/336 (13%), Positives = 92/336 (27%), Gaps = 30/336 (8%)
Query: 188 LEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFE 247
++++ L +P+ L SL S N+ + +LP + L+ + + +N +
Sbjct: 40 AHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQS---LKSLLVDNNNLK 91
Query: 248 GSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLS 307
L V+ + + + + L + I
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 308 NLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVI 367
L T +D + L L + + N
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 368 GMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGL------ALVRNS 421
+ +P ++ L + + + +L ++ GL N+
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 422 LRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLE 481
I L L + N L +P+ + L S N L +P
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER-------LIASFNHL-AEVPEL 322
Query: 482 VGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHL 517
NL+ L + N E P ++E L +
Sbjct: 323 PQNLKQL---HVEYNPLR-EFPDIPE---SVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.001
Identities = 46/325 (14%), Positives = 99/325 (30%), Gaps = 41/325 (12%)
Query: 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNF 222
+ +++ + L P+ + LE++ S N L +P+ L+SL + +
Sbjct: 39 QAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 223 SCKLPLSIWNISSLEIISLHSNRFE--------------------------GSLPLNIGF 256
S PL + S + + N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 257 NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316
+P + L + + L + + + + + L L+ ++
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 317 NNLGTEST-SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQIS 375
N L T + + ++ L + +I + +++ N S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 376 GTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTL 435
I S ++ V N+L +P L+ L N L +P+ NL
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPELPQNLKQ 328
Query: 436 LNRLFLGFNNLQGNVPSSLGNCQNL 460
L+ + +N L+ P + ++L
Sbjct: 329 LH---VEYNPLRE-FPDIPESVEDL 349
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 4e-05
Identities = 27/146 (18%), Positives = 47/146 (32%), Gaps = 12/146 (8%)
Query: 402 IPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLM 461
+ + + + AL LR L + L +++ + N L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68
Query: 462 TLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNS 521
+L+ L + + V NL +LS N +E + LE L L GNS
Sbjct: 69 SLN--LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 522 FSGSLPLS-------LKTLKSIKELD 540
S + + + LD
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 7e-05
Identities = 20/115 (17%), Positives = 43/115 (37%), Gaps = 3/115 (2%)
Query: 452 SSLGNCQNLMTLSRLLDLS-GNLLGGSIPLEVGNLRNLAEFDLSENHFSN--EIPVTLSA 508
L + +L+ + + L+ + + ++ + N+ L +LS N ++ +
Sbjct: 30 KGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
Query: 509 CTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYL 563
L+ L+L GN L ++EL L N+LS + +
Sbjct: 90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 41/216 (18%), Positives = 71/216 (32%), Gaps = 20/216 (9%)
Query: 362 AKITVIGMGDNQISGTIP-SEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRN 420
A I G + ++ T+ +++ + ++AFG + G + L NL GL L N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKDN 73
Query: 421 SLRGT-IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP 479
+ L +T L N+ +L + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 480 LEVGNLRNLAEFDL---------SENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSL 530
L + + L S + L+ + L L N S PL+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA- 192
Query: 531 KTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566
+L ++ E+ L N +S P L N L + L+
Sbjct: 193 -SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 31/221 (14%), Positives = 68/221 (30%), Gaps = 19/221 (8%)
Query: 257 NIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316
+ N ++ G++N T ++ + ++ + L + + + + L+NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGVQY--LNNLIGLELKD 72
Query: 317 NNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISG 376
N + + S + ++ + V +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 377 TIPSEIKNLVNINAFGVE-------YNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDT 429
+ ++ + NI+ + + L L L N + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 430 LGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLS 470
L +L L + L N + P L N NL ++ L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNL----FIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 38/240 (15%), Positives = 74/240 (30%), Gaps = 28/240 (11%)
Query: 178 FPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237
FPD + I + + + + L + LS ++++E
Sbjct: 13 FPD--PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTG-----------VTTIE 57
Query: 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSG 297
+ +N L N ++ + L+ P +A + S
Sbjct: 58 GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117
Query: 298 QVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSI 357
Q+ + L + + S L LT L S + +
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS---- 173
Query: 358 ANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLAL 417
K+T + DN+IS P + +L N+ ++ NQ++ P + NL + L
Sbjct: 174 -----KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 41/336 (12%), Positives = 91/336 (27%), Gaps = 27/336 (8%)
Query: 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGR----IPDSLCQLRSLNY 214
+ L++ + + +++ I +S N +G + +++ + L
Sbjct: 5 IEGKSLKLDAITTED-EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 215 LSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFL---SVGQNNF 271
S + F+ ++ I L + +L ++ L+ P + ++
Sbjct: 64 AEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 272 TGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLD--- 328
L + + + V L + +N L S +
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 329 ---FLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNL 385
L Q + L L + S + +K+
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 386 VNINAFGVEYNQLTGTIPHAIGE------LKNLQGLALVRNSLRGTIPDTL-----GNLT 434
N+ G+ L+ A+ + LQ L L N + TL +
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 435 LLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLS 470
L L L N + + + + +L
Sbjct: 303 DLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 44/348 (12%), Positives = 81/348 (23%), Gaps = 39/348 (11%)
Query: 208 QLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVG 267
+ +SL +I+ + + + S++ I L N
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTI--------------------- 43
Query: 268 QNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGT---EST 324
L + ++ +L++ + L L + L L T
Sbjct: 44 GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103
Query: 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKN 384
+ + L L A + + N+ + P
Sbjct: 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163
Query: 385 LVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDT--LGNLTLLNRLFLG 442
+ N + + L ++ + L L L L
Sbjct: 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 223
Query: 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIP------LEVGNLRNLAEFDLSEN 496
N S+L R L L+ LL L L N
Sbjct: 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 283
Query: 497 HFSNEIPVTLSA-----CTTLEYLHLQGNSFSGSLPLSLKTLKSIKEL 539
+ TL L +L L GN F + ++ +
Sbjct: 284 EIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 37/325 (11%), Positives = 81/325 (24%), Gaps = 28/325 (8%)
Query: 188 LEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCK----LPLSIWNISSLEIISLHS 243
L+ I+ + L + S+ + +S N + L +I + LEI
Sbjct: 10 LKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 244 NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDF 303
+ L + L + + N F +
Sbjct: 69 IFT---------------GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 113
Query: 304 NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAK 363
+ L + ++ + N + N
Sbjct: 114 IDFLSKHTPLEH-LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172
Query: 364 ITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLR 423
++ S + +K + N + L + + +
Sbjct: 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232
Query: 424 GTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL--LDLSGNLLGGSIPLE 481
+ L + L L L L +++ + + + L L L N +
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292
Query: 482 V-----GNLRNLAEFDLSENHFSNE 501
+ + +L +L+ N FS E
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.002
Identities = 13/92 (14%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 486 RNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSG----SLPLSLKTLKSIKELDL 541
++L ++ + L +++ + L GN+ L ++ + K ++ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 542 SRN---NLSGQIPKYLENLLFLAYLNLSYNHF 570
S + +IP+ L LL +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 5/52 (9%)
Query: 527 PLSLKTLKSIKELDLSRNNLSGQIPKYLENLLF-----LAYLNLSYNHFEGE 573
S ++ L L N + + L+ ++ L +L L+ N F E
Sbjct: 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 35/206 (16%), Positives = 68/206 (33%), Gaps = 22/206 (10%)
Query: 377 TIPSEIK------NLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTL 430
T+P+ IK ++ +T + EL ++ + + ++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I 64
Query: 431 GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAE 490
L + +LFL N L P + + L + L L+ +L +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 491 FDLSE----------NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELD 540
D++ +N+I + L S + L L ++ L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLY 184
Query: 541 LSRNNLSGQIPKYLENLLFLAYLNLS 566
LS+N++S + L L L L L
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.003
Identities = 31/229 (13%), Positives = 72/229 (31%), Gaps = 34/229 (14%)
Query: 249 SLPLNIGFNIPNVNF-----LSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDF 303
++P I + F ++ + + T ++ + + +++ + + I +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQY 66
Query: 304 NRLSNLSRLFLSKNNL-GTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSA 362
L N+++LFL+ N L + ++L L L + + S+ +
Sbjct: 67 --LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSL 422
+ Q+ K + + I ++ L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL---------- 174
Query: 423 RGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSG 471
LT L L+L N++ +L +NL +L+L
Sbjct: 175 --------AGLTKLQNLYLSKNHISD--LRALAGLKNL----DVLELFS 209
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 33/166 (19%), Positives = 60/166 (36%), Gaps = 24/166 (14%)
Query: 354 LRSI-ANLSAKITVIGMGDNQISGTIPSEIK-NLVNINAFGVEYNQLTGTIPHAIGELKN 411
L+ I ++ T + + DN++ + L ++ ++ NQLTG P+A +
Sbjct: 20 LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 412 LQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMT--------- 462
+Q L L N ++ L L L L N + +P S + +L +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 463 ----------LSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHF 498
R L+G P +R++ DL + F
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 8e-04
Identities = 27/136 (19%), Positives = 51/136 (37%), Gaps = 6/136 (4%)
Query: 157 QRLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLS 216
Q N ++ +D+ + I + A +AID S N + R D LR L L
Sbjct: 13 QYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 217 ISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT---G 273
++ N + L + L +N L+ ++ ++ +L + +N T
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 274 SLPHSFSNASNLQVLD 289
+ ++VLD
Sbjct: 130 YRLYVIYKVPQVRVLD 145
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 628 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.63 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.62 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.61 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.61 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.6 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.6 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.59 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.59 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.58 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.58 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.57 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.57 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.56 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.56 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.53 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.52 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.52 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.51 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.51 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.5 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.5 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.5 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.5 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.49 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.49 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.47 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.47 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.45 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.45 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.43 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.43 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.43 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.42 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.41 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.41 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.41 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.39 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.38 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.38 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.37 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.37 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.34 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.34 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.34 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.34 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.33 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.33 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.33 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.32 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.32 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.31 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.29 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.29 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.29 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.28 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.27 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.26 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.26 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.16 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.12 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.65 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.63 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.63 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.43 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.88 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.31 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 91.81 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=2.8e-31 Score=263.76 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=225.0
Q ss_pred CceeecccCCcccc--cchHHHhccccccEEEccC-CcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeE
Q 042887 339 MEMLYLNTNKFGGV--FLRSIANLSAKITVIGMGD-NQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGL 415 (628)
Q Consensus 339 L~~L~l~~n~~~~~--~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 415 (628)
++.|+|++|.+++. .+..+..++ +|++|++++ |.+.|.+|..+.++++|++|++++|++.+..+..+..+.+|+.+
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 44455555544442 345555555 677777765 77888889999999999999999999999888889999999999
Q ss_pred ecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcC
Q 042887 416 ALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSE 495 (628)
Q Consensus 416 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 495 (628)
++++|.+.+..|..+..++.++.+++++|.+++.+|..+..+..+. +.+++++|++++..|..+..+.. ..+++++
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~---~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~ 206 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF---TSMTISRNRLTGKIPPTFANLNL-AFVDLSR 206 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC---CEEECCSSEEEEECCGGGGGCCC-SEEECCS
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccc---ccccccccccccccccccccccc-ccccccc
Confidence 9999999999999999999999999999999999999888877763 67899999999999988888755 4799999
Q ss_pred CcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCC
Q 042887 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVP 575 (628)
Q Consensus 496 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p 575 (628)
|...+.+|..+..+++++.+++++|.+.+.+| .+..+++|+.|+|++|++++.+|+.|.++++|++|||++|+|+|.+|
T Consensus 207 ~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp SEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred cccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence 99999999999999999999999999986554 68889999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccCCCCCcccCCCCCCCCCC
Q 042887 576 RKGVFGNRTGIHLIGNERLCGGLEELHLPSCH 607 (628)
Q Consensus 576 ~~~~~~~l~~~~~~~n~~~c~~~~~l~l~~c~ 607 (628)
..+.+.+++.+++.||+.+||. ++|.|.
T Consensus 286 ~~~~L~~L~~l~l~~N~~l~g~----plp~c~ 313 (313)
T d1ogqa_ 286 QGGNLQRFDVSAYANNKCLCGS----PLPACT 313 (313)
T ss_dssp CSTTGGGSCGGGTCSSSEEEST----TSSCCC
T ss_pred CcccCCCCCHHHhCCCccccCC----CCCCCC
Confidence 8888899999999999999985 467784
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3.5e-30 Score=263.89 Aligned_cols=344 Identities=25% Similarity=0.304 Sum_probs=214.4
Q ss_pred cCCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCC
Q 042887 158 RLNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLE 237 (628)
Q Consensus 158 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 237 (628)
...+.+|++|+++++.|+.. +.+..+++|++|++++|+|++.. .|+++++|++|++++|.+++.. .+.++++|+
T Consensus 40 ~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~ 113 (384)
T d2omza2 40 QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLT 113 (384)
T ss_dssp HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCC
T ss_pred HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccc
Confidence 34566788888888887743 35777888888888888887543 3778888888888888877432 377778888
Q ss_pred EEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 238 IISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 238 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
.|++++|.++ .++... ....+.......|.+....+................. ....+...+.........|
T Consensus 114 ~L~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 185 (384)
T d2omza2 114 GLTLFNNQIT-DIDPLK--NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSN 185 (384)
T ss_dssp EEECCSSCCC-CCGGGT--TCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSS
T ss_pred cccccccccc-cccccc--ccccccccccccccccccccccccccccccccccccc-----hhhhhcccccccccccccc
Confidence 8888877776 333322 2556666666666665433322222222222111111 1112333333444444444
Q ss_pred cCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccc
Q 042887 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397 (628)
Q Consensus 318 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 397 (628)
.... ......+++++.+++++| .+++..| +...++|+.+++++|.
T Consensus 186 ~~~~--------~~~~~~l~~~~~l~l~~n-------------------------~i~~~~~--~~~~~~L~~L~l~~n~ 230 (384)
T d2omza2 186 KVSD--------ISVLAKLTNLESLIATNN-------------------------QISDITP--LGILTNLDELSLNGNQ 230 (384)
T ss_dssp CCCC--------CGGGGGCTTCSEEECCSS-------------------------CCCCCGG--GGGCTTCCEEECCSSC
T ss_pred cccc--------ccccccccccceeeccCC-------------------------ccCCCCc--ccccCCCCEEECCCCC
Confidence 3321 122233344444444444 4443322 3445566666777776
Q ss_pred ccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc
Q 042887 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS 477 (628)
Q Consensus 398 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~ 477 (628)
+++. ..+..+++|+.|++++|.+++.. .+..+++|+.|++++|++++.. .+..++.+ +.+++++|.+.+
T Consensus 231 l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l----~~l~~~~n~l~~- 299 (384)
T d2omza2 231 LKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTAL----TNLELNENQLED- 299 (384)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTC----SEEECCSSCCSC-
T ss_pred CCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccc----cccccccccccc-
Confidence 6532 34566677777777777776433 2666777777777777776432 24445555 677778887764
Q ss_pred cchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcc
Q 042887 478 IPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENL 557 (628)
Q Consensus 478 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 557 (628)
...+..++++++|++++|++++.. .+..+++|++|++++|++++ ++ .+.++++|++|++++|++++..| +.++
T Consensus 300 -~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l 372 (384)
T d2omza2 300 -ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANL 372 (384)
T ss_dssp -CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred -ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccC
Confidence 234677788888888888887543 36778888888888888874 33 57888888888888888886554 7888
Q ss_pred cCCCeEeccCC
Q 042887 558 LFLAYLNLSYN 568 (628)
Q Consensus 558 ~~L~~L~ls~N 568 (628)
++|+.|++++|
T Consensus 373 ~~L~~L~L~~N 383 (384)
T d2omza2 373 TRITQLGLNDQ 383 (384)
T ss_dssp TTCSEEECCCE
T ss_pred CCCCEeeCCCC
Confidence 88888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.8e-29 Score=258.53 Aligned_cols=357 Identities=22% Similarity=0.292 Sum_probs=255.9
Q ss_pred EEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccC
Q 042887 167 IDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRF 246 (628)
Q Consensus 167 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l 246 (628)
.+++.+.+++.+.. ..+.+|++|+++++.|+.. +.+..+++|++|+|++|+|++. | .+.++++|++|++++|.+
T Consensus 27 ~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccCH--HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence 35555666654432 4567888888888888743 4577888888888888888853 3 388888888888888888
Q ss_pred cccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCC
Q 042887 247 EGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSD 326 (628)
Q Consensus 247 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 326 (628)
+ .++. + ..+++|+.|++++|.+++..+ ......+..+....|.+.......................+.
T Consensus 101 ~-~i~~-l-~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~------ 169 (384)
T d2omza2 101 A-DITP-L-ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK------ 169 (384)
T ss_dssp C-CCGG-G-TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG------
T ss_pred c-cccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhh------
Confidence 7 4443 2 347777888877777764432 334556666666666665433322222211111111111110
Q ss_pred ccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCC
Q 042887 327 LDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAI 406 (628)
Q Consensus 327 ~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 406 (628)
.+.... .........|.. .....+..+++++.+++++|.+.+..| +
T Consensus 170 -----~~~~~~-------------------------~~~~~~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~ 215 (384)
T d2omza2 170 -----PLANLT-------------------------TLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--L 215 (384)
T ss_dssp -----GGTTCT-------------------------TCCEEECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred -----hhcccc-------------------------cccccccccccc--ccccccccccccceeeccCCccCCCCc--c
Confidence 011111 222223333332 234567788999999999999986644 4
Q ss_pred CCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccC
Q 042887 407 GELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLR 486 (628)
Q Consensus 407 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~ 486 (628)
...++|+.|++++|++++ ++.+..+++|+.|++++|++++..+ +..+++| +.|++++|++.+.. .+..++
T Consensus 216 ~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L----~~L~l~~~~l~~~~--~~~~~~ 285 (384)
T d2omza2 216 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKL----TELKLGANQISNIS--PLAGLT 285 (384)
T ss_dssp GGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC----SEEECCSSCCCCCG--GGTTCT
T ss_pred cccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccC----CEeeccCcccCCCC--cccccc
Confidence 667899999999999984 3468889999999999999986443 7778888 89999999998543 477899
Q ss_pred CCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEecc
Q 042887 487 NLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLS 566 (628)
Q Consensus 487 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls 566 (628)
.++.+++++|.+++ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .+.++++|++|+++
T Consensus 286 ~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 286 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAG 359 (384)
T ss_dssp TCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECC
T ss_pred cccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECC
Confidence 99999999999985 345788999999999999999653 37899999999999999985 34 68999999999999
Q ss_pred CCcCcccCCCCCCCCCCCcccccCC
Q 042887 567 YNHFEGEVPRKGVFGNRTGIHLIGN 591 (628)
Q Consensus 567 ~N~l~~~~p~~~~~~~l~~~~~~~n 591 (628)
+|++++.+| ...+++++.+++++|
T Consensus 360 ~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 360 HNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCcCCCChh-hccCCCCCEeeCCCC
Confidence 999998766 556788899998877
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.7e-29 Score=250.86 Aligned_cols=249 Identities=28% Similarity=0.472 Sum_probs=161.2
Q ss_pred CcccEEEccCCcccc--ccchhhhCCCCCCEEeccc-CcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 162 LKLEMIDVGDNQLIG--KFPDFIANFSALEAIDISA-NMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 162 ~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
.+++.|||++|++.+ .+|++++++++|++|+|++ |++++.+|.+|+++++|++|+|++|++.+..+..+..+.+|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 368889999988887 3677888888888888875 6777777777888888888888888777777777777777777
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCC-CEEEcccccceeecccccccCCCCCEEEccCC
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNL-QVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKN 317 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 317 (628)
+++++|.+.+.+|..+. .+++++.+++++|.+++.+|..+..+.++ +.+++++|++++..+..+..+.
T Consensus 130 l~l~~N~~~~~~p~~l~-~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~---------- 198 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN---------- 198 (313)
T ss_dssp EECCSSEEESCCCGGGG-GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC----------
T ss_pred cccccccccccCchhhc-cCcccceeeccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 77777777666665554 36666666666666666666665555554 5556666665555444443321
Q ss_pred cCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecccc
Q 042887 318 NLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQ 397 (628)
Q Consensus 318 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 397 (628)
...++++++...+.+|..+..+++++.+++++|.
T Consensus 199 ----------------------------------------------~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 232 (313)
T d1ogqa_ 199 ----------------------------------------------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp ----------------------------------------------CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred ----------------------------------------------cccccccccccccccccccccccccccccccccc
Confidence 2233334444444555555666666666666666
Q ss_pred ccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCc
Q 042887 398 LTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473 (628)
Q Consensus 398 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~ 473 (628)
+.+.+| .+..+++|+.|++++|++++.+|..++++++|++|+|++|+++|.+|. ++.+++| +.+++++|+
T Consensus 233 l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L----~~l~l~~N~ 302 (313)
T d1ogqa_ 233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF----DVSAYANNK 302 (313)
T ss_dssp ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGS----CGGGTCSSS
T ss_pred cccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCC----CHHHhCCCc
Confidence 664433 456666677777777777666666666667777777776666665553 3444444 445555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=8.7e-27 Score=230.20 Aligned_cols=266 Identities=23% Similarity=0.266 Sum_probs=120.1
Q ss_pred CCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEcc
Q 042887 236 LEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLS 315 (628)
Q Consensus 236 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 315 (628)
++++|-+++.++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|++++|.+..+.+..|..+++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l---~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCC---CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 344444444454 445443 2445555555555554444455556666666666666655555556666666666666
Q ss_pred CCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecc
Q 042887 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395 (628)
Q Consensus 316 ~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 395 (628)
+|+++.++... ...++.|++..|.+....... +.....+..++...
T Consensus 88 ~n~l~~l~~~~---------~~~l~~L~~~~n~l~~l~~~~-------------------------~~~~~~~~~l~~~~ 133 (305)
T d1xkua_ 88 KNQLKELPEKM---------PKTLQELRVHENEITKVRKSV-------------------------FNGLNQMIVVELGT 133 (305)
T ss_dssp SSCCSBCCSSC---------CTTCCEEECCSSCCCBBCHHH-------------------------HTTCTTCCEEECCS
T ss_pred CCccCcCccch---------hhhhhhhhccccchhhhhhhh-------------------------hhcccccccccccc
Confidence 66555432210 123344444444433332222 22222333333333
Q ss_pred cccc--ccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCc
Q 042887 396 NQLT--GTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNL 473 (628)
Q Consensus 396 n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~ 473 (628)
|... ...+..+..+++|+.+++++|.+.. .|..+ .++|+.|++++|.+.+..+..+.+++.+ +.|++++|.
T Consensus 134 n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l----~~L~~s~n~ 206 (305)
T d1xkua_ 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL----AKLGLSFNS 206 (305)
T ss_dssp SCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTC----CEEECCSSC
T ss_pred ccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccc----ccccccccc
Confidence 3211 1222334444555555555555442 22211 2444444554444444444444444443 444444444
Q ss_pred CccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCcc------ccCCCCCCEEECCCCccc
Q 042887 474 LGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLS------LKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 474 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------~~~l~~L~~L~Ls~N~l~ 547 (628)
+.+..+..+.++++|++|+|++|+++ .+|..+..+++|++|+|++|+|+...... ...+.+|+.|+|++|+++
T Consensus 207 l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 44444444444445555555555444 23344444455555555555444322212 223344555555555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=2.5e-26 Score=226.94 Aligned_cols=246 Identities=20% Similarity=0.292 Sum_probs=179.9
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
..+.+|=++++++. +|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCc-cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 46778888888884 455553 689999999999987767789999999999999999997778889999999999999
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccce--eecccccccCCCCCEEEccCCcCC
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFS--GQVKIDFNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~n~l~ 320 (628)
+|+++ .+|... .+.++.|++.+|.+....+..+.....+..++...|... ...+..|..+++|+.+++++|.+.
T Consensus 88 ~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 88 KNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp SSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 99998 777654 567888888888888777777778888888888877543 233456777788888888888765
Q ss_pred CcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccc
Q 042887 321 TESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTG 400 (628)
Q Consensus 321 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 400 (628)
.++.. .++ +++.|++++|...+..+..+.+++.++.|++++|.+.+
T Consensus 164 ~l~~~---------~~~-------------------------~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~ 209 (305)
T d1xkua_ 164 TIPQG---------LPP-------------------------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209 (305)
T ss_dssp SCCSS---------CCT-------------------------TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred ccCcc---------cCC-------------------------ccCEEECCCCcCCCCChhHhhccccccccccccccccc
Confidence 43221 012 34455555555555556666667777777777777776
Q ss_pred cCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccccccc
Q 042887 401 TIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNV 450 (628)
Q Consensus 401 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 450 (628)
..+.++.++++|++|+|++|+++ .+|.+|..+++|++|++++|+|+...
T Consensus 210 ~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~ 258 (305)
T d1xkua_ 210 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 258 (305)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred cccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccC
Confidence 66666777777777777777776 34566777777777777777776433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.6e-26 Score=224.05 Aligned_cols=231 Identities=24% Similarity=0.222 Sum_probs=193.5
Q ss_pred ccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecc-cCccccccCccccCCCCCCeEe
Q 042887 362 AKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALV-RNSLRGTIPDTLGNLTLLNRLF 440 (628)
Q Consensus 362 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~ 440 (628)
.++++|++++|+++...+..|.++++|++|++++|++....+..+..+..++.++.. .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 367788888888887777788999999999999999988888888888888888765 5677777788889999999999
Q ss_pred cCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCc
Q 042887 441 LGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGN 520 (628)
Q Consensus 441 L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 520 (628)
+++|.+....+..+....+| +.+++++|++++..+..|..+++|++|++++|++++..+..|.++++|+++++++|
T Consensus 112 l~~n~~~~~~~~~~~~~~~L----~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N 187 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAAL----QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTC----CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cCCcccccccccccchhccc----chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhc
Confidence 99999887777778888887 78899999998777788888999999999999999888888999999999999999
Q ss_pred eeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCCcc
Q 042887 521 SFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 521 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~ 596 (628)
++++..|..|..+++|++||+++|++++..++.|..+++|++|++++|++.+..+.......++......+...|.
T Consensus 188 ~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred cccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 9998889999999999999999999998888899999999999999999988766433333344444455556664
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.7e-25 Score=216.81 Aligned_cols=224 Identities=21% Similarity=0.226 Sum_probs=141.7
Q ss_pred EEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeec-c
Q 042887 166 MIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHS-N 244 (628)
Q Consensus 166 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~-n 244 (628)
.++.++++++ .+|..+. +.+++|+|++|+|+.+.+.+|.++++|++|++++|.+....+..+..+..++.++... |
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4456666666 4454332 4567777777777766666777777777777777777766666666666777666543 3
Q ss_pred cCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCC
Q 042887 245 RFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTEST 324 (628)
Q Consensus 245 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 324 (628)
.++ .++...+.++++|++|++++|.+....+..+...++|+.+++++|+++++.+..|..+++|++|++++|++
T Consensus 92 ~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l----- 165 (284)
T d1ozna_ 92 QLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI----- 165 (284)
T ss_dssp TCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-----
T ss_pred ccc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcc-----
Confidence 333 44444444455555555555555544444455555555555555555544444444444444444444433
Q ss_pred CCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCc
Q 042887 325 SDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPH 404 (628)
Q Consensus 325 ~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 404 (628)
.+..+..|.++++|+.+++++|++.+..|.
T Consensus 166 --------------------------------------------------~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~ 195 (284)
T d1ozna_ 166 --------------------------------------------------SSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (284)
T ss_dssp --------------------------------------------------CEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred --------------------------------------------------cccchhhhccccccchhhhhhccccccChh
Confidence 334445666777777777777777777777
Q ss_pred CCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccccc
Q 042887 405 AIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448 (628)
Q Consensus 405 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 448 (628)
.|..+++|++|++++|.+.+..+..|..+++|++|++++|++..
T Consensus 196 ~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 78888888888888888887777778888888888888887764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.6e-24 Score=206.35 Aligned_cols=200 Identities=24% Similarity=0.229 Sum_probs=135.9
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
.+..++.+++.++. +|..+. +++++|++++|+|++..+.+|..+++|++|+|++|+++.. | .+..+++|++|+++
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence 34556777777763 454442 4567777777777766666677777777777777777643 2 34567777777777
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
+|+++ ..+..+.++++| +.|++++|.+....+..+..+.++++|++++|.++...+..+..++.|+.|++++|++
T Consensus 86 ~N~l~-~~~~~~~~l~~L----~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPAL----TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp SSCCS-SCCCCTTTCTTC----CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccc-cccccccccccc----ccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 77776 345566666666 6677777777766666667777777777777777766666666677777777777777
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCccc
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGE 573 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 573 (628)
++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++...
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 7666666777777777777777777 5566666677777777777776543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.9e-23 Score=201.17 Aligned_cols=200 Identities=20% Similarity=0.195 Sum_probs=153.2
Q ss_pred CCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeE
Q 042887 336 CSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGL 415 (628)
Q Consensus 336 ~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 415 (628)
...+.+++.+++.++.+ |.. ++.+++.|++++|++++..+..|.++++|++|++++|+|+.. + .++.+++|++|
T Consensus 9 ~~~~~~v~C~~~~L~~i-P~~---lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLTAL-PPD---LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL 82 (266)
T ss_dssp STTCCEEECTTSCCSSC-CSC---CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred cCCCeEEEccCCCCCee-CcC---cCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence 34555667777777754 222 334788888888888877777788888888888888888743 2 35678888888
Q ss_pred ecccCccccccCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcC
Q 042887 416 ALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSE 495 (628)
Q Consensus 416 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 495 (628)
++++|++++ .+..+..+++|+.|++++|.+.+..+..+..+.++ +.|++++|.+....+..+..+++|+.|++++
T Consensus 83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l----~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~ 157 (266)
T d1p9ag_ 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL----QELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (266)
T ss_dssp ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC----CEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred ccccccccc-cccccccccccccccccccccceeecccccccccc----ccccccccccceeccccccccccchhccccc
Confidence 888888874 46677788888888888888877777777777777 7788888888877677777788888888888
Q ss_pred CcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCccc
Q 042887 496 NHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLS 547 (628)
Q Consensus 496 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (628)
|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 158 N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 8888777777888888888888888887 67777777888888888888776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=6.8e-21 Score=191.54 Aligned_cols=137 Identities=22% Similarity=0.328 Sum_probs=77.6
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEee
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLH 242 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 242 (628)
++++|||++|.++. +|+ ..++|++|+|++|+|+ .+|+. +.+|+.|++++|.++ .+++. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCC---CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 56777888777763 554 2456777777777776 44544 346777777777766 23321 1346777777
Q ss_pred cccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCC
Q 042887 243 SNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 243 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 320 (628)
+|.++ .+|.. ..+++|+.|++++|.+... +. ....+..+.+.++... ....+..++.++.+++++|...
T Consensus 107 ~n~l~-~lp~~--~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLPEL--QNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCCCC--TTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccch--hhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence 77766 55542 2366666666666665522 11 2344555555544432 2233445555555655555443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.4e-23 Score=219.51 Aligned_cols=387 Identities=16% Similarity=0.144 Sum_probs=214.9
Q ss_pred cccEEEccCCcccccc-chhhhCCCCCCEEecccCcCccc----ccccccCCCCCCEeecccccCcccC----CcCcc-C
Q 042887 163 KLEMIDVGDNQLIGKF-PDFIANFSALEAIDISANMLGGR----IPDSLCQLRSLNYLSISENNFSCKL----PLSIW-N 232 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~----p~~~~-~ 232 (628)
+|+.||++.|++++.. .+.+..+++++.|+|++|.++.. ++..+..+++|++|||++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788899998887643 34466778888888888887732 2445667888888888888876321 22222 2
Q ss_pred CCCCCEEEeecccCcccCChh---hhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCC
Q 042887 233 ISSLEIISLHSNRFEGSLPLN---IGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNL 309 (628)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 309 (628)
..+|++|+|++|.+++..-.. ....+++|++|++++|.++......+... ........
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~-------------------l~~~~~~~ 143 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG-------------------LLDPQCRL 143 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH-------------------HTSTTCCC
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhc-------------------cccccccc
Confidence 346777777777775321111 11234555555555555543211111100 00001111
Q ss_pred CEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccch----HHHhccccccEEEccCCcceee----Cchh
Q 042887 310 SRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLR----SIANLSAKITVIGMGDNQISGT----IPSE 381 (628)
Q Consensus 310 ~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~----~~~~~~~~L~~L~l~~n~l~~~----~~~~ 381 (628)
.........+.... .......+.....++.++++.+........ .+.........+++..+.+... ....
T Consensus 144 ~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 221 (460)
T d1z7xw1 144 EKLQLEYCSLSAAS--CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 221 (460)
T ss_dssp CEEECTTSCCBGGG--HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ccccccccccchhh--hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccc
Confidence 22222222111100 001111222333444455544443322111 1122222344555555544311 1123
Q ss_pred hhccCCcCeeeeccccccc-----cCCcCCCCCCCCCeEecccCccccc----cCccccCCCCCCeEecCCcccccccCC
Q 042887 382 IKNLVNINAFGVEYNQLTG-----TIPHAIGELKNLQGLALVRNSLRGT----IPDTLGNLTLLNRLFLGFNNLQGNVPS 452 (628)
Q Consensus 382 l~~l~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~ 452 (628)
+...+.++.+++++|.+.. ..+........++.+++++|.+... ....+...+.++.+++++|.++.....
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~ 301 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4456677777777776542 1223344567788888888877632 223345677888888888888643322
Q ss_pred ccc-----CCcchhcccceEEcCCCcCccccchh----hhccCCCCEeeCcCCcCcccC----Ccccc-CCCCCCeEECc
Q 042887 453 SLG-----NCQNLMTLSRLLDLSGNLLGGSIPLE----VGNLRNLAEFDLSENHFSNEI----PVTLS-ACTTLEYLHLQ 518 (628)
Q Consensus 453 ~~~-----~l~~L~~l~~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~Ls 518 (628)
.+. ....| +.+++++|.++...... +...++|++|+|++|++++.. +..+. ..+.|++|+|+
T Consensus 302 ~l~~~l~~~~~~L----~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls 377 (460)
T d1z7xw1 302 LLCETLLEPGCQL----ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 377 (460)
T ss_dssp HHHHHHTSTTCCC----CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred hhhcccccccccc----ccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECC
Confidence 221 12234 77888888887554333 344568999999999887532 22232 35678999999
Q ss_pred Cceeeee----cCccccCCCCCCEEECCCCcccccCchhhh-----cccCCCeEeccCCcCcccC
Q 042887 519 GNSFSGS----LPLSLKTLKSIKELDLSRNNLSGQIPKYLE-----NLLFLAYLNLSYNHFEGEV 574 (628)
Q Consensus 519 ~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~ls~N~l~~~~ 574 (628)
+|.|+.. ++..+...++|++|||++|+|+......+. +...|+.|++++|.+..+.
T Consensus 378 ~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 378 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp TSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred CCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHH
Confidence 9988742 344566778899999999988754443332 2336888999988887543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=4.1e-19 Score=178.32 Aligned_cols=139 Identities=22% Similarity=0.313 Sum_probs=105.0
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEe
Q 042887 186 SALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLS 265 (628)
Q Consensus 186 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~ 265 (628)
.++++|||++|.++ .+|+. .++|++|+|++|+|+ .+|+.+ .+|++|++++|+++ .++. -.+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LPPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CCTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hcccccccc
Confidence 47899999999998 56753 578999999999999 677654 57999999999998 6653 135799999
Q ss_pred cccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecc
Q 042887 266 VGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLN 345 (628)
Q Consensus 266 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~ 345 (628)
+++|.++. +| .++.+++|++|++++|.+..... ....+..+.+..+..... ..+..++.++.++++
T Consensus 105 L~~n~l~~-lp-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~--------~~l~~l~~l~~L~l~ 170 (353)
T d1jl5a_ 105 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEEL--------PELQNLPFLTAIYAD 170 (353)
T ss_dssp CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC--------CCCTTCTTCCEEECC
T ss_pred cccccccc-cc-chhhhccceeecccccccccccc----ccccccchhhcccccccc--------ccccccccceecccc
Confidence 99999984 45 36789999999999998864432 246677888877665431 234556677778887
Q ss_pred cCCccc
Q 042887 346 TNKFGG 351 (628)
Q Consensus 346 ~n~~~~ 351 (628)
.|....
T Consensus 171 ~n~~~~ 176 (353)
T d1jl5a_ 171 NNSLKK 176 (353)
T ss_dssp SSCCSS
T ss_pred cccccc
Confidence 776543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=4.2e-22 Score=208.12 Aligned_cols=379 Identities=16% Similarity=0.156 Sum_probs=211.2
Q ss_pred CCcCcccEEEccCCcccc----ccchhhhCCCCCCEEecccCcCcccc----ccccc-CCCCCCEeecccccCccc----
Q 042887 159 LNLLKLEMIDVGDNQLIG----KFPDFIANFSALEAIDISANMLGGRI----PDSLC-QLRSLNYLSISENNFSCK---- 225 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~-~l~~L~~L~Ls~N~i~~~---- 225 (628)
..++++++|+|++|.++. .++..+..+++|++|||++|.|+... ...+. ...+|++|+|++|++++.
T Consensus 24 ~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~ 103 (460)
T d1z7xw1 24 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103 (460)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred HhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccc
Confidence 356889999999999874 33566789999999999999986432 22333 235799999999999753
Q ss_pred CCcCccCCCCCCEEEeecccCcccCChhhhh----CCCCCcEEecccCcccccc----cccccCCCCCCEEEccccccee
Q 042887 226 LPLSIWNISSLEIISLHSNRFEGSLPLNIGF----NIPNVNFLSVGQNNFTGSL----PHSFSNASNLQVLDVYKNHFSG 297 (628)
Q Consensus 226 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~~ 297 (628)
++..+..+++|++|++++|.+.......+.. ..............+.... ...+.....++.++++++.+..
T Consensus 104 l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~ 183 (460)
T d1z7xw1 104 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 183 (460)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred ccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccc
Confidence 3566788999999999999987322222211 1222334444444333111 1223455677777777766542
Q ss_pred ecccc----c-ccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCC
Q 042887 298 QVKID----F-NRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDN 372 (628)
Q Consensus 298 ~~~~~----~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n 372 (628)
..... + ........+++..+.+...... .....+...+.++.+++..|.+........
T Consensus 184 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~--~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~--------------- 246 (460)
T d1z7xw1 184 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--DLCGIVASKASLRELALGSNKLGDVGMAEL--------------- 246 (460)
T ss_dssp HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHH---------------
T ss_pred ccccccccccccccccccccccccccccchhhh--cccccccccccccccchhhccccccccchh---------------
Confidence 21111 1 1123455666666654331110 112233344556666666665433211110
Q ss_pred cceeeCchhhhccCCcCeeeecccccccc----CCcCCCCCCCCCeEecccCccccccCccc-----cCCCCCCeEecCC
Q 042887 373 QISGTIPSEIKNLVNINAFGVEYNQLTGT----IPHAIGELKNLQGLALVRNSLRGTIPDTL-----GNLTLLNRLFLGF 443 (628)
Q Consensus 373 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~ 443 (628)
..........++.+++++|.+... ....+...+.++.+++++|.++......+ .....|+.+++++
T Consensus 247 -----~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 247 -----CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp -----HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred -----hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 111222334455555555544321 11122334555666666665543211111 1234566666666
Q ss_pred cccccccCCccc----CCcchhcccceEEcCCCcCcccc----chhhh-ccCCCCEeeCcCCcCccc----CCccccCCC
Q 042887 444 NNLQGNVPSSLG----NCQNLMTLSRLLDLSGNLLGGSI----PLEVG-NLRNLAEFDLSENHFSNE----IPVTLSACT 510 (628)
Q Consensus 444 N~l~~~~~~~~~----~l~~L~~l~~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~ 510 (628)
|.++......+. ..++| +.|+|++|++++.. +..+. ..+.|++|+|++|++++. ++..+..++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L----~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 397 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFL----LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 397 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSC----CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred cchhhhhhhhcccccccccch----hhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCC
Confidence 666543322222 22334 67777777776432 22222 346688888888888743 234456678
Q ss_pred CCCeEECcCceeeeecCcc----cc-CCCCCCEEECCCCcccccCchhh----hcccCCCeE
Q 042887 511 TLEYLHLQGNSFSGSLPLS----LK-TLKSIKELDLSRNNLSGQIPKYL----ENLLFLAYL 563 (628)
Q Consensus 511 ~L~~L~Ls~N~l~~~~~~~----~~-~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L 563 (628)
+|++|+|++|+|+...... +. +...|+.|++++|.+.....+.+ ...++|+.|
T Consensus 398 ~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 398 SLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp CCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred CCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 8888888888887533222 22 33479999999998875555444 234555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.7e-19 Score=168.52 Aligned_cols=105 Identities=19% Similarity=0.214 Sum_probs=51.4
Q ss_pred CEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEeccc
Q 042887 189 EAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQ 268 (628)
Q Consensus 189 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 268 (628)
+.++.+++.++ .+|..+. +++++|++++|.|+...+.+|.++++|++|++++|.+...++...+..+++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45555555555 3343332 34556666666655444445555556666666655554344444444444555444432
Q ss_pred -CcccccccccccCCCCCCEEEcccccce
Q 042887 269 -NNFTGSLPHSFSNASNLQVLDVYKNHFS 296 (628)
Q Consensus 269 -N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 296 (628)
|++....+..|.++++|+++++++|++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 3444444444444444444444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.9e-18 Score=161.71 Aligned_cols=185 Identities=22% Similarity=0.306 Sum_probs=125.4
Q ss_pred cccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecC
Q 042887 363 KITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLG 442 (628)
Q Consensus 363 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 442 (628)
+++.|++.+|.++.. +.+..+++|+.|++++|++.+.. .+..+++++.+++++|.++. + ..+..+++|+.++++
T Consensus 42 ~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECT
T ss_pred CcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cccccccccccccccccccc-c-ccccccccccccccc
Confidence 667777777777643 35777788888888888776543 36777788888888877763 2 346777788888887
Q ss_pred CcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCcee
Q 042887 443 FNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSF 522 (628)
Q Consensus 443 ~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 522 (628)
++...+.. .+...+.+ +.+.++++.+... ..+.+.++|++|++++|.+.+. ..+.++++|++|++++|++
T Consensus 116 ~~~~~~~~--~~~~~~~~----~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 116 STQITDVT--PLAGLSNL----QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp TSCCCCCG--GGTTCTTC----CEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred cccccccc--hhccccch----hhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 77765322 23344444 6677777777532 3356677788888888777633 2367777888888888877
Q ss_pred eeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccC
Q 042887 523 SGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSY 567 (628)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~ 567 (628)
++ ++ .+.++++|++|+|++|++++..| +.++++|+.|++++
T Consensus 186 ~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 186 SD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred CC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 74 33 36777788888888888775432 67777788877763
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=9.9e-19 Score=165.53 Aligned_cols=153 Identities=14% Similarity=0.123 Sum_probs=98.6
Q ss_pred cEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCccc-CCcCccCCCCCCEEEeec
Q 042887 165 EMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCK-LPLSIWNISSLEIISLHS 243 (628)
Q Consensus 165 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~L~~ 243 (628)
+.++.++++++ .+|+.+ .+++++||+++|+++.+.+.+|.++++|++|++++|.+... .+.+|.++++++++++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56777777777 455433 24678888888888766666788888888888888877653 345677788888887764
Q ss_pred -ccCcccCChhhhhCCCCCcEEecccCcccccccc-cccCCCCCCEEEcccccceeecccccccCC-CCCEEEccCCcCC
Q 042887 244 -NRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPH-SFSNASNLQVLDVYKNHFSGQVKIDFNRLS-NLSRLFLSKNNLG 320 (628)
Q Consensus 244 -n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~n~l~ 320 (628)
|.+. .++...+.++++|+++++++|++....+. .+..++.++.+...++.+..+.+..|.+++ .++.|++++|+++
T Consensus 88 ~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 5565 55555556688888888888877643222 233445555555566666655555555443 4555555555554
Q ss_pred C
Q 042887 321 T 321 (628)
Q Consensus 321 ~ 321 (628)
.
T Consensus 167 ~ 167 (242)
T d1xwdc1 167 E 167 (242)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=1.1e-18 Score=158.40 Aligned_cols=174 Identities=22% Similarity=0.227 Sum_probs=124.6
Q ss_pred CeEecccCccccccCccccCCCCCCeEecCCccccc-ccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEe
Q 042887 413 QGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG-NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEF 491 (628)
Q Consensus 413 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L 491 (628)
++++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++| +.|++++|.+....+..|..+++|++|
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L----~~L~L~~N~i~~~~~~~~~~~~~L~~L 83 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHL----VKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTC----CEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceE----eeeecccccccccccccccccccccee
Confidence 45666666666 3444432 567777777777764 334556667777 777888888877777788888888888
Q ss_pred eCcCCcCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCc
Q 042887 492 DLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFE 571 (628)
Q Consensus 492 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 571 (628)
+|++|+++...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++...... ..-...++.+.+..|.++
T Consensus 84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~ 162 (192)
T d1w8aa_ 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAAR 162 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCB
T ss_pred eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeE
Confidence 8888888877778888888888888888888877788888888899999998888743322 111234566777888887
Q ss_pred ccCCCCCCCCCCCcccccCCCCCcc
Q 042887 572 GEVPRKGVFGNRTGIHLIGNERLCG 596 (628)
Q Consensus 572 ~~~p~~~~~~~l~~~~~~~n~~~c~ 596 (628)
...|.. +..++..++..|...|.
T Consensus 163 c~~p~~--l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 163 CGAPSK--VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp BCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred eCCChh--hcCCEeeecCHhhCcCC
Confidence 766643 45566677777777774
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.2e-18 Score=161.23 Aligned_cols=141 Identities=17% Similarity=0.258 Sum_probs=65.6
Q ss_pred EEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccC
Q 042887 167 IDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRF 246 (628)
Q Consensus 167 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l 246 (628)
++++.+++++.. .+..+.+|+.|++++|+|+.. +.+..+++|++|++++|.+++.. .+..+++|+++++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cccccccccccccccccc
Confidence 344444444322 233444555555555555422 23455555555555555554322 245555555555555554
Q ss_pred cccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCcCC
Q 042887 247 EGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNNLG 320 (628)
Q Consensus 247 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 320 (628)
+ .++. + .++++|+.++++++...+. ..+...+.++.+.++.+.+... ..+...++|++|++++|.+.
T Consensus 98 ~-~i~~-l-~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 98 K-NVSA-I-AGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp S-CCGG-G-TTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred c-cccc-c-ccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence 4 3332 1 1355555555555544422 2244445555555555555432 22444555555555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.9e-18 Score=155.87 Aligned_cols=179 Identities=26% Similarity=0.327 Sum_probs=126.7
Q ss_pred ccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccccc
Q 042887 369 MGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448 (628)
Q Consensus 369 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 448 (628)
++.+.+.+.++ ...+.+|+.|++++|.+.+. ..+..+++|++|++++|++++.. .+..+++|++|++++|++++
T Consensus 31 l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 31 LKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred hCcCccCCccC--HHHhcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc
Confidence 34444443332 23456777778888777643 23667788888888888887533 35677888888888888874
Q ss_pred ccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCc
Q 042887 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL 528 (628)
Q Consensus 449 ~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 528 (628)
++ .+.++++| +.|++++|.+.. ...+..++.++.+++++|.+++ +..+..+++|+++++++|++++. +
T Consensus 105 -l~-~l~~l~~L----~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~- 172 (210)
T d1h6ta2 105 -LS-SLKDLKKL----KSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V- 172 (210)
T ss_dssp -GG-GGTTCTTC----CEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-
T ss_pred -cc-cccccccc----cccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-
Confidence 33 46666666 778888887763 2357778888888888888874 34566788888888888888743 3
Q ss_pred cccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccC
Q 042887 529 SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSY 567 (628)
Q Consensus 529 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~ 567 (628)
.+.++++|++|+|++|+|+. ++ .+.++++|++|++++
T Consensus 173 ~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 37788888888888888874 34 578888888888864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=8e-19 Score=159.36 Aligned_cols=155 Identities=23% Similarity=0.250 Sum_probs=131.0
Q ss_pred CCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCcc-ccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCe
Q 042887 436 LNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGG-SIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEY 514 (628)
Q Consensus 436 L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 514 (628)
.+.++.++++++ .+|..+. +++ ++|+|++|+|+. ..+..|.++++|++|+|++|++....+..+..+++|++
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l----~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHT----TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTC----SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCC----CEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce
Confidence 457899999998 6676553 345 889999999985 44667899999999999999999999999999999999
Q ss_pred EECcCceeeeecCccccCCCCCCEEECCCCcccccCchhhhcccCCCeEeccCCcCcccCCCCCCCCCCCcccccCCCCC
Q 042887 515 LHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYLNLSYNHFEGEVPRKGVFGNRTGIHLIGNERL 594 (628)
Q Consensus 515 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~ 594 (628)
|+|++|+|++..|.+|.++++|++|+|++|+|++..++.|..+++|++|+|++|++.+..+.......+....+.++...
T Consensus 83 L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~ 162 (192)
T d1w8aa_ 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAAR 162 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCB
T ss_pred eeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeE
Confidence 99999999988899999999999999999999999999999999999999999999876554332233455566666666
Q ss_pred ccc
Q 042887 595 CGG 597 (628)
Q Consensus 595 c~~ 597 (628)
|..
T Consensus 163 c~~ 165 (192)
T d1w8aa_ 163 CGA 165 (192)
T ss_dssp BCS
T ss_pred eCC
Confidence 754
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=8.6e-18 Score=154.74 Aligned_cols=167 Identities=23% Similarity=0.340 Sum_probs=134.4
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
..+.+|+.|++++|.++... .+..+++|++|++++|.+++.. .++.+++|++|++++|++++ +| .+..+++|+.
T Consensus 43 ~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~ 116 (210)
T d1h6ta2 43 NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (210)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccc
Confidence 34678899999999988543 3788999999999999998643 47889999999999999984 44 5888999999
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
|++++|.+. .++. + ..+++++.+++++|.+++ +..+..+++|+++++++|+++++. .+..+++|++|++++|+
T Consensus 117 L~l~~~~~~-~~~~-l-~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 117 LSLEHNGIS-DING-L-VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp EECTTSCCC-CCGG-G-GGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred ccccccccc-cccc-c-cccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCC
Confidence 999999887 5543 3 358999999999999874 345778899999999999998654 37889999999999998
Q ss_pred CCCcCCCCccccccccCCCCCceeeccc
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEMLYLNT 346 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L~l~~ 346 (628)
++++ ..+..+++|+.|++++
T Consensus 190 i~~l--------~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 190 ISDL--------RALAGLKNLDVLELFS 209 (210)
T ss_dssp CCBC--------GGGTTCTTCSEEEEEE
T ss_pred CCCC--------hhhcCCCCCCEEEccC
Confidence 8653 2467778888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.6e-17 Score=151.56 Aligned_cols=175 Identities=28% Similarity=0.399 Sum_probs=114.2
Q ss_pred ccCCcceeeCchhhhccCCcCeeeeccccccccCCcCCCCCCCCCeEecccCccccccCccccCCCCCCeEecCCccccc
Q 042887 369 MGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAIGELKNLQGLALVRNSLRGTIPDTLGNLTLLNRLFLGFNNLQG 448 (628)
Q Consensus 369 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 448 (628)
++.+.+++..+ ...+.+++.|++++|.+... +.+..+++|++|++++|++++..| +.++++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc
Confidence 44444443322 34566777777777777643 346667777777777777775432 6777777777777777653
Q ss_pred ccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCCCCCeEECcCceeeeecCc
Q 042887 449 NVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACTTLEYLHLQGNSFSGSLPL 528 (628)
Q Consensus 449 ~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 528 (628)
. + .+.++++| +.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|++|++++|++++. +
T Consensus 99 ~-~-~l~~l~~L----~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~- 166 (199)
T d2omxa2 99 I-T-PLANLTNL----TGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K- 166 (199)
T ss_dssp C-G-GGTTCTTC----SEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-
T ss_pred c-c-cccccccc----ccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-
Confidence 2 2 35566666 6777777776632 346667777778887777763 2 3466777777888877777643 2
Q ss_pred cccCCCCCCEEECCCCcccccCchhhhcccCCCeE
Q 042887 529 SLKTLKSIKELDLSRNNLSGQIPKYLENLLFLAYL 563 (628)
Q Consensus 529 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 563 (628)
.+.++++|++|++++|++++ ++ .+.++++|++|
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 36777778888888877774 22 46677777664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.3e-17 Score=150.56 Aligned_cols=163 Identities=22% Similarity=0.307 Sum_probs=122.4
Q ss_pred CCcCcccEEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCE
Q 042887 159 LNLLKLEMIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEI 238 (628)
Q Consensus 159 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 238 (628)
..+.+++.|++++|+++.. +.+..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .+.++++|++
T Consensus 37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccc
Confidence 3567788899999888753 347788899999999998885443 8888899999999888873 33 4788888999
Q ss_pred EEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccCCc
Q 042887 239 ISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSKNN 318 (628)
Q Consensus 239 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~ 318 (628)
|++++|.+. .++. +..+++|+.|++++|++... ..+..+++|+.|++++|++++.. .+.++++|++|++++|+
T Consensus 111 L~l~~~~~~-~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 111 LTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNK 183 (199)
T ss_dssp EECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred ccccccccc-cccc--cchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCC
Confidence 999888876 3332 33588888888888888743 35778888888888888887653 37788888888888888
Q ss_pred CCCcCCCCccccccccCCCCCcee
Q 042887 319 LGTESTSDLDFLTLLTNCSQMEML 342 (628)
Q Consensus 319 l~~~~~~~~~~~~~l~~~~~L~~L 342 (628)
+++++ .+..+++|+.|
T Consensus 184 i~~i~--------~l~~L~~L~~L 199 (199)
T d2omxa2 184 VSDIS--------VLAKLTNLESL 199 (199)
T ss_dssp CCCCG--------GGGGCTTCSEE
T ss_pred CCCCc--------cccCCCCCCcC
Confidence 86532 24455666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=2.4e-16 Score=137.74 Aligned_cols=127 Identities=13% Similarity=0.177 Sum_probs=65.9
Q ss_pred hCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCc
Q 042887 183 ANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVN 262 (628)
Q Consensus 183 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~ 262 (628)
.+..++++|||++|+|+. ++..+..+++|++|+|++|.|+. ++ .|..+++|++|++++|+++ .+|..++..+++|+
T Consensus 15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT 90 (162)
T ss_dssp ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred cCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhccccccc-CCCccccccccccc
Confidence 344455555555555552 23444455555555555555553 22 3555555555555555555 44444444455555
Q ss_pred EEecccCccccccc-ccccCCCCCCEEEcccccceeecc---cccccCCCCCEEE
Q 042887 263 FLSVGQNNFTGSLP-HSFSNASNLQVLDVYKNHFSGQVK---IDFNRLSNLSRLF 313 (628)
Q Consensus 263 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~ 313 (628)
.|++++|+++.... ..+..+++|++|++++|.++.... ..+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555553221 345566666666666666543321 2345556666655
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.1e-16 Score=152.24 Aligned_cols=98 Identities=22% Similarity=0.373 Sum_probs=86.2
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+.|++.+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|+++|++++|||||++++++. +....|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEE
Confidence 356899999999999999999999999999999998766666788999999999999999999999965 478899
Q ss_pred eeecccccCCchhhhhccccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
+|||||++|+|.+++.+....++
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~ 108 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLT 108 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCC
T ss_pred EEEecCCCCcHHHHHHhcCCCCC
Confidence 99999999999998866544443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.7e-16 Score=150.82 Aligned_cols=183 Identities=17% Similarity=0.121 Sum_probs=88.8
Q ss_pred CCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCcccccccccccCCCCCCEEEcccc-cceeec-ccccccCCCCC
Q 042887 233 ISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLPHSFSNASNLQVLDVYKN-HFSGQV-KIDFNRLSNLS 310 (628)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~-~~~~~~l~~L~ 310 (628)
..+|++||++++.+++.....++..+++|++|+++++.+++..+..++.+++|++|+++++ .++... ...+..+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 3455555555555543323333444566666666666655555555666666666666664 343221 11123466677
Q ss_pred EEEccCCc-CCCcCCCCccccccc-cCCCCCceeecccC--CcccccchHHHhccccccEEEccCCcceeeCchhhhccC
Q 042887 311 RLFLSKNN-LGTESTSDLDFLTLL-TNCSQMEMLYLNTN--KFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLV 386 (628)
Q Consensus 311 ~L~L~~n~-l~~~~~~~~~~~~~l-~~~~~L~~L~l~~n--~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~ 386 (628)
+|+++++. +++. .....+ ..++.|+.|+++++ .++......+ ..+++
T Consensus 125 ~L~ls~c~~~~~~-----~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l------------------------~~~~~ 175 (284)
T d2astb2 125 ELNLSWCFDFTEK-----HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL------------------------VRRCP 175 (284)
T ss_dssp EEECCCCTTCCHH-----HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHH------------------------HHHCT
T ss_pred ccccccccccccc-----cchhhhcccccccchhhhccccccccccccccc------------------------ccccc
Confidence 77766642 2210 000111 12245555555543 1222111111 23345
Q ss_pred CcCeeeeccc-cccccCCcCCCCCCCCCeEecccC-ccccccCccccCCCCCCeEecCCc
Q 042887 387 NINAFGVEYN-QLTGTIPHAIGELKNLQGLALVRN-SLRGTIPDTLGNLTLLNRLFLGFN 444 (628)
Q Consensus 387 ~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N 444 (628)
+|+.|++++| .+++.....+..+++|++|++++| .+++.....+..+++|+.|+++++
T Consensus 176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 5555555553 244444444555566666666653 454444445555666666666554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.6e-16 Score=150.81 Aligned_cols=92 Identities=25% Similarity=0.357 Sum_probs=82.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+++|++++|||||++++++. +.+..|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEE
Confidence 357999999999999999999999999999999998765555678999999999999999999999954 478899
Q ss_pred eeecccccCCchhhhhc
Q 042887 127 LIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~ 143 (628)
+|||||++|+|.+++.+
T Consensus 94 ivmEy~~gg~L~~~~~~ 110 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE 110 (293)
T ss_dssp EEEECCTTCBHHHHHHH
T ss_pred EEEEecCCCcHHHHhhc
Confidence 99999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=2.8e-16 Score=149.83 Aligned_cols=93 Identities=20% Similarity=0.295 Sum_probs=79.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|++++|||||++++++. +....
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 357999999999999999999999999999999997653 334567999999999999999999999954 47889
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
|+|||||++|+|.+++...
T Consensus 79 ~ivmEy~~gg~L~~~l~~~ 97 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPD 97 (271)
T ss_dssp EEEEECCTTEEGGGGSBTT
T ss_pred EEEEeccCCCcHHHHHhcC
Confidence 9999999999999998653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.2e-15 Score=133.14 Aligned_cols=127 Identities=19% Similarity=0.070 Sum_probs=66.1
Q ss_pred cCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCccccCCC
Q 042887 431 GNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVTLSACT 510 (628)
Q Consensus 431 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 510 (628)
.++..+++|+|++|+|+. ++..+..+++| +.|+|++|+|+.. +.+..+++|++|++++|+++...+..+..++
T Consensus 15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L----~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPV-IENLGATLDQF----DAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp ECTTSCEEEECTTSCCCS-CCCGGGGTTCC----SEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred cCcCcCcEEECCCCCCCc-cCccccccccC----CEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccc
Confidence 344444444554444442 23333334444 4455555555422 1345555666666666666544444445566
Q ss_pred CCCeEECcCceeeeecC-ccccCCCCCCEEECCCCcccccC---chhhhcccCCCeEe
Q 042887 511 TLEYLHLQGNSFSGSLP-LSLKTLKSIKELDLSRNNLSGQI---PKYLENLLFLAYLN 564 (628)
Q Consensus 511 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~ 564 (628)
+|+.|++++|+++.... ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 66666666666653211 34556666666666666665322 12456666666665
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.60 E-value=1.3e-16 Score=153.84 Aligned_cols=102 Identities=24% Similarity=0.470 Sum_probs=87.7
Q ss_pred cccHHHHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeee
Q 042887 37 MVSYADLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSS 116 (628)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 116 (628)
...+++|+...++|++.+.||+|+||.||+|++..+|+.||||+++.... ..++|.+|+.+|++++|||||++++++.
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~- 83 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT- 83 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEe-
Confidence 33455666677889999999999999999999998999999999875433 4567999999999999999999999964
Q ss_pred ccccccceeeeeecccccCCchhhhhcc
Q 042887 117 IDFKGVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+.+..|+|||||++|++.+++.+.
T Consensus 84 ----~~~~~~iv~E~~~~g~l~~~l~~~ 107 (287)
T d1opja_ 84 ----REPPFYIITEFMTYGNLLDYLREC 107 (287)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHS
T ss_pred ----eCCeeEEEeecccCcchHHHhhhc
Confidence 477889999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.59 E-value=4.7e-16 Score=154.06 Aligned_cols=99 Identities=20% Similarity=0.368 Sum_probs=87.0
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++. +....|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 468999999999999999999999999999999998766556678999999999999999999999954 478999
Q ss_pred eeecccccCCchhhhhcccccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEA 150 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~ 150 (628)
+|||||+||+|.+++.+....+++
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e 123 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSE 123 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCH
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCH
Confidence 999999999999999765544443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=3.9e-16 Score=148.93 Aligned_cols=95 Identities=17% Similarity=0.311 Sum_probs=80.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||.||+|+++.+|+.||+|.++... +...+.+.+|+++|++++|||||++++++.+ +....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 367999999999999999999999999999999997643 3345678999999999999999999998753 33567
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||++|+|.+++.+.
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~ 99 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKG 99 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHH
T ss_pred EEEEEecCCCCcHHHHHHhc
Confidence 89999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.59 E-value=5.4e-16 Score=153.70 Aligned_cols=99 Identities=19% Similarity=0.269 Sum_probs=86.5
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.+.|++.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.+|++++|||||++++++ ++....|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 45799999999999999999999999999999999876555567889999999999999999999994 4588999
Q ss_pred eeecccccCCchhhhhcccccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLEA 150 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~ 150 (628)
+|||||+||+|.+++......+++
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e 126 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSE 126 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCH
T ss_pred EEEEcCCCChHHHHHHhcCCCCCH
Confidence 999999999999888766544443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.3e-15 Score=124.84 Aligned_cols=77 Identities=23% Similarity=0.393 Sum_probs=40.2
Q ss_pred EEEccCCccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeeccc
Q 042887 166 MIDVGDNQLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNR 245 (628)
Q Consensus 166 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~ 245 (628)
+|||++|+++.. + .+..+++|++|++++|.++ .+|..|+.+++|++|++++|.|+. +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 455555555522 2 2555555555555555555 334455555555555555555552 22 25555555555555555
Q ss_pred Cc
Q 042887 246 FE 247 (628)
Q Consensus 246 l~ 247 (628)
++
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.59 E-value=1.5e-16 Score=158.81 Aligned_cols=249 Identities=16% Similarity=0.191 Sum_probs=127.2
Q ss_pred ccccccCCCCCCEEEcccccceeeccc----ccccCCCCCEEEccCCcCCCcCCCCc----cccccccCCCCCceeeccc
Q 042887 275 LPHSFSNASNLQVLDVYKNHFSGQVKI----DFNRLSNLSRLFLSKNNLGTESTSDL----DFLTLLTNCSQMEMLYLNT 346 (628)
Q Consensus 275 ~~~~~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~~----~~~~~l~~~~~L~~L~l~~ 346 (628)
+...+....+|++|+|++|.++..... .+...++|+.++++++.......... .....+..+++|+.|++++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 345567788899999998887543322 34556788888887775543221110 1122334445555555555
Q ss_pred CCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeeccccccccCCcCC-------------CCCCCCC
Q 042887 347 NKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEYNQLTGTIPHAI-------------GELKNLQ 413 (628)
Q Consensus 347 n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~-------------~~l~~L~ 413 (628)
|.++......+. ..+...++|+.|++++|.+.......+ ...+.|+
T Consensus 103 n~i~~~~~~~l~---------------------~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~ 161 (344)
T d2ca6a1 103 NAFGPTAQEPLI---------------------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 161 (344)
T ss_dssp CCCCTTTHHHHH---------------------HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred cccccccccchh---------------------hhhcccccchheecccccccccccccccccccccccccccccCcccc
Confidence 554433222222 234455667777777776542111111 1233444
Q ss_pred eEecccCccccc----cCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccc-----cchhhhc
Q 042887 414 GLALVRNSLRGT----IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGS-----IPLEVGN 484 (628)
Q Consensus 414 ~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~-----~~~~~~~ 484 (628)
.+++++|.++.. +...+...+.| +.|++++|+++.. +...+..
T Consensus 162 ~l~l~~n~i~~~~~~~l~~~l~~~~~L----------------------------~~L~L~~n~i~~~g~~~~l~~~l~~ 213 (344)
T d2ca6a1 162 SIICGRNRLENGSMKEWAKTFQSHRLL----------------------------HTVKMVQNGIRPEGIEHLLLEGLAY 213 (344)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTC----------------------------CEEECCSSCCCHHHHHHHHHTTGGG
T ss_pred eeecccccccccccccccchhhhhhhh----------------------------cccccccccccccccccchhhhhcc
Confidence 555554444321 11122233344 4455555554421 1223445
Q ss_pred cCCCCEeeCcCCcCccc----CCccccCCCCCCeEECcCceeeeecCc----ccc--CCCCCCEEECCCCcccccC----
Q 042887 485 LRNLAEFDLSENHFSNE----IPVTLSACTTLEYLHLQGNSFSGSLPL----SLK--TLKSIKELDLSRNNLSGQI---- 550 (628)
Q Consensus 485 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~--~l~~L~~L~Ls~N~l~~~~---- 550 (628)
.++|+.|++++|.++.. +...+..+++|++|+|++|.|++.... .+. ..+.|++|++++|+|+...
T Consensus 214 ~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l 293 (344)
T d2ca6a1 214 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293 (344)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHH
T ss_pred hhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHH
Confidence 56666666666665432 223445566666666666666543222 222 2345777777777765322
Q ss_pred chhhh-cccCCCeEeccCCcCcc
Q 042887 551 PKYLE-NLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 551 ~~~~~-~l~~L~~L~ls~N~l~~ 572 (628)
...+. +.++|+.|++++|++..
T Consensus 294 ~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 294 KTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHccCCCCCEEECCCCcCCC
Confidence 22232 45667777777777653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=3.7e-15 Score=123.54 Aligned_cols=118 Identities=19% Similarity=0.276 Sum_probs=98.7
Q ss_pred CEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEeccc
Q 042887 189 EAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQ 268 (628)
Q Consensus 189 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 268 (628)
|+|||++|+++ .++ .+..+++|++|++++|.|+ .+|..++.+++|++|++++|.++ .+|. + ..+++|++|++++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~-~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-V-ANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-G-TTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-c-ccccccCeEECCC
Confidence 68999999998 444 4899999999999999998 57888999999999999999998 6664 3 4699999999999
Q ss_pred Ccccccc-cccccCCCCCCEEEcccccceeec---ccccccCCCCCEE
Q 042887 269 NNFTGSL-PHSFSNASNLQVLDVYKNHFSGQV---KIDFNRLSNLSRL 312 (628)
Q Consensus 269 N~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~l~~L~~L 312 (628)
|+++... ...++.+++|++|++++|+++... ......+|+|+.|
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 9999654 357899999999999999997542 3334567888776
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=8e-16 Score=150.76 Aligned_cols=97 Identities=19% Similarity=0.290 Sum_probs=84.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|+++.... ....+.+|+++|+.++|||||++++++ ++....|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 5789999999999999999999999999999999976543 335688999999999999999999994 4578999
Q ss_pred eeecccccCCchhhhhccccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
+|||||+||+|.+++.+....++
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~ 100 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELN 100 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCC
T ss_pred EEEecCCCCcHHHHHHhcCCCCC
Confidence 99999999999999976654444
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=9.1e-16 Score=148.76 Aligned_cols=93 Identities=22% Similarity=0.338 Sum_probs=81.6
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc------cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ------KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.+.|++.+.||+|+||+||+|++..+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++ +
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 357999999999999999999999999999999997542 12346799999999999999999999995 4
Q ss_pred ccceeeeeecccccCCchhhhhcc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
+....|+|||||++|+|.+++...
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~ 107 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEK 107 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH
T ss_pred ECCEEEEEEEcCCCccccchhccc
Confidence 578999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1e-15 Score=145.40 Aligned_cols=93 Identities=25% Similarity=0.387 Sum_probs=81.7
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. ....+.+.+|+++|++++|||||++++++. +...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 57999999999999999999999999999999997532 334567899999999999999999999954 4788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||++|+|.+++....
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~ 101 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS 101 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS
T ss_pred EEEEEeecCCCcHHHHHhhcC
Confidence 999999999999999987543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.57 E-value=6.7e-16 Score=153.90 Aligned_cols=260 Identities=18% Similarity=0.218 Sum_probs=162.8
Q ss_pred CChhhhhCCCCCcEEecccCccccc----ccccccCCCCCCEEEcccccceeec----------ccccccCCCCCEEEcc
Q 042887 250 LPLNIGFNIPNVNFLSVGQNNFTGS----LPHSFSNASNLQVLDVYKNHFSGQV----------KIDFNRLSNLSRLFLS 315 (628)
Q Consensus 250 ~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~----------~~~~~~l~~L~~L~L~ 315 (628)
+...+. ...+|+.|+|++|.+... +...+...++|+.|+++++...... ...+...++|++|+++
T Consensus 23 l~~~L~-~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 23 VFAVLL-EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TSHHHH-HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHh-hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 333443 488999999999998753 3345678899999999987653221 1234567899999999
Q ss_pred CCcCCCcCCCCccccccccCCCCCceeecccCCcccccchHHHhccccccEEEccCCcceeeCchhhhccCCcCeeeecc
Q 042887 316 KNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFGGVFLRSIANLSAKITVIGMGDNQISGTIPSEIKNLVNINAFGVEY 395 (628)
Q Consensus 316 ~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 395 (628)
+|.++..... .....+..+++|+.|++++|.++......++.. +..+ .........+.|+.+.+++
T Consensus 102 ~n~i~~~~~~--~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~---l~~~---------~~~~~~~~~~~L~~l~l~~ 167 (344)
T d2ca6a1 102 DNAFGPTAQE--PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA---LQEL---------AVNKKAKNAPPLRSIICGR 167 (344)
T ss_dssp SCCCCTTTHH--HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH---HHHH---------HHHHHHHTCCCCCEEECCS
T ss_pred cccccccccc--chhhhhcccccchheeccccccccccccccccc---cccc---------ccccccccCcccceeeccc
Confidence 9988763222 233455677899999999998765443333321 1000 0112235667899999999
Q ss_pred ccccccC----CcCCCCCCCCCeEecccCccccc-----cCccccCCCCCCeEecCCcccccccCCcccCCcchhcccce
Q 042887 396 NQLTGTI----PHAIGELKNLQGLALVRNSLRGT-----IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRL 466 (628)
Q Consensus 396 n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~ 466 (628)
|.+.... ...+...+.|+.|++++|.++.. +...+..+++|+.|++++|.++.....
T Consensus 168 n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~-------------- 233 (344)
T d2ca6a1 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS-------------- 233 (344)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH--------------
T ss_pred ccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc--------------
Confidence 9886432 23345678999999999998742 223455566677777766665422111
Q ss_pred EEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCcc----cc--CCCCCCeEECcCceeeee----cCcccc-CCCC
Q 042887 467 LDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVT----LS--ACTTLEYLHLQGNSFSGS----LPLSLK-TLKS 535 (628)
Q Consensus 467 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~--~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~ 535 (628)
.+...+...++|++|++++|.+++..... +. ..+.|++|++++|.|+.. +...+. +.++
T Consensus 234 ----------~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~ 303 (344)
T d2ca6a1 234 ----------ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303 (344)
T ss_dssp ----------HHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred ----------cccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCC
Confidence 11223444556666666666665432222 22 235677888888877632 222332 4678
Q ss_pred CCEEECCCCcccc
Q 042887 536 IKELDLSRNNLSG 548 (628)
Q Consensus 536 L~~L~Ls~N~l~~ 548 (628)
|+.|+|++|++..
T Consensus 304 L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 304 LLFLELNGNRFSE 316 (344)
T ss_dssp CCEEECTTSBSCT
T ss_pred CCEEECCCCcCCC
Confidence 8888888888863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=9.2e-16 Score=147.62 Aligned_cols=93 Identities=17% Similarity=0.290 Sum_probs=81.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|++..+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++ ++...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 56999999999999999999999999999999997532 33456799999999999999999999995 45788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||++|+|.+++...+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~ 103 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG 103 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS
T ss_pred EEEEEEccCCCCHHHhhhccC
Confidence 999999999999999886543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=8.8e-16 Score=149.34 Aligned_cols=94 Identities=20% Similarity=0.307 Sum_probs=77.8
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
..+.|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++ ++.+.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3467999999999999999999999999999999997643 23345688999999999999999999994 45788
Q ss_pred eeeeecccccCCchhhhhcc
Q 042887 125 KALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~ 144 (628)
.|+|||||+||+|.+++...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~ 101 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK 101 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC
T ss_pred EEEEEeccCCCcHHHhhhcc
Confidence 99999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=9.1e-16 Score=150.73 Aligned_cols=94 Identities=17% Similarity=0.271 Sum_probs=82.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||+||+|++..+|+.||+|+++... ....+++.+|+.+|++++|||||++++++. +....
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 467999999999999999999999999999999997643 344567899999999999999999999954 47889
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
|+|||||++|+|.+++.+..
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~ 99 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG 99 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS
T ss_pred EEEEEcCCCCcHHHHHhhcC
Confidence 99999999999999987543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=7.2e-15 Score=141.60 Aligned_cols=59 Identities=27% Similarity=0.223 Sum_probs=30.0
Q ss_pred CCCCcEEecccCccccc-ccccccCCCCCCEEEcccccceeecccccccCCCCCEEEccC
Q 042887 258 IPNVNFLSVGQNNFTGS-LPHSFSNASNLQVLDVYKNHFSGQVKIDFNRLSNLSRLFLSK 316 (628)
Q Consensus 258 l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 316 (628)
..+|++|+++++.++.. .+..+..+++|++|+++++.+++.....+..+++|++|++++
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 44555555555555432 223344555555555555555444444445555555555554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.53 E-value=4.6e-15 Score=141.90 Aligned_cols=93 Identities=22% Similarity=0.365 Sum_probs=81.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc---------chhhhHHHHHHHHhhcC-CCCcccccceeeec
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK---------GAAKSFVTECEALSNVR-HRNLIKIITVCSSI 117 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 117 (628)
++|++.+.||+|+||+||+|++..+|+.||||++++... ...+++.+|+.+|++++ |||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 689999999999999999999999999999999976431 12346889999999997 99999999995
Q ss_pred cccccceeeeeecccccCCchhhhhccc
Q 042887 118 DFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.+.+..|+|||||++|+|.+++....
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~~~ 105 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTEKV 105 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred --ccCcceEEEEEcCCCchHHHHHHhcC
Confidence 45889999999999999999997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=7.8e-15 Score=138.80 Aligned_cols=95 Identities=23% Similarity=0.455 Sum_probs=81.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|++.+.||+|+||.||+|+++ +++.||||.++.... ..+.|.+|+.++++++|||||++++++. +....++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEE
Confidence 57999999999999999999994 778999999986543 3467999999999999999999999965 3678999
Q ss_pred eecccccCCchhhhhccccccc
Q 042887 128 IYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~~~~~ 149 (628)
||||+++|++.+++.......+
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~ 98 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQ 98 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCC
T ss_pred EEEccCCCcHHHhhhccccCCc
Confidence 9999999999999776655443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=7.8e-15 Score=139.70 Aligned_cols=94 Identities=29% Similarity=0.411 Sum_probs=78.8
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
|++.+.||+|+||+||+|++..+++.||+|.+.... ....+.+.+|+++|++++|||||++++++.+. .......|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEE
Confidence 356678999999999999999999999999987542 34456799999999999999999999986541 233567899
Q ss_pred eecccccCCchhhhhcc
Q 042887 128 IYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~ 144 (628)
|||||++|+|.+++.+.
T Consensus 90 vmE~~~~g~L~~~l~~~ 106 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF 106 (270)
T ss_dssp EEECCCSCBHHHHHHHH
T ss_pred EEeCCCCCcHHHHHhcc
Confidence 99999999999998654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.2e-15 Score=145.48 Aligned_cols=94 Identities=26% Similarity=0.339 Sum_probs=83.1
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||+|++++. .....+.+.+|+.+|++++|||||++++++ ++..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 46799999999999999999999999999999999764 233457789999999999999999999994 5588
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|||||++|+|.+++.+.+
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~ 100 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER 100 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS
T ss_pred ccccceeccCCCchhhhhhccc
Confidence 9999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=7.8e-15 Score=139.56 Aligned_cols=94 Identities=23% Similarity=0.461 Sum_probs=80.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|++.+.||+|+||.||+|++. +++.||||+++.... ..+.|.+|++++++++|||||++++++.+ .+..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence 57899999999999999999985 577899999976433 34679999999999999999999999653 678899
Q ss_pred eecccccCCchhhhhcccccc
Q 042887 128 IYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~~~~ 148 (628)
|||||++|+|.+++.......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~ 98 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLF 98 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCC
T ss_pred EEEecCCCcHHHHhhccccCC
Confidence 999999999999987655443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=6.2e-15 Score=143.30 Aligned_cols=91 Identities=26% Similarity=0.296 Sum_probs=78.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
+.|+..+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+ ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 35899999999999999999999999999999997643 2344678999999999999999999999654 788
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.|+|||||++|++..+...
T Consensus 90 ~~iv~E~~~~g~l~~~~~~ 108 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVH 108 (309)
T ss_dssp EEEEEECCSEEHHHHHHHH
T ss_pred EEEEEEecCCCchHHHHHh
Confidence 9999999999998766543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.50 E-value=7.8e-15 Score=143.16 Aligned_cols=93 Identities=23% Similarity=0.287 Sum_probs=81.8
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|+++.+|+.||||++++. .....+.+.+|+.+|+.++|||||++++++ .+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 5799999999999999999999999999999999753 234457789999999999999999999995 45889
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||+||++.+++....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~ 99 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ 99 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS
T ss_pred eeeEeeecCCccccccccccc
Confidence 999999999999988886554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=4.4e-15 Score=142.03 Aligned_cols=98 Identities=28% Similarity=0.425 Sum_probs=80.5
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
|+...++|++.+.||+|+||.||+|++. ..||||+++.. .....+.|.+|+++|++++|||||++++++.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~----- 74 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST----- 74 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----
Confidence 3445678999999999999999999873 35999999754 3445678999999999999999999998854
Q ss_pred ccceeeeeecccccCCchhhhhccccccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
....++|||||++|+|.+++......++
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~ 102 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIETKFE 102 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSCCCCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhccCCCC
Confidence 3567999999999999999976554443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=4.9e-15 Score=141.69 Aligned_cols=95 Identities=24% Similarity=0.441 Sum_probs=79.2
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
|+.+.++|++.+.||+|+||.||+|++. +++.||||+++.... ..+.|.+|+++|++++|||||++++++. .
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~ 79 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------Q 79 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec------c
Confidence 3445678999999999999999999984 678899999976433 3467999999999999999999999864 3
Q ss_pred ceeeeeecccccCCchhhhhccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+..|+|||||++|+|.+++....
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~ 102 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPS 102 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH
T ss_pred CCeEEEEEeCCCCcHHHHHhhcC
Confidence 45789999999999998775443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.49 E-value=8e-15 Score=142.09 Aligned_cols=98 Identities=24% Similarity=0.440 Sum_probs=79.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCc---EEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGT---TVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
.+.|++.+.||+|+||.||+|++..+|+ .||||.+... .....+.|.+|+.+|++++|||||++++++. ..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 3567888999999999999999977665 5889988654 3345577999999999999999999999964 36
Q ss_pred ceeeeeecccccCCchhhhhccccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
...++|||||++|+|.+++......++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~ 126 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFT 126 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSC
T ss_pred CEEEEEEEecCCCcceeeeccccCCCC
Confidence 789999999999999998876554443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.2e-14 Score=139.56 Aligned_cols=97 Identities=20% Similarity=0.421 Sum_probs=77.5
Q ss_pred hCCCCcCce-eecCCceeEEEEEECCC--CcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 47 TNNFSASNM-IGQGSFGFVYKGKLGET--GTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 47 ~~~~~~~~~-iG~G~~g~V~~~~~~~~--~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+++|.+.+. ||+|+||.||+|.++.+ +..||||+++... ....++|.+|+++|++++|||||++++++. .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~ 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec------c
Confidence 456777774 99999999999988643 4579999997643 445678999999999999999999999864 2
Q ss_pred ceeeeeecccccCCchhhhhccccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
+..|+|||||++|+|.+++......++
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~ 107 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIP 107 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSC
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCC
Confidence 457999999999999999866554443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.6e-14 Score=141.17 Aligned_cols=93 Identities=20% Similarity=0.335 Sum_probs=79.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHh-hcCCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALS-NVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.+.||+|+||+||+|++..+|+.||||++++.. ....+.+.+|+.++. .++|||||++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 67999999999999999999999999999999997542 334456778887765 67999999999995 4578
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|||||++|+|.+++....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~ 98 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH 98 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS
T ss_pred ceeEEEeecCCCcHHHHhhccC
Confidence 8999999999999999987544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.47 E-value=2.1e-14 Score=137.89 Aligned_cols=98 Identities=15% Similarity=0.219 Sum_probs=81.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 123 (628)
.++|++.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+.+|+.++|||||++++++... .....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCc
Confidence 467999999999999999999999999999999997542 33456799999999999999999999987541 11234
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|||||+||+|.+++...+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~ 106 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG 106 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC
T ss_pred eEEEEEECCCCCEehhhhcccC
Confidence 6899999999999998876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=7.5e-15 Score=139.16 Aligned_cols=92 Identities=28% Similarity=0.486 Sum_probs=76.7
Q ss_pred HhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 46 ATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..++|++.+.||+|+||.||+|++ .|+.||||+++... ..+.|.+|++++++++|||||++++++. +.....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~ 76 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL 76 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcE
Confidence 456788999999999999999999 57899999996533 4577999999999999999999999874 234667
Q ss_pred eeeecccccCCchhhhhccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~ 145 (628)
|+||||+++|++.+++.+..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~ 96 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRG 96 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHH
T ss_pred EEEEeccCCCCHHHHHHhcC
Confidence 99999999999999997543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.45 E-value=1.8e-15 Score=136.95 Aligned_cols=144 Identities=22% Similarity=0.236 Sum_probs=98.8
Q ss_pred cccEEEccCC--ccccccchhhhCCCCCCEEecccCcCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEE
Q 042887 163 KLEMIDVGDN--QLIGKFPDFIANFSALEAIDISANMLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIIS 240 (628)
Q Consensus 163 ~L~~L~Ls~n--~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 240 (628)
..+.++++++ .+. .++.++..+++|++|+|++|+|+.+ + .+..+++|++|+|++|.|+ .+|..+..+++|++|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccccc
Confidence 3455666654 232 4567788888888888888888743 3 5788888888888888887 4555555566788888
Q ss_pred eecccCcccCChhhhhCCCCCcEEecccCccccccc-ccccCCCCCCEEEcccccceeecccc----------cccCCCC
Q 042887 241 LHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFTGSLP-HSFSNASNLQVLDVYKNHFSGQVKID----------FNRLSNL 309 (628)
Q Consensus 241 L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~----------~~~l~~L 309 (628)
+++|.++ .++. +. .+++|+.|++++|+++.... ..++.+++|+.|++++|.+....+.. +..+++|
T Consensus 100 l~~N~i~-~l~~-~~-~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L 176 (198)
T d1m9la_ 100 ISYNQIA-SLSG-IE-KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176 (198)
T ss_dssp CSEEECC-CHHH-HH-HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred ccccccc-cccc-cc-ccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence 8888887 4432 32 47788888888888875432 45777888888888888775443322 3445666
Q ss_pred CEEE
Q 042887 310 SRLF 313 (628)
Q Consensus 310 ~~L~ 313 (628)
+.||
T Consensus 177 ~~LD 180 (198)
T d1m9la_ 177 KKLD 180 (198)
T ss_dssp CEES
T ss_pred CEeC
Confidence 6655
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2e-14 Score=137.92 Aligned_cols=95 Identities=25% Similarity=0.442 Sum_probs=79.1
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
+|....++|++.+.||+|+||.||+|++.. ++.||||+++.... ..+.|.+|+.+|++++|||||++++++.
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~------ 82 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------ 82 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe------
Confidence 334446789999999999999999999964 46799999975433 3477999999999999999999999864
Q ss_pred cceeeeeecccccCCchhhhhcc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~ 144 (628)
.+..++|||||++|++..++...
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~ 105 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGE 105 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHH
T ss_pred cCCeEEEEEecCCCchhhhhhhc
Confidence 34578999999999998887654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=3.9e-14 Score=137.47 Aligned_cols=97 Identities=25% Similarity=0.434 Sum_probs=77.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++. +....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 68999999999999999999999999999999996543 234578999999999999999999999954 47889
Q ss_pred eeeecccccCCchhhhhccccccc
Q 042887 126 ALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
|+|||||.++.+..........++
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~ 100 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIP 100 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCC
T ss_pred eEEEeecCCchhhhhhhhcccCCC
Confidence 999999987644433333333333
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=5.1e-14 Score=137.25 Aligned_cols=93 Identities=29% Similarity=0.539 Sum_probs=77.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcE--EEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTT--VAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVD 123 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~--~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 123 (628)
++|++.++||+|+||.||+|++..+|.. ||||.++.. .....+.|.+|+++|+++ +|||||++++++.+ .+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 5788999999999999999999888764 677887543 344567899999999999 69999999999754 78
Q ss_pred eeeeeecccccCCchhhhhccc
Q 042887 124 FKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
..|+|||||++|+|.+++....
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~ 106 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSR 106 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTC
T ss_pred eeEEEEEecCCCcHHHHHhhcc
Confidence 8999999999999999997653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=3.3e-14 Score=139.63 Aligned_cols=102 Identities=21% Similarity=0.417 Sum_probs=82.1
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCCc-----EEEEEEeecc-ccchhhhHHHHHHHHhhc-CCCCcccccceee
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETGT-----TVAVKVMNLK-QKGAAKSFVTECEALSNV-RHRNLIKIITVCS 115 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~-----~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 115 (628)
|+.++++|++.+.||+|+||.||+|++..+++ .||+|.+... .......+.+|+.+|.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 44566789999999999999999999865543 6999998654 334556799999999998 7999999999954
Q ss_pred eccccccceeeeeecccccCCchhhhhccccccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
.....|+|||||++|+|.+++........
T Consensus 112 -----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~ 140 (325)
T d1rjba_ 112 -----LSGPIYLIFEYCCYGDLLNYLRSKREKFS 140 (325)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHTTTTCC-
T ss_pred -----eCCeEEEEEEcCCCCcHHHHHHhccCCCc
Confidence 47789999999999999999987765443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=2.3e-14 Score=137.25 Aligned_cols=98 Identities=20% Similarity=0.302 Sum_probs=79.9
Q ss_pred HHhCCCCcCceeecCCceeEEEEEECCCC---cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccc
Q 042887 45 KATNNFSASNMIGQGSFGFVYKGKLGETG---TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
..+++|++.+.||+|+||.||+|++..++ ..||||.++... ....+.|.+|+.+|++++|||||++++++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----
Confidence 44678999999999999999999986543 458899886543 344567999999999999999999999863
Q ss_pred ccceeeeeecccccCCchhhhhcccccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
.+..|+|||||++|++.+++......+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l 105 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSL 105 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTS
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCC
Confidence 356899999999999999876655443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.5e-13 Score=118.89 Aligned_cols=107 Identities=16% Similarity=0.097 Sum_probs=86.4
Q ss_pred cccEEEccCCccccccchhhhCCCCCCEEecccC-cCcccccccccCCCCCCEeecccccCcccCCcCccCCCCCCEEEe
Q 042887 163 KLEMIDVGDNQLIGKFPDFIANFSALEAIDISAN-MLGGRIPDSLCQLRSLNYLSISENNFSCKLPLSIWNISSLEIISL 241 (628)
Q Consensus 163 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 241 (628)
..+.++.+++++. ..|..+..+++|++|++++| .++.+.+++|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3456788888877 45677888888999999765 488777788888999999999999988777888888899999999
Q ss_pred ecccCcccCChhhhhCCCCCcEEecccCccc
Q 042887 242 HSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT 272 (628)
Q Consensus 242 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 272 (628)
++|+++ .+|..++. ..+|+.|+|++|.+.
T Consensus 88 s~N~l~-~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALE-SLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCS-CCCSTTTC-SCCCCEEECCSSCCC
T ss_pred cCCCCc-ccChhhhc-cccccccccCCCccc
Confidence 999988 78877775 446888888888775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.42 E-value=6.8e-14 Score=138.38 Aligned_cols=93 Identities=23% Similarity=0.303 Sum_probs=81.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
++|++.+.||+|+||.||+|+++.+|+.||||++++.. ....+.+.+|+.+|+.++|||||++++++ .....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 57999999999999999999999999999999997532 33456789999999999999999999985 45788
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.++||||+.+|++.+++.+..
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~ 136 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG 136 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC
T ss_pred cccccccccccchhhhHhhcC
Confidence 999999999999999886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=4.5e-14 Score=137.19 Aligned_cols=101 Identities=26% Similarity=0.456 Sum_probs=84.8
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccce
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITV 113 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 113 (628)
+.+++.++++|++.+.||+|+||.||+|+++ .+++.||||+++... ....++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3345556789999999999999999999975 345789999997643 3345679999999999999999999999
Q ss_pred eeeccccccceeeeeecccccCCchhhhhccc
Q 042887 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+. .....+++|||+++|+|.+++....
T Consensus 85 ~~-----~~~~~~~v~e~~~~g~L~~~l~~~~ 111 (301)
T d1lufa_ 85 CA-----VGKPMCLLFEYMAYGDLNEFLRSMS 111 (301)
T ss_dssp EC-----SSSSCEEEEECCTTCBHHHHHHHTC
T ss_pred ec-----cCCceEEEEEecCCCcHHHHHHhcC
Confidence 64 4678899999999999999997654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=3.6e-14 Score=138.45 Aligned_cols=100 Identities=23% Similarity=0.379 Sum_probs=83.7
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEEC-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCccccccee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLG-----ETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITVC 114 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 114 (628)
.|....++|++.+.||+|+||.||+|++. .+++.||||+++... ......|.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 35556789999999999999999999863 456789999997643 34456799999999999 699999999996
Q ss_pred eeccccccceeeeeecccccCCchhhhhcccc
Q 042887 115 SSIDFKGVDFKALIYEYMKCGSSEDWMHQSND 146 (628)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 146 (628)
. +.+..++|||||++|++.+++.....
T Consensus 97 ~-----~~~~~~lvmE~~~~g~l~~~l~~~~~ 123 (311)
T d1t46a_ 97 T-----IGGPTLVITEYCCYGDLLNFLRRKRD 123 (311)
T ss_dssp C-----SSSSCEEEEECCTTEEHHHHHHHTTT
T ss_pred e-----eCCEEEEEEEcCCCCCHHHHHHhccc
Confidence 5 46788999999999999999976654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=9e-14 Score=132.95 Aligned_cols=86 Identities=22% Similarity=0.461 Sum_probs=69.9
Q ss_pred ceeecCCceeEEEEEEC--CCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeeee
Q 042887 54 NMIGQGSFGFVYKGKLG--ETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALIY 129 (628)
Q Consensus 54 ~~iG~G~~g~V~~~~~~--~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 129 (628)
+.||+|+||.||+|.+. .+++.||||+++.. +....+.|.+|+++|++++|||||+++++|. .+..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec------cCCEEEEE
Confidence 46999999999999874 34578999999653 2334567999999999999999999999864 24568999
Q ss_pred cccccCCchhhhhccc
Q 042887 130 EYMKCGSSEDWMHQSN 145 (628)
Q Consensus 130 e~~~~g~L~~~l~~~~ 145 (628)
|||++|+|.+++.+..
T Consensus 87 E~~~~g~L~~~l~~~~ 102 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR 102 (277)
T ss_dssp ECCTTEEHHHHHHHCT
T ss_pred EcCCCCcHHHHHhhcc
Confidence 9999999999987543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.41 E-value=7.5e-14 Score=138.84 Aligned_cols=94 Identities=24% Similarity=0.342 Sum_probs=76.9
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc---cchhhhHHHH---HHHHhhcCCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ---KGAAKSFVTE---CEALSNVRHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~ 120 (628)
.++|++.+.||+|+||.||+|++..+|+.||||++.+.. ......+.+| +.+++.++|||||++++++ +
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 468999999999999999999999999999999997532 1222334444 5667777899999999994 4
Q ss_pred ccceeeeeecccccCCchhhhhccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+....|+|||||++|+|.+++.+..
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~ 102 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHG 102 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcc
Confidence 5788999999999999999987643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=5.1e-15 Score=133.92 Aligned_cols=130 Identities=25% Similarity=0.288 Sum_probs=75.0
Q ss_pred cCccccCCCCCCeEecCCcccccccCCcccCCcchhcccceEEcCCCcCccccchhhhccCCCCEeeCcCCcCcccCCcc
Q 042887 426 IPDTLGNLTLLNRLFLGFNNLQGNVPSSLGNCQNLMTLSRLLDLSGNLLGGSIPLEVGNLRNLAEFDLSENHFSNEIPVT 505 (628)
Q Consensus 426 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 505 (628)
++..+..+++|++|++++|+|+. ++ .+.++++| +.|++++|+|+ .++..+..+++|++|++++|+++.. ..
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L----~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~ 110 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENL----RILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SG 110 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTC----CEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccc----cChhhcccccc-ccccccccccccccccccccccccc--cc
Confidence 34455566666666666666652 22 34444444 56666666665 3344444455666777777766632 23
Q ss_pred ccCCCCCCeEECcCceeeeecC-ccccCCCCCCEEECCCCcccccCch----------hhhcccCCCeEe
Q 042887 506 LSACTTLEYLHLQGNSFSGSLP-LSLKTLKSIKELDLSRNNLSGQIPK----------YLENLLFLAYLN 564 (628)
Q Consensus 506 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~----------~~~~l~~L~~L~ 564 (628)
+..+++|+.|++++|+|+.... ..+..+++|+.|++++|++....+. .+..+++|+.||
T Consensus 111 ~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 5566667777777776663221 3466677777777777766543322 255677777766
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.5e-13 Score=135.09 Aligned_cols=93 Identities=15% Similarity=0.250 Sum_probs=76.8
Q ss_pred hCCCCcCc-eeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhc-CCCCcccccceeeeccccccce
Q 042887 47 TNNFSASN-MIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNV-RHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~-~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+ .||+|+||.||+|++..+|+.||||+++. ...+.+|+.++.++ +|||||++++++.+. ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46898864 69999999999999999999999999864 24577899987665 799999999986531 223567
Q ss_pred eeeeecccccCCchhhhhccc
Q 042887 125 KALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.|+|||||+||+|.+++.+..
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~ 104 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG 104 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS
T ss_pred EEEEEECCCCCcHHHHHHhcC
Confidence 899999999999999997653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=6.8e-13 Score=114.57 Aligned_cols=106 Identities=20% Similarity=0.110 Sum_probs=90.6
Q ss_pred ceEEcCCCcCccccchhhhccCCCCEeeCcCC-cCcccCCccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCC
Q 042887 465 RLLDLSGNLLGGSIPLEVGNLRNLAEFDLSEN-HFSNEIPVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSR 543 (628)
Q Consensus 465 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (628)
+.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 56788888887 46777888999999999766 48877778899999999999999999988888899999999999999
Q ss_pred CcccccCchhhhcccCCCeEeccCCcCcc
Q 042887 544 NNLSGQIPKYLENLLFLAYLNLSYNHFEG 572 (628)
Q Consensus 544 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 572 (628)
|+|+...++.|..+ .|+.|+|++|+|..
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~C 117 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLHC 117 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCCC
T ss_pred CCCcccChhhhccc-cccccccCCCcccC
Confidence 99997666667655 69999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.4e-13 Score=132.17 Aligned_cols=96 Identities=26% Similarity=0.476 Sum_probs=78.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCC----cEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETG----TTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~----~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
+.|+..++||+|+||.||+|.+..++ ..||||+++... ......|.+|+.+|++++|||||++++++. ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence 56888899999999999999987554 469999997543 334567999999999999999999999964 36
Q ss_pred ceeeeeecccccCCchhhhhcccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
...++|||||.+|++.+++.......
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~ 107 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEF 107 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCS
T ss_pred CceEEEEEecccCcchhhhhcccccc
Confidence 78899999999999998877655444
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=5.3e-14 Score=137.01 Aligned_cols=99 Identities=24% Similarity=0.404 Sum_probs=82.4
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceee
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCS 115 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 115 (628)
+|....++|++.+.||+|+||.||+|.+.. +++.||||+++... ......|.+|+.++++++|||||++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 345556789999999999999999999842 35789999997543 344567999999999999999999999964
Q ss_pred eccccccceeeeeecccccCCchhhhhccc
Q 042887 116 SIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
.....++|||||++|++.+++....
T Consensus 94 -----~~~~~~lv~e~~~~g~l~~~~~~~~ 118 (308)
T d1p4oa_ 94 -----QGQPTLVIMELMTRGDLKSYLRSLR 118 (308)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHHH
T ss_pred -----cCCceeEEEeecCCCCHHHHHHhcc
Confidence 3678899999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.8e-13 Score=132.93 Aligned_cols=86 Identities=22% Similarity=0.409 Sum_probs=69.8
Q ss_pred cCceeecCCceeEEEEEECCCCcEEEEEEeecccc-----chhhhHHHHHHHHhhcCCCCcccccceeeeccccccceee
Q 042887 52 ASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK-----GAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
..+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++ ...+..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 35789999999999999999999999999965422 2346789999999999999999999995 4578899
Q ss_pred eeecccccCCchhhhh
Q 042887 127 LIYEYMKCGSSEDWMH 142 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~ 142 (628)
+|||||.++++.....
T Consensus 77 ivmE~~~~~~~~~~~~ 92 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD 92 (299)
T ss_dssp EEEECCSEEHHHHHTT
T ss_pred ehhhhhcchHHhhhhh
Confidence 9999999887665543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=3.3e-13 Score=131.91 Aligned_cols=96 Identities=25% Similarity=0.475 Sum_probs=76.3
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCc----EEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeecccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGT----TVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGV 122 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~----~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 122 (628)
++|++.+.||+|+||.||+|.+..+|+ .||+|.++.. .....+.|.+|+.+|++++|||||+++++|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999987776 4788887643 33456789999999999999999999999753
Q ss_pred ceeeeeecccccCCchhhhhccccccc
Q 042887 123 DFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
...++++||+.+|++.+++......++
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~ 109 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIG 109 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCC
T ss_pred CCeeEEEEeccCCcccccccccccCCC
Confidence 456889999999999998876655443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.34 E-value=5.5e-13 Score=131.31 Aligned_cols=89 Identities=18% Similarity=0.306 Sum_probs=76.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
.++|++.+.||+|+||+||+|++..+|+.||||+++... .+++.+|+++|+++. ||||+++++++.. ......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCce
Confidence 357999999999999999999999999999999987543 467889999999995 9999999998653 345678
Q ss_pred eeeecccccCCchhhh
Q 042887 126 ALIYEYMKCGSSEDWM 141 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l 141 (628)
++|||||.+|++.++.
T Consensus 108 ~~v~e~~~~~~L~~~~ 123 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY 123 (328)
T ss_dssp EEEEECCCSCBGGGTT
T ss_pred eEEEeecCCCcHHHHh
Confidence 9999999999987764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=5.1e-13 Score=129.81 Aligned_cols=92 Identities=26% Similarity=0.519 Sum_probs=75.0
Q ss_pred CceeecCCceeEEEEEECCCC---cEEEEEEeecc-ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeeee
Q 042887 53 SNMIGQGSFGFVYKGKLGETG---TTVAVKVMNLK-QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKALI 128 (628)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~---~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 128 (628)
.++||+|+||+||+|++..++ ..||||.++.. .....++|.+|+++|++++|||||++++++.+ .....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 578999999999999986643 25899999753 44556789999999999999999999998753 34678999
Q ss_pred ecccccCCchhhhhcccccc
Q 042887 129 YEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 129 ~e~~~~g~L~~~l~~~~~~~ 148 (628)
||||++|++.+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~ 127 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNP 127 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCC
T ss_pred EEEeecCchhhhhccccccc
Confidence 99999999999987655443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=3.5e-13 Score=133.98 Aligned_cols=97 Identities=19% Similarity=0.191 Sum_probs=79.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeeccccccce
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDF 124 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 124 (628)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+++.+|+++|++++|||||++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999999999999999997543 334567899999999999999999999875422223345
Q ss_pred eeeeecccccCCchhhhhc
Q 042887 125 KALIYEYMKCGSSEDWMHQ 143 (628)
Q Consensus 125 ~~lv~e~~~~g~L~~~l~~ 143 (628)
.+++|+|+.+|+|.+++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~ 115 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC 115 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT
T ss_pred eEEEEEeecCCchhhhccc
Confidence 5667788889999998854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=5.2e-13 Score=129.30 Aligned_cols=92 Identities=24% Similarity=0.410 Sum_probs=80.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||+||+|++..+|+.||||+++... .....++.+|+.+|+.++|||||++++++. .....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 57999999999999999999999999999999997543 345678999999999999999999999954 47788
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++++|++.++++..+....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~ 95 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCN 95 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT
T ss_pred eEEeeeccccccccccccc
Confidence 9999999999888776543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=2.3e-13 Score=129.78 Aligned_cols=96 Identities=28% Similarity=0.459 Sum_probs=71.2
Q ss_pred CCCCcCceeecCCceeEEEEEECCC-C--cEEEEEEeecc---ccchhhhHHHHHHHHhhcCCCCcccccceeeeccccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGET-G--TTVAVKVMNLK---QKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKG 121 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~-~--~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 121 (628)
++|++.+.||+|+||.||+|++... + ..||||+++.. .....+.|.+|+.+|++++|||||++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~------ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL------ 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe------
Confidence 5699999999999999999987533 3 36899998654 2344578999999999999999999999864
Q ss_pred cceeeeeecccccCCchhhhhccccccc
Q 042887 122 VDFKALIYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 149 (628)
....++|||||++|++.+++....+.++
T Consensus 82 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~ 109 (273)
T d1u46a_ 82 TPPMKMVTELAPLGSLLDRLRKHQGHFL 109 (273)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGSC
T ss_pred ecchheeeeeecCcchhhhhhcccCCCC
Confidence 2456899999999999988876554443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=4.9e-13 Score=133.01 Aligned_cols=93 Identities=20% Similarity=0.249 Sum_probs=75.4
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeee-ccccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSS-IDFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~~~ 123 (628)
.++|++.+.||+|+||+||+|++..+|+.||||++.... .....++.+|+.++++++|||||++++++.. ...+...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999999999999999997542 3445678999999999999999999999754 2223557
Q ss_pred eeeeeecccccCCchh
Q 042887 124 FKALIYEYMKCGSSED 139 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~ 139 (628)
..|+|||||.++.+..
T Consensus 96 ~~~iv~Ey~~~~l~~~ 111 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV 111 (355)
T ss_dssp EEEEEEECCSEEHHHH
T ss_pred eeEEEEeccchHHHHh
Confidence 8999999998765543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=4.8e-13 Score=132.76 Aligned_cols=95 Identities=23% Similarity=0.307 Sum_probs=71.7
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVD 123 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~ 123 (628)
.+.|++.+.||+|+||.||+|++..+|+.||||+++.. .....+.+.+|+++|++++|||||++++++... ......
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999999999999999999754 234456789999999999999999999997642 122345
Q ss_pred eeeeeecccccCCchhhhh
Q 042887 124 FKALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 124 ~~~lv~e~~~~g~L~~~l~ 142 (628)
.+|+||||| ++++..+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~ 114 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK 114 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH
T ss_pred eEEEEEecc-cccHHHHHH
Confidence 679999999 456666654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.32 E-value=5.6e-13 Score=128.47 Aligned_cols=89 Identities=24% Similarity=0.426 Sum_probs=76.0
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc--cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ--KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|++.+.||+|+||.||+|+++ +|+.||||+++... ....+++.+|+.+|++++|||||++++++. .....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 68999999999999999999995 78999999996643 334578999999999999999999999954 47889
Q ss_pred eeeecccccCCchhhhh
Q 042887 126 ALIYEYMKCGSSEDWMH 142 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~ 142 (628)
+++|||+.++.+..+..
T Consensus 76 ~i~~e~~~~~~~~~~~~ 92 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV 92 (286)
T ss_dssp EEEEECCSEEHHHHHHT
T ss_pred eEEEEeehhhhHHHHHh
Confidence 99999999876665544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.3e-13 Score=131.93 Aligned_cols=98 Identities=20% Similarity=0.389 Sum_probs=76.2
Q ss_pred HHHHhCCCCcCceeecCCceeEEEEEECCCC-------cEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccce
Q 042887 43 LSKATNNFSASNMIGQGSFGFVYKGKLGETG-------TTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIITV 113 (628)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 113 (628)
|....++|++.+.||+|+||.||+|++..++ ..||||+++... ......+.+|+..+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4455678999999999999999999975544 369999997653 34457789999999888 79999999999
Q ss_pred eeeccccccceeeeeecccccCCchhhhhccc
Q 042887 114 CSSIDFKGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
+. +.+..++|||||++|++.+++....
T Consensus 88 ~~-----~~~~~~~v~e~~~~g~l~~~i~~~~ 114 (299)
T d1fgka_ 88 CT-----QDGPLYVIVEYASKGNLREYLQARR 114 (299)
T ss_dssp EC-----SSSSCEEEECCCTTCBHHHHHHTTS
T ss_pred cc-----cCCeEEEEEEccCCCcHHHHHHhhc
Confidence 65 3678999999999999999997654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=5e-13 Score=127.61 Aligned_cols=92 Identities=21% Similarity=0.293 Sum_probs=76.6
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------chhhhHHHHHHHHhhcC--CCCcccccceeeeccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------GAAKSFVTECEALSNVR--HRNLIKIITVCSSIDF 119 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 119 (628)
++|++.+.||+|+||.||+|++..+|+.||||+++.... ....++.+|+.+|++++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 579999999999999999999999999999999975421 22345789999999996 89999999994
Q ss_pred cccceeeeeeccccc-CCchhhhhcc
Q 042887 120 KGVDFKALIYEYMKC-GSSEDWMHQS 144 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~-g~L~~~l~~~ 144 (628)
++....|+||||+.+ +++.+++...
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~ 104 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER 104 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc
Confidence 457889999999976 5677776543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.1e-12 Score=129.74 Aligned_cols=97 Identities=16% Similarity=0.217 Sum_probs=75.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccc-cchhhhHHHHHHHHhhcCCCCcccccceeeecccccccee
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQ-KGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
..+|++.+.||+|+||+||+|++..+|+.||||+++... ....+++.+|+.+|++++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356999999999999999999999999999999997543 3445678999999999999999999999765333333444
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
++ ++|+.+|+|.+++...
T Consensus 87 ~l-~~~~~~g~L~~~l~~~ 104 (345)
T d1pmea_ 87 YL-VTHLMGADLYKLLKTQ 104 (345)
T ss_dssp EE-EEECCCEEHHHHHHHC
T ss_pred EE-EEeecCCchhhhhhcC
Confidence 55 4567789999998643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.1e-12 Score=127.13 Aligned_cols=91 Identities=27% Similarity=0.456 Sum_probs=71.5
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHH--HHhhcCCCCcccccceeeecccccccee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECE--ALSNVRHRNLIKIITVCSSIDFKGVDFK 125 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~--~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 125 (628)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .+++.+|.+ .+..++|||||++++++.+.+ ......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence 4677889999999999999998 78999999986543 234444544 456778999999999987521 123468
Q ss_pred eeeecccccCCchhhhhcc
Q 042887 126 ALIYEYMKCGSSEDWMHQS 144 (628)
Q Consensus 126 ~lv~e~~~~g~L~~~l~~~ 144 (628)
|+|||||++|+|.+++.+.
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~ 95 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY 95 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC
T ss_pred EEEEecccCCCHHHHHhcC
Confidence 9999999999999999754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.3e-12 Score=127.11 Aligned_cols=102 Identities=20% Similarity=0.356 Sum_probs=79.3
Q ss_pred hCCCCcCceeecCCceeEEEEEECCC-CcEEEEEEeeccc--cchhhhHHHHHHHHhhc---CCCCcccccceeeecccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGET-GTTVAVKVMNLKQ--KGAAKSFVTECEALSNV---RHRNLIKIITVCSSIDFK 120 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~-~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~ 120 (628)
.++|++.+.||+|+||.||+|++.++ ++.||||+++... ......+.+|+.+|+.+ +||||+++++++.....+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999765 6679999997542 33445678899888776 699999999998654455
Q ss_pred ccceeeeeecccccCCchhhhhcccccc
Q 042887 121 GVDFKALIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
.....+++||||.+|.+...........
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~ 113 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGV 113 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCC
Confidence 6678999999999887765544433333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=6.4e-13 Score=129.80 Aligned_cols=93 Identities=23% Similarity=0.334 Sum_probs=78.8
Q ss_pred CCCCcCceeecCCceeEEEEEEC---CCCcEEEEEEeeccc----cchhhhHHHHHHHHhhcCC-CCcccccceeeeccc
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLG---ETGTTVAVKVMNLKQ----KGAAKSFVTECEALSNVRH-RNLIKIITVCSSIDF 119 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 119 (628)
++|++.+.||+|+||.||+|++. .+|+.||||++++.. ....+.+.+|+.+|++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 67999999999999999999974 468999999986532 2345678899999999976 8999999984
Q ss_pred cccceeeeeecccccCCchhhhhccc
Q 042887 120 KGVDFKALIYEYMKCGSSEDWMHQSN 145 (628)
Q Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~ 145 (628)
++....+++|||+.+|+|.+++....
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~ 124 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE 124 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS
T ss_pred ccCCceeeeeecccccHHHHHHHhcc
Confidence 44788999999999999999987554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.6e-12 Score=127.34 Aligned_cols=94 Identities=22% Similarity=0.427 Sum_probs=73.8
Q ss_pred hCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeecc--ccchhhhHHHHHHHHhhcCCCCcccccceeeecc---ccc
Q 042887 47 TNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLK--QKGAAKSFVTECEALSNVRHRNLIKIITVCSSID---FKG 121 (628)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~ 121 (628)
.++|++.+.||+|+||+||+|++..+|+.||||++... ......++.+|+.+|++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999999999999998654 3345577899999999999999999999875411 223
Q ss_pred cceeeeeecccccCCchhh
Q 042887 122 VDFKALIYEYMKCGSSEDW 140 (628)
Q Consensus 122 ~~~~~lv~e~~~~g~L~~~ 140 (628)
....|+|||||.++.+..+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~ 107 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL 107 (318)
T ss_dssp --CEEEEEECCCEEHHHHH
T ss_pred CceEEEEEeccCCCccchh
Confidence 4568999999998766544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1.7e-12 Score=125.86 Aligned_cols=104 Identities=20% Similarity=0.370 Sum_probs=81.3
Q ss_pred HHHHHHHhCCCCcCceeecCCceeEEEEEECC-----CCcEEEEEEeeccc-cchhhhHHHHHHHHhhc-CCCCcccccc
Q 042887 40 YADLSKATNNFSASNMIGQGSFGFVYKGKLGE-----TGTTVAVKVMNLKQ-KGAAKSFVTECEALSNV-RHRNLIKIIT 112 (628)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 112 (628)
...|+.+.++|++.+.||+|+||.||+|++.. +++.||||+++... ....+.+.+|..++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 34566667899999999999999999999754 34689999987543 34456788898888887 5899999998
Q ss_pred eeeeccccccceeeeeecccccCCchhhhhccccc
Q 042887 113 VCSSIDFKGVDFKALIYEYMKCGSSEDWMHQSNDK 147 (628)
Q Consensus 113 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 147 (628)
++. +.....++|||||++|+|.+++......
T Consensus 85 ~~~----~~~~~~~iv~E~~~~g~L~~~l~~~~~~ 115 (299)
T d1ywna1 85 ACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNE 115 (299)
T ss_dssp EEC----STTSCCEEEEECCTTCBHHHHHHHTGGG
T ss_pred eec----cCCCeEEEEEEecCCCcHHHHHHhcccc
Confidence 864 3456789999999999999999866543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=2.2e-12 Score=127.90 Aligned_cols=86 Identities=24% Similarity=0.425 Sum_probs=70.3
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeec-cccccceeee
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSI-DFKGVDFKAL 127 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~~~~~~l 127 (628)
+|...++||+|+||+||+|++..+|+.||||++..... ...+|+++|++++|||||++++++... ...+....|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58888999999999999999999999999999975432 234899999999999999999987642 2234556899
Q ss_pred eecccccCCch
Q 042887 128 IYEYMKCGSSE 138 (628)
Q Consensus 128 v~e~~~~g~L~ 138 (628)
|||||++|...
T Consensus 97 v~Ey~~~~~~~ 107 (350)
T d1q5ka_ 97 VLDYVPETVYR 107 (350)
T ss_dssp EEECCSEEHHH
T ss_pred EEeccCCccHH
Confidence 99999876443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.16 E-value=1.5e-11 Score=118.35 Aligned_cols=93 Identities=18% Similarity=0.264 Sum_probs=77.4
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCC-CCcccccceeeeccccccceee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRH-RNLIKIITVCSSIDFKGVDFKA 126 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~ 126 (628)
++|++.+.||+|+||.||+|++..+|+.||||+++... ..+.+.+|++.++.+.| +||+.+++++. .....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccE
Confidence 57999999999999999999999999999999886543 33567889999999975 89999988854 478889
Q ss_pred eeecccccCCchhhhhcccccc
Q 042887 127 LIYEYMKCGSSEDWMHQSNDKL 148 (628)
Q Consensus 127 lv~e~~~~g~L~~~l~~~~~~~ 148 (628)
+||||+ +|++.+++.......
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~ 98 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKF 98 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCC
T ss_pred EEEEec-CCCHHHHHHhhccch
Confidence 999998 688988887655444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.12 E-value=3.1e-11 Score=116.80 Aligned_cols=95 Identities=25% Similarity=0.367 Sum_probs=74.1
Q ss_pred CCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcCCCCcccccceeeeccccccceeee
Q 042887 48 NNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVRHRNLIKIITVCSSIDFKGVDFKAL 127 (628)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 127 (628)
++|++.+.||+|+||+||+|++..+|+.||||++.... ..+++.+|+++++.++|+++|..+..+. ......++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 56999999999999999999999999999999987543 2356889999999999887776655543 34678899
Q ss_pred eecccccCCchhhhhccccccc
Q 042887 128 IYEYMKCGSSEDWMHQSNDKLE 149 (628)
Q Consensus 128 v~e~~~~g~L~~~l~~~~~~~~ 149 (628)
||||+. |++.+.+......++
T Consensus 81 vme~~~-~~l~~~~~~~~~~~~ 101 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCSRKFS 101 (299)
T ss_dssp EEECCC-CBHHHHHHHTTTCCC
T ss_pred EEEEcC-CchhhhhhhccCCCc
Confidence 999995 566666554444443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.65 E-value=9.9e-09 Score=101.77 Aligned_cols=85 Identities=19% Similarity=0.260 Sum_probs=65.8
Q ss_pred CCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-----------CCCcccccceeeec
Q 042887 49 NFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-----------HRNLIKIITVCSSI 117 (628)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~ 117 (628)
+|++.+.||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.+++.+. |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~- 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH- 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence 49999999999999999999999999999999975432 3456788998888775 4678888887642
Q ss_pred cccccceeeeeecccccCCc
Q 042887 118 DFKGVDFKALIYEYMKCGSS 137 (628)
Q Consensus 118 ~~~~~~~~~lv~e~~~~g~L 137 (628)
+.....+++++++..+..
T Consensus 92 --~~~~~~~~~~~~~~~~~~ 109 (362)
T d1q8ya_ 92 --KGPNGVHVVMVFEVLGEN 109 (362)
T ss_dssp --EETTEEEEEEEECCCCEE
T ss_pred --ccccceeeeeeecccccc
Confidence 335566677777655543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=7.9e-10 Score=95.65 Aligned_cols=69 Identities=16% Similarity=0.056 Sum_probs=31.4
Q ss_pred cccccCCCCCCEeecccccCcccC--CcCccCCCCCCEEEeecccCcccCChhhhhCCCCCcEEecccCccc
Q 042887 203 PDSLCQLRSLNYLSISENNFSCKL--PLSIWNISSLEIISLHSNRFEGSLPLNIGFNIPNVNFLSVGQNNFT 272 (628)
Q Consensus 203 ~~~~~~l~~L~~L~Ls~N~i~~~~--p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 272 (628)
+..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.++ .++...+....+|+.|++++|.+.
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcC
Confidence 333445555555555555555321 222344555555555555554 333322222334444444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=1.6e-09 Score=93.61 Aligned_cols=86 Identities=23% Similarity=0.237 Sum_probs=53.6
Q ss_pred chhhhccCCCCEeeCcCCcCcccC--CccccCCCCCCeEECcCceeeeecCccccCCCCCCEEECCCCcccccCc-----
Q 042887 479 PLEVGNLRNLAEFDLSENHFSNEI--PVTLSACTTLEYLHLQGNSFSGSLPLSLKTLKSIKELDLSRNNLSGQIP----- 551 (628)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----- 551 (628)
+..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+..+....+|+.|++++|++.....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 334456777777777777776532 2345567777777777777774333333444567777777777765433
Q ss_pred --hhhhcccCCCeEe
Q 042887 552 --KYLENLLFLAYLN 564 (628)
Q Consensus 552 --~~~~~l~~L~~L~ 564 (628)
..+..+|+|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 2245667777665
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.43 E-value=1e-07 Score=84.74 Aligned_cols=79 Identities=16% Similarity=0.119 Sum_probs=58.2
Q ss_pred CCcCceeecCCceeEEEEEECCCCcEEEEEEeecccc------------------chhhhHHHHHHHHhhcCCCCccccc
Q 042887 50 FSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQK------------------GAAKSFVTECEALSNVRHRNLIKII 111 (628)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~ 111 (628)
+.+.+.||+|+||.||+|++. +|+.||||+++.... .....+.+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999984 789999998753210 0112345688889999999998877
Q ss_pred ceeeeccccccceeeeeecccccCCch
Q 042887 112 TVCSSIDFKGVDFKALIYEYMKCGSSE 138 (628)
Q Consensus 112 ~~~~~~~~~~~~~~~lv~e~~~~g~L~ 138 (628)
+.. ..+++|||++++...
T Consensus 81 ~~~---------~~~lvme~~~~~~~~ 98 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELY 98 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGG
T ss_pred Eec---------CCEEEEEeecccccc
Confidence 651 237999999876544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.98 E-value=2.6e-06 Score=73.26 Aligned_cols=88 Identities=13% Similarity=0.147 Sum_probs=50.4
Q ss_pred CcCcccEEEccCC-ccccc----cchhhhCCCCCCEEecccCcCccccc----ccccCCCCCCEeecccccCcccC----
Q 042887 160 NLLKLEMIDVGDN-QLIGK----FPDFIANFSALEAIDISANMLGGRIP----DSLCQLRSLNYLSISENNFSCKL---- 226 (628)
Q Consensus 160 ~l~~L~~L~Ls~n-~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~N~i~~~~---- 226 (628)
+.+.|+.|+|+++ .+... +...+...++|++|+|++|.+..... +.+...+.|++|+|++|.++...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456778888764 45432 22345566677777777777653322 23344566777777777666422
Q ss_pred CcCccCCCCCCEEEeecccCc
Q 042887 227 PLSIWNISSLEIISLHSNRFE 247 (628)
Q Consensus 227 p~~~~~l~~L~~L~L~~n~l~ 247 (628)
..++...++|++|++++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 223445556666666666544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.88 E-value=5.3e-06 Score=71.26 Aligned_cols=70 Identities=11% Similarity=0.072 Sum_probs=33.1
Q ss_pred ccCCCCCCEEEcccccceeeccc----ccccCCCCCEEEccCCcCCCcCCCCccccccccCCCCCceeecccCCcc
Q 042887 279 FSNASNLQVLDVYKNHFSGQVKI----DFNRLSNLSRLFLSKNNLGTESTSDLDFLTLLTNCSQMEMLYLNTNKFG 350 (628)
Q Consensus 279 ~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~ 350 (628)
+...++|++|++++|.+...... .+...+.|++|++++|.++..... .....+...++|+.|++++|.+.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~--~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA--RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH--HHHHHHHhCCcCCEEECCCCcCC
Confidence 44445555555555555432222 223345566666666655432111 22334455555666666555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.35 E-value=5.4e-05 Score=64.66 Aligned_cols=89 Identities=21% Similarity=0.294 Sum_probs=47.6
Q ss_pred hhccCCCCEeeCcCCcCcccC----CccccCCCCCCeEECcCceeeee----cCccccCCCCCCEEEC--CCCcccc---
Q 042887 482 VGNLRNLAEFDLSENHFSNEI----PVTLSACTTLEYLHLQGNSFSGS----LPLSLKTLKSIKELDL--SRNNLSG--- 548 (628)
Q Consensus 482 ~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~--- 548 (628)
+...+.|++|++++|.++... ...+...++++.+++++|.+... +...+...++|+.++| ++|.+..
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~ 121 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 121 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence 344556666666666654322 12233456666666666666432 2234455566765444 4555542
Q ss_pred -cCchhhhcccCCCeEeccCCcC
Q 042887 549 -QIPKYLENLLFLAYLNLSYNHF 570 (628)
Q Consensus 549 -~~~~~~~~l~~L~~L~ls~N~l 570 (628)
.+.+.+...+.|++|+++.+..
T Consensus 122 ~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 122 MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCcCEEeCcCCCC
Confidence 2333455666777777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.31 E-value=2.1e-05 Score=67.33 Aligned_cols=16 Identities=13% Similarity=0.017 Sum_probs=7.3
Q ss_pred CCCCCCEeecccccCc
Q 042887 208 QLRSLNYLSISENNFS 223 (628)
Q Consensus 208 ~l~~L~~L~Ls~N~i~ 223 (628)
..++|++|+|++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCCSCCEEECTTSCCC
T ss_pred cCCccCeeeccCCccc
Confidence 4444444444444443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=91.81 E-value=0.21 Score=44.73 Aligned_cols=93 Identities=13% Similarity=0.071 Sum_probs=63.1
Q ss_pred HHHHHhCCCCcCceeecCCceeEEEEEECCCCcEEEEEEeeccccchhhhHHHHHHHHhhcC-CCCcccccceeeecccc
Q 042887 42 DLSKATNNFSASNMIGQGSFGFVYKGKLGETGTTVAVKVMNLKQKGAAKSFVTECEALSNVR-HRNLIKIITVCSSIDFK 120 (628)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 120 (628)
+.....+.|+..+..+.|+-+.||+... +++.+.+|+...........+.+|..++..+. +--+.+++....
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----- 80 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----- 80 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence 4455567787766555555578998764 56778888887655545566788988887774 323445555532
Q ss_pred ccceeeeeecccccCCchhhh
Q 042887 121 GVDFKALIYEYMKCGSSEDWM 141 (628)
Q Consensus 121 ~~~~~~lv~e~~~~g~L~~~l 141 (628)
..+..++||++.+|..+.+..
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHT
T ss_pred cCCceEEEEEecccccccccc
Confidence 357789999999998775543
|